chr1	1005805	1005806	Body mass index
chr1	1079197	1079198	IgG glycosylation
chr1	1247493	1247494	Inflammatory bowel disease
chr1	2069171	2069172	Height
chr1	2069680	2069681	Reasoning
chr1	2205580	2205581	IgG glycosylation
chr1	2392647	2392648	Non-obstructive azoospermia
chr1	2452978	2452979	Obesity-related traits
chr1	2501337	2501338	Ulcerative colitis
chr1	2513215	2513216	Ulcerative colitis
chr1	2526745	2526746	Celiac disease
chr1	2553623	2553624	Rheumatoid arthritis
chr1	2553623	2553624	Rheumatoid arthritis
chr1	2553623	2553624	Rheumatoid arthritis
chr1	2709163	2709164	Multiple sclerosis
chr1	3083711	3083712	Migraine
chr1	3083711	3083712	Migraine
chr1	3280252	3280253	Response to statin therapy
chr1	3649561	3649562	Visceral adipose tissue adjusted for BMI
chr1	3651030	3651031	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr1	3651408	3651409	Visceral fat
chr1	3651408	3651409	Visceral fat
chr1	3669355	3669356	Obesity-related traits
chr1	3691527	3691528	Blood trace element (Cu levels)
chr1	4183005	4183006	Migraine - clinic-based
chr1	4315203	4315204	Factor VII
chr1	4444538	4444539	Obesity-related traits
chr1	4668669	4668670	Dental caries
chr1	5170711	5170712	Anthropometric traits
chr1	5354843	5354844	Major depressive disorder
chr1	5661008	5661009	Migraine with aura
chr1	5707815	5707816	Metabolite levels (MHPG)
chr1	5913620	5913621	Response to taxane treatment (placlitaxel)
chr1	6279369	6279370	QT interval
chr1	6279369	6279370	QT interval
chr1	6631430	6631431	White blood cell types
chr1	7113111	7113112	Stearic acid (18:0) plasma levels
chr1	7521584	7521585	Periodontal microbiota
chr1	7879062	7879063	Crohn's disease
chr1	8021972	8021973	Inflammatory bowel disease
chr1	8021972	8021973	Ulcerative colitis
chr1	8046671	8046672	Celiac disease
chr1	8338354	8338355	Economic and political preferences
chr1	8422675	8422676	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr1	8422675	8422676	Schizophrenia
chr1	8447721	8447722	Bone mineral density
chr1	8526141	8526142	Vitiligo
chr1	8759553	8759554	Vertical cup-disc ratio
chr1	9151324	9151325	Response to antidepressant treatment (citalopram)
chr1	9317603	9317604	Height
chr1	9408958	9408959	Response to tocilizumab in rheumatoid arthritis
chr1	9411468	9411469	Immune response to anthrax vaccine
chr1	9432389	9432390	Dental caries
chr1	10286175	10286176	Mean platelet volume
chr1	10353111	10353112	Multiple sclerosis
chr1	10385470	10385471	Hepatocellular carcinoma
chr1	10566214	10566215	Breast cancer
chr1	10566214	10566215	Breast cancer
chr1	10581657	10581658	Self-reported allergy
chr1	10638603	10638604	Optic disc size (rim)
chr1	10750431	10750432	Migraine - clinic-based
chr1	10796865	10796866	Blood pressure
chr1	10796865	10796866	Blood pressure
chr1	10799576	10799577	Systolic blood pressure
chr1	11033081	11033082	Male-pattern baldness
chr1	11046854	11046855	Ewing sarcoma
chr1	11171225	11171226	Corneal curvature
chr1	11736599	11736600	Visceral adipose tissue adjusted for BMI
chr1	11788563	11788564	Schizophrenia
chr1	11838645	11838646	Homocysteine levels
chr1	11852515	11852516	Atrial fibrillation
chr1	11856377	11856378	Homocysteine levels
chr1	11856377	11856378	Homocysteine levels
chr1	11862777	11862778	Blood pressure
chr1	11862777	11862778	Systolic blood pressure
chr1	11899032	11899033	Natriuretic peptide levels
chr1	11958722	11958723	Folate pathway vitamin levels
chr1	12046062	12046063	Platelet counts
chr1	12741239	12741240	Obesity-related traits
chr1	15339959	15339960	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel + carboplatin)
chr1	15347639	15347640	Chronic obstructive pulmonary disease-related biomarkers
chr1	15548635	15548636	Migraine
chr1	15792425	15792426	Erectile dysfunction and prostate cancer treatment
chr1	16071009	16071010	Obesity-related traits
chr1	16080170	16080171	Cardiac Troponin-T levels
chr1	16299311	16299312	Dilated cardiomyopathy
chr1	16393356	16393357	Cognitive performance
chr1	16505319	16505320	Gamma gluatamyl transferase levels
chr1	16505319	16505320	Liver enzyme levels (gamma-glutamyl transferase)
chr1	17216330	17216331	Allergic rhinitis
chr1	17306674	17306675	Height
chr1	17306674	17306675	Height
chr1	17306674	17306675	Pulmonary function
chr1	17306674	17306675	Pulmonary function (interaction)
chr1	17331675	17331676	Height
chr1	17591678	17591679	Pulmonary function (interaction)
chr1	17674536	17674537	Rheumatoid arthritis
chr1	17674536	17674537	Rheumatoid arthritis
chr1	17722362	17722363	Basal cell carcinoma
chr1	17834741	17834742	Response to hepatitis C treatment
chr1	17919816	17919817	Obesity-related traits
chr1	18244706	18244707	Obesity-related traits
chr1	18294486	18294487	Erectile dysfunction and prostate cancer treatment
chr1	18425010	18425011	Venous thromboembolism (gene x gene interaction)
chr1	18795254	18795255	Diabetic retinopathy
chr1	18979873	18979874	Orofacial clefts
chr1	18990250	18990251	Body mass index
chr1	19032271	19032272	Response to amphetamines
chr1	19139516	19139517	Parkinson's disease
chr1	19206333	19206334	Anorexia nervosa
chr1	19321494	19321495	Methotrexate phramacokinetics (acute lymphoblastic leukemia)
chr1	19332075	19332076	Methotrexate phramacokinetics (acute lymphoblastic leukemia)
chr1	19386584	19386585	Response to amphetamines
chr1	19568971	19568972	Brain structure
chr1	19718823	19718824	Crohn's disease and psoriasis
chr1	19765517	19765518	Thyroid volume
chr1	19765517	19765518	Thyroid volume
chr1	19839114	19839115	Thyroid volume
chr1	19841173	19841174	Thyroid hormone levels
chr1	19841173	19841174	Thyroid hormone levels
chr1	19841173	19841174	Thyroid hormone levels
chr1	19843353	19843354	Thyroid volume
chr1	19861105	19861106	Thyroid function
chr1	20140035	20140036	Ulcerative colitis
chr1	20142865	20142866	Ulcerative colitis
chr1	20171859	20171860	Ulcerative colitis
chr1	20171859	20171860	Ulcerative colitis
chr1	20171859	20171860	Ulcerative colitis
chr1	20171859	20171860	Ulcerative colitis
chr1	20171859	20171860	Ulcerative colitis
chr1	20200989	20200990	Ulcerative colitis
chr1	20227722	20227723	Ulcerative colitis
chr1	20455219	20455220	Obesity-related traits
chr1	21654734	21654735	Obesity-related traits
chr1	21766452	21766453	Liver enzyme levels (alkaline phosphatase)
chr1	21786067	21786068	Folate pathway vitamin levels
chr1	21786067	21786068	Folate pathway vitamin levels
chr1	21820989	21820990	Metabolic traits
chr1	21821756	21821757	Liver enzyme levels
chr1	21823291	21823292	Phosphorus levels
chr1	21837754	21837755	Adverse response to chemotherapy (neutropenia/leucopenia) (all platinum-based drugs)
chr1	21875915	21875916	Response to TNF-alpha inhibitors in rheumatoid arthritis
chr1	21890385	21890386	Folate pathway vitamin levels
chr1	21904528	21904529	Hematological and biochemical traits
chr1	22373623	22373624	Immune response to smallpox vaccine (IL-6)
chr1	22450486	22450487	Endometriosis
chr1	22485870	22485871	Endometriosis
chr1	22490723	22490724	Bone mineral density
chr1	22490723	22490724	Endometriosis
chr1	22490723	22490724	Ovarian cancer
chr1	22499529	22499530	Obesity-related traits
chr1	22573941	22573942	IgG glycosylation
chr1	22573941	22573942	Testosterone levels
chr1	22698446	22698447	Bone mineral density
chr1	22698446	22698447	Bone mineral density
chr1	22698446	22698447	Bone mineral density (hip)
chr1	22698446	22698447	Bone mineral density (hip)
chr1	22698446	22698447	Bone mineral density (spine)
chr1	22698446	22698447	Bone mineral density (spine)
chr1	22698446	22698447	Dupuytren's disease
chr1	22698446	22698447	Ulcerative colitis
chr1	22698446	22698447	Ulcerative colitis
chr1	22702230	22702231	Inflammatory bowel disease
chr1	22702857	22702858	Bone mineral density (spine)
chr1	22711472	22711473	Bone mineral density
chr1	22711472	22711473	Bone mineral density (hip)
chr1	23536890	23536891	Height
chr1	24431955	24431956	Bipolar disorder (mood-incongruent)
chr1	24519919	24519920	Psoriasis
chr1	24584489	24584490	Fasting insulin-related traits (interaction with BMI)
chr1	24626173	24626174	Adiponectin levels
chr1	25044110	25044111	Height
chr1	25193154	25193155	Alcohol dependence
chr1	25273199	25273200	Crohn's disease
chr1	25296742	25296743	IgG glycosylation
chr1	25297183	25297184	Ankylosing spondylitis
chr1	25303575	25303576	Celiac disease
chr1	25402623	25402624	IgG glycosylation
chr1	25570080	25570081	Erythrocyte sedimentation rate
chr1	25674784	25674785	Erythrocyte sedimentation rate
chr1	25768936	25768937	Cholesterol, total
chr1	25768936	25768937	Erythrocyte sedimentation rate
chr1	25775732	25775733	Cholesterol, total
chr1	25775732	25775733	LDL cholesterol
chr1	26521139	26521140	Height
chr1	26568541	26568542	Obesity-related traits
chr1	26619648	26619649	Obesity-related traits
chr1	26619648	26619649	Obesity-related traits
chr1	26650549	26650550	Obesity-related traits
chr1	26741543	26741544	Height
chr1	27731650	27731651	Estradiol plasma levels (breast cancer)
chr1	28262408	28262409	Corneal astigmatism
chr1	30185661	30185662	Prostate cancer (gene x gene interaction)
chr1	30265651	30265652	Non-alcoholic fatty liver disease
chr1	30431559	30431560	Schizophrenia
chr1	30432218	30432219	Bipolar disorder and schizophrenia
chr1	30437267	30437268	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr1	30525713	30525714	Bipolar disorder (mood-incongruent)
chr1	30567595	30567596	Smoking behavior
chr1	30627711	30627712	Attention deficit hyperactivity disorder and conduct disorder
chr1	31315592	31315593	Metabolite levels (5-HIAA)
chr1	31883924	31883925	Alcohol dependence
chr1	33928757	33928758	Estradiol plasma levels (breast cancer)
chr1	33983018	33983019	Metabolite levels (HVA/MHPG ratio)
chr1	34173819	34173820	Response to amphetamines
chr1	34248063	34248064	Brain structure
chr1	34359857	34359858	Attention deficit hyperactivity disorder
chr1	34750935	34750936	Epilepsy (generalized)
chr1	34989236	34989237	Visceral adipose tissue adjusted for BMI
chr1	35289038	35289039	Formal thought disorder in schizophrenia
chr1	35687814	35687815	Endometrial cancer
chr1	35908450	35908451	Systemic lupus erythematosus and Systemic sclerosis
chr1	36571919	36571920	Corneal structure
chr1	36904719	36904720	Diabetic retinopathy
chr1	37162351	37162352	Schizophrenia
chr1	37958812	37958813	Hemostatic factors and hematological phenotypes
chr1	38092722	38092723	Axial length
chr1	38196840	38196841	Prostate cancer (gene x gene interaction)
chr1	38247152	38247153	Cognitive performance
chr1	38279986	38279987	Hypothyroidism
chr1	38602072	38602073	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr1	38624128	38624129	Rheumatoid arthritis
chr1	38721662	38721663	Waist-to-hip circumference ratio (interaction)
chr1	39380384	39380385	Menopause (age at onset)
chr1	40028179	40028180	HDL cholesterol
chr1	40064960	40064961	C-reactive protein
chr1	40069938	40069939	Red blood cell traits
chr1	40132794	40132795	Amyotrophic lateral sclerosis
chr1	40433770	40433771	PR interval
chr1	41239510	41239511	Platelet counts
chr1	41530870	41530871	Height
chr1	41688937	41688938	Height
chr1	41745769	41745770	Height
chr1	41839821	41839822	Bipolar disorder
chr1	42297123	42297124	Bronchopulmonary dysplasia
chr1	43596383	43596384	Cardiac hypertrophy
chr1	43645410	43645411	Telomere length
chr1	44005279	44005280	Amyotrophic lateral sclerosis (age of onset)
chr1	44117005	44117006	Hypertension risk in short sleep duration
chr1	44129778	44129779	Amyotrophic lateral sclerosis (age of onset)
chr1	44215827	44215828	Aging (time to event)
chr1	44319372	44319373	Amyotrophic lateral sclerosis (age of onset)
chr1	45978674	45978675	Homocysteine levels
chr1	47179309	47179310	Response to hepatitis C treatment
chr1	47284922	47284923	Testosterone levels
chr1	47404185	47404186	Metabolic traits
chr1	47918820	47918821	Response to antidepressant treatment
chr1	48009996	48009997	Response to amphetamines
chr1	48025062	48025063	Obesity-related traits
chr1	48098405	48098406	Adverse response to chemotherapy (neutropenia/leucopenia) (etoposide)
chr1	48254781	48254782	Obesity-related traits
chr1	48321220	48321221	White matter integrity
chr1	50607028	50607029	Obesity-related traits
chr1	50937847	50937848	Depression and alcohol dependence
chr1	51546139	51546140	Ventricular conduction
chr1	51859241	51859242	IgE grass sensitization
chr1	53581669	53581670	Hippocampal atrophy
chr1	53629584	53629585	Systemic lupus erythematosus
chr1	53777630	53777631	Body mass index (interaction)
chr1	53871084	53871085	Chronic obstructive pulmonary disease
chr1	53958602	53958603	Nicotine use
chr1	53978118	53978119	Response to statin therapy
chr1	54320336	54320337	Nonalcoholic fatty liver disease
chr1	54375569	54375570	Multiple myeloma (hyperdiploidy)
chr1	54375569	54375570	Thyroid hormone levels
chr1	54375569	54375570	Thyroid hormone levels
chr1	54375569	54375570	Thyroid hormone levels
chr1	54668277	54668278	Migraine
chr1	55107018	55107019	Non-substance related behavioral disinhibition
chr1	55496038	55496039	Coronary heart disease
chr1	55496038	55496039	LDL cholesterol
chr1	55496038	55496039	LDL cholesterol
chr1	55496038	55496039	LDL cholesterol
chr1	55496038	55496039	Myocardial infarction (early onset)
chr1	55504649	55504650	Cholesterol, total
chr1	55504649	55504650	LDL cholesterol
chr1	55505646	55505647	LDL cholesterol
chr1	55505646	55505647	Response to statin therapy (LDL-C)
chr1	55512994	55512995	Wilms tumor
chr1	55625547	55625548	LDL cholesterol
chr1	55742836	55742837	Coronary heart disease
chr1	55958029	55958030	Metabolite levels
chr1	56060950	56060951	Inflammatory biomarkers
chr1	56108603	56108604	Paclitaxel-induced neuropathy
chr1	56112773	56112774	Adverse response to chemotherapy in breast cancer (alopecia) (docetaxel)
chr1	56116504	56116505	Lipid metabolism phenotypes
chr1	56359812	56359813	Airflow obstruction
chr1	56850685	56850686	AB1-42
chr1	56962820	56962821	Coronary heart disease
chr1	56966349	56966350	Coronary heart disease
chr1	56966349	56966350	Coronary heart disease
chr1	57126918	57126919	Lymphocyte counts
chr1	57243453	57243454	Resistin levels
chr1	57269520	57269521	Obesity-related traits
chr1	57625931	57625932	Pubertal anthropometrics
chr1	58319827	58319828	Bulimia nervosa
chr1	58757914	58757915	Kawasaki disease
chr1	59036624	59036625	Word reading
chr1	59162147	59162148	Diabetic retinopathy
chr1	59325625	59325626	Cognitive performance
chr1	59762467	59762468	Obesity-related traits
chr1	59799160	59799161	Response to antipsychotic therapy (extrapyramidal side effects)
chr1	59853318	59853319	Obesity-related traits
chr1	60084515	60084516	Neutrophil count
chr1	60691587	60691588	Periodontitis (PAL4Q3)
chr1	61041874	61041875	Response to tocilizumab in rheumatoid arthritis
chr1	61059258	61059259	Bipolar disorder
chr1	61059258	61059259	Bipolar disorder
chr1	61095557	61095558	Bipolar disorder
chr1	61205468	61205469	Phospholipid levels (plasma)
chr1	61620495	61620496	Thyroid hormone levels
chr1	61620495	61620496	Thyroid hormone levels
chr1	61620495	61620496	Thyroid hormone levels
chr1	61791862	61791863	Celiac disease
chr1	61815798	61815799	Bipolar disorder
chr1	61873676	61873677	Ventricular conduction
chr1	61897966	61897967	Electrocardiographic conduction measures
chr1	62380297	62380298	Obesity-related traits
chr1	62380297	62380298	Obesity-related traits
chr1	62380297	62380298	Obesity-related traits
chr1	62380297	62380298	Obesity-related traits
chr1	62380297	62380298	Obesity-related traits
chr1	62380297	62380298	Obesity-related traits
chr1	62380297	62380298	Obesity-related traits
chr1	62380297	62380298	Obesity-related traits
chr1	62380297	62380298	Obesity-related traits
chr1	62380297	62380298	Obesity-related traits
chr1	62380297	62380298	Obesity-related traits
chr1	62931631	62931632	Lipid metabolism phenotypes
chr1	62931631	62931632	Triglycerides
chr1	62950857	62950858	Metabolite levels
chr1	62969401	62969402	Lipid metabolism phenotypes
chr1	62996837	62996838	Triglycerides
chr1	63025941	63025942	Cholesterol, total
chr1	63025941	63025942	LDL cholesterol
chr1	63025941	63025942	Triglycerides
chr1	63049592	63049593	Triglycerides
chr1	63118195	63118196	Cholesterol, total
chr1	63118195	63118196	LDL cholesterol
chr1	63118195	63118196	Lipid metabolism phenotypes
chr1	63118195	63118196	Lipid metabolism phenotypes
chr1	63118195	63118196	Lipid metabolism phenotypes
chr1	63118195	63118196	Lipid metabolism phenotypes
chr1	63118195	63118196	Lipid metabolism phenotypes
chr1	63118195	63118196	Lipid metabolism phenotypes
chr1	63118195	63118196	Triglycerides
chr1	63118195	63118196	Triglycerides
chr1	63191776	63191777	Triglycerides
chr1	63480729	63480730	Body mass index
chr1	63480729	63480730	Weight
chr1	63591128	63591129	Blood pressure
chr1	64108770	64108771	Type 1 diabetes
chr1	64127467	64127468	Alcohol consumption (transferrin glycosylation)
chr1	64868351	64868352	Bilirubin levels
chr1	65515532	65515533	Estradiol plasma levels (breast cancer)
chr1	65695929	65695930	Venous thromboembolism (gene x gene interaction)
chr1	65815658	65815659	Anticoagulant levels
chr1	65979279	65979280	Obesity (early onset extreme)
chr1	65992624	65992625	Soluble leptin receptor levels
chr1	66086193	66086194	C-reactive protein
chr1	66089781	66089782	C-reactive protein
chr1	66102256	66102257	C-reactive protein
chr1	66105943	66105944	C-reactive protein
chr1	66117828	66117829	Fibrinogen
chr1	66161460	66161461	C-reactive protein
chr1	66169678	66169679	Metabolic traits
chr1	66279124	66279125	Economic and political preferences (feminism/equality)
chr1	66310864	66310865	Echocardiographic traits
chr1	66762465	66762466	Acute lymphoblastic leukemia (childhood)
chr1	66769099	66769100	Acute lymphoblastic leukemia (childhood)
chr1	67046125	67046126	Menopause (age at onset)
chr1	67123056	67123057	Presence of antiphospholipid antibodies
chr1	67597118	67597119	Leprosy
chr1	67648595	67648596	Crohn's disease
chr1	67675515	67675516	Crohn's disease
chr1	67681668	67681669	Crohn's disease
chr1	67681668	67681669	Inflammatory bowel disease
chr1	67694201	67694202	Psoriasis
chr1	67694201	67694202	Ulcerative colitis
chr1	67702525	67702526	Crohn's disease
chr1	67702525	67702526	Crohn's disease
chr1	67705957	67705958	Ankylosing spondylitis
chr1	67705957	67705958	Ankylosing spondylitis
chr1	67705957	67705958	Crohn's disease
chr1	67705957	67705958	Crohn's disease
chr1	67705957	67705958	Crohn's disease
chr1	67705957	67705958	Crohn's disease
chr1	67705957	67705958	Crohn's disease
chr1	67705957	67705958	Inflammatory bowel disease
chr1	67705957	67705958	Inflammatory bowel disease
chr1	67705957	67705958	Inflammatory bowel disease
chr1	67705957	67705958	Psoriasis
chr1	67705957	67705958	Ulcerative colitis
chr1	67705957	67705958	Ulcerative colitis
chr1	67705957	67705958	Ulcerative colitis
chr1	67725119	67725120	Ulcerative colitis
chr1	67753507	67753508	Behcet's disease
chr1	67760139	67760140	Behcet's disease
chr1	67822376	67822377	Primary biliary cirrhosis
chr1	67822376	67822377	Primary biliary cirrhosis
chr1	68105452	68105453	Response to irinotecan and platinum-based chemotherapy in non-small-cell lung cancer
chr1	68633923	68633924	Adverse response to chemotherapy (neutropenia/leucopenia) (all anthracycline-based drugs)
chr1	68635074	68635075	Bone mineral density (spine)
chr1	68635389	68635390	Bone mineral density (hip)
chr1	68647715	68647716	Bone mineral density
chr1	68785212	68785213	Airflow obstruction
chr1	68927512	68927513	IgG glycosylation
chr1	68927512	68927513	IgG glycosylation
chr1	68927512	68927513	IgG glycosylation
chr1	68927512	68927513	IgG glycosylation
chr1	68927512	68927513	IgG glycosylation
chr1	69579251	69579252	Attention deficit hyperactivity disorder
chr1	69579251	69579252	Inattentive symptoms
chr1	69684996	69684997	Inattentive symptoms
chr1	70154440	70154441	Orofacial clefts
chr1	70154440	70154441	Orofacial clefts
chr1	70335681	70335682	Hypertension risk in short sleep duration
chr1	70355980	70355981	Attention deficit hyperactivity disorder
chr1	70404539	70404540	Obesity-related traits
chr1	70887098	70887099	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+doxorubicin+/-5FU)
chr1	70921172	70921173	Antipsychotic-induced QTc interval prolongation
chr1	70995561	70995562	Inflammatory bowel disease
chr1	71443149	71443150	IgG glycosylation
chr1	72071128	72071129	Hemostatic factors and hematological phenotypes
chr1	72274472	72274473	Systemic lupus erythematosus
chr1	72751184	72751185	Obesity
chr1	72751184	72751185	Obesity (early onset extreme)
chr1	72765115	72765116	Body mass index
chr1	72765115	72765116	Body mass index
chr1	72765115	72765116	Obesity
chr1	72765115	72765116	Weight
chr1	72812439	72812440	Body mass index
chr1	72812439	72812440	Body mass index
chr1	72823712	72823713	Subcutaneous adipose tissue
chr1	72837238	72837239	Obesity
chr1	72838405	72838406	Body mass index
chr1	72838528	72838529	Obesity (early onset extreme)
chr1	73824908	73824909	Schizophrenia
chr1	74054059	74054060	Cardiac Troponin-T levels
chr1	74339166	74339167	Bipolar disorder and schizophrenia
chr1	74991401	74991402	Obesity
chr1	74991643	74991644	Body mass index
chr1	74991643	74991644	Body mass index
chr1	74993062	74993063	Obesity
chr1	74993062	74993063	Pubertal anthropometrics
chr1	75235316	75235317	Resistin levels
chr1	75298781	75298782	Visceral fat
chr1	75770624	75770625	Capecitabine sensitivity
chr1	75913825	75913826	MRI atrophy measures
chr1	76106674	76106675	Metabolic traits
chr1	76106674	76106675	Metabolite levels
chr1	76477206	76477207	Pubertal anthropometrics
chr1	76484013	76484014	Personality dimensions
chr1	76772327	76772328	Acute lymphoblastic leukemia (childhood)
chr1	76899463	76899464	Liver enzyme levels (alanine transaminase)
chr1	76899463	76899464	Liver enzyme levels (aspartate transaminase)
chr1	78048330	78048331	Obesity
chr1	78623625	78623626	Crohn's disease
chr1	78623625	78623626	Height
chr1	78987301	78987302	IgG glycosylation
chr1	79176867	79176868	IgG glycosylation
chr1	79227955	79227956	Anorexia nervosa
chr1	79238014	79238015	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr1	79238014	79238015	Bipolar disorder
chr1	79254761	79254762	Bipolar disorder
chr1	79263804	79263805	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr1	79509108	79509109	IgG glycosylation
chr1	79509108	79509109	IgG glycosylation
chr1	79509108	79509109	IgG glycosylation
chr1	80000647	80000648	Obesity-related traits
chr1	80134122	80134123	Bipolar disorder and schizophrenia
chr1	80243000	80243001	Endometriosis
chr1	80477879	80477880	Obesity-related traits
chr1	80734580	80734581	Aging (time to event)
chr1	80911113	80911114	Estradiol plasma levels (breast cancer)
chr1	82074851	82074852	Bilirubin levels
chr1	82247247	82247248	Temperament
chr1	82765051	82765052	Obesity-related traits
chr1	83054798	83054799	Response to taxane treatment (docetaxel)
chr1	83311834	83311835	Response to antipsychotic treatment
chr1	83489843	83489844	HIV-associated dementia
chr1	84232747	84232748	Obesity-related traits
chr1	84254550	84254551	Select biomarker traits
chr1	84254734	84254735	Alzheimer's disease
chr1	84387631	84387632	Obesity-related traits
chr1	84622512	84622513	Breast cancer (male)
chr1	84761347	84761348	Metabolic syndrome
chr1	84792972	84792973	Obesity-related traits
chr1	84865229	84865230	Response to hepatitis C treatment
chr1	84868960	84868961	IgG glycosylation
chr1	85226298	85226299	Dental caries
chr1	85268242	85268243	Lipoprotein-associated phospholipase A2 activity change in response to statin therapy
chr1	85290408	85290409	Economic and political preferences (time)
chr1	85311191	85311192	Type 1 diabetes
chr1	85531710	85531711	Venous thromboembolism (gene x gene interaction)
chr1	85772008	85772009	Multiple sclerosis
chr1	87051200	87051201	IgG glycosylation
chr1	87051200	87051201	IgG glycosylation
chr1	87051200	87051201	IgG glycosylation
chr1	87613357	87613358	Smoking behavior
chr1	87705030	87705031	White blood cell types
chr1	88132379	88132380	Response to TNF antagonist treatment
chr1	88625635	88625636	Periodontal microbiota
chr1	88651770	88651771	Serum protein levels (sST2)
chr1	88802011	88802012	Cognitive test performance
chr1	89123442	89123443	Height
chr1	89146233	89146234	Liver enzyme levels (gamma-glutamyl transferase)
chr1	89341407	89341408	Obesity-related traits
chr1	90022795	90022796	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel + carboplatin)
chr1	90025518	90025519	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel)
chr1	90539763	90539764	Brain structure (hippocampal volume)
chr1	90875887	90875888	Response to antidepressants
chr1	90943906	90943907	Coronary artery calcification
chr1	91288129	91288130	Pulmonary function decline
chr1	91569688	91569689	Metabolic syndrome
chr1	92077096	92077097	Optic disc parameters
chr1	92077096	92077097	Optic disc parameters
chr1	92077096	92077097	Optic disc size (disc)
chr1	92194321	92194322	Type 2 diabetes
chr1	92211019	92211020	Bone mineral density
chr1	92554282	92554283	Obesity-related traits
chr1	93009437	93009438	Cholesterol, total
chr1	93148376	93148377	Multiple sclerosis
chr1	93303602	93303603	Multiple sclerosis
chr1	93303602	93303603	Multiple sclerosis
chr1	93323970	93323971	Height
chr1	93401836	93401837	Bipolar disorder and schizophrenia
chr1	94462768	94462769	Dialysis-related mortality
chr1	94533013	94533014	Palmitoleic acid (16:1n-7) plasma levels
chr1	94553437	94553438	Orofacial clefts
chr1	94553437	94553438	Orofacial clefts
chr1	94611299	94611300	D-dimer levels
chr1	94674725	94674726	Thiazide-induced adverse metabolic effects in hypertensive patients
chr1	94721659	94721660	IgG glycosylation
chr1	95052475	95052476	End-stage coagulation
chr1	95053352	95053353	D-dimer levels
chr1	95070040	95070041	Type 2 diabetes
chr1	95081444	95081445	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+epirubicin+/-5FU)
chr1	95334186	95334187	Metabolite levels (Dihydroxy docosatrienoic acid)
chr1	95387207	95387208	Stearic acid (18:0) plasma levels
chr1	95485824	95485825	Palmitic acid (16:0) plasma levels
chr1	95515636	95515637	Stearic acid (18:0) plasma levels
chr1	95549535	95549536	Phospholipid levels (plasma)
chr1	95692309	95692310	Non-alcoholic fatty liver disease histology (AST)
chr1	95697528	95697529	Stearic acid (18:0) plasma levels
chr1	96145967	96145968	Pain
chr1	96943993	96943994	Weight
chr1	96944796	96944797	Body mass index
chr1	97037082	97037083	Body mass index
chr1	97113914	97113915	Schizophrenia
chr1	97164342	97164343	Schizophrenia
chr1	97819666	97819667	Platelet counts
chr1	98502933	98502934	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr1	98502933	98502934	Schizophrenia
chr1	98552831	98552832	Schizophrenia
chr1	98552831	98552832	Schizophrenia
chr1	99177252	99177253	Proinsulin levels
chr1	99348835	99348836	Dental caries
chr1	99386292	99386293	Dental caries
chr1	99453286	99453287	Obesity-related traits
chr1	99524046	99524047	Myopia (pathological)
chr1	99524046	99524047	Obesity-related traits
chr1	99589378	99589379	Adverse response to chemotherapy (neutropenia/leucopenia) (all topoisomerase inhibitors)
chr1	99589378	99589379	Adverse response to chemotherapy (neutropenia/leucopenia) (camptothecin)
chr1	99782956	99782957	Non-alcoholic fatty liver disease histology (other)
chr1	100049784	100049785	Aortic root size
chr1	100268990	100268991	White matter integrity (interaction)
chr1	100335976	100335977	Pulmonary function decline
chr1	101331535	101331536	Multiple sclerosis
chr1	101331535	101331536	Multiple sclerosis
chr1	101407518	101407519	Multiple sclerosis
chr1	101540998	101540999	QT interval (interaction)
chr1	101551925	101551926	Response to antipsychotic treatment
chr1	101938476	101938477	Bipolar disorder
chr1	103133908	103133909	Protein quantitative trait loci
chr1	103379917	103379918	Glaucoma (primary open-angle)
chr1	103459536	103459537	Bone mineral density
chr1	104019630	104019631	Obesity-related traits
chr1	104598940	104598941	Obesity-related traits
chr1	104598940	104598941	Obesity-related traits
chr1	104598940	104598941	Obesity-related traits
chr1	104852737	104852738	Glaucoma (primary open-angle)
chr1	106430286	106430287	Waist-to-hip circumference ratio (interaction)
chr1	106640942	106640943	Obesity (early onset extreme)
chr1	107336300	107336301	Non-obstructive azoospermia
chr1	107432575	107432576	Working memory
chr1	107463642	107463643	Intelligence
chr1	107546374	107546375	Sex hormone-binding globulin levels
chr1	107546374	107546375	Sex hormone-binding globulin levels
chr1	107577831	107577832	AIDS
chr1	107830857	107830858	Anorexia nervosa
chr1	108302921	108302922	Adverse response to chemotherapy (neutropenia/leucopenia) (cisplatin)
chr1	108366015	108366016	Hypothyroidism
chr1	109392836	109392837	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)
chr1	109417678	109417679	Fat distribution (HIV)
chr1	109417678	109417679	Fat distribution (HIV)
chr1	109417678	109417679	Fat distribution (HIV)
chr1	109817191	109817192	Lipoprotein-associated phospholipase A2 activity and mass
chr1	109817589	109817590	Coronary heart disease
chr1	109817589	109817590	LDL cholesterol
chr1	109817589	109817590	Lipoprotein-associated phospholipase A2 activity and mass
chr1	109817837	109817838	Cardiovascular disease risk factors
chr1	109817837	109817838	LDL cholesterol
chr1	109818305	109818306	Cholesterol, total
chr1	109818305	109818306	LDL cholesterol
chr1	109818529	109818530	Cholesterol, total
chr1	109818529	109818530	Coronary heart disease
chr1	109818529	109818530	LDL cholesterol
chr1	109818529	109818530	LDL cholesterol
chr1	109818529	109818530	LDL cholesterol
chr1	109818529	109818530	Lipid metabolism phenotypes
chr1	109818529	109818530	Lipid metabolism phenotypes
chr1	109818529	109818530	Lipid metabolism phenotypes
chr1	109818529	109818530	Lipid metabolism phenotypes
chr1	109818529	109818530	Myocardial infarction (early onset)
chr1	109818529	109818530	Progranulin levels
chr1	109818529	109818530	Response to statin therapy
chr1	109822165	109822166	Coronary heart disease
chr1	109822165	109822166	Coronary heart disease
chr1	109822165	109822166	LDL cholesterol
chr1	109822165	109822166	LDL cholesterol
chr1	109822165	109822166	LDL cholesterol
chr1	109822165	109822166	Lipoprotein-associated phospholipase A2 activity and mass
chr1	109822165	109822166	Metabolite levels
chr1	109999837	109999838	Chronic kidney disease
chr1	110031187	110031188	Major depressive disorder
chr1	110042443	110042444	Obesity-related traits
chr1	110082885	110082886	Stearic acid (18:0) plasma levels
chr1	110119731	110119732	Major depressive disorder
chr1	110147320	110147321	Obesity
chr1	110352476	110352477	Paget's disease
chr1	110366082	110366083	Paget's disease
chr1	110405270	110405271	Sensory disturbances after bilateral sagittal split ramus osteotomy
chr1	110439479	110439480	Obesity-related traits
chr1	110645326	110645327	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr1	110770222	110770223	Self-rated health
chr1	111033808	111033809	Immune reponse to smallpox (secreted IFN-alpha)
chr1	111237684	111237685	Panic disorder
chr1	111417914	111417915	Cytomegalovirus antibody response
chr1	111463623	111463624	Obesity-related traits
chr1	111684275	111684276	Liver enzyme levels (gamma-glutamyl transferase)
chr1	112107668	112107669	Obesity-related traits
chr1	112107668	112107669	Obesity-related traits
chr1	112107668	112107669	Obesity-related traits
chr1	112192121	112192122	Osteoporosis
chr1	112392359	112392360	Immune reponse to smallpox (secreted IFN-alpha)
chr1	112437343	112437344	Visceral adipose tissue adjusted for BMI
chr1	112464375	112464376	Cardiac repolarization
chr1	112856569	112856570	Cognitive performance
chr1	113190806	113190807	Blood pressure
chr1	113190806	113190807	Blood pressure
chr1	113216542	113216543	Blood pressure
chr1	113216542	113216543	Diastolic blood pressure
chr1	113216542	113216543	Hypertension
chr1	113216542	113216543	Systolic blood pressure
chr1	113313562	113313563	Hyperactive-impulsive symptoms
chr1	114226142	114226143	Bulimia nervosa
chr1	114303807	114303808	Crohn's disease
chr1	114303807	114303808	Hypothyroidism
chr1	114303807	114303808	Rheumatoid arthritis
chr1	114303807	114303808	Rheumatoid arthritis
chr1	114303807	114303808	Type 1 diabetes
chr1	114303807	114303808	Type 1 diabetes
chr1	114303807	114303808	Type 1 diabetes
chr1	114377567	114377568	Crohn's disease
chr1	114377567	114377568	Crohn's disease
chr1	114377567	114377568	Myasthenia gravis
chr1	114377567	114377568	Rheumatoid arthritis
chr1	114377567	114377568	Rheumatoid arthritis
chr1	114377567	114377568	Rheumatoid arthritis
chr1	114377567	114377568	Rheumatoid arthritis
chr1	114377567	114377568	Type 1 diabetes
chr1	114377567	114377568	Type 1 diabetes
chr1	114377567	114377568	Type 1 diabetes
chr1	114377567	114377568	Type 1 diabetes autoantibodies
chr1	114377567	114377568	Vitiligo
chr1	114444593	114444594	Obesity-related traits
chr1	114448388	114448389	Breast cancer
chr1	114607363	114607364	Obesity-related traits
chr1	114670968	114670969	Breast cancer (prognosis)
chr1	114677947	114677948	Illicit drug use
chr1	114715583	114715584	Bipolar disorder and schizophrenia
chr1	115677945	115677946	Migraine
chr1	115677945	115677946	Migraine without aura
chr1	115734090	115734091	Alcoholism (heaviness of drinking)
chr1	115875644	115875645	Bipolar disorder and schizophrenia
chr1	115921354	115921355	Non-alcoholic fatty liver disease
chr1	116310966	116310967	Ventricular conduction
chr1	116740449	116740450	Word reading
chr1	117038286	117038287	Multiple sclerosis
chr1	117100956	117100957	Multiple sclerosis
chr1	117100956	117100957	Multiple sclerosis
chr1	117104214	117104215	Multiple sclerosis
chr1	117104214	117104215	Multiple sclerosis
chr1	117129710	117129711	Asthma (childhood onset)
chr1	117469780	117469781	Erectile dysfunction and prostate cancer treatment
chr1	117751364	117751365	Arthritis (juvenile idiopathic)
chr1	118816728	118816729	Obesity-related traits
chr1	118855586	118855587	Height
chr1	118864615	118864616	Height
chr1	118868404	118868405	Height
chr1	118883972	118883973	Height
chr1	118902977	118902978	Congenital heart malformation
chr1	119503842	119503843	Waist-hip ratio
chr1	120255125	120255126	Metabolite levels
chr1	120257575	120257576	Metabolic traits
chr1	120451189	120451190	Crohn's disease
chr1	120517958	120517959	Type 2 diabetes
chr1	121200489	121200490	Hip geometry
chr1	121280612	121280613	Breast cancer
chr1	121280612	121280613	Breast cancer
chr1	144992180	144992181	Capecitabine sensitivity
chr1	145645605	145645606	Epilepsy (remission after treatment)
chr1	145723644	145723645	Urate levels
chr1	145723738	145723739	Urate levels
chr1	145725688	145725689	Uric acid levels
chr1	146560563	146560564	AIDS progression
chr1	146854835	146854836	Protein quantitative trait loci
chr1	146854835	146854836	Protein quantitative trait loci
chr1	147020455	147020456	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+doxorubicin+/-5FU)
chr1	147083113	147083114	Schizophrenia (negative symptoms)
chr1	147226790	147226791	Cognitive performance
chr1	149892871	149892872	Height
chr1	149892871	149892872	Height
chr1	149906412	149906413	Height
chr1	149914356	149914357	Obesity-related traits
chr1	150278388	150278389	Illicit drug use
chr1	150324283	150324284	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr1	150860470	150860471	Melanoma
chr1	150940624	150940625	Rhegmatogenous retinal detachment
chr1	150950061	150950062	Urate levels
chr1	150951476	150951477	Chronic kidney disease
chr1	150961868	150961869	Melanoma
chr1	151344740	151344741	Blood trace element (Cu levels)
chr1	151801679	151801680	Inflammatory bowel disease
chr1	151895092	151895093	Hair morphology
chr1	152037514	152037515	Hair morphology
chr1	152062766	152062767	Common traits (Other)
chr1	152083324	152083325	Hair morphology
chr1	152300816	152300817	Atopic dermatitis
chr1	152316589	152316590	Personality dimensions
chr1	152318160	152318161	Eating disorders
chr1	152442288	152442289	Atopic dermatitis
chr1	152454590	152454591	Hair morphology
chr1	152487916	152487917	Obesity-related traits
chr1	152492558	152492559	Asthma
chr1	152493153	152493154	Common traits (Other)
chr1	152537953	152537954	Response to antipsychotic treatment
chr1	152550017	152550018	Psoriasis
chr1	152551275	152551276	Psoriasis
chr1	153479997	153479998	Hippocampal atrophy
chr1	153640826	153640827	Multiple myeloma (IgH translocation)
chr1	153640826	153640827	Multiple myeloma (IgH translocation)
chr1	153769399	153769400	Lentiform nucleus volume
chr1	153774275	153774276	Conduct disorder (symptom count)
chr1	153848995	153848996	Lentiform nucleus volume
chr1	153913769	153913770	Lentiform nucleus volume
chr1	153939129	153939130	Lentiform nucleus volume
chr1	154418878	154418879	C-reactive protein
chr1	154426263	154426264	Asthma
chr1	154426263	154426264	C-reactive protein
chr1	154426263	154426264	Fibrinogen
chr1	154426263	154426264	Protein quantitative trait loci
chr1	154426263	154426264	Pulmonary function
chr1	154426969	154426970	C-reactive protein
chr1	154426969	154426970	Fibrinogen
chr1	154437895	154437896	Coronary heart disease
chr1	154754193	154754194	Obesity-related traits
chr1	154754193	154754194	Obesity-related traits
chr1	154814267	154814268	Atrial fibrillation
chr1	154814352	154814353	Atrial fibrillation
chr1	154834182	154834183	Prostate cancer
chr1	155098904	155098905	Obesity-related traits
chr1	155108166	155108167	Parkinson's disease
chr1	155126947	155126948	Liver enzyme levels (gamma-glutamyl transferase)
chr1	155151492	155151493	Urate levels
chr1	155162066	155162067	Esophageal cancer and gastric cancer
chr1	155162066	155162067	Magnesium levels
chr1	155194979	155194980	Renal function-related traits (BUN)
chr1	155230130	155230131	Crohn's disease
chr1	155868624	155868625	Conduct disorder (interaction)
chr1	155878731	155878732	Inflammatory bowel disease
chr1	155927751	155927752	Amyotrophic lateral sclerosis (age of onset)
chr1	156030036	156030037	Parkinson's disease
chr1	156169609	156169610	Testicular germ cell tumor
chr1	156255455	156255456	mean corpuscular hemoglobin concentration
chr1	156341493	156341494	Visceral adipose tissue adjusted for BMI
chr1	156356479	156356480	Subcutaneous adipose tissue
chr1	156446241	156446242	Migraine
chr1	156446241	156446242	Migraine - clinic-based
chr1	156456300	156456301	Migraine
chr1	156869046	156869047	Platelet aggregation
chr1	156869046	156869047	Platelet aggregation
chr1	157130565	157130566	Attention deficit hyperactivity disorder and conduct disorder
chr1	157437509	157437510	Renal sinus fat
chr1	157669277	157669278	Graves' disease
chr1	157669277	157669278	Multiple sclerosis
chr1	157670815	157670816	Type 1 diabetes autoantibodies
chr1	158058108	158058109	Obesity-related traits
chr1	158575728	158575729	Red blood cell traits
chr1	158585414	158585415	Glycated hemoglobin levels
chr1	158612547	158612548	Other erythrocyte phenotypes
chr1	158932554	158932555	Asthma
chr1	158971085	158971086	Hematology traits
chr1	159002221	159002222	Obesity-related traits
chr1	159005648	159005649	Celiac disease and Rheumatoid arthritis
chr1	159147451	159147452	Inflammatory biomarkers
chr1	159148512	159148513	Select biomarker traits
chr1	159173886	159173887	Lean body mass and age at menarche (combined)
chr1	159174682	159174683	Neutrophil count
chr1	159174682	159174683	White blood cell count
chr1	159175353	159175354	Inflammatory biomarkers
chr1	159175353	159175354	Obesity-related traits
chr1	159175353	159175354	White blood cell count
chr1	159175526	159175527	IgE levels
chr1	159196764	159196765	Select biomarker traits
chr1	159218265	159218266	Inflammatory biomarkers
chr1	159272059	159272060	IgE levels
chr1	159272059	159272060	IgE levels
chr1	159278250	159278251	Select biomarker traits
chr1	159326879	159326880	IgE levels
chr1	159342438	159342439	Chemerin levels
chr1	159357683	159357684	Chemerin levels
chr1	159405958	159405959	Select biomarker traits
chr1	159453936	159453937	Hemostatic factors and hematological phenotypes
chr1	159462380	159462381	Obesity-related traits
chr1	159647987	159647988	Protein quantitative trait loci
chr1	159649699	159649700	C-reactive protein
chr1	159655517	159655518	C-reactive protein
chr1	159674932	159674933	C-reactive protein
chr1	159676170	159676171	C-reactive protein
chr1	159678815	159678816	C-reactive protein
chr1	159678815	159678816	Metabolic traits
chr1	159678815	159678816	Select biomarker traits
chr1	159680867	159680868	Lung cancer
chr1	159684664	159684665	C-reactive protein
chr1	159685135	159685136	C-reactive protein
chr1	159691558	159691559	Inflammatory biomarkers
chr1	159692572	159692573	C-reactive protein
chr1	159698548	159698549	C-reactive protein
chr1	159698548	159698549	C-reactive protein
chr1	159698548	159698549	C-reactive protein
chr1	159700038	159700039	C-reactive protein
chr1	159710516	159710517	Vaccine-related adverse events
chr1	159753182	159753183	Interstitial lung disease
chr1	159818512	159818513	Multiple sclerosis (OCB status)
chr1	159856428	159856429	Bilirubin levels
chr1	160077853	160077854	Response to antipsychotic treatment
chr1	160421915	160421916	Cognitive performance
chr1	160464910	160464911	Graves' disease
chr1	160516307	160516308	Response to anti-TNF treatment in rheumatoid arthritis
chr1	160630142	160630143	Schizophrenia (treatment refractory)
chr1	160746075	160746076	Capecitabine sensitivity
chr1	160830267	160830268	Crohn's disease
chr1	160852045	160852046	Crohn's disease
chr1	160856963	160856964	Inflammatory bowel disease
chr1	161272440	161272441	Visceral adipose tissue adjusted for BMI
chr1	161463586	161463587	Functional impairment in major depressive disorder, bipolar disorder and schizophrenia
chr1	161472157	161472158	Ulcerative colitis
chr1	161479744	161479745	Inflammatory bowel disease
chr1	161479744	161479745	Kawasaki disease
chr1	161479744	161479745	Ulcerative colitis
chr1	161479744	161479745	Ulcerative colitis
chr1	161484209	161484210	Helicobacter pylori serologic status
chr1	161540856	161540857	Lipid metabolism phenotypes
chr1	161826614	161826615	IgG glycosylation
chr1	161915500	161915501	Parkinson's disease (age of onset)
chr1	161946726	161946727	Hematology traits
chr1	162014631	162014632	QT interval
chr1	162033889	162033890	QT interval
chr1	162033889	162033890	QT interval
chr1	162033889	162033890	QT interval
chr1	162033889	162033890	QT interval
chr1	162085308	162085309	Electrocardiographic traits
chr1	162085684	162085685	Electrocardiographic traits
chr1	162085684	162085685	QT interval
chr1	162089317	162089318	Obesity-related traits
chr1	162112909	162112910	QT interval
chr1	162133116	162133117	QT interval
chr1	162195737	162195738	QT interval
chr1	162210609	162210610	QT interval
chr1	162319523	162319524	Word reading
chr1	162821290	162821291	Colorectal cancer
chr1	163053288	163053289	Response to mTOR inhibitor (rapamycin)
chr1	163142554	163142555	Liver enzyme levels (alanine transaminase)
chr1	163956502	163956503	Sex hormone-binding globulin levels
chr1	164689761	164689762	Breast cancer (prognosis)
chr1	164739170	164739171	Height
chr1	165180088	165180089	Response to acetaminophen (hepatotoxicity)
chr1	165394881	165394882	Menarche (age at onset)
chr1	165403902	165403903	Personality dimensions
chr1	165409094	165409095	AIDS
chr1	165448156	165448157	Lentiform nucleus volume
chr1	165616587	165616588	Total ventricular volume
chr1	165687204	165687205	Glaucoma
chr1	165718978	165718979	Intraocular pressure
chr1	165736879	165736880	Intraocular pressure
chr1	165831648	165831649	Testicular germ cell tumor
chr1	165831648	165831649	Testicular germ cell tumor
chr1	165873391	165873392	Testicular germ cell tumor
chr1	167156499	167156500	Liver enzyme levels
chr1	167408669	167408670	Rheumatoid arthritis
chr1	167411383	167411384	Celiac disease
chr1	167411383	167411384	Celiac disease and Rheumatoid arthritis
chr1	167420424	167420425	Systemic sclerosis
chr1	167420424	167420425	Systemic sclerosis
chr1	167420424	167420425	Systemic sclerosis
chr1	167718498	167718499	Alzheimer's disease (late onset)
chr1	167903078	167903079	Schizophrenia
chr1	168618640	168618641	Morbidity-free survival
chr1	169073345	169073346	QT interval
chr1	169099482	169099483	QT interval
chr1	169135126	169135127	D-dimer levels
chr1	169135126	169135127	Venous thromboembolism
chr1	169477573	169477574	D-dimer levels
chr1	169481222	169481223	Venous thromboembolism
chr1	169491554	169491555	Hemostatic factors and hematological phenotypes
chr1	169498974	169498975	Uric acid levels
chr1	169514005	169514006	Venous thromboembolism
chr1	169519048	169519049	Venous thromboembolism
chr1	169550962	169550963	Hippocampal atrophy
chr1	169551681	169551682	Activated partial thromboplastin time
chr1	169563950	169563951	Soluble levels of adhesion molecules
chr1	169580289	169580290	Soluble levels of adhesion molecules
chr1	169608916	169608917	Total ventricular volume
chr1	169676485	169676486	Amyotrophic lateral sclerosis
chr1	169995801	169995802	Amyotrophic lateral sclerosis
chr1	170128607	170128608	Methotrexate phramacokinetics (acute lymphoblastic leukemia)
chr1	170569316	170569317	Atrial fibrillation
chr1	170633895	170633896	Response to angiotensin II receptor blocker therapy
chr1	171091874	171091875	Lentiform nucleus volume
chr1	171261192	171261193	Sudden cardiac arrest
chr1	171557599	171557600	Alzheimer's disease (cognitive decline)
chr1	171949749	171949750	Mean platelet volume
chr1	171949749	171949750	Mean platelet volume
chr1	171949749	171949750	Mean platelet volume
chr1	171949749	171949750	Platelet counts
chr1	172053286	172053287	Height
chr1	172189888	172189889	Height
chr1	172199572	172199573	Bone mineral density
chr1	172219994	172219995	Height
chr1	172241250	172241251	Height
chr1	172346547	172346548	Waist-hip ratio
chr1	172710999	172711000	Celiac disease
chr1	172853459	172853460	Crohn's disease
chr1	172862233	172862234	Crohn's disease
chr1	172862233	172862234	Crohn's disease
chr1	172898376	172898377	Crohn's disease
chr1	173191474	173191475	Systemic lupus erythematosus
chr1	173191474	173191475	Systemic lupus erythematosus
chr1	173226194	173226195	Systemic lupus erythematosus and Systemic sclerosis
chr1	173284198	173284199	Multiple sclerosis
chr1	173301515	173301516	Diabetic retinopathy
chr1	173309712	173309713	Systemic lupus erythematosus
chr1	174552810	174552811	Migraine - clinic-based
chr1	174552810	174552811	Migraine without aura
chr1	175120078	175120079	Alcohol dependence
chr1	175296447	175296448	Tonometry
chr1	175715605	175715606	Corneal astigmatism
chr1	176684431	176684432	Venous thromboembolism (gene x gene interaction)
chr1	176792248	176792249	Height
chr1	177568798	177568799	Age-related macular degeneration
chr1	177722906	177722907	Schizophrenia
chr1	177852579	177852580	Body mass index
chr1	177852579	177852580	Menarche (age at onset)
chr1	177852579	177852580	Obesity
chr1	177852579	177852580	Obesity
chr1	177852579	177852580	Obesity
chr1	177855516	177855517	Body mass index
chr1	177889479	177889480	Body mass index
chr1	177889479	177889480	Body mass index
chr1	177889479	177889480	Body mass index
chr1	177913518	177913519	Body mass index
chr1	177913518	177913519	Weight
chr1	178142207	178142208	Immune response to smallpox vaccine (IL-6)
chr1	178471221	178471222	Obesity-related traits
chr1	178491878	178491879	Obesity-related traits
chr1	179071755	179071756	IgE grass sensitization
chr1	179469313	179469314	Multiple sclerosis (age of onset)
chr1	180130722	180130723	Anorexia nervosa
chr1	180645440	180645441	Asthma (childhood onset)
chr1	180962281	180962282	Progressive supranuclear palsy
chr1	181426909	181426910	Coronary artery calcification
chr1	181655751	181655752	IgG glycosylation
chr1	182081959	182081960	Cardiovascular heart disease in diabetics
chr1	182168884	182168885	HDL cholesterol
chr1	182549018	182549019	Multiple sclerosis
chr1	183081193	183081194	Colorectal cancer
chr1	183170947	183170948	Coronary heart disease
chr1	183176429	183176430	Systemic lupus erythematosus
chr1	183180259	183180260	Systemic lupus erythematosus and Systemic sclerosis
chr1	183266181	183266182	Obesity-related traits
chr1	183358404	183358405	Obesity-related traits
chr1	183616883	183616884	Systemic lupus erythematosus
chr1	183837031	183837032	Response to antidepressants
chr1	183852913	183852914	Attention deficit hyperactivity disorder and conduct disorder
chr1	184002873	184002874	Height
chr1	184007118	184007119	Height
chr1	184020944	184020945	Height
chr1	184023528	184023529	Height
chr1	184068507	184068508	Venous thromboembolism (gene x gene interaction)
chr1	184677463	184677464	Obesity-related traits
chr1	184761364	184761365	Obesity-related traits
chr1	185014001	185014002	Obesity-related traits
chr1	185794882	185794883	QRS duration
chr1	186632316	186632317	Schizophrenia
chr1	186725002	186725003	Knee osteoarthritis
chr1	186870071	186870072	Epilepsy (generalized)
chr1	187412041	187412042	Metabolite levels (5-HIAA)
chr1	187902980	187902981	Hypothyroidism
chr1	188379427	188379428	Economic and political preferences
chr1	188383315	188383316	Obesity-related traits
chr1	189589338	189589339	Immune response to smallpox vaccine (IL-6)
chr1	189723622	189723623	Systemic lupus erythematosus
chr1	189861403	189861404	Subclinical atherosclerosis traits (other)
chr1	190066385	190066386	Echocardiographic traits
chr1	190841672	190841673	Response to statin therapy
chr1	191559355	191559356	Crohn's disease
chr1	191939787	191939788	IgG glycosylation
chr1	191939787	191939788	IgG glycosylation
chr1	191939787	191939788	IgG glycosylation
chr1	192431997	192431998	Blood pressure
chr1	192536812	192536813	Celiac disease
chr1	192536812	192536813	Celiac disease
chr1	192541020	192541021	Multiple sclerosis
chr1	192806240	192806241	Coronary artery calcification
chr1	192995212	192995213	Cannabis dependence
chr1	193734899	193734900	Subcutaneous adipose tissue
chr1	193921547	193921548	Major depressive disorder
chr1	194530913	194530914	Obesity-related traits
chr1	195531422	195531423	Neonatal lupus
chr1	195790657	195790658	Cocaine dependence
chr1	195914272	195914273	Total ventricular volume
chr1	196042661	196042662	Bipolar disorder and schizophrenia
chr1	196620916	196620917	Complement C3 and C4 levels
chr1	196642232	196642233	Circulating myeloperoxidase levels (serum)
chr1	196646175	196646176	Age-related macular degeneration
chr1	196646175	196646176	Age-related macular degeneration
chr1	196654323	196654324	Age-related macular degeneration
chr1	196659236	196659237	Age-related macular degeneration
chr1	196659236	196659237	Age-related macular degeneration
chr1	196659236	196659237	Age-related macular degeneration (CNV)
chr1	196659236	196659237	Age-related macular degeneration (GA)
chr1	196660260	196660261	Age-related macular degeneration
chr1	196673992	196673993	Age-related macular degeneration
chr1	196673992	196673993	Age-related macular degeneration (extreme sampling)
chr1	196679454	196679455	Age-related macular degeneration
chr1	196679454	196679455	Age-related macular degeneration
chr1	196686917	196686918	Nephropathy
chr1	196696932	196696933	Age-related macular degeneration
chr1	196696932	196696933	End-stage coagulation
chr1	196701050	196701051	Age-related macular degeneration
chr1	196702809	196702810	Age-related macular degeneration
chr1	196760416	196760417	Meningococcal disease
chr1	196844592	196844593	Acute lymphoblastic leukemia (childhood)
chr1	196886769	196886770	End-stage coagulation
chr1	196973182	196973183	End-stage coagulation
chr1	197020657	197020658	Erectile dysfunction
chr1	197070775	197070776	End-stage coagulation
chr1	197155020	197155021	End-stage coagulation
chr1	197325907	197325908	Asthma
chr1	197629341	197629342	Serum protein levels (sST2)
chr1	197631140	197631141	Inflammatory bowel disease
chr1	197727641	197727642	Crohn's disease
chr1	197781197	197781198	Primary biliary cirrhosis
chr1	198469161	198469162	Adverse response to chemotherapy (neutropenia/leucopenia) (cyclophosphamide)
chr1	198595505	198595506	Mean corpuscular hemoglobin
chr1	199007207	199007208	Red blood cell traits
chr1	199356515	199356516	Dialysis-related mortality
chr1	200007431	200007432	Pancreatic cancer
chr1	200101919	200101920	Ulcerative colitis
chr1	200672905	200672906	Electrocardiographic conduction measures
chr1	200826768	200826769	Epilepsy
chr1	200877561	200877562	Crohn's disease
chr1	200877561	200877562	Inflammatory bowel disease
chr1	200877561	200877562	Ulcerative colitis
chr1	200877561	200877562	Ulcerative colitis
chr1	200881594	200881595	Multiple sclerosis
chr1	200892136	200892137	Celiac disease
chr1	200935865	200935866	Crohn's disease
chr1	200935865	200935866	Ulcerative colitis
chr1	200960306	200960307	Ankylosing spondylitis
chr1	200960306	200960307	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr1	201081942	201081943	Permanent tooth development
chr1	201262431	201262432	Panic disorder
chr1	201345486	201345487	Cardiac Troponin-T levels
chr1	201345486	201345487	Cardiac Troponin-T levels
chr1	201594664	201594665	Celiac disease
chr1	201630954	201630955	Obesity-related traits
chr1	201884951	201884952	Breast size
chr1	201952573	201952574	Butyrylcholinesterase levels
chr1	202187175	202187176	Breast cancer
chr1	202391742	202391743	Obesity-related traits
chr1	202469722	202469723	Celiac disease
chr1	203155881	203155882	YKL-40 levels
chr1	203372484	203372485	Obesity-related traits
chr1	203492719	203492720	Metabolite levels (MHPG)
chr1	203651926	203651927	Mean corpuscular hemoglobin concentration
chr1	203654023	203654024	Malaria
chr1	204103617	204103618	Periodontitis (CDC/AAP)
chr1	204112983	204112984	Response to acetaminophen (hepatotoxicity)
chr1	204274518	204274519	Palmitoleic acid (16:1n-7) plasma levels
chr1	204516024	204516025	Breast Cancer in BRCA1 mutation carriers
chr1	204518841	204518842	Breast cancer
chr1	204518841	204518842	Prostate cancer
chr1	204572070	204572071	Cognitive performance
chr1	204576982	204576983	Educational attainment
chr1	204784017	204784018	Dental caries
chr1	204784017	204784018	Dental caries
chr1	205180409	205180410	Obesity-related traits
chr1	205235989	205235990	Mean platelet volume
chr1	205237136	205237137	Platelet counts
chr1	205244952	205244953	Mean platelet volume
chr1	205249449	205249450	Mean platelet volume
chr1	205483594	205483595	IgG glycosylation
chr1	205483594	205483595	IgG glycosylation
chr1	205638221	205638222	Prostate-specific antigen levels
chr1	205676262	205676263	White blood cell types
chr1	205678125	205678126	Pulmonary function decline
chr1	205689806	205689807	Pubertal anthropometrics
chr1	205713377	205713378	Parkinson's disease
chr1	205752664	205752665	Parkinson's disease
chr1	205764639	205764640	Parkinson's disease
chr1	205896234	205896235	Response to antipsychotic treatment
chr1	205914756	205914757	Cystic fibrosis-related diabetes
chr1	206626827	206626828	Cholesterol and Triglycerides
chr1	206939903	206939904	Crohn's disease
chr1	206939903	206939904	Inflammatory bowel disease
chr1	206939903	206939904	Type 1 diabetes
chr1	206939903	206939904	Type 1 diabetes autoantibodies
chr1	206939903	206939904	Ulcerative colitis
chr1	206939903	206939904	Ulcerative colitis
chr1	206939903	206939904	Ulcerative colitis
chr1	206943967	206943968	Ulcerative colitis
chr1	206943967	206943968	Ulcerative colitis
chr1	206944644	206944645	Behcet's disease
chr1	206946633	206946634	Behcet's disease
chr1	207032750	207032751	Economic and political preferences
chr1	207269857	207269858	C4b binding protein levels
chr1	207652175	207652176	Type 2 diabetes
chr1	207757514	207757515	Inflammatory biomarkers
chr1	207784967	207784968	Alzheimer's disease
chr1	207786288	207786289	Alzheimer's disease (late onset)
chr1	207803594	207803595	Erythrocyte sedimentation rate
chr1	207872289	207872290	Erythrocyte sedimentation rate
chr1	207875174	207875175	LDL cholesterol
chr1	207938235	207938236	Obesity-related traits
chr1	207940852	207940853	Heart rate
chr1	208024819	208024820	Biomedical quantitative traits
chr1	208039470	208039471	Age-related macular degeneration
chr1	208039470	208039471	Age-related macular degeneration
chr1	208128721	208128722	Resting heart rate
chr1	208129064	208129065	Heart rate
chr1	208757585	208757586	Cardiac hypertrophy
chr1	209334216	209334217	Response to amphetamines
chr1	209712888	209712889	Amyotrophic lateral sclerosis
chr1	209727256	209727257	Obesity (extreme)
chr1	209977110	209977111	Orofacial clefts
chr1	209988046	209988047	Cleft lip
chr1	209989269	209989270	Orofacial clefts
chr1	210536024	210536025	Schizophrenia
chr1	210898262	210898263	Smooth-surface caries
chr1	211168758	211168759	Circulating vasoactive peptide levels
chr1	211691705	211691706	Retinopathy in non-diabetics
chr1	211700657	211700658	Coronary heart disease
chr1	211918243	211918244	Stearic acid (18:0) plasma levels
chr1	212155007	212155008	Temperament (bipolar disorder)
chr1	212237797	212237798	Height
chr1	212392162	212392163	Intelligence (childhood)
chr1	213126564	213126565	Eye color
chr1	213834642	213834643	Metabolite levels (5-HIAA)
chr1	213855587	213855588	RR interval (heart rate)
chr1	213910493	213910494	Obesity
chr1	214118089	214118090	Alzheimer's disease
chr1	214159255	214159256	Fasting glucose-related traits
chr1	214159255	214159256	Fasting glucose-related traits
chr1	214159255	214159256	Fasting glucose-related traits (interaction with BMI)
chr1	214261349	214261350	Dietary macronutrient intake
chr1	214457008	214457009	IgG glycosylation
chr1	214457008	214457009	IgG glycosylation
chr1	214830616	214830617	Response to antineoplastic agents
chr1	214954938	214954939	Migraine without aura
chr1	216056347	216056348	IgG glycosylation
chr1	216504268	216504269	IgG glycosylation
chr1	216632947	216632948	Testosterone levels
chr1	216716319	216716320	Adverse response to chemotherapy (neutropenia/leucopenia) (all antimicrotubule drugs)
chr1	216716536	216716537	Cardiac hypertrophy
chr1	216738787	216738788	Alcohol consumption
chr1	217058478	217058479	Optic disc size (cup)
chr1	217200882	217200883	Major depressive disorder
chr1	217527023	217527024	Dialysis-related mortality
chr1	217718131	217718132	Visceral adipose tissue adjusted for BMI
chr1	218609701	218609702	Height
chr1	218705813	218705814	Attention deficit hyperactivity disorder
chr1	218705813	218705814	Hyperactive-impulsive symptoms
chr1	218860067	218860068	Pulmonary function
chr1	218995272	218995273	Height
chr1	219644223	219644224	Adiposity
chr1	219651132	219651133	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr1	219657162	219657163	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr1	219673827	219673828	Osteoarthritis
chr1	219676041	219676042	Adiponectin levels
chr1	219693219	219693220	Waist-hip ratio
chr1	219700518	219700519	Fasting insulin-related traits (interaction with BMI)
chr1	219727778	219727779	Adiponectin levels
chr1	219743718	219743719	Height
chr1	219750716	219750717	Waist-hip ratio
chr1	219753508	219753509	Sexual dimorphism in anthropometric traits
chr1	219775431	219775432	Axial length
chr1	220601622	220601623	Fat distribution (HIV)
chr1	220658233	220658234	Bipolar disorder
chr1	220914919	220914920	Response to antipsychotic therapy (extrapyramidal side effects)
chr1	220929355	220929356	Response to antipsychotic therapy (extrapyramidal side effects)
chr1	220973562	220973563	Cholesterol, total
chr1	220973562	220973563	LDL cholesterol
chr1	220977332	220977333	Monocyte early outgrowth colony forming units
chr1	221010204	221010205	F-cell distribution
chr1	221028507	221028508	Heart failure
chr1	221111779	221111780	Obesity-related traits
chr1	221551538	221551539	Mortality among heart failure patients
chr1	221617075	221617076	Dupuytren's disease
chr1	222045445	222045446	Colorectal cancer
chr1	222164947	222164948	Colorectal cancer
chr1	222164947	222164948	Progressive supranuclear palsy
chr1	222245257	222245258	Metabolite levels (HVA-5-HIAA Factor score)
chr1	222271766	222271767	Keloid
chr1	222823528	222823529	Coronary heart disease
chr1	222823528	222823529	Coronary heart disease
chr1	222823528	222823529	Myocardial infarction (early onset)
chr1	222923350	222923351	Cognitive performance
chr1	224256347	224256348	QT interval (interaction)
chr1	224538939	224538940	Major depressive disorder
chr1	225590674	225590675	IgG glycosylation
chr1	225592926	225592927	IgG glycosylation
chr1	225592926	225592927	IgG glycosylation
chr1	225901005	225901006	Obesity-related traits
chr1	226564690	226564691	Melanoma
chr1	226855888	226855889	Subcutaneous adipose tissue
chr1	227667789	227667790	Major depressive disorder
chr1	227797949	227797950	Height
chr1	227911882	227911883	Height
chr1	228880114	228880115	Type 2 diabetes
chr1	228996621	228996622	Endometriosis
chr1	228997834	228997835	Basal cell carcinoma
chr1	229019147	229019148	Aging
chr1	229285857	229285858	Dental caries
chr1	229285857	229285858	Dental caries
chr1	229718000	229718001	Circulating myeloperoxidase levels (plasma)
chr1	230294915	230294916	Circulating myeloperoxidase levels (serum)
chr1	230294915	230294916	HDL cholesterol
chr1	230294915	230294916	Triglycerides
chr1	230295690	230295691	HDL cholesterol
chr1	230295690	230295691	HDL cholesterol
chr1	230295690	230295691	HDL cholesterol
chr1	230295690	230295691	Triglycerides
chr1	230295690	230295691	Triglycerides
chr1	230295788	230295789	Metabolite levels
chr1	230304987	230304988	HDL cholesterol
chr1	230307181	230307182	Metabolic syndrome
chr1	230388988	230388989	Hematology traits
chr1	230674825	230674826	Attention deficit hyperactivity disorder and conduct disorder
chr1	230922950	230922951	Myopia (pathological)
chr1	231270635	231270636	Obesity-related traits
chr1	231816841	231816842	Neuranatomic and neurocognitive phenotypes
chr1	231844346	231844347	Alzheimer's disease
chr1	231899703	231899704	Response to antineoplastic agents
chr1	232155150	232155151	Amyotrophic lateral sclerosis
chr1	232246026	232246027	Response to statin therapy
chr1	232519149	232519150	Immunoglobulin A
chr1	233340153	233340154	Type 2 diabetes
chr1	233643855	233643856	Diabetic retinopathy
chr1	233719983	233719984	Periodontal microbiota
chr1	233719983	233719984	Periodontal microbiota
chr1	234583617	234583618	Cognitive test performance
chr1	234662889	234662890	Bipolar disorder
chr1	234726011	234726012	Coronary heart disease
chr1	234726355	234726356	IgG glycosylation
chr1	234816553	234816554	Life threatening arrhythmia
chr1	234858596	234858597	Cholesterol, total
chr1	234858596	234858597	LDL cholesterol
chr1	235092599	235092600	Immune reponse to smallpox (secreted IL-2)
chr1	235267126	235267127	Obesity-related traits
chr1	235600128	235600129	Adiposity
chr1	235720897	235720898	Aging traits
chr1	236179868	236179869	Cutaneous nevi
chr1	236313126	236313127	Working memory
chr1	236912056	236912057	Periodontitis (CDC/AAP)
chr1	237048675	237048676	Homocysteine levels
chr1	237266602	237266603	Acute lymphoblastic leukemia (childhood)
chr1	237349737	237349738	Obesity-related traits
chr1	237355984	237355985	Obesity-related traits
chr1	237598415	237598416	IgG glycosylation
chr1	237621238	237621239	Response to taxane treatment (docetaxel)
chr1	237911003	237911004	Exercise treadmill test traits
chr1	237990121	237990122	Response to cerivastatin
chr1	238103500	238103501	Non-alcoholic fatty liver disease histology (AST)
chr1	238669775	238669776	Serum selenium levels
chr1	238724740	238724741	Economic and political preferences (feminism/equality)
chr1	238908352	238908353	Pancreatic cancer
chr1	239075713	239075714	Treatment response for severe sepsis
chr1	239397103	239397104	IgG glycosylation
chr1	239436541	239436542	Hypertension
chr1	239601968	239601969	Platelet counts
chr1	239644170	239644171	Obesity-related traits
chr1	239970096	239970097	Epilepsy (generalized)
chr1	240045907	240045908	Venous thromboembolism (gene x gene interaction)
chr1	240283735	240283736	Thiazide-induced adverse metabolic effects in hypertensive patients
chr1	240445595	240445596	Coronary heart disease
chr1	240597213	240597214	Bone mineral density
chr1	240605051	240605052	Alzheimer's disease (cognitive decline)
chr1	240706106	240706107	Immune response to smallpox vaccine (IL-6)
chr1	240846123	240846124	Ankle-brachial index
chr1	240987753	240987754	Obesity-related traits
chr1	241755566	241755567	Obesity-related traits
chr1	241878546	241878547	Radiation response
chr1	241892234	241892235	Behavioural disinhibition (generation interaction)
chr1	241894085	241894086	Illicit drug use
chr1	242040774	242040775	Menopause (age at onset)
chr1	242274907	242274908	Coronary artery calcification
chr1	242522041	242522042	IgG glycosylation
chr1	242531653	242531654	IgG glycosylation
chr1	242955562	242955563	Obesity-related traits
chr1	243290641	243290642	Bronchopulmonary dysplasia
chr1	243544826	243544827	Schizophrenia
chr1	243608966	243608967	Schizophrenia
chr1	243663892	243663893	Schizophrenia
chr1	243835185	243835186	Menarche (age at onset)
chr1	243835185	243835186	Menarche (age at onset)
chr1	243943083	243943084	RR interval (heart rate)
chr1	244015992	244015993	Post-traumatic stress disorder (asjusted for relatedness)
chr1	244167800	244167801	Thiazide-induced adverse metabolic effects in hypertensive patients
chr1	244173871	244173872	Diabetic retinopathy
chr1	244176423	244176424	Diabetic retinopathy
chr1	244390563	244390564	Schizophrenia
chr1	244511175	244511176	Asthma (childhood onset)
chr1	244533213	244533214	Smoking behavior
chr1	244576716	244576717	Obesity-related traits
chr1	245733607	245733608	Schizophrenia
chr1	246223119	246223120	Migraine - clinic-based
chr1	246223119	246223120	Migraine with aura
chr1	246661235	246661236	Obesity-related traits
chr1	246661235	246661236	Obesity-related traits
chr1	247214877	247214878	Response to taxane treatment (docetaxel)
chr1	247348188	247348189	Alcohol dependence
chr1	247583676	247583677	Word reading
chr1	247600300	247600301	Fibrinogen
chr1	247601594	247601595	C-reactive protein
chr1	247605598	247605599	Fibrinogen
chr1	247675558	247675559	Platelet counts
chr1	247689531	247689532	Acute lymphoblastic leukemia (childhood)
chr1	248039450	248039451	Platelet counts
chr1	248039450	248039451	Red blood cell traits
chr1	248046271	248046272	Mean corpuscular volume
chr1	248496862	248496863	Common traits (Other)
chr1	249168435	249168436	Myopia (pathological)
chr2	38937	38938	Information processing speed
chr2	112495	112496	Suicide attempts in bipolar disorder
chr2	315214	315215	Cognitive performance
chr2	614167	614168	Menarche (age at onset)
chr2	622826	622827	Body mass index
chr2	624033	624034	Obesity
chr2	624033	624034	Obesity
chr2	624677	624678	Body mass index
chr2	629243	629244	Body mass index
chr2	629243	629244	Obesity (early onset extreme)
chr2	634904	634905	Body mass index
chr2	644952	644953	Body mass index
chr2	644952	644953	Weight
chr2	646363	646364	Obesity
chr2	663482	663483	Response to fenofibrate (adiponectin levels)
chr2	663482	663483	Uric acid levels
chr2	679178	679179	Obesity-related traits
chr2	773277	773278	Adverse response to chemotherapy (neutropenia/leucopenia) (doxorubicin)
chr2	1557926	1557927	IgG glycosylation
chr2	1557926	1557927	IgG glycosylation
chr2	1777149	1777150	Response to antipsychotic treatment
chr2	1925992	1925993	Attention deficit hyperactivity disorder
chr2	2519512	2519513	Diabetic retinopathy
chr2	2590380	2590381	White matter integrity
chr2	2926012	2926013	White matter integrity (interaction)
chr2	3392074	3392075	Obesity-related traits
chr2	3748970	3748971	Obesity-related traits
chr2	3841419	3841420	Type 2 diabetes
chr2	4318975	4318976	Pulmonary function decline
chr2	5437542	5437543	Obesity-related traits
chr2	5664007	5664008	Crohn's disease
chr2	5907879	5907880	Chronic kidney disease
chr2	6052750	6052751	Coronary artery calcification
chr2	6461420	6461421	Osteosarcoma
chr2	6694518	6694519	Visceral adipose tissue adjusted for BMI
chr2	6697087	6697088	Visceral fat
chr2	7032617	7032618	Venous thromboembolism (gene x gene interaction)
chr2	7147972	7147973	Response to antipsychotic treatment
chr2	8036259	8036260	Obesity-related traits
chr2	8053596	8053597	Multiple sclerosis
chr2	8434184	8434185	IgE levels
chr2	8442247	8442248	Self-reported allergy
chr2	8530255	8530256	Longevity
chr2	8949069	8949070	Neutrophil count
chr2	9250037	9250038	Multiple sclerosis
chr2	9259597	9259598	IgG glycosylation
chr2	9721895	9721896	Heart rate variability traits
chr2	9924386	9924387	Self-rated health
chr2	10117867	10117868	Prostate cancer
chr2	10903411	10903412	Cardiac Troponin-T levels
chr2	11220561	11220562	Cognitive performance
chr2	11255339	11255340	Metabolite levels (HVA/MHPG ratio)
chr2	11257504	11257505	Obesity-related traits
chr2	11510947	11510948	Sudden cardiac arrest
chr2	11727506	11727507	Endometriosis
chr2	11758430	11758431	Obesity-related traits
chr2	11758430	11758431	Obesity-related traits
chr2	12037178	12037179	Hair morphology
chr2	12037491	12037492	Bipolar disorder
chr2	12212444	12212445	Obesity-related traits
chr2	12252349	12252350	Bronchopulmonary dysplasia
chr2	12568995	12568996	Bipolar disorder and schizophrenia
chr2	12640740	12640741	Type 1 diabetes
chr2	12964496	12964497	Pericardial fat
chr2	12968899	12968900	Dental caries
chr2	14029747	14029748	IgG glycosylation
chr2	14398051	14398052	Response to antidepressant treatment
chr2	14801500	14801501	Visceral adipose tissue adjusted for BMI
chr2	15664755	15664756	Conduct disorder (case status)
chr2	15729819	15729820	Wilms tumor
chr2	15782470	15782471	Wilms tumor
chr2	15863001	15863002	Chronic kidney disease
chr2	15926167	15926168	Pulmonary function
chr2	15926167	15926168	Pulmonary function (interaction)
chr2	15961598	15961599	Hair morphology
chr2	16715407	16715408	Orofacial clefts
chr2	17427584	17427585	Alzheimer's disease
chr2	17609238	17609239	Subcutaneous adipose tissue
chr2	17775031	17775032	Alzheimer's disease
chr2	17988657	17988658	Response to amphetamines
chr2	18234445	18234446	Amyotrophic lateral sclerosis
chr2	18243533	18243534	Temperament (bipolar disorder)
chr2	18540643	18540644	Amyotrophic lateral sclerosis
chr2	18834650	18834651	Bulimia nervosa
chr2	19134747	19134748	Cognitive performance
chr2	19320802	19320803	Breast cancer
chr2	19629303	19629304	Response to irinotecan and platinum-based chemotherapy in non-small-cell lung cancer
chr2	19945576	19945577	Coronary heart disease
chr2	19958495	19958496	Inflammatory biomarkers
chr2	19999345	19999346	Inflammatory biomarkers
chr2	20261684	20261685	Major depressive disorder
chr2	20335708	20335709	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel)
chr2	20688518	20688519	Systemic sclerosis
chr2	20888264	20888265	Prostate cancer
chr2	20903014	20903015	LDL cholesterol
chr2	20903014	20903015	LDL cholesterol
chr2	21100777	21100778	Coronary heart disease
chr2	21123351	21123352	Metabolic syndrome
chr2	21198899	21198900	HDL cholesterol
chr2	21204024	21204025	Triglycerides
chr2	21206182	21206183	HDL cholesterol
chr2	21206182	21206183	Lipid metabolism phenotypes
chr2	21206182	21206183	Triglycerides
chr2	21208210	21208211	Triglycerides
chr2	21225280	21225281	HDL cholesterol
chr2	21225280	21225281	Triglycerides
chr2	21231523	21231524	LDL (oxidized)
chr2	21231523	21231524	Lipid metabolism phenotypes
chr2	21231523	21231524	Lipid metabolism phenotypes
chr2	21231523	21231524	Lipid metabolism phenotypes
chr2	21231591	21231592	Lipoprotein-associated phospholipase A2 activity and mass
chr2	21232194	21232195	Cholesterol, total
chr2	21232194	21232195	LDL cholesterol
chr2	21232194	21232195	LDL cholesterol
chr2	21232194	21232195	LDL cholesterol
chr2	21232194	21232195	Triglycerides
chr2	21232194	21232195	Triglycerides
chr2	21237543	21237544	Lipid metabolism phenotypes
chr2	21237543	21237544	Lipid metabolism phenotypes
chr2	21237543	21237544	Metabolic syndrome
chr2	21237543	21237544	Metabolic traits
chr2	21237543	21237544	Metabolite levels
chr2	21241504	21241505	LDL cholesterol
chr2	21243999	21244000	Cardiovascular disease risk factors
chr2	21263899	21263900	Cholesterol, total
chr2	21263899	21263900	LDL cholesterol
chr2	21263899	21263900	Lipid metabolism phenotypes
chr2	21263899	21263900	Lipid metabolism phenotypes
chr2	21286056	21286057	LDL cholesterol
chr2	21286056	21286057	LDL cholesterol
chr2	21288320	21288321	LDL cholesterol
chr2	21288320	21288321	LDL cholesterol
chr2	21294974	21294975	Response to statin therapy
chr2	21378804	21378805	Lipid metabolism phenotypes
chr2	21389658	21389659	Hypertriglyceridemia
chr2	21397181	21397182	Lipid metabolism phenotypes
chr2	21397181	21397182	Lipid metabolism phenotypes
chr2	21397181	21397182	Lipid metabolism phenotypes
chr2	21577742	21577743	Erectile dysfunction and prostate cancer treatment
chr2	21840092	21840093	Response to antipsychotic treatment
chr2	22297002	22297003	C-reactive protein and white blood cell count
chr2	22576099	22576100	Bipolar disorder and schizophrenia
chr2	22736986	22736987	Self-rated health
chr2	22822158	22822159	Coronary heart disease
chr2	23124557	23124558	Obesity-related traits
chr2	23187503	23187504	Dialysis-related mortality
chr2	23238942	23238943	Alzheimer's disease (late onset)
chr2	23414650	23414651	Depression (quantitative trait)
chr2	23548613	23548614	F-cell distribution
chr2	23592144	23592145	IgG glycosylation
chr2	23592144	23592145	IgG glycosylation
chr2	23898316	23898317	Coronary heart disease
chr2	23948952	23948953	Obesity-related traits
chr2	24154191	24154192	Obesity-related traits
chr2	24247513	24247514	Quantitative traits
chr2	24413297	24413298	Venous thromboembolism (gene x gene interaction)
chr2	24521765	24521766	Working memory
chr2	24692808	24692809	Type 1 diabetes
chr2	25036857	25036858	Height
chr2	25097643	25097644	Body mass index (non-asthmatics)
chr2	25103107	25103108	Body mass index (non-asthmatics)
chr2	25116976	25116977	Body mass index
chr2	25118884	25118885	Inflammatory bowel disease
chr2	25131315	25131316	Body mass index
chr2	25150295	25150296	Obesity
chr2	25150295	25150296	Obesity
chr2	25158007	25158008	Body mass index
chr2	25158280	25158281	Body mass index (non-asthmatics)
chr2	25169199	25169200	Pubertal anthropometrics
chr2	25187598	25187599	Height
chr2	25276283	25276284	Height
chr2	25301754	25301755	Type 1 diabetes
chr2	25305755	25305756	Body mass index (non-asthmatics)
chr2	25369001	25369002	Body mass index
chr2	25373297	25373298	Height
chr2	25492466	25492467	Crohn's disease
chr2	25613145	25613146	Multiple myeloma (IgH translocation)
chr2	25633241	25633242	Multiple myeloma (IgH translocation)
chr2	25659243	25659244	Multiple myeloma
chr2	25887557	25887558	Coronary heart disease
chr2	26228206	26228207	Metabolite levels (HVA/MHPG ratio)
chr2	26249898	26249899	Metabolite levels (HVA)
chr2	26249898	26249899	Metabolite levels (HVA-5-HIAA Factor score)
chr2	26272601	26272602	Immune response to smallpox vaccine (IL-6)
chr2	26526418	26526419	Non-small cell lung cancer
chr2	26667129	26667130	Metabolite levels (HVA)
chr2	26667129	26667130	Metabolite levels (HVA/MHPG ratio)
chr2	26782620	26782621	Periodontal microbiota
chr2	27083268	27083269	Obesity-related traits
chr2	27152873	27152874	Fasting glucose-related traits (interaction with BMI)
chr2	27587723	27587724	IgG glycosylation
chr2	27598096	27598097	Breast size
chr2	27598096	27598097	Triglycerides
chr2	27635462	27635463	Crohn's disease
chr2	27715415	27715416	Menopause (age at onset)
chr2	27730939	27730940	C-reactive protein
chr2	27730939	27730940	Cardiovascular disease risk factors
chr2	27730939	27730940	Cholesterol, total
chr2	27730939	27730940	Chronic kidney disease
chr2	27730939	27730940	Glycemic traits (pregnancy)
chr2	27730939	27730940	Glycemic traits (pregnancy)
chr2	27730939	27730940	Hematological and biochemical traits
chr2	27730939	27730940	Hypertriglyceridemia
chr2	27730939	27730940	Hypertriglyceridemia
chr2	27730939	27730940	Lipid metabolism phenotypes
chr2	27730939	27730940	Lipid metabolism phenotypes
chr2	27730939	27730940	Lipid metabolism phenotypes
chr2	27730939	27730940	Lipid metabolism phenotypes
chr2	27730939	27730940	Lipid metabolism phenotypes
chr2	27730939	27730940	Lipid metabolism phenotypes
chr2	27730939	27730940	Lipoprotein-associated phospholipase A2 activity and mass
chr2	27730939	27730940	Liver enzyme levels (gamma-glutamyl transferase)
chr2	27730939	27730940	Metabolic traits
chr2	27730939	27730940	Metabolite levels
chr2	27730939	27730940	Metabolite levels
chr2	27730939	27730940	Non-albumin protein levels
chr2	27730939	27730940	Platelet counts
chr2	27730939	27730940	Serum albumin level
chr2	27730939	27730940	Serum albumin level
chr2	27730939	27730940	Serum albumin level
chr2	27730939	27730940	Serum total protein level
chr2	27730939	27730940	Serum total protein level
chr2	27730939	27730940	Triglycerides
chr2	27730939	27730940	Triglycerides
chr2	27730939	27730940	Triglycerides
chr2	27730939	27730940	Two-hour glucose challenge
chr2	27730939	27730940	Urate levels
chr2	27730939	27730940	Waist circumference and related phenotypes
chr2	27741236	27741237	C-reactive protein
chr2	27741236	27741237	Calcium levels
chr2	27741236	27741237	Fasting glucose-related traits
chr2	27741236	27741237	Fasting glucose-related traits
chr2	27741236	27741237	Fasting glucose-related traits
chr2	27741236	27741237	Fasting glucose-related traits (interaction with BMI)
chr2	27741236	27741237	Fasting insulin-related traits
chr2	27741236	27741237	Fasting insulin-related traits
chr2	27741236	27741237	Fasting insulin-related traits (interaction with BMI)
chr2	27741236	27741237	LDL cholesterol
chr2	27741236	27741237	Metabolic syndrome
chr2	27741236	27741237	Metabolic traits
chr2	27741236	27741237	Phospholipid levels (plasma)
chr2	27741236	27741237	Triglycerides
chr2	27741236	27741237	Triglycerides
chr2	27741236	27741237	Triglycerides
chr2	27741236	27741237	Triglycerides
chr2	27741236	27741237	Urate levels
chr2	27741236	27741237	Uric acid levels
chr2	27742602	27742603	Breast size
chr2	27742602	27742603	Calcium levels
chr2	27742602	27742603	Crohn's disease
chr2	27742602	27742603	Palmitic acid (16:0) plasma levels
chr2	27742602	27742603	Palmitoleic acid (16:1n-7) plasma levels
chr2	27742602	27742603	Sex hormone-binding globulin levels
chr2	27742602	27742603	Sex hormone-binding globulin levels
chr2	27742602	27742603	Sex hormone-binding globulin levels
chr2	27742602	27742603	Triglycerides-Blood Pressure (TG-BP)
chr2	27742602	27742603	Urate levels
chr2	27742602	27742603	Waist Circumference - Triglycerides (WC-TG)
chr2	27743153	27743154	Lipid traits
chr2	27743153	27743154	Metabolite levels
chr2	27743153	27743154	Triglycerides
chr2	27748623	27748624	Triglycerides
chr2	27801758	27801759	Waist Circumference - Triglycerides (WC-TG)
chr2	27815509	27815510	Waist Circumference - Triglycerides (WC-TG)
chr2	27840639	27840640	Phospholipid levels (plasma)
chr2	27851917	27851918	Waist Circumference - Triglycerides (WC-TG)
chr2	27859316	27859317	Periodontitis (CDC/AAP)
chr2	27907472	27907473	Alzheimer's disease
chr2	27995780	27995781	Fasting glucose-related traits (interaction with BMI)
chr2	28347681	28347682	Waist circumference
chr2	28614793	28614794	Inflammatory bowel disease
chr2	28646800	28646801	Type 1 diabetes
chr2	29280760	29280761	Major depressive disorder
chr2	30445025	30445026	Celiac disease and Rheumatoid arthritis
chr2	30526779	30526780	vWF and FVIII levels
chr2	31376653	31376654	Methotrexate phramacokinetics (acute lymphoblastic leukemia)
chr2	31464384	31464385	Mean platelet volume
chr2	31464384	31464385	Mean platelet volume
chr2	31464828	31464829	Mean platelet volume
chr2	31474241	31474242	Estradiol levels
chr2	31482299	31482300	Platelet counts
chr2	31590784	31590785	Obesity-related traits
chr2	32865520	32865521	Hippocampal atrophy
chr2	33121503	33121504	Immune response to smallpox vaccine (IL-6)
chr2	33301946	33301947	Immune reponse to smallpox (secreted IFN-alpha)
chr2	33360337	33360338	Height
chr2	33361424	33361425	Height
chr2	33471191	33471192	Height
chr2	33527298	33527299	Height
chr2	33701889	33701890	Systemic lupus erythematosus
chr2	33701889	33701890	Systemic lupus erythematosus
chr2	34480074	34480075	Attention deficit hyperactivity disorder and conduct disorder
chr2	34631031	34631032	Ovarian reserve
chr2	35093292	35093293	Response to amphetamines
chr2	35526917	35526918	Conduct disorder (symptom count)
chr2	35662796	35662797	Metabolite levels (5-HIAA)
chr2	36526435	36526436	Anthropometric traits
chr2	36673554	36673555	Ventricular conduction
chr2	36675529	36675530	IgE levels in asthmatics
chr2	37248014	37248015	Ventricular conduction
chr2	37592627	37592628	Schizophrenia
chr2	37731664	37731665	Response to TNF-alpha inhibitors in rheumatoid arthritis
chr2	37750979	37750980	RR interval (heart rate)
chr2	37940541	37940542	Total ventricular volume
chr2	37957479	37957480	Metabolite levels (HVA/MHPG ratio)
chr2	37960612	37960613	Height
chr2	37960612	37960613	Height
chr2	37977016	37977017	Conduct disorder (interaction)
chr2	38044343	38044344	Bone mineral density (spine)
chr2	38277831	38277832	Erectile dysfunction and prostate cancer treatment
chr2	38916969	38916970	5-HTT brain serotonin transporter levels
chr2	39101208	39101209	Obesity-related traits
chr2	39109557	39109558	Amyotrophic lateral sclerosis
chr2	39843196	39843197	Response to angiotensin II receptor blocker therapy (opposite direction w/ diuretic therapy)
chr2	39939535	39939536	Obesity-related traits
chr2	39947720	39947721	Erectile dysfunction and prostate cancer treatment
chr2	39959059	39959060	Personality dimensions
chr2	40115695	40115696	Asthma (childhood onset)
chr2	40396077	40396078	HIV-associated dementia
chr2	40578558	40578559	Obesity (early onset extreme)
chr2	40662545	40662546	Obesity-related traits
chr2	40757790	40757791	QT interval
chr2	41273630	41273631	Adverse response to chemotherapy (neutropenia/leucopenia) (camptothecin)
chr2	42004996	42004997	Conduct disorder (interaction)
chr2	42250548	42250549	Bone mineral density
chr2	42276920	42276921	Atopy
chr2	42981238	42981239	Attention deficit hyperactivity disorder
chr2	42985802	42985803	Hyperactive-impulsive symptoms
chr2	43325569	43325570	Multiple sclerosis
chr2	43359060	43359061	Multiple sclerosis
chr2	43540124	43540125	Orofacial clefts
chr2	43540124	43540125	Orofacial clefts
chr2	43553948	43553949	Prostate cancer
chr2	43587503	43587504	Hair morphology
chr2	43638837	43638838	Polycystic ovary syndrome
chr2	43638837	43638838	Polycystic ovary syndrome
chr2	43638837	43638838	Response to amphetamines
chr2	43687878	43687879	Platelet counts
chr2	43721507	43721508	Polycystic ovary syndrome
chr2	43732822	43732823	Type 2 diabetes
chr2	43806917	43806918	Crohn's disease
chr2	43806917	43806918	Inflammatory bowel disease
chr2	43817504	43817505	DNA methylation (variation)
chr2	44065089	44065090	Cholesterol, total
chr2	44065089	44065090	LDL cholesterol
chr2	44066246	44066247	Gallstones
chr2	44072575	44072576	Cholesterol, total
chr2	44072575	44072576	LDL cholesterol
chr2	44072575	44072576	Lipid metabolism phenotypes
chr2	44073655	44073656	Phytosterol levels
chr2	44073880	44073881	LDL cholesterol
chr2	44074430	44074431	LDL cholesterol
chr2	44074430	44074431	Phytosterol levels
chr2	44135313	44135314	Intelligence (childhood)
chr2	44480949	44480950	Height
chr2	44662474	44662475	Immune reponse to smallpox (secreted TNF-alpha)
chr2	44705614	44705615	Adverse response to chemotherapy in breast cancer (alopecia) (paclitaxel)
chr2	44768201	44768202	Height
chr2	45154907	45154908	Alcohol and nictotine co-dependence
chr2	45188352	45188353	Metabolite levels
chr2	45646823	45646824	Glaucoma
chr2	46176961	46176962	QT interval
chr2	46321093	46321094	Suicide risk
chr2	46332168	46332169	Pulmonary function decline
chr2	46353165	46353166	Hematological and biochemical traits
chr2	46353165	46353166	Hemoglobin
chr2	46353165	46353166	Red blood cell count
chr2	46355050	46355051	Red blood cell traits
chr2	46355847	46355848	Red blood cell traits
chr2	46360906	46360907	Hematocrit
chr2	46360906	46360907	Hematological and biochemical traits
chr2	46537603	46537604	Renal cell carcinoma
chr2	46550768	46550769	IgG glycosylation
chr2	46550768	46550769	IgG glycosylation
chr2	46550768	46550769	IgG glycosylation
chr2	46550768	46550769	IgG glycosylation
chr2	46634644	46634645	Hair morphology
chr2	46642248	46642249	Coronary heart disease
chr2	46826025	46826026	Height
chr2	46921284	46921285	Height
chr2	47022542	47022543	Chronic obstructive pulmonary disease
chr2	47229838	47229839	Response to statin therapy
chr2	47240011	47240012	Erectile dysfunction and prostate cancer treatment
chr2	47399063	47399064	Dialysis-related mortality
chr2	47844504	47844505	Vitiligo
chr2	47885475	47885476	Alzheimer's disease
chr2	48047334	48047335	Schizophrenia
chr2	48646398	48646399	Sex hormone-binding globulin levels
chr2	48649704	48649705	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr2	48978158	48978159	Polycystic ovary syndrome
chr2	48978158	48978159	Polycystic ovary syndrome
chr2	49177600	49177601	Radiation response
chr2	49201327	49201328	Erectile dysfunction and prostate cancer treatment
chr2	49201611	49201612	Polycystic ovary syndrome
chr2	49715020	49715021	Adverse response to chemotherapy (neutropenia/leucopenia) (etoposide)
chr2	49955496	49955497	Systemic lupus erythematosus
chr2	50184393	50184394	Behavioural disinhibition (generation interaction)
chr2	50516017	50516018	Longevity
chr2	50731317	50731318	Temperament
chr2	50744773	50744774	Personality dimensions
chr2	50760502	50760503	Metabolite levels (HVA/MHPG ratio)
chr2	51667738	51667739	Cognitive performance
chr2	51736993	51736994	Response to tocilizumab in rheumatoid arthritis
chr2	52511793	52511794	Estradiol plasma levels (breast cancer)
chr2	52703589	52703590	Economic and political preferences (immigration/crime)
chr2	52713806	52713807	Cardiac Troponin-T levels
chr2	53237319	53237320	Hemostatic factors and hematological phenotypes
chr2	53266128	53266129	Hemostatic factors and hematological phenotypes
chr2	53502774	53502775	Obesity-related traits
chr2	53756541	53756542	Bulimia nervosa
chr2	53782558	53782559	Stroke (ischemic)
chr2	54347749	54347750	Sudden cardiac arrest
chr2	54659706	54659707	Bone mineral density
chr2	54684556	54684557	Bone mineral density (spine)
chr2	54684556	54684557	Bone mineral density (spine)
chr2	54684556	54684557	Bone mineral density (spine)
chr2	54718180	54718181	Myopia (pathological)
chr2	55081375	55081376	Economic and political preferences
chr2	55156629	55156630	Obesity (extreme)
chr2	55516322	55516323	Height
chr2	55843412	55843413	Metabolic syndrome
chr2	55973731	55973732	IgG glycosylation
chr2	56008903	56008904	Amyotrophic lateral sclerosis
chr2	56089539	56089540	Height
chr2	56096891	56096892	Height
chr2	56096891	56096892	Height
chr2	56096891	56096892	Height
chr2	56111308	56111309	Height
chr2	56111308	56111309	Height
chr2	56111308	56111309	Height
chr2	56111308	56111309	Height
chr2	56111308	56111309	Height
chr2	56112439	56112440	Venous thromboembolism (gene x gene interaction)
chr2	56592082	56592083	Menarche (age at onset)
chr2	57934054	57934055	Epilepsy (generalized)
chr2	58094872	58094873	Epilepsy (generalized)
chr2	58222927	58222928	Schizophrenia
chr2	58833492	58833493	Obesity
chr2	59036915	59036916	Myasthenia gravis
chr2	59036915	59036916	Myasthenia gravis
chr2	59072968	59072969	Cannabis dependence
chr2	59282590	59282591	Uterine fibroids
chr2	59302876	59302877	Body mass index
chr2	59302876	59302877	Obesity
chr2	59302876	59302877	Obesity
chr2	59499346	59499347	Breast cancer
chr2	59789704	59789705	IgG glycosylation
chr2	60126310	60126311	Eating disorders (purging via substances)
chr2	60281607	60281608	Monocyte early outgrowth colony forming units
chr2	60459805	60459806	Hypersomnia (HLA-DQB1*06:02 negative)
chr2	60500143	60500144	Response to antipsychotic treatment
chr2	60534198	60534199	Nevirapine-induced rash
chr2	60584818	60584819	Type 2 diabetes
chr2	60608758	60608759	Mean corpuscular volume
chr2	60620285	60620286	Red blood cell traits
chr2	60718042	60718043	F-cell distribution
chr2	60719969	60719970	Beta thalassemia/hemoglobin E disease
chr2	60719969	60719970	Fetal hemoglobin levels
chr2	60719969	60719970	Fetal hemoglobin levels
chr2	60719969	60719970	Sickle cell anemia (haemolysis)
chr2	60720245	60720246	Fetal hemoglobin levels
chr2	60762501	60762502	Attention deficit hyperactivity disorder
chr2	60924019	60924020	Obesity-related traits
chr2	61066665	61066666	Hodgkin's lymphoma
chr2	61081541	61081542	Psoriasis
chr2	61081541	61081542	Psoriatic arthritis
chr2	61091949	61091950	Psoriasis
chr2	61136128	61136129	Rheumatoid arthritis
chr2	61164330	61164331	Psoriatic arthritis
chr2	61164330	61164331	Rheumatoid arthritis
chr2	61186828	61186829	Celiac disease
chr2	61186828	61186829	Crohn's disease
chr2	61186828	61186829	Ulcerative colitis
chr2	61204855	61204856	Inflammatory bowel disease
chr2	61204855	61204856	Ulcerative colitis
chr2	61217541	61217542	Crohn's disease and celiac disease
chr2	61224258	61224259	Crohn's disease
chr2	61772256	61772257	Tuberculosis
chr2	62452660	62452661	Rheumatoid arthritis
chr2	62551471	62551472	Ankylosing spondylitis
chr2	62551471	62551472	Ankylosing spondylitis
chr2	62551471	62551472	Crohn's disease
chr2	62713532	62713533	Crohn's disease
chr2	63131730	63131731	Prostate cancer
chr2	63301163	63301164	Prostate cancer
chr2	63511434	63511435	Obesity-related traits
chr2	63596835	63596836	Protein quantitative trait loci
chr2	64349201	64349202	Kawasaki disease
chr2	64364631	64364632	Allergic dermatitis (nickel)
chr2	64495626	64495627	Breast size
chr2	64503894	64503895	Iron status biomarkers
chr2	64503894	64503895	Iron status biomarkers
chr2	64503894	64503895	Iron status biomarkers
chr2	65027623	65027624	Visceral fat
chr2	65208073	65208074	Metabolite levels
chr2	65220909	65220910	Metabolite levels
chr2	65595585	65595586	Rheumatoid arthritis
chr2	65608908	65608909	Celiac disease and Rheumatoid arthritis
chr2	65667271	65667272	Inflammatory bowel disease
chr2	65758524	65758525	Bipolar disorder
chr2	65862377	65862378	Iron status biomarkers
chr2	66756975	66756976	PR interval
chr2	66771999	66772000	PR interval
chr2	66781452	66781453	Restless legs syndrome
chr2	66781452	66781453	Restless legs syndrome
chr2	67297408	67297409	Periodontitis (CDC/AAP)
chr2	67601970	67601971	Waist-hip ratio
chr2	67864674	67864675	Endometriosis
chr2	67942479	67942480	Major depressive disorder (broad)
chr2	67973886	67973887	Response to antidepressant treatment
chr2	67976787	67976788	Response to antidepressant treatment
chr2	68070224	68070225	Restless legs syndrome
chr2	68359896	68359897	Immune reponse to smallpox (secreted IFN-alpha)
chr2	68570771	68570772	Metabolite levels
chr2	68598954	68598955	Celiac disease
chr2	68646782	68646783	Multiple sclerosis
chr2	68647094	68647095	Multiple sclerosis
chr2	68650996	68650997	Obesity-related traits
chr2	68652579	68652580	Obesity-related traits
chr2	69063908	69063909	RR interval (heart rate)
chr2	69198387	69198388	Lung cancer
chr2	69287942	69287943	Height
chr2	69723709	69723710	Parkinson's disease (age of onset)
chr2	69813457	69813458	Metabolite levels (Dihydroxy docosatrienoic acid)
chr2	69985434	69985435	Palmitoleic acid (16:1n-7) plasma levels
chr2	70182804	70182805	Obesity-related traits
chr2	70368922	70368923	Obesity-related traits
chr2	70697666	70697667	Obesity-related traits
chr2	70736218	70736219	Neutrophil count
chr2	70764687	70764688	Longevity
chr2	71063941	71063942	IgG glycosylation
chr2	71133013	71133014	Corneal astigmatism
chr2	71525784	71525785	Height
chr2	71958479	71958480	Protein quantitative trait loci
chr2	73743981	73743982	Metabolite levels
chr2	73818935	73818936	Metabolic traits
chr2	73868327	73868328	Chronic kidney disease
chr2	73900899	73900900	Creatinine levels
chr2	73900899	73900900	Glomerular filtration rate
chr2	73900899	73900900	Glomerular filtration rate
chr2	73900899	73900900	Glomerular filtration rate
chr2	74202577	74202578	Systemic lupus erythematosus
chr2	74208361	74208362	Systemic lupus erythematosus
chr2	74245776	74245777	Dialysis-related mortality
chr2	74463565	74463566	Immune reponse to smallpox (secreted TNF-alpha)
chr2	74463565	74463566	Post-traumatic stress disorder (asjusted for relatedness)
chr2	74939175	74939176	Myopia (pathological)
chr2	74972080	74972081	Iris characteristics
chr2	75074966	75074967	Femoral neck bone geometry
chr2	75419713	75419714	Brain connectivity
chr2	75459667	75459668	Sexual dimorphism in anthropometric traits
chr2	75790488	75790489	Presence of antiphospholipid antibodies
chr2	75792142	75792143	Obesity-related traits
chr2	75926564	75926565	Hippocampal atrophy
chr2	76240360	76240361	Economic and political preferences (fairness)
chr2	76375710	76375711	Economic and political preferences (fairness)
chr2	76759574	76759575	Response to amphetamines
chr2	77223937	77223938	IgG glycosylation
chr2	77223937	77223938	IgG glycosylation
chr2	77246330	77246331	IgG glycosylation
chr2	78075243	78075244	Attention deficit hyperactivity disorder and conduct disorder
chr2	78539665	78539666	Lung function (forced expiratory volume in 1 second to forced vital capacity ratio)
chr2	79539987	79539988	Bipolar disorder
chr2	79632346	79632347	Alcohol consumption
chr2	79687251	79687252	Response to antipsychotic treatment
chr2	79709353	79709354	Response to antipsychotic treatment
chr2	79922801	79922802	Protein quantitative trait loci
chr2	80281172	80281173	Alzheimer's disease (cognitive decline)
chr2	81668807	81668808	Aging traits
chr2	81751123	81751124	Aging traits
chr2	81855724	81855725	Orthostatic hypotension
chr2	81856525	81856526	Pulmonary function decline
chr2	81872921	81872922	Bilirubin levels
chr2	83029468	83029469	Response to antipsychotic therapy (extrapyramidal side effects)
chr2	84245167	84245168	Conduct disorder (case status)
chr2	84246585	84246586	RR interval (heart rate)
chr2	84350916	84350917	Response to antipsychotic treatment
chr2	84444885	84444886	IgG glycosylation
chr2	84709214	84709215	Coronary artery calcification
chr2	85699749	85699750	Protein quantitative trait loci
chr2	85705676	85705677	Estradiol plasma levels (breast cancer)
chr2	85794296	85794297	Prostate cancer
chr2	87044315	87044316	Progressive supranuclear palsy
chr2	88315792	88315793	Bilirubin levels
chr2	88388537	88388538	IgG glycosylation
chr2	88659587	88659588	Visceral fat
chr2	88895350	88895351	Progressive supranuclear palsy
chr2	88924621	88924622	Height
chr2	96841792	96841793	Cardiac Troponin-T levels
chr2	97228038	97228039	Event-related brain oscillations
chr2	97405439	97405440	Bipolar disorder
chr2	97410948	97410949	Bipolar disorder
chr2	97413487	97413488	Bipolar disorder
chr2	97500799	97500800	Erectile dysfunction and prostate cancer treatment
chr2	99083891	99083892	Bipolar disorder (mood-incongruent)
chr2	99239930	99239931	Bipolar disorder
chr2	99382891	99382892	Bipolar disorder
chr2	99465501	99465502	Bipolar disorder
chr2	99876243	99876244	IgG glycosylation
chr2	100460653	100460654	Type 1 diabetes nephropathy
chr2	100460653	100460654	Type 1 diabetes nephropathy
chr2	100806939	100806940	Rheumatoid arthritis
chr2	100818478	100818479	Educational attainment
chr2	100825366	100825367	Type 1 diabetes
chr2	100835733	100835734	Rheumatoid arthritis
chr2	101424330	101424331	Creutzfeldt-Jakob disease (variant)
chr2	101668856	101668857	Osteoporosis
chr2	101922169	101922170	Pancreatic cancer
chr2	102029645	102029646	Estradiol plasma levels (breast cancer)
chr2	102613012	102613013	Hormone measurements
chr2	102663627	102663628	Ankylosing spondylitis
chr2	102663627	102663628	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr2	102663627	102663628	Ulcerative colitis
chr2	102726660	102726661	Fibrinogen
chr2	102776201	102776202	Serum protein levels (sST2)
chr2	102810167	102810168	Serum protein levels (sST2)
chr2	102851707	102851708	Serum protein levels (sST2)
chr2	102875586	102875587	Waist circumference
chr2	102879463	102879464	Self-reported allergy
chr2	102915661	102915662	Serum protein levels (sST2)
chr2	102932561	102932562	Serum protein levels (sST2)
chr2	102948631	102948632	Serum protein levels (sST2)
chr2	102953443	102953444	Serum protein levels (sST2)
chr2	102953616	102953617	Asthma
chr2	102955081	102955082	Asthma
chr2	102957290	102957291	Serum protein levels (sST2)
chr2	102957715	102957716	Eosinophil counts
chr2	102960209	102960210	Allergic sensitization
chr2	102965391	102965392	Serum protein levels (sST2)
chr2	102971199	102971200	Asthma
chr2	102971864	102971865	Atopic dermatitis
chr2	102971864	102971865	Celiac disease
chr2	102986221	102986222	Asthma
chr2	103054448	103054449	Crohn's disease
chr2	103054766	103054767	Serum protein levels (sST2)
chr2	103070567	103070568	Celiac disease
chr2	103070567	103070568	Inflammatory bowel disease
chr2	103091539	103091540	White blood cell types
chr2	103149099	103149100	Serum protein levels (sST2)
chr2	103335440	103335441	Response to amphetamines
chr2	103388593	103388594	IgG glycosylation
chr2	103388593	103388594	IgG glycosylation
chr2	103512291	103512292	Thiazide-induced adverse metabolic effects in hypertensive patients
chr2	103770237	103770238	Bone mineral density (hip)
chr2	104573004	104573005	Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)
chr2	104578532	104578533	Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)
chr2	104580502	104580503	Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)
chr2	104587350	104587351	Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)
chr2	104589137	104589138	Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)
chr2	104667737	104667738	Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)
chr2	104808711	104808712	Obesity-related traits
chr2	104983266	104983267	Bipolar disorder
chr2	105158637	105158638	Response to taxane treatment (docetaxel)
chr2	105378956	105378957	Pancreatic cancer
chr2	105837597	105837598	Type 2 diabetes
chr2	105877869	105877870	Preeclampsia
chr2	105897739	105897740	AIDS
chr2	105910512	105910513	Obesity-related traits
chr2	106457290	106457291	Addiction
chr2	106457290	106457291	Addiction
chr2	106615273	106615274	Systolic blood pressure in sickle cell anemia
chr2	107678487	107678488	Alzheimer's disease
chr2	109635256	109635257	Alzheimer's disease (late onset)
chr2	111599705	111599706	IgA nephropathy
chr2	111616103	111616104	Chronic lymphocytic leukemia
chr2	111707404	111707405	Economic and political preferences (immigration/crime)
chr2	111797457	111797458	Chronic lymphocytic leukemia
chr2	111797457	111797458	Chronic lymphocytic leukemia
chr2	111797457	111797458	Chronic lymphocytic leukemia
chr2	111797530	111797531	Prostate cancer (gene x gene interaction)
chr2	111836537	111836538	White blood cell types
chr2	111849658	111849659	Red blood cell traits
chr2	111949326	111949327	Dehydroepiandrosterone sulphate levels
chr2	111989371	111989372	Primary sclerosing cholangitis
chr2	112003866	112003867	Atopic dermatitis
chr2	112375962	112375963	Obesity-related traits
chr2	112470154	112470155	Allergic sensitization
chr2	112500034	112500035	Bone mineral density
chr2	112665200	112665201	Multiple sclerosis
chr2	112770769	112770770	Hepatitis C induced liver fibrosis
chr2	113529182	113529183	Endometriosis
chr2	113529239	113529240	Working memory
chr2	113683874	113683875	Pulmonary function
chr2	113691403	113691404	Response to amphetamines
chr2	113832311	113832312	Protein quantitative trait loci
chr2	113841029	113841030	C-reactive protein
chr2	113841029	113841030	C-reactive protein
chr2	113841029	113841030	Fibrinogen
chr2	113890372	113890373	Obesity-related traits
chr2	113978939	113978940	Renal function-related traits (BUN)
chr2	114980966	114980967	Systolic blood pressure in sickle cell anemia
chr2	115049817	115049818	Inflammatory biomarkers
chr2	115586938	115586939	Obesity-related traits
chr2	116241185	116241186	Bipolar disorder
chr2	116655794	116655795	Attention deficit hyperactivity disorder
chr2	119038597	119038598	Bone mineral density
chr2	119395690	119395691	Multiple sclerosis
chr2	119845316	119845317	T-tau
chr2	120023691	120023692	Cocaine dependence
chr2	120145654	120145655	Obesity-related traits
chr2	120321816	120321817	Attention deficit hyperactivity disorder
chr2	120513132	120513133	Breast size
chr2	121089730	121089731	Breast size
chr2	121195180	121195181	Obesity
chr2	121245121	121245122	Breast cancer
chr2	121245121	121245122	Breast size
chr2	121282629	121282630	Age-related macular degeneration
chr2	121301910	121301911	Age-related macular degeneration
chr2	121306439	121306440	Urate levels
chr2	121701288	121701289	Erectile dysfunction and prostate cancer treatment
chr2	121812223	121812224	Capecitabine sensitivity
chr2	122018762	122018763	Behcet's disease
chr2	123126478	123126479	Lentiform nucleus volume
chr2	123127788	123127789	Lentiform nucleus volume
chr2	123136889	123136890	Lentiform nucleus volume
chr2	123141544	123141545	Lentiform nucleus volume
chr2	123225622	123225623	Immune reponse to smallpox (secreted IFN-alpha)
chr2	123291021	123291022	Erectile dysfunction and prostate cancer treatment
chr2	123641610	123641611	Attention deficit hyperactivity disorder
chr2	124515040	124515041	Attention deficit hyperactivity disorder (inattention symptoms)
chr2	124983055	124983056	Schizophrenia
chr2	124983055	124983056	Schizophrenia
chr2	124998363	124998364	Tonometry
chr2	125256735	125256736	IgG glycosylation
chr2	125256735	125256736	IgG glycosylation
chr2	125256735	125256736	IgG glycosylation
chr2	125281909	125281910	Response to antipsychotic treatment
chr2	125291836	125291837	IgG glycosylation
chr2	125327949	125327950	Response to statin therapy
chr2	127330953	127330954	Intelligence
chr2	127662896	127662897	Heart failure
chr2	127852020	127852021	Alzheimer's disease
chr2	127887984	127887985	Alzheimer's disease (late onset)
chr2	127889636	127889637	Alzheimer's disease
chr2	127889636	127889637	Alzheimer's disease (late onset)
chr2	127894614	127894615	Alzheimer's disease
chr2	127894614	127894615	Alzheimer's disease
chr2	127894614	127894615	Alzheimer's disease (late onset)
chr2	127982644	127982645	Self-rated health
chr2	128176039	128176040	Self-rated health
chr2	128177376	128177377	Protein C levels
chr2	128396166	128396167	Alzheimer's disease (cognitive decline)
chr2	128502584	128502585	Coronary artery calcification
chr2	128519796	128519797	Lung function (forced expiratory volume in 1 second to forced vital capacity ratio)
chr2	129478841	129478842	Bleomycin sensitivity
chr2	129504350	129504351	Palmitic acid (16:0) plasma levels
chr2	130034011	130034012	Adverse response to chemotherapy (neutropenia/leucopenia) (docetaxel)
chr2	130034325	130034326	Periodontitis (PAL4Q3)
chr2	130034325	130034326	Periodontitis (PAL4Q3)
chr2	130468365	130468366	Chronic obstructive pulmonary disease
chr2	131545191	131545192	Metabolite levels (Dihydroxy docosatrienoic acid)
chr2	133144391	133144392	Conduct disorder (case status)
chr2	133144391	133144392	Conduct disorder (symptom count)
chr2	133746629	133746630	Multiple sclerosis (age of onset)
chr2	134005568	134005569	Bipolar disorder and schizophrenia
chr2	134040518	134040519	Attention deficit hyperactivity disorder
chr2	134230216	134230217	Multiple sclerosis
chr2	134266000	134266001	Hypersomnia (HLA-DQB1*06:02 negative)
chr2	134363031	134363032	Glaucoma (primary open-angle)
chr2	134434823	134434824	Height
chr2	134437958	134437959	Response to gemcitabine in pancreatic cancer
chr2	134529090	134529091	Palmitoleic acid (16:1n-7) plasma levels
chr2	135068793	135068794	Multiple sclerosis (severity)
chr2	135143286	135143287	Subcutaneous adipose tissue
chr2	135479979	135479980	Type 2 diabetes
chr2	135539966	135539967	Parkinson's disease
chr2	135592380	135592381	Parkinson's disease
chr2	135599875	135599876	Obesity-related traits
chr2	135803424	135803425	Corneal structure
chr2	135837905	135837906	Cholesterol, total
chr2	136506926	136506927	Corneal structure
chr2	136545298	136545299	Phospholipid levels (plasma)
chr2	136976254	136976255	Electrocardiographic traits
chr2	136976254	136976255	Multiple sclerosis
chr2	137015990	137015991	Telomere length
chr2	137338939	137338940	Cognitive test performance
chr2	137491120	137491121	Subcutaneous adipose tissue
chr2	137555223	137555224	Pancreatic cancer
chr2	137768701	137768702	Corneal astigmatism
chr2	137873346	137873347	Liver enzyme levels (aspartate transaminase)
chr2	138142163	138142164	Non-small cell lung cancer
chr2	139278921	139278922	Response to antipsychotic treatment
chr2	139399353	139399354	Metabolite levels (MHPG)
chr2	139671954	139671955	Alcohol dependence
chr2	140147831	140147832	Male infertility
chr2	140626730	140626731	Methotrexate phramacokinetics (acute lymphoblastic leukemia)
chr2	141226308	141226309	Periodontitis (CDC/AAP)
chr2	141362057	141362058	Optic disc size (disc)
chr2	141721141	141721142	Aging
chr2	141741589	141741590	IgG glycosylation
chr2	141795619	141795620	Erectile dysfunction and prostate cancer treatment
chr2	142228508	142228509	Menarche (age at onset)
chr2	142959930	142959931	Body mass index
chr2	144428607	144428608	Quantitative traits
chr2	144690116	144690117	Obesity-related traits
chr2	145141540	145141541	Schizophrenia
chr2	145208192	145208193	Renal cell carcinoma
chr2	145223619	145223620	Myopia (severe)
chr2	145351820	145351821	Obesity-related traits
chr2	145359908	145359909	Epilepsy (generalized)
chr2	146044051	146044052	Attention deficit hyperactivity disorder (inattention symptoms)
chr2	146045564	146045565	Attention deficit hyperactivity disorder (inattention symptoms)
chr2	146071852	146071853	Attention deficit hyperactivity disorder (inattention symptoms)
chr2	146092755	146092756	Attention deficit hyperactivity disorder (inattention symptoms)
chr2	146105253	146105254	Obesity-related traits
chr2	146125522	146125523	Common traits (Other)
chr2	148478335	148478336	Response to statin therapy
chr2	148716427	148716428	Urate levels
chr2	149387967	149387968	Protein quantitative trait loci
chr2	149557859	149557860	Alzheimer's disease biomarkers
chr2	149568395	149568396	Alzheimer's disease biomarkers
chr2	149865249	149865250	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr2	150147277	150147278	Immune reponse to smallpox (secreted IL-2)
chr2	150397217	150397218	Acute lymphoblastic leukemia (childhood)
chr2	150457623	150457624	Acute lymphoblastic leukemia (childhood)
chr2	150509331	150509332	Waist-to-hip circumference ratio (interaction)
chr2	150564483	150564484	Liver enzyme levels (alanine transaminase)
chr2	150697147	150697148	Menopause (age at onset)
chr2	151126402	151126403	Alcoholism (alcohol dependence factor score)
chr2	151126402	151126403	Alcoholism (alcohol use disorder factor score)
chr2	151635831	151635832	Endometriosis
chr2	151637935	151637936	Type 2 diabetes
chr2	151725791	151725792	Immune reponse to smallpox (secreted IFN-alpha)
chr2	152253917	152253918	Lung cancer
chr2	152957410	152957411	Adverse response to chemotherapy in breast cancer (alopecia)
chr2	152981334	152981335	Adverse response to chemotherapy in breast cancer (alopecia)
chr2	153436569	153436570	IgG glycosylation
chr2	153436569	153436570	IgG glycosylation
chr2	153436569	153436570	IgG glycosylation
chr2	153436569	153436570	IgG glycosylation
chr2	154568756	154568757	Blood trace element (Zn levels)
chr2	155002846	155002847	Obesity-related traits
chr2	155070566	155070567	Aging traits
chr2	155226676	155226677	Sudden cardiac arrest
chr2	155226676	155226677	Sudden cardiac arrest
chr2	155234317	155234318	Liver enzyme levels (alanine transaminase)
chr2	156888499	156888500	Attention deficit hyperactivity disorder
chr2	156925285	156925286	Response to statin therapy
chr2	157096775	157096776	Menarche (age at onset)
chr2	157552859	157552860	QT interval
chr2	158780203	158780204	Sudden cardiac arrest
chr2	158977793	158977794	P-tau181p
chr2	159670448	159670449	Obesity-related traits
chr2	160069755	160069756	Sudden cardiac arrest
chr2	160190208	160190209	Sudden cardiac arrest
chr2	160867058	160867059	Bilirubin levels
chr2	160917496	160917497	Nephropathy (idiopathic membranous)
chr2	161171453	161171454	Type 2 diabetes
chr2	161380887	161380888	Amyotrophic lateral sclerosis
chr2	161757128	161757129	Obesity-related traits
chr2	161781772	161781773	Subcutaneous adipose tissue
chr2	161785168	161785169	Treatment response for severe sepsis
chr2	161886102	161886103	Presence of antiphospholipid antibodies
chr2	161894662	161894663	Dietary macronutrient intake
chr2	162092639	162092640	Educational attainment
chr2	162910222	162910223	Hippocampal volume
chr2	162959747	162959748	Common traits (Other)
chr2	163110535	163110536	Inflammatory bowel disease
chr2	163110535	163110536	Vitiligo
chr2	163124050	163124051	Immunoglobulin A
chr2	163124050	163124051	Type 1 diabetes
chr2	163124050	163124051	Type 1 diabetes
chr2	163124050	163124051	Type 1 diabetes autoantibodies
chr2	163260690	163260691	Psoriasis
chr2	163781786	163781787	Phospholipid levels (plasma)
chr2	164317875	164317876	Response to antipsychotic treatment
chr2	164490528	164490529	Folate pathway vitamin levels
chr2	164906819	164906820	Blood pressure
chr2	164915207	164915208	Blood pressure
chr2	164963485	164963486	Blood pressure
chr2	165501848	165501849	Type 2 diabetes
chr2	165513090	165513091	Triglycerides
chr2	165513090	165513091	Waist-hip ratio
chr2	165528875	165528876	Waist-hip ratio
chr2	165539660	165539661	Sexual dimorphism in anthropometric traits
chr2	165540799	165540800	HDL cholesterol
chr2	165551200	165551201	Fasting insulin-related traits (interaction with BMI)
chr2	165577163	165577164	Response to statin therapy
chr2	165750389	165750390	Coronary heart disease
chr2	165890732	165890733	Common traits (Other)
chr2	166144413	166144414	Periodontitis (DPAL)
chr2	166583243	166583244	Bone mineral density
chr2	166601045	166601046	Bone mineral density
chr2	166942139	166942140	Response to amphetamines
chr2	166943276	166943277	Epilepsy (generalized)
chr2	166978749	166978750	Mesial temporal lobe epilepsy with hippocampal sclerosis
chr2	166978749	166978750	Mesial temporal lobe epilepsy with hippocampal sclerosis
chr2	167177358	167177359	Dental caries
chr2	167377977	167377978	Amyotrophic lateral sclerosis
chr2	168159350	168159351	DNA methylation (parent-of-origin)
chr2	168565692	168565693	Obesity-related traits
chr2	168641969	168641970	Obesity-related traits
chr2	169041385	169041386	Blood pressure
chr2	169117024	169117025	Parkinson's disease
chr2	169143034	169143035	Parkinson's disease
chr2	169389090	169389091	Response to TNF antagonist treatment
chr2	169757353	169757354	Glycated hemoglobin levels
chr2	169763147	169763148	Fasting glucose-related traits
chr2	169763147	169763148	Fasting glucose-related traits
chr2	169763147	169763148	Fasting glucose-related traits (interaction with BMI)
chr2	169763147	169763148	Fasting plasma glucose
chr2	169763147	169763148	Fasting plasma glucose
chr2	169763147	169763148	Fasting plasma glucose
chr2	169763147	169763148	Glycemic traits (pregnancy)
chr2	169763147	169763148	Metabolic syndrome
chr2	169763147	169763148	Metabolic traits
chr2	169763147	169763148	Metabolite levels
chr2	169763147	169763148	Metabolite levels
chr2	169774070	169774071	Fasting plasma glucose
chr2	169782879	169782880	Metabolic syndrome (bivariate traits)
chr2	169784412	169784413	Metabolite levels
chr2	169791437	169791438	Glycated hemoglobin levels
chr2	169840573	169840574	Liver enzyme levels (alkaline phosphatase)
chr2	169853219	169853220	Systolic blood pressure in sickle cell anemia
chr2	170133085	170133086	Anorexia nervosa
chr2	170204845	170204846	Urate levels
chr2	170624220	170624221	Obesity-related traits
chr2	171256596	171256597	Obesity-related traits
chr2	171318893	171318894	Palmitoleic acid (16:1n-7) plasma levels
chr2	171365888	171365889	Visceral fat
chr2	171461131	171461132	Obesity-related traits
chr2	171540822	171540823	Coronary heart disease
chr2	171733224	171733225	Uric acid levels
chr2	171822465	171822466	Cognitive performance
chr2	171990970	171990971	Menopause (age at onset)
chr2	172127919	172127920	Hippocampal atrophy
chr2	172972970	172972971	Breast cancer
chr2	173311552	173311553	Prostate cancer
chr2	173493077	173493078	Erectile dysfunction
chr2	174212893	174212894	Breast cancer
chr2	174297658	174297659	Otitis media (chronic/recurrent)
chr2	174362348	174362349	Anthropometric traits
chr2	174462853	174462854	End-stage renal disease in Type 1 diabetics
chr2	174504923	174504924	Multiple myeloma (IgH translocation)
chr2	176239848	176239849	Bipolar disorder and major depressive disorder (combined)
chr2	176289318	176289319	Electrocardiographic conduction measures
chr2	176654737	176654738	Information processing speed
chr2	176717740	176717741	Periodontal microbiota
chr2	176734597	176734598	Obesity-related traits
chr2	176734597	176734598	Obesity-related traits
chr2	176784137	176784138	Obesity-related traits
chr2	176991778	176991779	Magnesium levels
chr2	177012577	177012578	IgG glycosylation
chr2	177042632	177042633	Ovarian cancer
chr2	177042632	177042633	Ovarian cancer
chr2	177042632	177042633	Ovarian cancer
chr2	177909594	177909595	Non-alcoholic fatty liver disease histology (other)
chr2	178680430	178680431	Heart rate
chr2	178684719	178684720	Height
chr2	179104297	179104298	Breast size
chr2	179248419	179248420	QT interval
chr2	179296270	179296271	Multiple sclerosis (OCB status)
chr2	179641974	179641975	QT interval
chr2	179721045	179721046	Heart rate
chr2	180146274	180146275	Migraine without aura
chr2	180216730	180216731	Presence of antiphospholipid antibodies
chr2	180566677	180566678	Sudden cardiac arrest
chr2	181041285	181041286	Prostate cancer (gene x gene interaction)
chr2	181076748	181076749	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr2	181362378	181362379	Obesity
chr2	181513728	181513729	Systemic lupus erythematosus
chr2	181996044	181996045	Celiac disease
chr2	182007799	182007800	Ankylosing spondylitis
chr2	182261868	182261869	Atrioventricular conduction
chr2	182319300	182319301	White blood cell count
chr2	182323664	182323665	White blood cell types
chr2	182328213	182328214	Monocyte count
chr2	182455993	182455994	Response to iloperidone treatment (QT prolongation)
chr2	182511855	182511856	Lung function (forced expiratory volume in 1 second)
chr2	182511855	182511856	Lung function (forced vital capacity)
chr2	183685561	183685562	Waist-to-hip circumference ratio (interaction)
chr2	185436261	185436262	Obesity-related traits
chr2	185533579	185533580	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr2	185778427	185778428	Schizophrenia
chr2	185797227	185797228	Malaria
chr2	185811939	185811940	Schizophrenia
chr2	186024734	186024735	IgG glycosylation
chr2	186184029	186184030	IgG glycosylation
chr2	188196468	188196469	Coronary heart disease
chr2	188333063	188333064	Heart rate
chr2	188343496	188343497	Coronary heart disease
chr2	189718961	189718962	Obesity-related traits
chr2	190607152	190607153	Obesity-related traits
chr2	190643648	190643649	Bilirubin levels
chr2	190678544	190678545	Subcutaneous adipose tissue
chr2	190985679	190985680	Body mass index
chr2	191538561	191538562	Primary biliary cirrhosis
chr2	191902757	191902758	Systemic lupus erythematosus
chr2	191902757	191902758	Systemic sclerosis
chr2	191902757	191902758	Systemic sclerosis
chr2	191931463	191931464	Inflammatory bowel disease
chr2	191935803	191935804	Sjgren's syndrome
chr2	191940450	191940451	Systemic lupus erythematosus and Systemic sclerosis
chr2	191964632	191964633	Celiac disease and Rheumatoid arthritis
chr2	191964632	191964633	Hepatocellular carcinoma (hepatitis B virus related)
chr2	191964632	191964633	Primary biliary cirrhosis
chr2	191964632	191964633	Rheumatoid arthritis
chr2	191964632	191964633	Rheumatoid arthritis
chr2	191964632	191964633	Systemic lupus erythematosus
chr2	191964632	191964633	Systemic lupus erythematosus
chr2	191964632	191964633	Systemic lupus erythematosus
chr2	191964632	191964633	Systemic lupus erythematosus
chr2	191964632	191964633	Systemic lupus erythematosus
chr2	191964632	191964633	Systemic lupus erythematosus
chr2	191964632	191964633	Systemic sclerosis
chr2	192010487	192010488	Behcet's disease
chr2	192017770	192017771	Behcet's disease
chr2	192117237	192117238	Liver enzyme levels (gamma-glutamyl transferase)
chr2	192118046	192118047	Obesity-related traits
chr2	192465597	192465598	Adverse response to chemotherapy (neutropenia/leucopenia) (5-fluorouracil)
chr2	192587203	192587204	Colorectal cancer
chr2	192914361	192914362	Diabetes (incident)
chr2	192955504	192955505	Sudden cardiac arrest
chr2	193742172	193742173	Major depressive disorder
chr2	193984620	193984621	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr2	193984620	193984621	Schizophrenia
chr2	194872182	194872183	Bipolar disorder
chr2	195871818	195871819	Temperament
chr2	196365889	196365890	Adverse response to chemotherapy (neutropenia/leucopenia) (all antimicrotubule drugs)
chr2	198631713	198631714	Intracranial aneurysm
chr2	198881667	198881668	Ulcerative colitis
chr2	198896894	198896895	Crohn's disease
chr2	198911165	198911166	Alcohol consumption
chr2	198914071	198914072	Self-reported allergy
chr2	198962242	198962243	Hip bone size
chr2	198987934	198987935	Neutrophil count
chr2	199169095	199169096	Prostate cancer (gene x gene interaction)
chr2	199385720	199385721	Educational attainment
chr2	199523121	199523122	Ulcerative colitis
chr2	199585555	199585556	Waist circumference
chr2	199601924	199601925	Brain cytoarchitecture
chr2	199632564	199632565	Menarche (age at onset)
chr2	199679109	199679110	Corneal astigmatism
chr2	200014482	200014483	Insomnia
chr2	200290358	200290359	Ulcerative colitis
chr2	200638508	200638509	Adverse response to chemotherapy (neutropenia/leucopenia) (all anthracycline-based drugs)
chr2	200676925	200676926	Osteoporosis
chr2	200715387	200715388	Schizophrenia
chr2	201021953	201021954	Response to treatment for acute lymphoblastic leukemia
chr2	201150039	201150040	Asthma (bronchodilator response)
chr2	201158121	201158122	Exercise (leisure time)
chr2	201648638	201648639	Response to citalopram treatment
chr2	202111379	202111380	Chronic lymphocytic leukemia
chr2	202162810	202162811	Melanoma
chr2	202807195	202807196	Response to antipsychotic treatment
chr2	202859616	202859617	Response to amphetamines
chr2	202949850	202949851	Attention deficit hyperactivity disorder and conduct disorder
chr2	203337000	203337001	Urate levels
chr2	203745884	203745885	Coronary heart disease
chr2	203745884	203745885	Myocardial infarction (early onset)
chr2	204089729	204089730	Obesity-related traits
chr2	204089729	204089730	Obesity-related traits
chr2	204089729	204089730	Obesity-related traits
chr2	204089729	204089730	Obesity-related traits
chr2	204165170	204165171	Height
chr2	204249398	204249399	Butyrylcholinesterase levels
chr2	204272089	204272090	Subclinical atherosclerosis traits (other)
chr2	204693875	204693876	Rheumatoid arthritis
chr2	204721751	204721752	Alopecia areata
chr2	204721751	204721752	Graves' disease
chr2	204734486	204734487	Hypothyroidism
chr2	204738918	204738919	Rheumatoid arthritis
chr2	204738918	204738919	Type 1 diabetes
chr2	204738918	204738919	Type 1 diabetes
chr2	204738918	204738919	Type 1 diabetes autoantibodies
chr2	204802577	204802578	Celiac disease
chr2	204983553	204983554	Obesity-related traits
chr2	205128020	205128021	Alzheimer's disease (late onset)
chr2	205368457	205368458	Lung function (forced expiratory volume in 1 second)
chr2	205864831	205864832	Tuberculosis
chr2	206060636	206060637	Attention deficit hyperactivity disorder (combined symptoms)
chr2	206063297	206063298	Attention deficit hyperactivity disorder (combined symptoms)
chr2	206086170	206086171	Autism
chr2	206150593	206150594	Knee osteoarthritis
chr2	206318592	206318593	AIDS progression
chr2	206836611	206836612	Obesity (extreme)
chr2	207121781	207121782	Bipolar disorder and schizophrenia
chr2	207634235	207634236	Height
chr2	207717782	207717783	QT interval (interaction)
chr2	207840331	207840332	Pulmonary function decline
chr2	207877464	207877465	Subcutaneous adipose tissue
chr2	208494233	208494234	Opioid sensitivity
chr2	208994044	208994045	Attention deficit hyperactivity disorder
chr2	209578599	209578600	Lung cancer-asbestos exposure interaction
chr2	211060049	211060050	Metabolite levels
chr2	211074908	211074909	Metabolite levels
chr2	211495586	211495587	Body mass index (asthmatics)
chr2	211540506	211540507	Chronic kidney disease
chr2	211540506	211540507	Fibrinogen
chr2	211540506	211540507	Homocysteine levels
chr2	211540506	211540507	Homocysteine levels
chr2	211543054	211543055	Fibrinogen
chr2	211543054	211543055	Metabolite levels
chr2	211569721	211569722	Non-small cell lung cancer
chr2	211616893	211616894	Metabolic traits
chr2	212868623	212868624	Personality dimensions
chr2	213168767	213168768	Type 1 diabetes nephropathy
chr2	213296862	213296863	Breast cancer
chr2	213824044	213824045	Eosinophil counts
chr2	214838512	214838513	Obesity-related traits
chr2	215188618	215188619	Obesity-related traits
chr2	215341889	215341890	PR interval
chr2	215635793	215635794	Neuroblastoma
chr2	215653886	215653887	Neuroblastoma
chr2	215672545	215672546	Neuroblastoma (high-risk)
chr2	216285374	216285375	Coronary heart disease
chr2	216860549	216860550	Blood trace element (Se levels)
chr2	216893636	216893637	Alcohol dependence
chr2	216898657	216898658	Alcohol dependence
chr2	217208570	217208571	Migraine
chr2	217481270	217481271	Esophageal cancer  (alcohol interaction)
chr2	217554212	217554213	Visceral fat
chr2	217625522	217625523	Thyroid hormone levels
chr2	217625522	217625523	Thyroid hormone levels
chr2	217625522	217625523	Thyroid hormone levels
chr2	217863480	217863481	Primary tooth development (number of teeth)
chr2	217878208	217878209	Primary tooth development (number of teeth)
chr2	217894755	217894756	Permanent tooth development
chr2	217905831	217905832	Breast cancer
chr2	217905831	217905832	Breast cancer
chr2	217905831	217905832	Breast cancer
chr2	217905831	217905832	Breast cancer
chr2	217905831	217905832	Breast cancer
chr2	217905831	217905832	Breast cancer
chr2	218123647	218123648	Height
chr2	218271718	218271719	Thyroid cancer
chr2	218271897	218271898	Height
chr2	218296507	218296508	Breast cancer
chr2	218310339	218310340	Thyroid cancer
chr2	218314252	218314253	Metabolite levels (MHPG)
chr2	218523161	218523162	Height
chr2	218683153	218683154	Pulmonary function
chr2	218683153	218683154	Pulmonary function (interaction)
chr2	218729864	218729865	Height
chr2	219010145	219010146	Ulcerative colitis
chr2	219081296	219081297	Obesity-related traits
chr2	219081296	219081297	Obesity-related traits
chr2	219084532	219084533	Obesity-related traits
chr2	219130513	219130514	Smooth-surface caries
chr2	219151217	219151218	Inflammatory bowel disease
chr2	219279096	219279097	Amyotrophic lateral sclerosis
chr2	219514758	219514759	Height
chr2	219545308	219545309	Amyotrophic lateral sclerosis
chr2	219756382	219756383	Common traits (Other)
chr2	219756382	219756383	Hair morphology
chr2	219829205	219829206	Obesity-related traits
chr2	219840890	219840891	Immune response to smallpox vaccine (IL-6)
chr2	219908368	219908369	Height
chr2	219934347	219934348	Height
chr2	219943845	219943846	Height
chr2	219949183	219949184	Height
chr2	220668737	220668738	Orofacial clefts
chr2	220698124	220698125	Systemic lupus erythematosus and Systemic sclerosis
chr2	220864653	220864654	IgG glycosylation
chr2	221899443	221899444	Echocardiographic traits
chr2	222072177	222072178	Paclitaxel-induced neuropathy
chr2	222801698	222801699	Body mass index
chr2	223068285	223068286	Facial morphology
chr2	223353445	223353446	Anorexia nervosa
chr2	223917982	223917983	Acute lymphoblastic leukemia (childhood)
chr2	223936737	223936738	Body mass index
chr2	223936737	223936738	Waist circumference
chr2	223937558	223937559	C-reactive protein and white blood cell count
chr2	224274621	224274622	Osteoporosis-related phenotypes
chr2	224459682	224459683	Response to hepatitis C treatment
chr2	224943684	224943685	Adverse response to chemotherapy (neutropenia/leucopenia) (5-fluorouracil)
chr2	225047743	225047744	Height
chr2	225558041	225558042	IgE levels in asthmatics (D.p. specific)
chr2	226225622	226225623	Menopause (age at onset)
chr2	226237909	226237910	Attention deficit hyperactivity disorder (time to onset)
chr2	227000985	227000986	Corneal astigmatism
chr2	227020652	227020653	Type 2 diabetes
chr2	227068079	227068080	Coronary heart disease
chr2	227068079	227068080	Fasting insulin-related traits (interaction with BMI)
chr2	227087283	227087284	Sexual dimorphism in anthropometric traits
chr2	227093584	227093585	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr2	227093744	227093745	Type 2 diabetes and other traits
chr2	227100697	227100698	HDL cholesterol
chr2	227100697	227100698	Triglycerides
chr2	227105920	227105921	Adiposity
chr2	227122215	227122216	Adiponectin levels
chr2	227179629	227179630	Adiponectin levels
chr2	227562138	227562139	P-tau181p
chr2	227773465	227773466	Pulmonary function
chr2	227915923	227915924	Immune reponse to smallpox (secreted IFN-alpha)
chr2	228092034	228092035	Metabolite levels (5-HIAA/ MHPG Ratio)
chr2	228135179	228135180	Corneal structure
chr2	228397565	228397566	Airway hyperresponsiveness
chr2	228481418	228481419	Immune reponse to smallpox (secreted TNF-alpha)
chr2	228584897	228584898	Obesity-related traits
chr2	228670574	228670575	Eating disorders (purging via substances)
chr2	228715374	228715375	Blood pressure
chr2	229510928	229510929	Pulmonary function (interaction)
chr2	229969797	229969798	Reasoning
chr2	230224030	230224031	Pulmonary function (interaction)
chr2	230224030	230224031	Pulmonary function (interaction)
chr2	230349988	230349989	IgG glycosylation
chr2	231035744	231035745	Obesity-related traits
chr2	231091222	231091223	Chronic lymphocytic leukemia
chr2	231091222	231091223	Chronic lymphocytic leukemia
chr2	231091222	231091223	Chronic lymphocytic leukemia
chr2	231097128	231097129	Crohn's disease
chr2	231106723	231106724	Multiple sclerosis
chr2	231116873	231116874	Crohn's disease
chr2	231230170	231230171	Nicotine use
chr2	231420400	231420401	Cognitive performance
chr2	232159211	232159212	Hormone measurements
chr2	232176540	232176541	Multiple myeloma
chr2	232192304	232192305	Thiazide-induced adverse metabolic effects in hypertensive patients
chr2	232271283	232271284	Heart rate
chr2	232298075	232298076	Eating disorders (purging via substances)
chr2	232318753	232318754	Attention deficit hyperactivity disorder
chr2	232378230	232378231	Height
chr2	232796609	232796610	Height
chr2	232797965	232797966	Height
chr2	232988581	232988582	Height
chr2	233077063	233077064	Height
chr2	233155109	233155110	Height
chr2	233379940	233379941	Refractive error
chr2	233406997	233406998	Refractive error
chr2	233426525	233426526	Non-small cell lung cancer
chr2	233513174	233513175	Liver enzyme levels (gamma-glutamyl transferase)
chr2	233736243	233736244	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr2	233743108	233743109	Schizophrenia
chr2	233998480	233998481	Coronary heart disease
chr2	234158838	234158839	Crohn's disease
chr2	234173502	234173503	Crohn's disease
chr2	234180409	234180410	Crohn's disease
chr2	234183367	234183368	Crohn's disease
chr2	234183367	234183368	Crohn's disease
chr2	234183367	234183368	Crohn's disease
chr2	234184416	234184417	Crohn's disease
chr2	234184416	234184417	Crohn's disease
chr2	234264847	234264848	Bilirubin levels
chr2	234264847	234264848	Calcium levels
chr2	234273241	234273242	Calcium levels
chr2	234406654	234406655	Bilirubin levels
chr2	234504097	234504098	Brain lesion load
chr2	234565282	234565283	Bladder cancer
chr2	234584323	234584324	Attention deficit hyperactivity disorder
chr2	234639309	234639310	Bilirubin levels
chr2	234668569	234668570	Bilirubin levels
chr2	234668569	234668570	Bilirubin levels
chr2	234668569	234668570	Bilirubin levels
chr2	234668569	234668570	Cholelithiasis-related traits in sickle cell anemia
chr2	234668569	234668570	Metabolic traits
chr2	234668569	234668570	Metabolite levels
chr2	234669143	234669144	Bilirubin levels
chr2	234669143	234669144	Bilirubin levels
chr2	234669143	234669144	Bilirubin levels
chr2	234669143	234669144	Bilirubin levels
chr2	234672638	234672639	Bilirubin levels
chr2	234672638	234672639	Bilirubin levels
chr2	234672638	234672639	Bilirubin levels
chr2	234672638	234672639	Bilirubin levels
chr2	234672638	234672639	Circulating cell-free DNA
chr2	234673308	234673309	Bilirubin levels
chr2	234698789	234698790	Bilirubin levels
chr2	234814058	234814059	Pulmonary function decline
chr2	234825092	234825093	Migraine
chr2	234825092	234825093	Migraine
chr2	234827660	234827661	Migraine
chr2	234827660	234827661	Migraine - clinic-based
chr2	234827660	234827661	Migraine with aura
chr2	234827660	234827661	Migraine without aura
chr2	234852691	234852692	Alcohol consumption
chr2	235210726	235210727	Osteoporosis
chr2	235601063	235601064	Response to angiotensin II receptor blocker therapy
chr2	235615196	235615197	Pancreatic cancer
chr2	235900170	235900171	Dialysis-related mortality
chr2	235960892	235960893	Orofacial clefts
chr2	236128950	236128951	Obesity-related traits
chr2	236539306	236539307	Menarche (age at onset)
chr2	236795342	236795343	Schizophrenia
chr2	236795342	236795343	Schizophrenia
chr2	237058143	237058144	Educational attainment
chr2	237105517	237105518	Educational attainment
chr2	237156548	237156549	Response to statin therapy
chr2	237521841	237521842	Airflow obstruction
chr2	238270893	238270894	Aging (time to event)
chr2	238387227	238387228	Prostate cancer
chr2	238443225	238443226	Prostate cancer
chr2	238499443	238499444	Obesity-related traits
chr2	238672424	238672425	Adiposity
chr2	238822330	238822331	Obesity-related traits
chr2	239095421	239095422	Phospholipid levels (plasma)
chr2	239306267	239306268	Iris characteristics
chr2	239306267	239306268	Iris characteristics
chr2	239349361	239349362	Pulmonary function
chr2	239694630	239694631	Male-pattern baldness
chr2	239877147	239877148	Pulmonary function
chr2	239877147	239877148	Pulmonary function
chr2	239877147	239877148	Pulmonary function (interaction)
chr2	240112971	240112972	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr2	240418659	240418660	Response to antipsychotic therapy (extrapyramidal side effects)
chr2	240687288	240687289	Obesity-related traits
chr2	240745717	240745718	Obesity-related traits
chr2	240843637	240843638	Response to amphetamines
chr2	240900120	240900121	Odorant perception (isobutyraldehyde)
chr2	241308504	241308505	Brain imaging in schizophrenia (interaction)
chr2	241495012	241495013	Mean platelet volume
chr2	241515595	241515596	Bipolar disorder
chr2	241522266	241522267	Bipolar disorder
chr2	241563738	241563739	Sclerosing cholangitis and ulcerative colitis (combined)
chr2	241569691	241569692	Inflammatory bowel disease
chr2	241579107	241579108	Ulcerative colitis
chr2	242012728	242012729	Sex hormone-binding globulin levels
chr2	242053545	242053546	Height
chr2	242262985	242262986	Height
chr2	242296448	242296449	Fibrinogen
chr2	242371100	242371101	Chronic lymphocytic leukemia
chr2	242371100	242371101	Chronic lymphocytic leukemia
chr2	242371100	242371101	Chronic lymphocytic leukemia
chr2	242382863	242382864	Prostate cancer
chr2	242502955	242502956	Brain structure
chr2	243026494	243026495	Coronary artery calcification
chr2	243048759	243048760	Obesity-related traits
chr3	108992	108993	Fasting insulin-related traits (interaction with BMI)
chr3	149985	149986	Prostate cancer (gene x gene interaction)
chr3	172476	172477	Response to antidepressant treatment
chr3	191046	191047	Scoliosis
chr3	312348	312349	Sudden cardiac arrest
chr3	397552	397553	Obesity-related traits
chr3	397552	397553	Obesity-related traits
chr3	883850	883851	Response to statin therapy
chr3	898660	898661	Response to statin therapy
chr3	1046037	1046038	Venous thromboembolism
chr3	1345424	1345425	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr3	1512586	1512587	Prostate cancer (gene x gene interaction)
chr3	1623392	1623393	Estradiol levels
chr3	1741764	1741765	Response to amphetamines
chr3	1839692	1839693	Total ventricular volume
chr3	1897972	1897973	Bipolar disorder
chr3	2624937	2624938	Amyotrophic lateral sclerosis
chr3	2654690	2654691	Blood pressure
chr3	2846315	2846316	Gallbladder cancer
chr3	2895683	2895684	Intelligence
chr3	3055246	3055247	Brain connectivity
chr3	3130220	3130221	Oleic acid (18:1n-9) plasma levels
chr3	3130644	3130645	Immune response to smallpox vaccine (IL-6)
chr3	3147980	3147981	QT interval
chr3	3199634	3199635	White matter integrity
chr3	3231837	3231838	IgG glycosylation
chr3	3356173	3356174	Pancreatic cancer
chr3	3375783	3375784	Immune response to smallpox vaccine (IL-6)
chr3	3614886	3614887	Asthma (childhood onset)
chr3	3628980	3628981	Callous-unemotional behaviour
chr3	3650238	3650239	Response to amphetamines
chr3	3658839	3658840	Bipolar disorder
chr3	3679851	3679852	Disc degeneration (lumbar)
chr3	4223615	4223616	Periodontitis (DPAL)
chr3	4437357	4437358	Multiple sclerosis--Brain Glutamate Levels
chr3	4633491	4633492	Airflow obstruction
chr3	4703936	4703937	Obesity-related traits
chr3	4742275	4742276	Breast cancer
chr3	5013875	5013876	Corneal structure
chr3	5188245	5188246	Disc degeneration (lumbar)
chr3	5705051	5705052	Bipolar disorder (mood-incongruent)
chr3	6255996	6255997	Response to tocilizumab in rheumatoid arthritis
chr3	6377694	6377695	Alzheimer's disease (age of onset)
chr3	6481624	6481625	Visceral adipose tissue adjusted for BMI
chr3	6903296	6903297	Panic disorder
chr3	7010080	7010081	Adverse response to chemotherapy (neutropenia/leucopenia) (all topoisomerase inhibitors)
chr3	7403645	7403646	Personality dimensions
chr3	7529554	7529555	Major depressive disorder (broad)
chr3	7538201	7538202	Orofacial clefts
chr3	7982826	7982827	Factor VII
chr3	8250789	8250790	QT interval
chr3	8808514	8808515	Depression and alcohol dependence
chr3	10535770	10535771	Metabolite levels
chr3	10774758	10774759	Economic and political preferences (feminism/equality)
chr3	10877610	10877611	Response to tocilizumab in rheumatoid arthritis
chr3	11040438	11040439	Conduct disorder (interaction)
chr3	11075013	11075014	Response to Vitamin E supplementation
chr3	11232778	11232779	IgG glycosylation
chr3	11625413	11625414	Metabolite levels (HVA)
chr3	11625413	11625414	Metabolite levels (HVA-5-HIAA Factor score)
chr3	11675788	11675789	Anorexia nervosa
chr3	11694466	11694467	Relative hand skill in reading disability
chr3	11956597	11956598	Alcohol dependence
chr3	12116619	12116620	Fasting insulin-related traits (interaction with BMI)
chr3	12267647	12267648	Platelet counts
chr3	12277844	12277845	Type 2 diabetes
chr3	12289799	12289800	Type 2 diabetes
chr3	12330410	12330411	Drug-induced liver injury
chr3	12393124	12393125	Fasting insulin-related traits (interaction with BMI)
chr3	12393124	12393125	Type 2 diabetes
chr3	12393124	12393125	Type 2 diabetes
chr3	12393124	12393125	Type 2 diabetes
chr3	12488881	12488882	Sexual dimorphism in anthropometric traits
chr3	12551806	12551807	Prostate cancer (gene x gene interaction)
chr3	12626515	12626516	Cardiac hypertrophy
chr3	12628919	12628920	Cholesterol, total
chr3	12923196	12923197	Periodontitis (DPAL)
chr3	13555835	13555836	Height
chr3	13736999	13737000	Bipolar disorder (mood-incongruent)
chr3	13743131	13743132	Personality dimensions
chr3	13857968	13857969	Chronic obstructive pulmonary disease-related biomarkers
chr3	13961156	13961157	Ovarian reserve
chr3	14480777	14480778	Response to taxane treatment (docetaxel)
chr3	14530720	14530721	Cognitive performance
chr3	15295363	15295364	Alcohol and nictotine co-dependence
chr3	15295363	15295364	Alcohol dependence
chr3	15440555	15440556	Uric acid levels
chr3	15648003	15648004	Coronary heart disease
chr3	16192142	16192143	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)
chr3	16395667	16395668	Optic disc size (cup)
chr3	16408488	16408489	Obesity (extreme)
chr3	16625047	16625048	Testicular germ cell tumor
chr3	16955258	16955259	Primary biliary cirrhosis
chr3	16970937	16970938	Multiple sclerosis
chr3	18311411	18311412	Platelet counts
chr3	18706857	18706858	Crohn's disease
chr3	18767403	18767404	Inflammatory bowel disease
chr3	18784422	18784423	Psoriasis
chr3	19375790	19375791	Hip geometry
chr3	20108545	20108546	Bipolar disorder and schizophrenia
chr3	20136958	20136959	Response to mTOR inhibitor (rapamycin)
chr3	20220711	20220712	Temperament (bipolar disorder)
chr3	20352765	20352766	Behavioural disinhibition (generation interaction)
chr3	20615272	20615273	Bipolar disorder and schizophrenia
chr3	20957809	20957810	IgG glycosylation
chr3	20957809	20957810	IgG glycosylation
chr3	21248641	21248642	Bipolar disorder
chr3	21706368	21706369	Bipolar disorder
chr3	21718840	21718841	Palmitic acid (16:0) plasma levels
chr3	21719245	21719246	Partial epilepsies
chr3	21955197	21955198	Attention deficit hyperactivity disorder
chr3	22171296	22171297	IgG glycosylation
chr3	22292570	22292571	Waist-to-hip circumference ratio (interaction)
chr3	22473728	22473729	Periodontitis (PAL4Q3)
chr3	23093573	23093574	Chronic kidney disease and serum creatinine levels
chr3	23143046	23143047	Colorectal cancer
chr3	23198483	23198484	Type 2 diabetes
chr3	24268435	24268436	Systolic blood pressure in sickle cell anemia
chr3	24350810	24350811	Mean corpuscular hemoglobin
chr3	24350810	24350811	Mean corpuscular volume
chr3	24350810	24350811	Red blood cell traits
chr3	25112170	25112171	Bipolar disorder and schizophrenia
chr3	25343614	25343615	IgG glycosylation
chr3	25520581	25520582	Pulmonary function
chr3	25520581	25520582	Pulmonary function (interaction)
chr3	25538316	25538317	Airflow obstruction
chr3	25560230	25560231	Obesity (extreme)
chr3	25922284	25922285	DNA methylation (variation)
chr3	27416012	27416013	Breast cancer
chr3	27416012	27416013	Breast cancer
chr3	27416012	27416013	Breast cancer
chr3	27537908	27537909	Blood pressure
chr3	27537908	27537909	Diastolic blood pressure
chr3	27537908	27537909	Systolic blood pressure
chr3	27788779	27788780	Multiple sclerosis
chr3	28071443	28071444	Multiple sclerosis
chr3	28079084	28079085	Multiple sclerosis
chr3	28206876	28206877	Behavioural disinhibition (generation interaction)
chr3	28705763	28705764	Parkinson's disease
chr3	28928859	28928860	Alzheimer's disease
chr3	29209150	29209151	Breast size
chr3	29275645	29275646	Metabolite levels (HVA)
chr3	29575462	29575463	Lung cancer
chr3	29853402	29853403	Bone mineral density
chr3	30346967	30346968	Fasting plasma glucose
chr3	30372052	30372053	Dental caries
chr3	30462402	30462403	Migraine
chr3	30480084	30480085	Migraine - clinic-based
chr3	30682938	30682939	Breast cancer
chr3	30710242	30710243	Tonometry
chr3	31040502	31040503	Eating disorders (purging via substances)
chr3	31795569	31795570	Peripheral artery disease
chr3	32240118	32240119	Alcohol dependence
chr3	32264990	32264991	IgG glycosylation
chr3	32329496	32329497	Bipolar disorder
chr3	32347823	32347824	Bipolar disorder
chr3	32488533	32488534	Mortality among heart failure patients
chr3	32842100	32842101	Attention deficit hyperactivity disorder (time to onset)
chr3	32929114	32929115	Pulmonary function
chr3	32941851	32941852	Venous thromboembolism (gene x gene interaction)
chr3	33015468	33015469	Celiac disease
chr3	33020034	33020035	Hepatocellular carcinoma
chr3	33065338	33065339	Atopic dermatitis
chr3	34013204	34013205	Non-substance related behavioral disinhibition
chr3	34212165	34212166	Visceral adipose tissue adjusted for BMI
chr3	34260091	34260092	Periodontitis (Mean PAL)
chr3	34962668	34962669	Tonometry
chr3	35142510	35142511	Entorhinal cortical thickness
chr3	35639825	35639826	Asthma (childhood onset)
chr3	35982129	35982130	Cognitive performance
chr3	36409600	36409601	Celiac disease
chr3	36680098	36680099	Erectile dysfunction
chr3	36842622	36842623	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr3	36856029	36856030	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr3	36856029	36856030	Bipolar disorder
chr3	36856029	36856030	Bipolar disorder (mood-incongruent)
chr3	36862979	36862980	Schizophrenia
chr3	36864488	36864489	Bipolar disorder
chr3	36864488	36864489	Schizophrenia
chr3	37234588	37234589	P-tau181p
chr3	37515826	37515827	Phospholipid levels (plasma)
chr3	37518544	37518545	Nasopharyngeal carcinoma
chr3	37574023	37574024	PR interval
chr3	37855113	37855114	Illicit drug use
chr3	37996476	37996477	Prostate cancer
chr3	38442489	38442490	Electrocardiographic conduction measures
chr3	38589162	38589163	Electrocardiographic traits
chr3	38589162	38589163	QT interval
chr3	38592405	38592406	Electrocardiographic conduction measures
chr3	38593392	38593393	Electrocardiographic traits
chr3	38593392	38593393	QT interval
chr3	38594972	38594973	Electrocardiographic conduction measures
chr3	38624252	38624253	PR interval
chr3	38624252	38624253	PR interval
chr3	38633922	38633923	Brugada syndrome
chr3	38633922	38633923	PR interval
chr3	38633922	38633923	Ventricular conduction
chr3	38657898	38657899	Ventricular conduction
chr3	38681393	38681394	PR interval
chr3	38719934	38719935	Ventricular conduction
chr3	38766674	38766675	Electrocardiographic conduction measures
chr3	38766674	38766675	Electrocardiographic traits
chr3	38766674	38766675	Electrocardiographic traits
chr3	38766674	38766675	Electrocardiographic traits
chr3	38767314	38767315	PR interval
chr3	38767314	38767315	Ventricular conduction
chr3	38774831	38774832	Atrioventricular conduction
chr3	38774831	38774832	PR interval
chr3	38777553	38777554	Brugada syndrome
chr3	38843646	38843647	Systemic lupus erythematosus
chr3	38886412	38886413	Migraine
chr3	39055316	39055317	Handedness
chr3	39475341	39475342	IgG glycosylation
chr3	39513277	39513278	Alzheimer's disease (cognitive decline)
chr3	39523002	39523003	Progressive supranuclear palsy
chr3	39553787	39553788	Cognitive performance
chr3	39555579	39555580	Attention deficit hyperactivity disorder
chr3	39749592	39749593	Brain structure (temporal lobe volume)
chr3	39847071	39847072	Acute lymphoblastic leukemia (childhood)
chr3	40008633	40008634	Information processing speed
chr3	40096617	40096618	Sleep duration
chr3	41123734	41123735	Bone mineral density (hip)
chr3	41128563	41128564	Bone mineral density
chr3	41137671	41137672	Bone mineral density (hip)
chr3	41786008	41786009	Multiple myeloma (hyperdiploidy)
chr3	41877413	41877414	Blood pressure
chr3	41912650	41912651	Diastolic blood pressure
chr3	41925397	41925398	Multiple myeloma
chr3	41987919	41987920	Blood pressure
chr3	41996135	41996136	Multiple myeloma (hyperdiploidy)
chr3	42093421	42093422	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr3	42303073	42303074	Body mass index
chr3	42448470	42448471	Reasoning
chr3	42808070	42808071	Periodontitis (DPAL)
chr3	42906115	42906116	Monocyte count
chr3	42907111	42907112	Monocyte count
chr3	42909159	42909160	Obesity-related traits
chr3	43230722	43230723	Bipolar disorder and schizophrenia
chr3	43297688	43297689	Obesity-related traits
chr3	43467894	43467895	Obesity-related traits
chr3	44333323	44333324	IgG glycosylation
chr3	45731450	45731451	Response to antidepressant treatment
chr3	45814093	45814094	Urinary metabolites
chr3	45817417	45817418	Immune reponse to smallpox (secreted TNF-alpha)
chr3	46205685	46205686	Behcet's disease
chr3	46235200	46235201	Celiac disease
chr3	46282390	46282391	Obesity-related traits
chr3	46339811	46339812	Brain structure
chr3	46352383	46352384	Celiac disease
chr3	46428189	46428190	AIDS progression
chr3	46451679	46451680	AIDS progression
chr3	47388946	47388947	Colorectal cancer
chr3	47927483	47927484	Blood pressure
chr3	48487047	48487048	Prion diseases
chr3	48487337	48487338	Longevity
chr3	48507574	48507575	Obesity-related traits
chr3	49210731	49210732	Menarche (age at onset)
chr3	49701982	49701983	Crohn's disease
chr3	49701982	49701983	Crohn's disease
chr3	49701982	49701983	Ulcerative colitis
chr3	49719728	49719729	Ulcerative colitis
chr3	49721531	49721532	Crohn's disease
chr3	49721531	49721532	Crohn's disease
chr3	49721531	49721532	Inflammatory bowel disease
chr3	49721531	49721532	Primary sclerosing cholangitis
chr3	49721531	49721532	Ulcerative colitis
chr3	50093208	50093209	Menarche (age at onset)
chr3	50352199	50352200	Keloid
chr3	51071712	51071713	Height
chr3	52279593	52279594	Bipolar disorder
chr3	52506425	52506426	Waist-hip ratio
chr3	52584786	52584787	Major mood disorders
chr3	52622085	52622086	Adiponectin levels
chr3	52718279	52718280	Bipolar disorder (mood-incongruent)
chr3	52720079	52720080	Adiponectin levels
chr3	52721304	52721305	Osteoarthritis
chr3	52733105	52733106	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr3	52821010	52821011	Bipolar disorder
chr3	52833218	52833219	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr3	52835353	52835354	Bipolar disorder
chr3	52838401	52838402	Schizophrenia
chr3	52844533	52844534	Immune reponse to smallpox (secreted IL-2)
chr3	52855228	52855229	Schizophrenia
chr3	52913278	52913279	Immune reponse to smallpox (secreted IL-2)
chr3	53062660	53062661	Ulcerative colitis
chr3	53100213	53100214	Urate levels
chr3	53118738	53118739	Height
chr3	53125584	53125585	Height
chr3	53147575	53147576	Immune reponse to smallpox (secreted IL-2)
chr3	53282302	53282303	Ventricular conduction
chr3	53378244	53378245	Heart rate
chr3	53680123	53680124	Insulin resistance/response
chr3	53680123	53680124	Insulin resistance/response
chr3	53847061	53847062	Axial length
chr3	53847407	53847408	Refractive error
chr3	54632546	54632547	Bipolar disorder and schizophrenia
chr3	55035873	55035874	Immune response to smallpox vaccine (IL-6)
chr3	55184212	55184213	Coronary artery calcification
chr3	55188272	55188273	Insomnia (caffeine-induced)
chr3	55313399	55313400	Type 2 diabetes
chr3	55563343	55563344	Periodontitis (Mean PAL)
chr3	55571759	55571760	Bipolar disorder and schizophrenia
chr3	56530708	56530709	Hip geometry
chr3	56667681	56667682	Height
chr3	56735179	56735180	Height
chr3	56798494	56798495	Obesity-related traits
chr3	56849748	56849749	Mean platelet volume
chr3	56849748	56849749	Mean platelet volume
chr3	56849748	56849749	Platelet counts
chr3	56849748	56849749	Platelet counts
chr3	56849748	56849749	Platelet counts
chr3	56849748	56849749	Platelet counts
chr3	56849748	56849749	Platelet counts
chr3	56865775	56865776	Mean platelet volume
chr3	56865775	56865776	Mean platelet volume
chr3	56966245	56966246	Rheumatoid arthritis
chr3	56966245	56966246	Rheumatoid arthritis
chr3	57394765	57394766	Prostate cancer (gene x gene interaction)
chr3	57779835	57779836	Obesity-related traits
chr3	58027196	58027197	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)
chr3	58105775	58105776	Eating disorders (purging via substances)
chr3	58331185	58331186	Systemic lupus erythematosus and Systemic sclerosis
chr3	58370176	58370177	Systemic lupus erythematosus
chr3	58556840	58556841	Rheumatoid arthritis
chr3	59354157	59354158	Capecitabine sensitivity
chr3	59902800	59902801	Aortic root size
chr3	59921019	59921020	Response to citalopram treatment
chr3	59928850	59928851	Myopia (pathological)
chr3	59981524	59981525	Orofacial clefts
chr3	60001824	60001825	Pit-and-Fissure caries
chr3	60123521	60123522	Adverse response to lamotrigine and phenytoin
chr3	60289841	60289842	Asperger disorder
chr3	60508339	60508340	Response to amphetamines
chr3	60763255	60763256	Breast size
chr3	60771107	60771108	Attention deficit hyperactivity disorder
chr3	61127204	61127205	Bronchopulmonary dysplasia
chr3	61413813	61413814	Major depressive disorder
chr3	61794053	61794054	QT interval
chr3	62036723	62036724	Fuchs's corneal dystrophy
chr3	62064768	62064769	Schizophrenia
chr3	62112140	62112141	Metabolite levels (HVA/5-HIAA ratio)
chr3	62478193	62478194	Economic and political preferences (environmentalism)
chr3	62733365	62733366	Breast size
chr3	62782467	62782468	IgG glycosylation
chr3	63813653	63813654	Lung function (forced expiratory volume in 1 second)
chr3	63813653	63813654	Lung function (forced vital capacity)
chr3	64029382	64029383	Metabolite levels (Dihydroxy docosatrienoic acid)
chr3	64048296	64048297	Type 2 diabetes
chr3	64078008	64078009	Folate pathway vitamin levels
chr3	64173900	64173901	IgG glycosylation
chr3	64292636	64292637	Coronary artery calcification
chr3	64536647	64536648	Liver enzyme levels (alanine transaminase)
chr3	64536647	64536648	Liver enzyme levels (aspartate transaminase)
chr3	64705364	64705365	Age-related macular degeneration
chr3	64705364	64705365	Waist-hip ratio
chr3	64711903	64711904	Type 2 diabetes
chr3	64718257	64718258	Sexual dimorphism in anthropometric traits
chr3	64727085	64727086	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr3	64727085	64727086	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr3	64729891	64729892	Visceral adipose tissue adjusted for BMI
chr3	64886109	64886110	White matter integrity (interaction)
chr3	64927024	64927025	Alzheimer's disease (age of onset)
chr3	65326881	65326882	Corneal astigmatism
chr3	65398897	65398898	IgG glycosylation
chr3	65486387	65486388	PR interval
chr3	66431601	66431602	Ventricular conduction
chr3	66525962	66525963	Adverse response to chemotherapy (neutropenia/leucopenia) (all platinum-based drugs)
chr3	66525962	66525963	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)
chr3	66768363	66768364	Carotid intima media thickness
chr3	66798949	66798950	Renal function-related traits (BUN)
chr3	66809941	66809942	Metabolite levels
chr3	66823156	66823157	Hematological and biochemical traits
chr3	67143837	67143838	Migraine - clinic-based
chr3	67373976	67373977	Response to amphetamines
chr3	67416321	67416322	Height
chr3	67417104	67417105	IgE levels
chr3	67531387	67531388	Corneal astigmatism
chr3	69173374	69173375	Alzheimer's disease (late onset)
chr3	69252898	69252899	Celiac disease
chr3	69442636	69442637	Hip geometry
chr3	70463329	70463330	Body mass index
chr3	70626359	70626360	Insomnia (caffeine-induced)
chr3	71020489	71020490	Attention deficit hyperactivity disorder
chr3	71055161	71055162	Intraocular pressure
chr3	71115750	71115751	QT interval
chr3	71300566	71300567	Subcutaneous adipose tissue
chr3	71414044	71414045	IgG glycosylation
chr3	71464334	71464335	Migraine - clinic-based
chr3	72023699	72023700	Bilirubin levels
chr3	72140531	72140532	Venous thromboembolism (gene x gene interaction)
chr3	72161232	72161233	Migraine - clinic-based
chr3	72393140	72393141	Height
chr3	72437412	72437413	Height
chr3	72509270	72509271	IgG glycosylation
chr3	72509270	72509271	IgG glycosylation
chr3	72518039	72518040	IgG glycosylation
chr3	73540617	73540618	QT interval
chr3	73619560	73619561	Dialysis-related mortality
chr3	74627702	74627703	Economic and political preferences
chr3	76261819	76261820	Eating disorders (purging via substances)
chr3	76484182	76484183	Sex hormone-binding globulin levels
chr3	76722765	76722766	Periodontitis (PAL4Q3)
chr3	76725902	76725903	IgG glycosylation
chr3	77652741	77652742	Metabolite levels (5-HIAA/ MHPG Ratio)
chr3	78044688	78044689	Brain imaging in schizophrenia (interaction)
chr3	78353590	78353591	Calcium levels
chr3	78498996	78498997	Protein quantitative trait loci
chr3	79604063	79604064	Liver enzyme levels (aspartate transaminase)
chr3	80368462	80368463	Migraine
chr3	80865763	80865764	Erectile dysfunction
chr3	84202202	84202203	Obesity-related traits
chr3	84481067	84481068	Brain structure
chr3	85502844	85502845	Visceral fat
chr3	85874475	85874476	Temperament
chr3	85884149	85884150	Body mass index
chr3	85884149	85884150	Obesity
chr3	86158884	86158885	Subcutaneous adipose tissue
chr3	86158884	86158885	Subcutaneous adipose tissue
chr3	86255671	86255672	Myopia (pathological)
chr3	86850617	86850618	Pubertal anthropometrics
chr3	86894477	86894478	Prostate cancer (gene x gene interaction)
chr3	86916881	86916882	Menarche (age at onset)
chr3	86968508	86968509	Obesity-related traits
chr3	87110673	87110674	Prostate cancer
chr3	87134799	87134800	Prostate cancer
chr3	87152168	87152169	Prostate cancer
chr3	87173323	87173324	Prostate cancer
chr3	87241496	87241497	Prostate cancer
chr3	87495549	87495550	Brain connectivity
chr3	87525448	87525449	Brain connectivity
chr3	87783975	87783976	Electroencephalographic traits in alcoholism
chr3	88524174	88524175	Response to acetaminophen (hepatotoxicity)
chr3	88977896	88977897	Periodontitis (Mean PAL)
chr3	89534376	89534377	Orofacial clefts
chr3	89534376	89534377	Orofacial clefts
chr3	95688842	95688843	Male infertility
chr3	95853631	95853632	Cocaine dependence
chr3	96328826	96328827	Obesity-related traits
chr3	96400598	96400599	Blood trace element (Zn levels)
chr3	96682261	96682262	Obesity-related traits
chr3	97168739	97168740	Blood trace element (Cu levels)
chr3	98034525	98034526	Drug-induced liver injury (flucloxacillin)
chr3	99167106	99167107	RR interval (heart rate)
chr3	99266336	99266337	Chronic kidney disease and serum creatinine levels
chr3	99396271	99396272	Age-related macular degeneration
chr3	99481538	99481539	Age-related macular degeneration
chr3	99592595	99592596	Orofacial clefts
chr3	99844292	99844293	Axial length
chr3	99956555	99956556	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr3	100476712	100476713	Asthma (childhood onset)
chr3	101411977	101411978	Response to amphetamines
chr3	101748637	101748638	Multiple sclerosis
chr3	101774042	101774043	Hip geometry
chr3	101848560	101848561	Waist-to-hip circumference ratio (interaction)
chr3	102203044	102203045	Sensory disturbances after bilateral sagittal split ramus osteotomy
chr3	102203044	102203045	Type 2 diabetes
chr3	103245091	103245092	Economic and political preferences (environmentalism)
chr3	103292225	103292226	Economic and political preferences (environmentalism)
chr3	103307641	103307642	Economic and political preferences (environmentalism)
chr3	103331482	103331483	Economic and political preferences (environmentalism)
chr3	103345438	103345439	Economic and political preferences (environmentalism)
chr3	103359217	103359218	Economic and political preferences (environmentalism)
chr3	103363060	103363061	Economic and political preferences (environmentalism)
chr3	103380851	103380852	Economic and political preferences (environmentalism)
chr3	103397768	103397769	Economic and political preferences (environmentalism)
chr3	103400081	103400082	Economic and political preferences (environmentalism)
chr3	103403513	103403514	Economic and political preferences (environmentalism)
chr3	103438873	103438874	Economic and political preferences (environmentalism)
chr3	103450590	103450591	IgG glycosylation
chr3	103513435	103513436	IgG glycosylation
chr3	105010889	105010890	Erectile dysfunction
chr3	105586713	105586714	Multiple sclerosis
chr3	106288949	106288950	Cannabis dependence
chr3	107465816	107465817	Smoking behavior
chr3	108243550	108243551	Hemostatic factors and hematological phenotypes
chr3	109204412	109204413	Cardiac hypertrophy
chr3	109462399	109462400	Corneal astigmatism
chr3	109529549	109529550	Sleep depth
chr3	109789569	109789570	DNA methylation (parent-of-origin)
chr3	109927375	109927376	Neutrophil count
chr3	111201784	111201785	Chronic obstructive pulmonary disease
chr3	111233238	111233239	Chronic obstructive pulmonary disease
chr3	111423128	111423129	Cognitive performance
chr3	112269286	112269287	Asthma (childhood onset)
chr3	112376307	112376308	Atopic dermatitis
chr3	112497879	112497880	Prostate cancer (gene x gene interaction)
chr3	112681584	112681585	Economic and political preferences
chr3	112822321	112822322	Alzheimer's disease
chr3	112995073	112995074	Dental caries
chr3	113275623	113275624	Prostate cancer
chr3	113290467	113290468	Dental caries
chr3	113370009	113370010	Bone mineral density
chr3	113430598	113430599	IgG glycosylation
chr3	113680950	113680951	Crohn's disease and psoriasis
chr3	113842012	113842013	Personality dimensions
chr3	114362763	114362764	Gastric cancer
chr3	117156254	117156255	Obesity-related traits
chr3	117307566	117307567	Waist circumference
chr3	117574821	117574822	Menarche (age at onset)
chr3	118121334	118121335	White matter integrity (interaction)
chr3	118162622	118162623	Obesity-related traits
chr3	118676491	118676492	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)
chr3	118745935	118745936	Response to amphetamines
chr3	119084330	119084331	Schizophrenia
chr3	119118795	119118796	Celiac disease
chr3	119219933	119219934	Multiple sclerosis
chr3	119219933	119219934	Primary biliary cirrhosis
chr3	119219933	119219934	Primary biliary cirrhosis
chr3	119227246	119227247	Arthritis (juvenile idiopathic)
chr3	119260943	119260944	Systemic lupus erythematosus
chr3	119261374	119261375	Lobular breast cancer (menopausal hormone therapy interaction)
chr3	119288413	119288414	Vitiligo
chr3	120043835	120043836	Economic and political preferences (feminism/equality)
chr3	120236328	120236329	Obesity-related traits
chr3	120425330	120425331	Obesity-related traits
chr3	120425330	120425331	Obesity-related traits
chr3	120585314	120585315	Aging (facial)
chr3	121154192	121154193	Multiple myeloma (IgH translocation)
chr3	121344139	121344140	Cognitive performance
chr3	121660663	121660664	Multiple sclerosis
chr3	121769521	121769522	Multiple sclerosis
chr3	121793186	121793187	Multiple sclerosis
chr3	121796767	121796768	Multiple sclerosis
chr3	121993246	121993247	Calcium levels
chr3	122003756	122003757	Calcium levels
chr3	122003756	122003757	Calcium levels
chr3	122014565	122014566	Cardiac Troponin-T levels
chr3	122048643	122048644	Phosphorus levels
chr3	122329159	122329160	Major depressive disorder
chr3	122356450	122356451	Periodontitis (CDC/AAP)
chr3	122368346	122368347	QT interval
chr3	122380922	122380923	Response to angiotensin II receptor blocker therapy (opposite direction w/ diuretic therapy)
chr3	122388992	122388993	Response to angiotensin II receptor blocker therapy
chr3	122730909	122730910	Esophageal cancer
chr3	122839875	122839876	Platelet counts
chr3	123003297	123003298	Obesity-related traits
chr3	123065777	123065778	Fasting glucose-related traits
chr3	123065777	123065778	Fasting glucose-related traits
chr3	123065777	123065778	Fasting glucose-related traits (interaction with BMI)
chr3	123065777	123065778	Type 2 diabetes
chr3	123094450	123094451	Two-hour glucose challenge
chr3	123096819	123096820	Birth weight
chr3	123096819	123096820	Birth weight
chr3	124340221	124340222	Mean platelet volume
chr3	125592856	125592857	Metabolite levels (HVA/5-HIAA ratio)
chr3	125904164	125904165	Metabolite levels
chr3	126950125	126950126	Adverse response to chemotherapy in breast cancer (alopecia) (docetaxel)
chr3	126961147	126961148	Response to angiotensin II receptor blocker therapy
chr3	126993098	126993099	MRI atrophy measures
chr3	127474029	127474030	Venous thromboembolism (gene x gene interaction)
chr3	127895225	127895226	Menarche (age at onset)
chr3	128038372	128038373	Prostate cancer
chr3	128260549	128260550	Eosinophil counts
chr3	128282696	128282697	Pit-and-Fissure caries
chr3	128297568	128297569	White blood cell count
chr3	128316434	128316435	White blood cell count
chr3	128316434	128316435	White blood cell types
chr3	128316434	128316435	White blood cell types
chr3	128338599	128338600	Monocyte count
chr3	128652552	128652553	Dental caries
chr3	128658491	128658492	IgG glycosylation
chr3	129050755	129050756	Height
chr3	129971100	129971101	Response to amphetamines
chr3	131713565	131713566	Amyotrophic lateral sclerosis
chr3	131813899	131813900	Neutrophil count
chr3	132610751	132610752	Menarche (age at onset)
chr3	132693587	132693588	Alcoholism (heaviness of drinking)
chr3	132727902	132727903	IgE grass sensitization
chr3	133260873	133260874	Bulimia nervosa
chr3	133399701	133399702	Iron status biomarkers
chr3	133410660	133410661	Iron status biomarkers
chr3	133475721	133475722	Iron status biomarkers
chr3	133475811	133475812	Alcohol consumption (transferrin glycosylation)
chr3	133484028	133484029	Alcohol consumption (transferrin glycosylation)
chr3	133484028	133484029	Hepcidin levels
chr3	133484028	133484029	Iron levels
chr3	133484028	133484029	Iron status biomarkers
chr3	133484028	133484029	Iron status biomarkers
chr3	133484028	133484029	Iron status biomarkers
chr3	133494353	133494354	Alcohol consumption (transferrin glycosylation)
chr3	133508463	133508464	Iron status biomarkers
chr3	133537066	133537067	Alcohol consumption (transferrin glycosylation)
chr3	134233091	134233092	Height
chr3	135225248	135225249	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr3	135235357	135235358	Visceral adipose tissue adjusted for BMI
chr3	135587810	135587811	Anticoagulant levels
chr3	135925190	135925191	Fibrinogen
chr3	135926621	135926622	Triglycerides
chr3	135950920	135950921	Fibrinogen
chr3	135974215	135974216	Height
chr3	137108481	137108482	Metabolite levels
chr3	137447484	137447485	Acenocoumarol maintenance dosage
chr3	138025395	138025396	MRI atrophy measures
chr3	138119951	138119952	Coronary heart disease
chr3	138122121	138122122	Coronary heart disease
chr3	138713703	138713704	Keloid
chr3	138903984	138903985	Obesity and blood pressure
chr3	138903984	138903985	Obesity and blood pressure
chr3	138916392	138916393	IgG glycosylation
chr3	138916392	138916393	IgG glycosylation
chr3	139043235	139043236	Kawasaki disease
chr3	139073010	139073011	Obesity-related traits
chr3	139073010	139073011	Obesity-related traits
chr3	139606793	139606794	Visceral adipose tissue adjusted for BMI
chr3	140099692	140099693	Multiple sclerosis (OCB status)
chr3	140175359	140175360	Sudden cardiac arrest
chr3	140247176	140247177	Myopia (pathological)
chr3	140540717	140540718	Multiple sclerosis
chr3	140799212	140799213	Stroke (ischemic)
chr3	140979410	140979411	Cognitive performance
chr3	141078187	141078188	Prion diseases
chr3	141094208	141094209	Height
chr3	141094208	141094209	Height
chr3	141102832	141102833	Height
chr3	141102832	141102833	Height
chr3	141102832	141102833	Prostate cancer
chr3	141105569	141105570	Height
chr3	141105569	141105570	Height
chr3	141105569	141105570	Height
chr3	141133449	141133450	Height
chr3	141137034	141137035	Height
chr3	141143429	141143430	Height
chr3	141143429	141143430	Height
chr3	141266492	141266493	Red blood cell traits
chr3	141376139	141376140	Coronary artery calcification
chr3	141463297	141463298	Hepatitis C induced liver fibrosis
chr3	141807136	141807137	Chronic kidney disease
chr3	142430999	142431000	Type 2 diabetes
chr3	142649109	142649110	Phospholipid levels (plasma)
chr3	142894410	142894411	Non-alcoholic fatty liver disease histology (other)
chr3	142982898	142982899	Attention deficit hyperactivity disorder
chr3	143005028	143005029	Response to cholinesterase inhibitors in Alzheimer's disease
chr3	143056466	143056467	Non-alcoholic fatty liver disease histology (lobular)
chr3	143250069	143250070	Tonometry
chr3	143424821	143424822	Non-alcoholic fatty liver disease histology (other)
chr3	143504532	143504533	Response to angiotensin II receptor blocker therapy
chr3	143772246	143772247	Economic and political preferences (feminism/equality)
chr3	143778707	143778708	Economic and political preferences (feminism/equality)
chr3	143902026	143902027	Myopia (pathological)
chr3	144340204	144340205	Smoking behavior
chr3	145173787	145173788	Prostate cancer
chr3	145888456	145888457	Obesity-related traits
chr3	146402170	146402171	Barrett's esophagus
chr3	146632163	146632164	Subcutaneous adipose tissue
chr3	146816710	146816711	Functional impairment in major depressive disorder, bipolar disorder and schizophrenia
chr3	147756685	147756686	Multiple sclerosis
chr3	148913125	148913126	Serum ceruloplasmin levels
chr3	148977313	148977314	Subcutaneous adipose tissue
chr3	149250588	149250589	Preeclampsia
chr3	150042617	150042618	Adiponectin levels
chr3	150087007	150087008	IgG glycosylation
chr3	150467807	150467808	Breast cancer
chr3	150697207	150697208	IgG glycosylation
chr3	150697207	150697208	IgG glycosylation
chr3	151042463	151042464	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)
chr3	151579872	151579873	Immunoglobulin A
chr3	151763700	151763701	Schizophrenia
chr3	151830308	151830309	Infantile hypertrophic pyloric stenosis
chr3	151830308	151830309	Infantile hypertrophic pyloric stenosis
chr3	152535364	152535365	Immune reponse to smallpox (secreted IL-2)
chr3	152672778	152672779	Response to antineoplastic agents
chr3	152721974	152721975	Response to antineoplastic agents
chr3	153184655	153184656	Immune reponse to smallpox (secreted IFN-alpha)
chr3	153350115	153350116	IgG glycosylation
chr3	153472162	153472163	Infantile hypertrophic pyloric stenosis
chr3	153472162	153472163	Infantile hypertrophic pyloric stenosis
chr3	153478422	153478423	IgG glycosylation
chr3	153478422	153478423	IgG glycosylation
chr3	155267439	155267440	IgG glycosylation
chr3	156102733	156102734	Aging traits
chr3	156336554	156336555	Corneal astigmatism
chr3	156397748	156397749	Ovarian cancer
chr3	156397748	156397749	Ovarian cancer in BRCA1 mutation carriers
chr3	156406996	156406997	Ovarian cancer
chr3	156406996	156406997	Ovarian cancer
chr3	156555983	156555984	Bone mineral density
chr3	156626090	156626091	Multiple sclerosis (severity)
chr3	156797608	156797609	Adiposity in newborns
chr3	156798472	156798473	Adiposity in newborns
chr3	156798472	156798473	Adiposity in newborns
chr3	156798472	156798473	Adiposity in newborns
chr3	156798774	156798775	Birth weight
chr3	156798774	156798775	Birth weight
chr3	156836905	156836906	Eating disorders
chr3	156854741	156854742	Diabetic retinopathy
chr3	156950578	156950579	Diabetic retinopathy
chr3	158109378	158109379	Height
chr3	158453278	158453279	Tetralogy of Fallot
chr3	158514359	158514360	Periodontitis (CDC/AAP)
chr3	159259290	159259291	Quantitative traits
chr3	159644296	159644297	Major depressive disorder
chr3	159665049	159665050	Behcet's disease
chr3	159665049	159665050	Celiac disease
chr3	159665049	159665050	Celiac disease
chr3	159698944	159698945	Multiple sclerosis
chr3	159709650	159709651	Multiple sclerosis
chr3	159728877	159728878	Primary biliary cirrhosis
chr3	159728877	159728878	Primary biliary cirrhosis
chr3	159745862	159745863	Primary biliary cirrhosis
chr3	160340895	160340896	Primary biliary cirrhosis
chr3	160776963	160776964	Kawasaki disease
chr3	160820523	160820524	Menarche (age at onset)
chr3	161392575	161392576	Hyperactive-impulsive symptoms
chr3	161392575	161392576	Hyperactive-impulsive symptoms
chr3	162069008	162069009	Reading and spelling
chr3	162131407	162131408	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr3	162681994	162681995	Aging (time to death)
chr3	162834300	162834301	Capecitabine sensitivity
chr3	163761963	163761964	Bipolar disorder
chr3	163855068	163855069	Bulimia nervosa
chr3	165125158	165125159	Response to amphetamines
chr3	165280208	165280209	Heart failure
chr3	165480099	165480100	Aspirin hydrolysis (plasma)
chr3	165491279	165491280	Butyrylcholinesterase levels
chr3	165491279	165491280	Cardiovascular disease risk factors
chr3	166014468	166014469	Alzheimer's disease biomarkers
chr3	167348837	167348838	Visceral fat
chr3	167508061	167508062	Heart rate
chr3	167837747	167837748	Height
chr3	167897820	167897821	Thiazide-induced adverse metabolic effects in hypertensive patients
chr3	168686675	168686676	Aging (time to event)
chr3	168916239	168916240	Multiple myeloma (hyperdiploidy)
chr3	168971230	168971231	Osteoporosis
chr3	169082632	169082633	Nasopharyngeal carcinoma
chr3	169100885	169100886	Blood pressure
chr3	169100885	169100886	Diastolic blood pressure
chr3	169100885	169100886	Systolic blood pressure
chr3	169100898	169100899	Magnesium levels
chr3	169100898	169100899	Systolic blood pressure
chr3	169150631	169150632	Renal function-related traits (BUN)
chr3	169165887	169165888	Diastolic blood pressure
chr3	169300218	169300219	Pulmonary function
chr3	169300218	169300219	Pulmonary function (interaction)
chr3	169477505	169477506	Multiple myeloma (IgH translocation)
chr3	169481270	169481271	Telomere length
chr3	169481270	169481271	Telomere length
chr3	169492100	169492101	Celiac disease
chr3	169492100	169492101	Colorectal cancer
chr3	169492100	169492101	Multiple myeloma
chr3	169492100	169492101	Multiple sclerosis
chr3	169492100	169492101	Telomere length
chr3	169497584	169497585	Telomere length
chr3	169518454	169518455	Interstitial lung disease
chr3	169528448	169528449	Telomere length
chr3	170130101	170130102	Prostate cancer
chr3	170163473	170163474	Bipolar disorder and schizophrenia
chr3	170494408	170494409	Menopause (age at onset)
chr3	170717520	170717521	Fasting glucose-related traits
chr3	170717520	170717521	Fasting glucose-related traits
chr3	170717520	170717521	Fasting glucose-related traits (interaction with BMI)
chr3	170725541	170725542	Liver enzyme levels (gamma-glutamyl transferase)
chr3	170834558	170834559	Coronary heart disease
chr3	170971290	170971291	Brain imaging in schizophrenia (interaction)
chr3	171558343	171558344	Body mass index
chr3	171653902	171653903	Response to angiotensin II receptor blocker therapy
chr3	171785167	171785168	Heart rate
chr3	171926372	171926373	Height
chr3	171969076	171969077	Height
chr3	171995604	171995605	Corneal structure
chr3	172165726	172165727	Height
chr3	172165726	172165727	Height
chr3	172385692	172385693	Obesity-related traits
chr3	172476418	172476419	Obesity-related traits
chr3	172843276	172843277	Prostate cancer (gene x gene interaction)
chr3	173180632	173180633	Periodontitis (DPAL)
chr3	174029044	174029045	Major depressive disorder
chr3	174194242	174194243	Obesity-related traits
chr3	174893774	174893775	Kawasaki disease
chr3	174961386	174961387	Systemic lupus erythematosus
chr3	175055758	175055759	Sleep duration
chr3	175075108	175075109	Venous thromboembolism (gene x gene interaction)
chr3	175103613	175103614	Metabolite levels (MHPG)
chr3	175647164	175647165	Esophageal cancer
chr3	175927450	175927451	Height
chr3	176030095	176030096	Eosinophilic esophagitis (pediatric)
chr3	176422651	176422652	Response to amphetamines
chr3	177095071	177095072	Systemic lupus erythematosus
chr3	177228978	177228979	Alcohol consumption
chr3	177291696	177291697	Major depressive disorder (broad)
chr3	177304297	177304298	Corneal structure
chr3	177596988	177596989	Cognitive performance
chr3	177766463	177766464	Myopia (pathological)
chr3	177793106	177793107	Uric acid levels
chr3	177855631	177855632	Asthma (childhood onset)
chr3	178341581	178341582	Bipolar disorder and schizophrenia
chr3	178429938	178429939	Acute lymphoblastic leukemia (childhood)
chr3	178782020	178782021	Post-traumatic stress disorder (asjusted for relatedness)
chr3	179172978	179172979	Heart rate
chr3	179661317	179661318	Type 2 diabetes
chr3	180550701	180550702	Schizophrenia
chr3	180551213	180551214	Schizophrenia
chr3	181851283	181851284	Estradiol plasma levels (breast cancer)
chr3	182760072	182760073	Parkinson's disease
chr3	182821274	182821275	Parkinson's disease
chr3	182869817	182869818	Bipolar disorder
chr3	182870435	182870436	Bipolar disorder
chr3	183843134	183843135	Obesity-related traits
chr3	183876511	183876512	Major depressive disorder
chr3	184010047	184010048	Menarche (age at onset)
chr3	184090265	184090266	Platelet counts
chr3	184090265	184090266	Platelet counts
chr3	184216129	184216130	Alcoholism (alcohol use disorder factor score)
chr3	184514612	184514613	vWF and FVIII levels
chr3	184876782	184876783	Major depressive disorder
chr3	184945848	184945849	Cognitive performance
chr3	185141856	185141857	Airflow obstruction
chr3	185511686	185511687	Type 2 diabetes
chr3	185511686	185511687	Type 2 diabetes
chr3	185511686	185511687	Type 2 diabetes
chr3	185511686	185511687	Type 2 diabetes
chr3	185511686	185511687	Type 2 diabetes
chr3	185511686	185511687	Type 2 diabetes
chr3	185529079	185529080	Diabetes (gestational)
chr3	185529079	185529080	Fasting glucose-related traits (interaction with BMI)
chr3	185529079	185529080	Type 2 diabetes
chr3	185529079	185529080	Type 2 diabetes
chr3	185529079	185529080	Type 2 diabetes
chr3	185529079	185529080	Type 2 diabetes
chr3	185529079	185529080	Type 2 diabetes
chr3	185529079	185529080	Type 2 diabetes
chr3	185529079	185529080	Type 2 diabetes
chr3	185530289	185530290	Type 2 diabetes
chr3	185531660	185531661	Type 2 diabetes
chr3	185548682	185548683	Height
chr3	185621828	185621829	Smoking behavior
chr3	185629567	185629568	Menarche (age at onset)
chr3	185686740	185686741	Attention deficit hyperactivity disorder symptoms (interaction)
chr3	185824003	185824004	Body mass index
chr3	185824003	185824004	Obesity
chr3	185834289	185834290	Body mass index
chr3	185834289	185834290	Weight
chr3	185834498	185834499	Body mass index
chr3	185834498	185834499	Obesity
chr3	185834498	185834499	Obesity
chr3	186220062	186220063	Illicit drug use
chr3	186390626	186390627	Activated partial thromboplastin time
chr3	186390626	186390627	Activated partial thromboplastin time
chr3	186433098	186433099	Adiponectin levels
chr3	186459926	186459927	Activated partial thromboplastin time
chr3	186459926	186459927	Activated partial thromboplastin time
chr3	186466251	186466252	Myopia (pathological)
chr3	186480205	186480206	Adiponectin levels
chr3	186530483	186530484	Adiponectin levels
chr3	186548564	186548565	Adiponectin levels
chr3	186551710	186551711	Adiponectin levels
chr3	186554291	186554292	Adiponectin levels
chr3	186560781	186560782	Adiponectin levels
chr3	186570452	186570453	Adiponectin levels
chr3	186573704	186573705	Adiponectin levels
chr3	186650789	186650790	Drug-induced liver injury (flucloxacillin)
chr3	186666460	186666461	Type 2 diabetes
chr3	186722943	186722944	IgG glycosylation
chr3	186722943	186722944	IgG glycosylation
chr3	186722943	186722944	IgG glycosylation
chr3	186722943	186722944	IgG glycosylation
chr3	186722943	186722944	IgG glycosylation
chr3	186722943	186722944	IgG glycosylation
chr3	186722943	186722944	IgG glycosylation
chr3	186722943	186722944	IgG glycosylation
chr3	186722943	186722944	IgG glycosylation
chr3	186725886	186725887	IgG glycosylation
chr3	186725886	186725887	IgG glycosylation
chr3	186725886	186725887	IgG glycosylation
chr3	186725886	186725887	IgG glycosylation
chr3	186725886	186725887	IgG glycosylation
chr3	186725886	186725887	IgG glycosylation
chr3	186725886	186725887	IgG glycosylation
chr3	186725886	186725887	IgG glycosylation
chr3	186725886	186725887	IgG glycosylation
chr3	186725886	186725887	IgG glycosylation
chr3	186725886	186725887	IgG glycosylation
chr3	186725886	186725887	IgG glycosylation
chr3	186725886	186725887	IgG glycosylation
chr3	186725886	186725887	IgG glycosylation
chr3	186725886	186725887	IgG glycosylation
chr3	186725886	186725887	IgG glycosylation
chr3	186725886	186725887	IgG glycosylation
chr3	186725886	186725887	IgG glycosylation
chr3	186725886	186725887	IgG glycosylation
chr3	186732678	186732679	IgG glycosylation
chr3	186732678	186732679	IgG glycosylation
chr3	186732724	186732725	IgG glycosylation
chr3	186793241	186793242	Esophageal cancer (squamous cell)
chr3	187413990	187413991	Response to citalopram treatment
chr3	187456708	187456709	PR interval
chr3	187543341	187543342	Pulmonary function (interaction)
chr3	187649418	187649419	B cell non-Hodgkin lymphoma
chr3	187687073	187687074	Hematological and biochemical traits
chr3	187687889	187687890	Myopia (pathological)
chr3	187713717	187713718	Renal function-related traits (BUN)
chr3	187716885	187716886	Adverse response to chemotherapy (neutropenia/leucopenia) (epirubicin)
chr3	187717539	187717540	Metabolite levels
chr3	187763397	187763398	Visceral adipose tissue adjusted for BMI
chr3	187763397	187763398	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr3	187944923	187944924	White matter integrity (interaction)
chr3	188072512	188072513	Allergic sensitization
chr3	188087627	188087628	Vitiligo
chr3	188112553	188112554	Celiac disease
chr3	188112553	188112554	Celiac disease
chr3	188112553	188112554	Vitiligo
chr3	188128978	188128979	Self-reported allergy
chr3	188289696	188289697	Obesity-related traits
chr3	188420896	188420897	Body mass index
chr3	188420896	188420897	Weight
chr3	188442479	188442480	IgE levels
chr3	188584678	188584679	Immune reponse to smallpox (secreted IFN-alpha)
chr3	189113260	189113261	Axial length
chr3	189356260	189356261	Lung cancer
chr3	189356260	189356261	Lung cancer
chr3	189383182	189383183	Lung adenocarcinoma
chr3	189383182	189383183	Lung adenocarcinoma
chr3	189401775	189401776	Acute lymphoblastic leukemia (childhood)
chr3	189401775	189401776	Acute lymphoblastic leukemia (childhood)
chr3	189645932	189645933	Bladder cancer
chr3	189645932	189645933	Urinary bladder cancer
chr3	189645932	189645933	Urinary bladder cancer
chr3	189997395	189997396	Working memory
chr3	190252634	190252635	Waist circumference
chr3	190350460	190350461	Lung cancer
chr3	190669517	190669518	Alzheimer's disease biomarkers
chr3	191000807	191000808	Total ventricular volume
chr3	191196591	191196592	Bipolar disorder and schizophrenia
chr3	191521851	191521852	Immune response to smallpox vaccine (IL-6)
chr3	191667776	191667777	Response to antipsychotic treatment
chr3	191818641	191818642	Major depressive disorder
chr3	191818641	191818642	Major depressive disorder
chr3	191897217	191897218	Ileal carcinoids
chr3	191912869	191912870	Sleep quality
chr3	192093974	192093975	Metabolite levels
chr3	192772294	192772295	Sleep time
chr3	193583709	193583710	Major depressive disorder
chr3	193722329	193722330	Estradiol plasma levels (breast cancer)
chr3	194327097	194327098	QT interval
chr3	194737872	194737873	Metabolite levels (Pyroglutamine)
chr3	194758009	194758010	Attention deficit hyperactivity disorder (time to onset)
chr3	194858373	194858374	Non-small cell lung cancer
chr3	195596906	195596907	Bronchopulmonary dysplasia
chr3	195751629	195751630	Pancreatic cancer
chr3	195800546	195800547	Mean corpuscular volume
chr3	195809138	195809139	Mean corpuscular hemoglobin
chr3	195834356	195834357	Red blood cell traits
chr3	195907652	195907653	Mean corpuscular hemoglobin
chr3	195907652	195907653	Mean corpuscular volume
chr3	196078426	196078427	Obesity-related traits
chr3	196187607	196187608	Fat distribution (HIV)
chr3	196553866	196553867	Total ventricular volume
chr4	282498	282499	Immune response to smallpox vaccine (IL-6)
chr4	735149	735150	Hemostatic factors and hematological phenotypes
chr4	852312	852313	Parkinson's disease (familial)
chr4	858331	858332	Parkinson's disease
chr4	939086	939087	Parkinson's disease
chr4	939112	939113	Parkinson's disease
chr4	964358	964359	Parkinson's disease
chr4	964358	964359	Parkinson's disease
chr4	964358	964359	Parkinson's disease
chr4	994413	994414	Bone mineral density
chr4	1039214	1039215	Obesity-related traits
chr4	1078186	1078187	Recombination rate (females)
chr4	1095280	1095281	Recombination rate (males)
chr4	1254534	1254535	Type 2 diabetes
chr4	1291112	1291113	Obesity-related traits
chr4	1309900	1309901	Type 2 diabetes
chr4	1309900	1309901	Type 2 diabetes
chr4	1365126	1365127	Longevity
chr4	1701316	1701317	Height
chr4	1734238	1734239	Bladder cancer
chr4	1734238	1734239	Urinary bladder cancer
chr4	2103095	2103096	Alzheimer's disease
chr4	2395296	2395297	Schizophrenia
chr4	3449651	3449652	Fibrinogen
chr4	4648046	4648047	Congenital heart disease
chr4	4704013	4704014	Response to amphetamines
chr4	4719493	4719494	Alcohol dependence
chr4	5110139	5110140	Sensory disturbances after bilateral sagittal split ramus osteotomy
chr4	5162388	5162389	Celiac disease
chr4	5221537	5221538	Electrocardiographic conduction measures
chr4	5237152	5237153	Alzheimer's disease (cognitive decline)
chr4	5758868	5758869	Prostate cancer (gene x gene interaction)
chr4	5930032	5930033	Blood trace element (Zn levels)
chr4	6058496	6058497	Response to angiotensin II receptor blocker therapy
chr4	6183183	6183184	IgG glycosylation
chr4	6270055	6270056	Type 2 diabetes and other traits
chr4	6303021	6303022	Type 2 diabetes
chr4	6697765	6697766	Obesity-related traits
chr4	6736364	6736365	IgG glycosylation
chr4	6891518	6891519	Mean platelet volume
chr4	6891518	6891519	Mean platelet volume
chr4	7018184	7018185	IgG glycosylation
chr4	7159701	7159702	Coronary artery calcification
chr4	7219932	7219933	Insulin-like growth factors
chr4	7423750	7423751	Obesity-related traits
chr4	7423750	7423751	Obesity-related traits
chr4	8503358	8503359	Response to antineoplastic agents
chr4	9790711	9790712	Economic and political preferences
chr4	9915740	9915741	Urate levels
chr4	9922166	9922167	Urate levels
chr4	9922166	9922167	Uric acid levels
chr4	9923003	9923004	Gout
chr4	9923003	9923004	Serum uric acid levels
chr4	9923003	9923004	Uric acid levels
chr4	9923003	9923004	Uric acid levels
chr4	9926966	9926967	Biochemical measures
chr4	9926966	9926967	Urate levels
chr4	9926966	9926967	Urate levels
chr4	9926966	9926967	Uric acid levels
chr4	9934743	9934744	Urate levels
chr4	9935909	9935910	Urate levels
chr4	9944051	9944052	Urate levels
chr4	9946655	9946656	Gout
chr4	9956078	9956079	Metabolic traits
chr4	9966379	9966380	Urate levels
chr4	9966379	9966380	Urate levels
chr4	9994214	9994215	Uric acid levels
chr4	9994214	9994215	Uric acid levels
chr4	9995181	9995182	Renal function-related traits (urea)
chr4	9995181	9995182	Uric acid levels
chr4	10050140	10050141	Alzheimer's disease
chr4	10056375	10056376	Cardiovascular disease risk factors
chr4	10062325	10062326	Alzheimer's disease
chr4	10104669	10104670	Uric acid levels
chr4	10286300	10286301	Uric acid levels
chr4	10324159	10324160	Bone mineral density
chr4	10331293	10331294	Cardiovascular disease risk factors
chr4	10726852	10726853	Myopia (pathological)
chr4	10726852	10726853	Vitiligo
chr4	11503603	11503604	Nonalcoholic fatty liver disease
chr4	11674660	11674661	Obesity-related traits
chr4	12111548	12111549	Metabolite levels (MHPG)
chr4	12498886	12498887	Obesity-related traits
chr4	12500220	12500221	Obesity-related traits
chr4	12579845	12579846	IgG glycosylation
chr4	12769231	12769232	Word reading
chr4	12773993	12773994	Response to mTOR inhibitor (everolimus)
chr4	13102350	13102351	Inflammatory biomarkers
chr4	13116761	13116762	Response to antidepressant treatment
chr4	13122534	13122535	Response to antidepressant treatment
chr4	13794415	13794416	Hemostatic factors and hematological phenotypes
chr4	13914372	13914373	Response to antipsychotic therapy (extrapyramidal side effects)
chr4	14144207	14144208	Obesity-related traits
chr4	15397363	15397364	Conduct disorder (symptom count)
chr4	15397905	15397906	Conduct disorder (case status)
chr4	15482359	15482360	Conduct disorder (case status)
chr4	15545409	15545410	Obesity-related traits
chr4	15737100	15737101	Parkinson's disease
chr4	15737347	15737348	Parkinson's disease
chr4	15737347	15737348	Parkinson's disease
chr4	15737936	15737937	Parkinson's disease
chr4	15964862	15964863	QT interval
chr4	16002287	16002288	Self-rated health
chr4	16018323	16018324	Dental caries
chr4	16022539	16022540	Smooth-surface caries
chr4	16514407	16514408	Rhegmatogenous retinal detachment
chr4	16893892	16893893	QT interval
chr4	16908003	16908004	QT interval
chr4	17135342	17135343	Temperament (bipolar disorder)
chr4	17221232	17221233	Metabolite levels (Pyroglutamine)
chr4	17797965	17797966	Height
chr4	17919810	17919811	Height
chr4	17944839	17944840	Height
chr4	17946431	17946432	Height
chr4	17952207	17952208	Height
chr4	17993409	17993410	Birth weight
chr4	17993409	17993410	Height
chr4	18017729	18017730	Height
chr4	18017729	18017730	Height
chr4	18017729	18017730	Height
chr4	18033487	18033488	Height
chr4	18128640	18128641	Illicit drug use
chr4	18866168	18866169	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+doxorubicin+/-5FU)
chr4	20495134	20495135	Echocardiographic traits
chr4	20620682	20620683	Echocardiographic traits
chr4	21206489	21206490	IgG glycosylation
chr4	21206489	21206490	IgG glycosylation
chr4	21455256	21455257	IgG glycosylation
chr4	21476989	21476990	Suicidal ideation
chr4	21511382	21511383	Obesity-related traits
chr4	21571086	21571087	Obesity-related traits
chr4	22021499	22021500	Obesity-related traits
chr4	23588461	23588462	Thiazide-induced adverse metabolic effects in hypertensive patients
chr4	24375832	24375833	Molar-incisor hypomineralization
chr4	24578096	24578097	Myopia (pathological)
chr4	24740957	24740958	Major depressive disorder
chr4	25403265	25403266	Weight
chr4	25417243	25417244	Rheumatoid arthritis
chr4	25810095	25810096	Non-alcoholic fatty liver disease histology (other)
chr4	25942750	25942751	Obesity-related traits
chr4	26085510	26085511	Type 1 diabetes
chr4	26108196	26108197	Rheumatoid arthritis
chr4	26108196	26108197	Rheumatoid arthritis
chr4	26137018	26137019	Obesity-related traits
chr4	26944313	26944314	Phospholipid levels (plasma)
chr4	27000994	27000995	Obesity-related traits
chr4	27194070	27194071	QT interval
chr4	29903051	29903052	Attention deficit hyperactivity disorder motor coordination
chr4	30068212	30068213	Obesity-related traits
chr4	30468165	30468166	Alzheimer's disease
chr4	31156177	31156178	Bulimia nervosa
chr4	31397617	31397618	Lipid traits
chr4	33079654	33079655	Brain structure (temporal lobe volume)
chr4	33203139	33203140	Alzheimer's disease (age of onset)
chr4	33624701	33624702	Response to antidepressant treatment
chr4	34893854	34893855	Response to antipsychotic treatment
chr4	34925063	34925064	Body mass index (non-asthmatics)
chr4	35372097	35372098	Response to TNF antagonist treatment
chr4	35410630	35410631	QT interval
chr4	35983110	35983111	Obesity-related traits
chr4	35983110	35983111	Obesity-related traits
chr4	35983110	35983111	Obesity-related traits
chr4	36026746	36026747	Adverse response to chemotherapy (neutropenia/leucopenia) (5-fluorouracil)
chr4	36079593	36079594	Amyotrophic lateral sclerosis (age of onset)
chr4	37064330	37064331	Multiple sclerosis--Brain Glutamate Levels
chr4	37645388	37645389	IgG glycosylation
chr4	37647233	37647234	IgG glycosylation
chr4	37651154	37651155	IgG glycosylation
chr4	37938517	37938518	Periodontal microbiota
chr4	38325035	38325036	Crohn's disease
chr4	38335822	38335823	Crohn's disease
chr4	38465470	38465471	Obesity-related traits
chr4	38784723	38784724	Helicobacter pylori serologic status
chr4	38792523	38792524	Alcohol consumption
chr4	38811550	38811551	Self-reported allergy
chr4	38812875	38812876	Allergic sensitization
chr4	39088340	39088341	Asthma (childhood onset)
chr4	40303632	40303633	Graves' disease
chr4	40973526	40973527	Dental caries
chr4	41284710	41284711	Cognitive performance
chr4	41639515	41639516	Migraine with aura
chr4	42453252	42453253	Immune reponse to smallpox (secreted IFN-alpha)
chr4	43052185	43052186	Obesity-related traits
chr4	43320506	43320507	Metabolite levels (5-HIAA/ MHPG Ratio)
chr4	43537599	43537600	Anticoagulant levels
chr4	44212164	44212165	Response to amphetamines
chr4	45175690	45175691	Body mass index
chr4	45175690	45175691	Obesity
chr4	45175690	45175691	Obesity
chr4	45182526	45182527	Body mass index
chr4	45182526	45182527	Body mass index
chr4	45182526	45182527	Body mass index
chr4	45182526	45182527	Obesity
chr4	45184441	45184442	Body mass index
chr4	45364913	45364914	Adiponectin levels
chr4	46823633	46823634	Migraine - clinic-based
chr4	46968049	46968050	Type 2 diabetes
chr4	47408708	47408709	Obesity-related traits
chr4	47551862	47551863	Sphingolipid levels
chr4	47563447	47563448	Sphingolipid levels
chr4	48363982	48363983	Crohn's disease
chr4	49062891	49062892	Response to hepatitis C treatment
chr4	53412128	53412129	Biochemical measures
chr4	53756999	53757000	Optic disc size (cup)
chr4	54330866	54330867	DNA methylation (variation)
chr4	54799244	54799245	Blood pressure
chr4	55087580	55087581	Corneal astigmatism
chr4	55087580	55087581	Corneal curvature
chr4	55092625	55092626	Corneal curvature
chr4	55124459	55124460	Corneal astigmatism
chr4	55234824	55234825	Height
chr4	55241580	55241581	Response to amphetamines
chr4	55394171	55394172	Mean corpuscular hemoglobin
chr4	55394171	55394172	Mean corpuscular volume
chr4	55394171	55394172	Red blood cell count
chr4	55395023	55395024	Red blood cell traits
chr4	55407761	55407762	Mean corpuscular volume
chr4	55407761	55407762	Mean corpuscular volume
chr4	55482817	55482818	Bipolar disorder
chr4	56298193	56298194	Personality dimensions
chr4	56467213	56467214	Adiponectin levels
chr4	56668430	56668431	Alzheimer's disease
chr4	56751739	56751740	Cervical cancer
chr4	57334111	57334112	Airflow obstruction
chr4	57786449	57786450	Age-related macular degeneration
chr4	57821308	57821309	Bleomycin sensitivity
chr4	57823475	57823476	Height
chr4	57939862	57939863	IgG glycosylation
chr4	59008411	59008412	Cognitive performance
chr4	59213844	59213845	Asthma (childhood onset)
chr4	59305131	59305132	Corneal curvature
chr4	59503725	59503726	Acute lymphoblastic leukemia (childhood)
chr4	60748828	60748829	Metabolite levels
chr4	61966272	61966273	Biochemical measures
chr4	62437317	62437318	Working memory
chr4	62453208	62453209	Partial epilepsies
chr4	63342269	63342270	Age-related macular degeneration
chr4	63424088	63424089	Adverse response to chemotherapy (neutropenia/leucopenia) (cisplatin)
chr4	63893277	63893278	Bulimia nervosa
chr4	65170414	65170415	Kawasaki disease
chr4	65273839	65273840	Axial length
chr4	65392211	65392212	Post-traumatic stress disorder (asjusted for relatedness)
chr4	67300801	67300802	Obesity-related traits
chr4	67301041	67301042	Sleep quality
chr4	67357453	67357454	Colorectal cancer
chr4	67733856	67733857	Cognitive test performance
chr4	68064439	68064440	Multiple sclerosis (severity)
chr4	68447248	68447249	Parkinson's disease
chr4	69167670	69167671	Obesity-related traits
chr4	69591781	69591782	Sex hormone-binding globulin levels
chr4	69591781	69591782	Sex hormone-binding globulin levels
chr4	69972462	69972463	Obesity-related traits
chr4	71329489	71329490	Alcoholism (heaviness of drinking)
chr4	72126888	72126889	QT interval
chr4	72604298	72604299	Non-alcoholic fatty liver disease histology (other)
chr4	72608382	72608383	Vitamin D insufficiency
chr4	72608382	72608383	Vitamin D levels
chr4	72608382	72608383	Vitamin D levels
chr4	72707820	72707821	Metabolite levels
chr4	73322564	73322565	Lipid metabolism phenotypes
chr4	73417523	73417524	Dental caries
chr4	73417523	73417524	Dental caries
chr4	73515312	73515313	Height
chr4	73645350	73645351	Metabolite levels
chr4	73783403	73783404	Dialysis-related mortality
chr4	74319282	74319283	Tumor biomarkers
chr4	74349157	74349158	Prostate cancer
chr4	74857707	74857708	Inflammatory bowel disease
chr4	74872444	74872445	Metabolite levels
chr4	74956371	74956372	White blood cell types
chr4	74977836	74977837	White blood cell count
chr4	75223710	75223711	Metabolite levels
chr4	75224589	75224590	Attention deficit hyperactivity disorder
chr4	75502486	75502487	Breast size
chr4	76030920	76030921	QT interval
chr4	76332974	76332975	Prion diseases
chr4	76416386	76416387	Response to tocilizumab in rheumatoid arthritis
chr4	76481729	76481730	Parkinson's disease (motor and cognition)
chr4	76889387	76889388	Longevity
chr4	77198985	77198986	Parkinson's disease
chr4	77198985	77198986	Parkinson's disease
chr4	77360430	77360431	Creatinine levels
chr4	77368846	77368847	Chronic kidney disease
chr4	77368846	77368847	Renal function and chronic kidney disease
chr4	77398014	77398015	Glomerular filtration rate
chr4	77410317	77410318	Glomerular filtration rate
chr4	77412139	77412140	Magnesium levels
chr4	77412139	77412140	Renal function-related traits (eGRFcrea)
chr4	77412139	77412140	Renal function-related traits (sCR)
chr4	77418680	77418681	Eosinophilic esophagitis (pediatric)
chr4	77420783	77420784	Eosinophilic esophagitis (pediatric)
chr4	77771344	77771345	Adverse response to lamotrigine and phenytoin
chr4	77955204	77955205	Waist-to-hip circumference ratio (interaction)
chr4	78136932	78136933	Response to tocilizumab in rheumatoid arthritis
chr4	78341659	78341660	Lung function (forced expiratory volume in 1 second to forced vital capacity ratio)
chr4	79079756	79079757	Uric acid levels
chr4	79280692	79280693	Hair morphology
chr4	79513214	79513215	Rheumatoid arthritis
chr4	79589044	79589045	Non-albumin protein levels
chr4	80530670	80530671	Refractive error
chr4	80564507	80564508	Quantitative traits
chr4	80946474	80946475	Ankylosing spondylitis
chr4	80949828	80949829	Ankylosing spondylitis
chr4	81164722	81164723	Blood pressure
chr4	81164722	81164723	Diastolic blood pressure
chr4	81164722	81164723	Systolic blood pressure
chr4	81169911	81169912	Urate levels
chr4	81184340	81184341	Diastolic blood pressure
chr4	81535392	81535393	Obesity-related traits
chr4	81930813	81930814	Refractive error
chr4	82144925	82144926	Pubertal anthropometrics
chr4	82149830	82149831	Height
chr4	82149830	82149831	Height
chr4	82150005	82150006	Height
chr4	82165789	82165790	Height
chr4	82184233	82184234	Height
chr4	82462596	82462597	Major depressive disorder
chr4	83499312	83499313	Cognitive performance
chr4	84373621	84373622	Menopause (age at onset)
chr4	84374479	84374480	Upper aerodigestive tract cancers
chr4	84721813	84721814	Obesity-related traits
chr4	86129615	86129616	IgG glycosylation
chr4	86641148	86641149	PR interval
chr4	86651463	86651464	Electrocardiographic traits
chr4	86683559	86683560	PR interval
chr4	86715311	86715312	Obesity-related traits
chr4	87473775	87473776	Migraine - clinic-based
chr4	87754418	87754419	Insulin-related traits
chr4	87832600	87832601	Amyotrophic lateral sclerosis
chr4	87931403	87931404	Alzheimer's disease (cognitive decline)
chr4	87958394	87958395	Systemic lupus erythematosus
chr4	88030260	88030261	Triglycerides
chr4	88030260	88030261	Triglycerides
chr4	88076128	88076129	Bulimia nervosa
chr4	88186508	88186509	Platelet counts
chr4	88213807	88213808	Liver enzyme levels (alanine transaminase)
chr4	88732691	88732692	Bone mineral density
chr4	88755827	88755828	Cardiovascular disease risk factors
chr4	88773848	88773849	Bone mineral density
chr4	88775242	88775243	Bone mineral density (hip)
chr4	88775242	88775243	Bone mineral density (spine)
chr4	88919105	88919106	Caffeine consumption
chr4	88959921	88959922	Renal function-related traits (urea)
chr4	89039081	89039082	Gout
chr4	89039081	89039082	Response to statin therapy (LDL-C)
chr4	89052322	89052323	Gout
chr4	89052322	89052323	Serum uric acid levels
chr4	89052322	89052323	Urate levels
chr4	89052322	89052323	Urate levels
chr4	89052322	89052323	Uric acid levels
chr4	89052322	89052323	Uric acid levels
chr4	89052322	89052323	Uric acid levels
chr4	89054666	89054667	Urate levels
chr4	89064580	89064581	Dental caries
chr4	89203669	89203670	Conduct disorder (interaction)
chr4	89220943	89220944	Bipolar disorder
chr4	89226421	89226422	Metabolite levels
chr4	89226421	89226422	Metabolite levels
chr4	89421085	89421086	Pulmonary function decline
chr4	89811194	89811195	Interstitial lung disease
chr4	89869331	89869332	Pulmonary function
chr4	89869331	89869332	Pulmonary function (interaction)
chr4	89875908	89875909	Chronic obstructive pulmonary disease
chr4	89883978	89883979	Chronic obstructive pulmonary disease
chr4	89978799	89978800	Response to antipsychotic therapy (extrapyramidal side effects)
chr4	90637600	90637601	Parkinson's disease
chr4	90637600	90637601	Parkinson's disease
chr4	90639514	90639515	Parkinson's disease
chr4	90641339	90641340	Parkinson's disease
chr4	90641339	90641340	Parkinson's disease
chr4	90641339	90641340	Parkinson's disease
chr4	90641339	90641340	Parkinson's disease
chr4	90641339	90641340	Parkinson's disease
chr4	90678540	90678541	Parkinson's disease
chr4	90678540	90678541	Parkinson's disease
chr4	90780901	90780902	Parkinson's disease
chr4	90797300	90797301	Parkinson's disease
chr4	91401610	91401611	Metabolite levels (HVA)
chr4	91401610	91401611	Metabolite levels (HVA-5-HIAA Factor score)
chr4	92003896	92003897	Response to amphetamines
chr4	92415528	92415529	DNA methylation (variation)
chr4	92917214	92917215	IgG glycosylation
chr4	92917214	92917215	IgG glycosylation
chr4	93321026	93321027	Obesity-related traits
chr4	94887030	94887031	Colorectal cancer
chr4	95146134	95146135	Bipolar disorder and schizophrenia
chr4	95153348	95153349	Capecitabine sensitivity
chr4	95224811	95224812	Testicular germ cell tumor
chr4	95514608	95514609	Prostate cancer
chr4	95562876	95562877	Prostate cancer
chr4	95614277	95614278	Visceral fat
chr4	95615768	95615769	Estradiol plasma levels (breast cancer)
chr4	95643956	95643957	QT interval
chr4	95834033	95834034	Attention deficit hyperactivity disorder
chr4	95856680	95856681	Hypertension
chr4	96159816	96159817	P-tau181p
chr4	96467502	96467503	Obesity-related traits
chr4	97880408	97880409	Response to mTOR inhibitor (everolimus)
chr4	99337880	99337881	Biochemical measures
chr4	99796783	99796784	Primary biliary cirrhosis
chr4	100011170	100011171	Obesity-related traits
chr4	100056997	100056998	Esophageal cancer  (alcohol interaction)
chr4	100137493	100137494	QRS duration
chr4	100163872	100163873	Cardiac Troponin-T levels
chr4	100228465	100228466	Esophageal cancer  (alcohol interaction)
chr4	100239318	100239319	Alcohol consumption
chr4	100239318	100239319	Alcohol dependence
chr4	100239318	100239319	Esophageal cancer
chr4	100239318	100239319	Upper aerodigestive tract cancers
chr4	100250418	100250419	Alcohol dependence
chr4	100250418	100250419	Conduct disorder (interaction)
chr4	100274285	100274286	Upper aerodigestive tract cancers
chr4	100322444	100322445	Hypertension
chr4	100341860	100341861	Upper aerodigestive tract cancers
chr4	100395413	100395414	Eating disorders
chr4	100444683	100444684	Metabolite levels (MHPG)
chr4	100539895	100539896	Celiac disease
chr4	100713764	100713765	Response to antipsychotic treatment
chr4	101806531	101806532	Response to angiotensin II receptor blocker therapy
chr4	101931825	101931826	Response to antipsychotic treatment
chr4	102037718	102037719	Corneal structure
chr4	102402214	102402215	C-reactive protein and white blood cell count
chr4	102560289	102560290	Blood pressure
chr4	102589282	102589283	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr4	102715887	102715888	Systemic lupus erythematosus
chr4	102751075	102751076	Systemic lupus erythematosus
chr4	102865303	102865304	Crohn's disease
chr4	103188708	103188709	Blood pressure
chr4	103188708	103188709	Body mass index
chr4	103188708	103188709	Diastolic blood pressure
chr4	103188708	103188709	HDL cholesterol
chr4	103188708	103188709	Hypertension
chr4	103188708	103188709	Systolic blood pressure
chr4	103457417	103457418	Schizophrenia (treatment refractory)
chr4	103511113	103511114	Ulcerative colitis
chr4	103551602	103551603	Primary biliary cirrhosis
chr4	103578636	103578637	Multiple sclerosis
chr4	104054685	104054686	Testicular germ cell tumor
chr4	104137789	104137790	Testicular germ cell tumor
chr4	105844272	105844273	Tuberculosis
chr4	106048359	106048360	Pulmonary function
chr4	106061533	106061534	Prostate cancer
chr4	106084777	106084778	Breast cancer
chr4	106106352	106106353	Height
chr4	106134315	106134316	Height
chr4	106268593	106268594	Immune response to anthrax vaccine
chr4	106297512	106297513	Response to antipsychotic treatment
chr4	106451310	106451311	Economic and political preferences (time)
chr4	106457329	106457330	Response to antipsychotic therapy (extrapyramidal side effects)
chr4	106463712	106463713	Economic and political preferences (time)
chr4	106578753	106578754	Lung function (forced expiratory volume in 1 second)
chr4	106619139	106619140	Pulmonary function
chr4	106688903	106688904	Pulmonary function
chr4	106808106	106808107	Pulmonary function (interaction)
chr4	107000461	107000462	Airflow obstruction
chr4	108115221	108115222	Mean forced vital capacity from 2 exams
chr4	109016823	109016824	Chronic lymphocytic leukemia
chr4	109046959	109046960	Systemic lupus erythematosus
chr4	109217928	109217929	Airflow obstruction
chr4	109723125	109723126	Systemic lupus erythematosus
chr4	110590478	110590479	Age-related macular degeneration
chr4	110638809	110638810	Age-related macular degeneration
chr4	110659066	110659067	Age-related macular degeneration
chr4	110659066	110659067	Age-related macular degeneration
chr4	110659066	110659067	Age-related macular degeneration (CNV)
chr4	110659066	110659067	Age-related macular degeneration (GA)
chr4	110800096	110800097	Exercise treadmill test traits
chr4	110825633	110825634	Hair morphology
chr4	110897584	110897585	IgG glycosylation
chr4	110897584	110897585	IgG glycosylation
chr4	110897584	110897585	IgG glycosylation
chr4	110964361	110964362	Obesity-related traits
chr4	111026926	111026927	Attention deficit hyperactivity disorder
chr4	111227815	111227816	IgG glycosylation
chr4	111334729	111334730	Metabolic traits
chr4	111381637	111381638	Blood pressure
chr4	111381637	111381638	Blood pressure
chr4	111705767	111705768	Atrial fibrillation
chr4	111708286	111708287	Atrial fibrillation
chr4	111710168	111710169	Atrial fibrillation
chr4	111710168	111710169	Atrial fibrillation/atrial flutter
chr4	111710168	111710169	Stroke (ischemic)
chr4	111718066	111718067	Atrial fibrillation
chr4	111718066	111718067	Stroke (ischemic)
chr4	111718066	111718067	Stroke (ischemic)
chr4	111720760	111720761	Atrial fibrillation/atrial flutter
chr4	112611749	112611750	Myopia (pathological)
chr4	112702634	112702635	Myopia (pathological)
chr4	112923236	112923237	Coronary heart disease
chr4	113311789	113311790	Obesity
chr4	113328077	113328078	Epirubicin-induced leukopenia
chr4	113948789	113948790	Blood trace element (Cu levels)
chr4	114000955	114000956	Prostate cancer (gene x gene interaction)
chr4	114379378	114379379	White matter integrity (interaction)
chr4	116196305	116196306	Resistin levels
chr4	116924183	116924184	Age-related macular degeneration
chr4	116934078	116934079	Age-related macular degeneration
chr4	117254288	117254289	Sudden cardiac arrest
chr4	117849448	117849449	IgG glycosylation
chr4	117849448	117849449	IgG glycosylation
chr4	117875260	117875261	Bronchopulmonary dysplasia
chr4	118079906	118079907	Visceral adipose tissue adjusted for BMI
chr4	118093136	118093137	Obesity (extreme)
chr4	118332254	118332255	QT interval
chr4	118651822	118651823	Neutrophil count
chr4	119863475	119863476	IgE levels in asthmatics
chr4	120187610	120187611	Corneal astigmatism
chr4	120962384	120962385	F-cell distribution
chr4	121513214	121513215	F-cell distribution
chr4	121801789	121801790	Fasting plasma glucose
chr4	121801789	121801790	Fasting plasma glucose
chr4	121862500	121862501	Obesity-related traits
chr4	122607177	122607178	Chronic obstructive pulmonary disease
chr4	122665513	122665514	Type 2 diabetes
chr4	123115501	123115502	Celiac disease
chr4	123132491	123132492	Type 1 diabetes
chr4	123161618	123161619	Inflammatory bowel disease
chr4	123198434	123198435	Type 1 diabetes
chr4	123218312	123218313	Rheumatoid arthritis
chr4	123329361	123329362	Self-reported allergy
chr4	123329361	123329362	Type 1 diabetes
chr4	123329361	123329362	Type 1 diabetes autoantibodies
chr4	123329361	123329362	Ulcerative colitis
chr4	123353431	123353432	Allergic sensitization
chr4	123373132	123373133	IgE grass sensitization
chr4	123377979	123377980	Type 1 diabetes autoantibodies
chr4	123478715	123478716	Progressive supranuclear palsy
chr4	123509420	123509421	Celiac disease
chr4	123509420	123509421	Celiac disease
chr4	123523874	123523875	Alopecia areata
chr4	125265312	125265313	Major depressive disorder
chr4	125415533	125415534	Major depressive disorder
chr4	125993501	125993502	Bilirubin levels
chr4	126359455	126359456	Bipolar disorder and major depressive disorder (combined)
chr4	126426694	126426695	Cognitive performance
chr4	126431918	126431919	Smoking behavior
chr4	126933291	126933292	Subclinical atherosclerosis traits (other)
chr4	128320907	128320908	Obesity-related traits
chr4	128342119	128342120	Obesity-related traits
chr4	128466699	128466700	IgG glycosylation
chr4	129696220	129696221	Thiazide-induced adverse metabolic effects in hypertensive patients
chr4	130731283	130731284	Obesity
chr4	131026487	131026488	Metabolite levels (HVA/MHPG ratio)
chr4	131137760	131137761	RR interval (heart rate)
chr4	131790500	131790501	Multiple sclerosis (severity)
chr4	133326394	133326395	Eating disorders
chr4	134947800	134947801	Lung function (forced expiratory volume in 1 second)
chr4	135522739	135522740	Coronary heart disease
chr4	136193339	136193340	Sexual dimorphism in anthropometric traits
chr4	137526583	137526584	DNA methylation (parent-of-origin)
chr4	137660382	137660383	Longevity
chr4	138134580	138134581	Adverse response to radiation therapy
chr4	138154811	138154812	Retinopathy in non-diabetics
chr4	138227608	138227609	Temperament
chr4	138582710	138582711	Obesity-related traits
chr4	138692249	138692250	Systemic lupus erythematosus
chr4	140423133	140423134	Smoking behavior
chr4	140795326	140795327	Congenital heart malformation
chr4	141387437	141387438	Select biomarker traits
chr4	142005572	142005573	Chronic obstructive pulmonary disease-related biomarkers
chr4	142117423	142117424	Conduct disorder (case status)
chr4	142142728	142142729	Conduct disorder (case status)
chr4	142709722	142709723	Response to treatment for acute lymphoblastic leukemia
chr4	144003158	144003159	Asthma
chr4	144357736	144357737	Asthma
chr4	145436323	145436324	Pulmonary function
chr4	145460229	145460230	Pulmonary function
chr4	145480779	145480780	Chronic obstructive pulmonary disease
chr4	145485737	145485738	Pulmonary function
chr4	145485737	145485738	Pulmonary function (interaction)
chr4	145486388	145486389	Chronic obstructive pulmonary disease
chr4	145506455	145506456	Chronic obstructive pulmonary disease
chr4	145522757	145522758	Height
chr4	145568351	145568352	Height
chr4	145568351	145568352	Height
chr4	145574843	145574844	Height
chr4	145574843	145574844	Height
chr4	145574843	145574844	Height
chr4	145643078	145643079	Height
chr4	145650020	145650021	Height
chr4	146769073	146769074	Behavioural disinhibition (generation interaction)
chr4	146794620	146794621	Liver enzyme levels (gamma-glutamyl transferase)
chr4	146821409	146821410	Gamma glutamyl transpeptidase
chr4	146853164	146853165	Immune reponse to smallpox (secreted IFN-alpha)
chr4	146875550	146875551	Smooth-surface caries
chr4	146904303	146904304	Dental caries
chr4	147499337	147499338	Heart rate
chr4	148047549	148047550	Coronary heart disease
chr4	148282341	148282342	Dental caries
chr4	148322386	148322387	Obesity-related traits
chr4	148393663	148393664	Carotid intima media thickness
chr4	148393663	148393664	Carotid intima media thickness
chr4	148400818	148400819	Intracranial aneurysm
chr4	148612487	148612488	Obesity-related traits
chr4	148974601	148974602	QT interval
chr4	149079496	149079497	Corneal structure
chr4	149311727	149311728	Subcutaneous adipose tissue
chr4	149321345	149321346	Biochemical measures
chr4	149570679	149570680	Non-alcoholic fatty liver disease histology (other)
chr4	149635024	149635025	Hypothyroidism
chr4	149652609	149652610	Thyroid function
chr4	149669505	149669506	Thyroid hormone levels
chr4	149669505	149669506	Thyroid hormone levels
chr4	150725211	150725212	Epilepsy (generalized)
chr4	150901756	150901757	Visceral adipose tissue adjusted for BMI
chr4	152907699	152907700	Volumetric brain MRI
chr4	152908168	152908169	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr4	153893353	153893354	Amyotrophic lateral sclerosis
chr4	153896159	153896160	Obesity-related traits
chr4	154153999	154154000	Multiple sclerosis
chr4	154374983	154374984	Adverse response to chemotherapy (neutropenia/leucopenia) (all antimicrotubule drugs)
chr4	154703595	154703596	Electrocardiographic conduction measures
chr4	154864749	154864750	DNA methylation (parent-of-origin)
chr4	154995462	154995463	Obesity-related traits
chr4	155301058	155301059	Fibrinogen
chr4	155347392	155347393	Alzheimer's disease (age of onset)
chr4	155389246	155389247	Bilirubin levels
chr4	155451758	155451759	Fibrinogen
chr4	155481288	155481289	Chronic obstructive pulmonary disease-related biomarkers
chr4	155482742	155482743	Fibrinogen
chr4	155483913	155483914	Fibrinogen
chr4	155488820	155488821	Fibrinogen
chr4	155507589	155507590	Fibrinogen
chr4	155514878	155514879	D-dimer levels
chr4	155520929	155520930	Venous thromboembolism
chr4	155542247	155542248	Fibrinogen
chr4	155543368	155543369	Venous thromboembolism
chr4	155654420	155654421	Alzheimer's disease
chr4	156511458	156511459	Coronary heart disease
chr4	156645512	156645513	Blood pressure
chr4	156645512	156645513	Diastolic blood pressure
chr4	156645512	156645513	Systolic blood pressure
chr4	156998540	156998541	Speech perception in dyslexia
chr4	157720123	157720124	Fasting insulin-related traits (interaction with BMI)
chr4	159630816	159630817	Metabolic traits
chr4	159630816	159630817	Metabolite levels
chr4	160282717	160282718	Intelligence (childhood)
chr4	161028816	161028817	DNA methylation (variation)
chr4	162173479	162173480	Response to amphetamines
chr4	162250931	162250932	Diabetic retinopathy
chr4	162602208	162602209	Height
chr4	163243052	163243053	Alcohol dependence
chr4	163738120	163738121	Hair morphology
chr4	164532800	164532801	Type 2 diabetes
chr4	165878334	165878335	Obesity-related traits
chr4	165908720	165908721	Ovarian cancer in BRCA1 mutation carriers
chr4	166255703	166255704	Insulin-related traits
chr4	166255703	166255704	Insulin-related traits
chr4	166830363	166830364	Multiple sclerosis
chr4	166872535	166872536	Post-traumatic stress disorder
chr4	166872535	166872536	Post-traumatic stress disorder
chr4	166872535	166872536	Post-traumatic stress disorder (asjusted for relatedness)
chr4	166872535	166872536	Post-traumatic stress disorder (asjusted for relatedness)
chr4	167343938	167343939	Obesity-related traits
chr4	167455492	167455493	Capecitabine sensitivity
chr4	168139379	168139380	Obesity-related traits
chr4	168139379	168139380	Obesity-related traits
chr4	169338519	169338520	Obesity-related traits
chr4	169409957	169409958	Non-alcoholic fatty liver disease histology (AST)
chr4	169530257	169530258	Response to iloperidone treatment (QT prolongation)
chr4	170880882	170880883	Myopia (pathological)
chr4	171053518	171053519	Thyroid hormone levels
chr4	171053518	171053519	Thyroid hormone levels
chr4	174515681	174515682	Response to amphetamines
chr4	174547156	174547157	Cocaine dependence
chr4	174547156	174547157	Cocaine dependence
chr4	174554831	174554832	Cocaine dependence
chr4	174554831	174554832	Cocaine dependence
chr4	174574405	174574406	Type 1 diabetes nephropathy
chr4	174602047	174602048	Obesity-related traits
chr4	174655913	174655914	Multiple myeloma (IgH translocation)
chr4	175071601	175071602	Thiazide-induced adverse metabolic effects in hypertensive patients
chr4	175300778	175300779	Response to acetaminophen (hepatotoxicity)
chr4	175816128	175816129	Venous thromboembolism (gene x gene interaction)
chr4	175846425	175846426	Breast cancer
chr4	176008217	176008218	Epilepsy (remission after treatment)
chr4	176270884	176270885	Obesity-related traits
chr4	176626271	176626272	Educational attainment
chr4	176648331	176648332	IgG glycosylation
chr4	176662086	176662087	Temperament (bipolar disorder)
chr4	176859025	176859026	Mortality among heart failure patients
chr4	178318190	178318191	Heart rate variability traits
chr4	178318190	178318191	Serum selenium levels
chr4	179401432	179401433	Response to mTOR inhibitor (everolimus)
chr4	180048361	180048362	Response to hepatitis C treatment
chr4	180284813	180284814	Ulcerative colitis
chr4	180383311	180383312	Breast size
chr4	180655624	180655625	Bipolar disorder
chr4	180655624	180655625	Bipolar disorder and schizophrenia
chr4	180655624	180655625	Bipolar disorder and schizophrenia
chr4	180664652	180664653	Body mass index
chr4	180667646	180667647	Multiple sclerosis
chr4	180687999	180688000	Bipolar disorder
chr4	180704917	180704918	Obesity-related traits
chr4	180704917	180704918	Obesity-related traits
chr4	180968430	180968431	Multiple myeloma (IgH translocation)
chr4	181229199	181229200	Metabolite levels (HVA)
chr4	181229199	181229200	Metabolite levels (HVA/MHPG ratio)
chr4	182222726	182222727	Thiazide-induced adverse metabolic effects in hypertensive patients
chr4	182399694	182399695	Multiple sclerosis
chr4	182484768	182484769	Obesity-related traits
chr4	182553042	182553043	Venous thromboembolism (gene x gene interaction)
chr4	182609864	182609865	Preeclampsia
chr4	182704550	182704551	Obesity-related traits
chr4	183137397	183137398	Schizophrenia
chr4	183260600	183260601	Systolic blood pressure in sickle cell anemia
chr4	183300613	183300614	IgG glycosylation
chr4	183300613	183300614	IgG glycosylation
chr4	183687788	183687789	Response to amphetamines
chr4	183751028	183751029	Wegener's granulomatosis
chr4	183821661	183821662	Obesity-related traits
chr4	184215674	184215675	Height
chr4	184278130	184278131	Gout
chr4	184921298	184921299	Thiazide-induced adverse metabolic effects in hypertensive patients
chr4	185639168	185639169	Kawasaki disease
chr4	186612674	186612675	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr4	187148386	187148387	Circulating vasoactive peptide levels
chr4	187148386	187148387	Circulating vasoactive peptide levels
chr4	187149539	187149540	Metabolite levels
chr4	187152326	187152327	Metabolite levels
chr4	187157457	187157458	Metabolic traits
chr4	187158033	187158034	Obesity-related traits
chr4	187185384	187185385	Venous thromboembolism
chr4	187188093	187188094	Venous thromboembolism
chr4	187195550	187195551	Activated partial thromboplastin time
chr4	187207380	187207381	Activated partial thromboplastin time
chr4	187257575	187257576	Response to statin therapy
chr4	187338334	187338335	Response to citalopram treatment
chr4	187338334	187338335	Response to citalopram treatment
chr4	187678865	187678866	Obesity
chr4	188191305	188191306	Major depressive disorder
chr4	188345367	188345368	Response to statin therapy
chr4	189120910	189120911	Myopia (pathological)
chr4	189584352	189584353	Obesity-related traits
chr4	189587078	189587079	Cognitive performance
chr4	189587078	189587079	Cognitive performance
chr4	189590858	189590859	Cognitive performance
chr4	189590858	189590859	Cognitive performance
chr4	189861250	189861251	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr4	190123317	190123318	Amyotrophic lateral sclerosis
chr4	190538062	190538063	Periodontitis (CDC/AAP)
chr4	190641169	190641170	Testosterone levels
chr5	428235	428236	Cystic fibrosis severity
chr5	438101	438102	Fat distribution (HIV)
chr5	583441	583442	Ulcerative colitis
chr5	594082	594083	Ulcerative colitis
chr5	594082	594083	Ulcerative colitis
chr5	618585	618586	Obesity-related traits
chr5	1113243	1113244	mean corpuscular hemoglobin concentration
chr5	1279789	1279790	Breast cancer
chr5	1279789	1279790	Breast cancer
chr5	1279789	1279790	Breast cancer
chr5	1280027	1280028	Prostate cancer
chr5	1286515	1286516	Glioma
chr5	1286515	1286516	Glioma
chr5	1286515	1286516	Glioma
chr5	1286515	1286516	Glioma
chr5	1286515	1286516	Idiopathic pulmonary fibrosis
chr5	1286515	1286516	Interstitial lung disease
chr5	1286515	1286516	Lung adenocarcinoma
chr5	1286515	1286516	Lung adenocarcinoma
chr5	1286515	1286516	Lung adenocarcinoma
chr5	1286515	1286516	Lung cancer
chr5	1286515	1286516	Lung cancer
chr5	1286515	1286516	Red blood cell count
chr5	1286515	1286516	Testicular germ cell cancer
chr5	1287193	1287194	Lung adenocarcinoma
chr5	1288546	1288547	Glioma
chr5	1308551	1308552	Testicular germ cell cancer
chr5	1308551	1308552	Testicular germ cell tumor
chr5	1315659	1315660	Lung cancer
chr5	1320721	1320722	Lung cancer
chr5	1322086	1322087	Basal cell carcinoma
chr5	1322086	1322087	Bladder cancer
chr5	1322086	1322087	Lung cancer
chr5	1322086	1322087	Melanoma
chr5	1322086	1322087	Pancreatic cancer
chr5	1322086	1322087	Prostate-specific antigen levels
chr5	1342713	1342714	Lung adenocarcinoma
chr5	1877279	1877280	Cardiovascular disease risk factors
chr5	1895828	1895829	Prostate cancer
chr5	1895828	1895829	Prostate cancer
chr5	2109900	2109901	Pancreatic cancer
chr5	2335580	2335581	Cognitive performance
chr5	2724361	2724362	Obesity-related traits
chr5	3092191	3092192	QT interval
chr5	3276695	3276696	Epilepsy (remission after treatment)
chr5	3558537	3558538	Immune response to smallpox vaccine (IL-6)
chr5	3939475	3939476	Cognitive performance
chr5	4029788	4029789	Myocardial infarction
chr5	4488244	4488245	DNA methylation (variation)
chr5	4720584	4720585	Bipolar disorder and schizophrenia
chr5	4831600	4831601	Heart rate
chr5	5297199	5297200	Functional impairment in major depressive disorder, bipolar disorder and schizophrenia
chr5	5407813	5407814	Adverse response to chemotherapy (neutropenia/leucopenia) (epirubicin)
chr5	5792506	5792507	Morbidity-free survival
chr5	5897693	5897694	QT interval
chr5	6324292	6324293	End-stage coagulation
chr5	6599221	6599222	Visceral fat
chr5	6635590	6635591	Response to amphetamines
chr5	6767311	6767312	Eye color
chr5	6813936	6813937	Paclitaxel-induced neuropathy
chr5	6821913	6821914	Sphingolipid levels
chr5	6834166	6834167	Attention deficit hyperactivity disorder
chr5	6879977	6879978	Obesity-related traits
chr5	7155611	7155612	Obesity-related traits
chr5	7228046	7228047	Cognitive performance
chr5	7368844	7368845	Myopia (pathological)
chr5	7649859	7649860	Capecitabine sensitivity
chr5	7649859	7649860	Capecitabine sensitivity
chr5	7816644	7816645	Visceral fat
chr5	8652869	8652870	Uric acid levels
chr5	8983720	8983721	Obesity-related traits
chr5	9332280	9332281	Parkinson's disease
chr5	9474945	9474946	Obesity-related traits
chr5	9623621	9623622	Autism
chr5	9756328	9756329	Hypersomnia (HLA-DQB1*06:02 negative)
chr5	9979083	9979084	Age-related macular degeneration (smoking status interaction)
chr5	10159540	10159541	Metabolite levels (HVA/MHPG ratio)
chr5	10169822	10169823	Pain
chr5	10372617	10372618	Body mass index
chr5	10464106	10464107	Body mass index
chr5	10467701	10467702	Breast cancer
chr5	10512696	10512697	Metabolite levels (HVA/MHPG ratio)
chr5	10671039	10671040	Obesity-related traits
chr5	10695525	10695526	Inflammatory bowel disease
chr5	10701513	10701514	Metabolite levels (Pyroglutamine)
chr5	10752314	10752315	Ulcerative colitis
chr5	10811473	10811474	Bipolar disorder and schizophrenia
chr5	11111770	11111771	Pulmonary function decline
chr5	11169944	11169945	Myopia (pathological)
chr5	11298222	11298223	Bipolar disorder and schizophrenia
chr5	13242973	13242974	Visceral fat
chr5	13505431	13505432	Prostate cancer (gene x gene interaction)
chr5	13740975	13740976	IgE grass sensitization
chr5	13764418	13764419	Subclinical atherosclerosis traits (other)
chr5	13769973	13769974	Subclinical atherosclerosis traits (other)
chr5	13779742	13779743	Subclinical atherosclerosis traits (other)
chr5	13798558	13798559	Corneal astigmatism
chr5	14072056	14072057	Adverse response to chemotherapy in breast cancer (alopecia) (paclitaxel)
chr5	14393620	14393621	Paclitaxel-induced neuropathy
chr5	15285413	15285414	Visceral fat
chr5	15364483	15364484	Obesity-related traits
chr5	15582004	15582005	Economic and political preferences (feminism/equality)
chr5	15618180	15618181	Obesity-related traits
chr5	16038101	16038102	IgG glycosylation
chr5	16812637	16812638	Major depressive disorder
chr5	16913854	16913855	Obesity-related traits
chr5	17003084	17003085	Thiazide-induced adverse metabolic effects in hypertensive patients
chr5	17148910	17148911	Hippocampal atrophy
chr5	17215443	17215444	Bipolar disorder (mood-incongruent)
chr5	18483650	18483651	IgG glycosylation
chr5	19440167	19440168	Depression (quantitative trait)
chr5	21749347	21749348	Response to tocilizumab in rheumatoid arthritis
chr5	21779153	21779154	Waist circumference
chr5	22812263	22812264	Multiple myeloma (IgH translocation)
chr5	23244024	23244025	Economic and political preferences (immigration/crime)
chr5	23542710	23542711	Recombination (females)
chr5	23542710	23542711	Recombination (males)
chr5	23907572	23907573	Venous thromboembolism (gene x gene interaction)
chr5	25087724	25087725	Uric acid levels
chr5	25420088	25420089	IgG glycosylation
chr5	25692972	25692973	&beta;2-Glycoprotein I (&beta;2-GPI) plasma levels
chr5	25760678	25760679	Hippocampal atrophy
chr5	25841612	25841613	Obesity-related traits
chr5	25902341	25902342	Autism
chr5	25967702	25967703	Autism
chr5	26139137	26139138	Visceral fat
chr5	26389261	26389262	Response to platinum-based chemotherapy in non-small-cell lung cancer
chr5	26389261	26389262	Response to platinum-based chemotherapy in non-small-cell lung cancer
chr5	26723782	26723783	Anorexia nervosa
chr5	26928065	26928066	Coronary artery calcification
chr5	27611430	27611431	Major depressive disorder
chr5	28340172	28340173	Response to antidepressant treatment
chr5	28747322	28747323	Hip geometry
chr5	29040120	29040121	Migraine without aura
chr5	30661572	30661573	Emphysema-related traits
chr5	30899516	30899517	Response to angiotensin II receptor blocker therapy
chr5	31020520	31020521	Liver enzyme levels (gamma-glutamyl transferase)
chr5	31927316	31927317	Obesity-related traits
chr5	32000482	32000483	Renal cell carcinoma
chr5	32689717	32689718	Height
chr5	32748636	32748637	Ovarian reserve
chr5	32768633	32768634	Height
chr5	32804527	32804528	Blood pressure
chr5	32804527	32804528	Blood pressure
chr5	32815027	32815028	Blood pressure
chr5	32815027	32815028	Blood pressure
chr5	32815027	32815028	Diastolic blood pressure
chr5	32815027	32815028	Hypertension
chr5	32815027	32815028	Systolic blood pressure
chr5	32819072	32819073	Height
chr5	32830520	32830521	Height
chr5	32888817	32888818	Height
chr5	32888817	32888818	Height
chr5	33636593	33636594	Mortality among heart failure patients
chr5	33879791	33879792	Stroke (pediatric)
chr5	33951692	33951693	Eye color
chr5	33951692	33951693	Hair color
chr5	33951692	33951693	Hair color
chr5	33951692	33951693	Skin pigmentation
chr5	33955325	33955326	Melanoma
chr5	33955672	33955673	Tanning
chr5	33958958	33958959	Black vs. blond hair color
chr5	33958958	33958959	Black vs. red hair color
chr5	34628626	34628627	Left ventricular mass
chr5	34951149	34951150	Response to angiotensin II receptor blocker therapy
chr5	35037114	35037115	Metabolite levels
chr5	35037114	35037115	Urinary metabolites
chr5	35461199	35461200	Metabolite levels (HVA/5-HIAA ratio)
chr5	35799993	35799994	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)
chr5	35803576	35803577	Multiple sclerosis
chr5	35852310	35852311	Primary biliary cirrhosis
chr5	35874574	35874575	Multiple sclerosis
chr5	35874574	35874575	Multiple sclerosis
chr5	35874574	35874575	Multiple sclerosis
chr5	35874574	35874575	Type 1 diabetes
chr5	35876273	35876274	Ulcerative colitis
chr5	35910528	35910529	Type 1 diabetes
chr5	35943041	35943042	Primary biliary cirrhosis
chr5	36137619	36137620	Response to treatment for acute lymphoblastic leukemia
chr5	36309096	36309097	Serum tamsulosin hydrochloride concentration
chr5	36473236	36473237	Height
chr5	36473236	36473237	IgG glycosylation
chr5	36900842	36900843	Obesity-related traits
chr5	38051592	38051593	Major depressive disorder
chr5	38452893	38452894	Response to citalopram treatment
chr5	38955795	38955796	Obesity-related traits
chr5	39058355	39058356	Obesity-related traits
chr5	39394988	39394989	Pancreatic cancer
chr5	39397131	39397132	Chronic kidney disease
chr5	39902364	39902365	Urate levels
chr5	39979171	39979172	Myopia (pathological)
chr5	40134776	40134777	Alcoholism (alcohol use disorder factor score)
chr5	40237373	40237374	Obesity-related traits
chr5	40392727	40392728	Crohn's disease
chr5	40392727	40392728	Multiple sclerosis
chr5	40401508	40401509	Crohn's disease
chr5	40410583	40410584	Crohn's disease
chr5	40410583	40410584	Crohn's disease
chr5	40410583	40410584	Inflammatory bowel disease
chr5	40410934	40410935	Ulcerative colitis
chr5	40415066	40415067	Crohn's disease
chr5	40424425	40424426	Multiple sclerosis
chr5	40431182	40431183	Crohn's disease
chr5	40437947	40437948	Crohn's disease
chr5	40437947	40437948	Crohn's disease
chr5	40437947	40437948	Multiple sclerosis
chr5	40486895	40486896	Self-reported allergy
chr5	40490789	40490790	Ankylosing spondylitis
chr5	40626752	40626753	Bipolar disorder and schizophrenia
chr5	40791883	40791884	Gastric cancer
chr5	41234045	41234046	Response to fenofibrate (adiponectin levels)
chr5	42288592	42288593	Response to taxane treatment (docetaxel)
chr5	42375242	42375243	Systemic lupus erythematosus
chr5	42473554	42473555	Iron status biomarkers
chr5	44186667	44186668	Brain structure
chr5	44365544	44365545	Prostate cancer
chr5	44662514	44662515	Breast cancer
chr5	44706497	44706498	Breast cancer
chr5	44875004	44875005	Breast cancer
chr5	45197778	45197779	Chronic kidney disease and serum creatinine levels
chr5	45285717	45285718	Breast cancer
chr5	50026464	50026465	Myopia (pathological)
chr5	50233198	50233199	Callous-unemotional behaviour
chr5	50928809	50928810	Dental caries
chr5	51164114	51164115	Congenital heart disease
chr5	51173323	51173324	IgG glycosylation
chr5	51173323	51173324	IgG glycosylation
chr5	51217850	51217851	Bipolar disorder and schizophrenia
chr5	51236325	51236326	Migraine without aura
chr5	51706905	51706906	Presence of antiphospholipid antibodies
chr5	51805741	51805742	Alzheimer's disease biomarkers
chr5	52020395	52020396	Response to platinum-based agents
chr5	52179789	52179790	Pulmonary function (interaction)
chr5	52193124	52193125	Liver enzyme levels (gamma-glutamyl transferase)
chr5	52195032	52195033	Pulmonary function
chr5	52552238	52552239	IgG glycosylation
chr5	53298024	53298025	Adiponectin levels
chr5	53298024	53298025	HDL cholesterol
chr5	53300661	53300662	Adiponectin levels
chr5	53311501	53311502	Rheumatoid arthritis
chr5	53380554	53380555	Migraine
chr5	53902338	53902339	Immune response to smallpox vaccine (IL-6)
chr5	55001898	55001899	Height
chr5	55322894	55322895	IgG glycosylation
chr5	55322894	55322895	IgG glycosylation
chr5	55322894	55322895	IgG glycosylation
chr5	55322894	55322895	IgG glycosylation
chr5	55322894	55322895	IgG glycosylation
chr5	55322894	55322895	IgG glycosylation
chr5	55322894	55322895	IgG glycosylation
chr5	55322894	55322895	IgG glycosylation
chr5	55322894	55322895	IgG glycosylation
chr5	55322894	55322895	IgG glycosylation
chr5	55322894	55322895	IgG glycosylation
chr5	55324801	55324802	IgG glycosylation
chr5	55324801	55324802	IgG glycosylation
chr5	55438579	55438580	Rheumatoid arthritis
chr5	55438850	55438851	Crohn's disease
chr5	55510655	55510656	Alzheimer's disease (cognitive decline)
chr5	55560026	55560027	Celiac disease and Rheumatoid arthritis
chr5	55811091	55811092	Urate levels
chr5	55854152	55854153	Triglycerides
chr5	55854152	55854153	Waist circumference
chr5	55859951	55859952	Sexual dimorphism in anthropometric traits
chr5	55861785	55861786	Triglycerides
chr5	56023082	56023083	Breast cancer
chr5	56031883	56031884	Breast cancer
chr5	56031883	56031884	Breast cancer
chr5	56031883	56031884	Breast cancer
chr5	56104307	56104308	Type 2 diabetes
chr5	56666499	56666500	Schizophrenia
chr5	56810137	56810138	Orthostatic hypotension
chr5	57130817	57130818	Prostate cancer (gene x gene interaction)
chr5	57172077	57172078	Birth weight
chr5	57320953	57320954	Hoarding
chr5	58082722	58082723	IgG glycosylation
chr5	58184060	58184061	Breast cancer
chr5	58337480	58337481	Breast cancer
chr5	58407770	58407771	Esophageal cancer
chr5	58560716	58560717	Immune response to smallpox vaccine (IL-6)
chr5	58676048	58676049	Sleepiness
chr5	58713679	58713680	Adverse response to chemotherapy (neutropenia/leucopenia) (gemcitabine)
chr5	58842773	58842774	Neuroticism
chr5	58979945	58979946	Response to antipsychotic treatment
chr5	59096922	59096923	Obesity-related traits
chr5	59369793	59369794	Asthma
chr5	60499130	60499131	Schizophrenia
chr5	60731457	60731458	Schizophrenia
chr5	60950210	60950211	Alzheimer's disease
chr5	61025081	61025082	IgG glycosylation
chr5	61984852	61984853	Venous thromboembolism (gene x gene interaction)
chr5	62384698	62384699	Bronchopulmonary dysplasia
chr5	62586300	62586301	Alcohol and nictotine co-dependence
chr5	62817899	62817900	Body mass index
chr5	63033717	63033718	Alcohol and nictotine co-dependence
chr5	64347620	64347621	Obesity-related traits
chr5	64417677	64417678	QT interval
chr5	64433399	64433400	Schizophrenia
chr5	64447776	64447777	Osteosarcoma
chr5	64534640	64534641	Bipolar disorder and schizophrenia
chr5	64625511	64625512	Corneal structure
chr5	65739438	65739439	RR interval (heart rate)
chr5	66152257	66152258	Epilepsy (generalized)
chr5	66452174	66452175	Carotid atherosclerosis in HIV infection
chr5	66833256	66833257	Prostate cancer (gene x gene interaction)
chr5	67194468	67194469	Menarche (age at onset)
chr5	67307461	67307462	Waist-to-hip circumference ratio (interaction)
chr5	70834891	70834892	Obesity-related traits
chr5	71410355	71410356	Attention deficit hyperactivity disorder
chr5	71716927	71716928	Hip geometry
chr5	72431481	72431482	Urate levels
chr5	72432035	72432036	Renal function-related traits (BUN)
chr5	72551133	72551134	Crohn's disease
chr5	72551133	72551134	Crohn's disease
chr5	73072353	73072354	Venous thromboembolism (gene x gene interaction)
chr5	73215236	73215237	D-dimer levels
chr5	73248511	73248512	Obesity-related traits
chr5	73276902	73276903	QT interval
chr5	74302657	74302658	Stearic acid (18:0) plasma levels
chr5	74480287	74480288	Response to amphetamines
chr5	74625486	74625487	LDL cholesterol
chr5	74648602	74648603	LDL cholesterol
chr5	74648602	74648603	Metabolite levels
chr5	74651083	74651084	Cholesterol, total
chr5	74651083	74651084	LDL cholesterol
chr5	74655725	74655726	LDL cholesterol
chr5	74655725	74655726	Quantitative traits
chr5	74655725	74655726	Quantitative traits
chr5	74656538	74656539	Cholesterol, total
chr5	74656538	74656539	LDL cholesterol
chr5	74656538	74656539	LDL cholesterol
chr5	75003677	75003678	Obesity
chr5	75015241	75015242	Body mass index
chr5	75015241	75015242	Obesity
chr5	75015241	75015242	Obesity
chr5	75502409	75502410	Migraine - clinic-based
chr5	75622813	75622814	Venous thromboembolism
chr5	75920971	75920972	Hearing impairment
chr5	76023493	76023494	Mean platelet volume
chr5	76046938	76046939	Platelet counts
chr5	76224170	76224171	Thiazide-induced adverse metabolic effects in hypertensive patients
chr5	76424948	76424949	Type 2 diabetes
chr5	76518441	76518442	Hypothyroidism
chr5	76518441	76518442	Thyroid stimulating hormone
chr5	76530348	76530349	Thyroid hormone levels
chr5	76530348	76530349	Thyroid hormone levels
chr5	76530348	76530349	Thyroid hormone levels
chr5	76535810	76535811	Thyroid function
chr5	76781470	76781471	Caudate nucleus volume
chr5	77291939	77291940	Insulin resistance/response
chr5	77630853	77630854	Hippocampal atrophy
chr5	77987523	77987524	Economic and political preferences
chr5	78110531	78110532	Attention deficit hyperactivity disorder
chr5	78259887	78259888	Hippocampal atrophy
chr5	78272941	78272942	Iron status biomarkers
chr5	78316475	78316476	Blood trace element (Se levels)
chr5	78341296	78341297	Metabolite levels
chr5	78414336	78414337	Blood trace element (Se levels)
chr5	78756777	78756778	Height
chr5	78829248	78829249	Major depressive disorder
chr5	78845710	78845711	Adiponectin levels
chr5	78943647	78943648	IgG glycosylation
chr5	79098997	79098998	Obesity
chr5	79099463	79099464	Bipolar disorder and schizophrenia
chr5	79446903	79446904	Borderline personality disorder features
chr5	80406565	80406566	Eating disorders
chr5	80406565	80406566	Eating disorders (purging via substances)
chr5	80411220	80411221	Orofacial clefts
chr5	80654965	80654966	Orofacial clefts
chr5	80719124	80719125	Glioblastoma
chr5	81087533	81087534	Anorexia nervosa
chr5	81939317	81939318	Eosinophilic esophagitis (pediatric)
chr5	82889909	82889910	Major depressive disorder
chr5	82960733	82960734	Visceral fat
chr5	82985738	82985739	Prostate cancer
chr5	83173592	83173593	Ankylosing spondylitis
chr5	83499642	83499643	Chemerin levels
chr5	84084775	84084776	Alzheimer's disease biomarkers
chr5	84583768	84583769	Blood trace element (Cu levels)
chr5	84606527	84606528	Echocardiographic traits
chr5	85217868	85217869	Obesity-related traits
chr5	86174146	86174147	Adverse response to chemotherapy in breast cancer (alopecia) (anti-microtubule)
chr5	86177772	86177773	Adverse response to chemotherapy in breast cancer (alopecia) (anti-microtubule)
chr5	86432616	86432617	Personality dimensions
chr5	87034351	87034352	Major depressive disorder
chr5	87798235	87798236	Retinal arteriolar caliber
chr5	87847585	87847586	Retinal vascular caliber
chr5	88088438	88088439	Tonometry
chr5	88099950	88099951	Mean platelet volume
chr5	88138730	88138731	Bone mineral density
chr5	88152116	88152117	Platelet counts
chr5	88183650	88183651	Thiazide-induced adverse metabolic effects in hypertensive patients
chr5	88354674	88354675	Height
chr5	88376060	88376061	Bone mineral density
chr5	88376060	88376061	Bone mineral density
chr5	88376060	88376061	Bone mineral density
chr5	88376060	88376061	Bone mineral density (hip)
chr5	89021577	89021578	Obesity-related traits
chr5	89109749	89109750	Sex hormone-binding globulin levels
chr5	89546108	89546109	Type 2 diabetes and other traits
chr5	89780970	89780971	Nevirapine-induced rash
chr5	90209823	90209824	Obesity-related traits
chr5	90299222	90299223	Response to antipsychotic treatment
chr5	90424278	90424279	Hip geometry
chr5	90762747	90762748	Smoking behavior
chr5	90981386	90981387	Subcutaneous adipose tissue
chr5	91275312	91275313	Breast cancer (prognosis)
chr5	91893791	91893792	Wilms tumor
chr5	92154578	92154579	Obesity-related traits
chr5	92154578	92154579	Obesity-related traits
chr5	92154578	92154579	Obesity-related traits
chr5	92154578	92154579	Obesity-related traits
chr5	92464415	92464416	Migraine
chr5	92487542	92487543	Obesity-related traits
chr5	92487542	92487543	Obesity-related traits
chr5	92567538	92567539	Natriuretic peptide levels
chr5	93557701	93557702	Diabetic retinopathy
chr5	93810207	93810208	Gallbladder cancer
chr5	94148537	94148538	Anorexia nervosa
chr5	94154587	94154588	Bipolar disorder
chr5	94653872	94653873	IgG glycosylation
chr5	95036699	95036700	Pulmonary function
chr5	95234790	95234791	Serum total protein level
chr5	95241221	95241222	IgG glycosylation
chr5	95246759	95246760	IgG glycosylation
chr5	95262512	95262513	IgG glycosylation
chr5	95273409	95273410	IgG glycosylation
chr5	95301462	95301463	IgG glycosylation
chr5	95428683	95428684	IgG glycosylation
chr5	95486939	95486940	IgG glycosylation
chr5	95521776	95521777	Breast size
chr5	95542725	95542726	Fasting glucose-related traits (interaction with BMI)
chr5	95728897	95728898	Glycemic traits (pregnancy)
chr5	95728897	95728898	Proinsulin levels
chr5	95850249	95850250	Body mass index
chr5	95856678	95856679	Waist circumference
chr5	96101943	96101944	Hodgkin's lymphoma
chr5	96101943	96101944	Psoriasis
chr5	96111370	96111371	Alcohol dependence
chr5	96118865	96118866	Behcet's disease
chr5	96118865	96118866	Behcet's disease
chr5	96124329	96124330	Ankylosing spondylitis
chr5	96129511	96129512	Ankylosing spondylitis
chr5	96244548	96244549	Crohn's disease
chr5	96252802	96252803	Inflammatory bowel disease
chr5	97076547	97076548	Estradiol plasma levels (breast cancer)
chr5	97888735	97888736	Asperger disorder
chr5	97969452	97969453	Venous thromboembolism (gene x gene interaction)
chr5	98579963	98579964	Renal sinus fat
chr5	98593452	98593453	Periodontitis (Mean PAL)
chr5	98715767	98715768	IgG glycosylation
chr5	98781102	98781103	Hemostatic factors and hematological phenotypes
chr5	99342046	99342047	Non-alcoholic fatty liver disease histology (lobular)
chr5	99991647	99991648	Panic disorder
chr5	100301805	100301806	IgG glycosylation
chr5	100301805	100301806	IgG glycosylation
chr5	100948544	100948545	Conduct disorder (interaction)
chr5	101403585	101403586	QRS duration
chr5	101769725	101769726	Schizophrenia
chr5	101859316	101859317	Schizophrenia
chr5	101946797	101946798	Crohn's disease
chr5	102596719	102596720	Rheumatoid arthritis
chr5	102759657	102759658	QT interval
chr5	102764047	102764048	Thiazide-induced adverse metabolic effects in hypertensive patients
chr5	104069916	104069917	Depression (quantitative trait)
chr5	104199059	104199060	Adverse response to chemotherapy (neutropenia/leucopenia) (all topoisomerase inhibitors)
chr5	104208012	104208013	Adverse response to chemotherapy (neutropenia/leucopenia) (all topoisomerase inhibitors)
chr5	104867935	104867936	Caffeine consumption
chr5	104954327	104954328	Personality dimensions
chr5	105297528	105297529	Obesity-related traits
chr5	105419512	105419513	Obesity-related traits
chr5	106724587	106724588	Bipolar disorder and schizophrenia
chr5	106982559	106982560	Hippocampal atrophy
chr5	107111175	107111176	Alzheimer's disease biomarkers
chr5	107400504	107400505	Eye color
chr5	107401450	107401451	Response to amphetamines
chr5	107731957	107731958	IgG glycosylation
chr5	107834246	107834247	Ulcerative colitis
chr5	107915735	107915736	Adiponectin levels
chr5	108113343	108113344	Height
chr5	108948936	108948937	Colorectal cancer
chr5	109221025	109221026	Alzheimer's disease (cognitive decline)
chr5	109496959	109496960	Hemostatic factors and hematological phenotypes
chr5	110008213	110008214	Cardiac structure and function
chr5	110146445	110146446	Allergic rhinitis
chr5	110146445	110146446	IgE grass sensitization
chr5	110190051	110190052	Allergic sensitization
chr5	110401871	110401872	Asthma
chr5	110401871	110401872	Asthma
chr5	110405674	110405675	Eosinophilic esophagitis (pediatric)
chr5	110408001	110408002	Allergic rhinitis
chr5	110435489	110435490	Eosinophil counts
chr5	110467498	110467499	Self-reported allergy
chr5	110502428	110502429	Periodontitis (PAL4Q3)
chr5	110539391	110539392	Periodontitis (PAL4Q3)
chr5	110719186	110719187	Alzheimer's disease (cognitive decline)
chr5	110772403	110772404	Blood pressure
chr5	110772403	110772404	Longevity
chr5	110958781	110958782	Obesity-related traits
chr5	111107114	111107115	Bipolar disorder and schizophrenia
chr5	111693370	111693371	vWF and FVIII levels
chr5	112242967	112242968	Attention deficit hyperactivity disorder
chr5	112580289	112580290	Bipolar disorder and schizophrenia
chr5	112715373	112715374	Brain cytoarchitecture
chr5	112723566	112723567	F-cell distribution
chr5	112996653	112996654	F-cell distribution
chr5	113030163	113030164	Sudden cardiac arrest
chr5	113798985	113798986	Coronary arterial lesions in patients with Kawasaki disease
chr5	113849293	113849294	Obesity-related traits
chr5	115138747	115138748	IgG glycosylation
chr5	115138747	115138748	IgG glycosylation
chr5	115512351	115512352	Inflammatory biomarkers
chr5	115568756	115568757	Bipolar disorder and schizophrenia
chr5	115727837	115727838	Amyotrophic lateral sclerosis
chr5	115733804	115733805	IgG glycosylation
chr5	115759489	115759490	Wegener's granulomatosis
chr5	115975655	115975656	Allergic rhinitis
chr5	116513604	116513605	Periodontitis (DPAL)
chr5	116513604	116513605	Periodontitis (DPAL)
chr5	117337752	117337753	Subcutaneous adipose tissue
chr5	118356414	118356415	Response to amphetamines
chr5	118435126	118435127	Alzheimer's disease (cognitive decline)
chr5	120216036	120216037	Bronchopulmonary dysplasia
chr5	121436595	121436596	Thiazide-induced adverse metabolic effects in hypertensive patients
chr5	122264735	122264736	Migraine
chr5	122531346	122531347	Aortic root size
chr5	122615523	122615524	Self-reported allergy
chr5	122657198	122657199	Height
chr5	122685127	122685128	Weight
chr5	122774784	122774785	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr5	123119564	123119565	Amyotrophic lateral sclerosis
chr5	123157421	123157422	Alzheimer's disease
chr5	123571159	123571160	Subcutaneous adipose tissue
chr5	123832651	123832652	Major depressive disorder
chr5	124332102	124332103	Body mass index
chr5	124347087	124347088	Body mass index
chr5	124365966	124365967	Erectile dysfunction and prostate cancer treatment
chr5	124848905	124848906	Obesity-related traits
chr5	125243019	125243020	Select biomarker traits
chr5	125319455	125319456	Diabetic retinopathy
chr5	125338474	125338475	Cognitive performance
chr5	125918147	125918148	Osteoporosis
chr5	126032963	126032964	QT interval
chr5	126181861	126181862	Parkinson's disease (motor and cognition)
chr5	126721852	126721853	IgG glycosylation
chr5	126729449	126729450	Alzheimer's disease (cognitive decline)
chr5	127054277	127054278	Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)
chr5	127059941	127059942	Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)
chr5	127061970	127061971	Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)
chr5	127110485	127110486	Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)
chr5	127122311	127122312	Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)
chr5	127125761	127125762	Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)
chr5	127139615	127139616	Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)
chr5	127151975	127151976	Amyotrophic lateral sclerosis (age of onset)
chr5	127169211	127169212	Brain imaging in schizophrenia (interaction)
chr5	127382301	127382302	Alzheimer's disease (cognitive decline)
chr5	127522542	127522543	Ileal carcinoids
chr5	127640860	127640861	Height
chr5	127653021	127653022	Temperament
chr5	127699374	127699375	Obesity (extreme)
chr5	127716566	127716567	Migraine - clinic-based
chr5	127716566	127716567	Migraine with aura
chr5	128722695	128722696	Obesity-related traits
chr5	129000385	129000386	Sexual dysfunction (SSRI/SNRI-related)
chr5	129792133	129792134	Response to amphetamines
chr5	129943318	129943319	Fasting plasma glucose
chr5	130017286	130017287	Inflammatory bowel disease
chr5	130413980	130413981	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr5	131402737	131402738	Crohn's disease
chr5	131430117	131430118	Rheumatoid arthritis
chr5	131665377	131665378	Metabolic traits
chr5	131671661	131671662	Fibrinogen
chr5	131686145	131686146	Height
chr5	131699866	131699867	Height
chr5	131721748	131721749	IgG glycosylation
chr5	131721748	131721749	IgG glycosylation
chr5	131723287	131723288	Asthma
chr5	131742227	131742228	Crohn's disease
chr5	131744573	131744574	Fibrinogen
chr5	131756057	131756058	Fibrinogen
chr5	131769173	131769174	Fibrinogen
chr5	131770804	131770805	Crohn's disease
chr5	131770804	131770805	Crohn's disease
chr5	131770804	131770805	Inflammatory bowel disease
chr5	131784392	131784393	Crohn's disease
chr5	131796921	131796922	Asthma
chr5	131801725	131801726	Fibrinogen
chr5	131819920	131819921	Platelet counts
chr5	131839617	131839618	C-reactive protein
chr5	131862976	131862977	Eosinophil counts
chr5	131901224	131901225	Asthma
chr5	131973176	131973177	IgE levels
chr5	131995842	131995843	Asthma
chr5	131995842	131995843	Atopic dermatitis
chr5	131995842	131995843	Atopic dermatitis
chr5	131995963	131995964	Hodgkin's lymphoma
chr5	131995963	131995964	IgE levels
chr5	131995963	131995964	Psoriasis
chr5	131995963	131995964	Self-reported allergy
chr5	132049026	132049027	Atopic dermatitis
chr5	132628883	132628884	Type 1 diabetes
chr5	133021850	133021851	Hypertension
chr5	133203595	133203596	Attention deficit hyperactivity disorder and conduct disorder
chr5	133446574	133446575	Multiple sclerosis
chr5	133849176	133849177	Menarche (age at onset)
chr5	134321545	134321546	Bulimia nervosa
chr5	134356704	134356705	Height
chr5	134356704	134356705	Height
chr5	134366199	134366200	Testicular germ cell tumor
chr5	134372684	134372685	Height
chr5	134443605	134443606	Ulcerative colitis
chr5	134443605	134443606	Ulcerative colitis
chr5	134467699	134467700	AIDS progression
chr5	134499091	134499092	Colorectal cancer
chr5	134499091	134499092	Colorectal cancer
chr5	134563156	134563157	Immune response to anthrax vaccine
chr5	134572228	134572229	Obesity-related traits
chr5	135164617	135164618	IgG glycosylation
chr5	135214676	135214677	Obesity-related traits
chr5	136902695	136902696	Bronchopulmonary dysplasia
chr5	137194761	137194762	Heart rate
chr5	137419988	137419989	Atrial fibrillation
chr5	137707314	137707315	Menarche (age at onset)
chr5	138850904	138850905	Chronic obstructive pulmonary disease-related biomarkers
chr5	138850904	138850905	Immune reponse to smallpox (secreted IFN-alpha)
chr5	138949361	138949362	Immune reponse to smallpox (secreted IFN-alpha)
chr5	140372221	140372222	Visceral adipose tissue adjusted for BMI
chr5	140682890	140682891	Obesity-related traits
chr5	140700488	140700489	Pulmonary function decline
chr5	141189167	141189168	Myopia (pathological)
chr5	141210752	141210753	Major depressive disorder
chr5	141445979	141445980	Asthma
chr5	141479064	141479065	Crohn's disease
chr5	141513203	141513204	Inflammatory bowel disease
chr5	141522999	141523000	Multiple sclerosis
chr5	141681787	141681788	Testicular germ cell cancer
chr5	141681787	141681788	Testicular germ cell tumor
chr5	141681787	141681788	Testicular germ cell tumor
chr5	141681787	141681788	Testicular germ cell tumor
chr5	141863603	141863604	Coronary heart disease
chr5	142017859	142017860	Cardiac hypertrophy
chr5	142441793	142441794	Uric acid levels
chr5	142899800	142899801	Migraine
chr5	143003604	143003605	Response to antipsychotic treatment
chr5	145038830	145038831	Vitamin B12 levels
chr5	145749534	145749535	Migraine without aura
chr5	146225243	146225244	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr5	146320822	146320823	Alcohol dependence
chr5	146415215	146415216	Cognitive test performance
chr5	147225513	147225514	Obesity-related traits
chr5	147603066	147603067	IgG glycosylation
chr5	147805119	147805120	Periodontal microbiota
chr5	147842352	147842353	Pulmonary function
chr5	147842352	147842353	Pulmonary function (interaction)
chr5	147845814	147845815	Pulmonary function
chr5	147856332	147856333	Airflow obstruction
chr5	148706298	148706299	Obesity-related traits
chr5	148904091	148904092	Esophageal cancer
chr5	149036975	149036976	Major depressive disorder
chr5	149142066	149142067	Response to fenofibrate
chr5	149210847	149210848	Tanning
chr5	149213455	149213456	Obesity-related traits
chr5	149623364	149623365	Obesity-related traits
chr5	149825869	149825870	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr5	150223386	150223387	Crohn's disease
chr5	150240075	150240076	Crohn's disease
chr5	150258866	150258867	Crohn's disease
chr5	150270419	150270420	Crohn's disease
chr5	150277908	150277909	Inflammatory bowel disease
chr5	150440096	150440097	Systemic sclerosis
chr5	150450235	150450236	Myasthenia gravis
chr5	150458145	150458146	Systemic lupus erythematosus
chr5	150458145	150458146	Systemic lupus erythematosus
chr5	150461048	150461049	Systemic lupus erythematosus and Systemic sclerosis
chr5	150473673	150473674	Myopia (pathological)
chr5	150478317	150478318	Psoriasis
chr5	150585866	150585867	Bulimia nervosa
chr5	150594801	150594802	Obesity-related traits
chr5	150746033	150746034	Metabolite levels (Pyroglutamine)
chr5	151344557	151344558	Interstitial lung disease
chr5	151568098	151568099	Periodontitis (PAL4Q3)
chr5	151734108	151734109	Optic disc size (cup)
chr5	152288452	152288453	Bipolar disorder and schizophrenia
chr5	152504928	152504929	Response to amphetamines
chr5	152540353	152540354	Schizophrenia
chr5	152639676	152639677	Aging (time to event)
chr5	152654478	152654479	Schizophrenia
chr5	152940404	152940405	Obesity-related traits
chr5	152979553	152979554	Anthropometric traits
chr5	153057547	153057548	Sudden cardiac arrest
chr5	153170373	153170374	Asparaginase hypersensitivity in acute lymphoblastic leukemia
chr5	153509595	153509596	Body mass index
chr5	153543465	153543466	Body mass index
chr5	153811489	153811490	Behavioural disinhibition (generation interaction)
chr5	153837105	153837106	Alzheimer's disease (cognitive decline)
chr5	153869039	153869040	Ventricular conduction
chr5	155202527	155202528	Smoking behavior
chr5	155302581	155302582	Obesity-related traits
chr5	155394229	155394230	Type 2 diabetes
chr5	155394229	155394230	Type 2 diabetes
chr5	155500991	155500992	Multiple sclerosis (age of onset)
chr5	156139568	156139569	Anthropometric traits
chr5	156139568	156139569	Anthropometric traits
chr5	156182047	156182048	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)
chr5	156390296	156390297	Cholesterol, total
chr5	156390296	156390297	LDL cholesterol
chr5	156390296	156390297	Triglycerides
chr5	156398168	156398169	LDL cholesterol
chr5	156464241	156464242	Hypertriglyceridemia
chr5	156608999	156609000	Personality dimensions
chr5	156815762	156815763	IgG glycosylation
chr5	156932375	156932376	Pulmonary function
chr5	156932375	156932376	Pulmonary function (interaction)
chr5	156942284	156942285	Bipolar disorder and schizophrenia
chr5	157410277	157410278	IgG glycosylation
chr5	157410277	157410278	IgG glycosylation
chr5	157683524	157683525	Metabolite levels (Dihydroxy docosatrienoic acid)
chr5	157804456	157804457	Blood pressure
chr5	157845401	157845402	Diastolic blood pressure
chr5	157845401	157845402	Hypertension
chr5	157845401	157845402	Systolic blood pressure
chr5	158175668	158175669	Obesity-related traits
chr5	158244082	158244083	Breast cancer
chr5	158244082	158244083	Breast cancer
chr5	158424390	158424391	Adverse response to chemotherapy (neutropenia/leucopenia) (all anthracycline-based drugs)
chr5	158603570	158603571	Mean platelet volume
chr5	158604962	158604963	Mean platelet volume
chr5	158717788	158717789	Psoriasis
chr5	158750768	158750769	Psoriasis
chr5	158750768	158750769	Psoriasis
chr5	158759899	158759900	Multiple sclerosis
chr5	158759899	158759900	Multiple sclerosis
chr5	158759899	158759900	Psoriasis
chr5	158787384	158787385	Crohn's disease
chr5	158814532	158814533	Crohn's disease
chr5	158814532	158814533	Crohn's disease
chr5	158818744	158818745	Ankylosing spondylitis
chr5	158822644	158822645	Crohn's disease
chr5	158826791	158826792	Inflammatory bowel disease
chr5	158826791	158826792	Ulcerative colitis
chr5	158829526	158829527	Psoriatic arthritis
chr5	158904312	158904313	Response to taxane treatment (placlitaxel)
chr5	158918893	158918894	Multiple sclerosis
chr5	159007777	159007778	Major depressive disorder
chr5	159007777	159007778	Major depressive disorder
chr5	159007777	159007778	Major depressive disorder
chr5	159367970	159367971	Migraine
chr5	159820930	159820931	Weight loss (gastric bypass surgery)
chr5	159849585	159849586	Insulin-related traits
chr5	159879977	159879978	Systemic lupus erythematosus
chr5	159972020	159972021	Response to anti-TNF alpha therapy in inflammatory bowel disease
chr5	162083517	162083518	Autism
chr5	162998514	162998515	Aging
chr5	163889279	163889280	Breast cancer
chr5	164764086	164764087	Phospholipid levels (plasma)
chr5	165063883	165063884	Carotid atherosclerosis in HIV infection
chr5	165377698	165377699	Waist circumference
chr5	165377698	165377699	Weight
chr5	165957085	165957086	Conduct disorder (symptom count)
chr5	166318189	166318190	Adverse response to lamotrigine and phenytoin
chr5	166389492	166389493	Diabetic retinopathy
chr5	167210471	167210472	Immune response to smallpox vaccine (IL-6)
chr5	167226978	167226979	Dietary macronutrient intake
chr5	167500459	167500460	Uric acid levels
chr5	167643544	167643545	Periodontal microbiota
chr5	168256239	168256240	Height
chr5	168899986	168899987	Waist circumference
chr5	169074055	169074056	Protein quantitative trait loci
chr5	169461546	169461547	IgG glycosylation
chr5	169542599	169542600	Adverse response to chemotherapy (neutropenia/leucopenia) (all platinum-based drugs)
chr5	169950393	169950394	Normalized brain volume
chr5	170240422	170240423	Smooth-surface caries
chr5	170720732	170720733	Visceral fat
chr5	171015622	171015623	Height
chr5	171076226	171076227	Quantitative traits
chr5	171151230	171151231	Venous thromboembolism (gene x gene interaction)
chr5	171181236	171181237	Height
chr5	171203437	171203438	Height
chr5	171559530	171559531	Migraine - clinic-based
chr5	172271006	172271007	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel)
chr5	172292305	172292306	Periodontitis (CDC/AAP)
chr5	172480335	172480336	PR interval
chr5	172595307	172595308	Infantile hypertrophic pyloric stenosis
chr5	172595307	172595308	Infantile hypertrophic pyloric stenosis
chr5	172664162	172664163	Heart rate
chr5	172934897	172934898	Adiponectin levels
chr5	172939425	172939426	Prostate cancer
chr5	172984113	172984114	Height
chr5	173279841	173279842	Crohn's disease
chr5	173337852	173337853	Crohn's disease
chr5	173352762	173352763	Obesity-related traits
chr5	173359330	173359331	Prion diseases
chr5	173362457	173362458	Waist-hip ratio
chr5	173625153	173625154	Adverse response to chemotherapy (neutropenia/leucopenia) (gemcitabine)
chr5	173648437	173648438	Information processing speed
chr5	173695777	173695778	Subcutaneous adipose tissue
chr5	173777519	173777520	Multiple myeloma (hyperdiploidy)
chr5	174014113	174014114	Alzheimer's disease (late onset)
chr5	174611339	174611340	Response to anti-TNF treatment in rheumatoid arthritis
chr5	174611339	174611340	Response to anti-TNF treatment in rheumatoid arthritis
chr5	174761094	174761095	Treatment response for severe sepsis
chr5	174782118	174782119	Obesity-related traits
chr5	174974575	174974576	Venous thromboembolism (gene x gene interaction)
chr5	175178874	175178875	Obesity-related traits
chr5	175244033	175244034	Attention deficit hyperactivity disorder (inattention symptoms)
chr5	175849988	175849989	Obesity-related traits
chr5	175956270	175956271	Menopause (age at onset)
chr5	176378573	176378574	Menarche and menopause (age at onset)
chr5	176378573	176378574	Menopause (age at onset)
chr5	176517325	176517326	Height
chr5	176691278	176691279	Migraine without aura
chr5	176734647	176734648	Obesity-related traits
chr5	176734647	176734648	Obesity-related traits
chr5	176784511	176784512	Multiple sclerosis
chr5	176794190	176794191	Inflammatory bowel disease
chr5	176794190	176794191	Renal function-related traits (eGRFcrea)
chr5	176794190	176794191	Renal function-related traits (sCR)
chr5	176797342	176797343	Calcium levels
chr5	176798305	176798306	Nephrolithiasis
chr5	176817635	176817636	Chronic kidney disease
chr5	176841338	176841339	Activated partial thromboplastin time
chr5	176841338	176841339	Metabolite levels
chr5	176842473	176842474	Activated partial thromboplastin time
chr5	176842473	176842474	Circulating vasoactive peptide levels
chr5	176842473	176842474	Circulating vasoactive peptide levels
chr5	176842473	176842474	Metabolite levels
chr5	176842473	176842474	Platelet function and related traits
chr5	177019261	177019262	Obesity-related traits
chr5	177808674	177808675	Bulimia nervosa
chr5	177840381	177840382	Obesity-related traits
chr5	178426318	178426319	Pubertal anthropometrics
chr5	178570913	178570914	Attention deficit hyperactivity disorder (time to onset)
chr5	178663407	178663408	Stroke (pediatric)
chr5	178699310	178699311	Visceral adipose tissue adjusted for BMI
chr5	179032487	179032488	Eating disorders
chr5	179471200	179471201	Coronary heart disease
chr5	179731013	179731014	Height
chr5	179794207	179794208	Parkinson's disease
chr5	179812667	179812668	Fat distribution (HIV)
chr5	180170818	180170819	Body mass index
chr5	180170818	180170819	Weight
chr5	180205937	180205938	Thiazide-induced adverse metabolic effects in hypertensive patients
chr5	180226672	180226673	Quantitative traits
chr5	180595137	180595138	Platelet counts
chr6	252144	252145	Hematology traits
chr6	383545	383546	Celiac disease
chr6	396320	396321	Black vs. blond hair color
chr6	396320	396321	Black vs. red hair color
chr6	396320	396321	Eye color
chr6	396320	396321	Freckling
chr6	396320	396321	Hair color
chr6	396320	396321	Hair color
chr6	396320	396321	Hair color
chr6	396320	396321	Non-melanoma skin cancer
chr6	396320	396321	Progressive supranuclear palsy
chr6	396320	396321	Sunburns
chr6	396320	396321	Tanning
chr6	411063	411064	Chronic lymphocytic leukemia
chr6	411063	411064	Chronic lymphocytic leukemia
chr6	411063	411064	Chronic lymphocytic leukemia
chr6	417726	417727	Chronic lymphocytic leukemia
chr6	466032	466033	Freckles
chr6	471135	471136	Non-melanoma skin cancer
chr6	475488	475489	Basal cell carcinoma
chr6	475488	475489	Schizophrenia
chr6	475488	475489	Schizophrenia
chr6	475488	475489	Tanning
chr6	542158	542159	Black vs. blond hair color
chr6	542158	542159	Black vs. red hair color
chr6	566740	566741	Dental caries
chr6	577819	577820	Pit-and-Fissure caries
chr6	858969	858970	Aging
chr6	1318877	1318878	Breast cancer
chr6	1340188	1340189	Pancreatic cancer
chr6	1524569	1524570	Metabolite levels (HVA/MHPG ratio)
chr6	1535997	1535998	Response to hepatitis C treatment
chr6	1573612	1573613	Response to platinum-based agents
chr6	1918261	1918262	Obesity-related traits
chr6	2235632	2235633	Caudate nucleus volume
chr6	2500819	2500820	Orthostatic hypotension
chr6	2565751	2565752	Obesity-related traits
chr6	2912276	2912277	Venous thromboembolism (gene x gene interaction)
chr6	3294823	3294824	Obesity-related traits
chr6	3359336	3359337	Antipsychotic-induced QTc interval prolongation
chr6	3433317	3433318	Crohn's disease
chr6	3837197	3837198	Adverse response to chemotherapy (neutropenia/leucopenia) (camptothecin)
chr6	4379510	4379511	Obesity-related traits
chr6	4512978	4512979	Uric acid levels
chr6	4874758	4874759	Chronic obstructive pulmonary disease
chr6	5071491	5071492	Venous thromboembolism (gene x gene interaction)
chr6	5260935	5260936	Height
chr6	5600437	5600438	Obesity (early onset extreme)
chr6	6283665	6283666	MRI atrophy measures
chr6	6318125	6318126	End-stage coagulation
chr6	6318794	6318795	End-stage coagulation
chr6	6331935	6331936	End-stage coagulation
chr6	6337505	6337506	End-stage coagulation
chr6	6341286	6341287	End-stage coagulation
chr6	6612466	6612467	Major depressive disorder (broad)
chr6	6738751	6738752	Waist-hip ratio
chr6	6743148	6743149	Waist-hip ratio
chr6	6743148	6743149	Waist-hip ratio
chr6	7102083	7102084	Urate levels
chr6	7102083	7102084	Urate levels
chr6	7106315	7106316	Visceral adipose tissue adjusted for BMI
chr6	7106315	7106316	Visceral adipose tissue adjusted for BMI
chr6	7118989	7118990	Age-related macular degeneration
chr6	7118989	7118990	Multiple sclerosis
chr6	7217516	7217517	Waist-hip ratio
chr6	7240576	7240577	Fasting glucose-related traits (interaction with BMI)
chr6	7563231	7563232	Interstitial lung disease
chr6	7652716	7652717	Obesity-related traits
chr6	7695972	7695973	Height
chr6	7720058	7720059	Height
chr6	7725759	7725760	Height
chr6	7736742	7736743	Orofacial clefts
chr6	7743662	7743663	Myopia (pathological)
chr6	8001116	8001117	Coronary artery calcification
chr6	8228941	8228942	Coronary artery calcification
chr6	9030335	9030336	Attention deficit hyperactivity disorder
chr6	9451196	9451197	Morbidity-free survival
chr6	9853918	9853919	Adiponectin levels
chr6	10163967	10163968	Calcium levels
chr6	10176035	10176036	Major depressive disorder
chr6	10897487	10897488	Menarche and menopause (age at onset)
chr6	10897487	10897488	Menopause (age at onset)
chr6	10960157	10960158	Phospholipid levels (plasma)
chr6	10969140	10969141	Phospholipid levels (plasma)
chr6	10969140	10969141	Phospholipid levels (plasma)
chr6	10982358	10982359	Phospholipid levels (plasma)
chr6	10982972	10982973	Phospholipid levels (plasma)
chr6	10995014	10995015	Phospholipid levels (plasma)
chr6	11008621	11008622	Phospholipid levels (plasma)
chr6	11040422	11040423	Metabolite levels
chr6	11042908	11042909	Metabolic traits
chr6	11074346	11074347	Phospholipid levels (plasma)
chr6	11076025	11076026	Phospholipid levels (plasma)
chr6	11076025	11076026	Phospholipid levels (plasma)
chr6	11618166	11618167	Reading and spelling
chr6	11730081	11730082	Orofacial clefts (interaction)
chr6	11943525	11943526	Disc degeneration (lumbar)
chr6	12048826	12048827	Alcohol and nictotine co-dependence
chr6	12197212	12197213	Response to antipsychotic treatment
chr6	12296254	12296255	Circulating vasoactive peptide levels
chr6	12510126	12510127	Obesity-related traits
chr6	12889003	12889004	Coronary heart disease
chr6	12903956	12903957	Coronary artery calcification
chr6	12903956	12903957	Coronary heart disease
chr6	12903956	12903957	Coronary heart disease
chr6	12903956	12903957	Coronary heart disease
chr6	12903956	12903957	Coronary heart disease
chr6	12903956	12903957	Coronary heart disease
chr6	12903956	12903957	Coronary heart disease
chr6	12903956	12903957	Migraine
chr6	12903956	12903957	Migraine
chr6	12903956	12903957	Migraine - clinic-based
chr6	12903956	12903957	Migraine without aura
chr6	12927543	12927544	Coronary heart disease
chr6	12927543	12927544	Myocardial infarction (early onset)
chr6	13216057	13216058	Hip geometry
chr6	13270944	13270945	Blood pressure
chr6	13332466	13332467	Major CVD
chr6	13722522	13722523	Breast cancer
chr6	14096657	14096658	Rheumatoid arthritis
chr6	14173427	14173428	Height
chr6	14200146	14200147	Obesity-related traits
chr6	14587002	14587003	Ovarian reserve
chr6	14596364	14596365	Cognitive test performance
chr6	14597981	14597982	Metabolite levels (HVA/MHPG ratio)
chr6	14598819	14598820	Working memory
chr6	14636962	14636963	Lymphoma
chr6	14719495	14719496	Inflammatory bowel disease
chr6	15089150	15089151	Multiple sclerosis (severity)
chr6	16127406	16127407	Cholesterol, total
chr6	16127406	16127407	LDL cholesterol
chr6	16161424	16161425	Response to statin therapy (LDL-C)
chr6	16197193	16197194	LDL cholesterol
chr6	16256042	16256043	Major depressive disorder
chr6	16343055	16343056	Gambling
chr6	16742032	16742033	Amyotrophic lateral sclerosis
chr6	17241153	17241154	Immune response to smallpox vaccine (IL-6)
chr6	17633060	17633061	Obesity-related traits
chr6	17633060	17633061	Obesity-related traits
chr6	17699321	17699322	Height
chr6	17813824	17813825	Prostate cancer (gene x gene interaction)
chr6	18791722	18791723	Hyperactive-impulsive symptoms
chr6	19443934	19443935	Breast cancer
chr6	19785587	19785588	Endometriosis
chr6	19803767	19803768	Endometriosis
chr6	19841492	19841493	Height
chr6	19969637	19969638	Response to statin therapy
chr6	20109591	20109592	Obesity-related traits
chr6	20156173	20156174	Hyperactive-impulsive symptoms
chr6	20382599	20382600	Obesity-related traits
chr6	20567540	20567541	Obesity-related traits
chr6	20641335	20641336	Glycemic traits
chr6	20652716	20652717	Type 2 diabetes
chr6	20657563	20657564	Type 2 diabetes
chr6	20657563	20657564	Type 2 diabetes and other traits
chr6	20657864	20657865	Type 2 diabetes
chr6	20661033	20661034	Type 2 diabetes
chr6	20661033	20661034	Type 2 diabetes
chr6	20661249	20661250	Diabetes (gestational)
chr6	20661249	20661250	Type 2 diabetes
chr6	20661249	20661250	Type 2 diabetes
chr6	20661249	20661250	Type 2 diabetes
chr6	20661249	20661250	Type 2 diabetes
chr6	20679708	20679709	Type 2 diabetes
chr6	20685485	20685486	Body mass index
chr6	20686572	20686573	Type 2 diabetes
chr6	20686572	20686573	Type 2 diabetes
chr6	20688120	20688121	Type 2 diabetes
chr6	20694883	20694884	Body mass index
chr6	20694883	20694884	Ileal carcinoids
chr6	20703951	20703952	Birth weight
chr6	20703951	20703952	Type 2 diabetes
chr6	20717254	20717255	Type 2 diabetes
chr6	20725422	20725423	Glycated hemoglobin levels
chr6	20728730	20728731	Crohn's disease
chr6	20728730	20728731	Crohn's disease
chr6	20812587	20812588	Inflammatory bowel disease
chr6	21384612	21384613	Bone mineral density
chr6	21384612	21384613	Bone mineral density
chr6	21430727	21430728	Crohn's disease
chr6	21455152	21455153	Metabolite levels (HVA-5-HIAA Factor score)
chr6	21996859	21996860	Pulmonary function (interaction)
chr6	22017737	22017738	Pulmonary function
chr6	22017737	22017738	Pulmonary function (interaction)
chr6	22125963	22125964	Neuroblastoma
chr6	22131928	22131929	Neuroblastoma
chr6	22140003	22140004	Neuroblastoma
chr6	22246603	22246604	Cardiac hypertrophy
chr6	22304203	22304204	Paget's disease
chr6	22709738	22709739	Metabolite levels (Pyroglutamine)
chr6	22743402	22743403	Quantitative traits
chr6	22753046	22753047	Obesity-related traits
chr6	23077310	23077311	Tourette syndrome
chr6	23841131	23841132	Major depressive disorder
chr6	24062787	24062788	Periodontitis (Mean PAL)
chr6	24107092	24107093	Information processing speed
chr6	24234932	24234933	Information processing speed
chr6	24306386	24306387	Airflow obstruction
chr6	24441745	24441746	Liver enzyme levels
chr6	24480294	24480295	Hematological and biochemical traits
chr6	24491474	24491475	Liver enzyme levels (alkaline phosphatase)
chr6	24544966	24544967	Radiation response
chr6	24749412	24749413	Neutrophil count
chr6	24863074	24863075	Electroencephalographic traits in alcoholism
chr6	25488582	25488583	Iron status biomarkers
chr6	25488582	25488583	Iron status biomarkers
chr6	25488582	25488583	Iron status biomarkers
chr6	25533533	25533534	Mean platelet volume
chr6	25548287	25548288	Platelet counts
chr6	25607570	25607571	Uric acid levels
chr6	25641199	25641200	Iron status biomarkers
chr6	25772046	25772047	Carotid intima media thickness
chr6	25776948	25776949	Cardiovascular disease risk factors
chr6	25813149	25813150	Serum uric acid levels
chr6	25813149	25813150	Urate levels
chr6	25820438	25820439	Iron status biomarkers
chr6	25821615	25821616	Urate levels
chr6	25821769	25821770	Iron levels
chr6	25821769	25821770	Iron status biomarkers
chr6	25821769	25821770	Red blood cell traits
chr6	25823443	25823444	Uric acid levels
chr6	25842950	25842951	Hematology traits
chr6	25842950	25842951	Iron status biomarkers
chr6	25842950	25842951	Mean corpuscular hemoglobin
chr6	25842950	25842951	Red blood cell traits
chr6	25869370	25869371	Homocysteine levels
chr6	25870541	25870542	Urate levels
chr6	25997457	25997458	Iron status biomarkers
chr6	26091178	26091179	Diastolic blood pressure
chr6	26091178	26091179	Hypertension
chr6	26091178	26091179	Iron levels
chr6	26091178	26091179	Systolic blood pressure
chr6	26093140	26093141	Alcohol consumption (transferrin glycosylation)
chr6	26093140	26093141	Cardiovascular disease risk factors
chr6	26093140	26093141	Cholesterol, total
chr6	26093140	26093141	Glycated hemoglobin levels
chr6	26093140	26093141	Hematocrit
chr6	26093140	26093141	Hematological parameters
chr6	26093140	26093141	Hematology traits
chr6	26093140	26093141	Hemoglobin
chr6	26093140	26093141	Hepcidin levels
chr6	26093140	26093141	Hepcidin levels
chr6	26093140	26093141	Hepcidin levels
chr6	26093140	26093141	Hepcidin levels
chr6	26093140	26093141	Iron status biomarkers
chr6	26093140	26093141	Iron status biomarkers
chr6	26093140	26093141	Iron status biomarkers
chr6	26093140	26093141	Iron status biomarkers
chr6	26093140	26093141	Iron status biomarkers
chr6	26093140	26093141	Iron status biomarkers
chr6	26093140	26093141	Iron status biomarkers
chr6	26093140	26093141	LDL cholesterol
chr6	26093140	26093141	Mean corpuscular hemoglobin
chr6	26093140	26093141	Mean corpuscular volume
chr6	26093140	26093141	Red blood cell traits
chr6	26093140	26093141	Red blood cell traits
chr6	26093140	26093141	Red blood cell traits
chr6	26093140	26093141	Red blood cell traits
chr6	26107462	26107463	Blood pressure
chr6	26107462	26107463	Hemoglobin
chr6	26107462	26107463	Mean corpuscular volume
chr6	26116981	26116982	Bilirubin levels
chr6	26200676	26200677	Height
chr6	26200676	26200677	Height
chr6	26233386	26233387	Height
chr6	26233386	26233387	Height
chr6	26233386	26233387	Height
chr6	26500562	26500563	Iron status biomarkers
chr6	26510563	26510564	Educational attainment
chr6	27037079	27037080	Iron status biomarkers
chr6	27143882	27143883	Schizophrenia
chr6	27143882	27143883	Schizophrenia
chr6	27248930	27248931	Schizophrenia
chr6	27278019	27278020	Schizophrenia
chr6	27710164	27710165	Schizophrenia
chr6	28020819	28020820	Cardiac Troponin-T levels
chr6	28129788	28129789	Pubertal anthropometrics
chr6	28227603	28227604	Schizophrenia
chr6	28322295	28322296	Pulmonary function
chr6	28776116	28776117	Lung adenocarcinoma
chr6	28916251	28916252	Platelet aggregation
chr6	29084231	29084232	Height
chr6	29180720	29180721	Social communication problems
chr6	29351783	29351784	Retinopathy in non-diabetics
chr6	29355201	29355202	Pulmonary function
chr6	29356330	29356331	Barrett's esophagus
chr6	29434413	29434414	Immune reponse to smallpox (secreted IFN-alpha)
chr6	29520876	29520877	Height
chr6	29607045	29607046	Migraine without aura
chr6	29611430	29611431	Nasopharyngeal carcinoma
chr6	29626320	29626321	Pulmonary function (interaction)
chr6	29670260	29670261	Nasopharyngeal carcinoma
chr6	29702509	29702510	Prostate cancer (gene x gene interaction)
chr6	29705658	29705659	Multiple sclerosis
chr6	29723160	29723161	Crohn's disease
chr6	29789170	29789171	Rheumatoid arthritis
chr6	29828659	29828660	Drug-induced liver injury (amoxicillin-clavulanate)
chr6	29849618	29849619	IgE levels
chr6	29899676	29899677	Bipolar disorder and schizophrenia
chr6	29906690	29906691	Nasopharyngeal carcinoma
chr6	29913297	29913298	Adverse response to carbamapezine
chr6	29918098	29918099	Nasopharyngeal carcinoma
chr6	29920331	29920332	Beta-2 microglubulin plasma levels
chr6	29920331	29920332	Multiple sclerosis
chr6	29923837	29923838	IgE levels
chr6	29934162	29934163	Ulcerative colitis
chr6	29935249	29935250	Graves' disease
chr6	29941942	29941943	IgA nephropathy
chr6	29943066	29943067	Vitiligo
chr6	29973924	29973925	Graves' disease
chr6	30017070	30017071	Lipid metabolism phenotypes
chr6	30032521	30032522	AIDS progression
chr6	30032521	30032522	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr6	30075863	30075864	Beta-2 microglubulin plasma levels
chr6	30080368	30080369	Cognitive performance
chr6	30093363	30093364	Cardiac hypertrophy
chr6	30165272	30165273	Schizophrenia
chr6	30174130	30174131	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr6	30174130	30174131	Schizophrenia
chr6	30537605	30537606	Graves' disease
chr6	30666668	30666669	IgG glycosylation
chr6	30666668	30666669	IgG glycosylation
chr6	30666668	30666669	IgG glycosylation
chr6	30666668	30666669	IgG glycosylation
chr6	30666668	30666669	IgG glycosylation
chr6	30679627	30679628	IgG glycosylation
chr6	30679627	30679628	IgG glycosylation
chr6	30679627	30679628	IgG glycosylation
chr6	30736150	30736151	Response to antipsychotic treatment
chr6	30737485	30737486	Migraine without aura
chr6	30774356	30774357	Age-related macular degeneration
chr6	30782001	30782002	Bipolar disorder and schizophrenia
chr6	30795170	30795171	Response to angiotensin II receptor blocker therapy
chr6	30797990	30797991	IgG glycosylation
chr6	30799398	30799399	Ulcerative colitis
chr6	30876151	30876152	Complement C3 and C4 levels
chr6	30913457	30913458	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr6	30938882	30938883	Pulmonary function (interaction)
chr6	30938882	30938883	Pulmonary function (interaction)
chr6	30976218	30976219	Preeclampsia
chr6	31002615	31002616	Graves' disease
chr6	31006854	31006855	Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS-TEN)
chr6	31018406	31018407	Hypothyroidism
chr6	31030121	31030122	White blood cell count
chr6	31058177	31058178	Behcet's disease
chr6	31058177	31058178	Graves' disease
chr6	31058339	31058340	Hematology traits
chr6	31058339	31058340	Myasthenia gravis
chr6	31074029	31074030	Follicular lymphoma
chr6	31074029	31074030	Follicular lymphoma
chr6	31085769	31085770	White blood cell count
chr6	31093586	31093587	Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS-TEN)
chr6	31097300	31097301	Chronic obstructive pulmonary disease-related biomarkers
chr6	31099576	31099577	Behcet's disease
chr6	31106267	31106268	Systemic sclerosis
chr6	31107186	31107187	Chronic obstructive pulmonary disease-related biomarkers
chr6	31107257	31107258	Multiple myeloma
chr6	31111355	31111356	Ulcerative colitis
chr6	31118018	31118019	Nevirapine-induced rash
chr6	31118510	31118511	Prostate cancer
chr6	31130592	31130593	Chronic hepatitis B infection
chr6	31136452	31136453	Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS-TEN)
chr6	31139451	31139452	Height
chr6	31142244	31142245	Crohn's disease
chr6	31168028	31168029	Common traits (Other)
chr6	31184195	31184196	Coronary heart disease
chr6	31186025	31186026	IgG glycosylation
chr6	31221667	31221668	White blood cell types
chr6	31238317	31238318	Beta-2 microglubulin plasma levels
chr6	31240430	31240431	Chronic obstructive pulmonary disease-related biomarkers
chr6	31241108	31241109	Psoriatic arthritis
chr6	31242173	31242174	White blood cell count
chr6	31252395	31252396	CD4:CD8 lymphocyte ratio
chr6	31252395	31252396	CD4:CD8 lymphocyte ratio
chr6	31252924	31252925	Psoriasis
chr6	31252924	31252925	Psoriasis
chr6	31258836	31258837	Vitiligo
chr6	31263750	31263751	Nasopharyngeal carcinoma
chr6	31265489	31265490	Height
chr6	31265489	31265490	Triglycerides
chr6	31271715	31271716	Protein quantitative trait loci
chr6	31272320	31272321	Atopic dermatitis
chr6	31274379	31274380	Crohn's disease
chr6	31274554	31274555	AIDS progression
chr6	31274554	31274555	Psoriasis
chr6	31274554	31274555	Psoriasis
chr6	31312325	31312326	Psoriasis
chr6	31322366	31322367	Platelet counts
chr6	31322558	31322559	Beta-2 microglubulin plasma levels
chr6	31327700	31327701	Bipolar disorder
chr6	31336099	31336100	Ankylosing spondylitis
chr6	31336417	31336418	Behcet's disease
chr6	31346821	31346822	Chronic obstructive pulmonary disease-related biomarkers
chr6	31350703	31350704	Graves' disease
chr6	31352112	31352113	Self-reported allergy
chr6	31354181	31354182	Allergic sensitization
chr6	31354559	31354560	Height
chr6	31360254	31360255	Pubertal anthropometrics
chr6	31362309	31362310	Beta-2 microglubulin plasma levels
chr6	31365786	31365787	Ankylosing spondylitis
chr6	31366594	31366595	Hepatocellular carcinoma
chr6	31377586	31377587	Visceral adipose tissue adjusted for BMI
chr6	31379930	31379931	Rheumatoid arthritis
chr6	31380528	31380529	Height
chr6	31390409	31390410	Cervical cancer
chr6	31405616	31405617	Beta-2 microglubulin plasma levels
chr6	31407827	31407828	Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS-TEN)
chr6	31408264	31408265	Capecitabine sensitivity
chr6	31431779	31431780	AIDS progression
chr6	31431779	31431780	Drug-induced liver injury (flucloxacillin)
chr6	31431779	31431780	Psoriasis
chr6	31440668	31440669	Renal function-related traits (eGRFcrea)
chr6	31440668	31440669	Renal function-related traits (sCR)
chr6	31446795	31446796	Hodgkin's lymphoma
chr6	31448975	31448976	Metabolic syndrome
chr6	31448975	31448976	Neonatal lupus
chr6	31472719	31472720	Pulmonary function
chr6	31475485	31475486	Dengue shock syndrome
chr6	31481298	31481299	White blood cell types
chr6	31499602	31499603	Atopic dermatitis
chr6	31505479	31505480	Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS-TEN)
chr6	31542307	31542308	Crohn's disease
chr6	31557790	31557791	Complement C3 and C4 levels
chr6	31568468	31568469	Pulmonary function
chr6	31568468	31568469	Pulmonary function (interaction)
chr6	31572955	31572956	Height
chr6	31572955	31572956	IgG glycosylation
chr6	31572955	31572956	IgG glycosylation
chr6	31572955	31572956	IgG glycosylation
chr6	31572955	31572956	IgG glycosylation
chr6	31572955	31572956	Weight
chr6	31575275	31575276	Crohn's disease
chr6	31602966	31602967	Menopause (age at onset)
chr6	31602966	31602967	Menopause (age at onset)
chr6	31602966	31602967	Schizophrenia
chr6	31616365	31616366	Diastolic blood pressure
chr6	31616365	31616366	Hypertension
chr6	31616365	31616366	Systolic blood pressure
chr6	31620519	31620520	Lung adenocarcinoma
chr6	31620519	31620520	Lung cancer
chr6	31620519	31620520	Lung cancer
chr6	31622605	31622606	Rheumatoid arthritis
chr6	31721032	31721033	Systemic lupus erythematosus
chr6	31778528	31778529	Complement C3 and C4 levels
chr6	31802464	31802465	IgG glycosylation
chr6	31802464	31802465	IgG glycosylation
chr6	31802464	31802465	IgG glycosylation
chr6	31837065	31837066	Vitiligo
chr6	31838712	31838713	Menopause (age at onset)
chr6	31843923	31843924	Telomere length
chr6	31851233	31851234	Chronic hepatitis B infection
chr6	31867252	31867253	Economic and political preferences (environmentalism)
chr6	31870855	31870856	Hepatitis B vaccine response
chr6	31883678	31883679	Hepatocellular carcinoma
chr6	31903803	31903804	Age-related macular degeneration
chr6	31903803	31903804	Age-related macular degeneration (CNV)
chr6	31903803	31903804	Age-related macular degeneration (GA)
chr6	31906009	31906010	Age-related macular degeneration
chr6	31914179	31914180	Age-related macular degeneration
chr6	31914179	31914180	Age-related macular degeneration
chr6	31914179	31914180	Age-related macular degeneration (CNV)
chr6	31914179	31914180	Age-related macular degeneration (GA)
chr6	31916950	31916951	Age-related macular degeneration
chr6	31919916	31919917	Age-related macular degeneration
chr6	31919916	31919917	Age-related macular degeneration (extreme sampling)
chr6	31930440	31930441	IgG glycosylation
chr6	31930440	31930441	IgG glycosylation
chr6	31930461	31930462	Age-related macular degeneration
chr6	31930461	31930462	Age-related macular degeneration
chr6	31930461	31930462	Age-related macular degeneration
chr6	31933160	31933161	Age-related macular degeneration
chr6	31940896	31940897	Hematology traits
chr6	32019745	32019746	Complement C3 and C4 levels
chr6	32050066	32050067	Height
chr6	32050757	32050758	Systemic lupus erythematosus
chr6	32071016	32071017	Phospholipid levels (plasma)
chr6	32074803	32074804	Age-related macular degeneration
chr6	32074803	32074804	Atopic dermatitis
chr6	32076498	32076499	Eosinophil counts
chr6	32079566	32079567	Ulcerative colitis
chr6	32109978	32109979	Serum total protein level
chr6	32109978	32109979	Serum total protein level
chr6	32114514	32114515	IgG glycosylation
chr6	32114514	32114515	IgG glycosylation
chr6	32114514	32114515	IgG glycosylation
chr6	32127476	32127477	Oleic acid (18:1n-9) plasma levels
chr6	32136546	32136547	Phospholipid levels (plasma)
chr6	32151442	32151443	Pulmonary function
chr6	32151442	32151443	Pulmonary function
chr6	32151442	32151443	Pulmonary function (interaction)
chr6	32155580	32155581	Asthma
chr6	32158318	32158319	Atopic dermatitis
chr6	32163747	32163748	Obesity-related traits
chr6	32165443	32165444	Complement C3 and C4 levels
chr6	32171074	32171075	Schizophrenia
chr6	32171074	32171075	Schizophrenia
chr6	32171682	32171683	Age-related macular degeneration
chr6	32172992	32172993	Schizophrenia
chr6	32184344	32184345	Asthma
chr6	32190027	32190028	Interstitial lung disease
chr6	32190405	32190406	Systemic sclerosis
chr6	32190619	32190620	Circulating myeloperoxidase levels (serum)
chr6	32192330	32192331	Prostate cancer
chr6	32205109	32205110	Crohn's disease
chr6	32208323	32208324	Celiac disease
chr6	32218842	32218843	Nephropathy
chr6	32218988	32218989	Rheumatoid arthritis
chr6	32218988	32218989	Systemic sclerosis
chr6	32223257	32223258	Systemic lupus erythematosus
chr6	32244626	32244627	Bone mineral density (spine)
chr6	32282853	32282854	Rheumatoid arthritis
chr6	32282853	32282854	Rheumatoid arthritis
chr6	32305978	32305979	Lumiracoxib-related liver injury
chr6	32308907	32308908	Atopic dermatitis
chr6	32315726	32315727	Hepatitis C induced liver cirrhosis
chr6	32319636	32319637	Obesity-related traits
chr6	32321553	32321554	Arthritis (juvenile idiopathic)
chr6	32325370	32325371	Visceral fat
chr6	32336186	32336187	Multiple sclerosis
chr6	32336186	32336187	Multiple sclerosis
chr6	32337629	32337630	Graves' disease
chr6	32338694	32338695	Asthma
chr6	32339075	32339076	Activated partial thromboplastin time
chr6	32341352	32341353	Coronary heart disease
chr6	32345282	32345283	Vitiligo
chr6	32358269	32358270	Bipolar disorder and schizophrenia
chr6	32358512	32358513	Asthma
chr6	32363214	32363215	Anti-cyclic Citrullinated Peptide Antibody
chr6	32363815	32363816	Sarcoidosis
chr6	32363843	32363844	Ulcerative colitis
chr6	32363954	32363955	Waist-hip ratio
chr6	32368086	32368087	Hepatitis C induced liver cirrhosis
chr6	32368086	32368087	Lung adenocarcinoma
chr6	32368086	32368087	Multiple sclerosis (OCB status)
chr6	32368086	32368087	Multiple sclerosis (OCB status)
chr6	32373231	32373232	Crohn's disease
chr6	32373311	32373312	Knee osteoarthritis
chr6	32373697	32373698	Vitiligo
chr6	32376787	32376788	Complement C3 and C4 levels
chr6	32379488	32379489	Asthma
chr6	32379735	32379736	Hepatitis C induced liver cirrhosis
chr6	32383049	32383050	Pubertal anthropometrics
chr6	32387808	32387809	Parkinson's disease
chr6	32389647	32389648	Hepatitis B vaccine response
chr6	32389647	32389648	Hepatitis C induced liver cirrhosis
chr6	32401078	32401079	Hepatitis C induced liver cirrhosis
chr6	32401216	32401217	Multiple sclerosis
chr6	32406341	32406342	Multiple sclerosis (OCB status)
chr6	32406341	32406342	Multiple sclerosis (OCB status)
chr6	32408526	32408527	Type 1 diabetes
chr6	32409529	32409530	Parkinson's disease
chr6	32409529	32409530	Systemic sclerosis
chr6	32411645	32411646	Non-obstructive azoospermia
chr6	32412434	32412435	Cholesterol, total
chr6	32412434	32412435	LDL cholesterol
chr6	32413050	32413051	Multiple sclerosis
chr6	32413050	32413051	Multiple sclerosis
chr6	32413458	32413459	Hematological parameters
chr6	32413544	32413545	Multiple sclerosis
chr6	32414272	32414273	Asthma
chr6	32428284	32428285	Hodgkin's lymphoma
chr6	32429642	32429643	Lymphoma
chr6	32429642	32429643	Rheumatoid arthritis
chr6	32429642	32429643	Ulcerative colitis
chr6	32429642	32429643	Ulcerative colitis
chr6	32431146	32431147	Ulcerative colitis
chr6	32431146	32431147	Ulcerative colitis
chr6	32431961	32431962	Schizophrenia
chr6	32432076	32432077	Cystic fibrosis severity
chr6	32432834	32432835	Ulcerative colitis
chr6	32433166	32433167	Hodgkin's lymphoma
chr6	32433166	32433167	Ulcerative colitis
chr6	32433166	32433167	Ulcerative colitis
chr6	32520906	32520907	Multiple sclerosis (OCB status)
chr6	32569690	32569691	Inflammatory bowel disease
chr6	32573990	32573991	Systemic lupus erythematosus
chr6	32574170	32574171	Rheumatoid arthritis
chr6	32576477	32576478	Systemic lupus erythematosus
chr6	32577379	32577380	IgA nephropathy
chr6	32577379	32577380	Rheumatoid arthritis
chr6	32578081	32578082	Chronic lymphocytic leukemia
chr6	32581888	32581889	Lymphoma
chr6	32581888	32581889	Lymphoma
chr6	32581888	32581889	Lymphoma
chr6	32581888	32581889	Schizophrenia
chr6	32586853	32586854	Crohn's disease
chr6	32586853	32586854	Immunoglobulin A
chr6	32586853	32586854	Inflammatory bowel disease
chr6	32586853	32586854	Inflammatory bowel disease
chr6	32586853	32586854	Inflammatory bowel disease
chr6	32586853	32586854	Multiple sclerosis
chr6	32586853	32586854	Multiple sclerosis
chr6	32586853	32586854	Ulcerative colitis
chr6	32590924	32590925	Systemic sclerosis
chr6	32590952	32590953	Sjgren's syndrome
chr6	32592199	32592200	Multiple sclerosis (OCB status)
chr6	32592736	32592737	Nasopharyngeal carcinoma
chr6	32595222	32595223	Leishmaniasis (visceral)
chr6	32599998	32599999	Hepatocellular carcinoma
chr6	32599998	32599999	Response to interferon beta therapy
chr6	32600802	32600803	Cervical cancer
chr6	32602268	32602269	Rheumatoid arthritis
chr6	32602268	32602269	Schizophrenia
chr6	32603006	32603007	Multiple sclerosis
chr6	32604371	32604372	Asthma
chr6	32604371	32604372	Type 1 diabetes
chr6	32604371	32604372	Type 1 diabetes
chr6	32605883	32605884	Celiac disease
chr6	32605883	32605884	Celiac disease
chr6	32605883	32605884	Immunoglobulin A
chr6	32605883	32605884	Nephropathy (idiopathic membranous)
chr6	32605883	32605884	Systemic lupus erythematosus
chr6	32605883	32605884	Systemic lupus erythematosus
chr6	32606755	32606756	Chronic lymphocytic leukemia
chr6	32612396	32612397	Ulcerative colitis
chr6	32625868	32625869	Asthma
chr6	32626310	32626311	Allergic sensitization
chr6	32626310	32626311	Self-reported allergy
chr6	32632831	32632832	Drug-induced liver injury (amoxicillin-clavulanate)
chr6	32657577	32657578	Primary biliary cirrhosis
chr6	32657577	32657578	Primary biliary cirrhosis
chr6	32658078	32658079	Asthma
chr6	32658078	32658079	IgE grass sensitization
chr6	32658309	32658310	Crohn's disease
chr6	32658309	32658310	IgE levels
chr6	32663630	32663631	Hypothyroidism
chr6	32663630	32663631	Multiple sclerosis (OCB status)
chr6	32663850	32663851	Graves' disease
chr6	32663850	32663851	Rheumatoid arthritis
chr6	32663850	32663851	Rheumatoid arthritis
chr6	32663850	32663851	Systemic sclerosis
chr6	32663850	32663851	Systemic sclerosis
chr6	32663998	32663999	Height
chr6	32663998	32663999	Rheumatoid arthritis
chr6	32664457	32664458	Follicular lymphoma
chr6	32664457	32664458	Systemic lupus erythematosus
chr6	32664959	32664960	HPV seropositivity
chr6	32665419	32665420	Follicular lymphoma
chr6	32666294	32666295	Hepatocellular carcinoma (hepatitis B virus related)
chr6	32667909	32667910	Pulmonary function
chr6	32667909	32667910	Type 1 diabetes
chr6	32668099	32668100	Lymphoma
chr6	32668335	32668336	Lymphoma
chr6	32669155	32669156	Systemic sclerosis
chr6	32669155	32669156	Systemic sclerosis
chr6	32669372	32669373	Coronary heart disease
chr6	32669954	32669955	Rheumatoid arthritis
chr6	32670254	32670255	Chronic hepatitis B infection
chr6	32670254	32670255	Hepatitis B
chr6	32671102	32671103	Rheumatoid arthritis
chr6	32671247	32671248	IgA nephropathy
chr6	32674736	32674737	IgG glycosylation
chr6	32674736	32674737	IgG glycosylation
chr6	32674736	32674737	IgG glycosylation
chr6	32675108	32675109	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr6	32677911	32677912	Multiple sclerosis (OCB status)
chr6	32678596	32678597	Chronic Hepatitis C infection
chr6	32678998	32678999	Alopecia areata
chr6	32678998	32678999	Hepatocellular carcinoma
chr6	32680575	32680576	Pulmonary function (interaction)
chr6	32680575	32680576	Pulmonary function (interaction)
chr6	32680927	32680928	Crohn's disease
chr6	32680927	32680928	Rheumatoid arthritis
chr6	32680927	32680928	Rheumatoid arthritis
chr6	32681276	32681277	IgE levels
chr6	32681276	32681277	IgE levels
chr6	32681630	32681631	Nephropathy
chr6	32681675	32681676	Immune response to anthrax vaccine
chr6	32685549	32685550	Type 2 diabetes
chr6	32687972	32687973	Asthma
chr6	32697784	32697785	IgG glycosylation
chr6	32700082	32700083	Narcolepsy
chr6	32725192	32725193	Systemic lupus erythematosus
chr6	32726802	32726803	IgG glycosylation
chr6	32726802	32726803	IgG glycosylation
chr6	32730011	32730012	Chronic hepatitis B infection
chr6	32730011	32730012	Hepatitis B
chr6	32730011	32730012	Lymphoma
chr6	32730085	32730086	Systemic lupus erythematosus
chr6	32736694	32736695	Complement C3 and C4 levels
chr6	32741867	32741868	Lymphoma
chr6	32763513	32763514	Kawasaki disease
chr6	32804069	32804070	Complement C3 and C4 levels
chr6	32809847	32809848	Nephropathy
chr6	32852646	32852647	Disc degeneration (lumbar)
chr6	32854696	32854697	Disc degeneration (lumbar)
chr6	32855716	32855717	Disc degeneration (lumbar)
chr6	32856380	32856381	Disc degeneration (lumbar)
chr6	32856481	32856482	Disc degeneration (lumbar)
chr6	32856933	32856934	Disc degeneration (lumbar)
chr6	32857418	32857419	Disc degeneration (lumbar)
chr6	32859711	32859712	Disc degeneration (lumbar)
chr6	32859747	32859748	Disc degeneration (lumbar)
chr6	32860751	32860752	Disc degeneration (lumbar)
chr6	32862606	32862607	Disc degeneration (lumbar)
chr6	32913245	32913246	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr6	32915850	32915851	IgG glycosylation
chr6	32953279	32953280	IgG glycosylation
chr6	32953279	32953280	IgG glycosylation
chr6	32953279	32953280	IgG glycosylation
chr6	32953279	32953280	IgG glycosylation
chr6	32953279	32953280	IgG glycosylation
chr6	32953279	32953280	IgG glycosylation
chr6	32953279	32953280	IgG glycosylation
chr6	32961360	32961361	Asthma
chr6	32972403	32972404	Periodontitis (CDC/AAP)
chr6	32975013	32975014	Platelet counts
chr6	33033021	33033022	Chronic hepatitis B infection
chr6	33033021	33033022	Hepatitis B
chr6	33033021	33033022	Hepatitis B (viral clearance)
chr6	33033021	33033022	Hepatitis B (viral clearance)
chr6	33042879	33042880	Asthma
chr6	33042879	33042880	Systemic sclerosis
chr6	33048660	33048661	Aspirin exacerbated respiratory disease in asthmatics
chr6	33054860	33054861	Chronic hepatitis B infection
chr6	33054860	33054861	Hepatitis B
chr6	33054860	33054861	Hepatitis B
chr6	33054860	33054861	Hepatitis B (viral clearance)
chr6	33054860	33054861	Hepatitis B (viral clearance)
chr6	33054860	33054861	Hepatitis B vaccine response
chr6	33055537	33055538	Wegener's granulomatosis
chr6	33060117	33060118	Graves' disease
chr6	33060821	33060822	Bilirubin levels
chr6	33069892	33069893	Antineutrophil cytoplasmic antibody-associated vasculitis
chr6	33072171	33072172	Cervical cancer
chr6	33072171	33072172	Sjgren's syndrome
chr6	33086248	33086249	RR interval (heart rate)
chr6	33086447	33086448	Nephropathy
chr6	33089622	33089623	Cervical cancer
chr6	33143947	33143948	LDL cholesterol
chr6	33204273	33204274	Cervical cancer
chr6	33465481	33465482	Chronic obstructive pulmonary disease
chr6	33478495	33478496	Chronic obstructive pulmonary disease
chr6	33486731	33486732	Self-reported allergy
chr6	33489881	33489882	Obesity-related traits
chr6	33540208	33540209	Mean platelet volume
chr6	33540208	33540209	Platelet counts
chr6	33540208	33540209	Platelet counts
chr6	33540208	33540209	Platelet counts
chr6	33541718	33541719	Platelet counts
chr6	33542537	33542538	Testicular germ cell tumor
chr6	33542537	33542538	Testicular germ cell tumor
chr6	33542537	33542538	Testicular germ cell tumor
chr6	33546836	33546837	Chronic lymphocytic leukemia
chr6	33546836	33546837	Chronic lymphocytic leukemia
chr6	33548393	33548394	Platelet counts
chr6	33618161	33618162	Graves' disease
chr6	33624732	33624733	Obesity (extreme)
chr6	33659045	33659046	Height
chr6	33662294	33662295	Educational attainment
chr6	33706478	33706479	Phosphorus levels
chr6	33740024	33740025	Obesity-related traits
chr6	33762241	33762242	Obesity (extreme)
chr6	33764032	33764033	Crohn's disease
chr6	33817928	33817929	Graves' disease
chr6	33825357	33825358	Alzheimer's disease (age of onset)
chr6	33851172	33851173	Schizophrenia
chr6	34036445	34036446	Osteosarcoma
chr6	34165720	34165721	Height
chr6	34194865	34194866	Height
chr6	34195010	34195011	Height
chr6	34195010	34195011	Height
chr6	34195010	34195011	Height
chr6	34199091	34199092	Height
chr6	34214321	34214322	Height
chr6	34238513	34238514	Height
chr6	34238513	34238514	Height
chr6	34302868	34302869	Body mass index
chr6	34546559	34546560	Cholesterol, total
chr6	34552796	34552797	HDL cholesterol
chr6	34581635	34581636	Height
chr6	34618892	34618893	Height
chr6	34683634	34683635	Height
chr6	34763981	34763982	Pubertal anthropometrics
chr6	34823186	34823187	Systemic lupus erythematosus
chr6	34845448	34845449	Fasting insulin-related traits (interaction with BMI)
chr6	34923863	34923864	Non-small cell lung cancer
chr6	34927279	34927280	Systemic lupus erythematosus and Systemic sclerosis
chr6	34975414	34975415	Alcoholism (alcohol dependence factor score)
chr6	34975414	34975415	Alcoholism (alcohol use disorder factor score)
chr6	35005083	35005084	Height
chr6	35034799	35034800	Coronary heart disease
chr6	35056442	35056443	Obesity-related traits
chr6	35322762	35322763	Cataracts in type 2 diabetes
chr6	35341849	35341850	Height
chr6	35363756	35363757	Response to antipsychotic treatment
chr6	35402784	35402785	Height
chr6	35402804	35402805	Height
chr6	35404353	35404354	Pulmonary function (interaction)
chr6	35502201	35502202	Hepatitis C induced liver fibrosis
chr6	36618820	36618821	Electrocardiographic conduction measures
chr6	36622899	36622900	Colorectal cancer
chr6	36622899	36622900	Electrocardiographic traits
chr6	36623378	36623379	Ventricular conduction
chr6	36792056	36792057	Heart rate
chr6	36922683	36922684	Chemerin levels
chr6	37174744	37174745	Bipolar disorder (mood-incongruent)
chr6	37451695	37451696	Cognitive performance
chr6	37487043	37487044	Cognitive performance
chr6	37532102	37532103	IgG glycosylation
chr6	38036419	38036420	Insulin resistance/response
chr6	38106843	38106844	Type 2 diabetes
chr6	38365840	38365841	Restless legs syndrome
chr6	38365872	38365873	Restless legs syndrome
chr6	38440969	38440970	Restless legs syndrome
chr6	39117697	39117698	Eating disorders
chr6	39183469	39183470	Migraine
chr6	39202156	39202157	Obesity-related traits
chr6	39284049	39284050	Type 2 diabetes
chr6	39361853	39361854	Obesity-related traits
chr6	39528981	39528982	Immune response to smallpox vaccine (IL-6)
chr6	39539206	39539207	Attention deficit hyperactivity disorder symptoms (interaction)
chr6	39784364	39784365	Pulmonary function
chr6	40440499	40440500	Obesity-related traits
chr6	40440499	40440500	Obesity-related traits
chr6	40536127	40536128	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)
chr6	40536127	40536128	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)
chr6	40536127	40536128	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)
chr6	40802260	40802261	Esophageal cancer
chr6	41127971	41127972	C-reactive protein
chr6	41129251	41129252	Alzheimer's disease
chr6	41303804	41303805	Total ventricular volume
chr6	41336100	41336101	Alzheimer's disease biomarkers
chr6	41379314	41379315	Periodontitis
chr6	41536426	41536427	Prostate cancer
chr6	41623032	41623033	Cardiovascular disease risk factors
chr6	41650735	41650736	Attention deficit hyperactivity disorder
chr6	41905274	41905275	Mean corpuscular hemoglobin
chr6	41905274	41905275	Mean corpuscular volume
chr6	41905274	41905275	Mean corpuscular volume
chr6	41905274	41905275	Red blood cell count
chr6	41914377	41914378	Red blood cell traits
chr6	41925158	41925159	Mean corpuscular hemoglobin
chr6	41925158	41925159	Mean corpuscular volume
chr6	41925289	41925290	Hematological parameters
chr6	41925303	41925304	Neutrophil count
chr6	41962670	41962671	Metabolite levels (5-HIAA/ MHPG Ratio)
chr6	42495277	42495278	Obesity-related traits
chr6	42731114	42731115	Bipolar disorder
chr6	43153786	43153787	Obesity-related traits
chr6	43272187	43272188	Urate levels
chr6	43757895	43757896	Adiponectin levels
chr6	43758872	43758873	Coronary heart disease
chr6	43758872	43758873	Waist-hip ratio
chr6	43764550	43764551	Sexual dimorphism in anthropometric traits
chr6	43795967	43795968	Ulcerative colitis
chr6	43804570	43804571	Urate levels
chr6	43806608	43806609	Chronic kidney disease
chr6	43811761	43811762	Thyroid hormone levels
chr6	43811761	43811762	Thyroid hormone levels
chr6	43811761	43811762	Thyroid hormone levels
chr6	43811761	43811762	Type 2 diabetes
chr6	43826626	43826627	Age-related macular degeneration
chr6	43828581	43828582	Age-related macular degeneration
chr6	43897726	43897727	Vascular endothelial growth factor levels
chr6	43904779	43904780	Thyroid hormone levels
chr6	43904779	43904780	Thyroid hormone levels
chr6	43925525	43925526	Vascular endothelial growth factor levels
chr6	44065310	44065311	Major depressive disorder
chr6	44232919	44232920	Rheumatoid arthritis
chr6	44232919	44232920	Rheumatoid arthritis
chr6	44424799	44424800	Migraine
chr6	44594158	44594159	Stroke (ischemic)
chr6	44639183	44639184	Bone mineral density
chr6	44739948	44739949	Obesity-related traits
chr6	44769236	44769237	Asthma (childhood onset)
chr6	44777690	44777691	Osteoarthritis
chr6	44837355	44837356	Attention deficit hyperactivity disorder
chr6	44946505	44946506	Height
chr6	44967489	44967490	Height
chr6	45095162	45095163	Height
chr6	45244414	45244415	Height
chr6	45696787	45696788	Periodontal microbiota
chr6	45885060	45885061	Age-related macular degeneration
chr6	46675024	46675025	Lipoprotein-associated phospholipase A2 activity and mass
chr6	46682078	46682079	Lipoprotein-associated phospholipase A2 activity and mass
chr6	46684221	46684222	Lipoprotein-associated phospholipase A2 activity and mass
chr6	46684221	46684222	Lipoprotein-associated phospholipase A2 activity and mass
chr6	47230614	47230615	Panic disorder
chr6	47453377	47453378	Alzheimer's disease (late onset)
chr6	49382192	49382193	Homocysteine levels
chr6	49409486	49409487	Folate pathway vitamin levels
chr6	49488907	49488908	Brain structure
chr6	50786007	50786008	Renal function-related traits (BUN)
chr6	50798525	50798526	Metabolic syndrome (bivariate traits)
chr6	50798525	50798526	Obesity
chr6	50798525	50798526	Obesity
chr6	50803049	50803050	Adiposity
chr6	50803049	50803050	Body mass index
chr6	50803049	50803050	Body mass index
chr6	50836278	50836279	Obesity (extreme)
chr6	50845489	50845490	Obesity
chr6	50987767	50987768	Sudden cardiac arrest
chr6	51058720	51058721	Electrocardiographic conduction measures
chr6	51068716	51068717	Body mass index (non-asthmatics)
chr6	51099255	51099256	Obesity-related traits
chr6	51159994	51159995	Waist circumference
chr6	51622448	51622449	Intraocular pressure
chr6	51643013	51643014	Weight loss (gastric bypass surgery)
chr6	51666630	51666631	Prostate cancer
chr6	52101738	52101739	Response to gemcitabine in pancreatic cancer
chr6	52835894	52835895	Epilepsy (remission after treatment)
chr6	53123117	53123118	Glaucoma
chr6	53307693	53307694	Electroencephalographic traits in alcoholism
chr6	53514945	53514946	Obesity-related traits
chr6	53924696	53924697	Liver enzyme levels (gamma-glutamyl transferase)
chr6	54265395	54265396	Radiation response
chr6	55473293	55473294	Obesity-related traits
chr6	56210763	56210764	Allergic sensitization
chr6	58308954	58308955	Eosinophilic esophagitis (pediatric)
chr6	62697745	62697746	Protein quantitative trait loci
chr6	63160146	63160147	Calcium levels
chr6	63803187	63803188	Obesity-related traits
chr6	65635922	65635923	Disc degeneration (lumbar)
chr6	65662620	65662621	Metabolite levels (Dihydroxy docosatrienoic acid)
chr6	66178479	66178480	IgG glycosylation
chr6	66178479	66178480	IgG glycosylation
chr6	66178479	66178480	IgG glycosylation
chr6	66565352	66565353	Metabolite levels
chr6	66929047	66929048	Blood trace element (Cu levels)
chr6	67248409	67248410	Corneal astigmatism
chr6	67649215	67649216	Brain structure
chr6	67653278	67653279	Bulimia nervosa
chr6	67885918	67885919	QT interval
chr6	68181696	68181697	Response to amphetamines
chr6	68327029	68327030	Response to amphetamines
chr6	68984929	68984930	Cannabis use (initiation)
chr6	69142007	69142008	Pancreatic cancer
chr6	69294484	69294485	Prostate cancer (gene x gene interaction)
chr6	69337786	69337787	Phospholipid levels (plasma)
chr6	70074231	70074232	Response to statin therapy
chr6	70741208	70741209	IgG glycosylation
chr6	71289188	71289189	Type 2 diabetes
chr6	71660110	71660111	Obesity-related traits
chr6	71726538	71726539	Metabolite levels (MHPG)
chr6	71776970	71776971	F-cell distribution
chr6	72139571	72139572	AB1-42
chr6	72406318	72406319	Response to anti-TNF alpha therapy in inflammatory bowel disease
chr6	72482457	72482458	Cognitive performance
chr6	73193150	73193151	Response to mTOR inhibitor (rapamycin)
chr6	73643288	73643289	Refractive error
chr6	74458736	74458737	Calcium levels
chr6	74871230	74871231	Obesity-related traits
chr6	75158265	75158266	Metabolite levels (MHPG)
chr6	76265641	76265642	Height
chr6	77266187	77266188	Adverse response to chemotherapy (neutropenia/leucopenia) (all antimicrotubule drugs)
chr6	77290798	77290799	Capecitabine sensitivity
chr6	77789807	77789808	Acute lymphoblastic leukemia (childhood)
chr6	80156258	80156259	Presence of antiphospholipid antibodies
chr6	80257280	80257281	Hoarding
chr6	80466123	80466124	Aging
chr6	80533186	80533187	Body mass index
chr6	80564835	80564836	Partial epilepsies
chr6	80845988	80845989	Height
chr6	81302804	81302805	Thiazide-induced adverse metabolic effects in hypertensive patients
chr6	81481353	81481354	Obesity-related traits
chr6	81800361	81800362	Height
chr6	81800361	81800362	Height
chr6	82193108	82193109	Breast cancer
chr6	82193108	82193109	Breast cancer
chr6	82193108	82193109	Breast cancer
chr6	82220551	82220552	Blood pressure
chr6	82515314	82515315	Coronary heart disease
chr6	82794593	82794594	Corneal structure
chr6	84226594	84226595	Bipolar disorder (mood-incongruent)
chr6	86117128	86117129	Metabolic traits
chr6	86691939	86691940	Response to antipsychotic treatment
chr6	87155253	87155254	Sexual dysfunction (female)
chr6	87466491	87466492	Bipolar disorder and schizophrenia
chr6	87606841	87606842	IgG glycosylation
chr6	87867062	87867063	MRI atrophy measures
chr6	88329941	88329942	Obesity-related traits
chr6	88377048	88377049	Obesity-related traits
chr6	88652579	88652580	Blood pressure
chr6	88717765	88717766	Echocardiographic traits
chr6	88975976	88975977	Conduct disorder (interaction)
chr6	89112816	89112817	Select biomarker traits
chr6	89183579	89183580	Subcutaneous adipose tissue
chr6	89253648	89253649	IgG glycosylation
chr6	89293744	89293745	Response to statin therapy
chr6	89732100	89732101	Bipolar disorder and schizophrenia
chr6	90299209	90299210	Metabolite levels (Pyroglutamine)
chr6	90310965	90310966	vWF and FVIII levels
chr6	90640490	90640491	Cognitive performance
chr6	90657782	90657783	IgG glycosylation
chr6	90657782	90657783	IgG glycosylation
chr6	90681465	90681466	Obesity-related traits
chr6	90698273	90698274	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr6	90921739	90921740	Graves' disease
chr6	90926611	90926612	Celiac disease
chr6	90957462	90957463	Type 1 diabetes
chr6	90957462	90957463	Vitiligo
chr6	90958230	90958231	Type 1 diabetes
chr6	90958230	90958231	Type 1 diabetes
chr6	90958230	90958231	Type 1 diabetes autoantibodies
chr6	90973158	90973159	Crohn's disease
chr6	90973158	90973159	Inflammatory bowel disease
chr6	90996768	90996769	Multiple sclerosis
chr6	91015038	91015039	Systemic lupus erythematosus
chr6	91207350	91207351	Attention deficit hyperactivity disorder (time to onset)
chr6	91417751	91417752	Brain structure
chr6	93197299	93197300	Metabolite levels (HVA)
chr6	93197299	93197300	Metabolite levels (HVA-5-HIAA Factor score)
chr6	93369654	93369655	Amyotrophic lateral sclerosis
chr6	93615449	93615450	Cognitive performance
chr6	93713804	93713805	Chronic obstructive pulmonary disease-related biomarkers
chr6	93847883	93847884	Dialysis-related mortality
chr6	93852251	93852252	C-reactive protein
chr6	93911118	93911119	Response to hepatitis C treatment
chr6	95156417	95156418	Brain connectivity
chr6	95156453	95156454	Brain connectivity
chr6	95422617	95422618	Methotrexate phramacokinetics (acute lymphoblastic leukemia)
chr6	95967411	95967412	Behavioural disinhibition (generation interaction)
chr6	96884885	96884886	Migraine
chr6	97065211	97065212	Migraine
chr6	97065211	97065212	Migraine - clinic-based
chr6	97065211	97065212	Migraine without aura
chr6	97080197	97080198	Coronary heart disease
chr6	97419597	97419598	Body mass index
chr6	98019079	98019080	Multiple sclerosis (OCB status)
chr6	98462500	98462501	Oleic acid (18:1n-9) plasma levels
chr6	98495951	98495952	Adverse response to chemotherapy (neutropenia/leucopenia) (all anthracycline-based drugs)
chr6	98584732	98584733	Educational attainment
chr6	98588753	98588754	QT interval (interaction)
chr6	98739773	98739774	Quantitative traits
chr6	98919263	98919264	Brain imaging in schizophrenia (interaction)
chr6	98937145	98937146	Response to amphetamines
chr6	98990488	98990489	C-reactive protein and white blood cell count
chr6	99011500	99011501	Cytomegalovirus antibody response
chr6	99028865	99028866	Obesity-related traits
chr6	99672013	99672014	Brain structure
chr6	99782878	99782879	Illicit drug use
chr6	100208437	100208438	Menarche (age at onset)
chr6	100328197	100328198	Age-related macular degeneration (smoking status interaction)
chr6	100756686	100756687	Bipolar disorder and schizophrenia
chr6	100957343	100957344	Economic and political preferences (immigration/crime)
chr6	101395406	101395407	Economic and political preferences (immigration/crime)
chr6	101674289	101674290	Renal function-related traits (eGRFcrea)
chr6	102355866	102355867	Biochemical measures
chr6	102971245	102971246	Obesity-related traits
chr6	103799045	103799046	Palmitic acid (16:0) plasma levels
chr6	104432164	104432165	Cardiac hypertrophy
chr6	104445366	104445367	Obsessive-compulsive disorder
chr6	104593866	104593867	Bipolar disorder and schizophrenia
chr6	104663777	104663778	IgG glycosylation
chr6	105180784	105180785	Neuroblastoma
chr6	105223863	105223864	Multiple sclerosis
chr6	105232232	105232233	Thyroid stimulating hormone
chr6	105364420	105364421	Pubertal anthropometrics
chr6	105367615	105367616	Height
chr6	105378953	105378954	Height
chr6	105378953	105378954	Menarche (age at onset)
chr6	105378953	105378954	Menarche (age at onset)
chr6	105378953	105378954	Pubertal anthropometrics
chr6	105400836	105400837	Menarche (age at onset)
chr6	105406273	105406274	Neuroblastoma
chr6	105407661	105407662	Digit length ratio
chr6	105407661	105407662	Height
chr6	105407661	105407662	Menarche and menopause (age at onset)
chr6	105407998	105407999	Menarche (age at onset)
chr6	105417977	105417978	Height
chr6	105443188	105443189	Menarche (age at onset)
chr6	105612219	105612220	Multiple sclerosis
chr6	106094056	106094057	Primary tooth development (time to first tooth eruption)
chr6	106188817	106188818	Primary tooth development (time to first tooth eruption)
chr6	106252998	106252999	Age-related macular degeneration
chr6	106260127	106260128	Age-related macular degeneration
chr6	106329054	106329055	Adverse response to chemotherapy (neutropenia/leucopenia) (all antimicrotubule drugs)
chr6	106329054	106329055	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel)
chr6	106435024	106435025	Crohn's disease
chr6	106435024	106435025	Inflammatory bowel disease
chr6	106435268	106435269	Crohn's disease
chr6	106522026	106522027	Ulcerative colitis
chr6	106568033	106568034	Systemic lupus erythematosus
chr6	106582919	106582920	Systemic lupus erythematosus
chr6	106685194	106685195	Systemic lupus erythematosus and Systemic sclerosis
chr6	106829536	106829537	Longevity
chr6	106899225	106899226	Select biomarker traits
chr6	106987369	106987370	Stroke
chr6	107660645	107660646	IgG glycosylation
chr6	108017670	108017671	Myopia (pathological)
chr6	108323758	108323759	Bipolar disorder and schizophrenia
chr6	108853492	108853493	Obesity-related traits
chr6	108916572	108916573	Normalized brain volume
chr6	108988183	108988184	Insulin-like growth factors
chr6	109268049	109268050	Pulmonary function
chr6	109268049	109268050	Pulmonary function
chr6	109268049	109268050	Pulmonary function (interaction)
chr6	109285188	109285189	Prostate cancer
chr6	109598963	109598964	Ankylosing spondylitis
chr6	109608496	109608497	Red blood cell traits
chr6	109616419	109616420	Mean corpuscular volume
chr6	109626964	109626965	Red blood cell traits
chr6	109634827	109634828	Mean corpuscular hemoglobin
chr6	109634827	109634828	Mean corpuscular volume
chr6	109634827	109634828	Red blood cell count
chr6	109742014	109742015	Height
chr6	109783940	109783941	Height
chr6	110007646	110007647	Response to hepatitis C treatment
chr6	110090048	110090049	Hematological parameters
chr6	111673713	111673714	Psoriasis
chr6	111747082	111747083	Metabolic traits
chr6	111794408	111794409	Metabolite levels
chr6	111848190	111848191	Inflammatory bowel disease
chr6	111913261	111913262	Psoriasis
chr6	111913261	111913262	Psoriatic arthritis
chr6	113479334	113479335	Asthma (childhood onset)
chr6	113665326	113665327	Coronary artery calcification
chr6	114017132	114017133	Disc degeneration (lumbar)
chr6	114591985	114591986	Optic disc size (rim)
chr6	115069716	115069717	IgG glycosylation
chr6	115069716	115069717	IgG glycosylation
chr6	116310286	116310287	Urate levels
chr6	116312892	116312893	Cholesterol, total
chr6	116312892	116312893	LDL cholesterol
chr6	116387133	116387134	Age-related macular degeneration
chr6	116443734	116443735	Age-related macular degeneration
chr6	116543846	116543847	Dental caries
chr6	117086377	117086378	Telomere length
chr6	117114024	117114025	C-reactive protein
chr6	117210051	117210052	Prostate cancer
chr6	117522155	117522156	Height
chr6	117605990	117605991	Myopia (pathological)
chr6	117730818	117730819	QT interval (interaction)
chr6	117771276	117771277	Response to irinotecan and platinum-based chemotherapy in non-small-cell lung cancer
chr6	117786179	117786180	Lung cancer
chr6	117819356	117819357	Colorectal cancer
chr6	117844071	117844072	Economic and political preferences
chr6	117871835	117871836	Height
chr6	118574060	118574061	Resting heart rate
chr6	118578042	118578043	Cardiac structure and function
chr6	118618980	118618981	Thiazide-induced adverse metabolic effects in hypertensive patients
chr6	118653203	118653204	QT interval
chr6	118667521	118667522	Heart rate
chr6	118667521	118667522	QT interval
chr6	118667521	118667522	Ventricular conduction
chr6	118680373	118680374	Electrocardiographic traits
chr6	118680373	118680374	QT interval
chr6	118788651	118788652	QT interval
chr6	118807846	118807847	Renal cell carcinoma
chr6	118962739	118962740	Electrocardiographic conduction measures
chr6	118993631	118993632	QT interval
chr6	119866140	119866141	Immune reponse to smallpox (secreted IL-2)
chr6	121098456	121098457	Primary tooth development (number of teeth)
chr6	121339178	121339179	Cognitive performance
chr6	121730721	121730722	Heart rate
chr6	121748541	121748542	Resting heart rate
chr6	121781389	121781390	Heart rate
chr6	121816878	121816879	Migraine
chr6	121816878	121816879	Migraine without aura
chr6	121902868	121902869	Protein quantitative trait loci
chr6	122114450	122114451	Resting heart rate
chr6	122131484	122131485	Heart rate
chr6	122146033	122146034	Resting heart rate
chr6	122158269	122158270	Biomedical quantitative traits
chr6	123282940	123282941	Prostate cancer (gene x gene interaction)
chr6	123989740	123989741	IgG glycosylation
chr6	124326226	124326227	Alzheimer's disease (cognitive decline)
chr6	124342662	124342663	Schizophrenia
chr6	124405154	124405155	Periodontitis (Mean PAL)
chr6	124559731	124559732	Periodontitis (Mean PAL)
chr6	124691236	124691237	Neuroticism
chr6	124951062	124951063	QRS duration
chr6	125156448	125156449	Subcutaneous adipose tissue
chr6	126090376	126090377	Brugada syndrome
chr6	126698718	126698719	Type 1 diabetes
chr6	126767599	126767600	Height
chr6	126767599	126767600	Menarche (age at onset)
chr6	126835654	126835655	Height
chr6	126851159	126851160	Height
chr6	126851159	126851160	Height
chr6	126964509	126964510	Intracranial volume
chr6	126966307	126966308	Height
chr6	127115453	127115454	Blood pressure
chr6	127115453	127115454	Blood pressure
chr6	127167071	127167072	Bone mineral density
chr6	127167071	127167072	Bone mineral density
chr6	127391843	127391844	Iron status biomarkers
chr6	127436063	127436064	Renal function-related traits (BUN)
chr6	127452638	127452639	Waist-hip ratio
chr6	127452638	127452639	Waist-hip ratio
chr6	127456121	127456122	Crohn's disease
chr6	127493610	127493611	Metabolite levels
chr6	127509156	127509157	Waist-hip ratio
chr6	127600629	127600630	Breast cancer
chr6	128021802	128021803	Immune response to smallpox vaccine (IL-6)
chr6	128194472	128194473	QRS duration
chr6	128245764	128245765	Crohn's disease
chr6	128278797	128278798	Celiac disease
chr6	128278797	128278798	Multiple sclerosis
chr6	128492181	128492182	Hearing impairment
chr6	129820037	129820038	Axial length
chr6	129834628	129834629	Refractive error
chr6	129861391	129861392	Body mass index
chr6	130008444	130008445	Adverse response to chemotherapy (neutropenia/leucopenia) (docetaxel)
chr6	130031492	130031493	Antineutrophil cytoplasmic antibody-associated vasculitis
chr6	130216509	130216510	Renal sinus fat
chr6	130345834	130345835	Height
chr6	130349118	130349119	Height
chr6	130358427	130358428	Height
chr6	130550062	130550063	PR interval
chr6	130886436	130886437	IgG glycosylation
chr6	130886436	130886437	IgG glycosylation
chr6	131256363	131256364	Response to statin therapy (LDL-C)
chr6	131282209	131282210	Lentiform nucleus volume
chr6	131355863	131355864	IgG glycosylation
chr6	131446790	131446791	Migraine - clinic-based
chr6	131446790	131446791	Migraine with aura
chr6	131563576	131563577	Multiple myeloma (IgH translocation)
chr6	131809919	131809920	Obesity
chr6	132058946	132058947	Response to fenofibrate (adiponectin levels)
chr6	132228768	132228769	Obesity-related traits
chr6	132643116	132643117	Obesity-related traits
chr6	132643116	132643117	Obesity-related traits
chr6	132643116	132643117	Obesity-related traits
chr6	132643116	132643117	Obesity-related traits
chr6	132643116	132643117	Obesity-related traits
chr6	132643116	132643117	Obesity-related traits
chr6	132643116	132643117	Obesity-related traits
chr6	132888938	132888939	Migraine without aura
chr6	133146795	133146796	Type 2 diabetes nephropathy
chr6	133315803	133315804	Bone mineral density
chr6	133663588	133663589	Response to angiotensin II receptor blocker therapy
chr6	133860344	133860345	Protein quantitative trait loci
chr6	133867801	133867802	Visceral fat
chr6	134158799	134158800	Infantile hypertrophic pyloric stenosis
chr6	134196673	134196674	Coronary heart disease
chr6	134214524	134214525	Coronary heart disease
chr6	134544732	134544733	Body mass index (interaction)
chr6	134576510	134576511	Immune reponse to smallpox (secreted IFN-alpha)
chr6	134720066	134720067	Dental caries
chr6	134773553	134773554	Urate levels
chr6	134898455	134898456	Melanoma
chr6	135094271	135094272	Coronary artery calcification
chr6	135138989	135138990	Non-alcoholic fatty liver disease histology (AST)
chr6	135418634	135418635	Hematological and biochemical traits
chr6	135418634	135418635	Hematology traits
chr6	135418634	135418635	Hematology traits
chr6	135418634	135418635	Mean corpuscular hemoglobin
chr6	135418634	135418635	Mean corpuscular hemoglobin
chr6	135418634	135418635	Mean corpuscular volume
chr6	135418634	135418635	Mean corpuscular volume
chr6	135418634	135418635	Platelet counts
chr6	135418634	135418635	Red blood cell count
chr6	135418634	135418635	Red blood cell traits
chr6	135418634	135418635	Red blood cell traits
chr6	135418634	135418635	mean corpuscular hemoglobin concentration
chr6	135418915	135418916	Mean corpuscular hemoglobin
chr6	135418915	135418916	Red blood cell traits
chr6	135419017	135419018	F-cell distribution
chr6	135419017	135419018	HbA2 levels
chr6	135419017	135419018	Hematology traits
chr6	135419017	135419018	Hematology traits
chr6	135419017	135419018	Mean corpuscular hemoglobin
chr6	135419017	135419018	Mean corpuscular volume
chr6	135419017	135419018	Platelet counts
chr6	135419017	135419018	Platelet counts
chr6	135423208	135423209	Other erythrocyte phenotypes
chr6	135423208	135423209	White blood cell types
chr6	135426572	135426573	Mean corpuscular hemoglobin concentration
chr6	135426572	135426573	Mean corpuscular volume
chr6	135426572	135426573	Red blood cell traits
chr6	135426572	135426573	White blood cell count
chr6	135427143	135427144	Beta thalassemia/hemoglobin E disease
chr6	135427158	135427159	Red blood cell traits
chr6	135427816	135427817	Hematological parameters
chr6	135432551	135432552	Mean platelet volume
chr6	135432551	135432552	Red blood cell traits
chr6	135435500	135435501	Hematocrit
chr6	135435500	135435501	Other erythrocyte phenotypes
chr6	135452151	135452152	Red blood cell traits
chr6	135452151	135452152	Red blood cell traits
chr6	135452151	135452152	Red blood cell traits
chr6	135494874	135494875	Multiple sclerosis
chr6	135540379	135540380	Obesity-related traits
chr6	135739354	135739355	Multiple sclerosis
chr6	136001002	136001003	Immune reponse to smallpox (secreted IL-2)
chr6	136133658	136133659	Phosphorus levels
chr6	136368004	136368005	Alzheimer's disease (cognitive decline)
chr6	136505035	136505036	Intraocular pressure
chr6	137452907	137452908	Multiple sclerosis
chr6	137673301	137673302	Thiazide-induced adverse metabolic effects in hypertensive patients
chr6	137967213	137967214	Multiple sclerosis
chr6	137973067	137973068	Celiac disease
chr6	138002636	138002637	Rheumatoid arthritis
chr6	138006503	138006504	Inflammatory bowel disease
chr6	138006503	138006504	Rheumatoid arthritis
chr6	138006503	138006504	Rheumatoid arthritis
chr6	138006503	138006504	Rheumatoid arthritis
chr6	138006503	138006504	Rheumatoid arthritis
chr6	138006503	138006504	Ulcerative colitis
chr6	138132515	138132516	Systemic lupus erythematosus and Systemic sclerosis
chr6	138195722	138195723	Sjgren's syndrome
chr6	138195722	138195723	Systemic lupus erythematosus
chr6	138196065	138196066	Rheumatoid arthritis
chr6	138196065	138196066	Systemic lupus erythematosus
chr6	138196065	138196066	Systemic lupus erythematosus
chr6	138199416	138199417	Psoriasis
chr6	138199416	138199417	Psoriasis
chr6	138266684	138266685	Cardiac Troponin-T levels
chr6	138426031	138426032	Bulimia nervosa
chr6	139660011	139660012	Obesity-related traits
chr6	139829665	139829666	HDL cholesterol
chr6	139831179	139831180	Blood trace element (Se levels)
chr6	139834011	139834012	Mean corpuscular hemoglobin
chr6	139834011	139834012	Mean corpuscular volume
chr6	139835688	139835689	Adiponectin levels
chr6	139835688	139835689	Mean corpuscular hemoglobin
chr6	139835688	139835689	Mean corpuscular volume
chr6	139838418	139838419	Mean corpuscular hemoglobin
chr6	139839422	139839423	Mean corpuscular volume
chr6	139840692	139840693	Adiponectin levels
chr6	139844428	139844429	Red blood cell traits
chr6	140139814	140139815	IgG glycosylation
chr6	140273646	140273647	Type 2 diabetes
chr6	141169824	141169825	Acute lymphoblastic leukemia (childhood)
chr6	141856593	141856594	Methotrexate phramacokinetics (acute lymphoblastic leukemia)
chr6	141857133	141857134	Methotrexate phramacokinetics (acute lymphoblastic leukemia)
chr6	142033725	142033726	Sleep quality
chr6	142512135	142512136	Thiazide-induced adverse metabolic effects in hypertensive patients
chr6	142527141	142527142	Height
chr6	142548098	142548099	Retinal vascular caliber
chr6	142655800	142655801	Height
chr6	142679571	142679572	Height
chr6	142679571	142679572	Height
chr6	142679571	142679572	Scoliosis
chr6	142679571	142679572	Scoliosis
chr6	142703876	142703877	Height
chr6	142750515	142750516	Pulmonary function
chr6	142750515	142750516	Pulmonary function (interaction)
chr6	142753337	142753338	Airflow obstruction
chr6	142767632	142767633	Height
chr6	142797288	142797289	Height
chr6	142822216	142822217	Neutrophil count
chr6	143898893	143898894	Inflammatory bowel disease
chr6	143943313	143943314	Lung Cancer (DNA repair capacity)
chr6	143994198	143994199	Obesity-related traits
chr6	144079853	144079854	Erectile dysfunction
chr6	146918949	146918950	Leprosy
chr6	147531080	147531081	Bronchopulmonary dysplasia
chr6	147549296	147549297	Bronchopulmonary dysplasia
chr6	147680358	147680359	Coagulation factor levels
chr6	147701132	147701133	Tuberculosis
chr6	147759533	147759534	IgG glycosylation
chr6	147759533	147759534	IgG glycosylation
chr6	147759533	147759534	IgG glycosylation
chr6	147934946	147934947	Obesity-related traits
chr6	147971573	147971574	Myopia (pathological)
chr6	148423370	148423371	Alzheimer's disease
chr6	148521291	148521292	Thyroid hormone levels
chr6	148521291	148521292	Thyroid hormone levels
chr6	148704953	148704954	Type 2 diabetes nephropathy
chr6	148788005	148788006	Protein quantitative trait loci
chr6	148923788	148923789	Migraine
chr6	149270828	149270829	Job-related exhaustion
chr6	149329266	149329267	Response to antidepressants
chr6	149329266	149329267	Response to antidepressants
chr6	149435110	149435111	Diabetic retinopathy
chr6	149525605	149525606	Hemostatic factors and hematological phenotypes
chr6	149593919	149593920	Hemostatic factors and hematological phenotypes
chr6	149608873	149608874	Breast cancer
chr6	149762536	149762537	Dupuytren's disease
chr6	150298841	150298842	Radiation response
chr6	150358011	150358012	Alopecia areata
chr6	150380883	150380884	Metabolite levels (HVA/5-HIAA ratio)
chr6	150570866	150570867	Pulmonary function
chr6	150570866	150570867	Pulmonary function (interaction)
chr6	150570866	150570867	Pulmonary function (interaction)
chr6	150651899	150651900	Metabolite levels
chr6	150913960	150913961	Panic disorder
chr6	151004769	151004770	Blood pressure
chr6	151004769	151004770	Blood pressure
chr6	151009888	151009889	Systolic blood pressure in sickle cell anemia
chr6	151102829	151102830	Alzheimer's disease (cognitive decline)
chr6	151125250	151125251	Obesity-related traits
chr6	151125250	151125251	Obesity-related traits
chr6	151125250	151125251	Obesity-related traits
chr6	151163114	151163115	Alcohol and nictotine co-dependence
chr6	151207077	151207078	Alzheimer's disease (late onset)
chr6	151252984	151252985	Coronary heart disease
chr6	151895455	151895456	Bone mineral density
chr6	151901408	151901409	Bone mineral density (hip)
chr6	151901408	151901409	Bone mineral density (spine)
chr6	151907747	151907748	Bone mineral density
chr6	151907747	151907748	Chronic myeloid leukemia
chr6	151914112	151914113	Breast cancer
chr6	151914112	151914113	Breast cancer
chr6	151933174	151933175	Bone mineral density (hip)
chr6	151933174	151933175	Bone mineral density (hip)
chr6	151933174	151933175	Bone mineral density (spine)
chr6	151936676	151936677	Bone mineral density (spine)
chr6	151939349	151939350	Breast cancer
chr6	151948365	151948366	Breast Cancer in BRCA1 mutation carriers
chr6	151948365	151948366	Breast cancer
chr6	151948365	151948366	Breast cancer
chr6	151957713	151957714	Breast size
chr6	151987356	151987357	Breast cancer
chr6	152009637	152009638	Bone mineral density (hip)
chr6	152068363	152068364	Bone mineral density (spine)
chr6	152080831	152080832	Obesity-related traits
chr6	152090706	152090707	Bone mineral density (spine)
chr6	152110942	152110943	Height
chr6	152157880	152157881	Alcohol dependence
chr6	152285686	152285687	Sudden cardiac arrest
chr6	152295612	152295613	Breast cancer
chr6	152358178	152358179	Height
chr6	152738753	152738754	Bipolar disorder
chr6	152738753	152738754	Bipolar disorder and major depressive disorder (combined)
chr6	152790572	152790573	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr6	152790572	152790573	Bipolar disorder
chr6	152791473	152791474	Bipolar disorder
chr6	152947952	152947953	Tonometry
chr6	153265209	153265210	Migraine
chr6	153441078	153441079	Prostate cancer
chr6	154004970	154004971	Migraine - clinic-based
chr6	154077192	154077193	Coronary artery calcification
chr6	154414562	154414563	Coronary heart disease
chr6	154726987	154726988	Parkinson's disease
chr6	154986663	154986664	Renal function-related traits (eGRFcrea)
chr6	155929800	155929801	Response to treatment for acute lymphoblastic leukemia
chr6	156197501	156197502	Pancreatic cancer
chr6	156657841	156657842	IgG glycosylation
chr6	156913011	156913012	Sensory disturbances after bilateral sagittal split ramus osteotomy
chr6	157009380	157009381	Alzheimer's disease biomarkers
chr6	157128256	157128257	Calcium levels
chr6	157441049	157441050	Uric acid levels
chr6	158041282	158041283	Response to antidepressant treatment
chr6	158389740	158389741	Cannabis use (initiation)
chr6	158435571	158435572	Colorectal cancer
chr6	158929441	158929442	Height
chr6	159465976	159465977	Celiac disease
chr6	159465976	159465977	Celiac disease
chr6	159465976	159465977	Multiple sclerosis
chr6	159465976	159465977	Multiple sclerosis
chr6	159490435	159490436	Crohn's disease
chr6	159490435	159490436	Crohn's disease
chr6	159490435	159490436	Crohn's disease and celiac disease
chr6	159646332	159646333	Coronary heart disease
chr6	160071158	160071159	Age-related macular degeneration (GA)
chr6	160137686	160137687	Iron status biomarkers
chr6	160402704	160402705	Brain lesion load
chr6	160459190	160459191	Periodontitis (CDC/AAP)
chr6	160564475	160564476	Metabolic traits
chr6	160578859	160578860	Cholesterol, total
chr6	160578859	160578860	LDL cholesterol
chr6	160581373	160581374	Prostate cancer
chr6	160581373	160581374	Prostate cancer
chr6	160668388	160668389	Chronic kidney disease
chr6	160681392	160681393	Creatinine levels
chr6	160741621	160741622	Lp (a) levels
chr6	160789295	160789296	Monocyte early outgrowth colony forming units
chr6	160824027	160824028	Response to hepatitis C treatment
chr6	160833663	160833664	Prostate cancer
chr6	160840251	160840252	Colorectal cancer
chr6	160910516	160910517	Lp (a) levels
chr6	160960358	160960359	Lp (a) levels
chr6	160961136	160961137	Coronary heart disease
chr6	161010117	161010118	Aortic-valve calcification
chr6	161010117	161010118	Lipoprotein-associated phospholipase A2 activity change in response to statin therapy
chr6	161010117	161010118	Lp (a) levels
chr6	161010117	161010118	Response to statin therapy
chr6	161010117	161010118	Response to statin therapy (LDL-C)
chr6	161018173	161018174	Protein quantitative trait loci
chr6	161089816	161089817	HDL cholesterol
chr6	161137989	161137990	Lp (a) levels
chr6	161333936	161333937	Aging
chr6	161933934	161933935	Aging
chr6	162001435	162001436	Metabolite levels
chr6	162161618	162161619	Disc degeneration (lumbar)
chr6	162236074	162236075	Pancreatic cancer
chr6	162314920	162314921	IgG glycosylation
chr6	164186676	164186677	Response to TNF antagonist treatment
chr6	164900597	164900598	Major depressive disorder
chr6	165466350	165466351	Visceral adipose tissue adjusted for BMI
chr6	165935420	165935421	Response to fenofibrate
chr6	165935420	165935421	Response to fenofibrate
chr6	166015430	166015431	Conduct disorder (symptom count)
chr6	166046482	166046483	Thyroid hormone levels
chr6	166046482	166046483	Thyroid hormone levels
chr6	166046482	166046483	Thyroid hormone levels
chr6	166128637	166128638	Economic and political preferences (immigration/crime)
chr6	166155456	166155457	Bipolar disorder
chr6	166534741	166534742	Asthma
chr6	166571442	166571443	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr6	166706168	166706169	Longevity
chr6	167177421	167177422	Dental caries
chr6	167360388	167360389	Vitiligo
chr6	167371109	167371110	Crohn's disease
chr6	167373546	167373547	Inflammatory bowel disease
chr6	167383074	167383075	Graves' disease
chr6	167406632	167406633	Crohn's disease
chr6	167437987	167437988	Crohn's disease
chr6	167437987	167437988	Crohn's disease
chr6	167532792	167532793	Rheumatoid arthritis
chr6	167534289	167534290	Rheumatoid arthritis
chr6	167754974	167754975	IgG glycosylation
chr6	168388927	168388928	Metabolite levels (5-HIAA)
chr6	168484084	168484085	Attention deficit hyperactivity disorder (combined symptoms)
chr6	168490567	168490568	Attention deficit hyperactivity disorder (combined symptoms)
chr6	168490567	168490568	Attention deficit hyperactivity disorder (inattention symptoms)
chr6	168511015	168511016	Immune reponse to smallpox (secreted IL-2)
chr6	168757110	168757111	Sexual dimorphism in anthropometric traits
chr6	168941623	168941624	Vitiligo
chr6	169727600	169727601	Obesity-related traits
chr6	169820380	169820381	Corneal astigmatism
chr6	170113243	170113244	Thiazide-induced adverse metabolic effects in hypertensive patients
chr6	170379024	170379025	Type 1 diabetes
chr6	170425520	170425521	Obesity-related traits
chr7	1022727	1022728	Bronchopulmonary dysplasia
chr7	1039002	1039003	Longevity
chr7	1273844	1273845	Renal function-related traits (BUN)
chr7	1285194	1285195	Renal function-related traits (eGRFcrea)
chr7	1285194	1285195	Renal function-related traits (sCR)
chr7	1288638	1288639	Fat distribution (HIV)
chr7	1886534	1886535	Bipolar disorder and schizophrenia
chr7	1912221	1912222	Longevity
chr7	1950808	1950809	Bipolar disorder
chr7	1968952	1968953	Testicular germ cell tumor
chr7	2004420	2004421	Schizophrenia
chr7	2017444	2017445	Schizophrenia
chr7	2041431	2041432	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr7	2041431	2041432	Bipolar disorder and schizophrenia
chr7	2278225	2278226	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr7	2298226	2298227	Bipolar disorder and schizophrenia
chr7	2448492	2448493	Multiple sclerosis
chr7	2582451	2582452	Obesity-related traits
chr7	2759794	2759795	Height
chr7	2763101	2763102	Height
chr7	2789879	2789880	Ulcerative colitis
chr7	2789879	2789880	Ulcerative colitis
chr7	2795956	2795957	Height
chr7	2801802	2801803	Height
chr7	2869984	2869985	Height
chr7	2915377	2915378	White matter integrity
chr7	3128788	3128789	Atopic dermatitis
chr7	3915563	3915564	Quantitative traits
chr7	4411208	4411209	Factor VII
chr7	4474131	4474132	Obesity-related traits
chr7	4723533	4723534	Lung function (forced vital capacity)
chr7	4839264	4839265	Obesity-related traits
chr7	5524804	5524805	Relative hand skill in reading disability
chr7	5880376	5880377	IgG glycosylation
chr7	7268430	7268431	Multiple sclerosis (severity)
chr7	7302292	7302293	Visceral adipose tissue adjusted for BMI
chr7	7399403	7399404	Bipolar disorder and schizophrenia
chr7	7848911	7848912	Obesity-related traits
chr7	7864750	7864751	Obesity-related traits
chr7	7864750	7864751	Obesity-related traits
chr7	7883322	7883323	Insulin-like growth factors
chr7	7938595	7938596	Obesity-related traits
chr7	8152066	8152067	Intraocular pressure
chr7	8157886	8157887	Metabolite levels (Pyroglutamine)
chr7	8177396	8177397	Obesity-related traits
chr7	8552613	8552614	Breast Cancer in BRCA1 mutation carriers
chr7	8642353	8642354	Obesity-related traits
chr7	8642353	8642354	Obesity-related traits
chr7	8718079	8718080	Neuroticism
chr7	8998975	8998976	Quantitative traits
chr7	9066819	9066820	Response to fenofibrate
chr7	9066819	9066820	Response to fenofibrate
chr7	9189540	9189541	Obesity-related traits
chr7	9266387	9266388	Protein quantitative trait loci
chr7	9539278	9539279	Hippocampal atrophy
chr7	10149975	10149976	Select biomarker traits
chr7	10364722	10364723	Capecitabine sensitivity
chr7	11291399	11291400	IgG glycosylation
chr7	11291399	11291400	IgG glycosylation
chr7	11291399	11291400	IgG glycosylation
chr7	12059805	12059806	Tourette syndrome
chr7	12094965	12094966	Adverse response to chemotherapy (neutropenia/leucopenia) (all topoisomerase inhibitors)
chr7	12193431	12193432	Anorexia nervosa
chr7	12219534	12219535	IgG glycosylation
chr7	12273151	12273152	Response to amphetamines
chr7	12391318	12391319	Response to taxane treatment (placlitaxel)
chr7	12713069	12713070	Adverse response to chemotherapy (neutropenia/leucopenia) (5-fluorouracil)
chr7	12932048	12932049	Sudden cardiac arrest
chr7	12937254	12937255	Bipolar disorder and schizophrenia
chr7	13543728	13543729	Reading and spelling
chr7	13554007	13554008	Word reading
chr7	13560220	13560221	Word reading
chr7	14445916	14445917	Response to treatment for acute lymphoblastic leukemia
chr7	15063832	15063833	Metabolic traits
chr7	15064308	15064309	Fasting glucose-related traits
chr7	15064308	15064309	Fasting glucose-related traits
chr7	15064308	15064309	Fasting glucose-related traits (interaction with BMI)
chr7	15064983	15064984	Metabolic syndrome
chr7	15133126	15133127	Paclitaxel-induced neuropathy
chr7	15335935	15335936	Obesity-related traits
chr7	15630870	15630871	Blood trace element (Zn levels)
chr7	15742785	15742786	Stroke
chr7	15757999	15758000	Migraine with aura
chr7	16326645	16326646	Serum tamsulosin hydrochloride concentration
chr7	16500141	16500142	Response to statin therapy
chr7	16707860	16707861	Alzheimer's disease (cognitive decline)
chr7	16837453	16837454	IgG glycosylation
chr7	16861848	16861849	Adverse response to chemotherapy (neutropenia/leucopenia) (cisplatin)
chr7	16889811	16889812	Type 2 diabetes (dietary heme iron intake interaction)
chr7	17085320	17085321	Adverse response to chemotherapy (neutropenia/leucopenia) (all antimicrotubule drugs)
chr7	17284576	17284577	Caffeine consumption
chr7	17287268	17287269	Coffee consumption
chr7	17309278	17309279	Metabolic traits
chr7	17318311	17318312	Sensory disturbances after bilateral sagittal split ramus osteotomy
chr7	17561582	17561583	Response to antipsychotic treatment
chr7	17997611	17997612	Fibrinogen
chr7	18375244	18375245	Obesity-related traits
chr7	18428920	18428921	Retinopathy in non-diabetics
chr7	18800412	18800413	Ulcerative colitis
chr7	18877873	18877874	Male-pattern baldness
chr7	18980266	18980267	Obesity-related traits
chr7	19031934	19031935	Stroke
chr7	19049387	19049388	Stroke (ischemic)
chr7	19049387	19049388	Stroke (ischemic)
chr7	19106538	19106539	Obesity-related traits
chr7	19248277	19248278	Obesity-related traits
chr7	19616521	19616522	Height
chr7	19805479	19805480	Thyroid stimulating hormone
chr7	20086981	20086982	Non-word repetition
chr7	20255704	20255705	Adverse response to chemotherapy (neutropenia/leucopenia) (etoposide)
chr7	20647014	20647015	Response to statin therapy
chr7	20791997	20791998	Dental caries
chr7	20862301	20862302	Bipolar disorder
chr7	20885094	20885095	IgG glycosylation
chr7	20994490	20994491	Prostate cancer
chr7	20994490	20994491	Prostate cancer
chr7	21147677	21147678	Obesity-related traits
chr7	21147677	21147678	Obesity-related traits
chr7	21163354	21163355	Obesity-related traits
chr7	21222789	21222790	Capecitabine sensitivity
chr7	21504426	21504427	Major depressive disorder
chr7	21504426	21504427	Major depressive disorder (broad)
chr7	21584087	21584088	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)
chr7	21584087	21584088	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)
chr7	21584087	21584088	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)
chr7	21584087	21584088	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)
chr7	21607351	21607352	Cholesterol, total
chr7	21607351	21607352	Cholesterol, total
chr7	21607351	21607352	LDL cholesterol
chr7	21607351	21607352	LDL cholesterol
chr7	21742973	21742974	MRI atrophy measures
chr7	21742973	21742974	Total ventricular volume
chr7	21938239	21938240	Multiple myeloma
chr7	21938239	21938240	Multiple myeloma (hyperdiploidy)
chr7	22024039	22024040	Height
chr7	22109458	22109459	Thyroid stimulating hormone
chr7	22514052	22514053	Dialysis-related mortality
chr7	22732838	22732839	C-reactive protein
chr7	22756462	22756463	Bilirubin levels
chr7	22856605	22856606	Fibrinogen
chr7	22985009	22985010	Bipolar disorder
chr7	22994185	22994186	Periodontitis (Mean PAL)
chr7	23420766	23420767	Personality dimensions
chr7	23480466	23480467	IgG glycosylation
chr7	23482684	23482685	Height
chr7	23502973	23502974	Height
chr7	24240164	24240165	Asthma (childhood onset)
chr7	24378039	24378040	Periodontitis
chr7	24692551	24692552	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr7	25133848	25133849	Colorectal cancer
chr7	25161601	25161602	Alzheimer's disease (cognitive decline)
chr7	25608408	25608409	Carotid atherosclerosis in HIV infection
chr7	25612660	25612661	Preeclampsia
chr7	25871108	25871109	Waist-hip ratio
chr7	25901638	25901639	Endometriosis
chr7	25901638	25901639	Endometriosis
chr7	25950544	25950545	Body mass index
chr7	26008051	26008052	Obesity-related traits
chr7	26481803	26481804	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr7	26557617	26557618	Smoking behavior
chr7	26891664	26891665	Type 1 diabetes
chr7	26892439	26892440	Crohn's disease
chr7	27231761	27231762	Ulcerative colitis
chr7	27330055	27330056	Heart failure
chr7	27337866	27337867	Blood pressure
chr7	27337866	27337867	Blood pressure
chr7	27976562	27976563	Prostate cancer
chr7	28004197	28004198	Thiazide-induced adverse metabolic effects in hypertensive patients
chr7	28180555	28180556	Crohn's disease
chr7	28180555	28180556	Type 2 diabetes
chr7	28185090	28185091	Height
chr7	28189082	28189083	Height
chr7	28189410	28189411	Height
chr7	28189410	28189411	Systemic lupus erythematosus and Systemic sclerosis
chr7	28189945	28189946	Height
chr7	28196221	28196222	Type 2 diabetes
chr7	28229041	28229042	Type 1 diabetes
chr7	28391141	28391142	Diabetic retinopathy
chr7	28432475	28432476	Airflow obstruction
chr7	28762962	28762963	Attention deficit hyperactivity disorder
chr7	29014194	29014195	Response to irinotecan and platinum-based chemotherapy in non-small-cell lung cancer
chr7	29041189	29041190	Cognitive performance
chr7	29184488	29184489	Diabetes related insulin traits
chr7	29218158	29218159	Obesity-related traits
chr7	29218158	29218159	Obesity-related traits
chr7	29921523	29921524	Corneal curvature
chr7	29962523	29962524	Obesity-related traits
chr7	30083020	30083021	Estradiol levels
chr7	30937177	30937178	Nephrolithiasis
chr7	31155346	31155347	Major depressive disorder
chr7	31904026	31904027	Endometriosis
chr7	32189539	32189540	Presence of antiphospholipid antibodies
chr7	32347334	32347335	Smoking behavior
chr7	32376747	32376748	Palmitic acid (16:0) plasma levels
chr7	32460723	32460724	Metabolite levels (HVA/MHPG ratio)
chr7	33256038	33256039	Sagittal craniosynostosis
chr7	33673264	33673265	Cytomegalovirus antibody response
chr7	34697059	34697060	IgG glycosylation
chr7	34697139	34697140	IgG glycosylation
chr7	35305305	35305306	Ventricular conduction
chr7	35401446	35401447	Information processing speed
chr7	35554787	35554788	Non-alcoholic fatty liver disease histology (other)
chr7	35607232	35607233	Obesity-related traits
chr7	36191698	36191699	Platelet counts
chr7	36211748	36211749	Obesity-related traits
chr7	36546068	36546069	Obesity-related traits
chr7	36917994	36917995	Type 2 diabetes nephropathy
chr7	36952020	36952021	Breast size
chr7	36961319	36961320	Anticoagulant levels
chr7	37067394	37067395	IgG glycosylation
chr7	37076853	37076854	QT interval
chr7	37266351	37266352	Response to treatment for acute lymphoblastic leukemia
chr7	37365195	37365196	Alzheimer's disease (cognitive decline)
chr7	37374509	37374510	Celiac disease
chr7	37374509	37374510	Primary biliary cirrhosis
chr7	37436853	37436854	Celiac disease and Rheumatoid arthritis
chr7	37562367	37562368	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel + carboplatin)
chr7	37757555	37757556	Obesity-related traits
chr7	37938421	37938422	Bone mineral density
chr7	37989094	37989095	Dupuytren's disease
chr7	38004405	38004406	Myopia (pathological)
chr7	38128325	38128326	Bone mineral density
chr7	38128325	38128326	Height
chr7	38136276	38136277	Bone mineral density (spine)
chr7	38240907	38240908	Treatment response for severe sepsis
chr7	38835034	38835035	Cognitive performance
chr7	39121499	39121500	IgG glycosylation
chr7	40466199	40466200	Migraine
chr7	40466199	40466200	Migraine - clinic-based
chr7	40466199	40466200	Migraine without aura
chr7	40954480	40954481	Iron status biomarkers
chr7	40965126	40965127	Prostate cancer (gene x gene interaction)
chr7	41470092	41470093	Menarche (age at onset)
chr7	41478607	41478608	Quantitative traits
chr7	41622529	41622530	Non-substance related behavioral disinhibition
chr7	41743293	41743294	Migraine without aura
chr7	41811907	41811908	Pit-and-Fissure caries
chr7	42036836	42036837	IgG glycosylation
chr7	42176281	42176282	Age-related macular degeneration
chr7	42264678	42264679	Allergic rhinitis
chr7	42325624	42325625	Inflammatory biomarkers
chr7	43158476	43158477	Obesity-related traits
chr7	43377275	43377276	Alzheimer's disease (cognitive decline)
chr7	43910881	43910882	Obesity-related traits
chr7	44223720	44223721	Glycated hemoglobin levels
chr7	44229067	44229068	Glycated hemoglobin levels
chr7	44229067	44229068	Glycemic traits
chr7	44229067	44229068	Glycemic traits
chr7	44229067	44229068	Glycemic traits
chr7	44229067	44229068	Metabolite levels
chr7	44231215	44231216	Metabolic syndrome
chr7	44235667	44235668	Fasting glucose-related traits
chr7	44235667	44235668	Fasting glucose-related traits
chr7	44235667	44235668	Fasting glucose-related traits (interaction with BMI)
chr7	44235667	44235668	Fasting plasma glucose
chr7	44235667	44235668	Fasting plasma glucose
chr7	44259870	44259871	Metabolic syndrome
chr7	44276650	44276651	Osteoarthritis (hip)
chr7	44579179	44579180	Cholesterol, total
chr7	44579179	44579180	LDL cholesterol
chr7	45982459	45982460	Major depressive disorder
chr7	46008109	46008110	Insulin-like growth factors
chr7	46242582	46242583	Sudden cardiac arrest
chr7	46275727	46275728	Select biomarker traits
chr7	46392566	46392567	Treatment response for severe sepsis
chr7	46620144	46620145	Ventricular conduction
chr7	46753490	46753491	Obesity-related traits
chr7	46753552	46753553	Insulin-like growth factors
chr7	46753552	46753553	Insulin-like growth factors
chr7	47779968	47779969	Hepatitis C induced liver fibrosis
chr7	48817964	48817965	Response to amphetamines
chr7	49329679	49329680	Thiazide-induced adverse metabolic effects in hypertensive patients
chr7	49633801	49633802	Obesity-related traits
chr7	50225390	50225391	Total ventricular volume
chr7	50253896	50253897	Self-reported allergy
chr7	50269671	50269672	Crohn's disease
chr7	50304460	50304461	Crohn's disease
chr7	50304460	50304461	Inflammatory bowel disease
chr7	50305862	50305863	Systemic lupus erythematosus
chr7	50313351	50313352	Hippocampal atrophy
chr7	50313351	50313352	Systemic lupus erythematosus
chr7	50335231	50335232	IgG glycosylation
chr7	50335231	50335232	IgG glycosylation
chr7	50346133	50346134	IgG glycosylation
chr7	50350266	50350267	IgG glycosylation
chr7	50350266	50350267	IgG glycosylation
chr7	50350266	50350267	IgG glycosylation
chr7	50350266	50350267	IgG glycosylation
chr7	50350266	50350267	IgG glycosylation
chr7	50350266	50350267	IgG glycosylation
chr7	50350266	50350267	IgG glycosylation
chr7	50350266	50350267	IgG glycosylation
chr7	50355206	50355207	IgG glycosylation
chr7	50355206	50355207	IgG glycosylation
chr7	50355206	50355207	IgG glycosylation
chr7	50355206	50355207	IgG glycosylation
chr7	50355206	50355207	IgG glycosylation
chr7	50355206	50355207	IgG glycosylation
chr7	50355206	50355207	IgG glycosylation
chr7	50355206	50355207	IgG glycosylation
chr7	50428427	50428428	Mean corpuscular volume
chr7	50428444	50428445	Red blood cell traits
chr7	50466303	50466304	Acute lymphoblastic leukemia (childhood)
chr7	50469980	50469981	Acute lymphoblastic leukemia (B-cell precursor)
chr7	50470603	50470604	Acute lymphoblastic leukemia (childhood)
chr7	50473250	50473251	Acute lymphoblastic leukemia (childhood)
chr7	50622711	50622712	Malaria
chr7	50664921	50664922	Systemic sclerosis
chr7	50751089	50751090	Fasting glucose-related traits (interaction with BMI)
chr7	50754678	50754679	Bone mineral density
chr7	51027193	51027194	Type 1 diabetes
chr7	51537886	51537887	Wegener's granulomatosis
chr7	52006414	52006415	Post-traumatic stress disorder (asjusted for relatedness)
chr7	52006414	52006415	Post-traumatic stress disorder (asjusted for relatedness)
chr7	52472449	52472450	Emphysema-related traits
chr7	53127558	53127559	IgG glycosylation
chr7	54181931	54181932	Vaccine-related adverse events
chr7	54674872	54674873	Obesity-related traits
chr7	54978923	54978924	Glioma
chr7	55159348	55159349	Glioma
chr7	55724444	55724445	Behavioural disinhibition (generation interaction)
chr7	57699150	57699151	Bipolar disorder and schizophrenia
chr7	62577769	62577770	Obesity-related traits
chr7	63346885	63346886	QT interval (interaction)
chr7	63733330	63733331	Response to statin therapy
chr7	65271196	65271197	Calcium levels
chr7	65326820	65326821	Corneal structure
chr7	65617594	65617595	Aortic root size
chr7	66030611	66030612	Aortic root size
chr7	66096027	66096028	Aortic root size
chr7	66421445	66421446	Corneal structure
chr7	67059266	67059267	Breast cancer
chr7	67188787	67188788	Menarche (age at onset)
chr7	67426322	67426323	Information processing speed
chr7	68050412	68050413	Immune reponse to smallpox (secreted IL-2)
chr7	68611959	68611960	Male-pattern baldness
chr7	69238157	69238158	IgG glycosylation
chr7	69238157	69238158	IgG glycosylation
chr7	69806022	69806023	Alcohol consumption
chr7	69887084	69887085	Obesity-related traits
chr7	70045940	70045941	Bipolar disorder
chr7	70473004	70473005	Major depressive disorder
chr7	71016158	71016159	Response to angiotensin II receptor blocker therapy
chr7	71388849	71388850	Airflow obstruction
chr7	71751315	71751316	Schizophrenia
chr7	72129666	72129667	Triglycerides
chr7	72311816	72311817	Subcutaneous adipose tissue
chr7	72856268	72856269	Caffeine consumption
chr7	72856268	72856269	Triglycerides
chr7	72856429	72856430	Triglycerides
chr7	72857048	72857049	Urate levels
chr7	72864868	72864869	Hypertriglyceridemia
chr7	72864868	72864869	Triglycerides
chr7	72864868	72864869	Triglycerides
chr7	72904809	72904810	Protein C levels
chr7	72971230	72971231	C-reactive protein
chr7	72977897	72977898	Gamma glutamyl transpeptidase
chr7	72982873	72982874	HDL cholesterol
chr7	72982873	72982874	Triglycerides
chr7	72982873	72982874	Triglycerides
chr7	72982873	72982874	Triglycerides
chr7	72987353	72987354	Hypertriglyceridemia
chr7	72987353	72987354	Triglycerides
chr7	72994475	72994476	Obesity-related traits
chr7	73010441	73010442	Lipid metabolism phenotypes
chr7	73017004	73017005	Metabolic syndrome
chr7	73020336	73020337	Triglycerides
chr7	73026377	73026378	Liver enzyme levels (gamma-glutamyl transferase)
chr7	74126033	74126034	Sjgren's syndrome
chr7	75059330	75059331	Obesity-related traits
chr7	75173179	75173180	Systemic lupus erythematosus
chr7	75211413	75211414	Alcoholism (12-month weekly alcohol consumption)
chr7	75951229	75951230	Multiple sclerosis
chr7	75953296	75953297	Multiple sclerosis
chr7	75975585	75975586	Multiple sclerosis
chr7	75978228	75978229	Multiple sclerosis
chr7	76639870	76639871	Body mass index
chr7	76738590	76738591	Obesity-related traits
chr7	77416438	77416439	Chronic kidney disease
chr7	77549905	77549906	Obesity-related traits
chr7	77596811	77596812	Dental caries
chr7	77964787	77964788	Height
chr7	78043290	78043291	Response to antidepressant treatment
chr7	78152671	78152672	Bronchopulmonary dysplasia
chr7	78158471	78158472	Obesity-related traits
chr7	78175976	78175977	Hippocampal atrophy
chr7	78331464	78331465	Acute lymphoblastic leukemia (childhood)
chr7	80236013	80236014	Mean platelet volume
chr7	80258809	80258810	Left ventricular mass
chr7	80286907	80286908	Response to fenofibrate
chr7	80340621	80340622	HDL cholesterol
chr7	80599356	80599357	Bilirubin levels
chr7	81731445	81731446	Response to taxane treatment (docetaxel)
chr7	81782513	81782514	Obesity-related traits
chr7	81786219	81786220	Bipolar disorder and schizophrenia
chr7	81839552	81839553	Crohn's disease (need for surgery)
chr7	81847650	81847651	Non-alcoholic fatty liver disease histology (lobular)
chr7	81857892	81857893	Ulcerative colitis
chr7	82115239	82115240	Metabolite levels (Dihydroxy docosatrienoic acid)
chr7	82337858	82337859	Aging traits
chr7	82450034	82450035	Major depressive disorder
chr7	83609038	83609039	Attention deficit hyperactivity disorder
chr7	83656799	83656800	Iris characteristics
chr7	83656799	83656800	Iris characteristics
chr7	83772414	83772415	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr7	83782838	83782839	Obesity-related traits
chr7	83911270	83911271	Prion diseases
chr7	86348998	86348999	IgG glycosylation
chr7	86696713	86696714	Brachial circumference
chr7	86821979	86821980	Bipolar disorder and major depressive disorder (combined)
chr7	88481441	88481442	Hypothyroidism
chr7	88560877	88560878	Body mass index
chr7	88596384	88596385	Anorexia nervosa
chr7	88695069	88695070	IgG glycosylation
chr7	88695069	88695070	IgG glycosylation
chr7	88695069	88695070	IgG glycosylation
chr7	89060732	89060733	Dental caries
chr7	89763863	89763864	Coronary artery calcification
chr7	89977759	89977760	Homocysteine levels
chr7	90915353	90915354	Dental caries
chr7	90915353	90915354	Dental caries
chr7	91240296	91240297	IgG glycosylation
chr7	91272343	91272344	Obesity-related traits
chr7	92246743	92246744	Rheumatoid arthritis
chr7	92248075	92248076	Height
chr7	92248075	92248076	Height
chr7	92256904	92256905	Height
chr7	92264409	92264410	Height
chr7	92264409	92264410	Height
chr7	92264409	92264410	Height
chr7	92408369	92408370	White blood cell count
chr7	92408369	92408370	White blood cell count
chr7	92408369	92408370	White blood cell types
chr7	92764981	92764982	Systemic lupus erythematosus and Systemic sclerosis
chr7	93241639	93241640	Birth weight
chr7	93538294	93538295	Pulmonary function decline
chr7	93549595	93549596	Heart rate
chr7	93691743	93691744	Aging
chr7	93713520	93713521	Obesity-related traits
chr7	94009633	94009634	Intelligence
chr7	94053999	94054000	Mean forced vital capacity from 2 exams
chr7	94930390	94930391	Response to TNF antagonist treatment
chr7	94938256	94938257	Metabolite levels
chr7	94938256	94938257	Paraoxonase activity
chr7	94954695	94954696	Paraoxonase activity
chr7	95631195	95631196	Obesity-related traits
chr7	95631195	95631196	Obesity-related traits
chr7	96117917	96117918	Bone mineral density (spine)
chr7	96120674	96120675	Bone mineral density
chr7	96133530	96133531	Bone mineral density (hip)
chr7	96362343	96362344	Attention deficit hyperactivity disorder
chr7	96415054	96415055	Immunoglobulin A
chr7	96581810	96581811	Radiation response
chr7	97017794	97017795	Adverse response to radiation therapy
chr7	97229777	97229778	Response to platinum-based agents
chr7	97422925	97422926	Myopia (pathological)
chr7	97620690	97620691	Sudden cardiac arrest
chr7	97816326	97816327	Prostate cancer
chr7	97816326	97816327	Prostate cancer
chr7	97924553	97924554	Obesity-related traits
chr7	97993361	97993362	Sex hormone-binding globulin levels
chr7	98021210	98021211	Prostate cancer (gene x gene interaction)
chr7	98759116	98759117	Inflammatory bowel disease
chr7	98760503	98760504	Ulcerative colitis
chr7	98957879	98957880	Dehydroepiandrosterone sulphate levels
chr7	99118800	99118801	Dehydroepiandrosterone sulphate levels
chr7	99207875	99207876	Anthropometric traits
chr7	99207875	99207876	Anthropometric traits
chr7	99207875	99207876	Anthropometric traits
chr7	99489570	99489571	Dehydroepiandrosterone sulphate levels
chr7	99489570	99489571	Metabolic traits
chr7	99593345	99593346	Interstitial lung disease
chr7	99940306	99940307	Obesity-related traits
chr7	100214014	100214015	Mean corpuscular volume
chr7	100235969	100235970	Hematocrit
chr7	100235969	100235970	Hematological parameters
chr7	100235969	100235970	Iron levels
chr7	100240295	100240296	Red blood cell traits
chr7	100315516	100315517	Inflammatory bowel disease
chr7	100345105	100345106	Other erythrocyte phenotypes
chr7	100453207	100453208	Resting heart rate
chr7	100458092	100458093	Coronary heart disease
chr7	100486753	100486754	Resting heart rate
chr7	100490076	100490077	Type 2 diabetes
chr7	100497130	100497131	Heart rate
chr7	100881402	100881403	QT interval
chr7	101115993	101115994	Response to citalopram treatment
chr7	101115993	101115994	Response to citalopram treatment
chr7	101809850	101809851	Response to antidepressants
chr7	103175443	103175444	Metabolite levels (Pyroglutamine)
chr7	103404814	103404815	Schizophrenia
chr7	103527368	103527369	Otosclerosis
chr7	103625876	103625877	Alzheimer's disease
chr7	103628035	103628036	Multiple sclerosis (age of onset)
chr7	104466963	104466964	Educational attainment
chr7	104503812	104503813	Obesity
chr7	104758249	104758250	Myopia (pathological)
chr7	105273719	105273720	Dental caries
chr7	105281187	105281188	Alzheimer's disease (late onset)
chr7	105542579	105542580	Obesity-related traits
chr7	105542579	105542580	Obesity-related traits
chr7	105671266	105671267	Warfarin maintenance dose
chr7	106359215	106359216	Platelet counts
chr7	106372218	106372219	Mean platelet volume
chr7	106372218	106372219	Mean platelet volume
chr7	106372218	106372219	Mean platelet volume
chr7	106372218	106372219	Mean platelet volume
chr7	106372218	106372219	Mean platelet volume
chr7	106372902	106372903	Mean platelet volume
chr7	106409451	106409452	Carotid intima media thickness
chr7	106409451	106409452	Carotid intima media thickness
chr7	106411857	106411858	Blood pressure
chr7	106495808	106495809	Menopause (age at onset)
chr7	106594884	106594885	Serum tamsulosin hydrochloride concentration
chr7	106662082	106662083	Adverse response to lamotrigine and phenytoin
chr7	106763217	106763218	Response to antipsychotic treatment
chr7	106938419	106938420	Osteoarthritis
chr7	107207694	107207695	Osteoarthritis
chr7	107244544	107244545	Coronary heart disease
chr7	107336057	107336058	Alcohol consumption
chr7	107443385	107443386	IgG glycosylation
chr7	107453102	107453103	Ulcerative colitis
chr7	107479518	107479519	Ulcerative colitis
chr7	107480314	107480315	Ulcerative colitis
chr7	107484436	107484437	Ulcerative colitis
chr7	107492788	107492789	Ulcerative colitis
chr7	107495433	107495434	Ulcerative colitis
chr7	107503440	107503441	Ulcerative colitis
chr7	107503440	107503441	Ulcerative colitis
chr7	107580838	107580839	Ulcerative colitis
chr7	107592197	107592198	IgG glycosylation
chr7	107592197	107592198	IgG glycosylation
chr7	107592197	107592198	IgG glycosylation
chr7	107592197	107592198	IgG glycosylation
chr7	107782199	107782200	Coffee consumption
chr7	107973296	107973297	Femoral neck bone geometry and menarche (age at onset)
chr7	108544460	108544461	Smoking behavior
chr7	108544460	108544461	Smoking behavior
chr7	108548659	108548660	Smoking behavior
chr7	108548659	108548660	Smoking behavior
chr7	108548659	108548660	Smoking behavior
chr7	109003573	109003574	Prostate cancer (gene x gene interaction)
chr7	109152710	109152711	Gallbladder cancer
chr7	110047470	110047471	Attention deficit hyperactivity disorder (time to onset)
chr7	110047963	110047964	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr7	110467220	110467221	Cognitive performance
chr7	111527559	111527560	C-reactive protein and white blood cell count
chr7	111642645	111642646	Breast size
chr7	111677905	111677906	Response to fenofibrate
chr7	112086332	112086333	Mortality among heart failure patients
chr7	112094742	112094743	Amyotrophic lateral sclerosis (age of onset)
chr7	112159177	112159178	Osteoarthritis (hip)
chr7	112628372	112628373	Attention deficit hyperactivity disorder and conduct disorder
chr7	112649413	112649414	IgG glycosylation
chr7	112649413	112649414	IgG glycosylation
chr7	112911409	112911410	Metabolite levels
chr7	113741104	113741105	IgG glycosylation
chr7	113741104	113741105	IgG glycosylation
chr7	113741104	113741105	IgG glycosylation
chr7	113741104	113741105	IgG glycosylation
chr7	113741104	113741105	IgG glycosylation
chr7	113741104	113741105	IgG glycosylation
chr7	113741104	113741105	IgG glycosylation
chr7	114357542	114357543	Crohn's disease
chr7	114629284	114629285	Obesity
chr7	116162728	116162729	Glaucoma (primary open-angle)
chr7	116186240	116186241	Atrial fibrillation
chr7	116186240	116186241	Electrocardiographic traits
chr7	116186240	116186241	PR interval
chr7	116191300	116191301	PR interval
chr7	116346602	116346603	Multiple sclerosis (severity)
chr7	116577123	116577124	Cognitive performance
chr7	116892845	116892846	Inflammatory bowel disease
chr7	116917117	116917118	Dupuytren's disease
chr7	117023534	117023535	Waist circumference
chr7	117067821	117067822	Coronary heart disease
chr7	117991894	117991895	Response to platinum-based chemotherapy in non-small-cell lung cancer
chr7	118159548	118159549	Smoking behavior
chr7	120305148	120305149	Alcohol and nictotine co-dependence
chr7	120785063	120785064	Bone mineral density
chr7	120903814	120903815	Bone mineral density
chr7	120969768	120969769	Bone mineral density
chr7	120974764	120974765	Bone mineral density
chr7	120979088	120979089	Cortical thickness
chr7	121018578	121018579	Bone mineral density
chr7	121033120	121033121	Biomedical quantitative traits
chr7	121033120	121033121	Biomedical quantitative traits
chr7	121275228	121275229	Alcoholism (alcohol dependence factor score)
chr7	122202592	122202593	Brain structure
chr7	122759979	122759980	Adverse response to chemotherapy (neutropenia/leucopenia) (docetaxel)
chr7	123376559	123376560	Migraine
chr7	123411222	123411223	Platelet counts
chr7	124384326	124384327	Reading and spelling
chr7	125391644	125391645	Obesity-related traits
chr7	126324590	126324591	Carotid atherosclerosis in HIV infection
chr7	126437896	126437897	Chemerin levels
chr7	126639603	126639604	Depression (quantitative trait)
chr7	127164957	127164958	Type 2 diabetes
chr7	127246902	127246903	Type 2 diabetes
chr7	127862801	127862802	Type 2 diabetes
chr7	128415194	128415195	Primary tooth development (number of teeth)
chr7	128415194	128415195	Primary tooth development (time to first tooth eruption)
chr7	128568959	128568960	Systemic lupus erythematosus
chr7	128568959	128568960	Systemic lupus erythematosus
chr7	128573966	128573967	Systemic lupus erythematosus
chr7	128573966	128573967	Ulcerative colitis
chr7	128573966	128573967	Ulcerative colitis
chr7	128594182	128594183	Primary biliary cirrhosis
chr7	128594182	128594183	Primary biliary cirrhosis
chr7	128594182	128594183	Rheumatoid arthritis
chr7	128594182	128594183	Systemic lupus erythematosus
chr7	128594182	128594183	Systemic lupus erythematosus
chr7	128594182	128594183	Systemic sclerosis
chr7	128594182	128594183	Systemic sclerosis
chr7	128594182	128594183	Systemic sclerosis
chr7	128594182	128594183	Systemic sclerosis
chr7	128594182	128594183	Systemic sclerosis
chr7	128594182	128594183	Systemic sclerosis
chr7	128617465	128617466	Primary biliary cirrhosis
chr7	128617465	128617466	Systemic lupus erythematosus
chr7	128617465	128617466	Systemic lupus erythematosus
chr7	128695982	128695983	Systemic lupus erythematosus and Systemic sclerosis
chr7	128717905	128717906	Systemic lupus erythematosus
chr7	128993755	128993756	Inflammatory biomarkers
chr7	129004846	129004847	Response to fenofibrate
chr7	129023596	129023597	Tuberculosis
chr7	129356205	129356206	Obesity-related traits
chr7	129663495	129663496	Coronary heart disease
chr7	130433383	130433384	HDL cholesterol
chr7	130466853	130466854	Type 2 diabetes
chr7	130653850	130653851	Breast cancer
chr7	130900120	130900121	Major depressive disorder (broad)
chr7	131021098	131021099	Asthma (childhood onset)
chr7	131287989	131287990	AB1-42
chr7	131370038	131370039	Rheumatoid arthritis
chr7	131453524	131453525	Body mass index
chr7	131453664	131453665	Body mass index
chr7	131713359	131713360	Self-employment
chr7	131829127	131829128	Economic and political preferences
chr7	132030010	132030011	Venous thromboembolism (gene x gene interaction)
chr7	132189688	132189689	Pulmonary function decline
chr7	132325308	132325309	Oleic acid (18:1n-9) plasma levels
chr7	133335175	133335176	Tonometry
chr7	133747945	133747946	Alzheimer's disease (cognitive decline)
chr7	134250321	134250322	Longevity
chr7	135293127	135293128	Paget's disease
chr7	135329977	135329978	Red blood cell traits
chr7	135479572	135479573	Obesity-related traits
chr7	135488620	135488621	Visceral adipose tissue adjusted for BMI
chr7	135501468	135501469	Periodontitis (CDC/AAP)
chr7	136146535	136146536	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr7	136584362	136584363	Migraine with aura
chr7	136642633	136642634	Heart rate
chr7	137203818	137203819	AIDS progression
chr7	137858765	137858766	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr7	137858765	137858766	Bipolar disorder (mood-incongruent)
chr7	138049386	138049387	Pulmonary function
chr7	138157389	138157390	Quantitative traits
chr7	138411424	138411425	F-cell distribution
chr7	139557946	139557947	Obesity-related traits
chr7	139591859	139591860	Migraine without aura
chr7	139702592	139702593	Acute lymphoblastic leukemia (childhood)
chr7	140231129	140231130	Optic disc size (cup)
chr7	140592226	140592227	Response to Vitamin E supplementation
chr7	141505086	141505087	Anorexia nervosa
chr7	141672603	141672604	Bitter taste perception
chr7	141673344	141673345	Bitter taste response
chr7	142104570	142104571	Capecitabine sensitivity
chr7	142456927	142456928	Pancreatitis
chr7	143109138	143109139	Alzheimer's disease (late onset)
chr7	143741579	143741580	Obesity-related traits
chr7	144074928	144074929	Breast cancer
chr7	144841530	144841531	Attention deficit hyperactivity disorder
chr7	145959242	145959243	Bipolar disorder and schizophrenia
chr7	146135937	146135938	Obesity-related traits
chr7	146897402	146897403	Alzheimer's disease
chr7	147226890	147226891	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr7	147577536	147577537	QT interval (interaction)
chr7	147615639	147615640	IgG glycosylation
chr7	147702691	147702692	Bone mineral density
chr7	147901015	147901016	Body mass index (interaction)
chr7	147901015	147901016	Body mass index (interaction)
chr7	148258047	148258048	Crohn's disease
chr7	148650633	148650634	Height
chr7	149203661	149203662	Amyotrophic lateral sclerosis
chr7	149289463	149289464	Multiple sclerosis
chr7	150512171	150512172	Height
chr7	150517021	150517022	Height
chr7	150622161	150622162	QT interval
chr7	150623136	150623137	QT interval
chr7	150637862	150637863	Electrocardiographic traits
chr7	150637862	150637863	QT interval
chr7	150667209	150667210	Electrocardiographic traits
chr7	150669975	150669976	QT interval
chr7	150915070	150915071	IgG glycosylation
chr7	150915070	150915071	IgG glycosylation
chr7	150915070	150915071	IgG glycosylation
chr7	150915070	150915071	IgG glycosylation
chr7	150915070	150915071	IgG glycosylation
chr7	150919828	150919829	Bone mineral density
chr7	151120947	151120948	Coronary heart disease
chr7	151406004	151406005	Red blood cell traits
chr7	151406004	151406005	Urate levels
chr7	151407800	151407801	Chronic kidney disease
chr7	151415040	151415041	Hematocrit
chr7	151415040	151415041	Hemoglobin
chr7	151546588	151546589	Bipolar disorder (age of onset and psychomotor symptoms)
chr7	152387868	152387869	Palmitic acid (16:0) plasma levels
chr7	152669839	152669840	Obesity-related traits
chr7	152878332	152878333	Nicotine use
chr7	152924892	152924893	Venous thromboembolism (gene x gene interaction)
chr7	153535688	153535689	Attention deficit hyperactivity disorder (combined symptoms)
chr7	153535688	153535689	Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)
chr7	153549295	153549296	Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)
chr7	153553063	153553064	Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)
chr7	153558948	153558949	Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)
chr7	153578415	153578416	IgG glycosylation
chr7	153625842	153625843	Pancreatic cancer
chr7	154072019	154072020	Tardive dyskinesia
chr7	154210797	154210798	Amyotrophic lateral sclerosis
chr7	154210797	154210798	Amyotrophic lateral sclerosis
chr7	154210797	154210798	Amyotrophic lateral sclerosis
chr7	154509323	154509324	QT interval
chr7	154970468	154970469	Formal thought disorder in schizophrenia
chr7	155008712	155008713	Personality dimensions
chr7	155285134	155285135	Migraine
chr7	155762156	155762157	Platelet aggregation
chr7	155768748	155768749	Obesity-related traits
chr7	155837294	155837295	Corneal astigmatism
chr7	156048648	156048649	Bipolar disorder and schizophrenia
chr7	156880397	156880398	Response to citalopram treatment
chr7	156880397	156880398	Response to citalopram treatment
chr7	157090295	157090296	Quantitative traits
chr7	157294937	157294938	Inattentive symptoms
chr7	157387440	157387441	Myopia (pathological)
chr7	157510194	157510195	Bipolar disorder and schizophrenia
chr7	158136985	158136986	Response to amphetamines
chr7	158223105	158223106	Obesity-related traits
chr7	158724788	158724789	Height
chr7	158846928	158846929	Myopia (pathological)
chr8	445600	445601	Bilirubin levels
chr8	516478	516479	Age-related macular degeneration (GA)
chr8	566206	566207	IgG glycosylation
chr8	1244223	1244224	Menarche (age at onset)
chr8	1746949	1746950	Gaucher disease severity
chr8	1883351	1883352	Multiple sclerosis
chr8	1951299	1951300	Obesity-related traits
chr8	2040103	2040104	Bipolar disorder and schizophrenia
chr8	2740501	2740502	Emphysema-related traits
chr8	2819808	2819809	IgG glycosylation
chr8	3076958	3076959	Periodontitis (CDC/AAP)
chr8	3088172	3088173	Alzheimer's disease (cognitive decline)
chr8	3088762	3088763	Periodontitis (CDC/AAP)
chr8	3091583	3091584	Systolic blood pressure in sickle cell anemia
chr8	3156219	3156220	Eating disorders (purging via substances)
chr8	3189895	3189896	Obesity-related traits
chr8	3316985	3316986	Obesity-related traits
chr8	3488337	3488338	Obesity-related traits
chr8	3594905	3594906	Pulmonary function decline
chr8	3828137	3828138	Multiple sclerosis
chr8	3978129	3978130	Serum selenium levels
chr8	4078352	4078353	Insulin resistance/response
chr8	4105146	4105147	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)
chr8	4110031	4110032	Illicit drug use
chr8	4164012	4164013	Coronary heart disease
chr8	4180843	4180844	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr8	4180843	4180844	Schizophrenia
chr8	4214178	4214179	Schizophrenia
chr8	4282617	4282618	Disc degeneration (lumbar)
chr8	4284691	4284692	Disc degeneration (lumbar)
chr8	4285389	4285390	Disc degeneration (lumbar)
chr8	4299882	4299883	Immune response to smallpox vaccine (IL-6)
chr8	4483140	4483141	Cognitive performance
chr8	4617809	4617810	Interstitial lung disease
chr8	4875171	4875172	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+doxorubicin+/-5FU)
chr8	4926464	4926465	Hair morphology
chr8	5071411	5071412	Endometriosis
chr8	5227101	5227102	Metabolite levels (5-HIAA)
chr8	5373539	5373540	Metabolite levels (HVA/MHPG ratio)
chr8	5426530	5426531	Waist-hip ratio
chr8	5461752	5461753	Attention deficit hyperactivity disorder symptoms (interaction)
chr8	5764941	5764942	Dietary macronutrient intake
chr8	6152918	6152919	Metabolite levels (5-HIAA)
chr8	6323277	6323278	Epirubicin-induced leukopenia
chr8	6351251	6351252	Cytomegalovirus antibody response
chr8	6821616	6821617	Periodontitis (PAL4Q3)
chr8	6821616	6821617	Periodontitis (PAL4Q3)
chr8	6822784	6822785	IgA nephropathy
chr8	6829084	6829085	Endometriosis
chr8	8577378	8577379	Obesity-related traits
chr8	8717006	8717007	Conduct disorder (interaction)
chr8	8722377	8722378	Prion diseases
chr8	8890097	8890098	Myopia (pathological)
chr8	8990576	8990577	Myopia (pathological)
chr8	8999018	8999019	Alzheimer's disease
chr8	9178267	9178268	Liver enzyme levels (alkaline phosphatase)
chr8	9183357	9183358	C-reactive protein
chr8	9183357	9183358	Cholesterol, total
chr8	9183357	9183358	HDL Cholesterol - Triglycerides (HDLC-TG)
chr8	9183357	9183358	HDL cholesterol
chr8	9183357	9183358	LDL cholesterol
chr8	9183357	9183358	Metabolic syndrome (bivariate traits)
chr8	9183595	9183596	Fasting glucose-related traits (interaction with BMI)
chr8	9183595	9183596	Fasting insulin-related traits (interaction with BMI)
chr8	9183595	9183596	Glycemic traits (pregnancy)
chr8	9183595	9183596	Glycemic traits (pregnancy)
chr8	9183595	9183596	Metabolite levels
chr8	9184690	9184691	Coronary heart disease
chr8	9185145	9185146	HDL cholesterol
chr8	9185145	9185146	LDL cholesterol
chr8	9187241	9187242	HDL cholesterol
chr8	9395531	9395532	Multiple myeloma (hyperdiploidy)
chr8	9601698	9601699	Multiple myeloma (hyperdiploidy)
chr8	9792661	9792662	Multiple myeloma (hyperdiploidy)
chr8	9814410	9814411	Myopia (pathological)
chr8	9860079	9860080	Adiposity
chr8	9986654	9986655	Bipolar disorder and schizophrenia
chr8	10022937	10022938	Schizophrenia
chr8	10071619	10071620	Hypertension
chr8	10086410	10086411	Bulimia nervosa
chr8	10334780	10334781	Alzheimer's disease
chr8	10352307	10352308	Obesity-related traits
chr8	10462805	10462806	Obesity-related traits
chr8	10671271	10671272	Carotid intima media thickness
chr8	10683928	10683929	Triglycerides
chr8	11045160	11045161	Triglycerides
chr8	11104110	11104111	Retinal vascular caliber
chr8	11119036	11119037	Response to antipsychotic therapy (extrapyramidal side effects)
chr8	11276541	11276542	Cognitive performance
chr8	11340180	11340181	Systemic lupus erythematosus
chr8	11343679	11343680	Kawasaki disease
chr8	11343679	11343680	Systemic lupus erythematosus
chr8	11343972	11343973	Kawasaki disease
chr8	11343972	11343973	Rheumatoid arthritis
chr8	11343972	11343973	Systemic lupus erythematosus
chr8	11343972	11343973	Systemic lupus erythematosus and Systemic sclerosis
chr8	11349185	11349186	Systemic lupus erythematosus
chr8	11349185	11349186	Systemic lupus erythematosus
chr8	11352540	11352541	Systemic lupus erythematosus
chr8	11359637	11359638	Rheumatoid arthritis
chr8	11359637	11359638	Rheumatoid arthritis
chr8	11409991	11409992	Immune response to smallpox vaccine (IL-6)
chr8	11480456	11480457	Periodontitis (CDC/AAP)
chr8	11480456	11480457	Periodontitis (CDC/AAP)
chr8	11480456	11480457	Periodontitis (CDC/AAP)
chr8	11612697	11612698	Myopia (pathological)
chr8	11638243	11638244	Neutrophil count
chr8	11643914	11643915	Alcohol dependence
chr8	11643914	11643915	Nicotine use
chr8	11684462	11684463	Non-alcoholic fatty liver disease histology (lobular)
chr8	11684462	11684463	Non-alcoholic fatty liver disease histology (other)
chr8	11698746	11698747	Parkinson's disease
chr8	12691870	12691871	IgG glycosylation
chr8	12711862	12711863	Morbidity-free survival
chr8	12811151	12811152	Migraine
chr8	12979399	12979400	Venous thromboembolism (gene x gene interaction)
chr8	13176406	13176407	Obesity-related traits
chr8	13260535	13260536	Bipolar disorder
chr8	14113815	14113816	IgG glycosylation
chr8	14113815	14113816	IgG glycosylation
chr8	14113815	14113816	IgG glycosylation
chr8	14113815	14113816	IgG glycosylation
chr8	14113815	14113816	IgG glycosylation
chr8	14389480	14389481	Platelet aggregation
chr8	14517293	14517294	Obesity-related traits
chr8	14550155	14550156	Obesity-related traits
chr8	14853780	14853781	Methamphetamine dependence
chr8	15197416	15197417	Corneal astigmatism
chr8	15532584	15532585	Pulmonary function decline
chr8	15665611	15665612	Intelligence
chr8	16929634	16929635	Depression and alcohol dependence
chr8	17143829	17143830	Tonometry
chr8	17205576	17205577	Creutzfeldt-Jakob disease (variant)
chr8	17282410	17282411	Obesity-related traits
chr8	17329826	17329827	Conduct disorder (case status)
chr8	17800768	17800769	Economic and political preferences
chr8	17977649	17977650	Obesity
chr8	17977649	17977650	Obesity
chr8	17977649	17977650	Obesity
chr8	18233581	18233582	QT interval (interaction)
chr8	18272437	18272438	Urinary metabolites
chr8	18272880	18272881	Bladder cancer
chr8	18272880	18272881	Cholesterol, total
chr8	18272880	18272881	Triglycerides
chr8	18273299	18273300	Metabolic traits
chr8	18381234	18381235	Paclitaxel-induced neuropathy
chr8	18673730	18673731	Lung function (forced expiratory volume in 1 second)
chr8	18707870	18707871	Obesity-related traits
chr8	18782046	18782047	Neutrophil count
chr8	19539637	19539638	Response to antidepressant treatment (citalopram)
chr8	19651160	19651161	Acute lymphoblastic leukemia (childhood)
chr8	19786890	19786891	Hyperactive-impulsive symptoms
chr8	19813528	19813529	Metabolic syndrome
chr8	19816237	19816238	Metabolic syndrome
chr8	19816933	19816934	Metabolic syndrome (bivariate traits)
chr8	19819327	19819328	HDL cholesterol
chr8	19819438	19819439	HDL cholesterol
chr8	19819438	19819439	Triglycerides
chr8	19819438	19819439	Triglycerides
chr8	19819723	19819724	HDL cholesterol
chr8	19819723	19819724	Triglycerides
chr8	19819723	19819724	Triglycerides
chr8	19819723	19819724	Triglycerides
chr8	19820404	19820405	Lipid metabolism phenotypes
chr8	19820404	19820405	Lipid metabolism phenotypes
chr8	19820404	19820405	Lipid metabolism phenotypes
chr8	19820404	19820405	Lipid metabolism phenotypes
chr8	19824491	19824492	HDL Cholesterol - Triglycerides (HDLC-TG)
chr8	19824562	19824563	Lipid metabolism phenotypes
chr8	19824562	19824563	Lipid metabolism phenotypes
chr8	19824666	19824667	Triglycerides-Blood Pressure (TG-BP)
chr8	19826372	19826373	Metabolic syndrome (bivariate traits)
chr8	19827847	19827848	Triglycerides
chr8	19830920	19830921	Metabolic traits
chr8	19830920	19830921	Triglycerides
chr8	19830920	19830921	Triglycerides
chr8	19832645	19832646	HDL cholesterol
chr8	19832645	19832646	Lipid traits
chr8	19844221	19844222	HDL cholesterol
chr8	19844221	19844222	HDL cholesterol
chr8	19844221	19844222	Hematological and biochemical traits
chr8	19844221	19844222	Metabolite levels
chr8	19844221	19844222	Triglycerides
chr8	19844221	19844222	Triglycerides
chr8	19845375	19845376	Metabolic syndrome
chr8	19847689	19847690	HDL cholesterol
chr8	19847689	19847690	HDL cholesterol
chr8	19847689	19847690	Triglycerides
chr8	19847689	19847690	Triglycerides
chr8	19848079	19848080	Triglycerides
chr8	19849756	19849757	Cardiovascular disease risk factors
chr8	19849756	19849757	Cardiovascular disease risk factors
chr8	19865174	19865175	HDL cholesterol
chr8	19865174	19865175	Metabolic syndrome
chr8	19865174	19865175	Waist circumference and related phenotypes
chr8	19868385	19868386	Metabolic syndrome (bivariate traits)
chr8	19876745	19876746	Hypertriglyceridemia
chr8	19912369	19912370	Lipid metabolism phenotypes
chr8	19928581	19928582	Hypertriglyceridemia
chr8	19987702	19987703	Amyotrophic lateral sclerosis (age of onset)
chr8	20066048	20066049	Bipolar disorder and schizophrenia
chr8	20066048	20066049	Major depressive disorder (broad)
chr8	20081889	20081890	Circulating myeloperoxidase levels (serum)
chr8	20246757	20246758	Preeclampsia
chr8	20301436	20301437	Dental caries
chr8	20336572	20336573	Dental caries
chr8	20626320	20626321	Serum tamsulosin hydrochloride concentration
chr8	20967550	20967551	Migraine with aura
chr8	21662444	21662445	Entorhinal cortical thickness
chr8	21820812	21820813	Mean corpuscular volume
chr8	21884543	21884544	Obesity-related traits
chr8	21978371	21978372	Obesity-related traits
chr8	22088431	22088432	Hypertriglyceridemia
chr8	22619550	22619551	Visceral fat
chr8	23082970	23082971	Age-related macular degeneration
chr8	23082970	23082971	Age-related macular degeneration
chr8	23101619	23101620	Attention deficit hyperactivity disorder
chr8	23526462	23526463	Prostate cancer
chr8	23526462	23526463	Prostate cancer
chr8	23526462	23526463	Prostate cancer
chr8	23534017	23534018	Prostate cancer
chr8	23584225	23584226	Treatment response for severe sepsis
chr8	23636280	23636281	Response to mTOR inhibitor (everolimus)
chr8	23751150	23751151	Chronic kidney disease
chr8	23777005	23777006	Urate levels
chr8	23818686	23818687	Subcutaneous adipose tissue
chr8	24044300	24044301	Migraine - clinic-based
chr8	24116303	24116304	Height
chr8	24378740	24378741	White matter integrity
chr8	25892141	25892142	Prostate cancer
chr8	26206076	26206077	Height
chr8	26718879	26718880	Response to amphetamines
chr8	27076597	27076598	Bipolar disorder and schizophrenia
chr8	27416800	27416801	Dental caries
chr8	27452846	27452847	Panic disorder
chr8	27464518	27464519	Alzheimer's disease
chr8	27466314	27466315	Alzheimer's disease (late onset)
chr8	27487789	27487790	Alzheimer's disease
chr8	27740416	27740417	Adverse response to chemotherapy (neutropenia/leucopenia) (cisplatin)
chr8	27905887	27905888	Cardiac Troponin-T levels
chr8	27923387	27923388	Suicidal ideation
chr8	28181754	28181755	IgG glycosylation
chr8	28791158	28791159	Obesity-related traits
chr8	28995021	28995022	Metabolite levels (HVA-5-HIAA Factor score)
chr8	29106058	29106059	Metabolite levels (HVA)
chr8	29344461	29344462	Colorectal cancer
chr8	29360304	29360305	Response to statin therapy
chr8	29509615	29509616	Breast cancer
chr8	29982517	29982518	Migraine
chr8	30262785	30262786	Heart rate variability traits
chr8	30498858	30498859	Cognitive performance
chr8	30936355	30936356	Exercise treadmill test traits
chr8	31034274	31034275	IgG glycosylation
chr8	31034274	31034275	IgG glycosylation
chr8	31034274	31034275	IgG glycosylation
chr8	31174829	31174830	Obesity-related traits
chr8	31633446	31633447	Hip geometry
chr8	31794108	31794109	Coronary artery calcification
chr8	32411215	32411216	Hirschsprung's disease
chr8	32412358	32412359	Dialysis-related mortality
chr8	32416273	32416274	Thyroid hormone levels
chr8	32416273	32416274	Thyroid hormone levels
chr8	32432368	32432369	Thyroid cancer
chr8	33565377	33565378	Immune response to smallpox vaccine (IL-6)
chr8	33665679	33665680	Immune response to smallpox vaccine (IL-6)
chr8	33673010	33673011	Immune response to smallpox vaccine (IL-6)
chr8	34045260	34045261	Asthma (childhood onset)
chr8	34126947	34126948	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr8	34126947	34126948	Bipolar disorder
chr8	34236991	34236992	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr8	34236991	34236992	Bipolar disorder
chr8	34524002	34524003	Pulmonary function decline
chr8	36459453	36459454	Obesity-related traits
chr8	36459453	36459454	Obesity-related traits
chr8	36846108	36846109	Breast size
chr8	36941541	36941542	Bipolar disorder
chr8	36951913	36951914	Insulin resistance/response
chr8	37096058	37096059	Heart rate
chr8	37681425	37681426	Axial length
chr8	37686748	37686749	Menopause (age at onset)
chr8	37977731	37977732	Menopause (age at onset)
chr8	37977731	37977732	Menopause (age at onset)
chr8	38004424	38004425	Orthostatic hypotension
chr8	38031344	38031345	Schizophrenia
chr8	38469302	38469303	Pancreatic cancer
chr8	40053604	40053605	Parkinson's disease (motor and cognition)
chr8	40252700	40252701	Inattentive symptoms
chr8	40484238	40484239	Fasting plasma glucose
chr8	40484238	40484239	Fasting plasma glucose
chr8	40726393	40726394	Refractive error
chr8	41519461	41519462	Type 2 diabetes
chr8	41549193	41549194	Glycated hemoglobin levels
chr8	41615137	41615138	Pulmonary function decline
chr8	41630404	41630405	Glycated hemoglobin levels
chr8	42546710	42546711	Nicotine dependence
chr8	42550497	42550498	Smoking behavior
chr8	43695233	43695234	Response to amphetamines
chr8	47947700	47947701	Visceral adipose tissue adjusted for BMI
chr8	49053164	49053165	Attention deficit hyperactivity disorder
chr8	49812200	49812201	Sudden cardiac arrest
chr8	51384986	51384987	IgG glycosylation
chr8	51384986	51384987	IgG glycosylation
chr8	51412590	51412591	Pulmonary function
chr8	52216761	52216762	Tuberculosis
chr8	52757092	52757093	Venous thromboembolism (gene x gene interaction)
chr8	52887540	52887541	Glaucoma (primary open-angle)
chr8	53214264	53214265	Alzheimer's disease (cognitive decline)
chr8	53684860	53684861	Obesity-related traits
chr8	54119213	54119214	IgE levels in asthmatics (D.p. specific)
chr8	54410207	54410208	Response to antineoplastic agents
chr8	54555199	54555200	Bipolar disorder (mood-incongruent)
chr8	55310710	55310711	Intracranial aneurysm
chr8	55327090	55327091	Intracranial aneurysm
chr8	55437523	55437524	Intracranial aneurysm
chr8	55437523	55437524	Intracranial aneurysm
chr8	55440067	55440068	Dengue shock syndrome
chr8	56599547	56599548	Myopia (pathological)
chr8	56599776	56599777	Migraine - clinic-based
chr8	57095807	57095808	Height
chr8	57095807	57095808	Height
chr8	57100148	57100149	Height
chr8	57100790	57100791	Height
chr8	57100790	57100791	Height
chr8	57155597	57155598	Height
chr8	57179019	57179020	Height
chr8	57194162	57194163	Height
chr8	57209245	57209246	Height
chr8	57313905	57313906	Obesity-related traits
chr8	58840923	58840924	Bipolar disorder and schizophrenia
chr8	59324161	59324162	Narcolepsy with cataplexy
chr8	59388564	59388565	Cholesterol, total
chr8	59388564	59388565	LDL cholesterol
chr8	59508579	59508580	IgG glycosylation
chr8	59708308	59708309	Cognitive performance
chr8	60130295	60130296	RR interval (heart rate)
chr8	60178720	60178721	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr8	60179085	60179086	Refractive error
chr8	60545663	60545664	Multiple myeloma (IgH translocation)
chr8	60623347	60623348	Obesity-related traits
chr8	60961820	60961821	Myopia (pathological)
chr8	61003896	61003897	Cardiac hypertrophy
chr8	61105198	61105199	Obesity-related traits
chr8	61194169	61194170	Response to amphetamines
chr8	61346196	61346197	Response to amphetamines
chr8	61876043	61876044	Pulmonary function decline
chr8	62054462	62054463	Migraine
chr8	62409427	62409428	MRI atrophy measures
chr8	63258916	63258917	Bulimia nervosa
chr8	63621568	63621569	Periodontitis (PAL4Q3)
chr8	63883592	63883593	Response to Vitamin E supplementation
chr8	65730206	65730207	Retinopathy in non-diabetics
chr8	65999962	65999963	Thiazide-induced adverse metabolic effects in hypertensive patients
chr8	66463477	66463478	Obesity-related traits
chr8	66624231	66624232	IgG glycosylation
chr8	66624231	66624232	IgG glycosylation
chr8	66624231	66624232	IgG glycosylation
chr8	66822029	66822030	Myopia (pathological)
chr8	66974251	66974252	Response to statin therapy
chr8	68799376	68799377	Adverse response to lamotrigine and phenytoin
chr8	69389216	69389217	Response to irinotecan in non-small-cell lung cancer
chr8	69563694	69563695	Obesity-related traits
chr8	69730718	69730719	Obesity-related traits
chr8	69992379	69992380	Dupuytren's disease
chr8	70412449	70412450	Height
chr8	70493973	70493974	Fasting insulin-related traits (interaction with BMI)
chr8	70809260	70809261	Attention deficit hyperactivity disorder
chr8	70976504	70976505	Testicular germ cell tumor
chr8	71139329	71139330	Metabolite levels (HVA-5-HIAA Factor score)
chr8	71167993	71167994	Non-small cell lung cancer
chr8	71386903	71386904	Cardiac Troponin-T levels
chr8	71544747	71544748	IgG glycosylation
chr8	71544747	71544748	IgG glycosylation
chr8	71544747	71544748	IgG glycosylation
chr8	71591202	71591203	Bone mineral density
chr8	72263955	72263956	Sleepiness
chr8	72270081	72270082	Chronic obstructive pulmonary disease-related biomarkers
chr8	72447417	72447418	Migraine
chr8	72561741	72561742	Autism
chr8	73070734	73070735	Attention deficit hyperactivity disorder (combined symptoms)
chr8	73106915	73106916	Blood pressure
chr8	73236809	73236810	Pulmonary function decline
chr8	73363988	73363989	Multiple sclerosis (age of onset)
chr8	73633027	73633028	Cognitive performance
chr8	73778641	73778642	Echocardiographic traits
chr8	74007346	74007347	Crohn's disease
chr8	74066178	74066179	Corneal curvature
chr8	74274190	74274191	Inattentive symptoms
chr8	74467503	74467504	Axial length
chr8	75294974	75294975	Waist circumference
chr8	75373947	75373948	Response to tocilizumab in rheumatoid arthritis
chr8	75513133	75513134	Protein quantitative trait loci
chr8	76036443	76036444	IgG glycosylation
chr8	76147953	76147954	Information processing speed
chr8	76230300	76230301	Breast cancer
chr8	76417936	76417937	Breast cancer
chr8	76478767	76478768	Urate levels
chr8	76573710	76573711	Body mass index
chr8	76615662	76615663	Obesity
chr8	76615662	76615663	Obesity
chr8	77507612	77507613	Orofacial clefts
chr8	77611624	77611625	Menarche (age at onset)
chr8	78093836	78093837	Menarche (age at onset)
chr8	78160178	78160179	Height
chr8	78178484	78178485	Height
chr8	78325884	78325885	Behavioural disinhibition (generation interaction)
chr8	78680348	78680349	Sudden cardiac arrest
chr8	78956657	78956658	Prostate cancer (gene x gene interaction)
chr8	79034458	79034459	Bone mineral density
chr8	79401037	79401038	Multiple sclerosis
chr8	80227447	80227448	Creutzfeldt-Jakob disease
chr8	80985034	80985035	Metabolite levels (HVA/MHPG ratio)
chr8	81031821	81031822	Metabolite levels (Pyroglutamine)
chr8	81228825	81228826	Sleep duration
chr8	81268154	81268155	Self-reported allergy
chr8	81308149	81308150	Atopic dermatitis
chr8	81357701	81357702	Migraine - clinic-based
chr8	81438419	81438420	Hypothyroidism
chr8	81461973	81461974	Sex hormone-binding globulin levels
chr8	81461973	81461974	Sex hormone-binding globulin levels
chr8	81470119	81470120	Neutrophil count
chr8	82027671	82027672	Serum total protein level
chr8	82151746	82151747	Myopia (pathological)
chr8	82445223	82445224	Visceral fat
chr8	82653643	82653644	Ovarian cancer
chr8	82653643	82653644	Ovarian cancer
chr8	82928597	82928598	Orofacial clefts
chr8	83073828	83073829	Prostate cancer (gene x gene interaction)
chr8	83669119	83669120	Heart failure
chr8	83903813	83903814	Response to antidepressant treatment
chr8	83991230	83991231	Information processing speed
chr8	86268312	86268313	Blood trace element (Zn levels)
chr8	87025012	87025013	Adverse response to lamotrigine and phenytoin
chr8	88868339	88868340	Orofacial clefts
chr8	89547931	89547932	Migraine without aura
chr8	89585047	89585048	Body mass index and cholesterol (psychopharmacological treatment)
chr8	89592082	89592083	Schizophrenia
chr8	89760310	89760311	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr8	89760310	89760311	Schizophrenia
chr8	89760310	89760311	Schizophrenia
chr8	89993487	89993488	Smooth-surface caries
chr8	90211099	90211100	Dental caries
chr8	90211099	90211100	Pit-and-Fissure caries
chr8	90211099	90211100	Smooth-surface caries
chr8	90342185	90342186	Cognitive performance
chr8	90656987	90656988	Tuberculosis
chr8	90778512	90778513	Leprosy
chr8	90823686	90823687	Leprosy
chr8	90875917	90875918	Crohn's disease
chr8	92075642	92075643	Migraine - clinic-based
chr8	92360395	92360396	Fat distribution (HIV)
chr8	92360395	92360396	Fat distribution (HIV)
chr8	92418627	92418628	Fat distribution (HIV)
chr8	92559914	92559915	Disc degeneration (lumbar)
chr8	94085538	94085539	Attention deficit hyperactivity disorder
chr8	94169349	94169350	Bipolar disorder and schizophrenia
chr8	94222944	94222945	IgG glycosylation
chr8	94222944	94222945	IgG glycosylation
chr8	94358097	94358098	Temperament
chr8	94916102	94916103	Response to amphetamines
chr8	95960510	95960511	Type 2 diabetes
chr8	96106036	96106037	Metabolite levels (HVA)
chr8	96106036	96106037	Metabolite levels (HVA-5-HIAA Factor score)
chr8	96120071	96120072	Radiation response
chr8	96127029	96127030	Radiation response
chr8	96504471	96504472	Anorexia nervosa
chr8	96515887	96515888	Obesity-related traits
chr8	96595735	96595736	Colorectal cancer
chr8	97263417	97263418	Lung function (forced vital capacity)
chr8	97369633	97369634	Obesity-related traits
chr8	97796730	97796731	DNA methylation (variation)
chr8	98154440	98154441	Sleep duration
chr8	98166912	98166913	Migraine
chr8	98282188	98282189	Estradiol plasma levels (breast cancer)
chr8	98329764	98329765	Antipsychotic-induced QTc interval prolongation
chr8	99022008	99022009	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel)
chr8	99088580	99088581	Eosinophilic esophagitis (pediatric)
chr8	99113686	99113687	Obesity-related traits
chr8	99129506	99129507	Prion diseases
chr8	99317738	99317739	Thiazide-induced adverse metabolic effects in hypertensive patients
chr8	100835181	100835182	Hippocampal atrophy
chr8	101330208	101330209	Atrioventricular conduction
chr8	101807229	101807230	Alcohol consumption
chr8	101813155	101813156	Premature ovarian failure
chr8	101841545	101841546	AIDS
chr8	101919320	101919321	Attention deficit hyperactivity disorder and conduct disorder
chr8	102227922	102227923	Reasoning
chr8	102596209	102596210	Bronchopulmonary dysplasia
chr8	102944862	102944863	Cognitive performance
chr8	103052376	103052377	Coffee consumption
chr8	103578873	103578874	Chronic lymphocytic leukemia
chr8	103639940	103639941	Migraine
chr8	103975988	103975989	Alzheimer's disease (late onset)
chr8	104118565	104118566	Attention deficit hyperactivity disorder (combined symptoms)
chr8	104573788	104573789	Cocaine dependence
chr8	105359431	105359432	Paget's disease
chr8	105700679	105700680	Periodontitis (DPAL)
chr8	105957539	105957540	Sudden cardiac arrest
chr8	105958019	105958020	Glaucoma (primary open-angle)
chr8	105992695	105992696	Response to antipsychotic treatment
chr8	106142332	106142333	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr8	106509974	106509975	Coronary artery calcification
chr8	106581527	106581528	Platelet counts
chr8	106581527	106581528	Vascular endothelial growth factor levels
chr8	107844446	107844447	Intelligence (childhood)
chr8	107909008	107909009	Dental caries
chr8	108040351	108040352	Obesity-related traits
chr8	108281426	108281427	IgG glycosylation
chr8	108789815	108789816	Brain structure
chr8	109228007	109228008	Dupuytren's disease
chr8	109629902	109629903	T-tau
chr8	110115675	110115676	Body mass (lean)
chr8	110217265	110217266	Myopia (pathological)
chr8	110478821	110478822	Obesity-related traits
chr8	112976140	112976141	Bilirubin levels
chr8	113074095	113074096	Temperament
chr8	114873379	114873380	Bronchopulmonary dysplasia
chr8	115121026	115121027	Periodontal microbiota
chr8	115578306	115578307	Post-traumatic stress disorder (asjusted for relatedness)
chr8	115578306	115578307	Post-traumatic stress disorder (asjusted for relatedness)
chr8	116110724	116110725	Eating disorders
chr8	116330854	116330855	IgG glycosylation
chr8	116394074	116394075	Attention deficit hyperactivity disorder (time to onset)
chr8	116599198	116599199	HDL cholesterol
chr8	116633698	116633699	Major depressive disorder
chr8	116648564	116648565	Cholesterol, total
chr8	116813904	116813905	Response to tocilizumab in rheumatoid arthritis
chr8	117556269	117556270	Aortic root size
chr8	117630682	117630683	Colorectal cancer
chr8	117630682	117630683	Colorectal cancer
chr8	117641609	117641610	Corneal curvature
chr8	118025644	118025645	Asthma
chr8	118089512	118089513	Intraocular pressure
chr8	118150992	118150993	Obesity-related traits
chr8	118184782	118184783	Glycated hemoglobin levels
chr8	118184782	118184783	Type 2 diabetes
chr8	118184782	118184783	Type 2 diabetes
chr8	118184782	118184783	Type 2 diabetes
chr8	118184782	118184783	Type 2 diabetes
chr8	118184782	118184783	Type 2 diabetes
chr8	118184782	118184783	Type 2 diabetes
chr8	118184782	118184783	Type 2 diabetes
chr8	118184782	118184783	Type 2 diabetes
chr8	118184782	118184783	Type 2 diabetes and other traits
chr8	118185024	118185025	Type 2 diabetes
chr8	118185024	118185025	Type 2 diabetes
chr8	118185732	118185733	Fasting glucose-related traits
chr8	118185732	118185733	Fasting glucose-related traits (interaction with BMI)
chr8	118185732	118185733	Proinsulin levels
chr8	118549375	118549376	Kawasaki disease
chr8	118827838	118827839	Height
chr8	118909259	118909260	Obesity-related traits
chr8	119391408	119391409	Multiple sclerosis
chr8	119766193	119766194	Pancreatitis
chr8	119830679	119830680	Chronic obstructive pulmonary disease-related biomarkers
chr8	119923872	119923873	Bone mineral density
chr8	119976541	119976542	Bone mineral density
chr8	119977336	119977337	Type 1 diabetes
chr8	119977791	119977792	Osteoporosis
chr8	120007419	120007420	Bone mineral density
chr8	120007419	120007420	Bone mineral density
chr8	120007419	120007420	Bone mineral density (spine)
chr8	120012699	120012700	Bone mineral density (hip)
chr8	120044828	120044829	Bone mineral density (spine)
chr8	120052237	120052238	Bone mineral density (hip)
chr8	120224805	120224806	Hippocampal atrophy
chr8	120435811	120435812	Blood pressure
chr8	120647928	120647929	Height
chr8	120953872	120953873	Interstitial lung disease
chr8	121562417	121562418	Myopia (pathological)
chr8	121610437	121610438	Myopia (severe)
chr8	121635395	121635396	Bipolar disorder and schizophrenia
chr8	121694649	121694650	Eosinophilic esophagitis (pediatric)
chr8	122182309	122182310	IgG glycosylation
chr8	122210889	122210890	Periodontitis (CDC/AAP)
chr8	122621908	122621909	Obesity-related traits
chr8	122622499	122622500	Dialysis-related mortality
chr8	122706290	122706291	Metabolite levels (5-HIAA)
chr8	122908502	122908503	Hemostatic factors and hematological phenotypes
chr8	122909686	122909687	Alzheimer's disease
chr8	122963214	122963215	Weight
chr8	123408090	123408091	Carotid intima media thickness
chr8	123706154	123706155	Type 1 diabetes nephropathy
chr8	123881217	123881218	Nicotine use
chr8	123973067	123973068	Immune response to smallpox vaccine (IL-6)
chr8	124696866	124696867	Event-related brain oscillations
chr8	124714721	124714722	Prostate cancer (gene x gene interaction)
chr8	124765701	124765702	Pancreatic cancer
chr8	124831833	124831834	Cognitive performance
chr8	125721365	125721366	IgG glycosylation
chr8	126477977	126477978	Triglycerides
chr8	126479314	126479315	Lipid metabolism phenotypes
chr8	126479314	126479315	Lipid metabolism phenotypes
chr8	126481474	126481475	Adiponectin levels
chr8	126481474	126481475	Adiponectin levels
chr8	126482076	126482077	LDL cholesterol
chr8	126482076	126482077	Liver enzyme levels (alanine transaminase)
chr8	126482076	126482077	Liver enzyme levels (alkaline phosphatase)
chr8	126484525	126484526	HDL Cholesterol - Triglycerides (HDLC-TG)
chr8	126486408	126486409	Triglycerides
chr8	126486408	126486409	Triglycerides
chr8	126490971	126490972	Cholesterol, total
chr8	126490971	126490972	HDL cholesterol
chr8	126490971	126490972	LDL cholesterol
chr8	126490971	126490972	Triglycerides
chr8	126490971	126490972	Triglycerides
chr8	126490971	126490972	Triglycerides
chr8	126490971	126490972	Triglycerides
chr8	126493745	126493746	Triglycerides-Blood Pressure (TG-BP)
chr8	126504725	126504726	Cholesterol, total
chr8	126504725	126504726	LDL cholesterol
chr8	126507388	126507389	Response to statin therapy
chr8	126534670	126534671	Inflammatory bowel disease
chr8	126534670	126534671	Obesity-related traits
chr8	126537569	126537570	Crohn's disease
chr8	126540050	126540051	Crohn's disease
chr8	126867504	126867505	Metabolite levels (Dihydroxy docosatrienoic acid)
chr8	127092881	127092882	Crohn's disease
chr8	127332656	127332657	Age-related macular degeneration
chr8	127332656	127332657	Age-related macular degeneration
chr8	127902002	127902003	Obesity-related traits
chr8	127911595	127911596	Obesity-related traits
chr8	128093296	128093297	Prostate cancer
chr8	128093296	128093297	Prostate cancer
chr8	128095155	128095156	Prostate cancer
chr8	128103936	128103937	Prostate cancer
chr8	128103936	128103937	Prostate cancer
chr8	128104342	128104343	Prostate cancer
chr8	128106879	128106880	Prostate cancer
chr8	128124915	128124916	Prostate cancer
chr8	128124915	128124916	Prostate cancer
chr8	128125194	128125195	Prostate cancer
chr8	128192980	128192981	Chronic lymphocytic leukemia
chr8	128320345	128320346	Prostate cancer
chr8	128323180	128323181	Prostate cancer
chr8	128323180	128323181	Prostate cancer
chr8	128355617	128355618	Breast cancer
chr8	128355617	128355618	Breast cancer
chr8	128387851	128387852	Breast cancer
chr8	128387851	128387852	Breast cancer
chr8	128407442	128407443	Colorectal cancer
chr8	128413304	128413305	Colorectal cancer
chr8	128413304	128413305	Colorectal cancer
chr8	128413304	128413305	Colorectal cancer
chr8	128413304	128413305	Colorectal cancer
chr8	128413304	128413305	Prostate cancer
chr8	128413304	128413305	Prostate cancer
chr8	128413304	128413305	Prostate cancer
chr8	128413304	128413305	Prostate cancer
chr8	128424791	128424792	Colorectal cancer
chr8	128485037	128485038	Prostate cancer
chr8	128485037	128485038	Prostate cancer
chr8	128485037	128485038	Prostate cancer
chr8	128504496	128504497	Response to antidepressant treatment
chr8	128517572	128517573	Prostate cancer
chr8	128518553	128518554	Prostate cancer
chr8	128518553	128518554	Prostate cancer
chr8	128518553	128518554	Prostate cancer
chr8	128532136	128532137	Prostate cancer
chr8	128539359	128539360	Prostate cancer
chr8	128718067	128718068	Bladder cancer
chr8	128718067	128718068	Urinary bladder cancer
chr8	128718067	128718068	Urinary bladder cancer
chr8	128815028	128815029	Allergic sensitization
chr8	128815028	128815029	Multiple sclerosis
chr8	129072160	129072161	End-stage renal disease
chr8	129075831	129075832	Hodgkin's lymphoma
chr8	129192270	129192271	Hodgkin's lymphoma
chr8	129192270	129192271	Multiple sclerosis
chr8	129194640	129194641	Breast cancer
chr8	129220072	129220073	Obesity-related traits
chr8	129246414	129246415	Immunoglobulin A
chr8	129264588	129264589	Celiac disease
chr8	129280948	129280949	Metabolite levels (Dihydroxy docosatrienoic acid)
chr8	129316013	129316014	Celiac disease and Rheumatoid arthritis
chr8	129427517	129427518	Atopic dermatitis
chr8	129543948	129543949	Ovarian cancer
chr8	129543948	129543949	Ovarian cancer
chr8	129543948	129543949	Ovarian cancer
chr8	129567180	129567181	Crohn's disease
chr8	129567180	129567181	Crohn's disease
chr8	129946153	129946154	Cleft lip
chr8	129946153	129946154	Orofacial clefts
chr8	129946153	129946154	Orofacial clefts
chr8	129946153	129946154	Orofacial clefts
chr8	129946153	129946154	Orofacial clefts
chr8	129946153	129946154	Orofacial clefts
chr8	130491751	130491752	Glioma
chr8	130572109	130572110	White blood cell types
chr8	130613613	130613614	White blood cell count
chr8	130624104	130624105	Inflammatory bowel disease
chr8	130676638	130676639	Retinopathy in non-diabetics
chr8	130685456	130685457	Glioma
chr8	130685456	130685457	Glioma
chr8	130725664	130725665	Height
chr8	130820038	130820039	Colorectal cancer
chr8	130958950	130958951	Post-traumatic stress disorder (asjusted for relatedness)
chr8	130980471	130980472	Protein quantitative trait loci
chr8	131033495	131033496	Migraine
chr8	131092412	131092413	Multiple sclerosis
chr8	131617849	131617850	Methotrexate phramacokinetics (acute lymphoblastic leukemia)
chr8	131812032	131812033	Total ventricular volume
chr8	132330715	132330716	IgG glycosylation
chr8	132330715	132330716	IgG glycosylation
chr8	132353734	132353735	Eye color
chr8	133103289	133103290	Common traits (Other)
chr8	133369093	133369094	Coronary artery calcification
chr8	133929916	133929917	Vitiligo
chr8	134071832	134071833	Temperament
chr8	134145511	134145512	Graves' disease
chr8	134196848	134196849	Type 2 diabetes
chr8	134270547	134270548	Post-traumatic stress disorder (asjusted for relatedness)
chr8	134461850	134461851	Personality dimensions
chr8	134475076	134475077	Functional impairment in major depressive disorder, bipolar disorder and schizophrenia
chr8	134615749	134615750	Intraocular pressure
chr8	134668676	134668677	Schizophrenia (negative symptoms)
chr8	134778341	134778342	Eating disorders (purging via substances)
chr8	135593724	135593725	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr8	135637336	135637337	Height
chr8	135638631	135638632	Height
chr8	135869975	135869976	Blood pressure
chr8	136713136	136713137	Non-alcoholic fatty liver disease histology (other)
chr8	136871738	136871739	Amyotrophic lateral sclerosis
chr8	136989203	136989204	Insomnia (caffeine-induced)
chr8	137768891	137768892	Bilirubin levels
chr8	137850010	137850011	IgG glycosylation
chr8	137850010	137850011	IgG glycosylation
chr8	138905295	138905296	Cognitive performance
chr8	138909718	138909719	PCA3 expression level
chr8	138918944	138918945	Neuroticism
chr8	139077727	139077728	Obesity-related traits
chr8	139255917	139255918	Inflammatory biomarkers
chr8	139301377	139301378	Periodontitis (PAL4Q3)
chr8	139504269	139504270	Cognitive performance
chr8	139884508	139884509	Asthma (bronchodilator response)
chr8	140519516	140519517	Adiponectin levels
chr8	140995242	140995243	Obesity-related traits
chr8	141150168	141150169	Response to amphetamines
chr8	141574193	141574194	Thiazide-induced adverse metabolic effects in hypertensive patients
chr8	142104943	142104944	Response to interferon beta therapy
chr8	142161063	142161064	Obesity-related traits
chr8	142300314	142300315	Bipolar disorder
chr8	142359549	142359550	Bipolar disorder and schizophrenia
chr8	142466820	142466821	Coronary artery calcification
chr8	142540924	142540925	Breast size
chr8	142556804	142556805	Obesity-related traits
chr8	142632314	142632315	Hair color
chr8	142736530	142736531	Obesity-related traits
chr8	143020730	143020731	IgG glycosylation
chr8	143121670	143121671	Amyotrophic lateral sclerosis
chr8	143312932	143312933	Schizophrenia
chr8	143691837	143691838	Bipolar disorder and schizophrenia
chr8	143761930	143761931	Bladder cancer
chr8	143761930	143761931	Bladder cancer
chr8	143761930	143761931	Duodenal ulcer
chr8	144565904	144565905	Venous thromboembolism (gene x gene interaction)
chr8	144657599	144657600	Attention deficit hyperactivity disorder
chr8	144693838	144693839	Rhegmatogenous retinal detachment
chr8	144802455	144802456	Obesity-related traits
chr8	145005560	145005561	Platelet counts
chr8	145021166	145021167	Fibrinogen
chr8	145043542	145043543	Cholesterol, total
chr8	145043542	145043543	LDL cholesterol
chr8	145139521	145139522	Metabolic traits
chr9	289060	289061	Obesity-related traits
chr9	331489	331490	Mean platelet volume
chr9	565916	565917	Pulmonary function decline
chr9	678836	678837	Migraine - clinic-based
chr9	841151	841152	Obesity-related traits
chr9	845515	845516	Testicular cancer
chr9	863634	863635	Testicular cancer
chr9	863634	863635	Testicular germ cell cancer
chr9	863634	863635	Testicular germ cell tumor
chr9	863634	863635	Testicular germ cell tumor
chr9	955793	955794	Major depressive disorder
chr9	1056958	1056959	Hyperactive-impulsive symptoms
chr9	1202370	1202371	Dupuytren's disease
chr9	1456796	1456797	Response to taxane treatment (docetaxel)
chr9	2194226	2194227	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr9	2203937	2203938	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+doxorubicin+/-5FU)
chr9	2548555	2548556	Gambling
chr9	2551653	2551654	Gambling
chr9	2691185	2691186	Vascular endothelial growth factor levels
chr9	2696554	2696555	Obesity-related traits
chr9	2742770	2742771	Alzheimer's disease (age of onset)
chr9	2777383	2777384	Blood trace element (Se levels)
chr9	2838469	2838470	Obesity-related traits
chr9	2978376	2978377	Systolic blood pressure in sickle cell anemia
chr9	3929423	3929424	Alzheimer's disease biomarkers
chr9	3929423	3929424	Alzheimer's disease biomarkers
chr9	4015369	4015370	Methotrexate phramacokinetics (acute lymphoblastic leukemia)
chr9	4267208	4267209	Thyroid hormone levels
chr9	4267208	4267209	Thyroid hormone levels
chr9	4287465	4287466	Type 2 diabetes
chr9	4289049	4289050	Fasting glucose-related traits
chr9	4289049	4289050	Fasting glucose-related traits
chr9	4289049	4289050	Fasting glucose-related traits (interaction with BMI)
chr9	4291746	4291747	Type 1 diabetes
chr9	4292082	4292083	Type 1 diabetes
chr9	4293149	4293150	Type 2 diabetes
chr9	4426630	4426631	Pancreatic cancer
chr9	4555304	4555305	Coronary artery calcification
chr9	4744742	4744743	Platelet counts
chr9	4763175	4763176	Hematological parameters
chr9	4763175	4763176	Platelet counts
chr9	4763175	4763176	Platelet counts
chr9	4774014	4774015	Handedness
chr9	4792338	4792339	Platelet counts
chr9	4814947	4814948	Platelet counts
chr9	4834393	4834394	Platelet counts
chr9	4844264	4844265	Mean corpuscular hemoglobin
chr9	4844264	4844265	Mean corpuscular volume
chr9	4844264	4844265	Mean corpuscular volume
chr9	4844264	4844265	Red blood cell traits
chr9	4845519	4845520	Mean corpuscular hemoglobin
chr9	4856876	4856877	Mean corpuscular hemoglobin
chr9	4856876	4856877	Mean corpuscular volume
chr9	4981601	4981602	Crohn's disease
chr9	4981601	4981602	Crohn's disease
chr9	4981601	4981602	Inflammatory bowel disease
chr9	4981601	4981602	Ulcerative colitis
chr9	4981601	4981602	Ulcerative colitis
chr9	4985878	4985879	Crohn's disease
chr9	5070830	5070831	Myeloproliferative neoplasms
chr9	5213686	5213687	Ulcerative colitis
chr9	5410722	5410723	Obesity-related traits
chr9	5893860	5893861	Multiple sclerosis
chr9	6172379	6172380	Self-reported allergy
chr9	6190075	6190076	Asthma
chr9	6193454	6193455	Asthma
chr9	6253570	6253571	Endometriosis
chr9	6486307	6486308	Periodontal microbiota
chr9	6784725	6784726	Bipolar disorder and schizophrenia
chr9	6849316	6849317	Radiation response
chr9	7043454	7043455	Response to fenofibrate (adiponectin levels)
chr9	7195407	7195408	Obesity-related traits
chr9	7274695	7274696	Obesity-related traits
chr9	7274695	7274696	Obesity-related traits
chr9	7518655	7518656	IgG glycosylation
chr9	7558260	7558261	Obesity-related traits
chr9	7558260	7558261	Obesity-related traits
chr9	7734249	7734250	Myopia (pathological)
chr9	7925380	7925381	Common traits (Other)
chr9	8012417	8012418	Prostate cancer (gene x gene interaction)
chr9	8045605	8045606	Personality dimensions
chr9	8196510	8196511	Platelet aggregation
chr9	8235632	8235633	Attention deficit hyperactivity disorder and conduct disorder
chr9	8846954	8846955	Restless legs syndrome
chr9	8846954	8846955	Restless legs syndrome
chr9	8879117	8879118	Type 2 diabetes
chr9	9020222	9020223	Migraine - clinic-based
chr9	9261736	9261737	Restless legs syndrome
chr9	9910122	9910123	Airflow obstruction
chr9	9924723	9924724	Myopia (pathological)
chr9	10043013	10043014	Temperament
chr9	10139579	10139580	Obesity-related traits
chr9	10260262	10260263	Partial epilepsies
chr9	10430601	10430602	Type 2 diabetes
chr9	10505223	10505224	Epilepsy (remission after treatment)
chr9	11257447	11257448	Response to amphetamines
chr9	11402318	11402319	Palmitic acid (16:0) plasma levels
chr9	12108915	12108916	Reading and spelling
chr9	12108915	12108916	Word reading
chr9	12396730	12396731	Hair color
chr9	12521825	12521826	Asthma (childhood onset)
chr9	12582564	12582565	Attention deficit hyperactivity disorder (time to onset)
chr9	12672096	12672097	Blue vs. green eyes
chr9	12672096	12672097	Eye color
chr9	12914395	12914396	Periodontitis (CDC/AAP)
chr9	13007128	13007129	AIDS
chr9	13557490	13557491	Corneal structure
chr9	14064740	14064741	Alzheimer's disease biomarkers
chr9	14441676	14441677	Alcohol consumption
chr9	14446000	14446001	AIDS
chr9	14470832	14470833	Hypothyroidism
chr9	14562313	14562314	Visceral adipose tissue adjusted for BMI
chr9	14898160	14898161	Height
chr9	15104560	15104561	Metabolite levels (Pyroglutamine)
chr9	15157976	15157977	Calcium levels
chr9	15283096	15283097	Bipolar disorder and schizophrenia
chr9	15289577	15289578	HDL cholesterol
chr9	15296033	15296034	HDL cholesterol
chr9	15305377	15305378	Cholesterol, total
chr9	15305377	15305378	HDL cholesterol
chr9	15309927	15309928	Bipolar disorder
chr9	15335913	15335914	Obesity-related traits
chr9	15335913	15335914	Obesity-related traits
chr9	15335913	15335914	Obesity-related traits
chr9	15986715	15986716	Body mass index
chr9	16000234	16000235	Metabolite levels (5-HIAA/ MHPG Ratio)
chr9	16034537	16034538	Bilirubin levels
chr9	16368731	16368732	Height
chr9	16385131	16385132	Metabolite levels (Dihydroxy docosatrienoic acid)
chr9	16512747	16512748	Metabolite levels (Pyroglutamine)
chr9	16864520	16864521	Freckling
chr9	16915020	16915021	Ovarian cancer
chr9	16915020	16915021	Ovarian cancer
chr9	16915020	16915021	Ovarian cancer
chr9	16915020	16915021	Ovarian cancer in BRCA1 mutation carriers
chr9	16970808	16970809	Corneal astigmatism
chr9	17458871	17458872	Response to amphetamines
chr9	17487944	17487945	Pulmonary function decline
chr9	17731920	17731921	Parkinson's disease
chr9	17895104	17895105	Cognitive performance
chr9	17899605	17899606	Cognitive performance
chr9	17938350	17938351	Multiple sclerosis
chr9	17979577	17979578	Obesity-related traits
chr9	18109234	18109235	Heart failure
chr9	18215279	18215280	Fat distribution (HIV)
chr9	18444137	18444138	Obesity-related traits
chr9	18458067	18458068	Obesity-related traits
chr9	18761098	18761099	QT interval (interaction)
chr9	18930221	18930222	Non-small cell lung cancer
chr9	19213633	19213634	Metabolite levels (HVA)
chr9	19579426	19579427	Body mass index (asthmatics)
chr9	19664080	19664081	Cognitive performance
chr9	20098710	20098711	Asthma (toluene diisocyanate-induced)
chr9	21035306	21035307	Axial length
chr9	21499623	21499624	Lipid traits
chr9	21747802	21747803	Cutaneous nevi
chr9	21816527	21816528	Melanoma
chr9	21816527	21816528	Melanoma
chr9	21984660	21984661	Acute lymphoblastic leukemia (B-cell precursor)
chr9	21986846	21986847	Platelet counts
chr9	22003366	22003367	Glaucoma (primary open-angle)
chr9	22003366	22003367	Vertical cup-disc ratio
chr9	22019128	22019129	Glaucoma
chr9	22026076	22026077	Migraine without aura
chr9	22029546	22029547	Type 2 diabetes
chr9	22031004	22031005	Coronary heart disease
chr9	22031004	22031005	Glaucoma (primary open-angle)
chr9	22033365	22033366	Glaucoma (primary open-angle)
chr9	22033365	22033366	Glaucoma (primary open-angle)
chr9	22033365	22033366	Glioma
chr9	22043925	22043926	Glioma (high-grade)
chr9	22043925	22043926	Nasopharyngeal carcinoma
chr9	22062133	22062134	Breast cancer
chr9	22062133	22062134	Breast cancer
chr9	22068651	22068652	Glaucoma
chr9	22068651	22068652	Glioma
chr9	22068651	22068652	Glioma
chr9	22072263	22072264	Ankle-brachial index
chr9	22081849	22081850	Intracranial aneurysm
chr9	22083403	22083404	Intracranial aneurysm
chr9	22083403	22083404	Intracranial aneurysm
chr9	22084309	22084310	Coronary artery calcification
chr9	22088259	22088260	Intracranial aneurysm
chr9	22096054	22096055	Coronary heart disease
chr9	22098573	22098574	Coronary heart disease
chr9	22098573	22098574	Coronary heart disease
chr9	22098573	22098574	Myocardial infarction (early onset)
chr9	22103812	22103813	Coronary heart disease
chr9	22115104	22115105	Endometriosis
chr9	22115285	22115286	Coronary heart disease
chr9	22115958	22115959	Abdominal aortic aneurysm
chr9	22124476	22124477	Myocardial infarction
chr9	22125502	22125503	Coronary artery calcification
chr9	22125502	22125503	Coronary heart disease
chr9	22125502	22125503	Coronary heart disease
chr9	22125502	22125503	Coronary heart disease
chr9	22129578	22129579	Type 2 diabetes
chr9	22132075	22132076	Type 2 diabetes
chr9	22132075	22132076	Type 2 diabetes
chr9	22132075	22132076	Type 2 diabetes
chr9	22133283	22133284	Type 2 diabetes
chr9	22134093	22134094	Fasting glucose-related traits (interaction with BMI)
chr9	22134093	22134094	Type 2 diabetes
chr9	22134093	22134094	Type 2 diabetes
chr9	22134093	22134094	Type 2 diabetes
chr9	22134093	22134094	Type 2 diabetes
chr9	22134093	22134094	Type 2 diabetes
chr9	22136488	22136489	Type 2 diabetes
chr9	22137684	22137685	Type 2 diabetes
chr9	22169699	22169700	Endometriosis
chr9	22206986	22206987	Chronic lymphocytic leukemia
chr9	22362103	22362104	Personality dimensions
chr9	22670714	22670715	Quantitative traits
chr9	22770885	22770886	Response to antipsychotic therapy (extrapyramidal side effects)
chr9	22819575	22819576	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr9	22842201	22842202	Response to amphetamines
chr9	23426270	23426271	Response to platinum-based chemotherapy in non-small-cell lung cancer
chr9	24092071	24092072	D-dimer levels
chr9	24111279	24111280	Quantitative traits
chr9	25414050	25414051	Metabolite levels (Dihydroxy docosatrienoic acid)
chr9	25449121	25449122	RR interval (heart rate)
chr9	25452811	25452812	RR interval (heart rate)
chr9	25501296	25501297	Sleep quality
chr9	25551356	25551357	Entorhinal cortical thickness
chr9	26208856	26208857	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr9	26614846	26614847	Drug-induced liver injury (flucloxacillin)
chr9	26694887	26694888	Gallbladder cancer
chr9	26789939	26789940	Smoking behavior
chr9	26935995	26935996	Schizophrenia
chr9	27075714	27075715	IgG glycosylation
chr9	27126414	27126415	IgG glycosylation
chr9	27309658	27309659	Obesity-related traits
chr9	27488091	27488092	Urinary symptoms in response to radiotherapy in prostate cancer
chr9	27490966	27490967	Response to TNF antagonist treatment
chr9	27533983	27533984	Heart failure
chr9	27536396	27536397	Amyotrophic lateral sclerosis
chr9	27543280	27543281	Amyotrophic lateral sclerosis
chr9	27543280	27543281	Amyotrophic lateral sclerosis
chr9	27543280	27543281	Amyotrophic lateral sclerosis
chr9	27561048	27561049	Amyotrophic lateral sclerosis
chr9	27610656	27610657	PCA3 expression level
chr9	27630561	27630562	Total ventricular volume
chr9	27882652	27882653	Immunoglobulin A
chr9	28181084	28181085	IgG glycosylation
chr9	28181084	28181085	IgG glycosylation
chr9	28359781	28359782	Obesity-related traits
chr9	28402042	28402043	Obesity-related traits
chr9	28414338	28414339	Body mass index
chr9	28414338	28414339	Obesity
chr9	28425514	28425515	Obesity
chr9	29545874	29545875	Obesity-related traits
chr9	29783988	29783989	Obesity-related traits
chr9	31546471	31546472	Alzheimer's disease
chr9	32422689	32422690	IgG glycosylation
chr9	32433525	32433526	Asthma
chr9	32556379	32556380	Immune response to smallpox vaccine (IL-6)
chr9	32755027	32755028	Immune response to anthrax vaccine
chr9	32870067	32870068	IgG glycosylation
chr9	32914588	32914589	Vitamin B12 levels
chr9	33122644	33122645	IgG glycosylation
chr9	33124871	33124872	IgG glycosylation
chr9	33124871	33124872	IgG glycosylation
chr9	33124871	33124872	IgG glycosylation
chr9	33124871	33124872	IgG glycosylation
chr9	33124871	33124872	IgG glycosylation
chr9	33124871	33124872	IgG glycosylation
chr9	33125803	33125804	IgG glycosylation
chr9	33128020	33128021	IgG glycosylation
chr9	33128020	33128021	IgG glycosylation
chr9	33128020	33128021	IgG glycosylation
chr9	33128020	33128021	IgG glycosylation
chr9	33128020	33128021	IgG glycosylation
chr9	33139452	33139453	IgG glycosylation
chr9	33139452	33139453	IgG glycosylation
chr9	33139452	33139453	IgG glycosylation
chr9	33153526	33153527	IgG glycosylation
chr9	33153526	33153527	IgG glycosylation
chr9	33153526	33153527	IgG glycosylation
chr9	33153526	33153527	IgG glycosylation
chr9	33180361	33180362	Urate levels
chr9	33217265	33217266	Bipolar disorder and schizophrenia
chr9	33283581	33283582	Erectile dysfunction and prostate cancer treatment
chr9	33799369	33799370	Bipolar disorder
chr9	34071540	34071541	Height
chr9	34710259	34710260	Rheumatoid arthritis
chr9	34743680	34743681	Rheumatoid arthritis
chr9	35141704	35141705	Weight
chr9	35269818	35269819	Parkinson's disease
chr9	35648949	35648950	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel)
chr9	35700836	35700837	IgE levels in asthmatics
chr9	36099398	36099399	IgG glycosylation
chr9	36099398	36099399	IgG glycosylation
chr9	36099398	36099399	IgG glycosylation
chr9	36099398	36099399	IgG glycosylation
chr9	36969204	36969205	Obesity and blood pressure
chr9	36969204	36969205	Obesity and blood pressure
chr9	37037975	37037976	Response to tocilizumab in rheumatoid arthritis
chr9	37916407	37916408	Metabolite levels (Dihydroxy docosatrienoic acid)
chr9	38041141	38041142	Brain structure
chr9	38456364	38456365	Hypertension
chr9	38675464	38675465	Obesity-related traits
chr9	38750578	38750579	Metabolite levels (HVA/MHPG ratio)
chr9	71229178	71229179	Body mass index (interaction)
chr9	71434706	71434707	Chronic kidney disease
chr9	71471911	71471912	Pit-and-Fissure caries
chr9	71766592	71766593	Refractive error
chr9	71865931	71865932	Renal sinus fat
chr9	71943001	71943002	Bipolar disorder
chr9	72998331	72998332	Body mass index
chr9	73094534	73094535	Migraine with aura
chr9	73157415	73157416	Pubertal anthropometrics
chr9	73784263	73784264	Longevity
chr9	74887702	74887703	Suicidal ideation
chr9	74887702	74887703	Suicidal ideation
chr9	75764564	75764565	Schizophrenia, bipolar disorder and depression (combined)
chr9	76157699	76157700	Obesity-related traits
chr9	77149836	77149837	Refractive error
chr9	77149836	77149837	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr9	77499795	77499796	Magnesium levels
chr9	78028345	78028346	Schizophrenia
chr9	78276674	78276675	Total ventricular volume
chr9	78425924	78425925	Non-alcoholic fatty liver disease histology (AST)
chr9	78542285	78542286	Height
chr9	78542285	78542286	Height
chr9	78665775	78665776	Amyotrophic lateral sclerosis (age of onset)
chr9	78665775	78665776	Metabolite levels (5-HIAA)
chr9	78841400	78841401	Response to fenofibrate (adiponectin levels)
chr9	78906149	78906150	Multiple sclerosis (age of onset)
chr9	79038169	79038170	Dialysis-related mortality
chr9	79408143	79408144	Hippocampal atrophy
chr9	79610627	79610628	Response to amphetamines
chr9	80320364	80320365	IgG glycosylation
chr9	80940575	80940576	Visceral fat
chr9	81083896	81083897	Obesity-related traits
chr9	81310679	81310680	vWF and FVIII levels
chr9	81889357	81889358	Inattentive symptoms
chr9	81952127	81952128	Type 2 diabetes
chr9	82039361	82039362	Asthma (childhood onset)
chr9	82310897	82310898	Bipolar disorder
chr9	82345880	82345881	Menopause (age at onset)
chr9	82807502	82807503	RR interval (heart rate)
chr9	84015036	84015037	Hippocampal atrophy
chr9	84213159	84213160	Visceral adipose tissue adjusted for BMI
chr9	84222617	84222618	Visceral fat
chr9	84372740	84372741	Hippocampal atrophy
chr9	84522748	84522749	IgG glycosylation
chr9	85135914	85135915	Insulin resistance/response
chr9	85311146	85311147	Ulcerative colitis
chr9	85414980	85414981	Select biomarker traits
chr9	85609780	85609781	Obesity-related traits
chr9	86552204	86552205	Height
chr9	86741460	86741461	Molar-incisor hypomineralization
chr9	86922035	86922036	Response to statin therapy
chr9	86944424	86944425	Obesity-related traits
chr9	87186404	87186405	Waist-to-hip circumference ratio (interaction)
chr9	87930044	87930045	Partial epilepsies
chr9	89116627	89116628	Height
chr9	89527457	89527458	Asthma (childhood onset)
chr9	89573082	89573083	Insulin resistance/response
chr9	90031668	90031669	Bipolar disorder and schizophrenia
chr9	90209136	90209137	Immune reponse to smallpox (secreted IFN-alpha)
chr9	90235793	90235794	Response to gemcitabine in pancreatic cancer
chr9	90811181	90811182	Height
chr9	90835725	90835726	Height
chr9	91260561	91260562	Obesity-related traits
chr9	91540058	91540059	Response to statin therapy (LDL-C)
chr9	92036426	92036427	Orofacial clefts
chr9	92249583	92249584	Alcoholism (heaviness of drinking)
chr9	92887230	92887231	Protein quantitative trait loci
chr9	93181530	93181531	Hepatitis C induced liver fibrosis
chr9	93409356	93409357	Cognitive test performance
chr9	93555738	93555739	Prostate cancer (gene x gene interaction)
chr9	93563535	93563536	Multiple sclerosis
chr9	93633239	93633240	Type 2 diabetes
chr9	93636663	93636664	Vascular dementia
chr9	93928415	93928416	Inflammatory bowel disease
chr9	93975470	93975471	Type 2 diabetes nephropathy
chr9	94822539	94822540	Bipolar disorder and schizophrenia
chr9	95429119	95429120	Height
chr9	95559504	95559505	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr9	95887319	95887320	Obesity (early onset extreme)
chr9	96562562	96562563	DNA methylation (variation)
chr9	96631133	96631134	Colorectal cancer
chr9	96893944	96893945	Height
chr9	97068925	97068926	Body mass index
chr9	97314740	97314741	Height
chr9	97444037	97444038	Obesity-related traits
chr9	97713458	97713459	Atrial fibrillation
chr9	97741273	97741274	Erectile dysfunction and prostate cancer treatment
chr9	97741335	97741336	Polycystic ovary syndrome
chr9	98231007	98231008	Pulmonary function
chr9	98231007	98231008	Pulmonary function (interaction)
chr9	98256234	98256235	Height
chr9	98259702	98259703	Height
chr9	98376698	98376699	Chemerin levels
chr9	98429265	98429266	Inattentive symptoms
chr9	98816483	98816484	IgG glycosylation
chr9	98816483	98816484	IgG glycosylation
chr9	99097526	99097527	Non-small cell lung cancer
chr9	99132043	99132044	Migraine with aura
chr9	99161511	99161512	Height
chr9	99539137	99539138	Height
chr9	100316229	100316230	Obesity-related traits
chr9	100546599	100546600	Hypothyroidism
chr9	100549012	100549013	Hypothyroidism
chr9	100550027	100550028	Obesity-related traits
chr9	100556108	100556109	Thyroid cancer
chr9	100556108	100556109	Thyroid cancer
chr9	100556108	100556109	Thyroid cancer (Papillary, radiation-related)
chr9	100591462	100591463	Thyroid hormone levels
chr9	100591462	100591463	Thyroid hormone levels
chr9	100591462	100591463	Thyroid hormone levels
chr9	100696202	100696203	Quantitative traits
chr9	100740123	100740124	Coronary heart disease
chr9	101123335	101123336	Folate pathway vitamin levels
chr9	101253225	101253226	Post-traumatic stress disorder (asjusted for relatedness)
chr9	101908364	101908365	Age-related macular degeneration
chr9	102037969	102037970	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)
chr9	102119089	102119090	Callous-unemotional behaviour
chr9	102234322	102234323	Dental caries
chr9	102234322	102234323	Smooth-surface caries
chr9	102723691	102723692	Alopecia areata
chr9	102808684	102808685	Preeclampsia
chr9	102976540	102976541	Preeclampsia
chr9	104223232	104223233	Liver enzyme levels (alkaline phosphatase)
chr9	104537609	104537610	Obesity-related traits
chr9	104537609	104537610	Obesity-related traits
chr9	104622867	104622868	Smoking behavior
chr9	104867837	104867838	Thiazide-induced adverse metabolic effects in hypertensive patients
chr9	104944754	104944755	Response to antipsychotic treatment
chr9	105442116	105442117	Obesity-related traits
chr9	105502497	105502498	Tourette syndrome
chr9	105735194	105735195	Response to antineoplastic agents
chr9	106024219	106024220	Alzheimer's disease
chr9	106369943	106369944	Metabolite levels (MHPG)
chr9	106793725	106793726	Orofacial clefts (interaction)
chr9	107324199	107324200	Gout
chr9	107531955	107531956	Obesity-related traits
chr9	107588776	107588777	Myopia (pathological)
chr9	107589133	107589134	Metabolite levels
chr9	107591271	107591272	Myopia (pathological)
chr9	107594363	107594364	Coronary heart disease
chr9	107620834	107620835	HDL cholesterol
chr9	107647219	107647220	HDL cholesterol
chr9	107647654	107647655	HDL cholesterol
chr9	107647654	107647655	HDL cholesterol
chr9	107653425	107653426	HDL cholesterol
chr9	107657069	107657070	HDL cholesterol
chr9	107657069	107657070	MRI atrophy measures
chr9	107664300	107664301	Cholesterol, total
chr9	107664300	107664301	HDL cholesterol
chr9	107664300	107664301	HDL cholesterol
chr9	107664300	107664301	Metabolic syndrome
chr9	107665738	107665739	Lipid metabolism phenotypes
chr9	107677288	107677289	Periodontitis (Mean PAL)
chr9	108427061	108427062	Cognitive performance
chr9	108440541	108440542	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr9	108631949	108631950	Alzheimer's disease (late onset)
chr9	108655095	108655096	Protein quantitative trait loci
chr9	108936673	108936674	Menarche and menopause (age at onset)
chr9	108967087	108967088	Menarche (age at onset)
chr9	108967087	108967088	Menarche (age at onset)
chr9	108967087	108967088	Pubertal anthropometrics
chr9	109599045	109599046	Height
chr9	109632352	109632353	Height
chr9	109676892	109676893	Adverse response to chemotherapy in breast cancer (alopecia) (anti-microtubule)
chr9	110125810	110125811	Body mass index
chr9	110156299	110156300	Prostate cancer
chr9	110306114	110306115	Breast cancer
chr9	110872306	110872307	Tonometry
chr9	110888477	110888478	Breast cancer
chr9	110888477	110888478	Breast cancer
chr9	111455574	111455575	Paclitaxel-induced neuropathy
chr9	111799562	111799563	Schizophrenia (negative symptoms)
chr9	111854245	111854246	Information processing speed
chr9	112526288	112526289	Type 2 diabetes
chr9	112596910	112596911	Obesity-related traits
chr9	112945404	112945405	Height
chr9	113131162	113131163	Longevity
chr9	113197262	113197263	Bipolar disorder
chr9	113300834	113300835	Pulmonary function decline
chr9	113419758	113419759	Type 2 diabetes (dietary heme iron intake interaction)
chr9	113662680	113662681	Corneal structure
chr9	113807081	113807082	Height
chr9	113915904	113915905	White blood cell count
chr9	114293633	114293634	Menarche (age at onset)
chr9	114293633	114293634	Pubertal anthropometrics
chr9	114293633	114293634	Pubertal anthropometrics
chr9	114301584	114301585	Menarche (age at onset)
chr9	114303678	114303679	Menarche (age at onset)
chr9	114348616	114348617	Monocyte count
chr9	114798036	114798037	Obesity-related traits
chr9	114823120	114823121	Venous thromboembolism
chr9	114850189	114850190	Amyotrophic lateral sclerosis
chr9	115687734	115687735	IgG glycosylation
chr9	115687734	115687735	IgG glycosylation
chr9	115687734	115687735	IgG glycosylation
chr9	115997248	115997249	Hematology traits
chr9	116991070	116991071	Tourette syndrome
chr9	117049890	117049891	Height
chr9	117088063	117088064	End-stage coagulation
chr9	117240905	117240906	Obesity-related traits
chr9	117260833	117260834	Bipolar disorder
chr9	117545665	117545666	Crohn's disease
chr9	117552884	117552885	Crohn's disease
chr9	117553248	117553249	Inflammatory bowel disease
chr9	117553248	117553249	Ulcerative colitis
chr9	117558702	117558703	Leprosy
chr9	117566439	117566440	Crohn's disease
chr9	117567012	117567013	Primary biliary cirrhosis
chr9	117568765	117568766	Inflammatory bowel disease
chr9	117592637	117592638	Inflammatory bowel disease
chr9	117592637	117592638	Inflammatory bowel disease
chr9	117605069	117605070	Ulcerative colitis
chr9	117830811	117830812	Prostate cancer (gene x gene interaction)
chr9	118050413	118050414	Pancreatic cancer
chr9	118202715	118202716	Visceral adipose tissue adjusted for BMI
chr9	118424986	118424987	Migraine
chr9	119122341	119122342	Height
chr9	119134795	119134796	Height
chr9	119181793	119181794	Migraine
chr9	119249338	119249339	Hippocampal volume
chr9	119252628	119252629	Migraine
chr9	119252628	119252629	Migraine - clinic-based
chr9	119252628	119252629	Migraine without aura
chr9	119314216	119314217	Pulmonary function (interaction)
chr9	119333682	119333683	Attention deficit hyperactivity disorder
chr9	119839327	119839328	Obesity-related traits
chr9	119925094	119925095	Immune response to anthrax vaccine
chr9	119926425	119926426	Response to antipsychotic treatment
chr9	120137757	120137758	Economic and political preferences (fairness)
chr9	120287707	120287708	Venous thromboembolism (gene x gene interaction)
chr9	120292333	120292334	Venous thromboembolism (gene x gene interaction)
chr9	120559010	120559011	IgG glycosylation
chr9	120795989	120795990	Obesity-related traits
chr9	121031028	121031029	Response to antipsychotic therapy (extrapyramidal side effects)
chr9	121346416	121346417	Schizophrenia
chr9	121359285	121359286	Bipolar disorder and schizophrenia
chr9	121984552	121984553	Multiple sclerosis
chr9	122059708	122059709	Parkinson's disease
chr9	122258576	122258577	Pulmonary function decline
chr9	122861296	122861297	Response to statin therapy
chr9	123056636	123056637	Response to antipsychotic therapy (extrapyramidal side effects)
chr9	123640499	123640500	Celiac disease and Rheumatoid arthritis
chr9	123652897	123652898	Rheumatoid arthritis
chr9	123690238	123690239	Rheumatoid arthritis
chr9	123690238	123690239	Rheumatoid arthritis
chr9	123914873	123914874	Immune reponse to smallpox (secreted IFN-alpha)
chr9	123951916	123951917	Immune reponse to smallpox (secreted IFN-alpha)
chr9	124098534	124098535	Bipolar disorder and schizophrenia
chr9	124422402	124422403	Abdominal aortic aneurysm
chr9	124476012	124476013	Heart rate
chr9	124521259	124521260	Adverse response to chemotherapy (neutropenia/leucopenia) (docetaxel)
chr9	124549641	124549642	Thiazide-induced adverse metabolic effects in hypertensive patients
chr9	124565819	124565820	Periodontal microbiota
chr9	124906722	124906723	Obesity-related traits
chr9	125573029	125573030	Obesity-related traits
chr9	126154353	126154354	Myopia (pathological)
chr9	126352217	126352218	Personality dimensions
chr9	126446777	126446778	Body mass index (non-asthmatics)
chr9	126446777	126446778	Polycystic ovary syndrome
chr9	126525211	126525212	Polycystic ovary syndrome
chr9	126525211	126525212	Polycystic ovary syndrome
chr9	126695769	126695770	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+doxorubicin+/-5FU)
chr9	126783846	126783847	Waist circumference
chr9	126926106	126926107	Cognitive performance
chr9	127327762	127327763	Follicule stimulating hormone
chr9	128831096	128831097	Economic and political preferences (immigration/crime)
chr9	128857850	128857851	Response to mTOR inhibitor (everolimus)
chr9	128929022	128929023	Response to antipsychotic treatment
chr9	129194772	129194773	Obesity-related traits
chr9	129465324	129465325	Body mass index
chr9	130107963	130107964	Bipolar disorder
chr9	130110410	130110411	Metabolite levels (HVA)
chr9	130504069	130504070	Eating disorders (purging via substances)
chr9	130619636	130619637	Metabolic syndrome
chr9	130976556	130976557	Attention deficit hyperactivity disorder
chr9	131084627	131084628	Obesity-related traits
chr9	131403220	131403221	Axial length
chr9	131475582	131475583	Obesity-related traits
chr9	131888115	131888116	Hypersomnia (HLA-DQB1*06:02 negative)
chr9	132339069	132339070	Metabolite levels (Pyroglutamine)
chr9	132349596	132349597	Metabolite levels (HVA/5-HIAA ratio)
chr9	132370359	132370360	Response to antidepressant treatment
chr9	132444098	132444099	Common traits (Other)
chr9	132939791	132939792	Alzheimer's disease (cognitive decline)
chr9	133464083	133464084	Height
chr9	133464083	133464084	Height
chr9	133464083	133464084	Height
chr9	133478826	133478827	Bone mineral density
chr9	133748082	133748083	Response to amphetamines
chr9	133765655	133765656	Bilirubin levels
chr9	134450072	134450073	Response to amphetamines
chr9	135096766	135096767	Systemic lupus erythematosus
chr9	135344406	135344407	Obesity-related traits
chr9	135618282	135618283	Attention deficit hyperactivity disorder
chr9	135632492	135632493	Major depressive disorder
chr9	135647020	135647021	Obesity-related traits
chr9	135776033	135776034	Psoriasis
chr9	135845034	135845035	Bipolar disorder
chr9	136131187	136131188	Tumor biomarkers
chr9	136131321	136131322	mean corpuscular hemoglobin concentration
chr9	136131414	136131415	End-stage coagulation
chr9	136132753	136132754	Malaria
chr9	136132907	136132908	Malaria
chr9	136132907	136132908	Venous thromboembolism
chr9	136135551	136135552	Coagulation factor levels
chr9	136137064	136137065	Activated partial thromboplastin time
chr9	136137064	136137065	D-dimer levels
chr9	136137064	136137065	Venous thromboembolism
chr9	136137105	136137106	Coagulation factor levels
chr9	136139264	136139265	Liver enzyme levels
chr9	136139264	136139265	Obesity-related traits
chr9	136139264	136139265	Phytosterol levels
chr9	136139264	136139265	Thyroid hormone levels
chr9	136139264	136139265	Thyroid hormone levels
chr9	136141869	136141870	Venous thromboembolism
chr9	136142202	136142203	Coronary heart disease
chr9	136142216	136142217	Protein biomarker
chr9	136142354	136142355	End-stage coagulation
chr9	136142354	136142355	Inflammatory biomarkers
chr9	136143441	136143442	Metabolic traits
chr9	136149228	136149229	Duodenal ulcer
chr9	136149228	136149229	End-stage coagulation
chr9	136149228	136149229	Graves' disease
chr9	136149228	136149229	Graves' disease
chr9	136149228	136149229	Pancreatic cancer
chr9	136149228	136149229	Protein quantitative trait loci
chr9	136149228	136149229	Venous thromboembolism
chr9	136149228	136149229	Venous thromboembolism
chr9	136153874	136153875	E-selectin levels
chr9	136153874	136153875	End-stage coagulation
chr9	136153874	136153875	Metabolite levels
chr9	136154167	136154168	Coronary heart disease
chr9	136154167	136154168	Liver enzyme levels (alkaline phosphatase)
chr9	136154167	136154168	Red blood cell traits
chr9	136154167	136154168	Soluble E-selectin levels
chr9	136154167	136154168	Soluble levels of adhesion molecules
chr9	136154303	136154304	Soluble levels of adhesion molecules
chr9	136154866	136154867	Angiotensin-converting enzyme activity
chr9	136154866	136154867	Hematological and biochemical traits
chr9	136154866	136154867	Hematological and biochemical traits
chr9	136154866	136154867	Hematological and biochemical traits
chr9	136154866	136154867	Red blood cell count
chr9	136154866	136154867	Venous thromboembolism
chr9	136154999	136155000	Cholesterol, total
chr9	136154999	136155000	LDL cholesterol
chr9	136187162	136187163	Venous thromboembolism (gene x gene interaction)
chr9	136323753	136323754	Liver enzyme levels
chr9	136478354	136478355	Smoking behavior
chr9	136676013	136676014	IgG glycosylation
chr9	136679079	136679080	IgG glycosylation
chr9	136723519	136723520	vWF and FVIII levels
chr9	136835342	136835343	Multiple sclerosis
chr9	136925662	136925663	Platelet counts
chr9	137125500	137125501	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel + carboplatin)
chr9	137436313	137436314	Central corneal thickness
chr9	137440211	137440212	Central corneal thickness
chr9	137440527	137440528	Central corneal thickness
chr9	137440527	137440528	Corneal structure
chr9	137506577	137506578	Crohn's disease (need for surgery)
chr9	137568050	137568051	Central corneal thickness
chr9	137568050	137568051	Corneal structure
chr9	137704781	137704782	Longevity
chr9	137816458	137816459	IgG glycosylation
chr9	138028676	138028677	Obesity-related traits
chr9	138029700	138029701	Response to hepatitis C treatment
chr9	138275775	138275776	Attention deficit hyperactivity disorder
chr9	138529721	138529722	Periodontitis
chr9	139089678	139089679	Thyroid hormone levels
chr9	139089678	139089679	Thyroid hormone levels
chr9	139089678	139089679	Thyroid hormone levels
chr9	139111869	139111870	Height
chr9	139121739	139121740	Height
chr9	139252147	139252148	Type 2 diabetes
chr9	139265595	139265596	Obesity-related traits
chr9	139266404	139266405	Inflammatory bowel disease
chr9	139266404	139266405	Ulcerative colitis
chr9	139266495	139266496	Crohn's disease
chr9	139266495	139266496	Crohn's disease
chr9	139266495	139266496	Ulcerative colitis
chr9	139269337	139269338	Ankylosing spondylitis
chr9	139269337	139269338	Ulcerative colitis
chr9	139860263	139860264	Corneal structure
chr9	139862632	139862633	Beta-trace protein levels
chr9	140088629	140088630	Obesity-related traits
chr10	566378	566379	Alzheimer's disease
chr10	618684	618685	Immune reponse to smallpox (secreted IFN-alpha)
chr10	759267	759268	Migraine
chr10	771531	771532	Uric acid levels
chr10	1078781	1078782	Response to angiotensin II receptor blocker therapy
chr10	1156164	1156165	Chronic kidney disease
chr10	1246882	1246883	Migraine
chr10	1343016	1343017	Thiazide-induced adverse metabolic effects in hypertensive patients
chr10	1406363	1406364	Radiation response
chr10	1471764	1471765	Migraine with aura
chr10	1630820	1630821	Emphysema-related traits
chr10	1676530	1676531	Quantitative traits
chr10	1676530	1676531	Quantitative traits
chr10	1897977	1897978	Metabolite levels (Dihydroxy docosatrienoic acid)
chr10	2424555	2424556	Obesity-related traits
chr10	2532018	2532019	Response to statin therapy
chr10	3155172	3155173	Disc degeneration (lumbar)
chr10	3284006	3284007	Attention deficit hyperactivity disorder and conduct disorder
chr10	3408946	3408947	Reading and spelling
chr10	3418123	3418124	Economic and political preferences (environmentalism)
chr10	3516104	3516105	Bone mineral density
chr10	3538793	3538794	Coronary artery calcification
chr10	3658918	3658919	Capecitabine sensitivity
chr10	3667725	3667726	Capecitabine sensitivity
chr10	3862541	3862542	Crohn's disease
chr10	4001896	4001897	Word reading
chr10	4050002	4050003	Longevity
chr10	4151120	4151121	Sex hormone-binding globulin levels
chr10	4240869	4240870	Asthma (bronchodilator response)
chr10	4655564	4655565	Body mass index
chr10	4676195	4676196	Multiple myeloma (IgH translocation)
chr10	4716541	4716542	Obesity-related traits
chr10	4719795	4719796	Neonatal lupus
chr10	5009758	5009759	Economic and political preferences (immigration/crime)
chr10	5138035	5138036	Metabolic traits
chr10	5804530	5804531	Osteosarcoma
chr10	5886733	5886734	Breast cancer
chr10	5918431	5918432	Obesity-related traits
chr10	6037725	6037726	Inflammatory biomarkers
chr10	6053162	6053163	Inflammatory biomarkers
chr10	6067687	6067688	Self-reported allergy
chr10	6081229	6081230	Inflammatory bowel disease
chr10	6094696	6094697	Type 1 diabetes
chr10	6097282	6097283	Type 1 diabetes autoantibodies
chr10	6098823	6098824	Vitiligo
chr10	6098948	6098949	Rheumatoid arthritis
chr10	6099044	6099045	Multiple sclerosis
chr10	6099044	6099045	Multiple sclerosis
chr10	6099044	6099045	Rheumatoid arthritis
chr10	6101712	6101713	Alopecia areata
chr10	6101712	6101713	Multiple sclerosis
chr10	6102011	6102012	Crohn's disease
chr10	6102011	6102012	Multiple sclerosis
chr10	6102011	6102012	Multiple sclerosis
chr10	6110828	6110829	Multiple sclerosis
chr10	6123494	6123495	Type 1 diabetes
chr10	6123494	6123495	Type 1 diabetes
chr10	6315793	6315794	Myopia (pathological)
chr10	6390449	6390450	Type 1 diabetes
chr10	6393259	6393260	Rheumatoid arthritis
chr10	6393259	6393260	Rheumatoid arthritis
chr10	6407736	6407737	Bipolar disorder and schizophrenia
chr10	6472890	6472891	Type 1 diabetes
chr10	6572224	6572225	Body mass index (asthmatics)
chr10	6606540	6606541	Immune response to smallpox vaccine (IL-6)
chr10	6789462	6789463	Response to anti-TNF treatment in rheumatoid arthritis
chr10	6924443	6924444	Migraine
chr10	6946262	6946263	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr10	6946751	6946752	Fasting insulin-related traits (interaction with BMI)
chr10	7089015	7089016	Orofacial clefts
chr10	7736903	7736904	Ovarian reserve
chr10	7887620	7887621	IgG glycosylation
chr10	8093033	8093034	Hodgkin's lymphoma
chr10	8104207	8104208	Acute lymphoblastic leukemia (B-cell precursor)
chr10	8150712	8150713	Response to treatment for acute lymphoblastic leukemia
chr10	8324888	8324889	Adverse response to chemotherapy in breast cancer (alopecia) (anti-microtubule)
chr10	8633860	8633861	Obesity-related traits
chr10	8701218	8701219	Colorectal cancer
chr10	8719268	8719269	Migraine
chr10	8954223	8954224	Tetralogy of Fallot
chr10	8972017	8972018	Asthma
chr10	9053131	9053132	Self-reported allergy
chr10	9328650	9328651	Calcium levels
chr10	9568909	9568910	IgG glycosylation
chr10	9996989	9996990	Obesity-related traits
chr10	10073543	10073544	Dental caries
chr10	10084565	10084566	Obesity-related traits
chr10	10296118	10296119	Obesity-related traits
chr10	10388194	10388195	Corneal astigmatism
chr10	10601859	10601860	Dental caries
chr10	10974255	10974256	Obesity-related traits
chr10	11000338	11000339	Alzheimer's disease (late onset)
chr10	11224664	11224665	Liver enzyme levels (alanine transaminase)
chr10	11224664	11224665	Liver enzyme levels (aspartate transaminase)
chr10	11719009	11719010	Obesity-related traits
chr10	12051815	12051816	Prostate cancer (gene x gene interaction)
chr10	12277991	12277992	Pulmonary function
chr10	12277991	12277992	Pulmonary function
chr10	12277991	12277992	Pulmonary function (interaction)
chr10	12307893	12307894	Type 2 diabetes
chr10	12314996	12314997	Type 2 diabetes
chr10	12328009	12328010	Type 2 diabetes
chr10	12435378	12435379	Obesity-related traits
chr10	12438782	12438783	Obesity-related traits
chr10	12438782	12438783	Obesity-related traits
chr10	12438782	12438783	Obesity-related traits
chr10	12675060	12675061	QT interval (interaction)
chr10	12702568	12702569	Anorexia nervosa
chr10	12875207	12875208	Eating disorders
chr10	12918763	12918764	Height
chr10	13103284	13103285	Platelet aggregation
chr10	13155725	13155726	Paget's disease
chr10	13155725	13155726	Paget's disease
chr10	13310070	13310071	Self-reported allergy
chr10	13355130	13355131	IgG glycosylation
chr10	13361975	13361976	IgG glycosylation
chr10	13361975	13361976	IgG glycosylation
chr10	13361975	13361976	IgG glycosylation
chr10	13361975	13361976	IgG glycosylation
chr10	13361975	13361976	IgG glycosylation
chr10	13361975	13361976	IgG glycosylation
chr10	13363045	13363046	IgG glycosylation
chr10	13530216	13530217	IgG glycosylation
chr10	13667730	13667731	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+epirubicin+/-5FU)
chr10	13755543	13755544	RR interval (heart rate)
chr10	13790264	13790265	Migraine
chr10	14945405	14945406	Migraine
chr10	15129401	15129402	Obesity-related traits
chr10	15561542	15561543	Parkinson's disease
chr10	15600670	15600671	Periodontitis (CDC/AAP)
chr10	15719620	15719621	Quantitative traits
chr10	16299950	16299951	Obesity
chr10	16634298	16634299	Migraine
chr10	16744522	16744523	Obesity-related traits
chr10	16744522	16744523	Obesity-related traits
chr10	16748609	16748610	Obesity-related traits
chr10	16748609	16748610	Obesity-related traits
chr10	16748609	16748610	Obesity-related traits
chr10	16919051	16919052	Urinary albumin excretion
chr10	16997890	16997891	Quantitative traits
chr10	17130692	17130693	Folate pathway vitamin levels
chr10	17142525	17142526	MRI atrophy measures
chr10	17156150	17156151	Folate pathway vitamin levels
chr10	17156150	17156151	Homocysteine levels
chr10	17223243	17223244	Homocysteine levels
chr10	17388142	17388143	Response to treatment for acute lymphoblastic leukemia
chr10	18388433	18388434	Bipolar disorder and schizophrenia
chr10	18397246	18397247	Response to antipsychotic treatment
chr10	18419971	18419972	Diastolic blood pressure
chr10	18419971	18419972	Hypertension
chr10	18419971	18419972	Systolic blood pressure
chr10	18442481	18442482	Primary tooth development (number of teeth)
chr10	18442481	18442482	Primary tooth development (time to first tooth eruption)
chr10	18525169	18525170	Metabolite levels (HVA/MHPG ratio)
chr10	18601927	18601928	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr10	18708797	18708798	Diastolic blood pressure
chr10	18708797	18708798	Hypertension
chr10	18708797	18708798	Systolic blood pressure
chr10	18727958	18727959	Blood pressure
chr10	18730367	18730368	Quantitative traits
chr10	18734527	18734528	Schizophrenia
chr10	18759628	18759629	Protein quantitative trait loci
chr10	18782879	18782880	Obesity-related traits
chr10	18950554	18950555	Sudden cardiac arrest
chr10	19160028	19160029	Brain structure (hippocampal volume)
chr10	19405530	19405531	Obesity-related traits
chr10	19929512	19929513	Ankylosing spondylitis
chr10	20434779	20434780	Bronchopulmonary dysplasia
chr10	20542633	20542634	Diabetic retinopathy
chr10	20593086	20593087	Diabetic retinopathy
chr10	20674652	20674653	Neutrophil count
chr10	20792333	20792334	Bipolar disorder
chr10	20810524	20810525	Response to antidepressants
chr10	20899607	20899608	Peripheral artery disease
chr10	21567564	21567565	Schizophrenia
chr10	21830103	21830104	Meningioma
chr10	21915618	21915619	Ovarian cancer
chr10	21915618	21915619	Ovarian cancer
chr10	22032941	22032942	Breast cancer
chr10	22315842	22315843	Breast cancer
chr10	22839627	22839628	Acute lymphoblastic leukemia (B-cell precursor)
chr10	22847438	22847439	Obesity-related traits
chr10	23303252	23303253	IgG glycosylation
chr10	23303252	23303253	IgG glycosylation
chr10	23303252	23303253	IgG glycosylation
chr10	23303252	23303253	IgG glycosylation
chr10	23369420	23369421	Sleep time
chr10	23434743	23434744	Obesity-related traits
chr10	23665437	23665438	Crohn's disease and sarcoidosis (combined)
chr10	23858210	23858211	Obesity (early onset extreme)
chr10	24495585	24495586	Common traits (Other)
chr10	24634955	24634956	Cognitive performance
chr10	25111909	25111910	Obesity-related traits
chr10	25224461	25224462	Metabolite levels (Pyroglutamine)
chr10	25880458	25880459	IgG glycosylation
chr10	25918878	25918879	Immune response to smallpox vaccine (IL-6)
chr10	26002247	26002248	IgG glycosylation
chr10	26162765	26162766	Obesity-related traits
chr10	26294827	26294828	PR interval
chr10	26433365	26433366	Obesity-related traits
chr10	26484153	26484154	Obesity-related traits
chr10	26734586	26734587	Response to angiotensin II receptor blocker therapy
chr10	26774693	26774694	Inflammatory biomarkers
chr10	27693304	27693305	Fasting insulin-related traits (interaction with BMI)
chr10	28025770	28025771	Immune response to smallpox vaccine (IL-6)
chr10	28150934	28150935	Obesity-related traits
chr10	28382932	28382933	MRI atrophy measures
chr10	28388149	28388150	Obesity-related traits
chr10	28479941	28479942	Bone mineral density
chr10	28504943	28504944	Alzheimer's disease
chr10	28617634	28617635	Pulmonary function decline
chr10	28752105	28752106	Obesity-related traits
chr10	29027222	29027223	Preeclampsia
chr10	29289030	29289031	Cannabis dependence
chr10	29291897	29291898	Major depressive disorder (broad)
chr10	29336848	29336849	Palmitoleic acid (16:1n-7) plasma levels
chr10	29364696	29364697	Migraine with aura
chr10	29487364	29487365	Methotrexate phramacokinetics (acute lymphoblastic leukemia)
chr10	30008662	30008663	Normalized brain volume
chr10	30087358	30087359	Migraine with aura
chr10	30096627	30096628	Non-alcoholic fatty liver disease histology (lobular)
chr10	30177887	30177888	Orofacial clefts
chr10	30316071	30316072	Coronary heart disease
chr10	30335121	30335122	Coronary heart disease
chr10	30490703	30490704	Suicide risk
chr10	30519831	30519832	Pancreatitis
chr10	30728100	30728101	Inflammatory bowel disease
chr10	30834631	30834632	QT interval
chr10	30912029	30912030	Dental caries
chr10	31366270	31366271	Response to antipsychotic treatment
chr10	31415105	31415106	Multiple sclerosis
chr10	31495973	31495974	Disc degeneration (lumbar)
chr10	31512097	31512098	Disc degeneration (lumbar)
chr10	31515131	31515132	Disc degeneration (lumbar)
chr10	31990622	31990623	Waist-hip ratio
chr10	32309004	32309005	Bipolar disorder (mood-incongruent)
chr10	32634971	32634972	Sexual dysfunction (female)
chr10	33294774	33294775	Depression (quantitative trait)
chr10	33405086	33405087	IgG glycosylation
chr10	33475281	33475282	Tetralogy of Fallot
chr10	33503178	33503179	Migraine
chr10	34088052	34088053	Schizophrenia
chr10	34231274	34231275	Emphysema-related traits
chr10	34257611	34257612	Major depressive disorder
chr10	34817987	34817988	Acute lymphoblastic leukemia (childhood)
chr10	35287649	35287650	Crohn's disease
chr10	35295430	35295431	Inflammatory bowel disease
chr10	35535694	35535695	Crohn's disease
chr10	35554053	35554054	Ulcerative colitis
chr10	36060308	36060309	Antineutrophil cytoplasmic antibody-associated vasculitis
chr10	36648039	36648040	Protein quantitative trait loci
chr10	36885920	36885921	Periodontal microbiota
chr10	37508449	37508450	Metabolite levels
chr10	37559579	37559580	Hemostatic factors and hematological phenotypes
chr10	37982096	37982097	Obesity (extreme)
chr10	43341104	43341105	Progressive supranuclear palsy
chr10	43612608	43612609	Hirschsprung's disease
chr10	43755753	43755754	Obesity-related traits
chr10	43755753	43755754	Obesity-related traits
chr10	43814048	43814049	Multiple sclerosis
chr10	44458713	44458714	Obesity-related traits
chr10	44524674	44524675	HIV-associated dementia
chr10	44541564	44541565	Endometriosis
chr10	44753866	44753867	Coronary heart disease
chr10	44775823	44775824	Coronary heart disease
chr10	44775823	44775824	Myocardial infarction (early onset)
chr10	44827196	44827197	Schizophrenia
chr10	45034671	45034672	Estradiol plasma levels (breast cancer)
chr10	45123378	45123379	Bipolar disorder and schizophrenia
chr10	45161108	45161109	Parkinson's disease
chr10	45319653	45319654	Emphysema-related traits
chr10	45553728	45553729	Lung function (forced expiratory volume in 1 second to forced vital capacity ratio)
chr10	45955063	45955064	Mean corpuscular hemoglobin
chr10	45955063	45955064	Mean corpuscular volume
chr10	45966421	45966422	Red blood cell traits
chr10	46024728	46024729	Mean corpuscular volume
chr10	49699956	49699957	Diabetic retinopathy
chr10	49735562	49735563	Conduct disorder (case status)
chr10	49763165	49763166	Self-employment
chr10	49936335	49936336	Systemic lupus erythematosus
chr10	49985109	49985110	Response to antidepressant treatment
chr10	50025395	50025396	Systemic lupus erythematosus
chr10	50042950	50042951	Systemic lupus erythematosus
chr10	50109222	50109223	Subclinical atherosclerosis traits (other)
chr10	50119053	50119054	Systemic lupus erythematosus
chr10	50224765	50224766	Uric acid levels
chr10	50229637	50229638	Migraine with aura
chr10	50500458	50500459	Oleic acid (18:1n-9) plasma levels
chr10	50576632	50576633	Inflammatory biomarkers
chr10	51524970	51524971	Prostate cancer
chr10	51549495	51549496	PCA3 expression level
chr10	51549495	51549496	Prostate cancer
chr10	51549495	51549496	Prostate cancer
chr10	51549495	51549496	Prostate cancer
chr10	51549495	51549496	Prostate cancer
chr10	51549495	51549496	Prostate-specific antigen levels
chr10	51549495	51549496	Prostate-specific antigen levels
chr10	51593353	51593354	Mean corpuscular hemoglobin
chr10	51593353	51593354	Mean corpuscular volume
chr10	52010707	52010708	Thiazide-induced adverse metabolic effects in hypertensive patients
chr10	52119296	52119297	Response to amphetamines
chr10	52646092	52646093	Urate levels
chr10	52789354	52789355	Migraine
chr10	53242702	53242703	Obesity-related traits
chr10	53262632	53262633	IgG glycosylation
chr10	53493472	53493473	Asthma
chr10	53681793	53681794	Migraine
chr10	54130752	54130753	Periodontitis (Mean PAL)
chr10	54223976	54223977	Electrocardiographic traits
chr10	54223976	54223977	Ventricular conduction
chr10	54427824	54427825	Bone mineral density
chr10	54574995	54574996	Age-related macular degeneration
chr10	54574995	54574996	Age-related macular degeneration
chr10	55294873	55294874	Select biomarker traits
chr10	55384742	55384743	Immune response to smallpox vaccine (IL-6)
chr10	55407090	55407091	Thiazide-induced adverse metabolic effects in hypertensive patients
chr10	56204290	56204291	Adverse response to chemotherapy in breast cancer (alopecia)
chr10	56391302	56391303	Pulmonary function decline
chr10	56790968	56790969	Weight
chr10	56848984	56848985	Response to tocilizumab in rheumatoid arthritis
chr10	57416960	57416961	Cardiac hypertrophy
chr10	57549295	57549296	Post-traumatic stress disorder (asjusted for relatedness)
chr10	58339240	58339241	Nicotine use
chr10	59189177	59189178	Diabetic retinopathy
chr10	59724387	59724388	Coronary artery calcification
chr10	59724402	59724403	Blood pressure
chr10	59913150	59913151	Crohn's disease
chr10	59985670	59985671	Obesity-related traits
chr10	59997925	59997926	Inflammatory bowel disease
chr10	60204601	60204602	Migraine without aura
chr10	60210789	60210790	Height
chr10	60265403	60265404	Refractive error
chr10	60318896	60318897	Corneal astigmatism
chr10	60555577	60555578	Obesity-related traits
chr10	61146581	61146582	Oleic acid (18:1n-9) plasma levels
chr10	61413352	61413353	Uric acid levels
chr10	61449563	61449564	Metabolic traits
chr10	61469537	61469538	Urate levels
chr10	62085336	62085337	Schizophrenia
chr10	62179811	62179812	Bipolar disorder
chr10	62181127	62181128	Bipolar disorder and major depressive disorder (combined)
chr10	62185493	62185494	Bipolar disorder
chr10	62222106	62222107	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr10	62279123	62279124	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr10	62279123	62279124	Bipolar disorder
chr10	62346637	62346638	Schizophrenia
chr10	62346637	62346638	Schizophrenia
chr10	62548389	62548390	Reading and spelling
chr10	62551889	62551890	Cocaine dependence
chr10	62551889	62551890	Cocaine dependence
chr10	63307474	63307475	Response to taxane treatment (placlitaxel)
chr10	63348766	63348767	Response to taxane treatment (placlitaxel)
chr10	63361986	63361987	Obesity-related traits
chr10	63467552	63467553	Blood pressure
chr10	63524590	63524591	Diastolic blood pressure
chr10	63636530	63636531	Serum total protein level
chr10	63695047	63695048	IgG glycosylation
chr10	63695047	63695048	IgG glycosylation
chr10	63721175	63721176	Acute lymphoblastic leukemia (B-cell precursor)
chr10	63723576	63723577	Acute lymphoblastic leukemia (childhood)
chr10	63723576	63723577	Acute lymphoblastic leukemia (childhood)
chr10	63752158	63752159	Acute lymphoblastic leukemia (childhood)
chr10	63785088	63785089	Rheumatoid arthritis
chr10	63805616	63805617	Systemic lupus erythematosus
chr10	63830285	63830286	Corneal structure
chr10	63958111	63958112	Rheumatoid arthritis
chr10	64187563	64187564	Breast size
chr10	64223382	64223383	Intelligence
chr10	64251976	64251977	Breast cancer
chr10	64278681	64278682	Breast cancer
chr10	64278681	64278682	Breast cancer
chr10	64278681	64278682	Breast cancer
chr10	64278681	64278682	Mammographic density
chr10	64398465	64398466	Atopic dermatitis
chr10	64415183	64415184	Crohn's disease
chr10	64438485	64438486	Crohn's disease
chr10	64445563	64445564	Crohn's disease
chr10	64445563	64445564	Crohn's disease
chr10	64445563	64445564	Crohn's disease
chr10	64445563	64445564	Inflammatory bowel disease
chr10	64470674	64470675	Crohn's disease
chr10	64560469	64560470	Atopic dermatitis
chr10	64580574	64580575	Ewing sarcoma
chr10	64655912	64655913	Temperament
chr10	64866911	64866912	IgG glycosylation
chr10	64866911	64866912	IgG glycosylation
chr10	64872410	64872411	IgG glycosylation
chr10	64872410	64872411	IgG glycosylation
chr10	64963448	64963449	Platelet counts
chr10	65006455	65006456	Arthritis (juvenile idiopathic)
chr10	65026857	65026858	Response to fenofibrate
chr10	65027609	65027610	Platelet counts
chr10	65027609	65027610	Platelet counts
chr10	65027609	65027610	Triglycerides
chr10	65050658	65050659	Mean platelet volume
chr10	65050658	65050659	Mean platelet volume
chr10	65104499	65104500	Mean platelet volume
chr10	65121564	65121565	Liver enzyme levels
chr10	65133155	65133156	Mean platelet volume
chr10	65133821	65133822	Liver enzyme levels (alkaline phosphatase)
chr10	65138909	65138910	Sex hormone-binding globulin levels
chr10	65138909	65138910	Sex hormone-binding globulin levels
chr10	65138909	65138910	Sex hormone-binding globulin levels
chr10	65162152	65162153	Fibrinogen
chr10	65261183	65261184	Platelet aggregation
chr10	65274926	65274927	Liver enzyme levels
chr10	65315396	65315397	Arthritis (juvenile idiopathic)
chr10	65337152	65337153	Androgen levels
chr10	66448471	66448472	Response to statin therapy
chr10	67743653	67743654	Bronchopulmonary dysplasia
chr10	67964372	67964373	Lung function (forced vital capacity)
chr10	67966573	67966574	Metabolite levels (Pyroglutamine)
chr10	68088507	68088508	Asthma (toluene diisocyanate-induced)
chr10	68165266	68165267	Dental caries
chr10	68224885	68224886	Interstitial lung disease
chr10	68374083	68374084	Obesity-related traits
chr10	68598291	68598292	Schizophrenia (cytomegalovirus infection interaction)
chr10	68640950	68640951	Nicotine dependence
chr10	68879802	68879803	Migraine without aura
chr10	69967446	69967447	Optic disc size (disc)
chr10	69991852	69991853	Optic disc parameters
chr10	70000880	70000881	Optic disc parameters
chr10	70000880	70000881	Vertical cup-disc ratio
chr10	70011837	70011838	Optic disc size (cup)
chr10	70011837	70011838	Optic disc size (disc)
chr10	70014229	70014230	Eating disorders (purging via substances)
chr10	70019370	70019371	Optic disc size (disc)
chr10	70626428	70626429	Disc degeneration (lumbar)
chr10	70712061	70712062	Depression (quantitative trait)
chr10	70931473	70931474	Type 2 diabetes
chr10	70982940	70982941	Glycemic traits (pregnancy)
chr10	71093391	71093392	Glycated hemoglobin levels
chr10	71093391	71093392	Hematocrit
chr10	71093391	71093392	Hemoglobin
chr10	71099887	71099888	Red blood cell traits
chr10	71099912	71099913	Glycated hemoglobin levels
chr10	71263263	71263264	Response to taxane treatment (placlitaxel)
chr10	71538291	71538292	Alzheimer's disease
chr10	71580119	71580120	Parkinson's disease
chr10	71583197	71583198	Non-alcoholic fatty liver disease histology (lobular)
chr10	71588503	71588504	Non-alcoholic fatty liver disease histology (lobular)
chr10	72040804	72040805	Acute lymphoblastic leukemia (childhood)
chr10	72114377	72114378	Brain connectivity
chr10	72332439	72332440	Obesity (extreme)
chr10	72462993	72462994	Bipolar disorder
chr10	72483009	72483010	Weight
chr10	72500762	72500763	Sleep duration
chr10	72527516	72527517	Prion diseases
chr10	72688370	72688371	Obesity-related traits
chr10	72767408	72767409	Multiple myeloma (IgH translocation)
chr10	72795876	72795877	Obesity-related traits
chr10	72982984	72982985	Attention deficit hyperactivity disorder
chr10	73115941	73115942	Systemic lupus erythematosus
chr10	73121944	73121945	Obesity-related traits
chr10	73121944	73121945	Obesity-related traits
chr10	73135918	73135919	Vitiligo
chr10	73527046	73527047	Pulmonary function decline
chr10	73591529	73591530	Asthma (childhood onset)
chr10	73806287	73806288	Smoking behavior
chr10	73849638	73849639	Insulin-like growth factors
chr10	75421207	75421208	Atrial fibrillation
chr10	75673100	75673101	Inflammatory bowel disease
chr10	76295788	76295789	Permanent tooth development
chr10	76295788	76295789	Primary tooth development (number of teeth)
chr10	76295788	76295789	Primary tooth development (time to first tooth eruption)
chr10	76703005	76703006	Breast size
chr10	76808759	76808760	Weight
chr10	77298608	77298609	Anorexia nervosa
chr10	77911031	77911032	Methotrexate phramacokinetics (acute lymphoblastic leukemia)
chr10	78157571	78157572	Response to tamoxifen in breast cancer
chr10	78315223	78315224	Pulmonary function
chr10	78315223	78315224	Pulmonary function (interaction)
chr10	78331317	78331318	Pulmonary function
chr10	78646535	78646536	Obesity
chr10	79401315	79401316	Bone mineral density
chr10	79444752	79444753	Mortality among heart failure patients
chr10	79540834	79540835	Obesity-related traits
chr10	79680433	79680434	Liver enzyme levels (gamma-glutamyl transferase)
chr10	80100860	80100861	Conduct disorder (interaction)
chr10	80515080	80515081	Migraine
chr10	80841147	80841148	Breast cancer
chr10	80841147	80841148	Breast cancer
chr10	80925576	80925577	Height
chr10	80931480	80931481	Height
chr10	80953135	80953136	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr10	80955066	80955067	Bipolar disorder
chr10	81015895	81015896	Vitiligo
chr10	81032531	81032532	Inflammatory bowel disease
chr10	81032884	81032885	Crohn's disease and psoriasis
chr10	81034669	81034670	Multiple sclerosis
chr10	81036006	81036007	Multiple sclerosis
chr10	81055625	81055626	Breast cancer
chr10	81058026	81058027	Celiac disease
chr10	81060316	81060317	Crohn's disease
chr10	81060316	81060317	Inflammatory bowel disease (early onset)
chr10	81060316	81060317	Multiple sclerosis
chr10	81121695	81121696	Height
chr10	81139461	81139462	Height
chr10	81694949	81694950	Chronic obstructive pulmonary disease-related biomarkers
chr10	81705432	81705433	Chronic obstructive pulmonary disease-related biomarkers
chr10	81735980	81735981	Chronic obstructive pulmonary disease-related biomarkers
chr10	81788103	81788104	Chronic obstructive pulmonary disease-related biomarkers
chr10	81847913	81847914	Chronic obstructive pulmonary disease-related biomarkers
chr10	81882369	81882370	Chronic obstructive pulmonary disease-related biomarkers
chr10	81911724	81911725	Sarcoidosis
chr10	81933747	81933748	Chronic obstructive pulmonary disease-related biomarkers
chr10	82254046	82254047	Inflammatory bowel disease
chr10	82377589	82377590	Capecitabine sensitivity
chr10	82699490	82699491	Cardiac hypertrophy
chr10	83153245	83153246	Carotid atherosclerosis in HIV infection
chr10	83188952	83188953	Retinopathy in non-diabetics
chr10	83819124	83819125	Response to iloperidone treatment (QT prolongation)
chr10	84419409	84419410	IgG glycosylation
chr10	84870075	84870076	Obesity-related traits
chr10	85253680	85253681	Self-reported allergy
chr10	85422853	85422854	Eosinophilic esophagitis (pediatric)
chr10	86588901	86588902	Obesity-related traits
chr10	86721180	86721181	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)
chr10	86953326	86953327	Stearic acid (18:0) plasma levels
chr10	87608459	87608460	Post-traumatic stress disorder (asjusted for relatedness)
chr10	87634923	87634924	Periodontal microbiota
chr10	87694291	87694292	Anorexia nervosa
chr10	87740752	87740753	Pancreatic cancer
chr10	87846958	87846959	Cardiac structure and function
chr10	88216401	88216402	Migraine without aura
chr10	89338632	89338633	Longevity
chr10	89443309	89443310	Exercise (leisure time)
chr10	89752210	89752211	Periodontitis (Mean PAL)
chr10	90023032	90023033	Type 1 diabetes
chr10	90727333	90727334	Lung cancer
chr10	90759723	90759724	Chronic lymphocytic leukemia
chr10	90771828	90771829	Immunoglobulin A
chr10	90818376	90818377	Obesity-related traits
chr10	90818376	90818377	Obesity-related traits
chr10	90818376	90818377	Obesity-related traits
chr10	90818376	90818377	Obesity-related traits
chr10	90826778	90826779	Atrioventricular conduction
chr10	90964613	90964614	Heart failure
chr10	91002926	91002927	Coronary heart disease
chr10	91002926	91002927	Coronary heart disease
chr10	91372532	91372533	Metabolic traits
chr10	91962669	91962670	Economic and political preferences (feminism/equality)
chr10	91963462	91963463	Economic and political preferences (feminism/equality)
chr10	92632898	92632899	Economic and political preferences (time)
chr10	93348119	93348120	Smoking behavior
chr10	94168796	94168797	Airflow obstruction
chr10	94347829	94347830	Type 2 diabetes
chr10	94436850	94436851	Inflammatory bowel disease
chr10	94462881	94462882	Type 2 diabetes
chr10	94462881	94462882	Type 2 diabetes
chr10	94462881	94462882	Type 2 diabetes
chr10	94462881	94462882	Type 2 diabetes
chr10	94462881	94462882	Type 2 diabetes
chr10	94465558	94465559	Type 2 diabetes
chr10	94465558	94465559	Type 2 diabetes
chr10	94465558	94465559	Type 2 diabetes
chr10	94465558	94465559	Type 2 diabetes
chr10	94465558	94465559	Type 2 diabetes
chr10	94481916	94481917	Multiple sclerosis
chr10	94485210	94485211	Dehydroepiandrosterone sulphate levels
chr10	94839641	94839642	Triglycerides
chr10	94924323	94924324	Refractive error
chr10	95348181	95348182	Retinol levels
chr10	95895176	95895177	Blood pressure
chr10	95895939	95895940	Diastolic blood pressure
chr10	95895939	95895940	Hypertension
chr10	95895939	95895940	Systolic blood pressure
chr10	96013704	96013705	Personality dimensions
chr10	96035979	96035980	Sudden cardiac arrest
chr10	96058297	96058298	Dengue shock syndrome
chr10	96058297	96058298	Esophageal cancer and gastric cancer
chr10	96058635	96058636	Chronic obstructive pulmonary disease
chr10	96066340	96066341	Esophageal cancer
chr10	96070374	96070375	Esophageal cancer and gastric cancer
chr10	96405328	96405329	Acenocoumarol maintenance dosage
chr10	96405501	96405502	Response to clopidogrel therapy
chr10	96405501	96405502	Warfarin maintenance dose
chr10	96534262	96534263	Migraine
chr10	96547462	96547463	Acenocoumarol maintenance dosage
chr10	96702046	96702047	Warfarin maintenance dose
chr10	96707201	96707202	Warfarin maintenance dose
chr10	96734338	96734339	Warfarin maintenance dose
chr10	96741052	96741053	Warfarin maintenance dose
chr10	96751269	96751270	Dehydroepiandrosterone sulphate levels
chr10	96766933	96766934	Immune response to smallpox vaccine (IL-6)
chr10	96797469	96797470	Immune response to smallpox vaccine (IL-6)
chr10	96798547	96798548	Osteonecrosis of the jaw
chr10	96852689	96852690	Response to amphetamines
chr10	97122240	97122241	Suicide risk
chr10	97196977	97196978	Migraine - clinic-based
chr10	97229761	97229762	Obesity-related traits
chr10	97295588	97295589	IgG glycosylation
chr10	97301003	97301004	IgG glycosylation
chr10	97301003	97301004	IgG glycosylation
chr10	97301003	97301004	IgG glycosylation
chr10	98135504	98135505	Attention deficit hyperactivity disorder
chr10	98417929	98417930	Orthostatic hypotension
chr10	98432702	98432703	IgG glycosylation
chr10	98639845	98639846	Multiple myeloma (IgH translocation)
chr10	98800098	98800099	Obesity-related traits
chr10	98908732	98908733	IgG glycosylation
chr10	99294796	99294797	Obesity-related traits
chr10	99359738	99359739	Metabolite levels
chr10	99637577	99637578	Metabolic syndrome
chr10	100127550	100127551	Aspartate aminotransferase
chr10	100147059	100147060	Metabolite levels
chr10	100156852	100156853	Metabolite levels
chr10	100170382	100170383	Obesity-related traits
chr10	100291175	100291176	Migraine
chr10	100300181	100300182	Type 1 diabetes
chr10	100580122	100580123	Migraine without aura
chr10	100583914	100583915	Obesity-related traits
chr10	100646180	100646181	Migraine without aura
chr10	100855701	100855702	Asthma (childhood onset)
chr10	101157437	101157438	Liver enzyme levels (aspartate transaminase)
chr10	101274364	101274365	Dental caries
chr10	101282199	101282200	Red blood cell traits
chr10	101284236	101284237	Crohn's disease
chr10	101284236	101284237	Inflammatory bowel disease
chr10	101287763	101287764	Crohn's disease
chr10	101287763	101287764	Crohn's disease
chr10	101290300	101290301	Ulcerative colitis
chr10	101290300	101290301	Ulcerative colitis
chr10	101290300	101290301	Ulcerative colitis
chr10	101291592	101291593	Crohn's disease
chr10	101291592	101291593	Ulcerative colitis
chr10	101292389	101292390	Crohn's disease
chr10	101365312	101365313	&beta;2-Glycoprotein I (&beta;2-GPI) plasma levels
chr10	101492402	101492403	Obesity-related traits
chr10	101795360	101795361	Liver enzyme levels (alanine transaminase)
chr10	101805441	101805442	Height
chr10	101813801	101813802	Bone mineral density
chr10	101861434	101861435	Liver enzyme levels
chr10	102066184	102066185	Obesity-related traits
chr10	102075478	102075479	Metabolic traits
chr10	102075478	102075479	Palmitic acid (16:0) plasma levels
chr10	102075478	102075479	Palmitoleic acid (16:1n-7) plasma levels
chr10	102075478	102075479	Phospholipid levels (plasma)
chr10	102256196	102256197	Thiazide-induced adverse metabolic effects in hypertensive patients
chr10	102302456	102302457	Palmitoleic acid (16:1n-7) plasma levels
chr10	102501570	102501571	Alzheimer's disease
chr10	102979206	102979207	Scoliosis
chr10	103698704	103698705	Coronary artery calcification
chr10	104414220	104414221	Prostate cancer
chr10	104591392	104591393	Parkinson's disease
chr10	104594506	104594507	Systolic blood pressure
chr10	104595848	104595849	Blood pressure
chr10	104628872	104628873	Schizophrenia
chr10	104660003	104660004	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr10	104662457	104662458	Schizophrenia
chr10	104719095	104719096	Coronary heart disease
chr10	104719095	104719096	Coronary heart disease
chr10	104719095	104719096	Intracranial aneurysm
chr10	104748717	104748718	Migraine
chr10	104775907	104775908	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr10	104775907	104775908	Schizophrenia
chr10	104846177	104846178	Blood pressure
chr10	104846177	104846178	Blood pressure
chr10	104846177	104846178	Blood pressure
chr10	104846177	104846178	Systolic blood pressure
chr10	104846177	104846178	Systolic blood pressure
chr10	104906210	104906211	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr10	104906210	104906211	Schizophrenia
chr10	104906210	104906211	Schizophrenia
chr10	104939214	104939215	Blood pressure
chr10	104939214	104939215	Blood pressure
chr10	105033014	105033015	Migraine
chr10	105257785	105257786	Platelet aggregation
chr10	105297769	105297770	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr10	105647094	105647095	Endothelial function traits
chr10	105672841	105672842	Interstitial lung disease
chr10	105675945	105675946	Telomere length
chr10	105676464	105676465	Telomere length
chr10	105677896	105677897	Telomere length
chr10	105714398	105714399	Uterine fibroids
chr10	105846073	105846074	Cardiac hypertrophy
chr10	105884115	105884116	Preeclampsia
chr10	105966403	105966404	Attention deficit hyperactivity disorder
chr10	107516351	107516352	Melanoma
chr10	108254463	108254464	Metabolite levels (MHPG)
chr10	108498077	108498078	Metabolite levels (Pyroglutamine)
chr10	109374383	109374384	Endometriosis
chr10	109569849	109569850	Prion diseases
chr10	109626065	109626066	Social communication problems
chr10	110971434	110971435	IgG glycosylation
chr10	111735749	111735750	Biliary atresia
chr10	112006485	112006486	Normalized brain volume
chr10	112036974	112036975	Multiple myeloma
chr10	112186147	112186148	Crohn's disease
chr10	112877800	112877801	Insomnia (caffeine-induced)
chr10	112909104	112909105	Platelet aggregation
chr10	113042092	113042093	Fasting glucose-related traits
chr10	113042092	113042093	Fasting glucose-related traits
chr10	113042092	113042093	Fasting glucose-related traits (interaction with BMI)
chr10	113933885	113933886	Cholesterol, total
chr10	113933885	113933886	LDL cholesterol
chr10	114202525	114202526	Migraine
chr10	114388271	114388272	Multiple sclerosis
chr10	114479261	114479262	Ventricular conduction
chr10	114498475	114498476	Lung cancer
chr10	114734095	114734096	Breast Cancer in BRCA1 mutation carriers
chr10	114754087	114754088	Coronary heart disease
chr10	114754087	114754088	Type 2 diabetes
chr10	114756040	114756041	Fasting glucose-related traits
chr10	114756040	114756041	Type 2 diabetes
chr10	114758348	114758349	Fasting glucose-related traits (interaction with BMI)
chr10	114758348	114758349	Fasting insulin-related traits (interaction with BMI)
chr10	114758348	114758349	Glycated hemoglobin levels
chr10	114758348	114758349	Metabolic syndrome
chr10	114758348	114758349	Proinsulin levels
chr10	114758348	114758349	Type 2 diabetes
chr10	114758348	114758349	Type 2 diabetes
chr10	114758348	114758349	Type 2 diabetes
chr10	114758348	114758349	Type 2 diabetes
chr10	114758348	114758349	Type 2 diabetes
chr10	114758348	114758349	Type 2 diabetes
chr10	114758348	114758349	Type 2 diabetes
chr10	114758348	114758349	Type 2 diabetes
chr10	114758348	114758349	Type 2 diabetes
chr10	114758348	114758349	Type 2 diabetes
chr10	114758348	114758349	Type 2 diabetes
chr10	114758348	114758349	Type 2 diabetes
chr10	114758348	114758349	Type 2 diabetes
chr10	114758348	114758349	Type 2 diabetes
chr10	114758348	114758349	Type 2 diabetes
chr10	114758348	114758349	Type 2 diabetes
chr10	114758348	114758349	Type 2 diabetes
chr10	114758348	114758349	Type 2 diabetes
chr10	114758348	114758349	Type 2 diabetes
chr10	114758348	114758349	Type 2 diabetes
chr10	114758348	114758349	Type 2 diabetes and other traits
chr10	114773926	114773927	Breast cancer
chr10	114788814	114788815	Two-hour glucose challenge
chr10	115235113	115235114	Myopia (pathological)
chr10	115238763	115238764	Migraine without aura
chr10	115481017	115481018	Vitiligo
chr10	115515119	115515120	Obesity-related traits
chr10	115756129	115756130	Gaucher disease severity
chr10	115781526	115781527	Blood pressure
chr10	115805055	115805056	Birth weight
chr10	115814391	115814392	Adiponectin levels
chr10	116139028	116139029	Cognitive performance
chr10	116199174	116199175	Obesity-related traits
chr10	116327549	116327550	Prostate cancer (gene x gene interaction)
chr10	117512587	117512588	Information processing speed
chr10	117824887	117824888	IgG glycosylation
chr10	117973596	117973597	Migraine with aura
chr10	118397970	118397971	Phospholipid levels (plasma)
chr10	118487099	118487100	Colorectal cancer
chr10	118575605	118575606	Heart failure
chr10	118827559	118827560	Orofacial clefts
chr10	118827559	118827560	Orofacial clefts
chr10	118827559	118827560	Orofacial clefts
chr10	119181870	119181871	Bipolar disorder and schizophrenia
chr10	119210374	119210375	Cardiac repolarization
chr10	119227341	119227342	Pulmonary function in asthmatics
chr10	119336745	119336746	Obesity-related traits
chr10	119379655	119379656	Airflow obstruction
chr10	119418103	119418104	Conduct disorder (case status)
chr10	119604937	119604938	Metabolite levels (MHPG)
chr10	119613609	119613610	Celiac disease
chr10	120278943	120278944	Pancreatic cancer
chr10	120966338	120966339	Obesity-related traits
chr10	121149402	121149403	Type 2 diabetes
chr10	121429632	121429633	Dilated cardiomyopathy
chr10	121821537	121821538	IgG glycosylation
chr10	122043488	122043489	IgG glycosylation
chr10	122043488	122043489	IgG glycosylation
chr10	122279475	122279476	Alzheimer's disease (cognitive decline)
chr10	122591372	122591373	Obesity-related traits
chr10	122720973	122720974	Pulmonary function decline
chr10	122900622	122900623	Response to treatment for acute lymphoblastic leukemia
chr10	122939373	122939374	Visceral fat
chr10	123032518	123032519	Prostate cancer
chr10	123033548	123033549	Prostate-specific antigen levels
chr10	123093900	123093901	Breast cancer
chr10	123280657	123280658	Gout
chr10	123332576	123332577	Breast cancer
chr10	123337334	123337335	Breast cancer
chr10	123337334	123337335	Breast cancer
chr10	123337334	123337335	Breast cancer
chr10	123338974	123338975	Breast cancer
chr10	123346115	123346116	Breast cancer
chr10	123346189	123346190	Breast cancer
chr10	123346189	123346190	Breast cancer
chr10	123346189	123346190	Breast cancer
chr10	123352316	123352317	Breast cancer
chr10	123625189	123625190	Breast cancer
chr10	123851826	123851827	Obesity-related traits
chr10	123913329	123913330	Myopia (pathological)
chr10	124165614	124165615	Height
chr10	124214447	124214448	Age-related macular degeneration
chr10	124214447	124214448	Age-related macular degeneration
chr10	124214447	124214448	Age-related macular degeneration
chr10	124214447	124214448	Age-related macular degeneration
chr10	124214447	124214448	Age-related macular degeneration
chr10	124214447	124214448	Age-related macular degeneration
chr10	124214447	124214448	Age-related macular degeneration (CNV vs. GA)
chr10	124214447	124214448	Age-related macular degeneration (CNV)
chr10	124214447	124214448	Age-related macular degeneration (GA)
chr10	124215314	124215315	Age-related macular degeneration (extreme sampling)
chr10	124219274	124219275	Age-related macular degeneration
chr10	124219274	124219275	Age-related macular degeneration
chr10	124219274	124219275	Age-related macular degeneration
chr10	124220543	124220544	Age-related macular degeneration (wet)
chr10	124729875	124729876	Migraine without aura
chr10	124887124	124887125	Periodontitis (Mean PAL)
chr10	124988152	124988153	Menopause (age at onset)
chr10	125207500	125207501	Cardiac Troponin-T levels
chr10	125222036	125222037	Venous thromboembolism (gene x gene interaction)
chr10	125251674	125251675	Migraine
chr10	126144178	126144179	Hemostatic factors and hematological phenotypes
chr10	126144838	126144839	Adverse response to chemotherapy (neutropenia/leucopenia) (epirubicin)
chr10	126275913	126275914	Subcutaneous adipose tissue
chr10	126294166	126294167	Obesity-related traits
chr10	126426147	126426148	Cocaine dependence
chr10	126426147	126426148	Cocaine dependence
chr10	126438018	126438019	Obesity-related traits
chr10	126696871	126696872	Prostate cancer
chr10	127135837	127135838	Obesity-related traits
chr10	127296144	127296145	Non-alcoholic fatty liver disease histology (other)
chr10	127699935	127699936	Visceral fat
chr10	127823150	127823151	Metabolite levels (5-HIAA/ MHPG Ratio)
chr10	127829011	127829012	Thiazide-induced adverse metabolic effects in hypertensive patients
chr10	128267639	128267640	Metabolite levels (MHPG)
chr10	128777389	128777390	Apolipoprotein Levels
chr10	129274502	129274503	Amyotrophic lateral sclerosis
chr10	129678673	129678674	Parkinson's disease (motor and cognition)
chr10	129737630	129737631	Response to amphetamines
chr10	129933455	129933456	Select biomarker traits
chr10	129998371	129998372	Orofacial clefts
chr10	130233807	130233808	IgG glycosylation
chr10	130248925	130248926	Cognitive performance
chr10	131426021	131426022	Response to temozolomide
chr10	131500939	131500940	Waist-to-hip circumference ratio (interaction)
chr10	131673985	131673986	Sleep time
chr10	131992244	131992245	Speech perception in dyslexia
chr10	132168064	132168065	Migraine
chr10	132547260	132547261	Obesity-related traits
chr10	132547260	132547261	Obesity-related traits
chr10	132747886	132747887	Insulin-related traits
chr10	132747886	132747887	Insulin-related traits
chr10	132947961	132947962	Type 2 diabetes
chr10	133172118	133172119	Crohn's disease
chr10	133330025	133330026	Temperament
chr10	133957760	133957761	Chronic obstructive pulmonary disease-related biomarkers
chr10	134295814	134295815	Periodontitis (CDC/AAP)
chr10	135306157	135306158	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr10	135352152	135352153	Obesity-related traits
chr11	202855	202856	Bone mineral density
chr11	202855	202856	Mean platelet volume
chr11	202855	202856	Platelet counts
chr11	203787	203788	Intracranial aneurysm
chr11	203787	203788	Uterine fibroids
chr11	243267	243268	Platelet counts
chr11	270714	270715	Mean platelet volume
chr11	589563	589564	Systemic lupus erythematosus
chr11	589563	589564	Systemic lupus erythematosus
chr11	601784	601785	Systemic lupus erythematosus and Systemic sclerosis
chr11	831882	831883	Obesity-related traits
chr11	1093944	1093945	Interstitial lung disease
chr11	1874071	1874072	Inflammatory bowel disease
chr11	1874071	1874072	Ulcerative colitis
chr11	1909005	1909006	Breast cancer
chr11	1909005	1909006	Breast cancer
chr11	1941945	1941946	Breast cancer
chr11	1985126	1985127	DNA methylation (variation)
chr11	2024543	2024544	DNA methylation (parent-of-origin)
chr11	2024543	2024544	DNA methylation (variation)
chr11	2048487	2048488	Celiac disease
chr11	2138138	2138139	Femoral neck bone geometry and menarche (age at onset)
chr11	2138138	2138139	Femoral neck bone geometry and menarche (age at onset)
chr11	2169773	2169774	Type 1 diabetes
chr11	2170142	2170143	Type 1 diabetes
chr11	2170142	2170143	Type 1 diabetes autoantibodies
chr11	2182223	2182224	Type 1 diabetes autoantibodies
chr11	2213165	2213166	Type 1 diabetes
chr11	2233573	2233574	Prostate cancer
chr11	2308761	2308762	Obesity-related traits
chr11	2311151	2311152	Chronic lymphocytic leukemia
chr11	2484802	2484803	QT interval
chr11	2486119	2486120	QT interval
chr11	2489341	2489342	Electrocardiographic traits
chr11	2489341	2489342	QT interval
chr11	2502318	2502319	QT interval
chr11	2550729	2550730	Platelet aggregation
chr11	2691470	2691471	Type 2 diabetes
chr11	2752608	2752609	QT interval
chr11	2766281	2766282	Protein quantitative trait loci
chr11	2810730	2810731	Height
chr11	2839750	2839751	Type 2 diabetes
chr11	2839750	2839751	Type 2 diabetes
chr11	2839750	2839751	Type 2 diabetes
chr11	2839750	2839751	Type 2 diabetes
chr11	2839750	2839751	Type 2 diabetes
chr11	2844215	2844216	Type 2 diabetes
chr11	2857193	2857194	Type 2 diabetes
chr11	2858545	2858546	Type 2 diabetes
chr11	2936951	2936952	Bilirubin levels
chr11	2953722	2953723	Calcium levels
chr11	3029088	3029089	Calcium levels
chr11	3036323	3036324	Longevity
chr11	3259808	3259809	Multiple sclerosis
chr11	3722303	3722304	Metabolite levels (Dihydroxy docosatrienoic acid)
chr11	4496845	4496846	Amyotrophic lateral sclerosis
chr11	4516575	4516576	Obesity-related traits
chr11	4563217	4563218	Obesity-related traits
chr11	4790574	4790575	Malaria
chr11	5029702	5029703	Sickle cell anemia (haemolysis)
chr11	5225446	5225447	HbA2 levels
chr11	5225634	5225635	Malaria
chr11	5230906	5230907	Red blood cell traits
chr11	5263852	5263853	Obesity-related traits
chr11	5263852	5263853	Obesity-related traits
chr11	5263852	5263853	Obesity-related traits
chr11	5264145	5264146	Beta thalassemia/hemoglobin E disease
chr11	5303062	5303063	Hematology traits
chr11	5303062	5303063	Mean corpuscular hemoglobin concentration
chr11	5306508	5306509	Fetal hemoglobin levels
chr11	5306508	5306509	Inflammatory biomarkers
chr11	5373250	5373251	Fetal hemoglobin levels
chr11	5471745	5471746	Sickle cell anemia (haemolysis)
chr11	5518155	5518156	Malaria
chr11	5625602	5625603	IgG glycosylation
chr11	5688023	5688024	IgG glycosylation
chr11	5688023	5688024	IgG glycosylation
chr11	5688023	5688024	IgG glycosylation
chr11	5959756	5959757	DNA methylation (variation)
chr11	6522803	6522804	DNA methylation (variation)
chr11	7367094	7367095	Phospholipid levels (plasma)
chr11	7464371	7464372	IgG glycosylation
chr11	7701502	7701503	Blood pressure
chr11	7708280	7708281	Waist circumference
chr11	7968358	7968359	Atopic dermatitis
chr11	8014776	8014777	Depression (quantitative trait)
chr11	8243797	8243798	Fasting glucose-related traits (interaction with BMI)
chr11	8250810	8250811	Alcohol consumption
chr11	8252852	8252853	Neuroblastoma
chr11	8252852	8252853	Neuroblastoma
chr11	8484088	8484089	Body mass index
chr11	8604592	8604593	Body mass index
chr11	8639199	8639200	Menarche (age at onset)
chr11	8662515	8662516	Obesity
chr11	9109286	9109287	&beta;2-Glycoprotein I (&beta;2-GPI) plasma levels
chr11	9111557	9111558	&beta;2-Glycoprotein I (&beta;2-GPI) plasma levels
chr11	9973061	9973062	Pancreatic cancer
chr11	10350537	10350538	Blood pressure
chr11	10350537	10350538	Diastolic blood pressure
chr11	10350537	10350538	Systolic blood pressure
chr11	10368118	10368119	Circulating vasoactive peptide levels
chr11	10388781	10388782	HDL cholesterol
chr11	10390580	10390581	Schizophrenia, bipolar disorder and depression (combined)
chr11	10669227	10669228	Platelet aggregation
chr11	10673738	10673739	Migraine
chr11	10740365	10740366	Bipolar disorder and schizophrenia
chr11	11228373	11228374	Type 2 diabetes
chr11	11504227	11504228	Response to tocilizumab in rheumatoid arthritis
chr11	11983884	11983885	Metabolite levels (Dihydroxy docosatrienoic acid)
chr11	12070664	12070665	Visceral fat
chr11	12072502	12072503	Response to taxane treatment (docetaxel)
chr11	12159660	12159661	PR interval
chr11	12469396	12469397	Mortality among heart failure patients
chr11	12698039	12698040	Height
chr11	13090941	13090942	Obesity-related traits
chr11	13293904	13293905	Menarche (age at onset)
chr11	13331225	13331226	Schizophrenia
chr11	13620171	13620172	Bone mineral density
chr11	14021638	14021639	Brain connectivity
chr11	14098481	14098482	Inflammatory biomarkers
chr11	14224345	14224346	Alzheimer's disease (cognitive decline)
chr11	14784109	14784110	Adiponectin levels
chr11	14914877	14914878	Vitamin D insufficiency
chr11	15355245	15355246	Prostate cancer (gene x gene interaction)
chr11	15457466	15457467	Menarche (age at onset)
chr11	15620585	15620586	Obesity-related traits
chr11	15694461	15694462	Bone mineral density (hip)
chr11	15710083	15710084	Bone mineral density
chr11	15952293	15952294	Wrist bone mass
chr11	16040174	16040175	Capecitabine sensitivity
chr11	16250182	16250183	Blood pressure
chr11	16250182	16250183	Blood pressure
chr11	16389593	16389594	Obesity and osteoporosis
chr11	16403510	16403511	Obesity and osteoporosis
chr11	16902267	16902268	Blood pressure
chr11	16902267	16902268	Blood pressure
chr11	16902267	16902268	Systolic blood pressure
chr11	16917218	16917219	Diastolic blood pressure
chr11	17008604	17008605	Glaucoma (primary open-angle)
chr11	17160147	17160148	Schizophrenia
chr11	17316028	17316029	Height
chr11	17408629	17408630	Type 2 diabetes
chr11	17408629	17408630	Type 2 diabetes
chr11	17409571	17409572	Type 2 diabetes
chr11	17409571	17409572	Type 2 diabetes
chr11	17409571	17409572	Type 2 diabetes
chr11	17409571	17409572	Type 2 diabetes
chr11	18265798	18265799	Bipolar disorder and schizophrenia
chr11	18285773	18285774	Amyloid A Levels
chr11	18323516	18323517	Amyloid A Levels
chr11	18325145	18325146	Metabolic traits
chr11	18384937	18384938	Pancreatic cancer
chr11	18419805	18419806	Amyloid A Levels
chr11	18632983	18632984	Cholesterol, total
chr11	18689652	18689653	Ovarian reserve
chr11	18822036	18822037	Adverse response to chemotherapy (neutropenia/leucopenia) (cisplatin)
chr11	19051871	19051872	IgG glycosylation
chr11	19051871	19051872	IgG glycosylation
chr11	19569562	19569563	Attention deficit hyperactivity disorder (time to onset)
chr11	19584501	19584502	Obesity-related traits
chr11	20356443	20356444	Obesity-related traits
chr11	20378123	20378124	Obesity-related traits
chr11	20562518	20562519	Response to treatment for acute lymphoblastic leukemia
chr11	20623022	20623023	Obesity-related traits
chr11	20698928	20698929	Crohn's disease
chr11	20984204	20984205	Response to amphetamines
chr11	21058730	21058731	Adverse response to lamotrigine and phenytoin
chr11	21565078	21565079	Thiazide-induced adverse metabolic effects in hypertensive patients
chr11	21620947	21620948	Cannabis use (initiation)
chr11	21669292	21669293	Obesity-related traits
chr11	21677341	21677342	Obesity-related traits
chr11	21896879	21896880	Multiple myeloma (hyperdiploidy)
chr11	22114092	22114093	Parkinson's disease
chr11	22312565	22312566	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr11	22829756	22829757	Dialysis-related mortality
chr11	22843154	22843155	Dialysis-related mortality
chr11	23044591	23044592	Sudden cardiac arrest
chr11	24252527	24252528	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr11	24611129	24611130	Alzheimer's disease (late onset)
chr11	24678818	24678819	Magnesium levels
chr11	24849565	24849566	Iron status biomarkers
chr11	25207703	25207704	Ovarian cancer
chr11	25490481	25490482	IgG glycosylation
chr11	26605330	26605331	Obesity (extreme)
chr11	27505676	27505677	Bone mineral density
chr11	27563381	27563382	Obesity
chr11	27583128	27583129	Body mass index
chr11	27583128	27583129	Weight
chr11	27667201	27667202	Body mass index
chr11	27667201	27667202	Weight
chr11	27679915	27679916	Body mass index
chr11	27679915	27679916	Smoking behavior
chr11	27679915	27679916	Weight
chr11	27725985	27725986	Body mass index
chr11	27728538	27728539	Body mass index
chr11	27728538	27728539	Body mass index
chr11	27728538	27728539	Obesity
chr11	27728538	27728539	Obesity
chr11	27728538	27728539	Obesity
chr11	28009462	28009463	Bipolar disorder
chr11	28233767	28233768	Obesity-related traits
chr11	29162135	29162136	Schizophrenia
chr11	29195136	29195137	Amyotrophic lateral sclerosis (age of onset)
chr11	30382898	30382899	Menopause (age at onset)
chr11	30467499	30467500	Dental caries
chr11	30508107	30508108	Dental caries
chr11	30749089	30749090	Renal function-related traits (eGRFcrea)
chr11	30749089	30749090	Renal function-related traits (sCR)
chr11	30760334	30760335	Chronic kidney disease
chr11	30760334	30760335	Magnesium levels
chr11	30768677	30768678	Renal function-related traits (BUN)
chr11	30951673	30951674	Bone mineral density
chr11	31210770	31210771	Bone mineral density (spine)
chr11	31884918	31884919	Metabolite levels (HVA/5-HIAA ratio)
chr11	31905533	31905534	Body mass index
chr11	32364186	32364187	Tuberculosis
chr11	32522006	32522007	Attention deficit hyperactivity disorder
chr11	32895663	32895664	Parkinson's disease (age of onset)
chr11	33588209	33588210	Suicide attempts in bipolar disorder
chr11	33806821	33806822	Coronary artery calcification
chr11	33868606	33868607	Cognitive performance
chr11	34555190	34555191	&beta;2-Glycoprotein I (&beta;2-GPI) plasma levels
chr11	34605434	34605435	Volumetric brain MRI
chr11	34655362	34655363	Response to antipsychotic treatment
chr11	34662960	34662961	Obesity-related traits
chr11	34764478	34764479	Systemic lupus erythematosus and Systemic sclerosis
chr11	34805848	34805849	Chronic obstructive pulmonary disease-related biomarkers
chr11	34834203	34834204	Cystic fibrosis severity
chr11	35093069	35093070	Systemic lupus erythematosus
chr11	35123050	35123051	Thiazide-induced adverse metabolic effects in hypertensive patients
chr11	35155731	35155732	Response to Vitamin E supplementation
chr11	35280851	35280852	Vitiligo
chr11	35329614	35329615	Essential tremor
chr11	35495440	35495441	Relative hand skill in reading disability
chr11	35539268	35539269	Bronchopulmonary dysplasia
chr11	35701235	35701236	Response to antipsychotic therapy (extrapyramidal side effects)
chr11	37012536	37012537	Inflammatory biomarkers
chr11	37870980	37870981	Cutaneous nevi
chr11	38278949	38278950	Metabolite levels (MHPG)
chr11	38285500	38285501	Bronchopulmonary dysplasia
chr11	39327958	39327959	Osteoporosis
chr11	39908661	39908662	Temperament (bipolar disorder)
chr11	40837712	40837713	Reasoning
chr11	41225432	41225433	IgG glycosylation
chr11	41225953	41225954	IgG glycosylation
chr11	41852663	41852664	RR interval (heart rate)
chr11	41915365	41915366	Type 2 diabetes
chr11	42315885	42315886	Immune response to smallpox vaccine (IL-6)
chr11	42874001	42874002	Methotrexate phramacokinetics (acute lymphoblastic leukemia)
chr11	43086093	43086094	Cognitive performance
chr11	43236060	43236061	Migraine
chr11	43728329	43728330	Neuroblastoma
chr11	44603327	44603328	Hemostatic factors and hematological phenotypes
chr11	44843133	44843134	Schizophrenia
chr11	45084530	45084531	IgG glycosylation
chr11	45227566	45227567	Thyroid hormone levels
chr11	45227566	45227567	Thyroid hormone levels
chr11	45528115	45528116	Obesity-related traits
chr11	45813580	45813581	Visceral fat
chr11	45873090	45873091	Fasting glucose-related traits
chr11	45873090	45873091	Fasting glucose-related traits (interaction with BMI)
chr11	45947463	45947464	Axial length
chr11	46052574	46052575	Menarche (age at onset)
chr11	46379441	46379442	Immunoglobulin A
chr11	46722220	46722221	Bone mineral density
chr11	46722220	46722221	Bone mineral density (hip)
chr11	46743246	46743247	HDL cholesterol
chr11	46849359	46849360	Bone mineral density (hip)
chr11	46893107	46893108	D-dimer levels
chr11	47127152	47127153	D-dimer levels
chr11	47275063	47275064	Metabolic syndrome
chr11	47286289	47286290	HDL cholesterol
chr11	47293798	47293799	Proinsulin levels
chr11	47312891	47312892	Proinsulin levels
chr11	47336319	47336320	Fasting glucose-related traits
chr11	47336319	47336320	Fasting glucose-related traits (interaction with BMI)
chr11	47440757	47440758	Serum albumin level
chr11	47440757	47440758	Serum albumin level
chr11	47441512	47441513	Height
chr11	47650992	47650993	Body mass index
chr11	47663048	47663049	Body mass index
chr11	48091302	48091303	Height
chr11	48098279	48098280	Height
chr11	48115088	48115089	Acute lymphoblastic leukemia (childhood)
chr11	48207258	48207259	D-dimer levels
chr11	48332027	48332028	Migraine - clinic-based
chr11	48333359	48333360	Fasting glucose-related traits (interaction with BMI)
chr11	48382470	48382471	D-dimer levels
chr11	48518892	48518893	HDL cholesterol
chr11	48540222	48540223	Axial length
chr11	49559171	49559172	Height
chr11	51414217	51414218	Height
chr11	55136218	55136219	Systemic lupus erythematosus
chr11	55862090	55862091	Phospholipid levels (plasma)
chr11	55895744	55895745	Odorant perception (-damascenone)
chr11	56019924	56019925	Obesity-related traits
chr11	56175670	56175671	Acute lymphoblastic leukemia (childhood)
chr11	56175670	56175671	Acute lymphoblastic leukemia (childhood)
chr11	56242260	56242261	Myopia (pathological)
chr11	56440235	56440236	Orofacial clefts
chr11	56466098	56466099	Hemostatic factors and hematological phenotypes
chr11	57203008	57203009	Crohn's disease
chr11	57365722	57365723	Obesity-related traits
chr11	58060191	58060192	Lymphoma
chr11	58060191	58060192	Lymphoma
chr11	58339123	58339124	Inflammatory bowel disease
chr11	58347764	58347765	Lymphoma
chr11	58347764	58347765	Lymphoma
chr11	58472798	58472799	Body mass (lean)
chr11	59224143	59224144	Odorant perception (-ionone)
chr11	59633492	59633493	Folate pathway vitamin levels
chr11	59633492	59633493	Folate pathway vitamin levels
chr11	59837191	59837192	Vitamin B12 levels
chr11	59939306	59939307	Alzheimer's disease
chr11	59940598	59940599	Fibrinogen
chr11	59997665	59997666	Lipoprotein-associated phospholipase A2 activity and mass
chr11	60023086	60023087	Alzheimer's disease
chr11	60034428	60034429	Alzheimer's disease (late onset)
chr11	60592275	60592276	Wegener's granulomatosis
chr11	60760611	60760612	Multiple sclerosis
chr11	60776208	60776209	Inflammatory bowel disease
chr11	60793650	60793651	Multiple sclerosis
chr11	60832281	60832282	Multiple sclerosis
chr11	61417471	61417472	Phospholipid levels (plasma)
chr11	61490485	61490486	Phospholipid levels (plasma)
chr11	61494326	61494327	Immune reponse to smallpox (secreted IL-2)
chr11	61551355	61551356	Phospholipid levels (plasma)
chr11	61551355	61551356	Phospholipid levels (plasma)
chr11	61551926	61551927	Phospholipid levels (plasma)
chr11	61557802	61557803	Crohn's disease
chr11	61557802	61557803	Metabolic syndrome
chr11	61557802	61557803	Metabolite levels
chr11	61557802	61557803	Oleic acid (18:1n-9) plasma levels
chr11	61557802	61557803	Palmitoleic acid (16:1n-7) plasma levels
chr11	61557802	61557803	Phospholipid levels (plasma)
chr11	61557802	61557803	Phospholipid levels (plasma)
chr11	61557802	61557803	Phospholipid levels (plasma)
chr11	61557802	61557803	Stearic acid (18:0) plasma levels
chr11	61560080	61560081	Phospholipid levels (plasma)
chr11	61564298	61564299	Inflammatory bowel disease
chr11	61564298	61564299	Phospholipid levels (plasma)
chr11	61564298	61564299	Phospholipid levels (plasma)
chr11	61564298	61564299	Phospholipid levels (plasma)
chr11	61564298	61564299	Platelet counts
chr11	61565907	61565908	Metabolite levels
chr11	61569829	61569830	Cholesterol, total
chr11	61569829	61569830	HDL cholesterol
chr11	61569829	61569830	LDL cholesterol
chr11	61569829	61569830	LDL cholesterol
chr11	61569829	61569830	Metabolic syndrome
chr11	61569829	61569830	Triglycerides
chr11	61570782	61570783	Comprehensive strength and appendicular lean mass
chr11	61570782	61570783	HDL cholesterol
chr11	61570782	61570783	Lipid metabolism phenotypes
chr11	61570782	61570783	Metabolic traits
chr11	61570782	61570783	Metabolite levels
chr11	61570782	61570783	Phospholipid levels (plasma)
chr11	61570782	61570783	Phospholipid levels (plasma)
chr11	61570782	61570783	Resting heart rate
chr11	61570782	61570783	Triglycerides
chr11	61571347	61571348	HDL cholesterol
chr11	61571347	61571348	Hematology traits
chr11	61571347	61571348	Metabolite levels
chr11	61571347	61571348	Triglycerides
chr11	61571381	61571382	Comprehensive strength and appendicular lean mass
chr11	61571381	61571382	Heart rate
chr11	61571381	61571382	Metabolite levels
chr11	61571477	61571478	Fasting glucose-related traits
chr11	61571477	61571478	Fasting glucose-related traits
chr11	61571477	61571478	Fasting glucose-related traits (interaction with BMI)
chr11	61571477	61571478	Phospholipid levels (plasma)
chr11	61597211	61597212	Cholesterol, total
chr11	61597211	61597212	HDL cholesterol
chr11	61597211	61597212	LDL cholesterol
chr11	61597971	61597972	Metabolic syndrome
chr11	61597971	61597972	Phospholipid levels (plasma)
chr11	61597971	61597972	Phospholipid levels (plasma)
chr11	61597971	61597972	Response to statin therapy
chr11	61600341	61600342	Phospholipid levels (plasma)
chr11	61609749	61609750	Response to statin therapy
chr11	61623139	61623140	Liver enzyme levels (alkaline phosphatase)
chr11	61639572	61639573	Phospholipid levels (plasma)
chr11	61639572	61639573	Phospholipid levels (plasma)
chr11	61639572	61639573	Phospholipid levels (plasma)
chr11	61655304	61655305	Sphingolipid levels
chr11	61663690	61663691	Phospholipid levels (plasma)
chr11	61663690	61663691	Phospholipid levels (plasma)
chr11	61663690	61663691	Phospholipid levels (plasma)
chr11	61678753	61678754	Sphingolipid levels
chr11	61711474	61711475	Phospholipid levels (plasma)
chr11	61712130	61712131	Estradiol levels
chr11	61722644	61722645	Phospholipid levels (plasma)
chr11	61746290	61746291	Phospholipid levels (plasma)
chr11	61795585	61795586	Phospholipid levels (plasma)
chr11	61815802	61815803	Phospholipid levels (plasma)
chr11	62103419	62103420	Chronic obstructive pulmonary disease-related biomarkers
chr11	62186541	62186542	Chronic obstructive pulmonary disease-related biomarkers
chr11	62197426	62197427	Chronic obstructive pulmonary disease-related biomarkers
chr11	62199816	62199817	Chronic obstructive pulmonary disease-related biomarkers
chr11	62771387	62771388	Visceral fat
chr11	63173683	63173684	Economic and political preferences
chr11	63592620	63592621	Electroencephalographic traits in alcoholism
chr11	63963946	63963947	Attention deficit hyperactivity disorder
chr11	63979642	63979643	Attention deficit hyperactivity disorder
chr11	63991800	63991801	Attention deficit hyperactivity disorder
chr11	64048911	64048912	Mean platelet volume
chr11	64097232	64097233	Alopecia areata
chr11	64097232	64097233	Crohn's disease
chr11	64107476	64107477	Sarcoidosis
chr11	64129721	64129722	Leprosy
chr11	64129721	64129722	Primary biliary cirrhosis
chr11	64150369	64150370	Inflammatory bowel disease
chr11	64313290	64313291	Obesity-related traits
chr11	64331461	64331462	Uric acid levels
chr11	64334113	64334114	Urate levels
chr11	64334113	64334114	Urate levels
chr11	64334113	64334114	Urate levels
chr11	64357071	64357072	Uric acid levels
chr11	64359220	64359221	Urate levels
chr11	64440919	64440920	Urate levels
chr11	64464084	64464085	Renal function-related traits (urea)
chr11	64478062	64478063	Urate levels
chr11	64525215	64525216	Urate levels
chr11	64546390	64546391	Urate levels
chr11	64557053	64557054	Urate levels
chr11	64584230	64584231	Economic and political preferences (fairness)
chr11	65249144	65249145	Vertical cup-disc ratio
chr11	65260645	65260646	Bone mineral density
chr11	65336818	65336819	Height
chr11	65349755	65349756	Non-alcoholic fatty liver disease histology (lobular)
chr11	65506821	65506822	Chronic kidney disease
chr11	65513106	65513107	Atopic dermatitis
chr11	65551956	65551957	Atopic dermatitis
chr11	65560619	65560620	Urate levels
chr11	65578671	65578672	DNA methylation (variation)
chr11	65583065	65583066	Breast cancer
chr11	65656563	65656564	Inflammatory bowel disease
chr11	65895165	65895166	Obesity (early onset extreme)
chr11	66335307	66335308	Bipolar disorder
chr11	66551001	66551002	Bipolar disorder
chr11	66826159	66826160	Height
chr11	67715027	67715028	QRS duration
chr11	67931760	67931761	IgG glycosylation
chr11	67931760	67931761	IgG glycosylation
chr11	68192345	68192346	Bone mineral density (spine)
chr11	68201294	68201295	Bone mineral density
chr11	68201294	68201295	Bone mineral density
chr11	68556781	68556782	Obesity-related traits
chr11	68562327	68562328	Lipid metabolism phenotypes
chr11	68840159	68840160	Hair color
chr11	68846398	68846399	Blond vs. brown hair color
chr11	68978579	68978580	Prostate cancer
chr11	68994496	68994497	Prostate cancer
chr11	68994666	68994667	Prostate cancer
chr11	68995957	68995958	Prostate cancer
chr11	68995957	68995958	Prostate cancer
chr11	69143283	69143284	Breast size
chr11	69234493	69234494	Renal cell carcinoma
chr11	69239740	69239741	Renal cell carcinoma
chr11	69328763	69328764	Breast cancer
chr11	69328763	69328764	Breast cancer
chr11	69457292	69457293	Multiple myeloma (hyperdiploidy)
chr11	69462909	69462910	Multiple myeloma (IgH translocation)
chr11	69462909	69462910	Multiple myeloma (IgH translocation)
chr11	69596522	69596523	Type 1 diabetes
chr11	69602411	69602412	IgG glycosylation
chr11	69602411	69602412	IgG glycosylation
chr11	70506205	70506206	Response to fenofibrate (adiponectin levels)
chr11	70665520	70665521	Renal transplant outcome
chr11	70845203	70845204	Obesity-related traits
chr11	71167448	71167449	Vitamin D insufficiency
chr11	72250122	72250123	Optic disc size (cup)
chr11	72373495	72373496	Rheumatoid arthritis
chr11	72432984	72432985	Fasting glucose-related traits (interaction with BMI)
chr11	72432984	72432985	Proinsulin levels
chr11	72433097	72433098	Type 2 diabetes
chr11	72670899	72670900	Crohn's disease
chr11	72863696	72863697	Crohn's disease
chr11	72894272	72894273	Body mass index (asthmatics)
chr11	72894847	72894848	Insomnia (caffeine-induced)
chr11	73036480	73036481	Pulmonary function (interaction)
chr11	73036480	73036481	Pulmonary function (interaction)
chr11	73312251	73312252	Pulmonary function (interaction)
chr11	73312251	73312252	Pulmonary function (interaction)
chr11	73477044	73477045	Obesity-related traits
chr11	74168410	74168411	Corneal astigmatism
chr11	74345549	74345550	Colorectal cancer
chr11	74971556	74971557	Thiazide-induced adverse metabolic effects in hypertensive patients
chr11	75276177	75276178	Height
chr11	75282051	75282052	Height
chr11	75909618	75909619	PR interval
chr11	76270682	76270683	Asthma
chr11	76270682	76270683	Atopic dermatitis
chr11	76299193	76299194	Allergic rhinitis
chr11	76299193	76299194	Allergic sensitization
chr11	76299193	76299194	IgE grass sensitization
chr11	76299193	76299194	Inflammatory bowel disease
chr11	76299193	76299194	Self-reported allergy
chr11	76299193	76299194	Ulcerative colitis
chr11	76301315	76301316	Atopic dermatitis
chr11	76301315	76301316	Crohn's disease
chr11	76301374	76301375	Crohn's disease
chr11	76332209	76332210	Atopic dermatitis
chr11	76823483	76823484	Cognitive performance
chr11	77154638	77154639	Orofacial clefts
chr11	77300047	77300048	Weight loss (gastric bypass surgery)
chr11	78091149	78091150	Alzheimer's disease (late onset)
chr11	78095372	78095373	Menarche (age at onset)
chr11	78659144	78659145	Retinopathy in non-diabetics
chr11	78992685	78992686	Obesity-related traits
chr11	79065100	79065101	Cognitive test performance
chr11	79077192	79077193	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr11	79077192	79077193	Bipolar disorder
chr11	79083619	79083620	Bipolar disorder
chr11	80058478	80058479	Response to antipsychotic treatment
chr11	80311670	80311671	IgG glycosylation
chr11	80377051	80377052	Lentiform nucleus volume
chr11	80562737	80562738	Cognitive performance
chr11	80928808	80928809	Blood trace element (Zn levels)
chr11	80985547	80985548	Body mass index
chr11	81235149	81235150	Smooth-surface caries
chr11	82649767	82649768	Obesity-related traits
chr11	82723071	82723072	Economic and political preferences (feminism/equality)
chr11	82821381	82821382	Age-related macular degeneration
chr11	82876269	82876270	Obesity-related traits
chr11	83256867	83256868	Obesity-related traits
chr11	83455706	83455707	Protein quantitative trait loci
chr11	83620786	83620787	Wilms tumor
chr11	84417845	84417846	Parkinson's disease
chr11	84822320	84822321	Hip geometry
chr11	85017475	85017476	Phospholipid levels (plasma)
chr11	85164750	85164751	Height
chr11	85677470	85677471	Alzheimer's disease
chr11	85783737	85783738	Tourette syndrome
chr11	85787823	85787824	Alzheimer's disease
chr11	85800278	85800279	Alzheimer's disease (late onset)
chr11	85838807	85838808	Alzheimer's disease
chr11	85868639	85868640	Alzheimer's disease
chr11	86055900	86055901	Cognitive performance
chr11	86188151	86188152	Adverse response to chemotherapy in breast cancer (alopecia) (anti-microtubule)
chr11	86414281	86414282	Adverse response to chemotherapy (neutropenia/leucopenia) (doxorubicin)
chr11	87125437	87125438	Inflammatory bowel disease
chr11	87819426	87819427	Multiple sclerosis (age of onset)
chr11	88557990	88557991	Tanning
chr11	88741659	88741660	Attention deficit hyperactivity disorder
chr11	88891113	88891114	Age-related macular degeneration
chr11	88911695	88911696	Freckles
chr11	88911695	88911696	Skin pigmentation
chr11	88913662	88913663	Age-related macular degeneration
chr11	89005252	89005253	Eye color
chr11	89011045	89011046	Blue vs. green eyes
chr11	89011045	89011046	Eye color
chr11	89011045	89011046	Melanoma
chr11	89011045	89011046	Melanoma
chr11	89011045	89011046	Skin sensitivity to sun
chr11	89011045	89011046	Tanning
chr11	89011045	89011046	Vitiligo
chr11	89017960	89017961	Sunburns
chr11	89017960	89017961	Tanning
chr11	89112649	89112650	Obesity-related traits
chr11	89148371	89148372	Homocysteine levels
chr11	89201626	89201627	Homocysteine levels
chr11	89345024	89345025	Amyotrophic lateral sclerosis
chr11	89502375	89502376	Response to taxane treatment (docetaxel)
chr11	89875436	89875437	White blood cell types
chr11	90884338	90884339	Aging traits
chr11	90956213	90956214	Response to angiotensin II receptor blocker therapy
chr11	91952153	91952154	Subclinical atherosclerosis traits (other)
chr11	92651001	92651002	Conduct disorder (case status)
chr11	92651001	92651002	Conduct disorder (symptom count)
chr11	92673827	92673828	Fasting plasma glucose
chr11	92673827	92673828	Glycated hemoglobin levels
chr11	92673827	92673828	Metabolic syndrome (bivariate traits)
chr11	92673827	92673828	Metabolic syndrome (bivariate traits)
chr11	92673827	92673828	Type 2 diabetes
chr11	92681012	92681013	Metabolic syndrome (bivariate traits)
chr11	92690031	92690032	Glycemic traits (pregnancy)
chr11	92690031	92690032	Glycemic traits (pregnancy)
chr11	92691531	92691532	Fasting plasma glucose
chr11	92698426	92698427	Diabetes (gestational)
chr11	92698426	92698427	Glycemic traits
chr11	92698426	92698427	Glycemic traits
chr11	92698426	92698427	Metabolic syndrome
chr11	92698426	92698427	Metabolite levels
chr11	92708709	92708710	Fasting glucose-related traits
chr11	92708709	92708710	Fasting glucose-related traits
chr11	92708709	92708710	Fasting glucose-related traits (interaction with BMI)
chr11	92708709	92708710	Fasting plasma glucose
chr11	92708709	92708710	Fasting plasma glucose
chr11	92708709	92708710	Metabolite levels
chr11	92708709	92708710	Obesity-related traits
chr11	92719680	92719681	Insomnia (caffeine-induced)
chr11	92722760	92722761	Metabolic traits
chr11	92784202	92784203	DNA methylation (parent-of-origin)
chr11	92792099	92792100	Adverse response to radiation therapy
chr11	92920401	92920402	Obesity-related traits
chr11	93093136	93093137	Obesity-related traits
chr11	93166730	93166731	Pulmonary function decline
chr11	93704048	93704049	Obesity-related traits
chr11	94132138	94132139	Response to angiotensin II receptor blocker therapy (opposite direction w/ diuretic therapy)
chr11	94271662	94271663	Response to angiotensin II receptor blocker therapy
chr11	94271662	94271663	Response to angiotensin II receptor blocker therapy (opposite direction w/ diuretic therapy)
chr11	94312322	94312323	Attention deficit hyperactivity disorder symptoms (interaction)
chr11	94667963	94667964	Attention deficit hyperactivity disorder and conduct disorder
chr11	95311421	95311422	Multiple sclerosis
chr11	95311421	95311422	Vitiligo
chr11	95422866	95422867	Eosinophilic esophagitis (pediatric)
chr11	95866699	95866700	Sudden cardiac arrest
chr11	95992128	95992129	Waist-to-hip circumference ratio (interaction)
chr11	95995447	95995448	Height
chr11	96000099	96000100	Response to treatment for acute lymphoblastic leukemia
chr11	96023213	96023214	Corneal astigmatism
chr11	96023426	96023427	Ulcerative colitis
chr11	96108427	96108428	Parkinson's disease
chr11	96959524	96959525	Formal thought disorder in schizophrenia
chr11	97574983	97574984	Information processing speed
chr11	97682563	97682564	Amyotrophic lateral sclerosis
chr11	98125403	98125404	Bipolar disorder and schizophrenia
chr11	98466267	98466268	Non-alcoholic fatty liver disease histology (lobular)
chr11	98723215	98723216	Obesity-related traits
chr11	98723215	98723216	Obesity-related traits
chr11	99493172	99493173	Atrial fibrillation
chr11	99585735	99585736	Volumetric brain MRI
chr11	100043419	100043420	Myopia (pathological)
chr11	100173536	100173537	Immune reponse to smallpox (secreted IL-2)
chr11	100406639	100406640	Menarche (age at onset)
chr11	100593537	100593538	Blood pressure
chr11	100593537	100593538	Diastolic blood pressure
chr11	100593537	100593538	Hypertension
chr11	100593537	100593538	Systolic blood pressure
chr11	102009279	102009280	Pubertal anthropometrics
chr11	102070638	102070639	Polycystic ovary syndrome
chr11	102155473	102155474	MRI atrophy measures
chr11	102401660	102401661	Prostate cancer
chr11	102628051	102628052	Multiple sclerosis
chr11	102691481	102691482	Matrix metalloproteinase levels
chr11	102695107	102695108	Matrix metalloproteinase levels
chr11	102733162	102733163	Alzheimer's disease
chr11	103418157	103418158	Small-cell lung cancer
chr11	103525753	103525754	Disc degeneration (lumbar)
chr11	103526023	103526024	Disc degeneration (lumbar)
chr11	103529631	103529632	Disc degeneration (lumbar)
chr11	103530365	103530366	Disc degeneration (lumbar)
chr11	103589093	103589094	Neutrophil count
chr11	103660566	103660567	Coronary heart disease
chr11	103808151	103808152	Coronary heart disease
chr11	104334238	104334239	Matrix metalloproteinase levels
chr11	104972517	104972518	Bronchopulmonary dysplasia
chr11	105556597	105556598	Refractive error
chr11	106330161	106330162	Inattentive symptoms
chr11	106496037	106496038	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr11	106523223	106523224	Obesity-related traits
chr11	107347276	107347277	IgG glycosylation
chr11	107347276	107347277	IgG glycosylation
chr11	107347276	107347277	IgG glycosylation
chr11	107481517	107481518	Common traits (Other)
chr11	107756550	107756551	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr11	108175461	108175462	Melanoma
chr11	108283160	108283161	Response to metformin
chr11	108283160	108283161	Response to metformin
chr11	108873118	108873119	QT interval (interaction)
chr11	108893366	108893367	IgG glycosylation
chr11	109995943	109995944	Exercise treadmill test traits
chr11	110395857	110395858	Renal sinus fat
chr11	110499252	110499253	Alzheimer's disease (cognitive decline)
chr11	110741013	110741014	Malaria
chr11	110913239	110913240	Corneal structure
chr11	111171708	111171709	Colorectal cancer
chr11	111171708	111171709	Colorectal cancer
chr11	111171708	111171709	Colorectal cancer
chr11	111275132	111275133	Primary biliary cirrhosis
chr11	111411607	111411608	Obesity-related traits
chr11	112085315	112085316	Protein quantitative trait loci
chr11	112456220	112456221	Response to antipsychotic treatment
chr11	112991617	112991618	Left ventricular mass
chr11	112991617	112991618	Left ventricular mass
chr11	112991617	112991618	Left ventricular mass
chr11	113106454	113106455	Entorhinal cortical thickness
chr11	113296618	113296619	Select biomarker traits
chr11	113309868	113309869	Working memory
chr11	113424557	113424558	Systolic blood pressure in sickle cell anemia
chr11	113961761	113961762	Conduct disorder (interaction)
chr11	114191015	114191016	Volumetric brain MRI
chr11	114231254	114231255	Asthma
chr11	114386829	114386830	Ulcerative colitis
chr11	114387101	114387102	IgG glycosylation
chr11	114390105	114390106	IgG glycosylation
chr11	114431955	114431956	Ulcerative colitis
chr11	114621468	114621469	Urinary albumin excretion
chr11	115140552	115140553	Orofacial clefts
chr11	115301870	115301871	Obesity-related traits
chr11	115398745	115398746	Metabolite levels (5-HIAA/ MHPG Ratio)
chr11	115398745	115398746	Metabolite levels (HVA/MHPG ratio)
chr11	115764044	115764045	Hip geometry
chr11	115943252	115943253	Hypertriglyceridemia
chr11	116298366	116298367	Brain structure
chr11	116400381	116400382	Bipolar disorder and schizophrenia
chr11	116584986	116584987	Triglycerides
chr11	116586282	116586283	Hematological and biochemical traits
chr11	116586282	116586283	Triglycerides
chr11	116599391	116599392	Multiple sclerosis (severity)
chr11	116603723	116603724	Carotenoid and tocopherol levels
chr11	116603723	116603724	Cholesterol, total
chr11	116603723	116603724	LDL cholesterol
chr11	116603723	116603724	Triglycerides
chr11	116607436	116607437	LDL cholesterol
chr11	116607436	116607437	Triglycerides
chr11	116613659	116613660	Cardiovascular disease risk factors
chr11	116617239	116617240	HDL cholesterol
chr11	116619072	116619073	Lipid traits
chr11	116619072	116619073	Triglycerides
chr11	116626257	116626258	Triglycerides-Blood Pressure (TG-BP)
chr11	116633861	116633862	Metabolic syndrome (bivariate traits)
chr11	116639103	116639104	HDL Cholesterol - Triglycerides (HDLC-TG)
chr11	116639103	116639104	Metabolic syndrome
chr11	116639103	116639104	Waist Circumference - Triglycerides (WC-TG)
chr11	116647606	116647607	Obesity-related traits
chr11	116648916	116648917	Cholesterol, total
chr11	116648916	116648917	Coronary heart disease
chr11	116648916	116648917	HDL cholesterol
chr11	116648916	116648917	HDL cholesterol
chr11	116648916	116648917	HDL cholesterol
chr11	116648916	116648917	HDL cholesterol
chr11	116648916	116648917	Hypertriglyceridemia
chr11	116648916	116648917	Hypertriglyceridemia
chr11	116648916	116648917	LDL cholesterol
chr11	116648916	116648917	Lipoprotein-associated phospholipase A2 activity and mass
chr11	116648916	116648917	Metabolic syndrome
chr11	116648916	116648917	Metabolite levels
chr11	116648916	116648917	Phospholipid levels (plasma)
chr11	116648916	116648917	Response to Vitamin E supplementation
chr11	116648916	116648917	Response to Vitamin E supplementation
chr11	116648916	116648917	Triglycerides
chr11	116648916	116648917	Triglycerides
chr11	116648916	116648917	Triglycerides
chr11	116648916	116648917	Vitamin E levels
chr11	116649134	116649135	Triglycerides-Blood Pressure (TG-BP)
chr11	116652206	116652207	Lipoprotein-associated phospholipase A2 activity and mass
chr11	116652206	116652207	Metabolic syndrome (bivariate traits)
chr11	116652206	116652207	Triglycerides
chr11	116652422	116652423	LDL cholesterol
chr11	116652422	116652423	Triglycerides
chr11	116653295	116653296	HDL Cholesterol - Triglycerides (HDLC-TG)
chr11	116653295	116653296	Metabolic syndrome
chr11	116653295	116653296	Waist Circumference - Triglycerides (WC-TG)
chr11	116654434	116654435	Triglycerides
chr11	116657560	116657561	Obesity-related traits
chr11	116660685	116660686	HDL Cholesterol - Triglycerides (HDLC-TG)
chr11	116660685	116660686	Metabolic syndrome
chr11	116660685	116660686	Triglycerides-Blood Pressure (TG-BP)
chr11	116660685	116660686	Waist Circumference - Triglycerides (WC-TG)
chr11	116662578	116662579	Lipid metabolism phenotypes
chr11	116662578	116662579	Triglycerides
chr11	116663706	116663707	Lipid traits
chr11	116681007	116681008	Coronary heart disease
chr11	116684027	116684028	Quantitative traits
chr11	116706046	116706047	Infantile hypertrophic pyloric stenosis
chr11	116722040	116722041	Iron status biomarkers
chr11	116732511	116732512	Triglycerides
chr11	116782973	116782974	Infantile hypertrophic pyloric stenosis
chr11	116829652	116829653	Visceral adipose tissue adjusted for BMI
chr11	116973928	116973929	Coronary heart disease
chr11	117037360	117037361	Protein quantitative trait loci
chr11	117075565	117075566	Cardiovascular disease risk factors
chr11	117091608	117091609	Iron status biomarkers
chr11	117156892	117156893	Cardiovascular disease risk factors
chr11	117388931	117388932	Menarche (age at onset)
chr11	117531730	117531731	Triglycerides
chr11	117851051	117851052	Obesity-related traits
chr11	118031985	118031986	Preeclampsia
chr11	118117017	118117018	Thiazide-induced adverse metabolic effects in hypertensive patients
chr11	118145685	118145686	Pain
chr11	118241994	118241995	Fat distribution (HIV)
chr11	118341648	118341649	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr11	118477366	118477367	Glioma
chr11	118477366	118477367	Glioma
chr11	118573518	118573519	Systemic lupus erythematosus
chr11	118574674	118574675	Height
chr11	118611780	118611781	Celiac disease and Rheumatoid arthritis
chr11	118698536	118698537	Vitiligo
chr11	118743771	118743772	Primary biliary cirrhosis
chr11	118754352	118754353	Inflammatory bowel disease
chr11	118754352	118754353	Multiple sclerosis
chr11	119099905	119099906	Platelet counts
chr11	119235403	119235404	Urate levels
chr11	120026747	120026748	Stroke (pediatric)
chr11	120026747	120026748	Stroke (pediatric)
chr11	120040441	120040442	Corneal curvature
chr11	120520628	120520629	Attention deficit hyperactivity disorder
chr11	120809459	120809460	Cognitive performance
chr11	121204600	121204601	Response to taxane treatment (placlitaxel)
chr11	121243715	121243716	Response to tocilizumab in rheumatoid arthritis
chr11	121435586	121435587	Alzheimer's disease (late onset)
chr11	121954656	121954657	Cardiovascular disease risk factors
chr11	122030189	122030190	Myopia (pathological)
chr11	122189464	122189465	Hemostatic factors and hematological phenotypes
chr11	122522374	122522375	Cholesterol, total
chr11	122522374	122522375	HDL cholesterol
chr11	122870682	122870683	Menarche (age at onset)
chr11	122873075	122873076	IgG glycosylation
chr11	123361396	123361397	Chronic lymphocytic leukemia
chr11	123361396	123361397	Chronic lymphocytic leukemia
chr11	123361396	123361397	Chronic lymphocytic leukemia
chr11	123361396	123361397	Follicular lymphoma
chr11	123595926	123595927	Response to antipsychotic therapy (extrapyramidal side effects)
chr11	123648332	123648333	IgE levels in asthmatics (D.p. specific)
chr11	123751827	123751828	Oleic acid (18:1n-9) plasma levels
chr11	123956465	123956466	Obesity-related traits
chr11	123956465	123956466	Obesity-related traits
chr11	124017492	124017493	Aging (time to death)
chr11	124537994	124537995	Bipolar disorder
chr11	124606284	124606285	Schizophrenia
chr11	125170638	125170639	Alcohol and nictotine co-dependence
chr11	125172592	125172593	Alcohol dependence
chr11	125178402	125178403	Alcohol dependence
chr11	125179852	125179853	Substance dependence
chr11	125241045	125241046	Creutzfeldt-Jakob disease (variant)
chr11	125277493	125277494	Obesity-related traits
chr11	125304008	125304009	Formal thought disorder in schizophrenia
chr11	125313598	125313599	Schizophrenia
chr11	125323964	125323965	Schizophrenia
chr11	125461708	125461709	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr11	125461708	125461709	Schizophrenia
chr11	125826701	125826702	Primary tooth development (time to first tooth eruption)
chr11	125873101	125873102	Breast size
chr11	125905257	125905258	Alzheimer's disease (late onset)
chr11	126028716	126028717	Heart failure
chr11	126030614	126030615	Estradiol plasma levels (breast cancer)
chr11	126243951	126243952	Cholesterol, total
chr11	126243951	126243952	LDL cholesterol
chr11	126281896	126281897	Coronary heart disease
chr11	126283784	126283785	Liver enzyme levels (alkaline phosphatase)
chr11	126296588	126296589	Hair color
chr11	126607579	126607580	Menarche (age at onset)
chr11	126619189	126619190	Attention deficit hyperactivity disorder and conduct disorder
chr11	126809704	126809705	Protein quantitative trait loci
chr11	126859156	126859157	Response to antipsychotic treatment
chr11	127081590	127081591	Amyotrophic lateral sclerosis
chr11	127110182	127110183	IgG glycosylation
chr11	127761665	127761666	Asthma (childhood onset)
chr11	128186881	128186882	Self-reported allergy
chr11	128189100	128189101	Alzheimer's disease (late onset)
chr11	128206409	128206410	Hippocampal atrophy
chr11	128311058	128311059	Systemic lupus erythematosus
chr11	128311058	128311059	Systemic lupus erythematosus
chr11	128328958	128328959	Systemic lupus erythematosus
chr11	128380973	128380974	Celiac disease
chr11	128436952	128436953	Obesity-related traits
chr11	128492738	128492739	Rheumatoid arthritis
chr11	128582556	128582557	Myopia (pathological)
chr11	128586154	128586155	Height
chr11	128816220	128816221	Metabolite levels (5-HIAA)
chr11	129461170	129461171	Breast cancer
chr11	129473689	129473690	Breast cancer
chr11	129473689	129473690	Type 2 diabetes
chr11	129698855	129698856	Obesity-related traits
chr11	130273229	130273230	Blood pressure
chr11	130529218	130529219	Periodontitis (Mean PAL)
chr11	130529218	130529219	Periodontitis (Mean PAL)
chr11	130629121	130629122	Obesity-related traits
chr11	130817578	130817579	Schizophrenia
chr11	130830747	130830748	Schizophrenia
chr11	130830747	130830748	Schizophrenia
chr11	131320069	131320070	Asperger disorder
chr11	131325245	131325246	Obesity-related traits
chr11	131336073	131336074	Bipolar disorder and schizophrenia
chr11	131350967	131350968	Sunburns
chr11	131807170	131807171	Cardiac Troponin-T levels
chr11	132010116	132010117	Chronic obstructive pulmonary disease-related biomarkers
chr11	132584118	132584119	Alcohol dependence
chr11	132641745	132641746	Waist-hip ratio
chr11	132829861	132829862	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr11	133120936	133120937	Smooth-surface caries
chr11	133566984	133566985	Menopause (age at onset)
chr11	133800218	133800219	Obesity-related traits
chr11	134088681	134088682	Cognitive test performance
chr11	134139779	134139780	Obesity-related traits
chr11	134139779	134139780	Obesity-related traits
chr11	134482465	134482466	Myopia (pathological)
chr11	134573809	134573810	IgG glycosylation
chr11	134626886	134626887	Myopia (pathological)
chr12	219987	219988	Response to angiotensin II receptor blocker therapy
chr12	320919	320920	Metabolite levels
chr12	349297	349298	Chronic kidney disease
chr12	551549	551550	Obesity (early onset extreme)
chr12	783483	783484	Stroke
chr12	1064437	1064438	Lung cancer
chr12	1638170	1638171	Bone mineral density
chr12	1856952	1856953	Adverse response to lamotrigine and phenytoin
chr12	1934580	1934581	Behavioural disinhibition (generation interaction)
chr12	2056362	2056363	Obesity-related traits
chr12	2091256	2091257	Response to gemcitabine in pancreatic cancer
chr12	2345294	2345295	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr12	2345294	2345295	Bipolar disorder
chr12	2345294	2345295	Bipolar disorder and major depressive disorder (combined)
chr12	2345294	2345295	Schizophrenia
chr12	2349583	2349584	Schizophrenia
chr12	2349583	2349584	Schizophrenia
chr12	2349583	2349584	Schizophrenia
chr12	2419895	2419896	Bipolar disorder
chr12	2523354	2523355	Red blood cell traits
chr12	2729631	2729632	Warfarin maintenance dose
chr12	2783971	2783972	Sleep quality
chr12	2882543	2882544	Quantitative traits
chr12	3164922	3164923	Narcolepsy with cataplexy
chr12	3287278	3287279	Temporomandibular joint disorders
chr12	3750127	3750128	Cytomegalovirus antibody response
chr12	3757547	3757548	Non-alcoholic fatty liver disease histology (lobular)
chr12	3814237	3814238	Male infertility
chr12	3913426	3913427	Cognitive performance
chr12	4118316	4118317	Major depressive disorder
chr12	4305882	4305883	Obesity-related traits
chr12	4332477	4332478	Red blood cell traits
chr12	4333918	4333919	Red blood cell count
chr12	4368351	4368352	Colorectal cancer
chr12	4368351	4368352	Colorectal cancer
chr12	4388270	4388271	Colorectal cancer
chr12	4399969	4399970	QT interval (interaction)
chr12	4405388	4405389	Colorectal cancer
chr12	4416303	4416304	Major depressive disorder
chr12	4425121	4425122	Acute lymphoblastic leukemia (childhood)
chr12	4523455	4523456	Migraine
chr12	4523455	4523456	Migraine - clinic-based
chr12	4523455	4523456	Migraine without aura
chr12	4606167	4606168	Phosphorus levels
chr12	5131552	5131553	Intelligence (childhood)
chr12	5140483	5140484	Conduct disorder (symptom count)
chr12	5751341	5751342	IgG glycosylation
chr12	5751341	5751342	IgG glycosylation
chr12	5797100	5797101	Panic disorder
chr12	5981352	5981353	Obesity-related traits
chr12	6153533	6153534	Coagulation factor levels
chr12	6289218	6289219	Mean platelet volume
chr12	6291092	6291093	Platelet counts
chr12	6308522	6308523	Paclitaxel-induced neuropathy
chr12	6435570	6435571	Obesity-related traits
chr12	6440008	6440009	Multiple sclerosis
chr12	6440008	6440009	Multiple sclerosis
chr12	6440008	6440009	Primary biliary cirrhosis
chr12	6442000	6442001	Adverse response to chemotherapy (neutropenia/leucopenia) (all anthracycline-based drugs)
chr12	6442000	6442001	Adverse response to chemotherapy (neutropenia/leucopenia) (epirubicin)
chr12	6442642	6442643	Multiple sclerosis
chr12	6466080	6466081	Obesity (early onset extreme)
chr12	6502741	6502742	Ankylosing spondylitis
chr12	6580581	6580582	Hip geometry
chr12	6683286	6683287	Myopia (pathological)
chr12	6938871	6938872	Response to Vitamin E supplementation
chr12	7334812	7334813	IgG glycosylation
chr12	7335216	7335217	IgG glycosylation
chr12	7691133	7691134	Hematological and biochemical traits
chr12	7855270	7855271	Thiazide-induced adverse metabolic effects in hypertensive patients
chr12	9371331	9371332	Non-alcoholic fatty liver disease histology (AST)
chr12	9380858	9380859	Breast size
chr12	9463805	9463806	Obesity-related traits
chr12	9546961	9546962	IgG glycosylation
chr12	9833627	9833628	Type 1 diabetes
chr12	9855957	9855958	Type 1 diabetes
chr12	9876090	9876091	Multiple sclerosis
chr12	9910163	9910164	Type 1 diabetes
chr12	10170160	10170161	Sensory disturbances after bilateral sagittal split ramus osteotomy
chr12	10170726	10170727	Systolic blood pressure in sickle cell anemia
chr12	10471049	10471050	Thiazide-induced adverse metabolic effects in hypertensive patients
chr12	10521388	10521389	Obesity-related traits
chr12	10560956	10560957	Behcet's disease
chr12	11279091	11279092	Bitter taste perception
chr12	11547531	11547532	Response to gemcitabine in pancreatic cancer
chr12	11558876	11558877	Periodontitis (CDC/AAP)
chr12	11648417	11648418	Information processing speed
chr12	11855623	11855624	Height
chr12	11855772	11855773	Height
chr12	11855772	11855773	Height
chr12	11942719	11942720	Lung function (forced expiratory volume in 1 second)
chr12	11962572	11962573	IgG glycosylation
chr12	12376464	12376465	Coronary artery calcification
chr12	12657512	12657513	Inflammatory bowel disease
chr12	12773520	12773521	Systemic lupus erythematosus
chr12	12834893	12834894	Systemic lupus erythematosus
chr12	12870694	12870695	Systemic lupus erythematosus
chr12	13452779	13452780	Coronary artery calcification
chr12	13519995	13519996	Major depressive disorder
chr12	13629380	13629381	Barrett's esophagus
chr12	13641705	13641706	Major depressive disorder
chr12	13787845	13787846	Cognitive performance
chr12	13872043	13872044	Immune reponse to smallpox (secreted IL-2)
chr12	13923327	13923328	Brain structure (temporal lobe volume)
chr12	13927895	13927896	Ovarian reserve
chr12	14064460	14064461	Total ventricular volume
chr12	14115481	14115482	Aging (time to event)
chr12	14413930	14413931	Breast cancer
chr12	14587300	14587301	Prostate-specific antigen levels
chr12	14653866	14653867	Testicular germ cell cancer
chr12	14653866	14653867	Testicular germ cell tumor
chr12	14660183	14660184	Response to amphetamines
chr12	14966603	14966604	Pubertal anthropometrics
chr12	15389636	15389637	Behavioural disinhibition (generation interaction)
chr12	15735441	15735442	Cognitive function
chr12	15930804	15930805	Protein quantitative trait loci
chr12	16406689	16406690	Visceral fat
chr12	16609037	16609038	Economic and political preferences
chr12	17362815	17362816	Word reading
chr12	17373738	17373739	Amyotrophic lateral sclerosis
chr12	17662234	17662235	Major depressive disorder
chr12	19052179	19052180	Personality dimensions
chr12	19779792	19779793	Obesity-related traits
chr12	19801594	19801595	Cognitive performance
chr12	19866128	19866129	Pulmonary function
chr12	20063967	20063968	Response to amphetamines
chr12	20230638	20230639	Aortic root size
chr12	20473757	20473758	HDL cholesterol
chr12	20498035	20498036	Adiponectin levels
chr12	20521653	20521654	Male infertility
chr12	20531755	20531756	QT interval
chr12	20758612	20758613	Height
chr12	20840838	20840839	Response to TNF-alpha inhibitors in rheumatoid arthritis
chr12	20857466	20857467	Height
chr12	20860092	20860093	Response to TNF-alpha inhibitors in rheumatoid arthritis
chr12	21017874	21017875	Bilirubin levels
chr12	21017874	21017875	Bilirubin levels
chr12	21017874	21017875	Bilirubin levels
chr12	21017874	21017875	Bilirubin levels
chr12	21074121	21074122	Bilirubin levels
chr12	21321369	21321370	Methotrexate phramacokinetics (acute lymphoblastic leukemia)
chr12	21329760	21329761	Methotrexate phramacokinetics (acute lymphoblastic leukemia)
chr12	21331548	21331549	Bilirubin levels
chr12	21331548	21331549	Response to statin therapy
chr12	21331548	21331549	Sex hormone-binding globulin levels
chr12	21368721	21368722	Bilirubin levels
chr12	21377558	21377559	Methotrexate clearance (acute lymphoblastic leukemia)
chr12	21378020	21378021	Metabolic traits
chr12	21382618	21382619	Metabolite levels
chr12	21382618	21382619	Methotrexate phramacokinetics (acute lymphoblastic leukemia)
chr12	21451394	21451395	Methotrexate phramacokinetics (acute lymphoblastic leukemia)
chr12	21457433	21457434	Progressive supranuclear palsy
chr12	21996044	21996045	Obesity-related traits
chr12	22151572	22151573	Entorhinal cortical thickness
chr12	22365834	22365835	Non-alcoholic fatty liver disease histology (lobular)
chr12	22566428	22566429	Coronary artery calcification
chr12	23639916	23639917	Economic and political preferences (feminism/equality)
chr12	23946145	23946146	Systemic sclerosis
chr12	23946145	23946146	Systemic sclerosis
chr12	24184543	24184544	Non-obstructive azoospermia
chr12	24278820	24278821	Response to statin therapy
chr12	24389659	24389660	Response to antipsychotic treatment
chr12	24394371	24394372	AIDS
chr12	24770877	24770878	Heart rate
chr12	24770877	24770878	Resting heart rate
chr12	24788338	24788339	PR interval
chr12	25484192	25484193	Thiazide-induced adverse metabolic effects in hypertensive patients
chr12	26453282	26453283	Renal cell carcinoma
chr12	26453282	26453283	Waist-hip ratio
chr12	26636385	26636386	Amyotrophic lateral sclerosis
chr12	28008768	28008769	Retinopathy in non-diabetics
chr12	28017158	28017159	Bone mineral density
chr12	28155079	28155080	Breast Cancer in BRCA1 mutation carriers
chr12	28155079	28155080	Breast cancer
chr12	28155079	28155080	Breast cancer
chr12	28156080	28156081	Breast size
chr12	28192988	28192989	IgG glycosylation
chr12	28228566	28228567	Attention deficit hyperactivity disorder
chr12	28228566	28228567	Hyperactive-impulsive symptoms
chr12	28534414	28534415	Height
chr12	28569713	28569714	Height
chr12	28744640	28744641	Obesity-related traits
chr12	28815791	28815792	Metabolite levels (Pyroglutamine)
chr12	29435479	29435480	Mean platelet volume
chr12	29872317	29872318	Schizophrenia
chr12	30104141	30104142	Heart failure
chr12	30113882	30113883	Aging traits
chr12	32097359	32097360	Corneal astigmatism
chr12	32150242	32150243	Obesity-related traits
chr12	32261238	32261239	Obesity-related traits
chr12	32380500	32380501	Emphysema-related traits
chr12	32380500	32380501	Weight
chr12	32436408	32436409	Pancreatic cancer
chr12	32476726	32476727	Normalized brain volume
chr12	32537487	32537488	Response to tocilizumab in rheumatoid arthritis
chr12	33017042	33017043	Obesity-related traits
chr12	33017042	33017043	Obesity-related traits
chr12	33017042	33017043	Obesity-related traits
chr12	33576989	33576990	Heart rate
chr12	33701165	33701166	Cognitive test performance
chr12	38743507	38743508	Drug-induced liver injury (flucloxacillin)
chr12	39106730	39106731	Heart rate
chr12	39253107	39253108	IgG glycosylation
chr12	39253107	39253108	IgG glycosylation
chr12	40341084	40341085	Sleep quality
chr12	40352995	40352996	Parkinson's disease
chr12	40354243	40354244	Insomnia
chr12	40428560	40428561	Parkinson's disease
chr12	40601939	40601940	Crohn's disease
chr12	40620807	40620808	Parkinson's disease
chr12	40620807	40620808	Parkinson's disease
chr12	40734201	40734202	Parkinson's disease
chr12	40757327	40757328	Parkinson's disease
chr12	40767361	40767362	Obesity-related traits
chr12	40792299	40792300	Crohn's disease
chr12	40792299	40792300	Inflammatory bowel disease
chr12	41247741	41247742	Bipolar disorder
chr12	41353748	41353749	IgG glycosylation
chr12	41721429	41721430	Protein quantitative trait loci
chr12	41965860	41965861	Multiple sclerosis
chr12	42171981	42171982	Biochemical measures
chr12	43160743	43160744	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr12	43160824	43160825	Panic disorder
chr12	43253414	43253415	Heart failure
chr12	43434281	43434282	Obesity-related traits
chr12	43929995	43929996	Adverse response to lamotrigine and phenytoin
chr12	44153825	44153826	Immune reponse to smallpox (secreted TNF-alpha)
chr12	45774907	45774908	Ankylosing spondylitis
chr12	46485837	46485838	Hippocampal atrophy
chr12	47372269	47372270	Prostate cancer (gene x gene interaction)
chr12	47639525	47639526	Alzheimer's disease
chr12	47771428	47771429	Migraine with aura
chr12	47814971	47814972	Metabolite levels (HVA/5-HIAA ratio)
chr12	47923015	47923016	Obesity-related traits
chr12	48173351	48173352	Urate levels
chr12	48187253	48187254	Obesity-related traits
chr12	48208367	48208368	Inflammatory bowel disease
chr12	48403764	48403765	Bipolar disorder and schizophrenia
chr12	48811099	48811100	Prostate cancer (gene x gene interaction)
chr12	49218170	49218171	Bipolar disorder
chr12	49474604	49474605	Bone mineral density
chr12	49676009	49676010	Prostate cancer
chr12	50226466	50226467	Obesity
chr12	50247467	50247468	Body mass index
chr12	50247467	50247468	Body mass index
chr12	50247467	50247468	Body mass index
chr12	50247467	50247468	Obesity
chr12	50247467	50247468	Obesity
chr12	50247467	50247468	Waist circumference
chr12	50247467	50247468	Weight
chr12	50319085	50319086	Obsessive-compulsive disorder
chr12	51134740	51134741	Fibrinogen
chr12	51155662	51155663	Colorectal cancer
chr12	51213432	51213433	Sudden cardiac arrest
chr12	51357541	51357542	Type 2 diabetes
chr12	51703833	51703834	Aging (time to death)
chr12	51727595	51727596	Obesity-related traits
chr12	51878759	51878760	Alzheimer's disease (cognitive decline)
chr12	52251271	52251272	Urate levels
chr12	52263955	52263956	Reasoning
chr12	53273903	53273904	Prostate cancer
chr12	53554282	53554283	Obesity-related traits
chr12	53727954	53727955	Bone mineral density
chr12	53727954	53727955	Bone mineral density (spine)
chr12	53731890	53731891	Bone mineral density (spine)
chr12	53916714	53916715	Height
chr12	53995076	53995077	Migraine without aura
chr12	54041191	54041192	Height
chr12	54114157	54114158	Panic disorder
chr12	54159276	54159277	Tanning
chr12	54270227	54270228	Biliary atresia
chr12	54319726	54319727	Adverse response to chemotherapy (neutropenia/leucopenia) (all antimetabolite drugs)
chr12	54342683	54342684	Waist-hip ratio
chr12	54417575	54417576	Bone mineral density
chr12	54687231	54687232	Mean platelet volume
chr12	54687231	54687232	Mean platelet volume
chr12	54712307	54712308	Mean platelet volume
chr12	54736469	54736470	Platelet counts
chr12	54909143	54909144	Obesity-related traits
chr12	55098995	55098996	Type 2 diabetes
chr12	55424915	55424916	IgG glycosylation
chr12	56070667	56070668	Response to amphetamines
chr12	56114768	56114769	Refractive error
chr12	56364320	56364321	Asthma
chr12	56390635	56390636	Polycystic ovary syndrome
chr12	56401084	56401085	Vitiligo
chr12	56412486	56412487	Alopecia areata
chr12	56412486	56412487	Asthma
chr12	56412486	56412487	Type 1 diabetes
chr12	56412486	56412487	Type 1 diabetes autoantibodies
chr12	56416927	56416928	Vitiligo
chr12	56439208	56439209	Psoriasis
chr12	56470624	56470625	Type 1 diabetes
chr12	56474142	56474143	Obesity-related traits
chr12	56482179	56482180	Type 1 diabetes
chr12	56482179	56482180	Type 1 diabetes
chr12	56482179	56482180	Type 1 diabetes
chr12	56482179	56482180	Type 1 diabetes autoantibodies
chr12	56518407	56518408	Systemic sclerosis
chr12	56680744	56680745	Height
chr12	56737972	56737973	Psoriasis
chr12	56737972	56737973	Psoriasis
chr12	56740681	56740682	Height
chr12	56815280	56815281	Axial length
chr12	56828055	56828056	Immune reponse to smallpox (secreted IFN-alpha)
chr12	56863769	56863770	Metabolite levels
chr12	56865055	56865056	Metabolite levels
chr12	56865337	56865338	Metabolic traits
chr12	56938382	56938383	Adiponectin levels
chr12	57023283	57023284	Platelet counts
chr12	57055290	57055291	Mean platelet volume
chr12	57065712	57065713	Age-related macular degeneration
chr12	57146068	57146069	Menopause (age at onset)
chr12	57204159	57204160	Platelet aggregation
chr12	57377346	57377347	Migraine
chr12	57489708	57489709	Allergic sensitization
chr12	57489708	57489709	IgE levels
chr12	57489708	57489709	Sensory disturbances after bilateral sagittal split ramus osteotomy
chr12	57503774	57503775	Eosinophilic esophagitis (pediatric)
chr12	57527282	57527283	Migraine
chr12	57527282	57527283	Migraine
chr12	57527282	57527283	Migraine
chr12	57527282	57527283	Migraine - clinic-based
chr12	57527282	57527283	Migraine without aura
chr12	57527282	57527283	Pulmonary function
chr12	57527282	57527283	Pulmonary function (interaction)
chr12	57534469	57534470	Abdominal aortic aneurysm
chr12	57792579	57792580	HDL cholesterol
chr12	57792579	57792580	Triglycerides
chr12	57809455	57809456	Urate levels
chr12	57844048	57844049	Urate levels
chr12	57968714	57968715	Rheumatoid arthritis
chr12	57968714	57968715	Rheumatoid arthritis
chr12	58062666	58062667	Celiac disease and Rheumatoid arthritis
chr12	58133255	58133256	Multiple sclerosis
chr12	58162738	58162739	Multiple sclerosis
chr12	58750679	58750680	Obesity-related traits
chr12	59259627	59259628	Heart failure
chr12	59440231	59440232	Temperament (bipolar disorder)
chr12	59849676	59849677	Methotrexate phramacokinetics (acute lymphoblastic leukemia)
chr12	60735172	60735173	Obesity-related traits
chr12	60735172	60735173	Obesity-related traits
chr12	60735172	60735173	Obesity-related traits
chr12	60797702	60797703	Cardiac hypertrophy
chr12	60810651	60810652	Obesity-related traits
chr12	61549080	61549081	IgG glycosylation
chr12	62234832	62234833	Obesity-related traits
chr12	62234832	62234833	Obesity-related traits
chr12	62610859	62610860	Pulmonary function decline
chr12	62818480	62818481	IgG glycosylation
chr12	62886122	62886123	IgG glycosylation
chr12	63004582	63004583	Waist circumference
chr12	63180815	63180816	Obesity-related traits
chr12	63445091	63445092	Hemostatic factors and hematological phenotypes
chr12	63445961	63445962	Obesity-related traits
chr12	65252117	65252118	Cognitive performance
chr12	65534623	65534624	Hippocampal volume
chr12	65718298	65718299	Hippocampal volume
chr12	65762057	65762058	Primary tooth development (number of teeth)
chr12	65762057	65762058	Primary tooth development (time to first tooth eruption)
chr12	65783377	65783378	Primary tooth development (number of teeth)
chr12	65783377	65783378	Primary tooth development (time to first tooth eruption)
chr12	65842257	65842258	Temperament
chr12	66117557	66117558	Type 2 diabetes nephropathy
chr12	66160970	66160971	AB1-42
chr12	66174893	66174894	Type 2 diabetes
chr12	66224460	66224461	Polycystic ovary syndrome
chr12	66227256	66227257	Height
chr12	66338201	66338202	Primary tooth development (number of teeth)
chr12	66338201	66338202	Primary tooth development (time to first tooth eruption)
chr12	66343809	66343810	Brain structure
chr12	66351825	66351826	Height
chr12	66351825	66351826	Height
chr12	66358346	66358347	Birth weight
chr12	66358346	66358347	Head circumference (infant)
chr12	66358346	66358347	Height
chr12	66358346	66358347	Height
chr12	66358346	66358347	Height
chr12	66359751	66359752	Height
chr12	66359751	66359752	Height
chr12	66359751	66359752	Height
chr12	66364508	66364509	Permanent tooth development
chr12	66364508	66364509	Primary tooth development (number of teeth)
chr12	66364508	66364509	Primary tooth development (time to first tooth eruption)
chr12	66371879	66371880	Height
chr12	66389967	66389968	Axial length
chr12	66394663	66394664	Aortic root size
chr12	67628830	67628831	Hippocampal atrophy
chr12	68500074	68500075	Inflammatory bowel disease
chr12	68500074	68500075	Ulcerative colitis
chr12	68504591	68504592	Ulcerative colitis
chr12	68504591	68504592	Ulcerative colitis
chr12	68532076	68532077	Bipolar disorder and schizophrenia
chr12	68596660	68596661	Ulcerative colitis
chr12	68779412	68779413	Temperament (bipolar disorder)
chr12	68961583	68961584	White blood cell count
chr12	69370755	69370756	Major depressive disorder
chr12	69523922	69523923	QRS duration
chr12	69581221	69581222	IgG glycosylation
chr12	69771072	69771073	Venous thromboembolism (gene x gene interaction)
chr12	69827657	69827658	Height
chr12	69827657	69827658	Height
chr12	69828680	69828681	Height
chr12	70054909	70054910	Orofacial clefts
chr12	70331826	70331827	Attention deficit hyperactivity disorder and conduct disorder
chr12	70690084	70690085	Amyotrophic lateral sclerosis (age of onset)
chr12	71249995	71249996	Refractive error
chr12	71289555	71289556	IgG glycosylation
chr12	71577100	71577101	Creutzfeldt-Jakob disease (variant)
chr12	71577100	71577101	Type 2 diabetes
chr12	71634793	71634794	Type 2 diabetes
chr12	71663101	71663102	Type 2 diabetes
chr12	72071044	72071045	Economic and political preferences (time)
chr12	72125284	72125285	Economic and political preferences (time)
chr12	72414562	72414563	Colorectal cancer
chr12	72724033	72724034	Rheumatoid arthritis
chr12	72724033	72724034	Rheumatoid arthritis
chr12	73163150	73163151	Metabolite levels (Dihydroxy docosatrienoic acid)
chr12	73307581	73307582	Cognitive performance
chr12	73601131	73601132	Body mass index and cholesterol (psychopharmacological treatment)
chr12	73828955	73828956	Chemerin levels
chr12	73989836	73989837	Breast cancer
chr12	74087807	74087808	Obesity-related traits
chr12	74586209	74586210	Bone mineral density
chr12	75054592	75054593	Obesity-related traits
chr12	75718422	75718423	Coronary artery calcification
chr12	76064527	76064528	Blood trace element (Cu levels)
chr12	76220617	76220618	Sudden cardiac arrest
chr12	76476955	76476956	Obesity-related traits
chr12	77009059	77009060	Systemic lupus erythematosus
chr12	77729384	77729385	Smoking behavior
chr12	77899509	77899510	Myopia (pathological)
chr12	78485993	78485994	Self-rated health
chr12	79775247	79775248	Obesity-related traits
chr12	80062229	80062230	Attention deficit hyperactivity disorder and conduct disorder
chr12	80463083	80463084	Thiazide-induced adverse metabolic effects in hypertensive patients
chr12	80496922	80496923	Hip geometry
chr12	81337457	81337458	Dental caries
chr12	81544535	81544536	Response to antidepressant treatment (citalopram)
chr12	81843127	81843128	Schizophrenia
chr12	82462225	82462226	IgG glycosylation
chr12	82984878	82984879	Immune response to smallpox vaccine (IL-6)
chr12	83019187	83019188	Immune response to smallpox vaccine (IL-6)
chr12	83164555	83164556	Prostate cancer (gene x gene interaction)
chr12	84008274	84008275	Neonatal lupus
chr12	84196528	84196529	Obesity-related traits
chr12	84564067	84564068	Major depressive disorder
chr12	85187510	85187511	Behavioural disinhibition (generation interaction)
chr12	88829293	88829294	Red blood cell traits
chr12	88890670	88890671	Testicular germ cell tumor
chr12	88890670	88890671	Testicular germ cell tumor
chr12	88890670	88890671	Testicular germ cell tumor
chr12	88890670	88890671	Testicular germ cell tumor
chr12	88953560	88953561	Testicular germ cell cancer
chr12	88953958	88953959	Testicular cancer
chr12	89328334	89328335	Blond vs. brown hair color
chr12	89328334	89328335	Hair color
chr12	90008958	90008959	Diastolic blood pressure
chr12	90008958	90008959	Hypertension
chr12	90013088	90013089	Systolic blood pressure
chr12	90060585	90060586	Biomedical quantitative traits
chr12	90060585	90060586	Biomedical quantitative traits
chr12	90060585	90060586	Blood pressure
chr12	90060585	90060586	Blood pressure
chr12	90060585	90060586	Blood pressure
chr12	90060585	90060586	Blood pressure
chr12	90060585	90060586	Blood pressure
chr12	90081187	90081188	Coronary heart disease
chr12	90305778	90305779	Magnesium levels
chr12	90443481	90443482	Optic disc size (cup)
chr12	90609016	90609017	vWF and FVIII levels
chr12	91077507	91077508	Smoking behavior
chr12	91473797	91473798	Pulmonary function (interaction)
chr12	91980373	91980374	Sudden cardiac arrest
chr12	92164301	92164302	Biochemical measures
chr12	92305269	92305270	Heart failure
chr12	92890519	92890520	Sudden cardiac arrest
chr12	92987207	92987208	Periodontitis (Mean PAL)
chr12	93550300	93550301	Non-alcoholic fatty liver disease histology (other)
chr12	93976953	93976954	Height
chr12	93978503	93978504	Height
chr12	93978503	93978504	Height
chr12	93980087	93980088	Height
chr12	93983553	93983554	Pubertal anthropometrics
chr12	94120338	94120339	Height
chr12	94235164	94235165	Alzheimer's disease (cognitive decline)
chr12	94528824	94528825	Behavioural disinhibition (generation interaction)
chr12	94683203	94683204	Estradiol plasma levels (breast cancer)
chr12	94865476	94865477	Obesity-related traits
chr12	95490247	95490248	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel + carboplatin)
chr12	95696419	95696420	Endometriosis
chr12	95711875	95711876	Endometriosis
chr12	95959787	95959788	Response to antidepressant treatment
chr12	96027758	96027759	Breast cancer
chr12	96027758	96027759	Breast cancer
chr12	96027758	96027759	Breast size
chr12	96057183	96057184	Allergic dermatitis (nickel)
chr12	96271427	96271428	Pulmonary function
chr12	96271427	96271428	Pulmonary function (interaction)
chr12	96479266	96479267	Height
chr12	96807916	96807917	Weight
chr12	96817421	96817422	Venous thromboembolism (gene x gene interaction)
chr12	96858361	96858362	Phospholipid levels (plasma)
chr12	97528139	97528140	IgG glycosylation
chr12	97689767	97689768	Sudden cardiac arrest
chr12	97901269	97901270	Obesity (early onset extreme)
chr12	99190371	99190372	Amyotrophic lateral sclerosis (age of onset)
chr12	99334528	99334529	Obesity-related traits
chr12	99498186	99498187	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr12	99816841	99816842	Response to antipsychotic treatment
chr12	99904539	99904540	Metabolite levels (HVA/5-HIAA ratio)
chr12	99961348	99961349	Body mass index
chr12	99961348	99961349	Waist circumference
chr12	100266112	100266113	Working memory
chr12	100820084	100820085	Squamous cell carcinoma
chr12	101221238	101221239	Alzheimer's disease (cognitive decline)
chr12	101687042	101687043	Brain structure (hippocampal volume)
chr12	101753953	101753954	Coronary artery calcification
chr12	102020445	102020446	Lung function (forced expiratory volume in 1 second)
chr12	102321934	102321935	Systemic lupus erythematosus
chr12	102373787	102373788	Height
chr12	102513530	102513531	Height
chr12	102726337	102726338	Height
chr12	102799597	102799598	Height
chr12	102875568	102875569	Fasting glucose-related traits
chr12	102875568	102875569	Fasting glucose-related traits
chr12	102875568	102875569	Fasting insulin-related traits
chr12	102875568	102875569	Fasting insulin-related traits
chr12	102912557	102912558	Fasting insulin-related traits (interaction with BMI)
chr12	102965328	102965329	Thiazide-induced adverse metabolic effects in hypertensive patients
chr12	103125689	103125690	Uterine fibroids
chr12	103483093	103483094	C-reactive protein
chr12	103495150	103495151	C-reactive protein
chr12	103912505	103912506	Coronary restenosis
chr12	104034318	104034319	IgG glycosylation
chr12	104034318	104034319	IgG glycosylation
chr12	104139033	104139034	vWF and FVIII levels
chr12	104192823	104192824	Attention deficit hyperactivity disorder
chr12	104421807	104421808	Hepatitis C induced liver fibrosis
chr12	104445741	104445742	Corneal structure
chr12	104818191	104818192	Obesity-related traits
chr12	105017163	105017164	Cannabis dependence
chr12	105452441	105452442	IgG glycosylation
chr12	105458796	105458797	IgG glycosylation
chr12	106108718	106108719	Alzheimer's disease biomarkers
chr12	106785553	106785554	Tourette syndrome
chr12	106949986	106949987	Parkinson's disease
chr12	106950694	106950695	Cognitive test performance
chr12	107149421	107149422	Heart rate
chr12	107367224	107367225	Bone mineral density
chr12	107704704	107704705	Cognitive performance
chr12	108602969	108602970	Temperament (bipolar disorder)
chr12	108699031	108699032	Response to platinum-based chemotherapy in non-small-cell lung cancer
chr12	108742819	108742820	Bipolar disorder
chr12	108767332	108767333	Erectile dysfunction and prostate cancer treatment
chr12	108841862	108841863	Obesity-related traits
chr12	108877540	108877541	IgG glycosylation
chr12	108877540	108877541	IgG glycosylation
chr12	109025426	109025427	Conduct disorder (symptom count)
chr12	109840939	109840940	HDL cholesterol
chr12	109895167	109895168	HDL cholesterol
chr12	109895167	109895168	HDL cholesterol
chr12	110000192	110000193	HDL cholesterol
chr12	110368200	110368201	Metabolic syndrome
chr12	110398144	110398145	Metabolite levels (MHPG)
chr12	110704486	110704487	Protein quantitative trait loci
chr12	111155530	111155531	Heart rate
chr12	111333621	111333622	Alcohol consumption
chr12	111340242	111340243	Drinking behavior
chr12	111350654	111350655	Coronary heart disease
chr12	111414460	111414461	Alcohol consumption
chr12	111414460	111414461	Gamma glutamyl transpeptidase
chr12	111414460	111414461	Glycemic traits
chr12	111414460	111414461	HDL cholesterol
chr12	111679213	111679214	Coronary heart disease
chr12	111708457	111708458	Type 1 diabetes
chr12	111884607	111884608	Beta-2 microglubulin plasma levels
chr12	111884607	111884608	Coronary heart disease
chr12	111884607	111884608	Diastolic blood pressure
chr12	111884607	111884608	Diastolic blood pressure
chr12	111884607	111884608	Eosinophil counts
chr12	111884607	111884608	Hypothyroidism
chr12	111884607	111884608	Platelet counts
chr12	111884607	111884608	Platelet counts
chr12	111884607	111884608	Red blood cell traits
chr12	111884607	111884608	Rheumatoid arthritis
chr12	111884607	111884608	Systolic blood pressure
chr12	111884607	111884608	Type 1 diabetes
chr12	111884607	111884608	Type 1 diabetes autoantibodies
chr12	111887658	111887659	Platelet counts
chr12	111904370	111904371	Vitiligo
chr12	111910218	111910219	Retinal vascular caliber
chr12	112007755	112007756	Blood pressure
chr12	112007755	112007756	Celiac disease
chr12	112007755	112007756	Celiac disease
chr12	112007755	112007756	Celiac disease and Rheumatoid arthritis
chr12	112007755	112007756	Chronic kidney disease
chr12	112007755	112007756	Diastolic blood pressure
chr12	112007755	112007756	Urate levels
chr12	112072423	112072424	Cholesterol, total
chr12	112072423	112072424	Hematocrit
chr12	112072423	112072424	Hemoglobin
chr12	112072423	112072424	LDL cholesterol
chr12	112072423	112072424	Tetralogy of Fallot
chr12	112110488	112110489	Hematological and biochemical traits
chr12	112168008	112168009	Coronary heart disease
chr12	112168008	112168009	Esophageal cancer
chr12	112190437	112190438	Mean platelet volume
chr12	112211832	112211833	Stroke (ischemic)
chr12	112241765	112241766	Coronary heart disease
chr12	112241765	112241766	Drinking behavior
chr12	112241765	112241766	Esophageal cancer
chr12	112241765	112241766	Hematological and biochemical traits
chr12	112241765	112241766	Intracranial aneurysm
chr12	112241765	112241766	Renal function-related traits (sCR)
chr12	112241765	112241766	Triglycerides
chr12	112241765	112241766	mean corpuscular hemoglobin concentration
chr12	112486817	112486818	Type 1 diabetes
chr12	112486817	112486818	Type 1 diabetes
chr12	112486817	112486818	Type 1 diabetes
chr12	112521447	112521448	Upper aerodigestive tract cancers
chr12	112645400	112645401	Alcohol consumption
chr12	112645400	112645401	Biomedical quantitative traits
chr12	112645400	112645401	Esophageal cancer
chr12	112645400	112645401	Gamma glutamyl transpeptidase
chr12	112645400	112645401	Glycemic traits
chr12	112645400	112645401	Glycemic traits
chr12	112645400	112645401	Glycemic traits
chr12	112645400	112645401	HDL cholesterol
chr12	112645400	112645401	Renal function-related traits (BUN)
chr12	112817782	112817783	Blood pressure
chr12	112817782	112817783	Blood pressure
chr12	112817782	112817783	Coronary heart disease
chr12	112817782	112817783	Drinking behavior
chr12	112817782	112817783	Esophageal cancer
chr12	112817782	112817783	Metabolite levels
chr12	112817782	112817783	Metabolite levels
chr12	112871371	112871372	Hematological parameters
chr12	113100993	113100994	Platelet counts
chr12	113158837	113158838	Methotrexate phramacokinetics (acute lymphoblastic leukemia)
chr12	113173493	113173494	Platelet counts
chr12	113365620	113365621	Gamma glutamyl transpeptidase
chr12	113365620	113365621	Glycemic traits
chr12	113409175	113409176	Alcohol consumption
chr12	113409175	113409176	HDL cholesterol
chr12	113491783	113491784	Visceral adipose tissue adjusted for BMI
chr12	113607501	113607502	Response to fenofibrate (adiponectin levels)
chr12	113979655	113979656	Quantitative traits
chr12	114637422	114637423	Visceral fat
chr12	114637847	114637848	Airflow obstruction
chr12	114685570	114685571	Prostate cancer
chr12	114705585	114705586	Schizophrenia
chr12	114714265	114714266	Obesity-related traits
chr12	114793239	114793240	Ventricular conduction
chr12	114795442	114795443	Electrocardiographic traits
chr12	114795442	114795443	Electrocardiographic traits
chr12	114795442	114795443	Electrocardiographic traits
chr12	114802137	114802138	PR interval
chr12	114868137	114868138	Mammographic density
chr12	115094259	115094260	Prostate-specific antigen levels
chr12	115116351	115116352	Colorectal cancer
chr12	115346423	115346424	PR interval
chr12	115352730	115352731	Blood pressure
chr12	115352730	115352731	Diastolic blood pressure
chr12	115380392	115380393	Alzheimer's disease
chr12	115381739	115381740	Ventricular conduction
chr12	115502717	115502718	Metabolite levels
chr12	115552436	115552437	Blood pressure
chr12	115552436	115552437	Blood pressure
chr12	115836521	115836522	Breast cancer
chr12	115891402	115891403	Colorectal cancer
chr12	116211862	116211863	IgG glycosylation
chr12	117002657	117002658	Acute lymphoblastic leukemia (childhood)
chr12	117199413	117199414	Obesity-related traits
chr12	117295332	117295333	Alzheimer's disease (age of onset)
chr12	117327591	117327592	Brain structure
chr12	117327591	117327592	Hippocampal volume
chr12	117751424	117751425	Inattentive symptoms
chr12	118106193	118106194	Endometriosis
chr12	118169908	118169909	Visceral adipose tissue adjusted for BMI
chr12	118272870	118272871	Migraine
chr12	118311742	118311743	Biochemical measures
chr12	118353870	118353871	Biochemical measures
chr12	118454668	118454669	Obesity-related traits
chr12	118524425	118524426	Obesity-related traits
chr12	118893247	118893248	Hemostatic factors and hematological phenotypes
chr12	119163078	119163079	Obesity-related traits
chr12	119387917	119387918	T-tau
chr12	119818508	119818509	Schizophrenia
chr12	119989645	119989646	Aging traits
chr12	120455763	120455764	Cognitive performance
chr12	120562973	120562974	Obesity-related traits
chr12	120880433	120880434	Insulin resistance/response
chr12	120974509	120974510	Type 1 diabetes nephropathy
chr12	121160614	121160615	Metabolic traits
chr12	121175523	121175524	Metabolite levels
chr12	121236257	121236258	Quantitative traits
chr12	121363723	121363724	Longevity
chr12	121388961	121388962	LDL cholesterol
chr12	121388961	121388962	Metabolic traits
chr12	121402931	121402932	C-reactive protein
chr12	121402931	121402932	Type 2 diabetes
chr12	121403723	121403724	Chronic obstructive pulmonary disease-related biomarkers
chr12	121403723	121403724	N-glycan levels
chr12	121405125	121405126	Homocysteine levels
chr12	121416649	121416650	Cholesterol, total
chr12	121416649	121416650	Gamma gluatamyl transferase levels
chr12	121416649	121416650	LDL cholesterol
chr12	121416987	121416988	Urate levels
chr12	121420259	121420260	C-reactive protein
chr12	121420806	121420807	C-reactive protein
chr12	121420806	121420807	C-reactive protein
chr12	121420806	121420807	C-reactive protein
chr12	121423955	121423956	C-reactive protein and white blood cell count
chr12	121423955	121423956	Gamma glutamyl transpeptidase
chr12	121424860	121424861	C-reactive protein
chr12	121424860	121424861	C-reactive protein
chr12	121424860	121424861	Liver enzyme levels (gamma-glutamyl transferase)
chr12	121435586	121435587	C-reactive protein
chr12	121435586	121435587	Coronary heart disease
chr12	121438843	121438844	N-glycan levels
chr12	121439432	121439433	C-reactive protein
chr12	121442669	121442670	Liver enzyme levels
chr12	121460685	121460686	Type 2 diabetes
chr12	121471336	121471337	Cardiovascular disease risk factors
chr12	121622303	121622304	Chronic obstructive pulmonary disease-related biomarkers
chr12	121938184	121938185	Fasting glucose-related traits (interaction with BMI)
chr12	122276254	122276255	Obesity-related traits
chr12	122365582	122365583	Mean platelet volume
chr12	122365582	122365583	Mean platelet volume
chr12	122365582	122365583	Mean platelet volume
chr12	122365582	122365583	Mean platelet volume
chr12	122365582	122365583	Platelet counts
chr12	122395776	122395777	Urinary metabolites
chr12	122625991	122625992	Urate levels
chr12	122630908	122630909	Adverse response to chemotherapy (neutropenia/leucopenia) (all antimicrotubule drugs)
chr12	123174742	123174743	Adiponectin levels
chr12	123296293	123296294	Parkinson's disease
chr12	123414348	123414349	IgG glycosylation
chr12	123457618	123457619	Platelet counts
chr12	123575741	123575742	Platelet counts
chr12	123656724	123656725	Multiple sclerosis
chr12	123731422	123731423	Schizophrenia
chr12	123796237	123796238	HDL cholesterol
chr12	123822710	123822711	Head circumference (infant)
chr12	123823545	123823546	Height
chr12	124085501	124085502	Pubertal anthropometrics
chr12	124203831	124203832	Adiponectin levels
chr12	124316875	124316876	IgG glycosylation
chr12	124375209	124375210	Osteoarthritis (hip)
chr12	124399549	124399550	Visceral adipose tissue adjusted for BMI
chr12	124399549	124399550	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr12	124399549	124399550	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr12	124460166	124460167	HDL cholesterol
chr12	124460166	124460167	Triglycerides
chr12	124499541	124499542	Visceral adipose tissue adjusted for BMI
chr12	124499541	124499542	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr12	124519845	124519846	Response to fenofibrate (adiponectin levels)
chr12	124894183	124894184	Adverse response to chemotherapy (neutropenia/leucopenia) (all antimetabolite drugs)
chr12	125002322	125002323	Cocaine dependence
chr12	125033932	125033933	Cognitive performance
chr12	125261592	125261593	HDL cholesterol
chr12	125307052	125307053	Vitamin E levels
chr12	125312424	125312425	Lipoprotein-associated phospholipase A2 activity and mass
chr12	125316742	125316743	Lipoprotein-associated phospholipase A2 activity and mass
chr12	125320849	125320850	Renal cell carcinoma
chr12	127792613	127792614	Sudden cardiac arrest
chr12	127813740	127813741	Depression (quantitative trait)
chr12	128304417	128304418	Response to amphetamines
chr12	128736521	128736522	Palmitic acid (16:0) plasma levels
chr12	128782021	128782022	Adverse response to chemotherapy in breast cancer (alopecia) (paclitaxel)
chr12	129095071	129095072	Suicide attempts in bipolar disorder
chr12	129186189	129186190	Height
chr12	129300693	129300694	Systemic lupus erythematosus
chr12	129300693	129300694	Systemic lupus erythematosus
chr12	129324937	129324938	Renal sinus fat
chr12	129475938	129475939	Aging
chr12	129637347	129637348	Heart rate
chr12	129646571	129646572	IgG glycosylation
chr12	129646600	129646601	IgG glycosylation
chr12	130230406	130230407	Behavioural disinhibition (generation interaction)
chr12	130230406	130230407	Illicit drug use
chr12	130497471	130497472	Obesity-related traits
chr12	130630934	130630935	Gambling
chr12	131022009	131022010	Alzheimer's disease
chr12	131352561	131352562	Response to amphetamines
chr12	131390753	131390754	Panic disorder
chr12	131525052	131525053	Longevity
chr12	131576190	131576191	Height
chr12	131621761	131621762	RR interval (heart rate)
chr12	131862902	131862903	Mortality among heart failure patients
chr12	131939919	131939920	Protein quantitative trait loci
chr12	132014205	132014206	Obesity-related traits
chr12	132085195	132085196	Longevity
chr12	132325238	132325239	Migraine
chr12	133345808	133345809	Immune response to smallpox vaccine (IL-6)
chr13	19311240	19311241	Fasting insulin-related traits (interaction with BMI)
chr13	20736215	20736216	Capecitabine sensitivity
chr13	21050574	21050575	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)
chr13	21093603	21093604	Obesity-related traits
chr13	21131210	21131211	Coronary artery calcification
chr13	21209511	21209512	Schizophrenia, bipolar disorder and depression (combined)
chr13	21280033	21280034	Dental caries
chr13	21815868	21815869	Obesity-related traits
chr13	21876095	21876096	Thiazide-induced adverse metabolic effects in hypertensive patients
chr13	21915113	21915114	Obesity-related traits
chr13	22305098	22305099	Response to antipsychotic treatment
chr13	22487624	22487625	Protein quantitative trait loci
chr13	22709669	22709670	RR interval (heart rate)
chr13	22754092	22754093	Adverse response to chemotherapy (neutropenia/leucopenia) (all antimetabolite drugs)
chr13	23228690	23228691	Central corneal thickness
chr13	23228690	23228691	Corneal structure
chr13	23294032	23294033	Myopia (pathological)
chr13	23692977	23692978	Bipolar disorder
chr13	23744378	23744379	Cannabis dependence
chr13	23755126	23755127	Alcohol dependence
chr13	23864656	23864657	Type 2 diabetes
chr13	23903790	23903791	Protein quantitative trait loci
chr13	24042509	24042510	Hypothyroidism
chr13	24127209	24127210	Nasopharyngeal carcinoma
chr13	24205194	24205195	Nasopharyngeal carcinoma
chr13	24293858	24293859	Lung cancer
chr13	24296861	24296862	Visceral adipose tissue adjusted for BMI
chr13	24432466	24432467	Myopia (pathological)
chr13	24504954	24504955	Weight
chr13	24598383	24598384	Inattentive symptoms
chr13	24654227	24654228	Orofacial clefts
chr13	24658355	24658356	Depression and alcohol dependence
chr13	24795488	24795489	Airflow obstruction
chr13	24980948	24980949	Obesity-related traits
chr13	25082629	25082630	Sudden cardiac arrest
chr13	25247285	25247286	Obesity-related traits
chr13	25533830	25533831	Obesity-related traits
chr13	26007976	26007977	Eating disorders
chr13	26037959	26037960	Bipolar disorder and schizophrenia
chr13	26724327	26724328	Alzheimer's disease
chr13	27415672	27415673	Asthma (toluene diisocyanate-induced)
chr13	27531266	27531267	Inflammatory bowel disease
chr13	27531266	27531267	Ulcerative colitis
chr13	27531266	27531267	Ulcerative colitis
chr13	27531266	27531267	Ulcerative colitis
chr13	27531266	27531267	Ulcerative colitis
chr13	27586872	27586873	Alcohol dependence
chr13	27879525	27879526	Electrocardiographic traits
chr13	27920610	27920611	Alcoholism (heaviness of drinking)
chr13	28020179	28020180	Body mass index
chr13	28058403	28058404	Weight
chr13	28077143	28077144	Schizophrenia
chr13	28197435	28197436	Large B-cell lymphoma
chr13	28360486	28360487	Adverse response to chemotherapy (neutropenia/leucopenia) (epirubicin)
chr13	28429737	28429738	Attention deficit hyperactivity disorder and conduct disorder
chr13	28491197	28491198	Fasting glucose-related traits (interaction with BMI)
chr13	28929710	28929711	Cognitive performance
chr13	28984062	28984063	Coronary heart disease
chr13	29164782	29164783	Breast cancer (menopausal hormone therapy interaction)
chr13	29278449	29278450	Non-alcoholic fatty liver disease histology (other)
chr13	29368705	29368706	Obesity-related traits
chr13	29431337	29431338	Attention deficit hyperactivity disorder symptoms (interaction)
chr13	29620653	29620654	Methotrexate phramacokinetics (acute lymphoblastic leukemia)
chr13	29898782	29898783	Obesity-related traits
chr13	29961331	29961332	Insomnia (caffeine-induced)
chr13	30347834	30347835	Non-word repetition
chr13	30458736	30458737	Biliary atresia
chr13	30885222	30885223	Antineutrophil cytoplasmic antibody-associated vasculitis
chr13	30957687	30957688	Fat distribution (HIV)
chr13	31113378	31113379	MRI atrophy measures
chr13	31314454	31314455	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+epirubicin+/-5FU)
chr13	31314679	31314680	Non-word repetition
chr13	31819324	31819325	Age-related macular degeneration
chr13	32125314	32125315	Metabolite levels (HVA/MHPG ratio)
chr13	32710519	32710520	IgG glycosylation
chr13	32972625	32972626	Breast cancer
chr13	32972625	32972626	Breast cancer
chr13	33147051	33147052	Height
chr13	33147547	33147548	Height
chr13	33387245	33387246	Total ventricular volume
chr13	33680853	33680854	Behavioural disinhibition (generation interaction)
chr13	33693836	33693837	Intracranial aneurysm
chr13	33798261	33798262	Body mass index (asthmatics)
chr13	34606185	34606186	Venous thromboembolism (gene x gene interaction)
chr13	34654917	34654918	Alzheimer's disease
chr13	34903091	34903092	Obesity-related traits
chr13	34906054	34906055	Obesity-related traits
chr13	35768788	35768789	Migraine with aura
chr13	36351765	36351766	Asthma (childhood onset)
chr13	36441098	36441099	Obesity-related traits
chr13	36454192	36454193	Non-alcoholic fatty liver disease
chr13	36476446	36476447	Height
chr13	36531547	36531548	Breast size
chr13	36652616	36652617	Vertical cup-disc ratio
chr13	36663301	36663302	Heart rate variability traits
chr13	36771016	36771017	Economic and political preferences
chr13	37762636	37762637	Palmitoleic acid (16:1n-7) plasma levels
chr13	38035188	38035189	Hip geometry
chr13	38065445	38065446	Age-related macular degeneration
chr13	38065445	38065446	Age-related macular degeneration
chr13	38363449	38363450	Obesity-related traits
chr13	38363449	38363450	Obesity-related traits
chr13	38531580	38531581	Self-rated health
chr13	39370594	39370595	Cytomegalovirus antibody response
chr13	39516626	39516627	Metabolic syndrome
chr13	39903242	39903243	Preeclampsia
chr13	40118067	40118068	Hippocampal atrophy
chr13	40350911	40350912	Psoriasis
chr13	40505509	40505510	Ulcerative colitis
chr13	40741906	40741907	Presence of antiphospholipid antibodies
chr13	40807482	40807483	Select biomarker traits
chr13	40948150	40948151	Bipolar disorder and schizophrenia
chr13	41013976	41013977	Inflammatory bowel disease
chr13	41013976	41013977	Ulcerative colitis
chr13	41109428	41109429	Central corneal thickness
chr13	41110883	41110884	Central corneal thickness
chr13	41110883	41110884	Corneal structure
chr13	41558109	41558110	Crohn's disease
chr13	41558109	41558110	Systemic lupus erythematosus
chr13	41558109	41558110	Systemic lupus erythematosus
chr13	42139244	42139245	Multiple sclerosis
chr13	42559075	42559076	Calcium levels
chr13	42631718	42631719	Height
chr13	42653436	42653437	Bipolar disorder
chr13	42754521	42754522	Nephrolithiasis
chr13	42951448	42951449	Bone mineral density
chr13	42951448	42951449	Bone mineral density (spine)
chr13	42952144	42952145	Bone mineral density
chr13	42952144	42952145	Bone mineral density (hip)
chr13	42956620	42956621	Bone mineral density
chr13	43032592	43032593	Bone mineral density (spine)
chr13	43032592	43032593	Bone mineral density (spine)
chr13	43052879	43052880	Crohn's disease
chr13	43116132	43116133	Bone mineral density
chr13	43116132	43116133	Bone mineral density
chr13	43128576	43128577	Cortical thickness
chr13	43570800	43570801	Obesity-related traits
chr13	43727848	43727849	Cognitive performance
chr13	43770473	43770474	End-stage coagulation
chr13	43834269	43834270	Major depressive disorder
chr13	44217063	44217064	Response to tocilizumab in rheumatoid arthritis
chr13	44457924	44457925	Crohn's disease
chr13	44457924	44457925	Crohn's disease
chr13	44457924	44457925	Crohn's disease
chr13	44457924	44457925	Leprosy
chr13	44627787	44627788	Uric acid levels
chr13	44637404	44637405	Prostate cancer (gene x gene interaction)
chr13	44808173	44808174	Amyotrophic lateral sclerosis
chr13	45055090	45055091	Antineutrophil cytoplasmic antibody-associated vasculitis
chr13	45493880	45493881	Oleic acid (18:1n-9) plasma levels
chr13	45900266	45900267	Myopia (pathological)
chr13	46703141	46703142	Non-alcoholic fatty liver disease histology (other)
chr13	46833716	46833717	Atrial fibrillation
chr13	47573615	47573616	Subcutaneous adipose tissue
chr13	47898878	47898879	Cannabis use (initiation)
chr13	48162557	48162558	QT interval
chr13	48198715	48198716	Cardiac hypertrophy
chr13	48387721	48387722	Aging (time to event)
chr13	48436924	48436925	Visceral adipose tissue adjusted for BMI
chr13	48436924	48436925	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr13	49466930	49466931	Multiple myeloma (IgH translocation)
chr13	50080846	50080847	Cardiac hypertrophy
chr13	50185203	50185204	Multiple sclerosis
chr13	50291841	50291842	Obesity-related traits
chr13	50306220	50306221	Menopause (age at onset)
chr13	50563446	50563447	Height
chr13	50835714	50835715	Celiac disease
chr13	50841322	50841323	Multiple sclerosis
chr13	50842439	50842440	Multiple sclerosis
chr13	50986117	50986118	Anthropometric traits
chr13	51066622	51066623	Bipolar disorder and major depressive disorder (combined)
chr13	51094113	51094114	Pulmonary function decline
chr13	51105333	51105334	Height
chr13	51106554	51106555	Height
chr13	51106787	51106788	Height
chr13	51106787	51106788	Pubertal anthropometrics
chr13	51111354	51111355	Height
chr13	51116900	51116901	Height
chr13	51119136	51119137	Obesity-related traits
chr13	51194404	51194405	Osteosarcoma
chr13	51390597	51390598	Primary tooth development (number of teeth)
chr13	51724663	51724664	IgG glycosylation
chr13	53494693	53494694	Airflow obstruction
chr13	53517883	53517884	Immune response to anthrax vaccine
chr13	53968090	53968091	Select biomarker traits
chr13	54064980	54064981	Obesity
chr13	54107351	54107352	Obesity
chr13	54290332	54290333	Obesity-related traits
chr13	54435236	54435237	Bipolar disorder and schizophrenia
chr13	54581086	54581087	Stroke
chr13	54633372	54633373	DNA methylation (variation)
chr13	55984995	55984996	Blood pressure
chr13	56772695	56772696	Warfarin maintenance dose
chr13	58904312	58904313	Sleep duration
chr13	59128525	59128526	Subcutaneous adipose tissue
chr13	59953465	59953466	Breast size
chr13	61113738	61113739	Menopause (age at onset)
chr13	61513668	61513669	Phospholipid levels (plasma)
chr13	61678911	61678912	Longevity
chr13	61965302	61965303	Schizophrenia
chr13	62930299	62930300	IgG glycosylation
chr13	62930299	62930300	IgG glycosylation
chr13	63436799	63436800	QT interval
chr13	63634349	63634350	Bone mineral density
chr13	63638328	63638329	Asthma
chr13	64141912	64141913	Pancreatic cancer
chr13	66120783	66120784	Body mass index
chr13	66212019	66212020	IgG glycosylation
chr13	66356340	66356341	Pulmonary function decline
chr13	66481814	66481815	Pancreatic cancer
chr13	66967621	66967622	Obesity
chr13	67696144	67696145	Dental caries
chr13	69530663	69530664	Diabetes related insulin traits
chr13	69919398	69919399	Obesity-related traits
chr13	70023684	70023685	Obesity-related traits
chr13	70430092	70430093	Response to amphetamines
chr13	70454959	70454960	Bilirubin levels
chr13	70455660	70455661	Cognitive performance
chr13	70810222	70810223	Word reading
chr13	70846202	70846203	Major depressive disorder
chr13	71883213	71883214	Longevity
chr13	72174352	72174353	Adverse response to lamotrigine and phenytoin
chr13	72345504	72345505	Urate levels
chr13	72347695	72347696	Chronic kidney disease
chr13	72688773	72688774	Obsessive-compulsive disorder
chr13	72768708	72768709	Cognitive performance
chr13	73728138	73728139	Prostate cancer
chr13	73741148	73741149	Myopia (pathological)
chr13	73908845	73908846	Pancreatic cancer
chr13	73916627	73916628	Pancreatic cancer
chr13	73932113	73932114	Pancreatic cancer
chr13	74433806	74433807	Bronchopulmonary dysplasia
chr13	74520185	74520186	Ventricular conduction
chr13	74730391	74730392	Optic disc size (rim)
chr13	74742321	74742322	Sudden cardiac arrest
chr13	74995659	74995660	Immune reponse to smallpox (secreted IFN-alpha)
chr13	75128113	75128114	Phospholipid levels (plasma)
chr13	75776267	75776268	Heart failure
chr13	76136647	76136648	Diabetic retinopathy
chr13	76249102	76249103	Corneal astigmatism
chr13	76326281	76326282	Type 1 diabetes
chr13	77879375	77879376	Preeclampsia
chr13	78381145	78381146	Hair color
chr13	78808913	78808914	Total ventricular volume
chr13	79359423	79359424	Cognitive performance
chr13	79380815	79380816	IgG glycosylation
chr13	79382100	79382101	IgG glycosylation
chr13	79410573	79410574	Conduct disorder (case status)
chr13	79410573	79410574	Conduct disorder (symptom count)
chr13	79455831	79455832	Response to statin therapy
chr13	79550933	79550934	Ulcerative colitis
chr13	79888475	79888476	Response to anti-TNF alpha therapy in inflammatory bowel disease
chr13	80169003	80169004	Major depressive disorder
chr13	80299721	80299722	Pancreatic cancer
chr13	80623345	80623346	Fasting insulin-related traits (interaction with BMI)
chr13	80644617	80644618	Obesity-related traits
chr13	80668873	80668874	Orofacial clefts
chr13	80692810	80692811	Orofacial clefts
chr13	80692810	80692811	Orofacial clefts
chr13	80717155	80717156	Type 2 diabetes
chr13	80959206	80959207	Adiposity
chr13	81357670	81357671	Major depressive disorder
chr13	82075591	82075592	Obesity-related traits
chr13	84130231	84130232	Response to citalopram treatment
chr13	85032326	85032327	Temperament (bipolar disorder)
chr13	85054265	85054266	Coronary heart disease
chr13	85251711	85251712	Obesity-related traits
chr13	85549735	85549736	Anorexia nervosa
chr13	85665878	85665879	Bipolar disorder (mania)
chr13	86690526	86690527	Economic and political preferences (fairness)
chr13	87242856	87242857	Hippocampal atrophy
chr13	88704705	88704706	Coronary heart disease
chr13	88762345	88762346	Cognitive performance
chr13	90622454	90622455	Longevity
chr13	90865545	90865546	Prostate cancer (gene x gene interaction)
chr13	91732769	91732770	Metabolite levels (5-HIAA)
chr13	92015976	92015977	Height
chr13	92024573	92024574	Height
chr13	92203812	92203813	Nephrotic syndrome (acquired)
chr13	92445228	92445229	Lung cancer
chr13	92501663	92501664	Obesity-related traits
chr13	92501663	92501664	Obesity-related traits
chr13	92988322	92988323	Tetralogy of Fallot
chr13	93088650	93088651	Adverse response to chemotherapy (neutropenia/leucopenia) (all antimicrotubule drugs)
chr13	93323145	93323146	Metabolite levels
chr13	93331885	93331886	Multiple sclerosis
chr13	93581790	93581791	Breast size
chr13	93890669	93890670	Tonometry
chr13	93938705	93938706	Visceral fat
chr13	93945857	93945858	Alzheimer's disease (cognitive decline)
chr13	94011168	94011169	Neuroticism
chr13	94233128	94233129	Obesity-related traits
chr13	94233128	94233129	Obesity-related traits
chr13	94233128	94233129	Obesity-related traits
chr13	94341095	94341096	Bipolar disorder and schizophrenia
chr13	94408505	94408506	Attention deficit hyperactivity disorder
chr13	94870764	94870765	Renal sinus fat
chr13	94952831	94952832	Disc degeneration (lumbar)
chr13	95463391	95463392	Panic disorder
chr13	95505261	95505262	Obesity-related traits
chr13	95505261	95505262	Obesity-related traits
chr13	95680284	95680285	Longevity
chr13	95775431	95775432	Response to irinotecan and platinum-based chemotherapy in non-small-cell lung cancer
chr13	95874955	95874956	Breast cancer
chr13	95898206	95898207	Platelet counts
chr13	96951432	96951433	Diabetic retinopathy
chr13	97017547	97017548	Obesity
chr13	98016415	98016416	Alcoholism (alcohol dependence factor score)
chr13	98016415	98016416	Alcoholism (alcohol use disorder factor score)
chr13	98053791	98053792	Obesity-related traits
chr13	98200571	98200572	Metabolite levels (Dihydroxy docosatrienoic acid)
chr13	98203726	98203727	Obesity-related traits
chr13	98827034	98827035	Migraine
chr13	98831594	98831595	Response to amphetamines
chr13	98960761	98960762	Total ventricular volume
chr13	98966316	98966317	Brain structure
chr13	98994029	98994030	Non-alcoholic fatty liver disease histology (lobular)
chr13	99096033	99096034	Obesity-related traits
chr13	99111208	99111209	Educational attainment
chr13	99126302	99126303	Longevity
chr13	99131293	99131294	Alzheimer's disease
chr13	99774646	99774647	Self-reported allergy
chr13	99956621	99956622	Inflammatory bowel disease
chr13	100041737	100041738	Basal cell carcinoma
chr13	100196951	100196952	Obesity-related traits
chr13	100493159	100493160	Obesity-related traits
chr13	100518633	100518634	Vitamin B12 levels
chr13	100555037	100555038	Attention deficit hyperactivity disorder
chr13	100638391	100638392	Orofacial clefts
chr13	100818091	100818092	Refractive error
chr13	101708309	101708310	Bipolar disorder and schizophrenia
chr13	102000944	102000945	HIV-associated dementia
chr13	102051089	102051090	Non-small cell lung cancer
chr13	102145559	102145560	Obesity-related traits
chr13	102227494	102227495	Waist-to-hip circumference ratio (interaction)
chr13	102553247	102553248	QT interval
chr13	102680125	102680126	Preeclampsia
chr13	102965002	102965003	Venous thromboembolism (gene x gene interaction)
chr13	103867103	103867104	Smoking behavior
chr13	103928006	103928007	Prostate cancer
chr13	103969490	103969491	Uric acid levels
chr13	104060086	104060087	Phospholipid levels (plasma)
chr13	104091544	104091545	Response to amphetamines
chr13	104186918	104186919	Insulin resistance/response
chr13	105039145	105039146	Esophageal cancer  (alcohol interaction)
chr13	105807022	105807023	Response to citalopram treatment
chr13	105807022	105807023	Response to citalopram treatment
chr13	105835169	105835170	Obesity-related traits
chr13	106067919	106067920	Periodontitis (DPAL)
chr13	106096811	106096812	Myopia (pathological)
chr13	106249308	106249309	Obesity-related traits
chr13	106589140	106589141	Visceral fat
chr13	106596718	106596719	Adverse response to chemotherapy (neutropenia/leucopenia) (docetaxel)
chr13	106651660	106651661	Bipolar disorder and schizophrenia
chr13	106785264	106785265	Immune reponse to smallpox (secreted IL-2)
chr13	107700217	107700218	Obesity-related traits
chr13	107780315	107780316	Depression (quantitative trait)
chr13	108134908	108134909	Reading and spelling
chr13	108257219	108257220	Anorexia nervosa
chr13	108484453	108484454	Obesity-related traits
chr13	108491591	108491592	Metabolite levels (Pyroglutamine)
chr13	108668546	108668547	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr13	108816224	108816225	Attention deficit hyperactivity disorder and conduct disorder
chr13	109347658	109347659	Blood pressure
chr13	109380725	109380726	Presence of antiphospholipid antibodies
chr13	109455834	109455835	Obesity-related traits
chr13	109473945	109473946	Alzheimer's disease (cognitive decline)
chr13	109502848	109502849	Dental caries
chr13	109511058	109511059	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)
chr13	110572209	110572210	Lung function (forced vital capacity)
chr13	110790231	110790232	Obesity-related traits
chr13	110818597	110818598	Arterial stiffness
chr13	110929161	110929162	Obesity-related traits
chr13	110960711	110960712	Coronary heart disease
chr13	110960942	110960943	Coronary artery calcification
chr13	111030577	111030578	Bipolar disorder and schizophrenia
chr13	111449114	111449115	Obesity-related traits
chr13	111470037	111470038	Cognitive performance
chr13	111818831	111818832	Bilirubin levels
chr13	112181436	112181437	Menarche (age at onset)
chr13	112221296	112221297	Menopause (age at onset)
chr13	112575603	112575604	Axial length
chr13	112836654	112836655	Renal transplant outcome
chr13	113331867	113331868	Glycated hemoglobin levels
chr13	113536626	113536627	Interstitial lung disease
chr13	113694508	113694509	Osteoarthritis
chr13	113752830	113752831	End-stage coagulation
chr13	113753163	113753164	End-stage coagulation
chr13	113756539	113756540	End-stage coagulation
chr13	113760033	113760034	Factor VII
chr13	113760033	113760034	Prothrombin time
chr13	113772706	113772707	End-stage coagulation
chr13	113793848	113793849	End-stage coagulation
chr13	114012897	114012898	Mean platelet volume
chr13	114507238	114507239	IgG glycosylation
chr13	114622596	114622597	Response to tocilizumab in rheumatoid arthritis
chr14	20957432	20957433	Response to antipsychotic therapy (extrapyramidal side effects)
chr14	21024618	21024619	Prostate cancer (gene x gene interaction)
chr14	21261732	21261733	Obesity-related traits
chr14	21725653	21725654	Bipolar disorder
chr14	22235889	22235890	Intraocular pressure
chr14	22481823	22481824	Renal transplant outcome
chr14	22607501	22607502	Obesity-related traits
chr14	22782376	22782377	Obesity-related traits
chr14	22937655	22937656	Adverse response to chemotherapy (neutropenia/leucopenia) (all platinum-based drugs)
chr14	22956709	22956710	Relative hand skill in reading disability
chr14	23002683	23002684	Narcolepsy
chr14	23002683	23002684	Narcolepsy
chr14	23464481	23464482	Primary tooth development (number of teeth)
chr14	23464481	23464482	Primary tooth development (time to first tooth eruption)
chr14	23585332	23585333	Acute lymphoblastic leukemia (childhood)
chr14	23589056	23589057	Acute lymphoblastic leukemia (B-cell precursor)
chr14	23589056	23589057	Acute lymphoblastic leukemia (childhood)
chr14	23840032	23840033	Type 1 diabetes
chr14	23861810	23861811	Electrocardiographic traits
chr14	23861810	23861811	Heart rate
chr14	23865884	23865885	Resting heart rate
chr14	23865884	23865885	Resting heart rate
chr14	23977009	23977010	Resting heart rate
chr14	24033069	24033070	Sudden cardiac arrest
chr14	24381514	24381515	Bipolar disorder
chr14	24609146	24609147	IgG glycosylation
chr14	24830849	24830850	Height
chr14	24830849	24830850	Height
chr14	24883886	24883887	LDL cholesterol
chr14	25102159	25102160	Vitiligo
chr14	25271519	25271520	MRI atrophy measures
chr14	25479541	25479542	Subcutaneous adipose tissue
chr14	25503798	25503799	White blood cell types
chr14	26129565	26129566	Obesity-related traits
chr14	26488466	26488467	Liver enzyme levels (aspartate transaminase)
chr14	27260042	27260043	Attention deficit hyperactivity disorder and conduct disorder
chr14	27406891	27406892	Bipolar disorder and schizophrenia
chr14	27800176	27800177	Diabetes related insulin traits
chr14	27800176	27800177	Diabetes related insulin traits
chr14	29021927	29021928	Longevity
chr14	29116694	29116695	Phospholipid levels (plasma)
chr14	29132876	29132877	Ulcerative colitis
chr14	29249348	29249349	Multiple sclerosis--Brain Glutamate Levels
chr14	30088137	30088138	IgG glycosylation
chr14	30489622	30489623	Obesity-related traits
chr14	30515111	30515112	Body mass index
chr14	30515111	30515112	Body mass index
chr14	30594656	30594657	Sexual dysfunction (SSRI/SNRI-related)
chr14	32093547	32093548	Response to iloperidone treatment (QT prolongation)
chr14	32353249	32353250	Brain lesion load
chr14	32433857	32433858	Bipolar disorder and schizophrenia
chr14	32851024	32851025	Economic and political preferences (environmentalism)
chr14	33207521	33207522	Fasting insulin-related traits (interaction with BMI)
chr14	33282469	33282470	Anorexia nervosa
chr14	33381097	33381098	Ankylosing spondylitis
chr14	33476265	33476266	Schizophrenia, bipolar disorder and depression (combined)
chr14	33480921	33480922	Bipolar disorder
chr14	33586562	33586563	Inflammatory biomarkers
chr14	33918037	33918038	Self-reported allergy
chr14	34844375	34844376	Celiac disease
chr14	35135185	35135186	Response to anti-TNF treatment in rheumatoid arthritis
chr14	35682171	35682172	Psoriasis
chr14	35832665	35832666	Psoriasis
chr14	36397679	36397680	Response to antineoplastic agents
chr14	36574017	36574018	Thyroid hormone levels
chr14	36649245	36649246	Thyroid cancer
chr14	36738360	36738361	Thyroid cancer
chr14	36854135	36854136	Malaria
chr14	36989418	36989419	Menarche (age at onset)
chr14	37000048	37000049	Height
chr14	37132768	37132769	Breast cancer
chr14	38066574	38066575	Periodontitis (CDC/AAP)
chr14	38077147	38077148	Self-reported allergy
chr14	38683260	38683261	Metabolite levels (5-HIAA/ MHPG Ratio)
chr14	39020504	39020505	Coronary spasm
chr14	41523461	41523462	Hemostatic factors and hematological phenotypes
chr14	41702597	41702598	QT interval (interaction)
chr14	42655274	42655275	Alcoholism (12-month weekly alcohol consumption)
chr14	43403458	43403459	Multiple myeloma (hyperdiploidy)
chr14	45106631	45106632	Obesity-related traits
chr14	46029686	46029687	Bilirubin levels
chr14	47403683	47403684	Neuroticism
chr14	47454985	47454986	Obesity-related traits
chr14	47863834	47863835	Hemostatic factors and hematological phenotypes
chr14	47874556	47874557	Response to tocilizumab in rheumatoid arthritis
chr14	48015981	48015982	Sexual dysfunction (SSRI/SNRI-related)
chr14	48054158	48054159	IgG glycosylation
chr14	48054158	48054159	IgG glycosylation
chr14	48564955	48564956	Cognitive performance
chr14	49372800	49372801	Cognitive test performance
chr14	49426841	49426842	Post-traumatic stress disorder (asjusted for relatedness)
chr14	49426841	49426842	Post-traumatic stress disorder (asjusted for relatedness)
chr14	49437930	49437931	Social communication problems
chr14	49463483	49463484	Immune reponse to smallpox (secreted IL-2)
chr14	49534424	49534425	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr14	49951349	49951350	Visceral fat
chr14	50877982	50877983	Cognitive performance
chr14	50973631	50973632	Cognitive performance
chr14	51084234	51084235	Cognitive performance
chr14	51170878	51170879	Cognitive performance
chr14	51323741	51323742	Dietary macronutrient intake
chr14	51403530	51403531	Acute lymphoblastic leukemia (childhood)
chr14	51919821	51919822	Total ventricular volume
chr14	52010798	52010799	Brain structure
chr14	52077088	52077089	Anticoagulant levels
chr14	52233275	52233276	Hippocampal atrophy
chr14	52310103	52310104	Non-melanoma skin cancer
chr14	52518810	52518811	Pulmonary function
chr14	52989227	52989228	Orofacial clefts
chr14	53372329	53372330	Prostate cancer
chr14	53837484	53837485	Economic and political preferences (fairness)
chr14	54072857	54072858	Alcoholism (heaviness of drinking)
chr14	54167471	54167472	Immune reponse to smallpox (secreted IFN-alpha)
chr14	54290829	54290830	Parkinson's disease
chr14	54410918	54410919	Colorectal cancer
chr14	54417521	54417522	Primary tooth development (time to first tooth eruption)
chr14	54652478	54652479	Dental caries
chr14	54857285	54857286	Working memory
chr14	54876183	54876184	Dental caries
chr14	54876183	54876184	Dental caries
chr14	55122917	55122918	Obesity-related traits
chr14	55176343	55176344	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)
chr14	55348117	55348118	Obesity-related traits
chr14	55348117	55348118	Obesity-related traits
chr14	55348117	55348118	Rheumatoid arthritis
chr14	55614635	55614636	Protein biomarker
chr14	56231799	56231800	Adverse response to chemotherapy (neutropenia/leucopenia) (all topoisomerase inhibitors)
chr14	56333512	56333513	Body mass index (interaction)
chr14	56333512	56333513	Body mass index (interaction)
chr14	56418118	56418119	Obesity-related traits
chr14	56525568	56525569	Telomere length
chr14	56886685	56886686	Chronic obstructive pulmonary disease-related biomarkers
chr14	57221138	57221139	Type 1 diabetes nephropathy
chr14	57607066	57607067	Multiple myeloma (IgH translocation)
chr14	57669532	57669533	Alcohol consumption
chr14	57822215	57822216	Alcohol consumption
chr14	58119195	58119196	Bipolar disorder
chr14	58119195	58119196	Bipolar disorder
chr14	58200724	58200725	Bipolar disorder and schizophrenia
chr14	58385364	58385365	Attention deficit hyperactivity disorder (time to onset)
chr14	58397915	58397916	Pulmonary function
chr14	59189360	59189361	Colorectal cancer
chr14	59334127	59334128	Panic disorder
chr14	59366314	59366315	Obesity-related traits
chr14	60683429	60683430	Allergic rhinitis
chr14	60903756	60903757	Refractive error
chr14	60957278	60957279	Height
chr14	60957278	60957279	Height
chr14	61072874	61072875	Glaucoma (primary open-angle)
chr14	61072874	61072875	Glaucoma (primary open-angle)
chr14	61072874	61072875	Optic disc size (rim)
chr14	61072874	61072875	Vertical cup-disc ratio
chr14	61308336	61308337	Immune reponse to smallpox (secreted IFN-alpha)
chr14	61734639	61734640	Obesity-related traits
chr14	61895044	61895045	Word reading
chr14	61898838	61898839	Reading and spelling
chr14	61908110	61908111	Obesity (early onset extreme)
chr14	61908331	61908332	Rheumatoid arthritis
chr14	62185294	62185295	Select biomarker traits
chr14	62518347	62518348	Self-rated health
chr14	62654697	62654698	Iron status biomarkers
chr14	62678302	62678303	Attention deficit hyperactivity disorder
chr14	62732663	62732664	Economic and political preferences (immigration/crime)
chr14	62968394	62968395	Estradiol plasma levels (breast cancer)
chr14	63177143	63177144	Subcutaneous adipose tissue
chr14	63322346	63322347	Major depressive disorder
chr14	63953521	63953522	Response to antineoplastic agents
chr14	64232385	64232386	Sphingolipid levels
chr14	64235555	64235556	Sphingolipid levels
chr14	64275811	64275812	Pulmonary function decline
chr14	64680847	64680848	Atrial fibrillation
chr14	64899054	64899055	Cognitive performance
chr14	65240948	65240949	Obesity-related traits
chr14	65240948	65240949	Obesity-related traits
chr14	65473195	65473196	Blood trace element (Zn levels)
chr14	65475539	65475540	Mean corpuscular volume
chr14	65502238	65502239	Red blood cell traits
chr14	65604727	65604728	Obesity-related traits
chr14	65645249	65645250	Anthropometric traits
chr14	65747758	65747759	Conduct disorder (symptom count)
chr14	65758641	65758642	IgG glycosylation
chr14	65758641	65758642	N-glycan levels
chr14	65775694	65775695	IgG glycosylation
chr14	65775694	65775695	IgG glycosylation
chr14	65775694	65775695	IgG glycosylation
chr14	65775694	65775695	IgG glycosylation
chr14	65775694	65775695	IgG glycosylation
chr14	65775694	65775695	IgG glycosylation
chr14	65775694	65775695	IgG glycosylation
chr14	65775694	65775695	IgG glycosylation
chr14	65775694	65775695	IgG glycosylation
chr14	65775694	65775695	IgG glycosylation
chr14	65775694	65775695	IgG glycosylation
chr14	65775694	65775695	IgG glycosylation
chr14	65775694	65775695	IgG glycosylation
chr14	65775694	65775695	IgG glycosylation
chr14	65865624	65865625	Chronic obstructive pulmonary disease-related biomarkers
chr14	65914866	65914867	N-glycan levels
chr14	66262962	66262963	Multiple sclerosis--Brain Glutamate Levels
chr14	66287909	66287910	Obesity-related traits
chr14	67453857	67453858	Depression (quantitative trait)
chr14	67939482	67939483	Obesity-related traits
chr14	67975821	67975822	Phospholipid levels (plasma)
chr14	68520905	68520906	Platelet counts
chr14	68660427	68660428	Breast cancer
chr14	68699593	68699594	Breast cancer (male)
chr14	68749926	68749927	Breast cancer (survival)
chr14	68749926	68749927	Breast cancer (survival)
chr14	68753592	68753593	Primary biliary cirrhosis
chr14	68785076	68785077	Age-related macular degeneration
chr14	68788923	68788924	Primary tooth development (number of teeth)
chr14	68813114	68813115	Height
chr14	68986156	68986157	Obesity-related traits
chr14	69034681	69034682	Breast cancer
chr14	69034681	69034682	Breast cancer
chr14	69126743	69126744	Prostate cancer
chr14	69210198	69210199	Crohn's disease
chr14	69254190	69254191	Multiple sclerosis
chr14	69263598	69263599	Type 1 diabetes
chr14	69273904	69273905	Inflammatory bowel disease
chr14	69278203	69278204	Celiac disease
chr14	69314058	69314059	Fibrinogen
chr14	69360630	69360631	Periodontitis (Mean PAL)
chr14	69408696	69408697	Smoking behavior
chr14	70347347	70347348	Digit length ratio
chr14	70365923	70365924	Red blood cell traits
chr14	70517182	70517183	Cystic fibrosis severity
chr14	70620641	70620642	IgG glycosylation
chr14	70644168	70644169	Corneal curvature
chr14	71249801	71249802	Reasoning
chr14	71352647	71352648	Alcohol dependence
chr14	71395603	71395604	Alcohol dependence
chr14	71507600	71507601	Alzheimer's disease (late onset)
chr14	71666296	71666297	Alzheimer's disease (late onset)
chr14	72057354	72057355	Ventricular conduction
chr14	72194400	72194401	Obesity-related traits
chr14	72432148	72432149	Economic and political preferences (environmentalism)
chr14	72692492	72692493	Obesity (extreme)
chr14	72883873	72883874	Smoking cessation
chr14	73019235	73019236	C-reactive protein
chr14	73081067	73081068	C-reactive protein and white blood cell count
chr14	73756298	73756299	Coronary artery calcification
chr14	73767213	73767214	Bipolar disorder (mood-incongruent)
chr14	74551969	74551970	Common traits (Other)
chr14	74990745	74990746	Height
chr14	75322793	75322794	Caffeine consumption
chr14	75327442	75327443	IgG glycosylation
chr14	75365728	75365729	Non-small cell lung cancer
chr14	75626041	75626042	Height
chr14	75701220	75701221	Inflammatory bowel disease
chr14	75814027	75814028	Periodontal microbiota
chr14	75916463	75916464	Obesity-related traits
chr14	75960535	75960536	Rheumatoid arthritis
chr14	76005556	76005557	Multiple sclerosis
chr14	76129590	76129591	Height
chr14	76613677	76613678	Blood pressure
chr14	76650763	76650764	Blood pressure
chr14	76703350	76703351	Acute lymphoblastic leukemia (childhood)
chr14	76703350	76703351	Acute lymphoblastic leukemia (childhood)
chr14	76812490	76812491	Attention deficit hyperactivity disorder symptoms (interaction)
chr14	77497974	77497975	Adverse response to lamotrigine and phenytoin
chr14	77513843	77513844	Sleep quality
chr14	77684669	77684670	Bipolar disorder
chr14	77684841	77684842	Bipolar disorder
chr14	78534905	78534906	Response to platinum-based chemotherapy in non-small-cell lung cancer
chr14	78775305	78775306	Brain structure (temporal lobe volume)
chr14	78786076	78786077	Obesity
chr14	78786158	78786159	Cognitive performance
chr14	79899453	79899454	Obesity
chr14	79903375	79903376	Obesity
chr14	79936963	79936964	Body mass index
chr14	79945161	79945162	Waist circumference
chr14	80002095	80002096	Amyotrophic lateral sclerosis (age of onset)
chr14	80587140	80587141	Lung function (forced expiratory volume in 1 second)
chr14	81405921	81405922	Palmitoleic acid (16:1n-7) plasma levels
chr14	81451228	81451229	Graves' disease
chr14	81523127	81523128	Optic disc size (rim)
chr14	81575453	81575454	Hair morphology
chr14	81594379	81594380	Visceral fat
chr14	81635322	81635323	IgG glycosylation
chr14	81778643	81778644	Obesity-related traits
chr14	83255204	83255205	Obesity-related traits
chr14	83342321	83342322	Obesity-related traits
chr14	83378002	83378003	Word reading
chr14	84597384	84597385	Obesity-related traits
chr14	84775208	84775209	Alzheimer's disease
chr14	85654018	85654019	Pulmonary function decline
chr14	85683052	85683053	IgG glycosylation
chr14	85737168	85737169	QRS duration
chr14	85809910	85809911	Heart rate
chr14	85963855	85963856	Menarche (age at onset)
chr14	86817095	86817096	Blood trace element (Zn levels)
chr14	86902053	86902054	Adverse response to chemotherapy (neutropenia/leucopenia) (all antimicrotubule drugs)
chr14	87506247	87506248	Sudden cardiac arrest
chr14	87741024	87741025	Adverse response to chemotherapy (neutropenia/leucopenia) (docetaxel)
chr14	88295599	88295600	Breast cancer
chr14	88472594	88472595	Crohn's disease
chr14	88472594	88472595	Inflammatory bowel disease
chr14	88487688	88487689	Multiple sclerosis
chr14	88559991	88559992	Bipolar disorder
chr14	88826481	88826482	Coronary artery calcification
chr14	88826681	88826682	Information processing speed
chr14	89372750	89372751	Obesity-related traits
chr14	89437415	89437416	Hormone measurements
chr14	89594294	89594295	Weight loss (gastric bypass surgery)
chr14	90034971	90034972	Fasting glucose-related traits (interaction with BMI)
chr14	90227250	90227251	IgG glycosylation
chr14	90227250	90227251	IgG glycosylation
chr14	90298274	90298275	Metabolite levels (HVA/MHPG ratio)
chr14	90301034	90301035	Hepatocellular carcinoma
chr14	90396573	90396574	Thiazide-induced adverse metabolic effects in hypertensive patients
chr14	90615512	90615513	Coronary artery calcification
chr14	90679909	90679910	Mortality among heart failure patients
chr14	90758890	90758891	Longevity
chr14	91022184	91022185	Cytomegalovirus antibody response
chr14	91442778	91442779	Bone mineral density
chr14	91841068	91841069	Breast cancer
chr14	92427221	92427222	Height
chr14	92459957	92459958	Height
chr14	92485880	92485881	Height
chr14	92536958	92536959	Coronary artery calcification
chr14	92556054	92556055	Orofacial clefts
chr14	92636712	92636713	Dialysis-related mortality
chr14	92702595	92702596	Obesity-related traits
chr14	92763390	92763391	Iris characteristics
chr14	92773662	92773663	Black vs. blond hair color
chr14	92773662	92773663	Blond vs. brown hair color
chr14	92773662	92773663	Blue vs. green eyes
chr14	92773662	92773663	Eye color
chr14	92773662	92773663	Eye color
chr14	92773662	92773663	Eye color
chr14	92773662	92773663	Eye color
chr14	92773662	92773663	Hair color
chr14	92773662	92773663	Hair color
chr14	92972161	92972162	Dialysis-related mortality
chr14	93103308	93103309	Paget's disease
chr14	93223989	93223990	IgG glycosylation
chr14	93501025	93501026	Platelet counts
chr14	93595590	93595591	Thyroid hormone levels
chr14	93595590	93595591	Thyroid hormone levels
chr14	93644378	93644379	Endometriosis
chr14	94205344	94205345	Insomnia (caffeine-induced)
chr14	94563192	94563193	Anthropometric traits
chr14	94796183	94796184	Breast size
chr14	94844842	94844843	Metabolite levels
chr14	94863635	94863636	Antineutrophil cytoplasmic antibody-associated vasculitis
chr14	94957713	94957714	Obesity-related traits
chr14	94957713	94957714	Obesity-related traits
chr14	94957713	94957714	Obesity-related traits
chr14	94972241	94972242	Obesity-related traits
chr14	95012383	95012384	Vaspin levels
chr14	95094396	95094397	Body mass index
chr14	95410528	95410529	Body mass index (interaction)
chr14	95410528	95410529	Body mass index (interaction)
chr14	95671870	95671871	Response to antipsychotic treatment
chr14	95720677	95720678	Response to statin therapy
chr14	95764563	95764564	Alzheimer's disease (cognitive decline)
chr14	95848293	95848294	Obesity-related traits
chr14	95892273	95892274	Follicule stimulating hormone
chr14	95942446	95942447	Response to irinotecan and platinum-based chemotherapy in non-small-cell lung cancer
chr14	96010588	96010589	Obesity-related traits
chr14	96027152	96027153	Tuberculosis
chr14	96122407	96122408	QT interval
chr14	96169130	96169131	Adverse response to aromatase inhibitors
chr14	96175977	96175978	Adverse response to aromatase inhibitors
chr14	96206069	96206070	Neutrophil count
chr14	97103806	97103807	Tanning
chr14	97345805	97345806	Neutrophil count
chr14	97393684	97393685	Obesity-related traits
chr14	97523744	97523745	DNA methylation (variation)
chr14	97987856	97987857	Adverse response to chemotherapy (neutropenia/leucopenia) (all antimicrotubule drugs)
chr14	98303330	98303331	Radiation response
chr14	98463156	98463157	Immune response to smallpox vaccine (IL-6)
chr14	98486544	98486545	IgE levels in asthmatics (D.f. specific)
chr14	98488006	98488007	Graves' disease
chr14	98498950	98498951	Type 1 diabetes
chr14	98499457	98499458	Lipoprotein-associated phospholipase A2 activity change in response to statin therapy
chr14	98588320	98588321	Aortic stiffness
chr14	98642571	98642572	Hemostatic factors and hematological phenotypes
chr14	98670157	98670158	Sexual dysfunction (SSRI/SNRI-related)
chr14	98840442	98840443	Response to antipsychotic therapy (extrapyramidal side effects)
chr14	99240315	99240316	Obesity-related traits
chr14	99607479	99607480	Corneal curvature
chr14	99742186	99742187	IgG glycosylation
chr14	99746273	99746274	IgG glycosylation
chr14	100133941	100133942	Coronary heart disease
chr14	100625901	100625902	Sudden cardiac arrest
chr14	100684191	100684192	Electroencephalographic traits in alcoholism
chr14	101032216	101032217	Menarche (age at onset)
chr14	101142889	101142890	Type 2 diabetes
chr14	101159415	101159416	Platelet counts
chr14	101251988	101251989	Optic disc size (disc)
chr14	101306044	101306045	Type 1 diabetes
chr14	101539383	101539384	Corneal astigmatism
chr14	101690044	101690045	Body mass index (interaction)
chr14	101727106	101727107	Prostate cancer (gene x gene interaction)
chr14	102360744	102360745	Autism
chr14	102454932	102454933	Menopause (age at onset)
chr14	102595624	102595625	Behavioural disinhibition (generation interaction)
chr14	103040086	103040087	Platelet counts
chr14	103377320	103377321	Brain imaging in schizophrenia (interaction)
chr14	103484824	103484825	Large B-cell lymphoma
chr14	103563194	103563195	Primary biliary cirrhosis
chr14	103566784	103566785	Platelet counts
chr14	103572814	103572815	Gamma gluatamyl transferase levels
chr14	103572814	103572815	Liver enzyme levels (gamma-glutamyl transferase)
chr14	103572814	103572815	Mean platelet volume
chr14	103822761	103822762	Red blood cell traits
chr14	103883632	103883633	Bone mineral density
chr14	104509075	104509076	Bipolar disorder
chr14	104509075	104509076	Bipolar disorder
chr14	105346906	105346907	IgG glycosylation
chr14	105349387	105349388	IgG glycosylation
chr14	105391004	105391005	Rheumatoid arthritis
chr14	105729791	105729792	Mean platelet volume
chr14	106232584	106232585	IgG levels
chr14	107176212	107176213	Kawasaki disease
chr15	23817720	23817721	IgG glycosylation
chr15	24062914	24062915	Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)
chr15	24741290	24741291	Obesity-related traits
chr15	24924662	24924663	Periodontitis (DPAL)
chr15	25022987	25022988	Periodontitis (DPAL)
chr15	25078786	25078787	Pulmonary function
chr15	25133985	25133986	Obesity-related traits
chr15	25602949	25602950	Obesity-related traits
chr15	25894657	25894658	Immune reponse to smallpox (secreted IFN-alpha)
chr15	25912338	25912339	Cardiac hypertrophy
chr15	26277544	26277545	Cortical thickness
chr15	26288393	26288394	Insulin resistance/response
chr15	26288393	26288394	Insulin resistance/response
chr15	26424046	26424047	Smoking behavior
chr15	26973085	26973086	Cognitive performance
chr15	27012140	27012141	Longevity
chr15	27507772	27507773	Corneal curvature
chr15	27712643	27712644	Alzheimer's disease (cognitive decline)
chr15	27997246	27997247	Parkinson's disease (age of onset)
chr15	28196820	28196821	Eye color
chr15	28205563	28205564	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)
chr15	28335819	28335820	Black vs. blond hair color
chr15	28335819	28335820	Black vs. red hair color
chr15	28356858	28356859	Vitiligo
chr15	28365617	28365618	Black vs. blond hair color
chr15	28365617	28365618	Black vs. red hair color
chr15	28365617	28365618	Eye color
chr15	28365617	28365618	Eye color
chr15	28365617	28365618	Eye color
chr15	28365617	28365618	Eye color
chr15	28365617	28365618	Eye color traits
chr15	28365617	28365618	Hair color
chr15	28365617	28365618	Hair color
chr15	28365617	28365618	Tanning
chr15	28488887	28488888	Multiple myeloma (IgH translocation)
chr15	28513363	28513364	Iris color
chr15	28530181	28530182	Blond vs. brown hair color
chr15	28530181	28530182	Blue vs. brown eyes
chr15	28530181	28530182	Blue vs. green eyes
chr15	28530181	28530182	Eye color
chr15	29006092	29006093	Black vs. blond hair color
chr15	29006092	29006093	Black vs. red hair color
chr15	29239816	29239817	Temperament
chr15	29338501	29338502	Response to mTOR inhibitor (rapamycin)
chr15	29424754	29424755	Obesity-related traits
chr15	29731443	29731444	Life threatening arrhythmia
chr15	29888395	29888396	Inattentive symptoms
chr15	30173884	30173885	Corneal structure
chr15	30193467	30193468	Response to antipsychotic treatment
chr15	30898331	30898332	Epilepsy (remission after treatment)
chr15	31215934	31215935	Hypertriglyceridemia
chr15	31334361	31334362	Response to antipsychotic treatment
chr15	31463377	31463378	Myasthenia gravis
chr15	31793929	31793930	Venous thromboembolism
chr15	31829706	31829707	Mortality among heart failure patients
chr15	32927475	32927476	Obesity-related traits
chr15	32994755	32994756	Colorectal cancer
chr15	32994755	32994756	Colorectal cancer
chr15	32994755	32994756	Colorectal cancer
chr15	33050422	33050423	Orofacial clefts
chr15	33050422	33050423	Orofacial clefts
chr15	33493220	33493221	IgG glycosylation
chr15	33493220	33493221	IgG glycosylation
chr15	33505066	33505067	Major depressive disorder
chr15	33597075	33597076	Periodontitis (Mean PAL)
chr15	33905409	33905410	Carotid atherosclerosis in HIV infection
chr15	34989625	34989626	Axial length
chr15	35005885	35005886	Refractive error
chr15	35006072	35006073	Refractive error
chr15	35068308	35068309	Prostate cancer (gene x gene interaction)
chr15	35346540	35346541	Bronchopulmonary dysplasia
chr15	35858582	35858583	Menopause (age at onset)
chr15	36049491	36049492	Paclitaxel-induced neuropathy
chr15	36293604	36293605	Attention deficit hyperactivity disorder
chr15	36313964	36313965	Major depressive disorder
chr15	36349845	36349846	Response to tocilizumab in rheumatoid arthritis
chr15	37342601	37342602	Hyperactive-impulsive symptoms
chr15	37349801	37349802	Response to antipsychotic treatment
chr15	37449618	37449619	Response to amphetamines
chr15	37660048	37660049	Intraocular pressure
chr15	38464873	38464874	Hypersomnia (HLA-DQB1*06:02 negative)
chr15	38511982	38511983	Bipolar disorder
chr15	38822904	38822905	Type 2 diabetes
chr15	38838263	38838264	Type 1 diabetes
chr15	38899189	38899190	Crohn's disease
chr15	38907040	38907041	Type 1 diabetes autoantibodies
chr15	38986367	38986368	Bipolar disorder
chr15	38986367	38986368	Bipolar disorder and major depressive disorder (combined)
chr15	38995490	38995491	Bipolar disorder
chr15	39003762	39003763	Bipolar disorder and schizophrenia
chr15	39148648	39148649	Metabolic traits
chr15	39315357	39315358	Cardiac hypertrophy
chr15	39543945	39543946	Metabolite levels (Dihydroxy docosatrienoic acid)
chr15	39573534	39573535	PR interval
chr15	39576559	39576560	PR interval
chr15	40038432	40038433	Obesity-related traits
chr15	40322551	40322552	Corneal curvature
chr15	40334575	40334576	Obesity-related traits
chr15	40339493	40339494	Ewing sarcoma
chr15	40360740	40360741	Dehydroepiandrosterone sulphate levels
chr15	40532867	40532868	Obesity-related traits
chr15	40595626	40595627	Schizophrenia
chr15	40700021	40700022	Metabolic traits
chr15	40717301	40717302	Interstitial lung disease
chr15	41196383	41196384	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr15	41563949	41563950	Ulcerative colitis
chr15	42683786	42683787	Triglycerides
chr15	42984287	42984288	Protein quantitative trait loci
chr15	43559230	43559231	Lung cancer
chr15	43836477	43836478	Tumor biomarkers
chr15	44219606	44219607	Serum albumin level
chr15	44245930	44245931	Triglycerides
chr15	45500046	45500047	Uric acid levels
chr15	45641224	45641225	Chronic kidney disease
chr15	45652702	45652703	Homoarginine levels
chr15	45698792	45698793	Renal function and chronic kidney disease
chr15	45719186	45719187	Glomerular filtration rate
chr15	45801034	45801035	Response to fenofibrate (adiponectin levels)
chr15	45934868	45934869	Obesity-related traits
chr15	45985070	45985071	Waist circumference
chr15	45985070	45985071	Weight
chr15	46639807	46639808	Prostate cancer
chr15	47892297	47892298	Eating disorders
chr15	48005469	48005470	Coronary artery calcification
chr15	48392164	48392165	Skin pigmentation
chr15	48597513	48597514	Metabolite levels (Pyroglutamine)
chr15	48633152	48633153	Protein quantitative trait loci
chr15	48900585	48900586	Breast cancer
chr15	48914774	48914775	Thoracic aortic aneurysms and dissections
chr15	48992896	48992897	Insomnia
chr15	49039796	49039797	Prostate cancer (gene x gene interaction)
chr15	49048127	49048128	Obesity-related traits
chr15	49192790	49192791	Major depressive disorder
chr15	49221590	49221591	Eating disorders
chr15	49735296	49735297	Thyroid volume
chr15	49735296	49735297	Thyroid volume
chr15	49746363	49746364	Thyroid hormone levels
chr15	49746363	49746364	Thyroid hormone levels
chr15	49939845	49939846	Response to antidepressant treatment
chr15	50873343	50873344	QT interval
chr15	51048601	51048602	Fibrinogen
chr15	51352248	51352249	Cognitive performance
chr15	51513728	51513729	Thiazide-induced adverse metabolic effects in hypertensive patients
chr15	51516054	51516055	AB1-42
chr15	51524291	51524292	Follicule stimulating hormone
chr15	51524291	51524292	Hormone measurements
chr15	51530494	51530495	Height
chr15	51534546	51534547	Estradiol levels
chr15	51545453	51545454	Menarche (age at onset)
chr15	51569409	51569410	Height
chr15	51573532	51573533	Height
chr15	51617707	51617708	Hormone measurements
chr15	51653118	51653119	Follicule stimulating hormone
chr15	51969667	51969668	Asthma
chr15	52773022	52773023	Metabolite levels (Pyroglutamine)
chr15	53203300	53203301	Obesity-related traits
chr15	53279377	53279378	Cognitive function
chr15	53805824	53805825	Longevity
chr15	53907947	53907948	Renal function-related traits (BUN)
chr15	53940306	53940307	Hematological and biochemical traits
chr15	53942927	53942928	Renal function-related traits (eGRFcrea)
chr15	53942927	53942928	Renal function-related traits (sCR)
chr15	53946592	53946593	Chronic kidney disease
chr15	54341464	54341465	Cognitive performance
chr15	54380199	54380200	Menarche (age at onset)
chr15	54380199	54380200	Menarche (age at onset)
chr15	54680631	54680632	Select biomarker traits
chr15	54868667	54868668	Immune response to smallpox vaccine (IL-6)
chr15	55456509	55456510	Neutrophil count
chr15	55950081	55950082	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)
chr15	56194876	56194877	Keloid
chr15	56210928	56210929	Brain connectivity
chr15	56340895	56340896	Chronic lymphocytic leukemia
chr15	56736477	56736478	Relative hand skill in reading disability
chr15	57762792	57762793	Bipolar disorder (age of onset and psychomotor symptoms)
chr15	57910163	57910164	Coronary heart disease
chr15	58080616	58080617	Myopia (pathological)
chr15	58213413	58213414	Hypertension
chr15	58471978	58471979	Metabolite levels
chr15	58635582	58635583	Cognitive performance
chr15	58674668	58674669	Non-small cell lung cancer
chr15	58674694	58674695	HDL cholesterol
chr15	58674694	58674695	Metabolite levels
chr15	58674694	58674695	Triglycerides
chr15	58678511	58678512	Age-related macular degeneration
chr15	58678511	58678512	Age-related macular degeneration
chr15	58678511	58678512	Cardiovascular disease risk factors
chr15	58678511	58678512	HDL cholesterol
chr15	58678511	58678512	Metabolic syndrome (bivariate traits)
chr15	58678511	58678512	Phospholipid levels (plasma)
chr15	58680642	58680643	Lipid metabolism phenotypes
chr15	58680953	58680954	Metabolic syndrome (bivariate traits)
chr15	58683365	58683366	Cholesterol, total
chr15	58683365	58683366	Cholesterol, total
chr15	58683365	58683366	HDL cholesterol
chr15	58683365	58683366	HDL cholesterol
chr15	58683365	58683366	HDL cholesterol
chr15	58683365	58683366	Lipid metabolism phenotypes
chr15	58683365	58683366	Lipid metabolism phenotypes
chr15	58683365	58683366	Lipid metabolism phenotypes
chr15	58683365	58683366	Metabolic syndrome
chr15	58683365	58683366	Metabolite levels
chr15	58683365	58683366	Red blood cell traits
chr15	58683365	58683366	Triglycerides
chr15	58687879	58687880	Age-related macular degeneration
chr15	58687879	58687880	Age-related macular degeneration
chr15	58688466	58688467	Age-related macular degeneration
chr15	58694019	58694020	HDL cholesterol
chr15	58712202	58712203	Obesity-related traits
chr15	58723425	58723426	HDL cholesterol
chr15	58723478	58723479	Hematological and biochemical traits
chr15	58723674	58723675	HDL cholesterol
chr15	58726743	58726744	HDL cholesterol
chr15	58730497	58730498	Lipid traits
chr15	58730638	58730639	Alzheimer's disease (cognitive decline)
chr15	58731152	58731153	Metabolite levels
chr15	58746829	58746830	Amyotrophic lateral sclerosis
chr15	59174538	59174539	Asperger disorder
chr15	59428657	59428658	Social communication problems
chr15	59487929	59487930	Metabolite levels
chr15	59719168	59719169	Bipolar disorder and schizophrenia
chr15	59824986	59824987	Visceral adipose tissue adjusted for BMI
chr15	60781512	60781513	Menarche (age at onset)
chr15	60878029	60878030	Gamma gluatamyl transferase levels
chr15	60883280	60883281	Liver enzyme levels (gamma-glutamyl transferase)
chr15	60894964	60894965	C-reactive protein
chr15	60900962	60900963	Menarche (age at onset)
chr15	60910549	60910550	Total ventricular volume
chr15	60937401	60937402	Menarche (age at onset)
chr15	61060706	61060707	Subcutaneous adipose tissue
chr15	61069987	61069988	Asthma
chr15	61164198	61164199	Pulmonary function decline
chr15	61267095	61267096	Depression (quantitative trait)
chr15	61329787	61329788	Response to citalopram treatment
chr15	61336441	61336442	Schizophrenia
chr15	61702778	61702779	Breast cancer (prognosis)
chr15	61702778	61702779	Response to amphetamines
chr15	61840102	61840103	Schizophrenia
chr15	61870942	61870943	Schizophrenia
chr15	62001131	62001132	Parkinson's disease
chr15	62312839	62312840	Bipolar disorder and schizophrenia
chr15	62332979	62332980	Two-hour glucose challenge
chr15	62338796	62338797	IgG glycosylation
chr15	62380258	62380259	Height
chr15	62383154	62383155	Proinsulin levels
chr15	62396388	62396389	Type 2 diabetes
chr15	62396388	62396389	Type 2 diabetes
chr15	62396941	62396942	Fasting glucose-related traits (interaction with BMI)
chr15	62404381	62404382	Type 2 diabetes
chr15	62414013	62414014	Type 2 diabetes
chr15	62433961	62433962	Fasting glucose-related traits
chr15	62687338	62687339	Brain structure (temporal lobe volume)
chr15	62899159	62899160	Sleep depth
chr15	63290644	63290645	Obesity-related traits
chr15	63312631	63312632	Orofacial clefts
chr15	63333723	63333724	Platelet counts
chr15	63341995	63341996	Mean platelet volume
chr15	63396866	63396867	HDL cholesterol
chr15	63422771	63422772	Metabolic traits
chr15	63737924	63737925	Heart failure
chr15	63915785	63915786	Iris characteristics
chr15	65153689	65153690	Coronary heart disease
chr15	65183800	65183801	Platelet counts
chr15	66051344	66051345	Mean corpuscular hemoglobin
chr15	66070692	66070693	Red blood cell traits
chr15	67066562	67066563	Subcutaneous adipose tissue
chr15	67442595	67442596	Crohn's disease
chr15	67442595	67442596	Inflammatory bowel disease
chr15	67446784	67446785	Asthma
chr15	67450304	67450305	Self-reported allergy
chr15	67458638	67458639	Coronary heart disease
chr15	67467506	67467507	Corneal structure
chr15	67702906	67702907	Menarche (age at onset)
chr15	68036851	68036852	Restless legs syndrome
chr15	68036851	68036852	Restless legs syndrome
chr15	68043056	68043057	Obesity
chr15	68043056	68043057	Obesity
chr15	68080885	68080886	Body mass index
chr15	68086837	68086838	Body mass index
chr15	68198910	68198911	Cognitive performance
chr15	68597126	68597127	Major depressive disorder
chr15	68597126	68597127	Major depressive disorder
chr15	68715031	68715032	Attention deficit hyperactivity disorder
chr15	68718986	68718987	IgG glycosylation
chr15	68718986	68718987	IgG glycosylation
chr15	68735585	68735586	Coronary heart disease
chr15	68892988	68892989	Cognitive performance
chr15	69059083	69059084	Esophageal cancer
chr15	69346945	69346946	Obesity-related traits
chr15	69346945	69346946	Obesity-related traits
chr15	69398025	69398026	Lipoprotein-associated phospholipase A2 activity change in response to statin therapy
chr15	69650052	69650053	Bipolar disorder and schizophrenia
chr15	69995343	69995344	Rheumatoid arthritis
chr15	70006872	70006873	Atrial fibrillation
chr15	70018989	70018990	Chronic lymphocytic leukemia
chr15	70018989	70018990	Chronic lymphocytic leukemia
chr15	70018989	70018990	Chronic lymphocytic leukemia
chr15	70048156	70048157	Height
chr15	70480613	70480614	Bipolar disorder
chr15	70576137	70576138	Amyotrophic lateral sclerosis
chr15	70634708	70634709	Migraine with aura
chr15	70798558	70798559	Self-reported allergy
chr15	71109146	71109147	Proinsulin levels
chr15	71424008	71424009	Thiazide-induced adverse metabolic effects in hypertensive patients
chr15	71574798	71574799	Periodontitis (PAL4Q3)
chr15	71576754	71576755	Periodontitis (Mean PAL)
chr15	71576754	71576755	Periodontitis (PAL4Q3)
chr15	71645119	71645120	Pulmonary function
chr15	71645119	71645120	Pulmonary function (interaction)
chr15	71679958	71679959	Airflow obstruction
chr15	71696885	71696886	Pulmonary function
chr15	72161402	72161403	Height
chr15	72169465	72169466	Metabolite levels (HVA/MHPG ratio)
chr15	73082365	73082366	Urate levels
chr15	73652173	73652174	Atrial fibrillation
chr15	73665505	73665506	Heart rate
chr15	73749607	73749608	IgG glycosylation
chr15	73749607	73749608	IgG glycosylation
chr15	73749607	73749608	IgG glycosylation
chr15	73978336	73978337	Liver enzyme levels (gamma-glutamyl transferase)
chr15	74012436	74012437	Bipolar disorder
chr15	74219581	74219582	Glaucoma (exfoliation)
chr15	74226764	74226765	Height
chr15	74229064	74229065	Aortic root size
chr15	74241505	74241506	Height
chr15	74305965	74305966	Myopia (pathological)
chr15	74336632	74336633	Height
chr15	74336632	74336633	Paget's disease
chr15	74548772	74548773	Obesity-related traits
chr15	74548772	74548773	Obesity-related traits
chr15	74716608	74716609	Airflow obstruction
chr15	75019448	75019449	Caffeine consumption
chr15	75019448	75019449	Coffee consumption
chr15	75027879	75027880	Coffee consumption
chr15	75033399	75033400	Coronary heart disease
chr15	75044237	75044238	Caffeine consumption
chr15	75077366	75077367	Blood pressure
chr15	75077366	75077367	Diastolic blood pressure
chr15	75077366	75077367	Diastolic blood pressure
chr15	75077366	75077367	Systolic blood pressure
chr15	75125644	75125645	Caffeine consumption
chr15	75125644	75125645	Coffee consumption
chr15	75125644	75125645	Diastolic blood pressure
chr15	75132318	75132319	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)
chr15	75334183	75334184	Blood trace element (Zn levels)
chr15	75382541	75382542	Caffeine consumption
chr15	75424592	75424593	Systemic lupus erythematosus and Systemic sclerosis
chr15	75449673	75449674	Adverse response to chemotherapy (neutropenia/leucopenia) (all platinum-based drugs)
chr15	75449673	75449674	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel)
chr15	75718668	75718669	Sudden cardiac arrest
chr15	75755466	75755467	Height
chr15	76158982	76158983	Chronic kidney disease
chr15	76158982	76158983	Urate levels
chr15	76293970	76293971	Red blood cell traits
chr15	76546932	76546933	Response to tocilizumab in rheumatoid arthritis
chr15	77747189	77747190	Type 2 diabetes
chr15	77747189	77747190	Type 2 diabetes
chr15	77777631	77777632	Type 2 diabetes
chr15	77851534	77851535	Anticoagulant levels
chr15	77963886	77963887	Essential tremor
chr15	78164705	78164706	Adverse response to chemotherapy (neutropenia/leucopenia) (doxorubicin)
chr15	78269471	78269472	Breast cancer
chr15	78530939	78530940	Personality dimensions
chr15	78698758	78698759	Obesity-related traits
chr15	78783276	78783277	Chronic obstructive pulmonary disease
chr15	78789487	78789488	Chronic obstructive pulmonary disease
chr15	78806022	78806023	Chronic obstructive pulmonary disease
chr15	78806022	78806023	Lung cancer
chr15	78806022	78806023	Lung cancer
chr15	78806022	78806023	Lung cancer
chr15	78806022	78806023	Lung cancer
chr15	78816056	78816057	Airflow obstruction
chr15	78827630	78827631	Chronic obstructive pulmonary disease
chr15	78833222	78833223	Response to tocilizumab in rheumatoid arthritis
chr15	78851614	78851615	Pulmonary function
chr15	78851614	78851615	Smoking behavior
chr15	78863471	78863472	Smoking behavior
chr15	78867481	78867482	Airflow obstruction
chr15	78894338	78894339	Lung adenocarcinoma
chr15	78894338	78894339	Lung cancer
chr15	78894338	78894339	Nicotine dependence
chr15	78894338	78894339	Smoking behavior
chr15	78894338	78894339	Smoking behavior
chr15	78894338	78894339	Smoking behavior
chr15	78898722	78898723	Pulmonary function
chr15	78898722	78898723	Serum albumin level
chr15	78908031	78908032	Lung cancer
chr15	78911180	78911181	Obesity-related traits
chr15	78911180	78911181	Pulmonary function (interaction)
chr15	78911180	78911181	Pulmonary function (interaction)
chr15	78926017	78926018	Sudden cardiac arrest
chr15	79080233	79080234	Coronary heart disease
chr15	79089110	79089111	Coronary artery calcification
chr15	79089110	79089111	Coronary heart disease
chr15	79111092	79111093	Coronary heart disease
chr15	79224682	79224683	Bipolar disorder
chr15	79235445	79235446	Type 1 diabetes
chr15	79235445	79235446	Type 1 diabetes
chr15	79274045	79274046	RR interval (heart rate)
chr15	79372874	79372875	Refractive error
chr15	79451868	79451869	Refractive error
chr15	79463846	79463847	Bronchopulmonary dysplasia
chr15	79533371	79533372	IgG glycosylation
chr15	80013421	80013422	IgG glycosylation
chr15	80192974	80192975	Periodontitis (Mean PAL)
chr15	80219592	80219593	Periodontitis (Mean PAL)
chr15	80432221	80432222	Type 2 diabetes
chr15	80694921	80694922	Bipolar disorder
chr15	81001277	81001278	Immune response to smallpox vaccine (IL-6)
chr15	81359136	81359137	QT interval (interaction)
chr15	81533694	81533695	Inattentive symptoms
chr15	81626724	81626725	Parkinson's disease
chr15	82352199	82352200	Body mass index
chr15	83254707	83254708	Chronic lymphocytic leukemia
chr15	83352281	83352282	Lipoprotein-associated phospholipase A2 activity change in response to statin therapy
chr15	83726178	83726179	Kawasaki disease
chr15	84286491	84286492	Height
chr15	84315883	84315884	Height
chr15	84522754	84522755	Height
chr15	84568157	84568158	Height
chr15	84568157	84568158	Height
chr15	84573040	84573041	Height
chr15	84580155	84580156	Height
chr15	84580581	84580582	Height
chr15	84582123	84582124	Height
chr15	84582123	84582124	Height
chr15	85187244	85187245	Periodontitis (CDC/AAP)
chr15	85415385	85415386	Adverse response to chemotherapy (neutropenia/leucopenia) (gemcitabine)
chr15	85430968	85430969	Alzheimer's disease (age of onset)
chr15	85699206	85699207	Bulimia nervosa
chr15	85825566	85825567	Central corneal thickness
chr15	85825566	85825567	Corneal structure
chr15	86067305	86067306	Interstitial lung disease
chr15	86369429	86369430	Aging traits
chr15	86462851	86462852	Adverse response to chemotherapy in breast cancer (alopecia) (anti-microtubule)
chr15	86462851	86462852	Adverse response to chemotherapy in breast cancer (alopecia) (docetaxel)
chr15	86854589	86854590	Thiazide-induced adverse metabolic effects in hypertensive patients
chr15	86859475	86859476	Barrett's esophagus
chr15	86984239	86984240	Schizophrenia
chr15	87053845	87053846	Cytomegalovirus antibody response
chr15	87064088	87064089	Psychosis (methamphetamine induced)
chr15	87191976	87191977	Activated partial thromboplastin time
chr15	87436744	87436745	Response to antidepressant treatment
chr15	87695510	87695511	Migraine
chr15	87710065	87710066	Bulimia nervosa
chr15	87977475	87977476	Coronary artery calcification
chr15	88661738	88661739	Gaucher disease severity
chr15	88723711	88723712	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr15	89119103	89119104	Thyroid hormone levels
chr15	89119103	89119104	Thyroid hormone levels
chr15	89245238	89245239	Dupuytren's disease
chr15	89249138	89249139	Obesity-related traits
chr15	89359688	89359689	Height
chr15	89388904	89388905	Height
chr15	89395625	89395626	Height
chr15	89395625	89395626	Height
chr15	89398104	89398105	Height
chr15	89617080	89617081	Height
chr15	89617080	89617081	Obesity-related traits
chr15	89863927	89863928	Menopause (age at onset)
chr15	89902031	89902032	Height
chr15	90168107	90168108	Obesity-related traits
chr15	90374256	90374257	Type 2 diabetes
chr15	90374256	90374257	Type 2 diabetes
chr15	90447945	90447946	Common traits (Other)
chr15	90893667	90893668	Rheumatoid arthritis
chr15	91114375	91114376	Information processing speed
chr15	91172900	91172901	Inflammatory bowel disease
chr15	91437387	91437388	Blood pressure
chr15	91437387	91437388	Diastolic blood pressure
chr15	91437387	91437388	Hypertension
chr15	91437387	91437388	Systolic blood pressure
chr15	91450440	91450441	Attention deficit hyperactivity disorder
chr15	91521336	91521337	Type 2 diabetes
chr15	91717351	91717352	Metabolite levels
chr15	92211773	92211774	Response to tocilizumab in rheumatoid arthritis
chr15	92445872	92445873	Response to iloperidone treatment (QT prolongation)
chr15	92552028	92552029	Inattentive symptoms
chr15	92657372	92657373	Acute lymphoblastic leukemia (childhood)
chr15	92685777	92685778	Obesity-related traits
chr15	92806290	92806291	DNA methylation (variation)
chr15	92883839	92883840	Airflow obstruction
chr15	92930410	92930411	Weight loss (gastric bypass surgery)
chr15	93044338	93044339	Alcoholism (heaviness of drinking)
chr15	93044338	93044339	Bipolar disorder
chr15	93050965	93050966	Pulmonary function
chr15	93131631	93131632	Subcutaneous adipose tissue
chr15	93564971	93564972	IgG glycosylation
chr15	93638400	93638401	Response to angiotensin II receptor blocker therapy (opposite direction w/ diuretic therapy)
chr15	93713665	93713666	Periodontitis (CDC/AAP)
chr15	93815128	93815129	Obesity-related traits
chr15	93877424	93877425	Adiponectin levels
chr15	94036687	94036688	Attention deficit hyperactivity disorder
chr15	94141832	94141833	Type 1 diabetes nephropathy
chr15	94689652	94689653	Hoarding
chr15	94939507	94939508	Drug-induced liver injury (flucloxacillin)
chr15	95165579	95165580	Sudden cardiac arrest
chr15	95270466	95270467	Hematological and biochemical traits
chr15	95318585	95318586	Response to mTOR inhibitor (rapamycin)
chr15	95318766	95318767	Stearic acid (18:0) plasma levels
chr15	95511836	95511837	Cognitive performance
chr15	96052741	96052742	Alcoholism (alcohol dependence factor score)
chr15	96141866	96141867	Response to TNF-alpha inhibitors in rheumatoid arthritis
chr15	96156367	96156368	Conduct disorder (interaction)
chr15	96332860	96332861	Information processing speed
chr15	96372628	96372629	Obesity-related traits
chr15	96647792	96647793	Migraine
chr15	96708290	96708291	Sex hormone-binding globulin levels
chr15	96708290	96708291	Sex hormone-binding globulin levels
chr15	96708290	96708291	Sex hormone-binding globulin levels
chr15	96809781	96809782	Migraine
chr15	96830549	96830550	Hypertension
chr15	96844726	96844727	Electroencephalographic traits in alcoholism
chr15	97002652	97002653	Prostate cancer (gene x gene interaction)
chr15	97018732	97018733	Response to amphetamines
chr15	97262426	97262427	Attention deficit hyperactivity disorder and conduct disorder
chr15	97750334	97750335	Obesity-related traits
chr15	98518791	98518792	Neuroticism
chr15	98606312	98606313	Fat distribution (HIV)
chr15	98876028	98876029	Obesity (extreme)
chr15	99072904	99072905	Arthritis (juvenile idiopathic)
chr15	99194895	99194896	Height
chr15	99271134	99271135	Urate levels
chr15	100297662	100297663	Coronary artery calcification
chr15	100299238	100299239	Major depressive disorder
chr15	100357434	100357435	IgG glycosylation
chr15	100728662	100728663	Osteosarcoma
chr15	100758384	100758385	Height
chr15	100759613	100759614	Height
chr15	100786270	100786271	Height
chr15	101251718	101251719	Response to taxane treatment (placlitaxel)
chr15	101558561	101558562	Corneal structure
chr15	101721891	101721892	Corneal astigmatism
chr15	101781933	101781934	Corneal structure
chr15	101865471	101865472	Relative hand skill in reading disability
chr15	101875122	101875123	Handedness in dyslexia
chr16	163597	163598	Red blood cell traits
chr16	184389	184390	Hematology traits
chr16	184389	184390	Hematology traits
chr16	184389	184390	Mean corpuscular hemoglobin
chr16	184389	184390	Mean corpuscular hemoglobin concentration
chr16	184389	184390	Mean corpuscular volume
chr16	184389	184390	Sickle cell anemia (haemolysis)
chr16	225652	225653	Mean corpuscular hemoglobin
chr16	240279	240280	Hematology traits
chr16	240279	240280	Mean corpuscular hemoglobin
chr16	240279	240280	Mean corpuscular volume
chr16	298587	298588	Red blood cell traits
chr16	304802	304803	Mean corpuscular volume
chr16	309154	309155	Mean corpuscular hemoglobin
chr16	309154	309155	Red blood cell traits
chr16	309154	309155	Red blood cell traits
chr16	310379	310380	Red blood cell traits
chr16	310379	310380	Red blood cell traits
chr16	310379	310380	Red blood cell traits
chr16	310379	310380	Red blood cell traits
chr16	314779	314780	Red blood cell traits
chr16	314779	314780	Red blood cell traits
chr16	314779	314780	Red blood cell traits
chr16	375781	375782	Bone mineral density
chr16	580123	580124	Mean corpuscular hemoglobin concentration
chr16	630664	630665	Disc degeneration (lumbar)
chr16	637211	637212	Disc degeneration (lumbar)
chr16	661334	661335	Disc degeneration (lumbar)
chr16	675679	675680	Height
chr16	792189	792190	Height
chr16	1073551	1073552	Multiple sclerosis
chr16	1532462	1532463	Bone mineral density
chr16	1838835	1838836	Insulin-like growth factors
chr16	2097157	2097158	Longevity
chr16	2107112	2107113	Obesity-related traits
chr16	2249375	2249376	Height
chr16	3023604	3023605	Metabolic syndrome
chr16	3769580	3769581	Metabolite levels (HVA/5-HIAA ratio)
chr16	3778336	3778337	Obesity-related traits
chr16	3796146	3796147	QT interval (interaction)
chr16	4013466	4013467	Obesity
chr16	4038386	4038387	Body mass index
chr16	4103870	4103871	Partial epilepsies
chr16	4257312	4257313	Obesity-related traits
chr16	4646877	4646878	Obesity-related traits
chr16	5001379	5001380	Lung cancer-asbestos exposure interaction
chr16	5003073	5003074	Metabolite levels (HVA/MHPG ratio)
chr16	5585851	5585852	Phospholipid levels (plasma)
chr16	5585851	5585852	Subcutaneous adipose tissue
chr16	6108429	6108430	Intraocular pressure
chr16	6113660	6113661	Conduct disorder (interaction)
chr16	6148029	6148030	Obesity-related traits
chr16	6156325	6156326	Obesity-related traits
chr16	6156325	6156326	Obesity-related traits
chr16	6699260	6699261	Visceral adipose tissue adjusted for BMI
chr16	6817374	6817375	Dengue shock syndrome
chr16	6896127	6896128	Heart rate
chr16	6910384	6910385	Attention deficit hyperactivity disorder and conduct disorder
chr16	7139172	7139173	Periodontitis (PAL4Q3)
chr16	7164218	7164219	Sleep time
chr16	7227121	7227122	Response to antipsychotic therapy (extrapyramidal side effects)
chr16	7415551	7415552	Diabetic retinopathy
chr16	7459346	7459347	Refractive error
chr16	7459682	7459683	Refractive error
chr16	7504853	7504854	Metabolite levels
chr16	7753703	7753704	Bipolar disorder and schizophrenia
chr16	7836296	7836297	Smoking behavior
chr16	7903608	7903609	Metabolite levels (MHPG)
chr16	8329326	8329327	Response to antidepressant treatment
chr16	8503221	8503222	QT interval
chr16	8517744	8517745	Epilepsy (remission after treatment)
chr16	9213879	9213880	Behavioural disinhibition (generation interaction)
chr16	9213879	9213880	Non-substance related behavioral disinhibition
chr16	9343346	9343347	Obesity-related traits
chr16	9399723	9399724	IgE grass sensitization
chr16	9675245	9675246	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr16	9744094	9744095	Sudden cardiac arrest
chr16	9862555	9862556	Hepatitis B
chr16	9911385	9911386	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr16	10188059	10188060	Thiazide-induced adverse metabolic effects in hypertensive patients
chr16	10559262	10559263	Response to antipsychotic treatment
chr16	10630776	10630777	Metabolite levels (MHPG)
chr16	10633164	10633165	Attention deficit hyperactivity disorder
chr16	10663626	10663627	Eating disorders
chr16	10975310	10975311	Ulcerative colitis
chr16	11081248	11081249	Immunoglobulin A
chr16	11158884	11158885	Allergic rhinitis
chr16	11166687	11166688	Multiple sclerosis
chr16	11177800	11177801	Multiple sclerosis
chr16	11179872	11179873	Type 1 diabetes
chr16	11179872	11179873	Type 1 diabetes
chr16	11179872	11179873	Type 1 diabetes
chr16	11179872	11179873	Type 1 diabetes
chr16	11179872	11179873	Type 1 diabetes autoantibodies
chr16	11187782	11187783	Primary biliary cirrhosis
chr16	11189887	11189888	Systemic lupus erythematosus
chr16	11210414	11210415	Atopic dermatitis
chr16	11222237	11222238	Obesity-related traits
chr16	11222237	11222238	Obesity-related traits
chr16	11230702	11230703	Self-reported allergy
chr16	11238782	11238783	Type 1 diabetes
chr16	11249328	11249329	Multiple sclerosis
chr16	11347857	11347858	Crohn's disease and psoriasis
chr16	11364078	11364079	Type 1 diabetes
chr16	11373319	11373320	Inflammatory bowel disease
chr16	11374865	11374866	Obesity-related traits
chr16	11374865	11374866	Obesity-related traits
chr16	11374865	11374866	Obesity-related traits
chr16	11386959	11386960	Bulimia nervosa
chr16	11403892	11403893	Celiac disease
chr16	11406802	11406803	Multiple sclerosis
chr16	11641179	11641180	Coronary heart disease
chr16	11691752	11691753	QT interval
chr16	11691752	11691753	QT interval
chr16	11691752	11691753	QT interval
chr16	12016918	12016919	Menopause (age at onset)
chr16	12016918	12016919	Menopause (age at onset)
chr16	12077631	12077632	Schizophrenia
chr16	12641114	12641115	Visceral adipose tissue adjusted for BMI
chr16	12708207	12708208	Obesity-related traits
chr16	13061610	13061611	Schizophrenia
chr16	13154877	13154878	Palmitoleic acid (16:1n-7) plasma levels
chr16	13238896	13238897	Lung function (forced expiratory volume in 1 second to forced vital capacity ratio)
chr16	13253955	13253956	Response to antipsychotic treatment
chr16	13656884	13656885	Response to citalopram treatment
chr16	13976355	13976356	Metabolic syndrome
chr16	14038173	14038174	Conduct disorder (symptom count)
chr16	14045398	14045399	Bilirubin levels
chr16	14388304	14388305	Height
chr16	14388304	14388305	Menarche (age at onset)
chr16	15082864	15082865	Phospholipid levels (plasma)
chr16	15129458	15129459	Bone mineral density
chr16	15129969	15129970	Metabolic traits
chr16	15131973	15131974	Height
chr16	15140210	15140211	Phospholipid levels (plasma)
chr16	15148645	15148646	Lipid metabolism phenotypes
chr16	15881966	15881967	Waist-hip ratio
chr16	16256766	16256767	IgG glycosylation
chr16	16730727	16730728	Obesity-related traits
chr16	16957914	16957915	Response to irinotecan and platinum-based chemotherapy in non-small-cell lung cancer
chr16	17739691	17739692	Corneal astigmatism
chr16	18024849	18024850	Obesity-related traits
chr16	18062135	18062136	IgG glycosylation
chr16	19028548	19028549	Response to angiotensin II receptor blocker therapy
chr16	19156015	19156016	Alcohol dependence
chr16	19404644	19404645	Sleep duration
chr16	19933599	19933600	Body mass index
chr16	19935072	19935073	Obesity
chr16	19935388	19935389	Obesity
chr16	19944362	19944363	Obesity
chr16	19960319	19960320	Obesity-related traits
chr16	20031204	20031205	IgG glycosylation
chr16	20056992	20056993	Attention deficit hyperactivity disorder (inattention symptoms)
chr16	20057660	20057661	Attention deficit hyperactivity disorder (inattention symptoms)
chr16	20059676	20059677	Attention deficit hyperactivity disorder (inattention symptoms)
chr16	20060829	20060830	Attention deficit hyperactivity disorder (inattention symptoms)
chr16	20089753	20089754	Attention deficit hyperactivity disorder (inattention symptoms)
chr16	20090644	20090645	Attention deficit hyperactivity disorder (inattention symptoms)
chr16	20094053	20094054	Attention deficit hyperactivity disorder (inattention symptoms)
chr16	20094545	20094546	Attention deficit hyperactivity disorder (inattention symptoms)
chr16	20094885	20094886	Attention deficit hyperactivity disorder (inattention symptoms)
chr16	20095627	20095628	Attention deficit hyperactivity disorder (inattention symptoms)
chr16	20100369	20100370	Attention deficit hyperactivity disorder (inattention symptoms)
chr16	20109652	20109653	Attention deficit hyperactivity disorder (inattention symptoms)
chr16	20122289	20122290	Attention deficit hyperactivity disorder (inattention symptoms)
chr16	20123514	20123515	Attention deficit hyperactivity disorder (inattention symptoms)
chr16	20126973	20126974	Attention deficit hyperactivity disorder (inattention symptoms)
chr16	20257866	20257867	Body mass index
chr16	20342571	20342572	Type 1 diabetes
chr16	20351230	20351231	Femoral neck bone geometry
chr16	20364587	20364588	Chronic kidney disease and serum creatinine levels
chr16	20365653	20365654	Hypertension
chr16	20367689	20367690	Chronic kidney disease
chr16	20367689	20367690	Renal function and chronic kidney disease
chr16	20367689	20367690	Renal function and chronic kidney disease
chr16	20400838	20400839	Renal function-related traits (eGRFcrea)
chr16	20400838	20400839	Renal function-related traits (sCR)
chr16	20674491	20674492	Schizophrenia
chr16	20680205	20680206	Schizophrenia
chr16	22889185	22889186	Adverse response to chemotherapy (neutropenia/leucopenia) (cyclophosphamide)
chr16	23067259	23067260	Multiple sclerosis
chr16	23634025	23634026	Bipolar disorder
chr16	23634025	23634026	Bipolar disorder
chr16	23640466	23640467	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr16	23765773	23765774	Platelet counts
chr16	23864589	23864590	Inflammatory bowel disease
chr16	23888839	23888840	Rheumatoid arthritis
chr16	24531717	24531718	Brain structure
chr16	24578457	24578458	Obesity-related traits
chr16	24675588	24675589	Alzheimer's disease (cognitive decline)
chr16	24810680	24810681	Type 2 diabetes (dietary heme iron intake interaction)
chr16	26170939	26170940	Obesity-related traits
chr16	27056454	27056455	Cognitive performance
chr16	27214983	27214984	Obesity-related traits
chr16	27374399	27374400	IgE levels
chr16	27410828	27410829	Self-reported allergy
chr16	27434926	27434927	Bone mineral density
chr16	28052962	28052963	Obesity-related traits
chr16	28490516	28490517	Crohn's disease
chr16	28517708	28517709	Inflammatory bowel disease
chr16	28539847	28539848	Type 1 diabetes
chr16	28539847	28539848	Type 1 diabetes autoantibodies
chr16	28837514	28837515	Educational attainment
chr16	28837514	28837515	Inflammatory bowel disease (early onset)
chr16	28883240	28883241	Body mass index
chr16	28883240	28883241	Body mass index
chr16	28883240	28883241	Obesity
chr16	28883240	28883241	Obesity
chr16	28883240	28883241	Weight
chr16	28885658	28885659	Body mass index
chr16	28921808	28921809	Obesity
chr16	29882489	29882490	Systemic lupus erythematosus
chr16	29885446	29885447	Anthropometric traits
chr16	29906545	29906546	Response to taxane treatment (placlitaxel)
chr16	29967433	29967434	Pubertal anthropometrics
chr16	30482493	30482494	Ulcerative colitis
chr16	30635658	30635659	Systemic lupus erythematosus
chr16	30642866	30642867	Systemic lupus erythematosus
chr16	30918486	30918487	Triglycerides
chr16	30942624	30942625	Psoriasis
chr16	31048078	31048079	Warfarin maintenance dose
chr16	31095170	31095171	Parkinson's disease
chr16	31107688	31107689	Warfarin maintenance dose
chr16	31107688	31107689	Warfarin maintenance dose
chr16	31298938	31298939	Systemic lupus erythematosus
chr16	31313252	31313253	Systemic lupus erythematosus
chr16	31313252	31313253	Systemic lupus erythematosus
chr16	31326705	31326706	Systemic lupus erythematosus and Systemic sclerosis
chr16	31334235	31334236	Systemic lupus erythematosus
chr16	31347747	31347748	IgA nephropathy
chr16	31368873	31368874	Systemic lupus erythematosus
chr16	32480923	32480924	Response to amphetamines
chr16	34682192	34682193	Obesity-related traits
chr16	35088130	35088131	Palmitoleic acid (16:1n-7) plasma levels
chr16	48621401	48621402	Response to tocilizumab in rheumatoid arthritis
chr16	49394275	49394276	Prostate cancer (gene x gene interaction)
chr16	49643565	49643566	IgG glycosylation
chr16	49643565	49643566	IgG glycosylation
chr16	49652778	49652779	IgG glycosylation
chr16	49750789	49750790	Inattentive symptoms
chr16	50103733	50103734	Esophageal cancer (squamous cell)
chr16	50142943	50142944	Testicular germ cell tumor
chr16	50142943	50142944	Testicular germ cell tumor
chr16	50437527	50437528	Liver enzyme levels (alanine transaminase)
chr16	50719102	50719103	Leprosy
chr16	50739581	50739582	Crohn's disease
chr16	50756773	50756774	Crohn's disease
chr16	50756773	50756774	Crohn's disease
chr16	50756773	50756774	Inflammatory bowel disease
chr16	50756880	50756881	Crohn's disease
chr16	50756880	50756881	Crohn's disease
chr16	50756880	50756881	Crohn's disease
chr16	50756880	50756881	Crohn's disease
chr16	50756880	50756881	Crohn's disease
chr16	50756880	50756881	Inflammatory bowel disease
chr16	50763777	50763778	Crohn's disease
chr16	50763777	50763778	Crohn's disease
chr16	50763777	50763778	Crohn's disease
chr16	50854417	50854418	Leprosy
chr16	50986307	50986308	Bone mineral density
chr16	51021802	51021803	Bone mineral density
chr16	51158709	51158710	C-reactive protein
chr16	51245486	51245487	Weight loss (gastric bypass surgery)
chr16	51330530	51330531	Personality dimensions
chr16	51458289	51458290	Optic disc parameters
chr16	52321975	52321976	Methotrexate phramacokinetics (acute lymphoblastic leukemia)
chr16	52347818	52347819	Polycystic ovary syndrome
chr16	52586340	52586341	Breast cancer
chr16	52586340	52586341	Breast cancer
chr16	52586340	52586341	Breast cancer
chr16	52586340	52586341	Breast cancer
chr16	52586340	52586341	Breast cancer
chr16	52586340	52586341	Breast cancer
chr16	52586340	52586341	Breast cancer
chr16	52586340	52586341	Breast cancer (male)
chr16	52599187	52599188	Breast cancer
chr16	52624737	52624738	Restless legs syndrome
chr16	52635163	52635164	Breast cancer
chr16	52831461	52831462	Tetralogy of Fallot
chr16	52912298	52912299	Bipolar disorder
chr16	53073787	53073788	IgG glycosylation
chr16	53192330	53192331	Fibrinogen
chr16	53639437	53639438	Vitiligo (non-segmental)
chr16	53757739	53757740	Subcutaneous adipose tissue
chr16	53769676	53769677	Body mass index
chr16	53769676	53769677	Weight
chr16	53800753	53800754	Body mass index
chr16	53800753	53800754	Metabolic syndrome
chr16	53800953	53800954	Dietary macronutrient intake
chr16	53800953	53800954	Obesity
chr16	53800953	53800954	Obesity
chr16	53800953	53800954	Obesity (early onset extreme)
chr16	53803573	53803574	Body mass index
chr16	53803573	53803574	Obesity
chr16	53803573	53803574	Obesity
chr16	53803573	53803574	Obesity (extreme)
chr16	53803573	53803574	Waist circumference
chr16	53809246	53809247	Body mass index
chr16	53809246	53809247	Obesity (early onset extreme)
chr16	53813366	53813367	Breast cancer
chr16	53813366	53813367	Breast cancer
chr16	53813366	53813367	Obesity
chr16	53813449	53813450	Obesity
chr16	53816274	53816275	Adiposity
chr16	53816274	53816275	Body mass in chronic obstructive pulmonary disease
chr16	53816274	53816275	Body mass index
chr16	53816274	53816275	Type 2 diabetes
chr16	53816274	53816275	Type 2 diabetes
chr16	53816274	53816275	Type 2 diabetes
chr16	53816274	53816275	Type 2 diabetes
chr16	53816274	53816275	Type 2 diabetes
chr16	53816274	53816275	Weight
chr16	53819892	53819893	Body mass index
chr16	53820526	53820527	Biomedical quantitative traits
chr16	53820526	53820527	Body mass index
chr16	53820526	53820527	Body mass index
chr16	53820526	53820527	Menarche (age at onset)
chr16	53820526	53820527	Type 2 diabetes
chr16	53820526	53820527	Type 2 diabetes
chr16	53821614	53821615	Body mass index
chr16	53822650	53822651	Obesity
chr16	53825487	53825488	Obesity (extreme)
chr16	53828065	53828066	Body mass index
chr16	53830464	53830465	Obesity-related traits
chr16	53830464	53830465	Obesity-related traits
chr16	53830464	53830465	Obesity-related traits
chr16	53831770	53831771	Subcutaneous adipose tissue
chr16	53839134	53839135	Osteoarthritis
chr16	53842907	53842908	Body mass index
chr16	53845486	53845487	Type 2 diabetes
chr16	53855290	53855291	Breast cancer
chr16	54027970	54027971	Sex hormone-binding globulin levels
chr16	54114823	54114824	Melanoma
chr16	54494423	54494424	Dialysis-related mortality
chr16	55245036	55245037	Information processing speed
chr16	55255190	55255191	Visceral fat
chr16	55604127	55604128	Thyroid hormone levels
chr16	55604127	55604128	Thyroid hormone levels
chr16	55844608	55844609	Response to dabigatran etexilate treatment
chr16	55861793	55861794	Response to dabigatran etexilate treatment
chr16	56725172	56725173	Gambling
chr16	56969147	56969148	Metabolic syndrome
chr16	56985138	56985139	HDL cholesterol
chr16	56985138	56985139	HDL cholesterol
chr16	56985138	56985139	HDL cholesterol
chr16	56985138	56985139	Lipid traits
chr16	56988043	56988044	Cardiovascular disease risk factors
chr16	56988043	56988044	HDL Cholesterol - Triglycerides (HDLC-TG)
chr16	56988043	56988044	HDL cholesterol
chr16	56988043	56988044	Metabolic syndrome
chr16	56988043	56988044	Metabolic syndrome (bivariate traits)
chr16	56988043	56988044	Metabolite levels
chr16	56989589	56989590	Cardiovascular disease risk factors
chr16	56989589	56989590	Lipoprotein-associated phospholipase A2 activity and mass
chr16	56990715	56990716	HDL cholesterol
chr16	56990715	56990716	HDL cholesterol
chr16	56990715	56990716	Metabolic syndrome
chr16	56993323	56993324	Age-related macular degeneration
chr16	56993323	56993324	Age-related macular degeneration
chr16	56993323	56993324	Cholesterol, total
chr16	56993323	56993324	HDL cholesterol
chr16	56993323	56993324	HDL cholesterol
chr16	56993323	56993324	HDL cholesterol
chr16	56993323	56993324	HDL cholesterol
chr16	56993323	56993324	Hematological and biochemical traits
chr16	56993323	56993324	LDL cholesterol
chr16	56993323	56993324	Lipid metabolism phenotypes
chr16	56993323	56993324	Lipoprotein-associated phospholipase A2 activity and mass
chr16	56993323	56993324	Metabolic syndrome
chr16	56993323	56993324	Metabolic syndrome (bivariate traits)
chr16	56993323	56993324	Triglycerides
chr16	56993323	56993324	Waist circumference and related phenotypes
chr16	56995235	56995236	HDL cholesterol
chr16	56995235	56995236	HDL cholesterol
chr16	56995235	56995236	Lipid metabolism phenotypes
chr16	56995235	56995236	Lipid metabolism phenotypes
chr16	56995235	56995236	Lipid metabolism phenotypes
chr16	56995235	56995236	Lipid metabolism phenotypes
chr16	56995235	56995236	Lipid metabolism phenotypes
chr16	56995235	56995236	Lipid metabolism phenotypes
chr16	56995235	56995236	Lipid traits
chr16	56995235	56995236	Triglycerides
chr16	56995235	56995236	Triglycerides
chr16	56997232	56997233	Age-related macular degeneration
chr16	56997232	56997233	HDL cholesterol
chr16	56997232	56997233	Lipid metabolism phenotypes
chr16	56997232	56997233	Lipid metabolism phenotypes
chr16	57002731	57002732	Metabolic syndrome (bivariate traits)
chr16	57005478	57005479	Cholesterol
chr16	57005478	57005479	HDL cholesterol
chr16	57005478	57005479	HDL cholesterol
chr16	57005478	57005479	Lipid metabolism phenotypes
chr16	57005478	57005479	Lipid metabolism phenotypes
chr16	57005478	57005479	Lipid metabolism phenotypes
chr16	57006589	57006590	Biochemical measures
chr16	57006589	57006590	Lipid metabolism phenotypes
chr16	57006589	57006590	Lipid metabolism phenotypes
chr16	57012378	57012379	HDL cholesterol
chr16	57024316	57024317	Schizophrenia
chr16	57047298	57047299	Coronary heart disease
chr16	57058581	57058582	Bipolar disorder and schizophrenia
chr16	57303193	57303194	Sleep duration
chr16	57563670	57563671	Cataracts in type 2 diabetes
chr16	58075281	58075282	Pulmonary function
chr16	58075281	58075282	Pulmonary function (interaction)
chr16	58566303	58566304	QT interval
chr16	58567237	58567238	Electrocardiographic traits
chr16	58567237	58567238	QT interval
chr16	58622177	58622178	QT interval
chr16	58759331	58759332	Aortic root size
chr16	59890697	59890698	Brain structure (hippocampal volume)
chr16	59940187	59940188	Obesity-related traits
chr16	60314655	60314656	Phospholipid levels (plasma)
chr16	60733602	60733603	Myopia (pathological)
chr16	61123146	61123147	Morbidity-free survival
chr16	61778094	61778095	Non-small cell lung cancer
chr16	62100210	62100211	Myopia (pathological)
chr16	62377152	62377153	Cystic fibrosis severity
chr16	62798851	62798852	Relative hand skill in reading disability
chr16	63955446	63955447	Attention deficit hyperactivity disorder and conduct disorder
chr16	64635402	64635403	Metabolite levels (Pyroglutamine)
chr16	65895363	65895364	Molar-incisor hypomineralization
chr16	66158735	66158736	Response to antipsychotic treatment
chr16	67225500	67225501	Coronary heart disease
chr16	67693796	67693797	Obesity-related traits
chr16	67708896	67708897	HDL cholesterol
chr16	67902069	67902070	HDL cholesterol
chr16	67902069	67902070	HDL cholesterol
chr16	67911516	67911517	Coronary heart disease
chr16	67911516	67911517	Metabolic syndrome
chr16	67928041	67928042	HDL cholesterol
chr16	67971379	67971380	Crohn's disease
chr16	68013470	68013471	HDL cholesterol
chr16	68024994	68024995	HDL cholesterol
chr16	68326199	68326200	Metabolic traits
chr16	68383046	68383047	Magnesium levels
chr16	68591229	68591230	Ulcerative colitis
chr16	68591229	68591230	Ulcerative colitis
chr16	68600350	68600351	Reasoning
chr16	68674787	68674788	Ulcerative colitis
chr16	68820945	68820946	Colorectal cancer
chr16	69135048	69135049	Attention deficit hyperactivity disorder
chr16	69563889	69563890	Urate levels
chr16	69588571	69588572	Menarche (age at onset)
chr16	69830327	69830328	IgE levels
chr16	70505358	70505359	Obesity-related traits
chr16	70505358	70505359	Obesity-related traits
chr16	71634810	71634811	Metabolite levels
chr16	71634810	71634811	Metabolite levels
chr16	71653636	71653637	Malaria
chr16	71965195	71965196	Attention deficit hyperactivity disorder and conduct disorder
chr16	72108092	72108093	Cholesterol, total
chr16	72108092	72108093	Haptoglobin levels
chr16	72108092	72108093	LDL cholesterol
chr16	72114001	72114002	Metabolite levels
chr16	72220372	72220373	Liver enzyme levels (alkaline phosphatase)
chr16	72257698	72257699	Thiazide-induced adverse metabolic effects in hypertensive patients
chr16	72756100	72756101	Metabolite levels
chr16	72931084	72931085	Coronary heart disease
chr16	73009023	73009024	Kawasaki disease
chr16	73029159	73029160	Atrial fibrillation
chr16	73051619	73051620	Atrial fibrillation
chr16	73051619	73051620	Atrial fibrillation
chr16	73068677	73068678	Stroke (ischemic)
chr16	73439354	73439355	Breast cancer (survival)
chr16	73501535	73501536	Major depressive disorder
chr16	73581057	73581058	Multiple sclerosis (severity)
chr16	73713682	73713683	Word reading
chr16	73829269	73829270	Thiazide-induced adverse metabolic effects in hypertensive patients
chr16	74076251	74076252	Treatment response for severe sepsis
chr16	74472695	74472696	Breast cancer
chr16	74670457	74670458	Testicular germ cell tumor
chr16	74978617	74978618	Obesity-related traits
chr16	74978617	74978618	Obesity-related traits
chr16	74978617	74978618	Obesity-related traits
chr16	74978617	74978618	Obesity-related traits
chr16	75167578	75167579	Crohn's disease (time to surgery)
chr16	75247244	75247245	Type 1 diabetes
chr16	75390315	75390316	Pulmonary function
chr16	75390315	75390316	Pulmonary function (interaction)
chr16	75991445	75991446	Tuberculosis
chr16	76318541	76318542	Response to amphetamines
chr16	76566156	76566157	Sphingolipid levels
chr16	76878861	76878862	Inattentive symptoms
chr16	76890125	76890126	Response to TNF-alpha inhibitors in rheumatoid arthritis
chr16	77328894	77328895	Adverse response to chemotherapy (neutropenia/leucopenia) (all antimicrotubule drugs)
chr16	77329640	77329641	White matter integrity
chr16	77427768	77427769	Bone mineral density
chr16	77783579	77783580	Obesity-related traits
chr16	77876762	77876763	Alzheimer's disease (cognitive decline)
chr16	77916190	77916191	Bipolar disorder and schizophrenia
chr16	78187902	78187903	Pulmonary function (interaction)
chr16	78188495	78188496	Pulmonary function (interaction)
chr16	78188737	78188738	Pulmonary function
chr16	78258809	78258810	Cardiac structure and function
chr16	78335043	78335044	Metabolite levels (5-HIAA)
chr16	78569956	78569957	Reasoning
chr16	78631793	78631794	Radiation response
chr16	78952438	78952439	Obesity
chr16	79073420	79073421	Response to amphetamines
chr16	79186885	79186886	Anorexia nervosa
chr16	79363813	79363814	Obesity-related traits
chr16	79406917	79406918	Type 2 diabetes
chr16	79431852	79431853	Dental caries
chr16	79585020	79585021	Height
chr16	79645988	79645989	Renal function-related traits (urea)
chr16	79652540	79652541	Multiple sclerosis
chr16	79682750	79682751	Obesity
chr16	79734986	79734987	Urate levels
chr16	79744547	79744548	Thyroid volume
chr16	79749275	79749276	Thyroid volume
chr16	79749352	79749353	Thyroid function
chr16	79749352	79749353	Thyroid hormone levels
chr16	79749352	79749353	Thyroid hormone levels
chr16	80192604	80192605	Presence of antiphospholipid antibodies
chr16	80305550	80305551	Corneal astigmatism
chr16	80497600	80497601	Liver enzyme levels (gamma-glutamyl transferase)
chr16	80650804	80650805	Breast cancer
chr16	81156521	81156522	Attention deficit hyperactivity disorder and conduct disorder
chr16	81264596	81264597	Carotenoid and tocopherol levels
chr16	81303758	81303759	Protein quantitative trait loci
chr16	81473648	81473649	Menarche (age at onset)
chr16	81489372	81489373	Type 2 diabetes
chr16	81534789	81534790	Adiponectin levels
chr16	81534789	81534790	HDL cholesterol
chr16	81774797	81774798	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)
chr16	81958297	81958298	Breast cancer (menopausal hormone therapy interaction)
chr16	81960957	81960958	IgG glycosylation
chr16	81960957	81960958	IgG glycosylation
chr16	82326804	82326805	Obesity-related traits
chr16	82326804	82326805	Obesity-related traits
chr16	82326804	82326805	Obesity-related traits
chr16	82326804	82326805	Obesity-related traits
chr16	82326804	82326805	Obesity-related traits
chr16	82326804	82326805	Obesity-related traits
chr16	82326804	82326805	Obesity-related traits
chr16	82377780	82377781	Bone mineral density
chr16	82379952	82379953	Cognitive performance
chr16	82457732	82457733	Non-word repetition
chr16	82485250	82485251	Response to fenofibrate (adiponectin levels)
chr16	82519227	82519228	D-dimer levels
chr16	82594382	82594383	Response to antipsychotic treatment
chr16	82642650	82642651	Hypertension
chr16	82646332	82646333	Adverse response to chemotherapy in breast cancer (alopecia) (paclitaxel)
chr16	82650716	82650717	Adiponectin levels
chr16	82650716	82650717	Adiponectin levels
chr16	82662267	82662268	Adiponectin levels
chr16	82663287	82663288	Adiponectin levels
chr16	82663287	82663288	Adiponectin levels
chr16	82663287	82663288	Adiponectin levels
chr16	82692811	82692812	Schizophrenia
chr16	82746936	82746937	Attention deficit hyperactivity disorder
chr16	82787052	82787053	Multiple myeloma (IgH translocation)
chr16	82817590	82817591	Tuberculosis
chr16	82962762	82962763	Migraine - clinic-based
chr16	83212397	83212398	Coronary heart disease
chr16	83284337	83284338	Depression (quantitative trait)
chr16	83326058	83326059	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+doxorubicin+/-5FU)
chr16	83358775	83358776	IgE levels in asthmatics (D.f. specific)
chr16	83360774	83360775	Malaria
chr16	83487470	83487471	Response to antipsychotic treatment
chr16	83639334	83639335	Height
chr16	83712434	83712435	Response to amphetamines
chr16	83757327	83757328	Cognitive performance
chr16	83757327	83757328	Cognitive performance
chr16	83764203	83764204	Blood pressure
chr16	83771495	83771496	IgG glycosylation
chr16	83783827	83783828	Periodontitis (Mean PAL)
chr16	84046714	84046715	Non-alcoholic fatty liver disease histology (other)
chr16	84213683	84213684	Autism
chr16	84274404	84274405	Visceral adipose tissue adjusted for BMI
chr16	84423033	84423034	Chronic obstructive pulmonary disease-related biomarkers
chr16	84446383	84446384	Attention deficit hyperactivity disorder
chr16	84578240	84578241	Eosinophilic esophagitis (pediatric)
chr16	84685508	84685509	Waist circumference
chr16	84796602	84796603	Response to mTOR inhibitor (everolimus)
chr16	84987678	84987679	Height
chr16	85092747	85092748	Amyotrophic lateral sclerosis
chr16	85906615	85906616	Thiazide-induced adverse metabolic effects in hypertensive patients
chr16	85944438	85944439	Chronic lymphocytic leukemia
chr16	85946449	85946450	Monocyte count
chr16	85961561	85961562	QRS duration
chr16	85973027	85973028	Systemic lupus erythematosus and Systemic sclerosis
chr16	85975658	85975659	Chronic lymphocytic leukemia
chr16	85975658	85975659	Chronic lymphocytic leukemia
chr16	85991704	85991705	Systemic sclerosis
chr16	86009739	86009740	Ulcerative colitis
chr16	86011032	86011033	Multiple sclerosis
chr16	86011336	86011337	Inflammatory bowel disease
chr16	86014240	86014241	Ulcerative colitis
chr16	86014240	86014241	Ulcerative colitis
chr16	86017662	86017663	Multiple sclerosis
chr16	86018632	86018633	Rheumatoid arthritis
chr16	86019270	86019271	Primary biliary cirrhosis
chr16	86104141	86104142	Major depressive disorder
chr16	86322458	86322459	Obesity-related traits
chr16	86365570	86365571	Diabetic retinopathy
chr16	86368525	86368526	Obesity-related traits
chr16	86381183	86381184	Response to statin therapy
chr16	86403117	86403118	Barrett's esophagus
chr16	86485130	86485131	Corneal astigmatism
chr16	86511914	86511915	Obesity (early onset extreme)
chr16	86680995	86680996	IgG glycosylation
chr16	86680995	86680996	IgG glycosylation
chr16	86681030	86681031	Obesity-related traits
chr16	86710659	86710660	Bone mineral density
chr16	86710659	86710660	Bone mineral density (hip)
chr16	86710659	86710660	Bone mineral density (spine)
chr16	87111629	87111630	Alzheimer's disease (age of onset)
chr16	87461968	87461969	Major depressive disorder
chr16	87991050	87991051	Menopause (age at onset)
chr16	88298123	88298124	Central corneal thickness
chr16	88298123	88298124	Central corneal thickness
chr16	88321435	88321436	Axial length
chr16	88331639	88331640	Central corneal thickness
chr16	88331639	88331640	Corneal structure
chr16	88528779	88528780	Follicule stimulating hormone
chr16	88777241	88777242	Height
chr16	88840461	88840462	Red blood cell traits
chr16	88853728	88853729	mean corpuscular hemoglobin concentration
chr16	89448662	89448663	Multiple myeloma (IgH translocation)
chr16	89471245	89471246	Multiple myeloma (IgH translocation)
chr16	89667336	89667337	Tanning
chr16	89708095	89708096	Homocysteine levels
chr16	89726034	89726035	Height
chr16	89741495	89741496	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr16	89755902	89755903	Black vs. red hair color
chr16	89755902	89755903	Melanoma
chr16	89755902	89755903	Melanoma
chr16	89818088	89818089	Vitiligo
chr16	89818731	89818732	Freckling
chr16	89818731	89818732	Hair color
chr16	89818731	89818732	Hair color
chr16	89851032	89851033	Caffeine consumption
chr16	89859752	89859753	Homocysteine levels
chr16	89986116	89986117	Basal cell carcinoma
chr16	89986116	89986117	Blond vs. brown hair color
chr16	89986116	89986117	Freckles
chr16	89986116	89986117	Hair color
chr16	89986116	89986117	Non-melanoma skin cancer
chr16	89986116	89986117	Red vs non-red hair color
chr16	89986116	89986117	Skin sensitivity to sun
chr16	89986116	89986117	Sunburns
chr16	89986116	89986117	Tanning
chr16	90066935	90066936	Melanoma
chr16	90084560	90084561	Tanning
chr17	38923	38924	AIDS progression
chr17	618964	618965	Prostate cancer
chr17	700019	700020	Type 2 diabetes
chr17	831666	831667	Economic and political preferences
chr17	1618362	1618363	Serum albumin level
chr17	1618362	1618363	Serum albumin level
chr17	1634103	1634104	Calcium levels
chr17	1634103	1634104	Calcium levels
chr17	2068931	2068932	Bone mineral density
chr17	2125604	2125605	Coronary heart disease
chr17	2126503	2126504	Coronary heart disease
chr17	2143459	2143460	Aortic root size
chr17	2145192	2145193	Metabolite levels (5-HIAA)
chr17	2171636	2171637	Esophageal cancer (squamous cell)
chr17	2208898	2208899	Schizophrenia
chr17	2216257	2216258	Type 2 diabetes
chr17	2262702	2262703	Proinsulin levels
chr17	2428507	2428508	HDL cholesterol
chr17	2771511	2771512	Sudden cardiac arrest
chr17	3029553	3029554	Endometriosis
chr17	3188011	3188012	Cocaine dependence
chr17	3188011	3188012	Cocaine dependence
chr17	3393067	3393068	Myopia (pathological)
chr17	3664974	3664975	Attention deficit hyperactivity disorder
chr17	3786906	3786907	Smoking behavior
chr17	4007593	4007594	Functional impairment in major depressive disorder, bipolar disorder and schizophrenia
chr17	4393497	4393498	Obesity-related traits
chr17	4683034	4683035	Metabolite levels
chr17	4683034	4683035	Sphingolipid levels
chr17	4836380	4836381	Platelet counts
chr17	4836380	4836381	Platelet counts
chr17	4901981	4901982	Obesity-related traits
chr17	5907442	5907443	Non-small cell lung cancer
chr17	6093950	6093951	Bipolar disorder (mood-incongruent)
chr17	6141676	6141677	Wegener's granulomatosis
chr17	6607017	6607018	Economic and political preferences (time)
chr17	6940392	6940393	Type 2 diabetes
chr17	7091649	7091650	Liver enzyme levels (alkaline phosphatase)
chr17	7118321	7118322	Adiponectin levels
chr17	7142850	7142851	Metabolite levels
chr17	7184480	7184481	Birth weight
chr17	7417662	7417663	Protein quantitative trait loci
chr17	7462554	7462555	IgM levels
chr17	7462968	7462969	IgA levels
chr17	7462968	7462969	IgA nephropathy
chr17	7462968	7462969	Non-albumin protein levels
chr17	7469228	7469229	IgM levels
chr17	7484811	7484812	Sex hormone-binding globulin levels
chr17	7487107	7487108	Hormone measurements
chr17	7487107	7487108	Hormone measurements
chr17	7491176	7491177	IgA nephropathy
chr17	7512073	7512074	IgM levels
chr17	7521914	7521915	Sex hormone-binding globulin levels
chr17	7521914	7521915	Sex hormone-binding globulin levels
chr17	7521914	7521915	Sex hormone-binding globulin levels
chr17	7521914	7521915	Sex hormone-binding globulin levels
chr17	7521914	7521915	Testosterone levels
chr17	7534677	7534678	Sex hormone-binding globulin levels
chr17	7534677	7534678	Testosterone levels
chr17	7537791	7537792	Androgen levels
chr17	7537791	7537792	Androgen levels
chr17	7537791	7537792	Sex hormone-binding globulin levels
chr17	7545720	7545721	Sex hormone-binding globulin levels
chr17	7552122	7552123	Androgen levels
chr17	7552122	7552123	Androgen levels
chr17	7571751	7571752	Basal cell carcinoma
chr17	7578114	7578115	Sex hormone-binding globulin levels
chr17	7633691	7633692	Type 1 diabetes
chr17	8130866	8130867	Parkinson's disease (motor and cognition)
chr17	8136091	8136092	Telomere length
chr17	8943928	8943929	Orofacial clefts
chr17	9090223	9090224	Breast cancer (prognosis)
chr17	9875204	9875205	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel)
chr17	10031089	10031090	Intraocular pressure
chr17	10033678	10033679	Intraocular pressure
chr17	10567482	10567483	Relative hand skill in reading disability
chr17	10574158	10574159	Malaria
chr17	11100664	11100665	Obesity-related traits
chr17	11250218	11250219	IgG glycosylation
chr17	11342607	11342608	Obesity-related traits
chr17	11407900	11407901	Refractive error
chr17	11803460	11803461	Myopia (pathological)
chr17	12047543	12047544	Response to amphetamines
chr17	12637370	12637371	Testosterone levels
chr17	12777401	12777402	Adverse response to chemotherapy (neutropenia/leucopenia) (all antimicrotubule drugs)
chr17	12804549	12804550	Economic and political preferences
chr17	13062794	13062795	Cannabis use (initiation)
chr17	13539803	13539804	Tonometry
chr17	13559079	13559080	Asthma (childhood onset)
chr17	13684916	13684917	Conduct disorder (symptom count)
chr17	13708860	13708861	IgG glycosylation
chr17	13733805	13733806	Systemic lupus erythematosus
chr17	13910548	13910549	Temperament
chr17	14294020	14294021	Protein quantitative trait loci
chr17	14561015	14561016	Corneal structure
chr17	14629745	14629746	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr17	14889924	14889925	Obesity-related traits
chr17	15193055	15193056	QT interval
chr17	15331516	15331517	Pulmonary function
chr17	16246015	16246016	Amyotrophic lateral sclerosis
chr17	16816542	16816543	Metabolite levels (Pyroglutamine)
chr17	16845166	16845167	IgG levels
chr17	16848749	16848750	Hematology traits
chr17	16848749	16848750	Serum total protein level
chr17	16848749	16848750	Serum total protein level
chr17	16848749	16848750	Serum total protein level
chr17	16849138	16849139	Hematological and biochemical traits
chr17	16849138	16849139	Multiple myeloma
chr17	16863637	16863638	Non-albumin protein levels
chr17	16863637	16863638	Non-albumin protein levels
chr17	16933403	16933404	Diabetic retinopathy
chr17	16960977	16960978	IgG glycosylation
chr17	17068181	17068182	Obesity-related traits
chr17	17142895	17142896	IgG glycosylation
chr17	17142895	17142896	IgG glycosylation
chr17	17543721	17543722	Coronary heart disease
chr17	17715100	17715101	Parkinson's disease
chr17	18064729	18064730	Obesity-related traits
chr17	18753869	18753870	Pancreatic cancer
chr17	19804246	19804247	Platelet counts
chr17	20023098	20023099	Obesity-related traits
chr17	20924076	20924077	Blood trace element (Se levels)
chr17	21284222	21284223	Height
chr17	21707059	21707060	Psoriasis
chr17	25320888	25320889	Response to amphetamines
chr17	25541277	25541278	Chronic myeloid leukemia
chr17	25567079	25567080	Dental caries
chr17	25843642	25843643	Crohn's disease
chr17	26106674	26106675	Psoriasis
chr17	26601132	26601133	Amyotrophic lateral sclerosis
chr17	27675225	27675226	Mean platelet volume
chr17	27703348	27703349	Mean platelet volume
chr17	27703348	27703349	Mean platelet volume
chr17	27714586	27714587	Mean platelet volume
chr17	27769597	27769598	Mean platelet volume
chr17	27814495	27814496	Platelet counts
chr17	27917770	27917771	Height
chr17	29164022	29164023	Height
chr17	29164022	29164023	Height
chr17	29247714	29247715	Height
chr17	29333515	29333516	Myopia (pathological)
chr17	30343281	30343282	Height
chr17	30535855	30535856	Obesity-related traits
chr17	30877657	30877658	Pancreatic cancer
chr17	30896454	30896455	Hypertension risk in short sleep duration
chr17	31078271	31078272	Refractive error
chr17	31393701	31393702	Obesity-related traits
chr17	31737420	31737421	vWF and FVIII levels
chr17	32287448	32287449	Coronary heart disease
chr17	32464153	32464154	Hypothyroidism
chr17	32593664	32593665	Crohn's disease
chr17	32593973	32593974	Crohn's disease
chr17	32593973	32593974	Inflammatory bowel disease
chr17	32972728	32972729	Personality dimensions
chr17	32989537	32989538	Lobular breast cancer (menopausal hormone therapy interaction)
chr17	33324381	33324382	QT interval
chr17	33843511	33843512	Depression (quantitative trait)
chr17	33884803	33884804	Platelet counts
chr17	33944054	33944055	Mean platelet volume
chr17	34358296	34358297	Pulmonary function
chr17	34819190	34819191	Protein quantitative trait loci
chr17	35189090	35189091	Orofacial clefts
chr17	35306311	35306312	Obesity-related traits
chr17	35306311	35306312	Obesity-related traits
chr17	35850552	35850553	Tuberculosis
chr17	35898341	35898342	Response to angiotensin II receptor blocker therapy
chr17	36026334	36026335	Bipolar disorder and schizophrenia
chr17	36096514	36096515	Ovarian cancer
chr17	36098039	36098040	Endometrial cancer
chr17	36098039	36098040	Prostate cancer
chr17	36098039	36098040	Prostate cancer
chr17	36098039	36098040	Prostate cancer
chr17	36098039	36098040	Prostate-specific antigen levels
chr17	36098039	36098040	Type 2 diabetes
chr17	36098039	36098040	Type 2 diabetes
chr17	36098039	36098040	Type 2 diabetes
chr17	36101155	36101156	Prostate cancer
chr17	36101155	36101156	Prostate cancer
chr17	36101155	36101156	Prostate cancer
chr17	36101155	36101156	Prostate cancer
chr17	36922195	36922196	Height
chr17	37101379	37101380	Obesity-related traits
chr17	37331344	37331345	IgG glycosylation
chr17	37332962	37332963	IgG glycosylation
chr17	37543448	37543449	Primary biliary cirrhosis
chr17	37813855	37813856	HDL cholesterol
chr17	37912376	37912377	Inflammatory bowel disease
chr17	37922258	37922259	Primary biliary cirrhosis
chr17	37976468	37976469	Primary biliary cirrhosis
chr17	37976468	37976469	Primary biliary cirrhosis
chr17	37976468	37976469	Systemic lupus erythematosus and Systemic sclerosis
chr17	38040762	38040763	Crohn's disease
chr17	38040762	38040763	Crohn's disease
chr17	38040762	38040763	Rheumatoid arthritis
chr17	38040762	38040763	Type 1 diabetes autoantibodies
chr17	38040762	38040763	Ulcerative colitis
chr17	38051347	38051348	Cervical cancer
chr17	38051347	38051348	Ulcerative colitis
chr17	38062195	38062196	Asthma
chr17	38062195	38062196	Ulcerative colitis
chr17	38064404	38064405	Asthma
chr17	38066239	38066240	Type 1 diabetes
chr17	38069948	38069949	Asthma
chr17	38074030	38074031	Self-reported allergy
chr17	38089343	38089344	Asthma
chr17	38095173	38095174	Asthma
chr17	38110688	38110689	Hematological parameters
chr17	38121992	38121993	Asthma
chr17	38128647	38128648	White blood cell count
chr17	38143547	38143548	White blood cell count
chr17	38156711	38156712	Neutrophil count
chr17	38156711	38156712	White blood cell count
chr17	38156711	38156712	White blood cell types
chr17	38166878	38166879	C-reactive protein and white blood cell count
chr17	38166878	38166879	White blood cell count
chr17	38179491	38179492	Multiple myeloma (hyperdiploidy)
chr17	38599171	38599172	Height
chr17	38770285	38770286	Type 1 diabetes
chr17	39046880	39046881	Height
chr17	39250638	39250639	Bipolar disorder and schizophrenia
chr17	39897263	39897264	Esophageal cancer (squamous cell)
chr17	40481528	40481529	Multiple sclerosis
chr17	40507979	40507980	Crohn's disease
chr17	40507979	40507980	Multiple sclerosis
chr17	40514200	40514201	Crohn's disease
chr17	40514200	40514201	Multiple sclerosis
chr17	40527543	40527544	Inflammatory bowel disease
chr17	40570771	40570772	Crohn's disease
chr17	41798823	41798824	Bone mineral density
chr17	41807330	41807331	Bone mineral density (hip)
chr17	42064986	42064987	Response to taxane treatment (placlitaxel)
chr17	42193184	42193185	Bone mineral density (hip)
chr17	42193184	42193185	Bone mineral density (spine)
chr17	42225546	42225547	Bone mineral density
chr17	42225546	42225547	Bone mineral density (hip)
chr17	42330728	42330729	Obesity-related traits
chr17	42442343	42442344	Platelet counts
chr17	43038208	43038209	DNA methylation (variation)
chr17	43208120	43208121	Systolic blood pressure
chr17	43212962	43212963	Economic and political preferences
chr17	43216280	43216281	Height
chr17	43403004	43403005	Multiple sclerosis
chr17	43513440	43513441	Parkinson's disease
chr17	43516401	43516402	Ovarian cancer in BRCA1 mutation carriers
chr17	43516401	43516402	Ovarian cancer in BRCA1 mutation carriers
chr17	43714849	43714850	Parkinson's disease
chr17	43719142	43719143	Parkinson's disease
chr17	43795432	43795433	Head circumference (infant)
chr17	43805193	43805194	Bone mineral density (hip)
chr17	43805193	43805194	Bone mineral density (spine)
chr17	43923682	43923683	Parkinson's disease
chr17	43924218	43924219	Male-pattern baldness
chr17	43977826	43977827	Bone mineral density
chr17	44019711	44019712	Progressive supranuclear palsy
chr17	44056766	44056767	Interstitial lung disease
chr17	44081063	44081064	Parkinson's disease
chr17	44081063	44081064	Progressive supranuclear palsy
chr17	44187256	44187257	Intracranial volume
chr17	44788309	44788310	Ovarian cancer in BRCA1 mutation carriers
chr17	44788309	44788310	Ovarian cancer in BRCA1 mutation carriers
chr17	44788309	44788310	Parkinson's disease
chr17	44828930	44828931	Parkinson's disease
chr17	44828930	44828931	Parkinson's disease
chr17	44856640	44856641	Parkinson's disease
chr17	44859143	44859144	Parkinson's disease
chr17	44865438	44865439	Celiac disease
chr17	44949099	44949100	Antineutrophil cytoplasmic antibody-associated vasculitis
chr17	45013270	45013271	Blood pressure
chr17	45013270	45013271	Blood pressure
chr17	45013270	45013271	Systolic blood pressure
chr17	45013270	45013271	Ventricular conduction
chr17	45309692	45309693	IgG glycosylation
chr17	45351117	45351118	IgG glycosylation
chr17	45425114	45425115	Cholesterol, total
chr17	45425114	45425115	LDL cholesterol
chr17	45768835	45768836	Ankylosing spondylitis
chr17	45768835	45768836	Multiple sclerosis
chr17	45830947	45830948	IgG glycosylation
chr17	45835277	45835278	IgG glycosylation
chr17	45835277	45835278	IgG glycosylation
chr17	45835277	45835278	IgG glycosylation
chr17	45930538	45930539	Alzheimer's disease (cognitive decline)
chr17	46047655	46047656	Metabolite levels (Pyroglutamine)
chr17	46123003	46123004	Epilepsy (generalized)
chr17	46123931	46123932	Body mass index
chr17	46357119	46357120	Ovarian cancer
chr17	46411499	46411500	Ovarian cancer
chr17	46411499	46411500	Ovarian cancer
chr17	46411499	46411500	Ovarian cancer
chr17	46617018	46617019	Primary tooth development (number of teeth)
chr17	46669429	46669430	Obesity
chr17	46720564	46720565	Body mass index (non-asthmatics)
chr17	46720564	46720565	Cognitive performance
chr17	46749790	46749791	Body mass index (non-asthmatics)
chr17	46757574	46757575	Metabolite levels (Dihydroxy docosatrienoic acid)
chr17	46988596	46988597	Coronary heart disease
chr17	47080430	47080431	Primary tooth development (number of teeth)
chr17	47080430	47080431	Primary tooth development (time to first tooth eruption)
chr17	47084710	47084711	Primary tooth development (number of teeth)
chr17	47084710	47084711	Primary tooth development (time to first tooth eruption)
chr17	47290794	47290795	IgG glycosylation
chr17	47345185	47345186	Prostate cancer
chr17	47390013	47390014	Height
chr17	47402806	47402807	Blood pressure
chr17	47436748	47436749	Prostate cancer
chr17	47440465	47440466	Diastolic blood pressure
chr17	47445750	47445751	Sex hormone-binding globulin levels
chr17	47445750	47445751	Sex hormone-binding globulin levels
chr17	47564011	47564012	Bipolar disorder
chr17	47566311	47566312	Immune reponse to smallpox (secreted IL-2)
chr17	48274290	48274291	Breast cancer
chr17	48289069	48289070	Response to taxane treatment (docetaxel)
chr17	48591208	48591209	Visceral fat
chr17	48692081	48692082	Alzheimer's disease (cognitive decline)
chr17	49244746	49244747	Height
chr17	49613784	49613785	Menarche (age at onset)
chr17	50293637	50293638	Thiazide-induced adverse metabolic effects in hypertensive patients
chr17	51237940	51237941	Conduct disorder (interaction)
chr17	52548124	52548125	Obesity-related traits
chr17	53056470	53056471	Breast cancer
chr17	53364787	53364788	Urate levels
chr17	53519843	53519844	Obesity-related traits
chr17	53757786	53757787	Height
chr17	54123972	54123973	IgG glycosylation
chr17	54123972	54123973	IgG glycosylation
chr17	54123972	54123973	IgG glycosylation
chr17	54192522	54192523	Cannabis dependence
chr17	54203359	54203360	Cannabis dependence
chr17	54278714	54278715	Cannabis dependence
chr17	54430154	54430155	Height
chr17	54611290	54611291	Celiac disease
chr17	54615616	54615617	Orofacial clefts
chr17	54773237	54773238	Orofacial clefts
chr17	54773237	54773238	Orofacial clefts
chr17	54778816	54778817	Height
chr17	54839758	54839759	Height
chr17	54850328	54850329	Height
chr17	55108733	55108734	Age-related macular degeneration
chr17	55119993	55119994	Response to amphetamines
chr17	55747415	55747416	Coronary artery calcification
chr17	55823551	55823552	Sex hormone-binding globulin levels
chr17	55866286	55866287	Bipolar disorder
chr17	56010959	56010960	Multiple sclerosis--Brain Glutamate Levels
chr17	56313903	56313904	IgG glycosylation
chr17	56313903	56313904	IgG glycosylation
chr17	56369848	56369849	Circulating myeloperoxidase levels (plasma)
chr17	56448296	56448297	Pancreatic cancer
chr17	56584204	56584205	Dental caries
chr17	56632542	56632543	Testicular germ cell tumor
chr17	56632542	56632543	Testicular germ cell tumor
chr17	56709057	56709058	Primary tooth development (time to first tooth eruption)
chr17	56847944	56847945	Cognitive test performance
chr17	57287453	57287454	Circulating myeloperoxidase levels (plasma)
chr17	57850250	57850251	Lipoprotein-associated phospholipase A2 activity and mass
chr17	57963536	57963537	Inflammatory bowel disease
chr17	58024274	58024275	Multiple sclerosis
chr17	58024323	58024324	Obesity-related traits
chr17	58966537	58966538	Immune reponse to smallpox (secreted IL-2)
chr17	59239220	59239221	Renal function-related traits (BUN)
chr17	59286643	59286644	Vertical cup-disc ratio
chr17	59292435	59292436	Alzheimer's disease (cognitive decline)
chr17	59323042	59323043	Obesity-related traits
chr17	59456588	59456589	Chronic kidney disease
chr17	59456588	59456589	Renal function-related traits (eGRFcrea)
chr17	59456588	59456589	Renal function-related traits (sCR)
chr17	59465696	59465697	Urate levels
chr17	59483765	59483766	Creatinine levels
chr17	59496648	59496649	Height
chr17	59496648	59496649	Height
chr17	59496648	59496649	Height
chr17	59497276	59497277	Height
chr17	59667952	59667953	Osteoarthritis (hip)
chr17	59880645	59880646	Ovarian cancer
chr17	59897454	59897455	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)
chr17	60778931	60778932	Sudden cardiac arrest
chr17	61563457	61563458	Metabolic traits
chr17	61566030	61566031	Angiotensin-converting enzyme activity
chr17	61569731	61569732	Metabolite levels
chr17	61712963	61712964	Height
chr17	61763030	61763031	Height
chr17	61763030	61763031	Height
chr17	61966464	61966465	Height
chr17	61977247	61977248	Height
chr17	61978547	61978548	Height
chr17	62007497	62007498	Height
chr17	62408298	62408299	Coronary heart disease
chr17	62600934	62600935	Periodontitis (Mean PAL)
chr17	63642541	63642542	Attention deficit hyperactivity disorder
chr17	64098544	64098545	&beta;2-Glycoprotein I (&beta;2-GPI) plasma levels
chr17	64133725	64133726	&beta;2-Glycoprotein I (&beta;2-GPI) plasma levels
chr17	64133725	64133726	Weight
chr17	64236317	64236318	&beta;2-Glycoprotein I (&beta;2-GPI) plasma levels
chr17	64318356	64318357	Ventricular conduction
chr17	64447164	64447165	Post-traumatic stress disorder (asjusted for relatedness)
chr17	64517312	64517313	Coronary artery calcification
chr17	64779429	64779430	Height
chr17	64917032	64917033	Bipolar disorder and schizophrenia
chr17	65488020	65488021	Pulmonary function
chr17	65898808	65898809	Lung adenocarcinoma
chr17	65898808	65898809	Lung cancer
chr17	66875293	66875294	HDL cholesterol
chr17	67802351	67802352	Response to TNF-alpha inhibitors in rheumatoid arthritis
chr17	67850900	67850901	Palmitoleic acid (16:1n-7) plasma levels
chr17	68090206	68090207	Height
chr17	68108416	68108417	Periodontitis (DPAL)
chr17	68185585	68185586	Primary tooth development (number of teeth)
chr17	68185585	68185586	Primary tooth development (time to first tooth eruption)
chr17	68190825	68190826	Primary tooth development (number of teeth)
chr17	68190825	68190826	Primary tooth development (time to first tooth eruption)
chr17	68259445	68259446	Thyrotoxic hypokalemic periodic paralysis
chr17	68291132	68291133	Eosinophilic esophagitis (pediatric)
chr17	68326337	68326338	Thyrotoxic hypokalemic periodic paralysis
chr17	68494991	68494992	QT interval
chr17	68521860	68521861	Cardiac repolarization
chr17	68634064	68634065	Obesity-related traits
chr17	68644188	68644189	Sudden cardiac arrest
chr17	68718733	68718734	Refractive error
chr17	68828088	68828089	Obesity-related traits
chr17	68878486	68878487	Formal thought disorder in schizophrenia
chr17	69108752	69108753	Prostate cancer
chr17	69108752	69108753	Prostate cancer
chr17	69108752	69108753	Prostate cancer
chr17	69108752	69108753	Prostate cancer
chr17	69125605	69125606	Pulmonary function (interaction)
chr17	69125605	69125606	Pulmonary function (interaction)
chr17	69236997	69236998	Adolescent idiopathic scoliosis (severe)
chr17	69490072	69490073	Coronary artery calcification
chr17	69949015	69949016	Bone mineral density
chr17	70098160	70098161	Liver enzyme levels (gamma-glutamyl transferase)
chr17	70127535	70127536	Thyroid hormone levels
chr17	70127535	70127536	Thyroid hormone levels
chr17	70127535	70127536	Thyroid hormone levels
chr17	70363394	70363395	Pulmonary function decline
chr17	70584264	70584265	Relative hand skill in reading disability
chr17	70594628	70594629	Thiazide-induced adverse metabolic effects in hypertensive patients
chr17	70641697	70641698	Ulcerative colitis
chr17	70696102	70696103	Amyotrophic lateral sclerosis
chr17	70713538	70713539	Serum selenium levels
chr17	70826403	70826404	Visceral adipose tissue adjusted for BMI
chr17	71000939	71000940	Body mass index (interaction)
chr17	71061933	71061934	Liver enzyme levels (alanine transaminase)
chr17	71335259	71335260	Panic disorder
chr17	71807712	71807713	IgG glycosylation
chr17	72268207	72268208	Information processing speed
chr17	72699832	72699833	Fibrinogen
chr17	72699832	72699833	Fibrinogen
chr17	73060072	73060073	Information processing speed
chr17	73872947	73872948	White matter hyperintensity burden
chr17	73888671	73888672	White matter hyperintensity burden
chr17	74283668	74283669	Urate levels
chr17	74733402	74733403	Retinal arteriolar caliber
chr17	74997896	74997897	Cannabis use (initiation)
chr17	75004212	75004213	Cardiac repolarization
chr17	75211207	75211208	Cognitive performance
chr17	75313334	75313335	Illicit drug use
chr17	75400099	75400100	Airflow obstruction
chr17	75701696	75701697	Body mass index
chr17	75944649	75944650	Alzheimer's disease
chr17	76110517	76110518	Thiazide-induced adverse metabolic effects in hypertensive patients
chr17	76219590	76219591	Behavioural disinhibition (generation interaction)
chr17	76219944	76219945	Periodontitis (Mean PAL)
chr17	76304509	76304510	Blood trace element (Se levels)
chr17	76311990	76311991	IgG glycosylation
chr17	76403983	76403984	HDL cholesterol
chr17	76868613	76868614	Obesity-related traits
chr17	76870580	76870581	Periodontitis (CDC/AAP)
chr17	76881702	76881703	Dupuytren's disease
chr17	77410858	77410859	Self-reported allergy
chr17	78060742	78060743	IgG glycosylation
chr17	78060742	78060743	IgG glycosylation
chr17	78066616	78066617	IgG glycosylation
chr17	78324258	78324259	Lipoprotein-associated phospholipase A2 activity change in response to statin therapy
chr17	78348493	78348494	Moyamoya disease
chr17	78591110	78591111	Obesity
chr17	78737286	78737287	Myopia (pathological)
chr17	79118572	79118573	Obesity-related traits
chr17	79168267	79168268	IgG glycosylation
chr17	79218713	79218714	IgG glycosylation
chr17	79218713	79218714	IgG glycosylation
chr17	79218713	79218714	IgG glycosylation
chr17	79218713	79218714	IgG glycosylation
chr17	79235787	79235788	IgG glycosylation
chr17	79261808	79261809	Longevity
chr17	79596810	79596811	Eye color traits
chr17	79682050	79682051	Dental caries
chr17	80408814	80408815	Protein quantitative trait loci
chr17	80685532	80685533	Glycated hemoglobin levels
chr18	120295	120296	Periodontitis (Mean PAL)
chr18	278795	278796	Bipolar disorder
chr18	278795	278796	Bipolar disorder and major depressive disorder (combined)
chr18	322521	322522	Obesity-related traits
chr18	355943	355944	Obesity-related traits
chr18	849177	849178	Pulmonary function in asthmatics
chr18	905124	905125	Obesity-related traits
chr18	1206983	1206984	Metabolite levels (Dihydroxy docosatrienoic acid)
chr18	1595020	1595021	Exercise (leisure time)
chr18	2498053	2498054	Acute lymphoblastic leukemia (childhood)
chr18	2946290	2946291	Body mass index (asthmatics)
chr18	2948028	2948029	Type 2 diabetes
chr18	3328745	3328746	Antineutrophil cytoplasmic antibody-associated vasculitis
chr18	3415830	3415831	Periodontitis (DPAL)
chr18	3512215	3512216	Cardiac Troponin-T levels
chr18	3522005	3522006	Economic and political preferences (time)
chr18	3879738	3879739	Obesity-related traits
chr18	4539084	4539085	Adverse response to chemotherapy (neutropenia/leucopenia) (all antimetabolite drugs)
chr18	4721358	4721359	Eating disorders
chr18	4773109	4773110	White blood cell types
chr18	5762617	5762618	Obesity-related traits
chr18	5857090	5857091	Immunoglobulin A
chr18	5978930	5978931	Sleep time
chr18	6567181	6567182	Hypothyroidism
chr18	6668049	6668050	Obesity-related traits
chr18	6939946	6939947	Sudden cardiac arrest
chr18	6941107	6941108	Response to citalopram treatment
chr18	6941661	6941662	Response to citalopram treatment
chr18	7042910	7042911	Non-small cell lung cancer
chr18	7068461	7068462	Type 2 diabetes
chr18	7755770	7755771	Dialysis-related mortality
chr18	8209268	8209269	Dialysis-related mortality
chr18	8966143	8966144	Obesity-related traits
chr18	8966143	8966144	Obesity-related traits
chr18	8966143	8966144	Obesity-related traits
chr18	8966143	8966144	Obesity-related traits
chr18	9288455	9288456	Dental caries
chr18	10078070	10078071	Pulmonary function (interaction)
chr18	10078070	10078071	Pulmonary function (interaction)
chr18	10321346	10321347	Metabolite levels (Pyroglutamine)
chr18	10382882	10382883	Serum protein levels (sST2)
chr18	10766424	10766425	Metabolite levels (5-HIAA/ MHPG Ratio)
chr18	10899027	10899028	Non-small cell lung cancer
chr18	10923807	10923808	Major depressive disorder
chr18	10923807	10923808	Major depressive disorder
chr18	11064408	11064409	Thiazide-induced adverse metabolic effects in hypertensive patients
chr18	11282318	11282319	Dental caries
chr18	11494198	11494199	Schizophrenia
chr18	11759431	11759432	QT interval (interaction)
chr18	11987271	11987272	Stroke
chr18	12550746	12550747	Immune response to smallpox vaccine (IL-6)
chr18	12606462	12606463	Immune response to smallpox vaccine (IL-6)
chr18	12779946	12779947	Crohn's disease
chr18	12779946	12779947	Crohn's disease
chr18	12779946	12779947	Crohn's disease
chr18	12779946	12779947	Type 1 diabetes
chr18	12779946	12779947	Type 1 diabetes
chr18	12779946	12779947	Type 1 diabetes autoantibodies
chr18	12797693	12797694	Rheumatoid arthritis
chr18	12809339	12809340	Celiac disease
chr18	12809339	12809340	Celiac disease and Rheumatoid arthritis
chr18	12809339	12809340	Crohn's disease
chr18	12809339	12809340	Inflammatory bowel disease
chr18	12809339	12809340	Type 1 diabetes
chr18	12821592	12821593	C-reactive protein
chr18	12821592	12821593	Esophageal cancer (squamous cell)
chr18	13366861	13366862	Pancreatic cancer
chr18	13708573	13708574	Bone mineral density
chr18	19261412	19261413	Phospholipid levels (plasma)
chr18	20084673	20084674	Migraine - clinic-based
chr18	20190794	20190795	Tuberculosis
chr18	20223694	20223695	Intracranial aneurysm
chr18	20720972	20720973	Height
chr18	20720972	20720973	Platelet counts
chr18	20720972	20720973	Platelet counts
chr18	20720972	20720973	Smoking behavior
chr18	20724327	20724328	Height
chr18	20727610	20727611	Height
chr18	20735407	20735408	Height
chr18	20879216	20879217	Hypertriglyceridemia
chr18	21140431	21140432	Obesity
chr18	21365852	21365853	Amyotrophic lateral sclerosis
chr18	21749614	21749615	Protein quantitative trait loci
chr18	21938657	21938658	Osteoporosis
chr18	22106775	22106776	Obesity-related traits
chr18	22136568	22136569	Response to taxane treatment (docetaxel)
chr18	22731359	22731360	Adverse response to lamotrigine and phenytoin
chr18	23257185	23257186	Weight
chr18	23393103	23393104	Obesity-related traits
chr18	23393103	23393104	Obesity-related traits
chr18	23393103	23393104	Obesity-related traits
chr18	23405187	23405188	Periodontitis (Mean PAL)
chr18	23614702	23614703	Rhegmatogenous retinal detachment
chr18	23764234	23764235	Periodontitis (Mean PAL)
chr18	23785647	23785648	Periodontitis (Mean PAL)
chr18	23892671	23892672	Visceral adipose tissue adjusted for BMI
chr18	24156424	24156425	Sudden cardiac arrest
chr18	24337423	24337424	Breast cancer
chr18	24570666	24570667	Breast cancer
chr18	24687323	24687324	Dental caries
chr18	24687370	24687371	Bronchopulmonary dysplasia
chr18	25070354	25070355	White matter integrity
chr18	25167944	25167945	Obesity-related traits
chr18	25569057	25569058	vWF and FVIII levels
chr18	25700790	25700791	Obesity-related traits
chr18	25773015	25773016	Response to amphetamines
chr18	25926058	25926059	Non-alcoholic fatty liver disease histology (lobular)
chr18	26059111	26059112	Hip geometry
chr18	26124687	26124688	Lung function (forced vital capacity)
chr18	26606646	26606647	Temperament (bipolar disorder)
chr18	26676671	26676672	Cognitive performance
chr18	27956442	27956443	Obesity-related traits
chr18	28141687	28141688	Protein quantitative trait loci
chr18	28639547	28639548	Bronchopulmonary dysplasia
chr18	28789724	28789725	Multiple sclerosis
chr18	28902321	28902322	Eosinophilic esophagitis (pediatric)
chr18	29038122	29038123	Parkinson's disease (age of onset)
chr18	29187278	29187279	Retinol levels
chr18	29273128	29273129	Amyotrophic lateral sclerosis
chr18	29336590	29336591	Coronary artery calcification
chr18	30927774	30927775	Prostate cancer (gene x gene interaction)
chr18	31266740	31266741	Pulmonary function
chr18	31420009	31420010	Response to antidepressants
chr18	31645378	31645379	Response to citalopram treatment
chr18	33097959	33097960	Capecitabine sensitivity
chr18	33694119	33694120	Esophageal squamous cell cancer (length of survival)
chr18	34107451	34107452	Response to antipsychotic treatment
chr18	34371860	34371861	Obesity-related traits
chr18	34928638	34928639	Response to iloperidone treatment (QT prolongation)
chr18	35198295	35198296	Response to amphetamines
chr18	35214005	35214006	Telomere length
chr18	37165304	37165305	Obesity-related traits
chr18	38765658	38765659	Obesity
chr18	39228309	39228310	Blood trace element (Zn levels)
chr18	39937508	39937509	Obesity-related traits
chr18	39940965	39940966	Periodontitis (PAL4Q3)
chr18	40023305	40023306	Periodontitis (PAL4Q3)
chr18	40023781	40023782	Economic and political preferences (immigration/crime)
chr18	40058881	40058882	Economic and political preferences (immigration/crime)
chr18	40059620	40059621	Coronary artery calcification
chr18	40075955	40075956	Economic and political preferences (immigration/crime)
chr18	40102640	40102641	Economic and political preferences (immigration/crime)
chr18	40105656	40105657	Economic and political preferences (immigration/crime)
chr18	40288292	40288293	Cognitive performance
chr18	40437650	40437651	Response to tocilizumab in rheumatoid arthritis
chr18	40591083	40591084	Acute lymphoblastic leukemia (childhood)
chr18	40673379	40673380	Parkinson's disease
chr18	40678234	40678235	Parkinson's disease
chr18	40808797	40808798	Conduct disorder (interaction)
chr18	40872272	40872273	Major depressive disorder
chr18	41480526	41480527	Obesity-related traits
chr18	42090666	42090667	Schizophrenia
chr18	42439885	42439886	Ventricular conduction
chr18	42725661	42725662	Prostate cancer (gene x gene interaction)
chr18	42800147	42800148	Male-pattern baldness
chr18	42956671	42956672	Menarche (age at onset)
chr18	43153948	43153949	Biochemical measures
chr18	43187129	43187130	Renal function-related traits (BUN)
chr18	43202403	43202404	Metabolite levels
chr18	43231621	43231622	Hematological and biochemical traits
chr18	43309910	43309911	Bladder cancer
chr18	43316965	43316966	Bladder cancer
chr18	43688575	43688576	Migraine - clinic-based
chr18	44585419	44585420	Personality dimensions
chr18	44752237	44752238	Menarche (age at onset)
chr18	44860263	44860264	Migraine
chr18	45815416	45815417	Response to taxane treatment (docetaxel)
chr18	45865596	45865597	Height
chr18	46227443	46227444	IgG glycosylation
chr18	46227443	46227444	IgG glycosylation
chr18	46240710	46240711	IgG glycosylation
chr18	46317087	46317088	Lung function (forced vital capacity)
chr18	46336701	46336702	Migraine with aura
chr18	46395021	46395022	Inflammatory bowel disease
chr18	46453462	46453463	Colorectal cancer
chr18	46453462	46453463	Colorectal cancer
chr18	46453462	46453463	Colorectal cancer
chr18	46453462	46453463	Colorectal cancer
chr18	46453462	46453463	Colorectal cancer
chr18	46579969	46579970	Dental caries
chr18	46587653	46587654	Height
chr18	46587653	46587654	Height
chr18	46959499	46959500	Height
chr18	46959499	46959500	Height
chr18	46991159	46991160	Height
chr18	47109692	47109693	Testicular germ cell tumor
chr18	47121315	47121316	Obesity-related traits
chr18	47159089	47159090	HDL cholesterol
chr18	47160813	47160814	Lipid metabolism phenotypes
chr18	47160952	47160953	Cholesterol, total
chr18	47160952	47160953	HDL cholesterol
chr18	47167213	47167214	Cholesterol, total
chr18	47167213	47167214	HDL cholesterol
chr18	47167213	47167214	HDL cholesterol
chr18	47167213	47167214	Lipid metabolism phenotypes
chr18	47167213	47167214	Lipid metabolism phenotypes
chr18	47167213	47167214	Lipid metabolism phenotypes
chr18	47167213	47167214	Lipid metabolism phenotypes
chr18	47167213	47167214	Lipid metabolism phenotypes
chr18	47167213	47167214	Lipid metabolism phenotypes
chr18	47167213	47167214	Lipid metabolism phenotypes
chr18	47167213	47167214	Lipid metabolism phenotypes
chr18	47181667	47181668	HDL cholesterol
chr18	47181667	47181668	HDL cholesterol
chr18	47181667	47181668	HDL cholesterol
chr18	47843533	47843534	Chronic lymphocytic leukemia
chr18	48378233	48378234	Entorhinal cortical thickness
chr18	48524160	48524161	Immune reponse to smallpox (secreted IFN-alpha)
chr18	48690618	48690619	Immune response to anthrax vaccine
chr18	48713039	48713040	Immune response to smallpox vaccine (IL-6)
chr18	49404963	49404964	Obesity-related traits
chr18	50192395	50192396	Obesity-related traits
chr18	50215411	50215412	Response to mTOR inhibitor (everolimus)
chr18	50285397	50285398	Alcoholism (alcohol use disorder factor score)
chr18	50517775	50517776	Gallbladder cancer
chr18	50906030	50906031	Body mass index (interaction)
chr18	51526567	51526568	Periodontitis (Mean PAL)
chr18	52752016	52752017	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr18	52752016	52752017	Schizophrenia
chr18	52752699	52752700	Schizophrenia
chr18	52821123	52821124	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr18	52863107	52863108	Diabetic retinopathy
chr18	52949656	52949657	Schizophrenia
chr18	53026356	53026357	Obesity (early onset extreme)
chr18	53058237	53058238	Schizophrenia
chr18	53066327	53066328	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr18	53155001	53155002	Schizophrenia
chr18	53194960	53194961	Schizophrenia
chr18	53207206	53207207	Sclerosing cholangitis and ulcerative colitis (combined)
chr18	53210301	53210302	Fuchs's corneal dystrophy
chr18	53664281	53664282	Breast cancer
chr18	54397621	54397622	Depression and alcohol dependence
chr18	54752313	54752314	Multiple sclerosis (age of onset)
chr18	55322501	55322502	Liver enzyme levels (gamma-glutamyl transferase)
chr18	55434201	55434202	Attention deficit hyperactivity disorder and conduct disorder
chr18	55454376	55454377	Vitiligo
chr18	55496304	55496305	Metabolite levels (MHPG)
chr18	55627839	55627840	Antineutrophil cytoplasmic antibody-associated vasculitis
chr18	55810732	55810733	Response to amphetamines
chr18	55910522	55910523	Insomnia (caffeine-induced)
chr18	56009603	56009604	Migraine with aura
chr18	56084053	56084054	Liver enzyme levels (gamma-glutamyl transferase)
chr18	56109858	56109859	Platelet counts
chr18	56213389	56213390	Multiple sclerosis
chr18	56384191	56384192	Multiple sclerosis
chr18	56752053	56752054	Alzheimer's disease (age of onset)
chr18	57314806	57314807	Major depressive disorder
chr18	57503377	57503378	Bleomycin sensitivity
chr18	57622286	57622287	Chronic lymphocytic leukemia
chr18	57734856	57734857	Body mass index
chr18	57751013	57751014	Metabolic syndrome
chr18	57828636	57828637	Body mass index
chr18	57839768	57839769	Body mass index
chr18	57849022	57849023	HDL cholesterol
chr18	57850421	57850422	Obesity
chr18	57851096	57851097	Body mass index
chr18	57851096	57851097	Body mass index
chr18	57851096	57851097	Height
chr18	57851096	57851097	Obesity
chr18	57851762	57851763	Obesity
chr18	57851762	57851763	Obesity (extreme)
chr18	57852586	57852587	Obesity (early onset extreme)
chr18	57852947	57852948	Obesity
chr18	57858828	57858829	Body mass index
chr18	57872988	57872989	Urate levels
chr18	57882786	57882787	Antipsychotic drug-induced weight gain
chr18	57882786	57882787	Waist circumference
chr18	57884749	57884750	Body mass index
chr18	57884749	57884750	Waist circumference and related phenotypes
chr18	57884749	57884750	Weight
chr18	57963116	57963117	Obesity and blood pressure
chr18	58067036	58067037	Age-related macular degeneration
chr18	58109189	58109190	Tuberculosis
chr18	58375933	58375934	Gout
chr18	59266370	59266371	Obesity-related traits
chr18	60054856	60054857	Bone mineral density
chr18	60054856	60054857	Bone mineral density (spine)
chr18	60060734	60060735	Paget's disease
chr18	60080111	60080112	Response to antipsychotic treatment
chr18	60082092	60082093	Bone mineral density (hip)
chr18	60082092	60082093	Paget's disease
chr18	60082092	60082093	Paget's disease
chr18	60126111	60126112	Serum albumin level
chr18	60126111	60126112	Serum albumin level
chr18	60793548	60793549	Chronic lymphocytic leukemia
chr18	60793920	60793921	Chronic lymphocytic leukemia
chr18	60859320	60859321	Cardiac Troponin-T levels
chr18	61176265	61176266	Adverse response to chemotherapy in breast cancer (alopecia) (anti-microtubule)
chr18	61877155	61877156	Airflow obstruction
chr18	62170725	62170726	Adverse response to chemotherapy (neutropenia/leucopenia) (docetaxel)
chr18	62418443	62418444	Age-related macular degeneration (smoking status interaction)
chr18	62884917	62884918	Cardiac Troponin-T levels
chr18	62898665	62898666	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+doxorubicin+/-5FU)
chr18	62998774	62998775	D-dimer levels
chr18	63031235	63031236	Atrioventricular conduction
chr18	64952212	64952213	Multiple myeloma (IgH translocation)
chr18	65017099	65017100	Cognitive performance
chr18	65285278	65285279	Major depressive disorder
chr18	65400424	65400425	Hyperactive-impulsive symptoms
chr18	66292258	66292259	Attention deficit hyperactivity disorder
chr18	66314071	66314072	Bipolar disorder and schizophrenia
chr18	66544754	66544755	Liver enzyme levels (alanine transaminase)
chr18	67142856	67142857	Osteoporosis
chr18	67516844	67516845	Mean platelet volume
chr18	67530438	67530439	Inflammatory bowel disease
chr18	67531641	67531642	Type 1 diabetes
chr18	67531641	67531642	Type 1 diabetes autoantibodies
chr18	67536495	67536496	Mean platelet volume
chr18	68142413	68142414	Response to antipsychotic treatment
chr18	68153619	68153620	Response to antipsychotic treatment
chr18	68628077	68628078	Iron status biomarkers
chr18	68842242	68842243	Systemic lupus erythematosus
chr18	69248594	69248595	Response to TNF-alpha inhibitors in rheumatoid arthritis
chr18	69365299	69365300	IgG glycosylation
chr18	69379389	69379390	IgG glycosylation
chr18	69379389	69379390	IgG glycosylation
chr18	69439072	69439073	Orofacial clefts
chr18	69774277	69774278	Multiple sclerosis (severity)
chr18	70150938	70150939	Pulmonary arterial hypertension (without BMPR2 mutations)
chr18	70227020	70227021	Airflow obstruction
chr18	70442067	70442068	Economic and political preferences (time)
chr18	71058621	71058622	P-tau181p
chr18	71167751	71167752	Thyroid hormone levels
chr18	71476132	71476133	Coronary artery calcification
chr18	71581505	71581506	Sleep duration
chr18	71788675	71788676	Venous thromboembolism (gene x gene interaction)
chr18	71878516	71878517	Chronic obstructive pulmonary disease-related biomarkers
chr18	72174022	72174023	Refractive error
chr18	72787045	72787046	Estradiol levels
chr18	72897160	72897161	IgG glycosylation
chr18	72897160	72897161	IgG glycosylation
chr18	73050333	73050334	Anorexia nervosa
chr18	73192445	73192446	Intelligence
chr18	73507568	73507569	Obesity-related traits
chr18	73527635	73527636	Response to amphetamines
chr18	73536710	73536711	Obesity-related traits
chr18	73536710	73536711	Obesity-related traits
chr18	73549962	73549963	Obesity-related traits
chr18	74101940	74101941	Longevity
chr18	74182974	74182975	Renal transplant outcome
chr18	74318609	74318610	Dental caries
chr18	74488279	74488280	Adverse response to chemotherapy (neutropenia/leucopenia) (cisplatin)
chr18	74735134	74735135	QT interval
chr18	74859043	74859044	Age-related macular degeneration (GA)
chr18	74952757	74952758	Obesity-related traits
chr18	74987631	74987632	RR interval (heart rate)
chr18	75605398	75605399	Adverse response to chemotherapy (neutropenia/leucopenia) (gemcitabine)
chr18	75638022	75638023	IgG glycosylation
chr18	75638022	75638023	IgG glycosylation
chr18	75653522	75653523	Inflammatory biomarkers
chr18	75912921	75912922	Schizophrenia
chr18	76409596	76409597	Rheumatoid arthritis
chr18	76415449	76415450	Response to amphetamines
chr18	76591634	76591635	Subcutaneous adipose tissue
chr18	76657778	76657779	Obesity-related traits
chr18	76773972	76773973	Prostate cancer
chr18	77392378	77392379	Schizophrenia
chr18	77573547	77573548	Amyotrophic lateral sclerosis
chr19	348742	348743	Non-small cell lung cancer
chr19	406933	406934	Obesity-related traits
chr19	950379	950380	Vertical cup-disc ratio
chr19	1046519	1046520	Alzheimer's disease
chr19	1050419	1050420	Alzheimer's disease (late onset)
chr19	1056491	1056492	Alzheimer's disease (late onset)
chr19	1124030	1124031	Crohn's disease
chr19	1124834	1124835	Crohn's disease
chr19	1207237	1207238	Alzheimer's disease
chr19	1423198	1423199	Reading and spelling
chr19	1423198	1423199	Word reading
chr19	1803581	1803582	Obesity-related traits
chr19	1811602	1811603	Bipolar disorder
chr19	2160528	2160529	Body mass index
chr19	2170953	2170954	Height
chr19	2176402	2176403	Height
chr19	2177192	2177193	Height
chr19	2177192	2177193	Osteoarthritis
chr19	2275078	2275079	Height
chr19	2410483	2410484	Neuroticism
chr19	3159768	3159769	Heart failure
chr19	3251218	3251219	Bipolar disorder and schizophrenia
chr19	3318509	3318510	Non-alcoholic fatty liver disease histology (other)
chr19	3428833	3428834	Height
chr19	3613471	3613472	Obesity-related traits
chr19	3797099	3797100	Obesity-related traits
chr19	3927770	3927771	Aging (time to event)
chr19	3944239	3944240	Age-related macular degeneration
chr19	3944239	3944240	Age-related macular degeneration
chr19	4717671	4717672	Interstitial lung disease
chr19	4830627	4830628	Vitiligo
chr19	5022603	5022604	Periodontitis (CDC/AAP)
chr19	5080646	5080647	Periodontitis (CDC/AAP)
chr19	5582534	5582535	vWF and FVIII levels
chr19	5834211	5834212	Tumor biomarkers
chr19	5839745	5839746	N-glycan levels
chr19	5839745	5839746	N-glycan levels
chr19	5839745	5839746	N-glycan levels
chr19	5839745	5839746	N-glycan levels
chr19	5839745	5839746	Tumor biomarkers
chr19	5839745	5839746	Vitamin B12 levels
chr19	5841355	5841356	Tumor biomarkers
chr19	5841355	5841356	Tumor biomarkers
chr19	6080481	6080482	Bipolar disorder and schizophrenia
chr19	6475612	6475613	Adverse response to chemotherapy (neutropenia/leucopenia) (cyclophosphamide)
chr19	6668971	6668972	Multiple sclerosis
chr19	6690770	6690771	Complement C3 and C4 levels
chr19	6718386	6718387	Age-related macular degeneration
chr19	6718386	6718387	Age-related macular degeneration
chr19	6718386	6718387	Age-related macular degeneration
chr19	6718386	6718387	Age-related macular degeneration
chr19	6718386	6718387	Age-related macular degeneration
chr19	6718386	6718387	Age-related macular degeneration (CNV)
chr19	6718386	6718387	Age-related macular degeneration (GA)
chr19	6887735	6887736	Periodontitis
chr19	7166108	7166109	Polycystic ovary syndrome
chr19	7184761	7184762	Height
chr19	7196564	7196565	Diabetic retinopathy
chr19	7199802	7199803	Urate levels
chr19	7223847	7223848	Hypothyroidism
chr19	7223847	7223848	Thyroid hormone levels
chr19	7223847	7223848	Thyroid hormone levels
chr19	7424527	7424528	Sexual dysfunction (SSRI/SNRI-related)
chr19	7734510	7734511	Resistin levels
chr19	8271720	8271721	Sphingolipid levels
chr19	8271720	8271721	Sphingolipid levels
chr19	8433195	8433196	HDL cholesterol
chr19	8469737	8469738	HDL cholesterol
chr19	8644030	8644031	Height
chr19	8671999	8672000	Height
chr19	8789380	8789381	Atopic dermatitis
chr19	10000321	10000322	Menarche (age at onset)
chr19	10213153	10213154	Protein quantitative trait loci
chr19	10310391	10310392	Thiazide-induced adverse metabolic effects in hypertensive patients
chr19	10397402	10397403	Soluble levels of adhesion molecules
chr19	10469974	10469975	Crohn's disease
chr19	10469974	10469975	Psoriasis
chr19	10472932	10472933	Psoriasis
chr19	10475651	10475652	Type 1 diabetes
chr19	10475651	10475652	Type 1 diabetes autoantibodies
chr19	10512910	10512911	Inflammatory bowel disease
chr19	10520063	10520064	Multiple sclerosis
chr19	10798903	10798904	Obesity-related traits
chr19	10838485	10838486	Coronary heart disease
chr19	11092138	11092139	Coronary heart disease
chr19	11163600	11163601	Coronary heart disease
chr19	11163600	11163601	Myocardial infarction (early onset)
chr19	11188152	11188153	Lipid metabolism phenotypes
chr19	11195029	11195030	LDL cholesterol
chr19	11200007	11200008	LDL cholesterol
chr19	11202305	11202306	Abdominal aortic aneurysm
chr19	11202305	11202306	Cardiovascular disease risk factors
chr19	11202305	11202306	Carotid intima media thickness
chr19	11202305	11202306	Cholesterol, total
chr19	11202305	11202306	LDL cholesterol
chr19	11202305	11202306	LDL cholesterol
chr19	11202305	11202306	LDL cholesterol
chr19	11202305	11202306	LDL cholesterol
chr19	11202305	11202306	Lipid metabolism phenotypes
chr19	11202305	11202306	Lipid metabolism phenotypes
chr19	11202305	11202306	Lipid metabolism phenotypes
chr19	11202305	11202306	Lipid metabolism phenotypes
chr19	11202305	11202306	Lipoprotein-associated phospholipase A2 activity and mass
chr19	11202305	11202306	Metabolite levels
chr19	11210911	11210912	Cholesterol, total
chr19	11210911	11210912	LDL cholesterol
chr19	11227325	11227326	Metabolite levels
chr19	11238472	11238473	LDL cholesterol
chr19	11330941	11330942	Bipolar disorder and schizophrenia
chr19	11334294	11334295	Coronary heart disease
chr19	11342702	11342703	HDL cholesterol
chr19	11347492	11347493	HDL cholesterol
chr19	11350487	11350488	HDL cholesterol
chr19	11655009	11655010	IgG glycosylation
chr19	11655009	11655010	IgG glycosylation
chr19	11655009	11655010	IgG glycosylation
chr19	11682494	11682495	Multiple sclerosis (severity)
chr19	12146369	12146370	Multiple sclerosis
chr19	12225371	12225372	Cognitive performance
chr19	12691184	12691185	Bipolar disorder
chr19	12932268	12932269	Mean corpuscular volume
chr19	13001546	13001547	Mean corpuscular hemoglobin
chr19	13024249	13024250	Red blood cell traits
chr19	13245967	13245968	Obesity-related traits
chr19	14139920	14139921	Obesity-related traits
chr19	14351573	14351574	Mortality among heart failure patients
chr19	14713492	14713493	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr19	15677709	15677710	Response to tocilizumab in rheumatoid arthritis
chr19	15724202	15724203	Inflammatory biomarkers
chr19	15990430	15990431	Acenocoumarol maintenance dosage
chr19	15990430	15990431	Metabolite levels
chr19	15990430	15990431	Response to Vitamin E supplementation
chr19	15990430	15990431	Vitamin E levels
chr19	15990430	15990431	Warfarin maintenance dose
chr19	15990430	15990431	Warfarin maintenance dose
chr19	16185558	16185559	Mean platelet volume
chr19	16185558	16185559	Mean platelet volume
chr19	16185558	16185559	Mean platelet volume
chr19	16185558	16185559	Platelet counts
chr19	16467758	16467759	White matter integrity
chr19	16548374	16548375	Multiple sclerosis
chr19	16548374	16548375	White blood cell count
chr19	17118432	17118433	Brain lesion load
chr19	17283302	17283303	Height
chr19	17389703	17389704	Breast Cancer in BRCA1 mutation carriers
chr19	17389703	17389704	Breast cancer
chr19	17389703	17389704	Breast cancer
chr19	17389703	17389704	Ovarian cancer
chr19	17389703	17389704	Ovarian cancer
chr19	17389703	17389704	Ovarian cancer
chr19	17392893	17392894	Breast cancer
chr19	17394123	17394124	Ovarian cancer
chr19	17420288	17420289	Systemic lupus erythematosus
chr19	17590280	17590281	Response to antidepressants
chr19	17752688	17752689	Amyotrophic lateral sclerosis
chr19	17752688	17752689	Amyotrophic lateral sclerosis
chr19	17762889	17762890	Obesity-related traits
chr19	17902333	17902334	Tumor biomarkers
chr19	18132539	18132540	Pulmonary function in asthmatics
chr19	18304699	18304700	Multiple sclerosis
chr19	18467885	18467886	Bipolar disorder and schizophrenia
chr19	18487666	18487667	Periodontitis (Mean PAL)
chr19	18567038	18567039	Self-reported allergy
chr19	18571140	18571141	Breast cancer
chr19	18747604	18747605	Orofacial clefts
chr19	18817902	18817903	Menarche (age at onset)
chr19	19276358	19276359	IgG glycosylation
chr19	19361734	19361735	Bipolar disorder
chr19	19407717	19407718	Cholesterol, total
chr19	19407717	19407718	LDL cholesterol
chr19	19407717	19407718	LDL cholesterol
chr19	19407717	19407718	LDL cholesterol
chr19	19407717	19407718	Triglycerides
chr19	19473444	19473445	Schizophrenia
chr19	19658471	19658472	LDL cholesterol
chr19	19658471	19658472	LDL cholesterol
chr19	19658471	19658472	Triglycerides
chr19	19658471	19658472	Triglycerides
chr19	19662219	19662220	Triglycerides
chr19	19721721	19721722	Obesity-related traits
chr19	19789527	19789528	Cholesterol, total
chr19	19789527	19789528	LDL cholesterol
chr19	19789527	19789528	Sphingolipid levels
chr19	19789527	19789528	Triglycerides
chr19	19789527	19789528	Triglycerides
chr19	20036175	20036176	Smoking behavior
chr19	20329110	20329111	Adverse response to chemotherapy (neutropenia/leucopenia) (all anthracycline-based drugs)
chr19	20846270	20846271	Thiazide-induced adverse metabolic effects in hypertensive patients
chr19	21666209	21666210	Pain
chr19	21956135	21956136	Capecitabine sensitivity
chr19	22359439	22359440	Telomere length
chr19	22515250	22515251	Telomere length
chr19	22554853	22554854	Dental caries
chr19	22608373	22608374	Dental caries
chr19	22614121	22614122	Dental caries
chr19	22614121	22614122	Response to statin therapy (LDL-C)
chr19	22741674	22741675	Corneal structure
chr19	23056345	23056346	Bronchopulmonary dysplasia
chr19	24222785	24222786	Response to taxane treatment (placlitaxel)
chr19	24355492	24355493	Response to taxane treatment (docetaxel)
chr19	28866595	28866596	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel + carboplatin)
chr19	29012920	29012921	Femoral neck bone geometry and menarche (age at onset)
chr19	29035555	29035556	Femoral neck bone geometry and menarche (age at onset)
chr19	29035555	29035556	Femoral neck bone geometry and menarche (age at onset)
chr19	29736341	29736342	Lentiform nucleus volume
chr19	29903676	29903677	Bulimia nervosa
chr19	29908106	29908107	Obesity-related traits
chr19	29912293	29912294	Obesity-related traits
chr19	30079603	30079604	Diabetic retinopathy
chr19	30296852	30296853	Bladder cancer
chr19	30937842	30937843	Adverse response to chemotherapy (neutropenia/leucopenia) (all platinum-based drugs)
chr19	30943676	30943677	Obesity-related traits
chr19	30990699	30990700	Myopia (pathological)
chr19	31099889	31099890	Select biomarker traits
chr19	31596777	31596778	Phospholipid levels (plasma)
chr19	31801129	31801130	Cognitive performance
chr19	31911128	31911129	Estradiol levels
chr19	32158463	32158464	Narcolepsy with cataplexy
chr19	32917454	32917455	Bipolar disorder
chr19	33089430	33089431	Major depressive disorder
chr19	33181483	33181484	Red blood cell traits
chr19	33356890	33356891	Chronic kidney disease
chr19	33364627	33364628	Urinary metabolites
chr19	33453658	33453659	Creatinine levels
chr19	33524918	33524919	Obesity-related traits
chr19	33532299	33532300	Colorectal cancer
chr19	33599126	33599127	Bone mineral density
chr19	33713927	33713928	Visceral adipose tissue adjusted for BMI
chr19	33713927	33713928	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr19	33731550	33731551	Inflammatory bowel disease
chr19	33750313	33750314	Inflammatory bowel disease (early onset)
chr19	33757061	33757062	Crohn's disease
chr19	33893007	33893008	Type 2 diabetes
chr19	33899064	33899065	Adiponectin levels
chr19	33906122	33906123	Adiponectin levels
chr19	33909709	33909710	Fasting insulin-related traits (interaction with BMI)
chr19	34168272	34168273	Working memory
chr19	34309531	34309532	Body mass index
chr19	34309531	34309532	Body mass index
chr19	34309531	34309532	Weight
chr19	34320853	34320854	Major depressive disorder
chr19	34321257	34321258	Major depressive disorder
chr19	34322136	34322137	Body mass index
chr19	34333913	34333914	Obesity-related traits
chr19	34766587	34766588	Functional MRI
chr19	35555189	35555190	Serum albumin level
chr19	35555189	35555190	Serum albumin level
chr19	35559473	35559474	Serum albumin level
chr19	35973288	35973289	Bipolar disorder
chr19	37684965	37684966	Obesity-related traits
chr19	37747107	37747108	Coronary artery calcification
chr19	38325535	38325536	Longevity
chr19	38735612	38735613	Prostate cancer
chr19	38912763	38912764	Asperger disorder
chr19	39174331	39174332	Migraine with aura
chr19	39188111	39188112	Heart rate
chr19	39580736	39580737	Type 2 diabetes
chr19	39731782	39731783	Lipid levels in hepatitis C treatment
chr19	39738786	39738787	Chronic Hepatitis C infection
chr19	39738786	39738787	Response to hepatitis C treatment
chr19	39743164	39743165	Chronic Hepatitis C infection
chr19	39743164	39743165	Response to hepatitis C treatment
chr19	39743164	39743165	Response to hepatitis C treatment
chr19	39743164	39743165	Response to hepatitis C treatment
chr19	39849788	39849789	Obesity-related traits
chr19	40170052	40170053	Obesity-related traits
chr19	40229408	40229409	Schizophrenia
chr19	41224203	41224204	Kawasaki disease
chr19	41281015	41281016	Kawasaki disease
chr19	41302705	41302706	Chronic obstructive pulmonary disease
chr19	41310570	41310571	Smoking behavior
chr19	41354532	41354533	Smoking behavior
chr19	41358623	41358624	Smoking behavior
chr19	41363764	41363765	Smoking behavior
chr19	41521637	41521638	Smoking behavior
chr19	41673847	41673848	Prion diseases
chr19	41851508	41851509	Migraine
chr19	41937094	41937095	Height
chr19	41985586	41985587	Prostate cancer
chr19	41985586	41985587	Prostate cancer
chr19	42066278	42066279	Schizophrenia
chr19	42521107	42521108	Bipolar disorder
chr19	44286512	44286513	Breast cancer
chr19	44511388	44511389	Acute lymphoblastic leukemia (childhood)
chr19	44614207	44614208	Alzheimer's disease
chr19	44888275	44888276	Myopia (pathological)
chr19	44932971	44932972	Tuberculosis
chr19	44970934	44970935	Personality dimensions
chr19	44970934	44970935	Personality dimensions
chr19	45146102	45146103	Multiple sclerosis
chr19	45247626	45247627	Lipid metabolism phenotypes
chr19	45247626	45247627	Lipid metabolism phenotypes
chr19	45247626	45247627	Lipid metabolism phenotypes
chr19	45326767	45326768	Waist-to-hip circumference ratio (interaction)
chr19	45376283	45376284	Alzheimer's disease (late onset)
chr19	45376283	45376284	HDL cholesterol
chr19	45382033	45382034	Alzheimer's disease
chr19	45382033	45382034	Alzheimer's disease
chr19	45382033	45382034	Alzheimer's disease (late onset)
chr19	45392253	45392254	Age-related macular degeneration
chr19	45392253	45392254	Age-related macular degeneration
chr19	45392253	45392254	Alzheimer's disease (age of onset)
chr19	45392253	45392254	Alzheimer's disease biomarkers
chr19	45395265	45395266	Alzheimer's disease
chr19	45395265	45395266	Alzheimer's disease
chr19	45395265	45395266	Alzheimer's disease biomarkers
chr19	45395265	45395266	HDL cholesterol
chr19	45395265	45395266	LDL cholesterol
chr19	45395265	45395266	LDL cholesterol
chr19	45395618	45395619	AB1-42
chr19	45395618	45395619	Age-related macular degeneration
chr19	45395618	45395619	Age-related macular degeneration
chr19	45395618	45395619	Alzheimer's disease
chr19	45395618	45395619	Alzheimer's disease
chr19	45395618	45395619	Alzheimer's disease
chr19	45395618	45395619	Alzheimer's disease
chr19	45395618	45395619	Alzheimer's disease (late onset)
chr19	45395618	45395619	Alzheimer's disease biomarkers
chr19	45395618	45395619	C-reactive protein
chr19	45395618	45395619	C-reactive protein
chr19	45395618	45395619	Cardiovascular disease risk factors
chr19	45395618	45395619	Cardiovascular disease risk factors
chr19	45395618	45395619	Cholesterol, total
chr19	45395618	45395619	Cognitive decline
chr19	45395618	45395619	Longevity
chr19	45396218	45396219	Metabolic syndrome
chr19	45396664	45396665	Alzheimer's disease biomarkers
chr19	45403411	45403412	C-reactive protein
chr19	45403411	45403412	LDL cholesterol
chr19	45410001	45410002	Alzheimer's disease biomarkers
chr19	45410001	45410002	Alzheimer's disease biomarkers
chr19	45410001	45410002	C-reactive protein
chr19	45411940	45411941	Alzheimer's disease biomarkers
chr19	45411940	45411941	Alzheimer's disease biomarkers
chr19	45412078	45412079	LDL cholesterol
chr19	45412078	45412079	Lipid metabolism phenotypes
chr19	45412078	45412079	Lipid traits
chr19	45412078	45412079	Lipid traits
chr19	45412078	45412079	Response to statin therapy (LDL-C)
chr19	45414450	45414451	Alzheimer's disease biomarkers
chr19	45414450	45414451	HDL Cholesterol - Triglycerides (HDLC-TG)
chr19	45414450	45414451	Triglycerides
chr19	45414450	45414451	Triglycerides
chr19	45415639	45415640	Apolipoprotein Levels
chr19	45415639	45415640	Apolipoprotein Levels
chr19	45415639	45415640	Cardiovascular disease risk factors
chr19	45415639	45415640	Carotid intima media thickness
chr19	45415639	45415640	Carotid intima media thickness
chr19	45415639	45415640	Lipoprotein-associated phospholipase A2 activity and mass
chr19	45415639	45415640	Metabolite levels
chr19	45422586	45422587	Triglycerides
chr19	45422845	45422846	Alzheimer's disease biomarkers
chr19	45422945	45422946	Age-related macular degeneration
chr19	45422945	45422946	Alzheimer's disease
chr19	45422945	45422946	Alzheimer's disease
chr19	45422945	45422946	Alzheimer's disease
chr19	45422945	45422946	Alzheimer's disease (age of onset)
chr19	45422945	45422946	Alzheimer's disease (late onset)
chr19	45422945	45422946	C-reactive protein
chr19	45422945	45422946	C-reactive protein
chr19	45422945	45422946	C-reactive protein
chr19	45422945	45422946	Cholesterol, total
chr19	45422945	45422946	Cognitive decline
chr19	45422945	45422946	HDL cholesterol
chr19	45422945	45422946	LDL cholesterol
chr19	45422945	45422946	LDL cholesterol
chr19	45422945	45422946	LDL cholesterol
chr19	45422945	45422946	LDL cholesterol
chr19	45422945	45422946	LDL cholesterol
chr19	45422945	45422946	LDL cholesterol
chr19	45422945	45422946	LDL cholesterol
chr19	45422945	45422946	Lipid traits
chr19	45422945	45422946	Lipoprotein-associated phospholipase A2 activity and mass
chr19	45422945	45422946	Lipoprotein-associated phospholipase A2 activity and mass
chr19	45422945	45422946	Longevity
chr19	45422945	45422946	Quantitative traits
chr19	45422945	45422946	Quantitative traits
chr19	45422945	45422946	Quantitative traits
chr19	45422945	45422946	Triglycerides
chr19	45432556	45432557	Sphingolipid levels
chr19	45695737	45695738	Quantitative traits
chr19	45695737	45695738	Quantitative traits
chr19	45740770	45740771	Platelet counts
chr19	45854918	45854919	Lung Cancer (DNA repair capacity)
chr19	46034557	46034558	Depression and alcohol dependence
chr19	46172277	46172278	Body mass index
chr19	46172277	46172278	Body mass index
chr19	46181391	46181392	Obesity
chr19	46182303	46182304	Obesity
chr19	46182303	46182304	Two-hour glucose challenge
chr19	46195755	46195756	Subcutaneous adipose tissue
chr19	46195755	46195756	Subcutaneous adipose tissue
chr19	46202171	46202172	Body mass index
chr19	46307405	46307406	Sudden cardiac arrest
chr19	46849805	46849806	Crohn's disease
chr19	47123782	47123783	Ulcerative colitis
chr19	47207653	47207654	Chronic lymphocytic leukemia
chr19	47208480	47208481	Type 1 diabetes
chr19	47268372	47268373	Chronic lymphocytic leukemia
chr19	47569002	47569003	Body mass index
chr19	47575715	47575716	Obesity-related traits
chr19	47661492	47661493	Multiple sclerosis
chr19	48348362	48348363	Lung function (forced vital capacity)
chr19	48401892	48401893	Dehydroepiandrosterone sulphate levels
chr19	48527581	48527582	Intelligence
chr19	49206171	49206172	Crohn's disease
chr19	49206171	49206172	Liver enzyme levels (gamma-glutamyl transferase)
chr19	49206171	49206172	Obesity-related traits
chr19	49206416	49206417	Cholesterol, total
chr19	49206416	49206417	Vitamin B12 levels
chr19	49206602	49206603	Liver enzyme levels (alkaline phosphatase)
chr19	49206630	49206631	Tumor biomarkers
chr19	49206630	49206631	Tumor biomarkers
chr19	49206630	49206631	Vitamin B12 levels
chr19	49206984	49206985	Folate pathway vitamin levels
chr19	49206984	49206985	Folate pathway vitamin levels
chr19	49208864	49208865	Crohn's disease
chr19	49209009	49209010	Metabolic traits
chr19	49214273	49214274	Crohn's disease
chr19	49214273	49214274	Pubertal anthropometrics
chr19	49214469	49214470	Multiple sclerosis
chr19	49228271	49228272	Bipolar disorder
chr19	49228271	49228272	Retinal vascular caliber
chr19	49246865	49246866	Dietary macronutrient intake
chr19	49248729	49248730	Dietary macronutrient intake
chr19	49248729	49248730	Dietary macronutrient intake
chr19	49259528	49259529	Dietary macronutrient intake
chr19	49259528	49259529	Homocysteine levels
chr19	49497154	49497155	Follicule stimulating hormone
chr19	49869050	49869051	Multiple sclerosis
chr19	50000008	50000009	Hematological and biochemical traits
chr19	50000008	50000009	Metabolite levels
chr19	50000008	50000009	Serum albumin level
chr19	50000008	50000009	Serum albumin level
chr19	50000008	50000009	Serum total protein level
chr19	50000008	50000009	Serum total protein level
chr19	50223265	50223266	Panic disorder
chr19	50338235	50338236	Blood trace element (Se levels)
chr19	50721073	50721074	Disc degeneration (lumbar)
chr19	50909764	50909765	Obesity-related traits
chr19	50926741	50926742	Primary biliary cirrhosis
chr19	50926741	50926742	Primary biliary cirrhosis
chr19	51349089	51349090	Prostate-specific antigen levels
chr19	51361756	51361757	Prostate-specific antigen levels
chr19	51364622	51364623	Prostate cancer
chr19	51364622	51364623	Prostate-specific antigen levels
chr19	51374966	51374967	PCA3 expression level
chr19	51377162	51377163	Celiac disease
chr19	51393117	51393118	Prostate-specific antigen levels
chr19	51419545	51419546	Obesity-related traits
chr19	51430595	51430596	Alzheimer's disease (cognitive decline)
chr19	51726612	51726613	Alzheimer's disease
chr19	51727961	51727962	Alzheimer's disease (late onset)
chr19	51773801	51773802	Body mass index
chr19	51796298	51796299	Palmitic acid (16:0) plasma levels
chr19	52084835	52084836	Response to tocilizumab in rheumatoid arthritis
chr19	52372975	52372976	Breast cancer
chr19	53284134	53284135	Phospholipid levels (plasma)
chr19	53384184	53384185	Alzheimer's disease
chr19	53682041	53682042	Asthma
chr19	53780025	53780026	IgG glycosylation
chr19	54604821	54604822	Response to taxane treatment (docetaxel)
chr19	54612627	54612628	Obesity-related traits
chr19	54612627	54612628	Obesity-related traits
chr19	54612627	54612628	Obesity-related traits
chr19	54697078	54697079	Obesity-related traits
chr19	54792760	54792761	HDL cholesterol
chr19	54797847	54797848	Prostate cancer
chr19	54916103	54916104	Blood trace element (Se levels)
chr19	55383050	55383051	Inflammatory bowel disease
chr19	55526344	55526345	Platelet aggregation
chr19	55819844	55819845	Menarche and menopause (age at onset)
chr19	55819844	55819845	Menopause (age at onset)
chr19	55833663	55833664	Menopause (age at onset)
chr19	55833663	55833664	Menopause (age at onset)
chr19	55879871	55879872	Response to antidepressants
chr19	56091331	56091332	Periodontitis (Mean PAL)
chr19	56111074	56111075	Periodontitis (Mean PAL)
chr19	56265663	56265664	Major depressive disorder
chr19	56265663	56265664	Major depressive disorder
chr19	56313527	56313528	Multiple sclerosis (severity)
chr19	56320662	56320663	Menopause (age at onset)
chr19	56320662	56320663	Menopause (age at onset)
chr19	56451048	56451049	Immune reponse to smallpox (secreted IFN-alpha)
chr19	56497959	56497960	Obesity-related traits
chr19	57089834	57089835	Obesity-related traits
chr19	57132237	57132238	IgE levels in asthmatics
chr19	57678193	57678194	Dupuytren's disease
chr19	57760017	57760018	Hyperactive-impulsive symptoms
chr19	58469015	58469016	Obesity-related traits
chr19	58770882	58770883	Attention deficit hyperactivity disorder
chr19	58992000	58992001	Obesity-related traits
chr20	168019	168020	Obesity-related traits
chr20	351943	351944	Information processing speed
chr20	549917	549918	IgG glycosylation
chr20	594779	594780	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr20	759314	759315	Adverse response to chemotherapy in breast cancer (alopecia) (docetaxel)
chr20	819661	819662	Obesity-related traits
chr20	1205885	1205886	Multiple sclerosis
chr20	1459059	1459060	Circulating myeloperoxidase levels (serum)
chr20	1610550	1610551	Type 1 diabetes
chr20	1759589	1759590	Non-obstructive azoospermia
chr20	1923733	1923734	Mean platelet volume
chr20	1924706	1924707	Mean platelet volume
chr20	1929541	1929542	Liver enzyme levels (alanine transaminase)
chr20	1941170	1941171	Aortic root size
chr20	1995533	1995534	Immune response to smallpox vaccine (IL-6)
chr20	2384971	2384972	Alzheimer's disease (cognitive decline)
chr20	2518564	2518565	Systemic lupus erythematosus
chr20	2575368	2575369	Obesity-related traits
chr20	2755487	2755488	Response to tocilizumab in rheumatoid arthritis
chr20	2800800	2800801	White matter integrity
chr20	3185122	3185123	Response to hepatitis C treatment
chr20	3185122	3185123	Response to hepatitis C treatment
chr20	3187732	3187733	Response to hepatitis C treatment
chr20	3187732	3187733	Response to hepatitis C treatment
chr20	3193841	3193842	Chronic Hepatitis C infection
chr20	3193841	3193842	Ribavirin-induced anemia
chr20	3193892	3193893	Chronic Hepatitis C infection
chr20	3381548	3381549	IFN-related cytopenia
chr20	3756596	3756597	Visceral adipose tissue adjusted for BMI
chr20	3776174	3776175	Bipolar disorder
chr20	3776174	3776175	Bipolar disorder
chr20	3827308	3827309	Asthma
chr20	4101799	4101800	Height
chr20	4169078	4169079	Panic disorder
chr20	4215556	4215557	Preeclampsia
chr20	4352103	4352104	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr20	4387133	4387134	IgG glycosylation
chr20	4387133	4387134	IgG glycosylation
chr20	4611876	4611877	Platelet aggregation
chr20	4677091	4677092	Creutzfeldt-Jakob disease (variant)
chr20	4680250	4680251	Creutzfeldt-Jakob disease
chr20	4680250	4680251	Prion diseases
chr20	4698625	4698626	Creutzfeldt-Jakob disease (variant)
chr20	5037773	5037774	Hair morphology
chr20	5588448	5588449	Cortical structure
chr20	5840538	5840539	Information processing speed
chr20	5935384	5935385	Menopause (age at onset)
chr20	5948226	5948227	Menarche and menopause (age at onset)
chr20	5948226	5948227	Menopause (age at onset)
chr20	5948226	5948227	Menopause (age at onset)
chr20	5949533	5949534	Preeclampsia
chr20	6035227	6035228	Menopause (age at onset)
chr20	6404280	6404281	Colorectal cancer
chr20	6609876	6609877	Body mass index
chr20	6620892	6620893	Height
chr20	6621684	6621685	Body mass index
chr20	6621684	6621685	Height
chr20	6626217	6626218	Height
chr20	6699594	6699595	Colorectal cancer
chr20	6751088	6751089	Obesity-related traits
chr20	6761511	6761512	Axial length
chr20	6761764	6761765	Refractive error
chr20	6980634	6980635	Alzheimer's disease (late onset)
chr20	7106288	7106289	Sagittal craniosynostosis
chr20	7180055	7180056	Uric acid levels
chr20	7294902	7294903	Response to amphetamines
chr20	7385957	7385958	Asthma (childhood onset)
chr20	7552503	7552504	Hemostatic factors and hematological phenotypes
chr20	7752365	7752366	Adverse response to chemotherapy (neutropenia/leucopenia) (cisplatin)
chr20	7812349	7812350	Colorectal cancer
chr20	7812349	7812350	Colorectal cancer
chr20	8114703	8114704	Cognitive performance
chr20	8277942	8277943	Response to irinotecan in non-small-cell lung cancer
chr20	8704551	8704552	Estradiol plasma levels (breast cancer)
chr20	8836770	8836771	Cognitive performance
chr20	9365302	9365303	Neutrophil count
chr20	9778728	9778729	Obesity-related traits
chr20	10183516	10183517	Adverse response to chemotherapy (neutropenia/leucopenia) (etoposide)
chr20	10639542	10639543	Bone mineral density
chr20	10639987	10639988	Bone mineral density
chr20	10850463	10850464	Information processing speed
chr20	10969029	10969030	Blood pressure
chr20	10969029	10969030	Diastolic blood pressure
chr20	10969029	10969030	Systolic blood pressure
chr20	11157010	11157011	Response to citalopram treatment
chr20	11157010	11157011	Response to citalopram treatment
chr20	11174902	11174903	Cardiac hypertrophy
chr20	11209521	11209522	Relative hand skill
chr20	12082641	12082642	Obesity-related traits
chr20	12730041	12730042	Body mass index (interaction)
chr20	12874584	12874585	Brain structure
chr20	12969399	12969400	Sphingolipid levels
chr20	12969399	12969400	Sphingolipid levels
chr20	13123732	13123733	Personality dimensions
chr20	13148151	13148152	Body mass index (interaction)
chr20	13296911	13296912	Parkinson's disease
chr20	13696128	13696129	Intelligence (childhood)
chr20	14327898	14327899	Non-alcoholic fatty liver disease histology (other)
chr20	14388214	14388215	Mean platelet volume
chr20	14747470	14747471	Autism
chr20	15120743	15120744	Eating disorders
chr20	15177579	15177580	Obesity-related traits
chr20	15335753	15335754	Obesity (extreme)
chr20	16003405	16003406	Presence of antiphospholipid antibodies
chr20	16054981	16054982	Brain connectivity
chr20	16054981	16054982	Brain connectivity
chr20	16311309	16311310	Ileal carcinoids
chr20	16536413	16536414	Response to taxane treatment (docetaxel)
chr20	16740824	16740825	Post-traumatic stress disorder (asjusted for relatedness)
chr20	17122592	17122593	Menarche (age at onset)
chr20	17357572	17357573	Dialysis-related mortality
chr20	17368541	17368542	Biochemical measures
chr20	17436472	17436473	Obesity-related traits
chr20	17566068	17566069	Presence of antiphospholipid antibodies
chr20	17592299	17592300	Migraine - clinic-based
chr20	17825142	17825143	IgG glycosylation
chr20	17829279	17829280	IgG glycosylation
chr20	17829279	17829280	IgG glycosylation
chr20	17829279	17829280	IgG glycosylation
chr20	17829279	17829280	IgG glycosylation
chr20	17829279	17829280	IgG glycosylation
chr20	17829279	17829280	IgG glycosylation
chr20	17829279	17829280	IgG glycosylation
chr20	18079130	18079131	Anorexia nervosa
chr20	19363978	19363979	Pulmonary function decline
chr20	19571580	19571581	Matrix metalloproteinase levels
chr20	19802187	19802188	Obesity-related traits
chr20	19852502	19852503	Bipolar disorder and schizophrenia
chr20	20634105	20634106	IgG glycosylation
chr20	20634105	20634106	IgG glycosylation
chr20	20634105	20634106	IgG glycosylation
chr20	20634105	20634106	IgG glycosylation
chr20	20634105	20634106	IgG glycosylation
chr20	20634105	20634106	IgG glycosylation
chr20	21853099	21853100	Male-pattern baldness
chr20	21853099	21853100	Male-pattern baldness
chr20	22037574	22037575	Male-pattern baldness
chr20	22050502	22050503	Male-pattern baldness
chr20	22559600	22559601	Fasting glucose-related traits (interaction with BMI)
chr20	22567941	22567942	Fasting plasma glucose
chr20	22887256	22887257	Obesity-related traits
chr20	23097879	23097880	Obesity-related traits
chr20	23141654	23141655	Liver enzyme levels (alanine transaminase)
chr20	23268636	23268637	Obesity-related traits
chr20	23578188	23578189	Cystatin C
chr20	23612736	23612737	Chronic kidney disease
chr20	23847008	23847009	Response to TNF antagonist treatment
chr20	24058406	24058407	Erectile dysfunction and prostate cancer treatment
chr20	24717084	24717085	Bipolar disorder and schizophrenia
chr20	25019098	25019099	Cognitive performance
chr20	25206653	25206654	Allergic rhinitis
chr20	25240188	25240189	Calcium levels
chr20	25298086	25298087	Liver enzyme levels (alkaline phosphatase)
chr20	30725647	30725648	Inflammatory bowel disease
chr20	31376281	31376282	Inflammatory bowel disease
chr20	31376994	31376995	Attention deficit hyperactivity disorder (combined symptoms)
chr20	31384879	31384880	Attention deficit hyperactivity disorder (combined symptoms)
chr20	31395476	31395477	Attention deficit hyperactivity disorder (combined symptoms)
chr20	31410336	31410337	Attention deficit hyperactivity disorder (combined symptoms)
chr20	31410336	31410337	Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)
chr20	31419808	31419809	Attention deficit hyperactivity disorder (combined symptoms)
chr20	31419808	31419809	Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)
chr20	31437606	31437607	Attention deficit hyperactivity disorder (combined symptoms)
chr20	31445146	31445147	Attention deficit hyperactivity disorder (combined symptoms)
chr20	31446857	31446858	Attention deficit hyperactivity disorder (combined symptoms)
chr20	31447367	31447368	Attention deficit hyperactivity disorder (combined symptoms)
chr20	31531543	31531544	Type 1 diabetes nephropathy
chr20	31718652	31718653	Ulcerative colitis
chr20	31950844	31950845	Hair color
chr20	32304652	32304653	Height
chr20	32333180	32333181	Height
chr20	32482631	32482632	Stearic acid (18:0) plasma levels
chr20	32556776	32556777	IgG glycosylation
chr20	32556776	32556777	IgG glycosylation
chr20	32556776	32556777	IgG glycosylation
chr20	32556776	32556777	IgG glycosylation
chr20	32556776	32556777	IgG glycosylation
chr20	32588094	32588095	Breast cancer
chr20	32729443	32729444	Tanning
chr20	33171771	33171772	Melanoma
chr20	33565754	33565755	Anticoagulant levels
chr20	33722862	33722863	Prothrombin time
chr20	33730386	33730387	Protein C levels
chr20	33764553	33764554	Anticoagulant levels
chr20	33764553	33764554	Coagulation factor levels
chr20	33764553	33764554	D-dimer levels
chr20	33764553	33764554	Hemostatic factors and hematological phenotypes
chr20	33764553	33764554	Protein C levels
chr20	33789141	33789142	Height
chr20	33799279	33799280	Ulcerative colitis
chr20	33849178	33849179	Attention deficit hyperactivity disorder
chr20	33867696	33867697	Freckling
chr20	33907160	33907161	Height
chr20	33907160	33907161	Height
chr20	33909783	33909784	Height
chr20	33914207	33914208	Height
chr20	33914207	33914208	Spine bone size
chr20	33975180	33975181	Height
chr20	34023961	34023962	Height
chr20	34025755	34025756	Height
chr20	34097352	34097353	Height
chr20	34152781	34152782	Cholesterol, total
chr20	34383633	34383634	Migraine - clinic-based
chr20	34712309	34712310	Height
chr20	34865239	34865240	Obesity-related traits
chr20	35766336	35766337	Hippocampal atrophy
chr20	35809782	35809783	Hippocampal atrophy
chr20	36068388	36068389	Retinopathy in non-diabetics
chr20	36469693	36469694	Bone mineral density
chr20	36844037	36844038	Heart rate
chr20	36957836	36957837	Bipolar disorder and schizophrenia
chr20	36977635	36977636	Periodontitis (DPAL)
chr20	36977969	36977970	IgG glycosylation
chr20	37690463	37690464	Dialysis-related mortality
chr20	37845476	37845477	Alcohol and nictotine co-dependence
chr20	38129001	38129002	Telomere length
chr20	38300806	38300807	Estradiol levels
chr20	38644557	38644558	Obesity-related traits
chr20	38685540	38685541	Cytomegalovirus antibody response
chr20	38820804	38820805	Response to TNF antagonist treatment
chr20	39028435	39028436	Dupuytren's disease
chr20	39091486	39091487	Cholesterol, total
chr20	39091486	39091487	LDL cholesterol
chr20	39228783	39228784	LDL cholesterol
chr20	39269073	39269074	Orofacial clefts
chr20	39439482	39439483	Metabolite levels (HVA-5-HIAA Factor score)
chr20	39471426	39471427	IgG glycosylation
chr20	39478532	39478533	IgG glycosylation
chr20	39478532	39478533	IgG glycosylation
chr20	39478532	39478533	IgG glycosylation
chr20	39672617	39672618	Cholesterol, total
chr20	39672617	39672618	LDL cholesterol
chr20	40064558	40064559	Hippocampal atrophy
chr20	40840778	40840779	Periodontitis (Mean PAL)
chr20	40994093	40994094	IgG glycosylation
chr20	41991600	41991601	Smooth-surface caries
chr20	42487203	42487204	Response to amphetamines
chr20	42573821	42573822	Conduct disorder (symptom count)
chr20	42854133	42854134	Cognitive performance
chr20	42946965	42946966	Type 2 diabetes
chr20	42989266	42989267	Type 2 diabetes
chr20	43042363	43042364	C-reactive protein
chr20	43042363	43042364	C-reactive protein
chr20	43042363	43042364	Cholesterol, total
chr20	43042363	43042364	HDL cholesterol
chr20	43042363	43042364	HDL cholesterol
chr20	43065027	43065028	Ulcerative colitis
chr20	43065027	43065028	Ulcerative colitis
chr20	43065027	43065028	Ulcerative colitis
chr20	43371319	43371320	Obesity-related traits
chr20	43721492	43721493	Bipolar disorder
chr20	43773736	43773737	IgG glycosylation
chr20	43980725	43980726	Psoriasis
chr20	44124522	44124523	Brain structure
chr20	44534650	44534651	Lipid metabolism phenotypes
chr20	44534650	44534651	Lipid metabolism phenotypes
chr20	44545047	44545048	Metabolite levels
chr20	44554014	44554015	HDL cholesterol
chr20	44554014	44554015	Lipid metabolism phenotypes
chr20	44554014	44554015	Lipid metabolism phenotypes
chr20	44554014	44554015	Lipid metabolism phenotypes
chr20	44554014	44554015	Triglycerides
chr20	44576501	44576502	HDL cholesterol
chr20	44576501	44576502	Triglycerides
chr20	44702119	44702120	Multiple sclerosis
chr20	44740195	44740196	Multiple sclerosis
chr20	44740195	44740196	Multiple sclerosis
chr20	44742063	44742064	Inflammatory bowel disease
chr20	44742063	44742064	Kawasaki disease
chr20	44747946	44747947	Rheumatoid arthritis
chr20	44747946	44747947	Rheumatoid arthritis
chr20	44761484	44761485	Response to amphetamines
chr20	44763283	44763284	Kawasaki disease
chr20	44921630	44921631	IgG glycosylation
chr20	45460322	45460323	Quantitative traits
chr20	45497722	45497723	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr20	45680501	45680502	Thiazide-induced adverse metabolic effects in hypertensive patients
chr20	46095648	46095649	Osteoarthritis (hip)
chr20	46208604	46208605	Response to treatment for acute lymphoblastic leukemia
chr20	46400712	46400713	Attention deficit hyperactivity disorder (time to onset)
chr20	46425575	46425576	Atrial fibrillation
chr20	46779234	46779235	Nephrotic syndrome (acquired)
chr20	46801223	46801224	Alcohol consumption
chr20	47088153	47088154	Attention deficit hyperactivity disorder (combined symptoms)
chr20	47088153	47088154	Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)
chr20	47088199	47088200	Attention deficit hyperactivity disorder (combined symptoms)
chr20	47088199	47088200	Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)
chr20	47088731	47088732	Attention deficit hyperactivity disorder (combined symptoms)
chr20	47088731	47088732	Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)
chr20	47089524	47089525	Attention deficit hyperactivity disorder (combined symptoms)
chr20	47089524	47089525	Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)
chr20	47089536	47089537	Attention deficit hyperactivity disorder (combined symptoms)
chr20	47089536	47089537	Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)
chr20	47343058	47343059	Tonometry
chr20	47379810	47379811	Narcolepsy with cataplexy
chr20	47903018	47903019	Height
chr20	47982127	47982128	QT interval
chr20	48019817	48019818	Obesity-related traits
chr20	48344310	48344311	Palmitic acid (16:0) plasma levels
chr20	48522329	48522330	Psoriasis
chr20	48522329	48522330	Psoriasis
chr20	48955423	48955424	Inflammatory bowel disease
chr20	49375241	49375242	Bipolar disorder
chr20	49671434	49671435	Molar-incisor hypomineralization
chr20	49739859	49739860	QT interval (interaction)
chr20	50141263	50141264	Self-reported allergy
chr20	50559651	50559652	Male infertility
chr20	50637659	50637660	Subcutaneous adipose tissue
chr20	50702632	50702633	Amyotrophic lateral sclerosis
chr20	51092995	51092996	Obesity
chr20	51318350	51318351	Hemoglobin
chr20	51557160	51557161	Body mass index (non-asthmatics)
chr20	51583982	51583983	Attention deficit hyperactivity disorder
chr20	52268994	52268995	Obesity-related traits
chr20	52349891	52349892	Calcium levels
chr20	52447302	52447303	Polycystic ovary syndrome
chr20	52610495	52610496	Bipolar disorder and schizophrenia
chr20	52701292	52701293	IgG glycosylation
chr20	52774426	52774427	Calcium levels
chr20	52791517	52791518	Multiple sclerosis
chr20	52807220	52807221	Atopic dermatitis
chr20	52843798	52843799	Obesity-related traits
chr20	53267110	53267111	Functional MRI
chr20	53411018	53411019	Relative hand skill
chr20	53414538	53414539	Celiac disease
chr20	53462974	53462975	Axial length
chr20	53801128	53801129	Response to antipsychotic treatment
chr20	54126508	54126509	Migraine without aura
chr20	55109303	55109304	Obesity-related traits
chr20	55638536	55638537	White blood cell types
chr20	55638749	55638750	Response to citalopram treatment
chr20	55638749	55638750	Response to citalopram treatment
chr20	55683995	55683996	Schizophrenia
chr20	55990404	55990405	Red blood cell traits
chr20	55991694	55991695	Mean corpuscular volume
chr20	56029603	56029604	Type 2 diabetes
chr20	56044183	56044184	Response to statin therapy
chr20	56058354	56058355	Alcohol consumption
chr20	56070504	56070505	Obesity-related traits
chr20	56190633	56190634	Hippocampal atrophy
chr20	56428704	56428705	Response to fenofibrate (adiponectin levels)
chr20	56501978	56501979	Obesity-related traits
chr20	56663273	56663274	Pulmonary function decline
chr20	56796783	56796784	Height
chr20	57164854	57164855	Cardiovascular disease risk factors
chr20	57408425	57408426	DNA methylation (variation)
chr20	57469072	57469073	Renal function-related traits (BUN)
chr20	57475190	57475191	Event-related brain oscillations
chr20	57562101	57562102	Response to diuretic therapy in hypertension
chr20	57587770	57587771	Mean platelet volume
chr20	57587770	57587771	Mean platelet volume
chr20	57614001	57614002	Mean platelet volume
chr20	57751116	57751117	Blood pressure
chr20	57751116	57751117	Blood pressure
chr20	57751116	57751117	Diastolic blood pressure
chr20	57751116	57751117	Hypertension
chr20	57751116	57751117	Systolic blood pressure
chr20	57758719	57758720	Hypertension
chr20	57790435	57790436	Response to antipsychotic therapy (extrapyramidal side effects)
chr20	57824308	57824309	Inflammatory bowel disease
chr20	58177614	58177615	Response to tocilizumab in rheumatoid arthritis
chr20	58895845	58895846	Type 1 diabetes nephropathy
chr20	58896714	58896715	Type 1 diabetes nephropathy
chr20	58898208	58898209	Lentiform nucleus volume
chr20	58946488	58946489	Metabolite levels (MHPG)
chr20	59268709	59268710	Non-alcoholic fatty liver disease histology (other)
chr20	59853937	59853938	Volumetric brain MRI
chr20	59928236	59928237	Longevity
chr20	59947043	59947044	T-tau
chr20	60212493	60212494	Longevity
chr20	60243410	60243411	Sudden cardiac arrest
chr20	60258850	60258851	Axial length
chr20	60293562	60293563	Migraine - clinic-based
chr20	60381798	60381799	&beta;2-Glycoprotein I (&beta;2-GPI) plasma levels
chr20	60508181	60508182	Obesity-related traits
chr20	60508181	60508182	Obesity-related traits
chr20	60514223	60514224	Obesity-related traits
chr20	60921043	60921044	Colorectal cancer
chr20	61015610	61015611	Prostate cancer
chr20	61491493	61491494	Obesity-related traits
chr20	61669035	61669036	Prostate cancer (gene x gene interaction)
chr20	61895919	61895920	Cardiovascular disease risk factors
chr20	62297801	62297802	Dental caries
chr20	62309838	62309839	Glioma
chr20	62309838	62309839	Glioma
chr20	62309838	62309839	Glioma
chr20	62309838	62309839	Glioma (high-grade)
chr20	62318219	62318220	Glioma (high-grade)
chr20	62327581	62327582	Ulcerative colitis
chr20	62343955	62343956	Inflammatory bowel disease
chr20	62348906	62348907	Inflammatory bowel disease
chr20	62349585	62349586	Crohn's disease
chr20	62362562	62362563	Prostate cancer
chr20	62409712	62409713	Multiple sclerosis
chr20	62418336	62418337	Obesity-related traits
chr21	10971950	10971951	Celiac disease
chr21	11002010	11002011	Bipolar disorder and schizophrenia
chr21	15681993	15681994	Non-word repetition
chr21	15845051	15845052	Bone mineral density (spine)
chr21	16340288	16340289	Cognitive performance
chr21	16520831	16520832	Breast cancer
chr21	16805219	16805220	Crohn's disease
chr21	16805219	16805220	Ulcerative colitis
chr21	16812551	16812552	Crohn's disease
chr21	16817050	16817051	Ulcerative colitis
chr21	16817937	16817938	Inflammatory bowel disease
chr21	16914904	16914905	Parkinson's disease
chr21	17069165	17069166	Panic disorder
chr21	17483132	17483133	Obesity-related traits
chr21	17667719	17667720	Chronic obstructive pulmonary disease-related biomarkers
chr21	17828290	17828291	Attention deficit hyperactivity disorder
chr21	18046231	18046232	Amyotrophic lateral sclerosis
chr21	19481353	19481354	Adverse response to chemotherapy (neutropenia/leucopenia) (all antimetabolite drugs)
chr21	19531441	19531442	Bulimia nervosa
chr21	20536648	20536649	Attention deficit hyperactivity disorder symptoms (interaction)
chr21	21777729	21777730	Hippocampal atrophy
chr21	21820407	21820408	Obesity-related traits
chr21	21820407	21820408	Obesity-related traits
chr21	21820407	21820408	Obesity-related traits
chr21	21885301	21885302	Attention deficit hyperactivity disorder and conduct disorder
chr21	22689343	22689344	Obesity
chr21	22910115	22910116	Longevity
chr21	23631675	23631676	Alcoholism (heaviness of drinking)
chr21	24198814	24198815	Self-rated health
chr21	24789555	24789556	Visceral fat
chr21	25143118	25143119	Major depressive disorder
chr21	26645082	26645083	Non-alcoholic fatty liver disease histology (other)
chr21	26826513	26826514	Adverse response to chemotherapy (neutropenia/leucopenia) (all antimetabolite drugs)
chr21	27002376	27002377	Cognitive performance
chr21	27716653	27716654	Airflow obstruction
chr21	28146188	28146189	Metabolite levels (HVA)
chr21	28146188	28146189	Metabolite levels (HVA-5-HIAA Factor score)
chr21	28657948	28657949	Liver enzyme levels (aspartate transaminase)
chr21	28665346	28665347	Response to citalopram treatment
chr21	28696475	28696476	AB1-42
chr21	28734996	28734997	Dialysis-related mortality
chr21	28744355	28744356	Dialysis-related mortality
chr21	29475195	29475196	Urinary albumin excretion
chr21	30141020	30141021	Cognitive test performance
chr21	30489299	30489300	Dental caries
chr21	30594531	30594532	Response to mTOR inhibitor (everolimus)
chr21	30713597	30713598	Visceral fat
chr21	30717736	30717737	Pancreatic cancer
chr21	31013158	31013159	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr21	31050816	31050817	Hyperactive-impulsive symptoms
chr21	31100796	31100797	Body mass index
chr21	31146168	31146169	Hepatocellular carcinoma
chr21	31177510	31177511	Breast cancer
chr21	31244477	31244478	Periodontitis (DPAL)
chr21	31386242	31386243	Response to statin therapy
chr21	32060489	32060490	HDL cholesterol
chr21	32216252	32216253	Information processing speed
chr21	32440539	32440540	Coronary heart disease
chr21	32817506	32817507	Renal sinus fat
chr21	32918293	32918294	Amyotrophic lateral sclerosis
chr21	33285299	33285300	Reasoning
chr21	33296112	33296113	IgG glycosylation
chr21	33381039	33381040	Vitiligo
chr21	33385185	33385186	Type 2 diabetes
chr21	33552511	33552512	Temperament
chr21	34168572	34168573	Bilirubin levels
chr21	34262686	34262687	IgG glycosylation
chr21	34369760	34369761	Bulimia nervosa
chr21	34542786	34542787	Inflammatory biomarkers
chr21	34776694	34776695	Crohn's disease
chr21	34781049	34781050	Obesity-related traits
chr21	34796885	34796886	Crohn's disease
chr21	35354522	35354523	Red blood cell traits
chr21	35599127	35599128	Coronary heart disease
chr21	35599127	35599128	Myocardial infarction (early onset)
chr21	35652238	35652239	Pulmonary function
chr21	35690785	35690786	Height
chr21	35698389	35698390	Body mass index (interaction)
chr21	35880071	35880072	Electrocardiographic traits
chr21	36208061	36208062	Preeclampsia
chr21	36238506	36238507	Immune response to smallpox vaccine (IL-6)
chr21	36357860	36357861	Esophageal cancer
chr21	36416331	36416332	Phospholipid levels (plasma)
chr21	36688527	36688528	Corneal curvature
chr21	36849418	36849419	C-reactive protein and white blood cell count
chr21	37013620	37013621	Obesity-related traits
chr21	37485061	37485062	Bone mineral density
chr21	37801433	37801434	Pulmonary function
chr21	37809376	37809377	Myopia (pathological)
chr21	37833306	37833307	Kidney stones
chr21	37935668	37935669	QT interval
chr21	38491094	38491095	Eye color traits
chr21	38817811	38817812	IgG glycosylation
chr21	38932777	38932778	Metabolic syndrome
chr21	39027271	39027272	Electroencephalographic traits in alcoholism
chr21	39721763	39721764	Metabolite levels (HVA)
chr21	39852550	39852551	White blood cell types
chr21	40056422	40056423	Neonatal lupus
chr21	40173527	40173528	Non-small cell lung cancer
chr21	40283732	40283733	Periodontitis (Mean PAL)
chr21	40291739	40291740	Crohn's disease
chr21	40314703	40314704	Immune response to smallpox vaccine (IL-6)
chr21	40380248	40380249	Nicotine dependence
chr21	40465177	40465178	Ankylosing spondylitis
chr21	40465511	40465512	Fibrinogen
chr21	40465533	40465534	C-reactive protein
chr21	40465533	40465534	Inflammatory bowel disease
chr21	40465533	40465534	Inflammatory bowel disease
chr21	40465533	40465534	Ulcerative colitis
chr21	40469519	40469520	Ankylosing spondylitis
chr21	40569778	40569779	Temperament (bipolar disorder)
chr21	41021751	41021752	Suicide risk
chr21	41123300	41123301	Coronary heart disease
chr21	41415043	41415044	Non-small cell lung cancer
chr21	41702946	41702947	Estradiol plasma levels (breast cancer)
chr21	41993706	41993707	Obesity-related traits
chr21	41993706	41993707	Obesity-related traits
chr21	42174959	42174960	Neutrophil count
chr21	42471627	42471628	Economic and political preferences (immigration/crime)
chr21	42511917	42511918	Rheumatoid arthritis
chr21	42583737	42583738	Glycemic traits (pregnancy)
chr21	42698906	42698907	Tumor biomarkers
chr21	42746080	42746081	Melanoma
chr21	42793790	42793791	IgG glycosylation
chr21	42793790	42793791	IgG glycosylation
chr21	43092200	43092201	Adverse response to chemotherapy in breast cancer (alopecia) (paclitaxel)
chr21	43227914	43227915	Tanning
chr21	43275494	43275495	Response to taxane treatment (placlitaxel)
chr21	43286351	43286352	Parkinson's disease
chr21	43443497	43443498	Preeclampsia
chr21	43502761	43502762	Obesity-related traits
chr21	43513479	43513480	IgG glycosylation
chr21	43707100	43707101	Common traits (Other)
chr21	43778894	43778895	Pancreatic cancer
chr21	43836185	43836186	Celiac disease and Rheumatoid arthritis
chr21	43836185	43836186	Rheumatoid arthritis
chr21	43836185	43836186	Type 1 diabetes
chr21	43836185	43836186	Vitiligo
chr21	43836389	43836390	Type 1 diabetes
chr21	43841327	43841328	Type 1 diabetes autoantibodies
chr21	44156768	44156769	Pulmonary function decline
chr21	44436176	44436177	Biochemical measures
chr21	44436176	44436177	Biochemical measures
chr21	44445291	44445292	Cognitive performance
chr21	44448717	44448718	Information processing speed
chr21	44478496	44478497	Blood trace element (Se levels)
chr21	44478496	44478497	Homocysteine levels
chr21	44486963	44486964	Homocysteine levels
chr21	44487403	44487404	Homocysteine levels
chr21	44487403	44487404	Obesity-related traits
chr21	44768561	44768562	Non-alcoholic fatty liver disease histology (other)
chr21	44779679	44779680	Metabolic syndrome
chr21	45404337	45404338	Phospholipid levels (plasma)
chr21	45615022	45615023	Crohn's disease
chr21	45615022	45615023	Ulcerative colitis
chr21	45615560	45615561	Crohn's disease
chr21	45615740	45615741	Inflammatory bowel disease
chr21	45647420	45647421	Celiac disease
chr21	45709152	45709153	Rheumatoid arthritis
chr21	46629589	46629590	Pulmonary function
chr21	46846943	46846944	Hippocampal atrophy
chr21	47124177	47124178	Insulin resistance/response
chr21	47165428	47165429	Immune reponse to smallpox (secreted IFN-alpha)
chr21	47445790	47445791	Alcoholism (alcohol dependence factor score)
chr21	47690067	47690068	Testicular germ cell tumor
chr21	48019867	48019868	Lymphocyte counts
chr22	16504398	16504399	Celiac disease
chr22	18283246	18283247	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)
chr22	18439957	18439958	Liver enzyme levels (gamma-glutamyl transferase)
chr22	18448112	18448113	Presence of antiphospholipid antibodies
chr22	18972449	18972450	Metabolic traits
chr22	19154521	19154522	Metabolite levels
chr22	19156116	19156117	Metabolite levels
chr22	19565256	19565257	IgG glycosylation
chr22	19691501	19691502	DNA methylation (parent-of-origin)
chr22	19889824	19889825	Glaucoma (primary open-angle)
chr22	19984276	19984277	Platelet counts
chr22	20228541	20228542	Obesity-related traits
chr22	20797288	20797289	Retinopathy in non-diabetics
chr22	21917189	21917190	Systemic lupus erythematosus
chr22	21922903	21922904	Inflammatory bowel disease
chr22	21928640	21928641	Crohn's disease
chr22	21932067	21932068	HDL cholesterol
chr22	21939674	21939675	Red blood cell traits
chr22	21939674	21939675	Systemic lupus erythematosus
chr22	21939674	21939675	Systemic lupus erythematosus
chr22	21964760	21964761	Mean corpuscular volume
chr22	21982891	21982892	Celiac disease
chr22	21982891	21982892	Celiac disease and Rheumatoid arthritis
chr22	22131124	22131125	Multiple sclerosis
chr22	22307518	22307519	Attention deficit hyperactivity disorder
chr22	22506568	22506569	Periodontitis (PAL4Q3)
chr22	22512414	22512415	Iron deficiency
chr22	22512414	22512415	Iron status biomarkers
chr22	22512414	22512415	Iron status biomarkers
chr22	22845239	22845240	Prostate cancer (gene x gene interaction)
chr22	23477969	23477970	Bone mineral density
chr22	23593050	23593051	Height
chr22	23644793	23644794	Immune response to smallpox vaccine (IL-6)
chr22	23765264	23765265	Pulmonary function decline
chr22	23922982	23922983	Migraine
chr22	24170995	24170996	IgG glycosylation
chr22	24170995	24170996	IgG glycosylation
chr22	24170995	24170996	IgG glycosylation
chr22	24170995	24170996	IgG glycosylation
chr22	24170995	24170996	IgG glycosylation
chr22	24170995	24170996	IgG glycosylation
chr22	24170995	24170996	IgG glycosylation
chr22	24170995	24170996	IgG glycosylation
chr22	24170995	24170996	IgG glycosylation
chr22	24170995	24170996	IgG glycosylation
chr22	24170995	24170996	IgG glycosylation
chr22	24170995	24170996	IgG glycosylation
chr22	24170995	24170996	IgG glycosylation
chr22	24170995	24170996	IgG glycosylation
chr22	24170995	24170996	IgG glycosylation
chr22	24170995	24170996	IgG glycosylation
chr22	24170995	24170996	IgG glycosylation
chr22	24170995	24170996	IgG glycosylation
chr22	24170995	24170996	IgG glycosylation
chr22	24170995	24170996	IgG glycosylation
chr22	24170995	24170996	IgG glycosylation
chr22	24170995	24170996	IgG glycosylation
chr22	24170995	24170996	IgG glycosylation
chr22	24295285	24295286	Liver enzyme levels (gamma-glutamyl transferase)
chr22	24582040	24582041	Amyotrophic lateral sclerosis
chr22	24990212	24990213	Gamma glutamyl transpeptidase
chr22	24990212	24990213	Liver enzyme levels
chr22	24992265	24992266	Protein quantitative trait loci
chr22	24996629	24996630	Hematological and biochemical traits
chr22	24999103	24999104	Liver enzyme levels (gamma-glutamyl transferase)
chr22	25875264	25875265	Bipolar disorder (mood-incongruent)
chr22	26159288	26159289	Mathematical ability in children with dyslexia
chr22	26394723	26394724	Uric acid levels
chr22	26403598	26403599	Schizophrenia, bipolar disorder and depression (combined)
chr22	26653361	26653362	Airflow obstruction
chr22	26689634	26689635	Coronary heart disease
chr22	26697194	26697195	Insulin resistance/response
chr22	27011419	27011420	Bipolar disorder and schizophrenia
chr22	27041282	27041283	IgG glycosylation
chr22	27042105	27042106	RR interval (heart rate)
chr22	27051298	27051299	Obesity-related traits
chr22	27416824	27416825	Fat distribution (HIV)
chr22	27435819	27435820	Metabolite levels (HVA/MHPG ratio)
chr22	27852182	27852183	Prostate cancer (gene x gene interaction)
chr22	28029537	28029538	Alcohol consumption
chr22	28090206	28090207	Sudden cardiac arrest
chr22	28378471	28378472	Obesity
chr22	29100710	29100711	Vertical cup-disc ratio
chr22	29115065	29115066	Esophageal cancer (squamous cell)
chr22	29130011	29130012	Esophageal cancer and gastric cancer
chr22	29161006	29161007	Breast size
chr22	29192669	29192670	Esophageal cancer (squamous cell)
chr22	29451670	29451671	Waist-hip ratio
chr22	29621476	29621477	Breast cancer
chr22	29793640	29793641	Myopia (pathological)
chr22	29847721	29847722	Carotid atherosclerosis in HIV infection
chr22	29929238	29929239	Lipid traits
chr22	30337585	30337586	Lung cancer
chr22	30423459	30423460	IgA nephropathy
chr22	30486825	30486826	Inflammatory bowel disease
chr22	30494370	30494371	Nephropathy
chr22	30529630	30529631	Inflammatory bowel disease (early onset)
chr22	30581721	30581722	Type 1 diabetes
chr22	30592068	30592069	Dialysis-related mortality
chr22	30592486	30592487	Crohn's disease
chr22	30681256	30681257	Rheumatoid arthritis
chr22	30751626	30751627	Coronary artery calcification
chr22	31013295	31013296	Wilms tumor
chr22	31153275	31153276	Adverse response to chemotherapy (neutropenia/leucopenia) (gemcitabine)
chr22	31438360	31438361	Bulimia nervosa
chr22	31645758	31645759	Type 2 diabetes nephropathy
chr22	31675184	31675185	Paclitaxel-induced neuropathy
chr22	32229648	32229649	Intelligence
chr22	32265902	32265903	Chronic Hepatitis C infection
chr22	32745915	32745916	T-tau
chr22	32783903	32783904	IgG glycosylation
chr22	32832873	32832874	Migraine with aura
chr22	32867527	32867528	Hematological parameters
chr22	32880584	32880585	Red blood cell traits
chr22	33056340	33056341	Height
chr22	33059664	33059665	Age-related macular degeneration
chr22	33059664	33059665	Height
chr22	33084510	33084511	Age-related macular degeneration
chr22	33084510	33084511	Age-related macular degeneration
chr22	33084510	33084511	Age-related macular degeneration
chr22	33561745	33561746	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr22	33566586	33566587	Visceral adipose tissue adjusted for BMI
chr22	33746525	33746526	Visceral fat
chr22	34602187	34602188	Coronary artery calcification
chr22	34823827	34823828	Major depressive disorder
chr22	34859792	34859793	Attention deficit hyperactivity disorder
chr22	34889096	34889097	Immune reponse to smallpox (secreted TNF-alpha)
chr22	34941575	34941576	Behavioural disinhibition (generation interaction)
chr22	35371247	35371248	Metabolite levels (HVA-5-HIAA Factor score)
chr22	35777617	35777618	Obesity-related traits
chr22	36517931	36517932	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel + carboplatin)
chr22	36616444	36616445	End-stage renal disease (non-diabetic)
chr22	36661329	36661330	Glomerulosclerosis
chr22	36679057	36679058	Optic disc size (rim)
chr22	37199805	37199806	Pit-and-Fissure caries
chr22	37208148	37208149	Obesity-related traits
chr22	37209295	37209296	Sexual dysfunction (female)
chr22	37258502	37258503	Atopic dermatitis
chr22	37310045	37310046	Ankylosing spondylitis
chr22	37462935	37462936	Glycated hemoglobin levels
chr22	37462935	37462936	Hematology traits
chr22	37462935	37462936	Hemoglobin
chr22	37462935	37462936	Hemoglobin
chr22	37462935	37462936	Hepcidin levels
chr22	37462935	37462936	Hepcidin levels
chr22	37462935	37462936	Hepcidin levels
chr22	37462935	37462936	Iron status biomarkers
chr22	37462935	37462936	Iron status biomarkers
chr22	37462935	37462936	Iron status biomarkers
chr22	37462935	37462936	Mean corpuscular hemoglobin
chr22	37462935	37462936	Mean corpuscular hemoglobin
chr22	37462935	37462936	Mean corpuscular hemoglobin
chr22	37462935	37462936	Mean corpuscular hemoglobin
chr22	37462935	37462936	Mean corpuscular hemoglobin concentration
chr22	37462935	37462936	Mean corpuscular volume
chr22	37462935	37462936	Mean corpuscular volume
chr22	37462935	37462936	Mean corpuscular volume
chr22	37462935	37462936	Red blood cell traits
chr22	37462935	37462936	Red blood cell traits
chr22	37462935	37462936	Red blood cell traits
chr22	37462935	37462936	mean corpuscular hemoglobin concentration
chr22	37467269	37467270	Hematological and biochemical traits
chr22	37467391	37467392	Hematological parameters
chr22	37469590	37469591	Hematology traits
chr22	37469590	37469591	Hematology traits
chr22	37469590	37469591	Iron levels
chr22	37469590	37469591	Iron levels
chr22	37469590	37469591	Iron status biomarkers
chr22	37469590	37469591	Red blood cell traits
chr22	37470223	37470224	Hematocrit
chr22	37470223	37470224	Hematological and biochemical traits
chr22	37470223	37470224	Mean corpuscular hemoglobin
chr22	37470223	37470224	Mean corpuscular volume
chr22	37470223	37470224	Red blood cell traits
chr22	37470223	37470224	Red blood cell traits
chr22	37534033	37534034	Asthma
chr22	37551606	37551607	Rheumatoid arthritis
chr22	37551606	37551607	Rheumatoid arthritis
chr22	37551606	37551607	Type 1 diabetes autoantibodies
chr22	37581421	37581422	Hypothyroidism
chr22	37581484	37581485	Graves' disease
chr22	37581484	37581485	Vitiligo
chr22	37591317	37591318	Type 1 diabetes
chr22	37591317	37591318	Type 1 diabetes
chr22	37613308	37613309	Longevity
chr22	37919266	37919267	Optic disc parameters
chr22	37982011	37982012	Response to antidepressant treatment
chr22	38071042	38071043	Fat distribution (HIV)
chr22	38476275	38476276	Age-related macular degeneration
chr22	38544297	38544298	Cutaneous nevi
chr22	38544297	38544298	Melanoma
chr22	38545618	38545619	Melanoma
chr22	38546032	38546033	Triglycerides
chr22	38569005	38569006	Cutaneous nevi
chr22	39178374	39178375	IgG glycosylation
chr22	39332622	39332623	Bladder cancer
chr22	39519195	39519196	Multiple myeloma (IgH translocation)
chr22	39519195	39519196	Multiple myeloma (hyperdiploidy)
chr22	39542291	39542292	Multiple myeloma
chr22	39659772	39659773	Crohn's disease
chr22	39659772	39659773	Inflammatory bowel disease
chr22	39670850	39670851	Primary biliary cirrhosis
chr22	39687483	39687484	Sudden cardiac arrest
chr22	39739637	39739638	IgG glycosylation
chr22	39748853	39748854	IgG glycosylation
chr22	39835586	39835587	IgG glycosylation
chr22	39835586	39835587	IgG glycosylation
chr22	39841699	39841700	IgG glycosylation
chr22	39859168	39859169	IgG glycosylation
chr22	39859168	39859169	IgG glycosylation
chr22	39859168	39859169	IgG glycosylation
chr22	39859168	39859169	IgG glycosylation
chr22	39859168	39859169	IgG glycosylation
chr22	39859168	39859169	IgG glycosylation
chr22	39859168	39859169	IgG glycosylation
chr22	39859168	39859169	IgG glycosylation
chr22	39859168	39859169	IgG glycosylation
chr22	39859168	39859169	IgG glycosylation
chr22	39859168	39859169	IgG glycosylation
chr22	39859168	39859169	IgG glycosylation
chr22	39859168	39859169	IgG glycosylation
chr22	39859168	39859169	IgG glycosylation
chr22	39859168	39859169	IgG glycosylation
chr22	39859168	39859169	IgG glycosylation
chr22	39859168	39859169	IgG glycosylation
chr22	39859168	39859169	IgG glycosylation
chr22	39859168	39859169	IgG glycosylation
chr22	39859168	39859169	IgG glycosylation
chr22	39955872	39955873	Schizophrenia
chr22	39972161	39972162	IgG glycosylation
chr22	40436972	40436973	Prostate cancer
chr22	40436972	40436973	Prostate cancer
chr22	40452118	40452119	Prostate cancer
chr22	40652872	40652873	Uterine fibroids
chr22	40654275	40654276	Prostate cancer (gene x gene interaction)
chr22	40675090	40675091	Prostate cancer (gene x gene interaction)
chr22	40697580	40697581	Height
chr22	40820150	40820151	Height
chr22	40876233	40876234	Breast cancer
chr22	40876233	40876234	Breast cancer
chr22	40996366	40996367	Bipolar disorder and schizophrenia
chr22	41042090	41042091	Treatment response for severe sepsis
chr22	41431341	41431342	Crohn's disease
chr22	41661153	41661154	Self-reported allergy
chr22	41757646	41757647	Vitiligo
chr22	42218855	42218856	Alzheimer's disease biomarkers
chr22	42336171	42336172	Birth weight
chr22	42670964	42670965	Bipolar disorder and schizophrenia
chr22	43500211	43500212	Prostate cancer
chr22	43518274	43518275	Prostate cancer
chr22	43579048	43579049	Molar-incisor hypomineralization
chr22	43624764	43624765	IgG glycosylation
chr22	43635572	43635573	Response to fenofibrate (adiponectin levels)
chr22	44204318	44204319	IgG glycosylation
chr22	44248503	44248504	Type 2 diabetes (dietary heme iron intake interaction)
chr22	44324726	44324727	Liver enzyme levels (alanine transaminase)
chr22	44324726	44324727	Nonalcoholic fatty liver disease
chr22	44324726	44324727	Nonalcoholic fatty liver disease
chr22	44325995	44325996	Metabolite levels
chr22	44325995	44325996	Metabolite levels
chr22	44332569	44332570	Liver enzyme levels
chr22	44333693	44333694	Hematological and biochemical traits
chr22	44333693	44333694	Hematological and biochemical traits
chr22	44333693	44333694	Non-alcoholic fatty liver disease
chr22	44391685	44391686	Nonalcoholic fatty liver disease
chr22	44394401	44394402	Nonalcoholic fatty liver disease
chr22	44526104	44526105	Alzheimer's disease (cognitive decline)
chr22	44561286	44561287	IgG glycosylation
chr22	44561286	44561287	IgG glycosylation
chr22	44968529	44968530	Economic and political preferences (time)
chr22	45011760	45011761	Economic and political preferences (feminism/equality)
chr22	45150658	45150659	Orofacial clefts
chr22	45183013	45183014	Electroencephalographic traits in alcoholism
chr22	45668011	45668012	Pulmonary function in asthmatics
chr22	45961903	45961904	Temperament (bipolar disorder)
chr22	46421841	46421842	Dupuytren's disease
chr22	47532395	47532396	Longevity
chr22	48188252	48188253	Obesity-related traits
chr22	48284513	48284514	Attention deficit hyperactivity disorder
chr22	48453590	48453591	Economic and political preferences (fairness)
chr22	48630183	48630184	Obesity-related traits
chr22	48651996	48651997	DNA methylation (variation)
chr22	48929568	48929569	Pancreatic cancer
chr22	50086372	50086373	Natriuretic peptide levels
chr22	50218610	50218611	Schizophrenia
chr22	50350970	50350971	Cannabis dependence
chr22	50435479	50435480	Ulcerative colitis
chr22	50435479	50435480	Ulcerative colitis
chr22	50557406	50557407	Behavioural disinhibition (generation interaction)
chr22	50661868	50661869	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)
chr22	50676258	50676259	Obesity-related traits
chr22	50902389	50902390	IgG glycosylation
chr22	50966913	50966914	Mean corpuscular hemoglobin
chr22	50971265	50971266	Multiple sclerosis
chr22	50971265	50971266	Red blood cell traits
chr22	50971751	50971752	Mean corpuscular volume
chr22	50976753	50976754	Obesity-related traits
chr22	51017352	51017353	Narcolepsy
chr22	51101937	51101938	Fibrinogen
chr22	51104679	51104680	Longevity
chrX	2885722	2885723	Height
chrX	2885722	2885723	Height
chrX	3410668	3410669	Antineutrophil cytoplasmic antibody-associated vasculitis
chrX	4596137	4596138	Amyotrophic lateral sclerosis
chrX	5184701	5184702	Antineutrophil cytoplasmic antibody-associated vasculitis
chrX	6220473	6220474	Biochemical measures
chrX	8394252	8394253	Cognitive performance
chrX	8913825	8913826	Androgen levels
chrX	9751473	9751474	Colorectal cancer
chrX	9814134	9814135	Prostate cancer
chrX	10231690	10231691	Alcohol dependence
chrX	11048691	11048692	Cognitive performance
chrX	12971523	12971524	Celiac disease
chrX	13615117	13615118	Multiple sclerosis
chrX	14950530	14950531	Waist-to-hip circumference ratio (interaction)
chrX	17698396	17698397	Wilms tumor
chrX	22134657	22134658	Tourette syndrome
chrX	22148050	22148051	Immune reponse to smallpox (secreted IFN-alpha)
chrX	22160991	22160992	F-cell distribution
chrX	22892076	22892077	Erectile dysfunction and prostate cancer treatment
chrX	23383443	23383444	Immune reponse to smallpox (secreted IFN-alpha)
chrX	25853613	25853614	Erectile dysfunction and prostate cancer treatment
chrX	26369898	26369899	Metabolite levels (5-HIAA/ MHPG Ratio)
chrX	26369898	26369899	Metabolite levels (HVA/MHPG ratio)
chrX	28233052	28233053	Erectile dysfunction and prostate cancer treatment
chrX	29640817	29640818	Cardiovascular disease risk factors
chrX	30119776	30119777	Metabolite levels (HVA/MHPG ratio)
chrX	32015375	32015376	Response to antidepressant treatment
chrX	32225254	32225255	Bipolar disorder and schizophrenia
chrX	33811840	33811841	Periodontitis (Mean PAL)
chrX	34892502	34892503	Multiple sclerosis
chrX	37854726	37854727	Erectile dysfunction and prostate cancer treatment
chrX	37999651	37999652	Anorexia nervosa
chrX	39885629	39885630	Pit-and-Fissure caries
chrX	43607032	43607033	Smoking behavior
chrX	44400185	44400186	Personality dimensions
chrX	47174275	47174276	Optic disc size (disc)
chrX	50182183	50182184	Hypospadias
chrX	51210056	51210057	Prostate cancer
chrX	51229682	51229683	Prostate cancer
chrX	51241671	51241672	Prostate cancer
chrX	53974053	53974054	Bipolar disorder and schizophrenia
chrX	56811694	56811695	Blood trace element (Zn levels)
chrX	62625198	62625199	Periodontitis (Mean PAL)
chrX	64367018	64367019	Erectile dysfunction and prostate cancer treatment
chrX	65606692	65606693	Erectile dysfunction and prostate cancer treatment
chrX	66510983	66510984	Male-pattern baldness
chrX	66563017	66563018	Male-pattern baldness
chrX	66563017	66563018	Male-pattern baldness
chrX	66942624	66942625	LDL cholesterol
chrX	67021549	67021550	Prostate cancer
chrX	68798702	68798703	Primary tooth development (number of teeth)
chrX	68798702	68798703	Primary tooth development (time to first tooth eruption)
chrX	68805317	68805318	Primary tooth development (number of teeth)
chrX	68892915	68892916	Primary tooth development (time to first tooth eruption)
chrX	75347433	75347434	Amyotrophic lateral sclerosis
chrX	78497117	78497118	Graves' disease
chrX	78649192	78649193	Height
chrX	82535168	82535169	Bipolar disorder and schizophrenia
chrX	82711941	82711942	Bipolar disorder and schizophrenia
chrX	82871194	82871195	Depression and alcohol dependence
chrX	82954489	82954490	Depression and alcohol dependence
chrX	86192002	86192003	Bone mineral density (hip)
chrX	89288226	89288227	Cognitive performance
chrX	89804126	89804127	Antineutrophil cytoplasmic antibody-associated vasculitis
chrX	90812717	90812718	Antineutrophil cytoplasmic antibody-associated vasculitis
chrX	91402219	91402220	Alzheimer's disease
chrX	95079869	95079870	Major depressive disorder (broad)
chrX	105493918	105493919	Pancreatitis
chrX	106244766	106244767	Pancreatitis
chrX	109820067	109820068	Sex hormone-binding globulin levels
chrX	109820067	109820068	Sex hormone-binding globulin levels
chrX	109939204	109939205	Coronary heart disease
chrX	111155232	111155233	Smoking behavior
chrX	111646463	111646464	Biochemical measures
chrX	115302191	115302192	Cystic fibrosis severity
chrX	116222262	116222263	Response to citalopram treatment
chrX	116869913	116869914	Metabolite levels (5-HIAA/ MHPG Ratio)
chrX	117088055	117088056	Iron status biomarkers
chrX	118567701	118567702	Paget's disease
chrX	118716986	118716987	Brain connectivity
chrX	119867474	119867475	Antineutrophil cytoplasmic antibody-associated vasculitis
chrX	121967358	121967359	Metabolite levels (MHPG)
chrX	124073661	124073662	Immune reponse to smallpox (secreted IFN-alpha)
chrX	129104733	129104734	Periodontitis (Mean PAL)
chrX	129199811	129199812	Dental caries
chrX	132024503	132024504	Periodontitis (Mean PAL)
chrX	133125790	133125791	Relative hand skill
chrX	133322603	133322604	Response to anti-TNF alpha therapy in inflammatory bowel disease
chrX	136055294	136055295	Coronary heart disease
chrX	138117408	138117409	Response to taxane treatment (placlitaxel)
chrX	139166682	139166683	Bipolar disorder and schizophrenia
chrX	139314055	139314056	Bipolar disorder and schizophrenia
chrX	141360570	141360571	Antineutrophil cytoplasmic antibody-associated vasculitis
chrX	144141318	144141319	Bipolar disorder and schizophrenia
chrX	145748907	145748908	Immune reponse to smallpox (secreted IFN-alpha)
chrX	146322622	146322623	Coronary heart disease
chrX	147042773	147042774	Antineutrophil cytoplasmic antibody-associated vasculitis
chrX	147324255	147324256	Response to acetaminophen (hepatotoxicity)
chrX	147381020	147381021	Schizophrenia
chrX	148567450	148567451	Cognitive performance
chrX	149635294	149635295	Immune reponse to smallpox (secreted IFN-alpha)
chrX	151655561	151655562	Cognitive performance
chrX	152862637	152862638	Type 2 diabetes
chrX	152899921	152899922	Type 2 diabetes
chrX	152899921	152899922	Type 2 diabetes
chrX	152899921	152899922	Type 2 diabetes
chrX	153006494	153006495	Bipolar disorder and schizophrenia
chrX	153207544	153207545	Schizophrenia
chrX	153554403	153554404	Bilirubin levels
chrX	153764216	153764217	Red blood cell traits
chrX	153764216	153764217	Red blood cell traits
chrX	153764216	153764217	Red blood cell traits
chrX	153764216	153764217	Red blood cell traits
chrX	153764216	153764217	Red blood cell traits
chrX	153764662	153764663	Red blood cell traits
chrX	153764662	153764663	Red blood cell traits
chrX	153764662	153764663	Red blood cell traits
chrX	153945601	153945602	Type 1 diabetes
chrX	154014106	154014107	Hematology traits
chrX	154014106	154014107	Mean corpuscular volume
chrX	154233773	154233774	Antineutrophil cytoplasmic antibody-associated vasculitis
